{
 "cells": [
  {
   "cell_type": "markdown",
   "id": "ca010aa1",
   "metadata": {},
   "source": [
    "# **GenAI Medical_Chatbot**"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 1,
   "id": "e23fbf59",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "ok\n"
     ]
    }
   ],
   "source": [
    "#\n",
    "print(\"ok\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'d:\\\\PRACTICE ON PYTHON\\\\GenerativeAI practice & projects\\\\GenAI_End_To_End_Medical_Chatbot\\\\research'"
      ]
     },
     "execution_count": 2,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Project working directory \n",
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "id": "8f426e2c",
   "metadata": {},
   "outputs": [],
   "source": [
    "# \n",
    "import os\n",
    "os.chdir(\"../.\")"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 4,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "'d:\\\\PRACTICE ON PYTHON\\\\GenerativeAI practice & projects\\\\GenAI_End_To_End_Medical_Chatbot'"
      ]
     },
     "execution_count": 4,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# \n",
    "%pwd"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "extracted_data\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 0, 'page_label': '1'}, page_content=''),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 1, 'page_label': '2'}, page_content=\"INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   1 \\n \\nCHAPTER 06 \\nMental, behavioural or neurodevelopmental \\ndisorders \\nThis chapter has 161 four-character categories. \\nCode range starts with 6A00 \\nMental, behavioural and neurodevelopmental disorders are syndromes characterized by c linically \\nsignificant disturbance in an individual's cognition, emotional regulation, or b ehaviour that reflects a \\ndysfunction in the psychological, biological, or developmental processes that un derlie mental and \\nbehavioural functioning. These disturbances are usually associated with distres s or impairment in \\npersonal, family, social, educational, occupational, or other important areas of functioning. \\nExclusions: Acute stress reaction (QE84) \\nUncomplicated bereavement (QE62) \\nCoded Elsewhere: Sleep-wake disorders (7A00-7B2Z) \\nSexual dysfunctions (HA00-HA0Z) \\nGender incongruence (HA60-HA6Z) \\nThis chapter contains the following top level blocks: \\n\\uf0b7 Neurodevelopmental disorders \\n\\uf0b7 Schizophrenia or other primary psychotic disorders \\n\\uf0b7 Catatonia \\n\\uf0b7 Mood disorders \\n\\uf0b7 Anxiety or fear-related disorders \\n\\uf0b7 Obsessive-compulsive or related disorders \\n\\uf0b7 Disorders specifically associated with stress \\n\\uf0b7 Dissociative disorders \\n\\uf0b7 Feeding or eating disorders \\n\\uf0b7 Elimination disorders \\n\\uf0b7 Disorders of bodily distress or bodily experience \\n\\uf0b7 Disorders due to substance use or addictive behaviours \\n\\uf0b7 Impulse control disorders \\n\\uf0b7 Disruptive behaviour or dissocial disorders \\n\\uf0b7 Personality disorders and related traits \\n\\uf0b7 Paraphilic disorders \\n\\uf0b7 Factitious disorders \\n\\uf0b7 Neurocognitive disorders\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 2, 'page_label': '3'}, page_content='2  ICD-11 MMS - 2018 \\n \\n\\uf0b7 Mental or behavioural disorders associated with pregnancy, childbirth and the puerperium \\n\\uf0b7 Secondary mental or behavioural syndromes associated with disorders or diseases classif ied \\nelsewhere \\n \\nNeurodevelopmental disorders (BlockL1‑6A0) \\nNeurodevelopmental disorders are behavioural and cognitive disorders that arise during th e \\ndevelopmental period that involve significant difficulties in the acquis ition and execution of specific \\nintellectual, motor, or social functions. Although behavioural and cognitive defic its are present in many \\nmental and behavioural disorders that can arise during the developmental period (e.g., Schiz ophrenia, \\nBipolar disorder), only disorders whose core features are neurodevelopmental are include d in this \\ngrouping. The presumptive etiology for neurodevelopmental disorders is complex, and i n many \\nindividual cases is unknown. \\nCoded Elsewhere: Primary tics or tic disorders (8A05.0) \\nSecondary neurodevelopmental syndrome (6E60) \\n  6A00   Disorders of intellectual development \\nDisorders of intellectual development are a group of etiologically diverse conditions  \\noriginating during the developmental period characterized by significantly be low \\naverage intellectual functioning and adaptive behavior that are approximately two or \\nmore standard deviations below the mean (approximately less than the 2.3rd \\npercentile), based on appropriately normed, individually administered standard ized \\ntests. Where appropriately normed and standardized tests are not available, \\ndiagnosis of disorders of intellectual development requires greater reliance on \\nclinical judgment based on appropriate assessment of comparable behavioural \\nindicators. \\nNote: Use additional code, if desired, to identify any known aetiology. \\n \\n6A00.0 Disorder of intellectual development, mild \\nA mild disorder of intellectual development is a condition originating dur ing the \\ndevelopmental period characterized by significantly below average intellect ual \\nfunctioning and adaptive behaviour that are approximately two to three standard \\ndeviations below the mean (approximately 0.1 – 2.3 percentile), based on \\nappropriately normed, individually administered standardized tests or by \\ncomparable behavioural indicators when standardized testing is unavailab le. \\nAffected persons often exhibit difficulties in the acquisition and comprehensio n of \\ncomplex language concepts and academic skills. Most master basic self-care, \\ndomestic, and practical activities. Persons affected by a mild disorder of intellec tual \\ndevelopment can generally achieve relatively independent living and employme nt \\nas adults but may require appropriate support.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 3, 'page_label': '4'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   3 \\n \\n6A00.1 Disorder of intellectual development, moderate \\nA moderate disorder of intellectual development is a condition originating during  the \\ndevelopmental period characterized by significantly below average intellect ual \\nfunctioning and adaptive behaviour that are approximately three to four standard \\ndeviations below the mean (approximately 0.003 – 0.1 percentile), based on \\nappropriately normed, individually administered standardized tests or by \\ncomparable behavioural indicators when standardized testing is unavailab le. \\nLanguage and capacity for acquisition of academic skills of persons affected by a \\nmoderate disorder of intellectual development vary but are generally limited t o basic \\nskills. Some may master basic self-care, domestic, and practical activities. Mos t \\naffected persons require considerable and consistent support in order to achieve \\nindependent living and employment as adults. \\n \\n6A00.2 Disorder of intellectual development, severe \\nA severe disorder of intellectual development is a condition originating during the \\ndevelopmental period characterized by significantly below average intellect ual \\nfunctioning and adaptive behaviour that are approximately four of more standard  \\ndeviations below the mean (less than approximately the 0.003rd percentile), based \\non appropriately normed, individually administered standardized tests or by  \\ncomparable behavioural indicators when standardized testing is unavailab le. \\nAffected persons exhibit very limited language and capacity for acquisit ion of \\nacademic skills. They may also have motor impairments and typicall y require daily \\nsupport in a supervised environment for adequate care, but may acquire basic sel f-\\ncare skills with intensive training. Severe and profound disorders of intellectual \\ndevelopment are differentiated exclusively on the basis of adaptive behaviour \\ndifferences because existing standardized tests of intelligence cannot reliably or \\nvalidly distinguish among individuals with intellectual functioning below the 0.003rd \\npercentile. \\n \\n6A00.3 Disorder of intellectual development, profound \\nA profound disorder of intellectual development is a condition originatin g during the \\ndevelopmental period characterized by significantly below average intellect ual \\nfunctioning and adaptive behaviour that are approximately four of more standard  \\ndeviations below the mean (approximately less than the 0.003rd percentile), based  \\non individually administered appropriately normed, standardized tests or by  \\ncomparable behavioural indicators when standardized testing is unavailab le. \\nAffected persons possess very limited communication abilities and capac ity for \\nacquisition of academic skills is restricted to basic concrete skill s. They may also \\nhave co-occurring motor and sensory impairments and typically require daily \\nsupport in a supervised environment for adequate care. Severe and profound \\ndisorders of intellectual development are differentiated exclusively on the basis  of \\nadaptive behaviour differences because existing standardized tests of intelligenc e \\ncannot reliably or validly distinguish among individuals with intellectual functioning \\nbelow the 0.003rd percentile.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 4, 'page_label': '5'}, page_content='4  ICD-11 MMS - 2018 \\n \\n6A00.4 Disorder of intellectual development, provisional \\nDisorder of intellectual development, provisional is assigned when there is evidence \\nof a disorder of intellectual development but the individual is an infant or child under \\nthe age of four or it is not possible to conduct a valid assessment of intellectual \\nfunctioning and adaptive behaviour because of sensory or physical impairm ents \\n(e.g., blindness, pre-lingual deafness), locomotor disability, severe problem \\nbehaviours or co-occurring mental and behavioural disorders. \\n \\n6A00.Z Disorders of intellectual development, unspecified \\n \\n  6A01   Developmental speech or language disorders \\nDevelopmental speech or language disorders arise during the developmental period \\nand are characterized by difficulties in understanding or producing speech and \\nlanguage or in using language in context for the purposes of communication that \\nare outside the limits of normal variation expected for age and level of intellec tual \\nfunctioning. The observed speech and language problems are not attributable to \\nsocial or cultural factors (e.g., regional dialects) and are not fully explained b y \\nanatomical or neurological abnormalities. The presumptive etiology for \\nDevelopmental speech or language disorders is complex, and in many individual \\ncases is unknown. \\n \\n6A01.0 Developmental speech sound disorder \\nDevelopmental speech sound disorder is characterized by difficulties in the \\nacquisition, production and perception of speech that result in errors of \\npronunciation, either in number or types of speech errors made or the overall qualit y \\nof speech production, that are outside the limits of normal variation expected for age \\nand level of intellectual functioning and result in reduced intelligibi lity and \\nsignificantly affect communication. The errors in pronunciation arise during the early \\ndevelopmental period and cannot be explained by social, cultural, and other \\nenvironmental variations (e.g., regional dialects). The speech errors are not full y \\nexplained by a hearing impairment or a structural or neurological abnormality. \\nInclusions: Functional speech articulation disorder \\nExclusions: Deafness not otherwise specified (AB52) \\nDiseases of the nervous system (chapter 08) \\nDysarthria (MA80.2) \\n \\n6A01.1 Developmental speech fluency disorder \\nDevelopmental speech fluency disorder is characterized by persistent and frequ ent \\nor pervasive disruption of the rhythmic flow of speech that arises during the  \\ndevelopmental period and is outside the limits of normal variation expected for age \\nand level of intellectual functioning and results in reduced intelligibil ity and \\nsignificantly affects communication. It can involve repetitions of sounds , syllables or \\nwords, prolongations, word breaks, blockage of production, excessive use of \\ninterjections, and rapid short bursts of speech. \\nExclusions: Tic disorders (8A05)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 5, 'page_label': '6'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   5 \\n \\n6A01.2 Developmental language disorder \\nDevelopmental language disorder is characterized by persistent difficulties i n the \\nacquisition, understanding, production or use of language (spoken or signed), that \\narise during the developmental period, typically during early childhood, and cause \\nsignificant limitations in the individual ’s ability to communicate. The individual ’s \\nability to understand, produce or use language is markedly below what would be \\nexpected given the individual ’s age and level of intellectual functioning. The \\nlanguage deficits are not explained by another neurodevelopmental disorder or a \\nsensory impairment or neurological condition, including the effects of brain i njury or \\ninfection. \\nExclusions: Autism spectrum disorder (6A02) \\nDiseases of the nervous system (chapter 08) \\nDeafness not otherwise specified (AB52) \\nSelective mutism (6B06) \\n \\n6A01.20 Developmental language disorder with impairment of receptive and expressive \\nlanguage \\nDevelopmental language disorder with impairment of receptive and expressive \\nlanguage is characterized by persistent difficulties in the acquisition, unde rstanding, \\nproduction, and use of language that arise during the developmental period, \\ntypically during early childhood, and cause significant limitations in the individual ’s \\nability to communicate. The ability to understand spoken or signed language (i.e., \\nreceptive language) is markedly below the expected level given the individual ’s age \\nand level of intellectual functioning, and is accompanied by persistent impairment in \\nthe ability to produce and use spoken or signed language (i.e., expressive \\nlanguage). \\nInclusions: developmental dysphasia or aphasia, receptive type \\ndevelopmental Wernicke aphasia \\nExclusions: acquired aphasia with epilepsy [Landau-Kleffner] (8A62.2) \\nAutism spectrum disorder (6A02) \\nSelective mutism (6B06) \\ndysphasia NOS (MA80.1) \\nDiseases of the nervous system (chapter 08) \\nDeafness not otherwise specified (AB52)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 6, 'page_label': '7'}, page_content='6  ICD-11 MMS - 2018 \\n \\n6A01.21 Developmental language disorder with impairment of mainly expressive language  \\nDevelopmental language disorder with impairment of mainly expressive language is  \\ncharacterized by persistent difficulties in the acquisition, production, and use of \\nlanguage that arise during the developmental period, typically during early \\nchildhood, and cause significant limitations in the individual ’s ability to \\ncommunicate. The ability to produce and use spoken or signed language (i. e., \\nexpressive language) is markedly below the expected level given the indi vidual’s \\nage and level of intellectual functioning, but the ability to understand spoken  or \\nsigned language (i.e., receptive language) is relatively intact. \\nInclusions: Developmental dysphasia or aphasia, expressive type \\nExclusions: acquired aphasia with epilepsy [Landau-Kleffner] (8A62.2) \\nSelective mutism (6B06) \\ndysphasia and aphasia: developmental, receptive type \\n(6A01.20) \\ndysphasia NOS (MA80.1) \\naphasia NOS (MA80.0) \\nDiseases of the nervous system (chapter 08) \\nDeafness not otherwise specified (AB52) \\n \\n6A01.22 Developmental language disorder with impairment of mainly pragmatic language  \\nDevelopmental language disorder with impairment of mainly pragmatic language is \\ncharacterized by persistent and marked difficulties with the understanding and  use \\nof language in social contexts, for example making inferences, understanding verbal \\nhumour, and resolving ambiguous meaning. These difficulties arise during the \\ndevelopmental period, typically during early childhood, and cause signifi cant \\nlimitations in the individual ’s ability to communicate. Pragmatic language abilities \\nare markedly below the expected level given the individual ’s age and level of \\nintellectual functioning, but the other components of receptive and expressiv e \\nlanguage are relatively intact. This qualifier should not be used if the pragmatic \\nlanguage impairment is better explained by Autism Spectrum Disorder or by \\nimpairments in other components of receptive or expressive language. \\nExclusions: Autism spectrum disorder (6A02) \\nDiseases of the nervous system (chapter 08) \\nSelective mutism (6B06)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 7, 'page_label': '8'}, page_content=\"INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   7 \\n \\n6A01.23 Developmental language disorder, with other specified language impairment  \\nDevelopmental language disorder with other specified language impairment is \\ncharacterized by persistent difficulties in the acquisition, understanding, pro duction \\nor use of language (spoken or signed), that arise during the developmental period \\nand cause significant limitations in the individual ’s ability to communicate. The \\npattern of specific deficits in language abilities is not adequately cap tured by any of \\nthe other developmental language disorder categories. \\nExclusions: Autism spectrum disorder (6A02) \\nDiseases of the nervous system (chapter 08) \\nDisorders of intellectual development (6A00) \\nSelective mutism (6B06) \\n \\n6A01.Y Other specified developmental speech or language disorders \\n \\n6A01.Z Developmental speech or language disorders, unspecified \\n \\n  6A02   Autism spectrum disorder \\nAutism spectrum disorder is characterized by persistent deficits in the a bility to \\ninitiate and to sustain reciprocal social interaction and social communication, and  by \\na range of restricted, repetitive, and inflexible patterns of behaviour and i nterests. \\nThe onset of the disorder occurs during the developmental period, typically  in early \\nchildhood, but symptoms may not become fully manifest until later, when social  \\ndemands exceed limited capacities. Deficits are sufficiently severe to cause \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning and are usually a pervasive feature of the individual ’s \\nfunctioning observable in all settings, although they may vary according to social, \\neducational, or other context. Individuals along the spectrum exhibit a full rang e of \\nintellectual functioning and language abilities. \\nInclusions: Autistic disorder \\nPervasive developmental delay \\nExclusions: Developmental language disorder (6A01.2) \\nSchizophrenia or other primary psychotic disorders \\n(BlockL1‑6A2) \\n \\n6A02.0 Autism spectrum disorder without disorder of intellectual development and \\nwith mild or no impairment of functional language \\nAll definitional requirements for autism spectrum disorder are met, intellectual  \\nfunctioning and adaptive behaviour are found to be at least within the average  \\nrange (approximately greater than the 2.3rd percentile), and there is only mild or no \\nimpairment in the individual's capacity to use functional language ( spoken or \\nsigned) for instrumental purposes, such as to express personal needs and desires. \\n \\n6A02.1 Autism spectrum disorder with disorder of intellectual development and with \\nmild or no impairment of functional language \\nAll definitional requirements for both autism spectrum disorder and disorder of \\nintellectual development are met and there is only mild or no impairment in the  \\nindividual's capacity to use functional language (spoken or signed) for instrumental \\npurposes, such as to express personal needs and desires.\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 8, 'page_label': '9'}, page_content='8  ICD-11 MMS - 2018 \\n \\n6A02.2 Autism spectrum disorder without disorder of intellectual development and \\nwith impaired functional language \\nAll definitional requirements for autism spectrum disorder are met, intellectual  \\nfunctioning and adaptive behaviour are found to be at least within the average  \\nrange (approximately greater than the 2.3rd percentile), and there is marked \\nimpairment in functional language (spoken or signed) relative to the individual ’s age, \\nwith the individual not able to use more than single words or simple phrases fo r \\ninstrumental purposes, such as to express personal needs and desires. \\n \\n6A02.3 Autism spectrum disorder with disorder of intellectual development and with \\nimpaired functional language \\nAll definitional requirements for both autism spectrum disorder and disorder of \\nintellectual development are met and there is marked impairment in functional \\nlanguage (spoken or signed) relative to the individual ’s age, with the individual not \\nable to use more than single words or simple phrases for instrumental purposes, \\nsuch as to express personal needs and desires. \\n \\n6A02.4 Autism spectrum disorder without disorder of intellectual development and \\nwith absence of functional language \\nAll definitional requirements for autism spectrum disorder are met, intellectual  \\nfunctioning and adaptive behaviour are found to be at least within the averag e \\nrange (approximately greater than the 2.3rd percentile), and there is complete, or \\nalmost complete, absence of ability relative to the individual ’s age to use functional \\nlanguage (spoken or signed) for instrumental purposes, such as to express \\npersonal needs and desires. \\n \\n6A02.5 Autism spectrum disorder with disorder of intellectual development and with \\nabsence of functional language \\nAll definitional requirements for both autism spectrum disorder and disorder of \\nintellectual development are met and there is complete, or almost complete, \\nabsence of ability relative to the individual ’s age to use functional language (spoken \\nor signed) for instrumental purposes, such as to express personal needs and \\ndesires \\n \\n6A02.Y Other specified autism spectrum disorder \\n \\n6A02.Z Autism spectrum disorder, unspecified \\n \\n  6A03   Developmental learning disorder \\nDevelopmental learning disorder is characterized by significant and persistent \\ndifficulties in learning academic skills, which may include reading, writing, or \\narithmetic. The individual ’s performance in the affected academic skill(s) is \\nmarkedly below what would be expected for chronological age and general level of \\nintellectual functioning, and results in significant impairment in the indiv idual’s \\nacademic or occupational functioning. Developmental learning disorder first \\nmanifests when academic skills are taught during the early school years. \\nDevelopmental learning disorder is not due to a disorder of intellectual \\ndevelopment, sensory impairment (vision or hearing), neurological or motor \\ndisorder, lack of availability of education, lack of proficiency in the lang uage of \\nacademic instruction, or psychosocial adversity. \\nExclusions: Symbolic dysfunctions (MB4B)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 9, 'page_label': '10'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   9 \\n \\n6A03.0 Developmental learning disorder with impairment in reading \\nDevelopmental learning disorder with impairment in reading is characterized by \\nsignificant and persistent difficulties in learning academic skills related to reading, \\nsuch as word reading accuracy, reading fluency, and reading comprehension. The \\nindividual’s performance in reading is markedly below what would be expected for \\nchronological age and level of intellectual functioning and results in signif icant \\nimpairment in the individual ’s academic or occupational functioning. Developmental \\nlearning disorder with impairment in reading is not due to a disorder of intellect ual \\ndevelopment, sensory impairment (vision or hearing), neurological disorder, l ack of \\navailability of education, lack of proficiency in the language of academic i nstruction, \\nor psychosocial adversity. \\nInclusions: Developmental dyslexia \\nExclusions: Disorders of intellectual development (6A00) \\n \\n6A03.1 Developmental learning disorder with impairment in written expression \\nDevelopmental learning disorder with impairment in written expression is \\ncharacterized by significant and persistent difficulties in learning academic  skills \\nrelated to writing, such as spelling accuracy, grammar and punctuation accuracy, \\nand organization and coherence of ideas in writing. The individual ’s performance in \\nwritten expression is markedly below what would be expected for chronological age \\nand level of intellectual functioning and results in significant impair ment in the \\nindividual’s academic or occupational functioning. Developmental learning disorder \\nwith impairment in written expression is not due to a disorder of intellectual \\ndevelopment, sensory impairment (vision or hearing), a neurological or motor \\ndisorder, lack of availability of education, lack of proficiency in the lang uage of \\nacademic instruction, or psychosocial adversity. \\nExclusions: Disorders of intellectual development (6A00) \\n \\n6A03.2 Developmental learning disorder with impairment in mathematics \\nDevelopmental learning disorder with impairment in mathematics is characterized  \\nby significant and persistent difficulties in learning academic ski lls related to \\nmathematics or arithmetic, such as number sense, memorization of number facts , \\naccurate calculation, fluent calculation, and accurate mathematic reasoning. The \\nindividual’s performance in mathematics or arithmetic is markedly below what would \\nbe expected for chronological or developmental age and level of intellectual \\nfunctioning and results in significant impairment in the individual ’s academic or \\noccupational functioning. Developmental learning disorder with impairment in \\nmathematics is not due to a disorder of intellectual development, sensory \\nimpairment (vision or hearing), a neurological disorder, lack of availability of \\neducation, lack of proficiency in the language of academic instruction, or \\npsychosocial adversity. \\nExclusions: Disorders of intellectual development (6A00)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 10, 'page_label': '11'}, page_content=\"10  ICD-11 MMS - 2018 \\n \\n6A03.3 Developmental learning disorder with other specified impairment of learning  \\nDevelopmental learning disorder with other specified impairment of learning is \\ncharacterized by significant and persistent difficulties in learning academic  skills \\nother than reading, mathematics, and written expression. The individual ’s \\nperformance in the relevant academic skill is markedly below what would be \\nexpected for chronological age and level of intellectual functioning and results  in \\nsignificant impairment in the individual ’s academic or occupational functioning. \\nDevelopmental learning disorder with other specified impairment of learning is no t \\ndue to a disorder of intellectual development, sensory impairment (vision or \\nhearing), neurological disorder, lack of availability of education, lack of profic iency in \\nthe language of academic instruction, or psychosocial adversity. \\nExclusions: Disorders of intellectual development (6A00) \\n \\n6A03.Z Developmental learning disorder, unspecified \\n \\n  6A04   Developmental motor coordination disorder \\nDevelopmental motor coordination disorder is characterized by a significant d elay in \\nthe acquisition of gross and fine motor skills and impairment in the executio n of \\ncoordinated motor skills that manifest in clumsiness, slowness, or inaccurac y of \\nmotor performance. Coordinated motor skills are substantially below that expected \\ngiven the individual's chronological age and level of intellectual functioning . Onset of \\ncoordinated motor skills difficulties occurs during the developmental period a nd is \\ntypically apparent from early childhood. Coordinated motor skills difficulti es cause \\nsignificant and persistent limitations in functioning (e.g., in activities  of daily living, \\nschool work, and vocational and leisure activities). Difficulties with coor dinated \\nmotor skills are not solely attributable to a Disease of the Nervous System, Disease \\nof the Musculoskeletal System or Connective Tissue, sensory impairment, and not \\nbetter explained by a Disorder of Intellectual Development. \\nExclusions: Abnormalities of gait and mobility (MB44) \\nDiseases of the musculoskeletal system or connective tissue \\n(chapter 15) \\nDiseases of the nervous system (chapter 08)\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 11, 'page_label': '12'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   11 \\n \\n  6A05   Attention deficit hyperactivity disorder \\nAttention deficit hyperactivity disorder is characterized by a persistent patter n (at \\nleast 6 months) of inattention and/or hyperactivity-impulsivity, with onset du ring the \\ndevelopmental period, typically early to mid-childhood. The degree of inattention \\nand hyperactivity-impulsivity is outside the limits of normal variation ex pected for \\nage and level of intellectual functioning and significantly interferes with academic, \\noccupational, or social functioning. Inattention refers to significant difficul ty in \\nsustaining attention to tasks that do not provide a high level of stimulation  or \\nfrequent rewards, distractibility and problems with organization. Hyperactivit y refers \\nto excessive motor activity and difficulties with remaining still, most evi dent in \\nstructured situations that require behavioural self-control. Impulsivity is a ten dency \\nto act in response to immediate stimuli, without deliberation or consideration of  the \\nrisks and consequences. The relative balance and the specific manifestations  of \\ninattentive and hyperactive-impulsive characteristics varies across indiv iduals, and \\nmay change over the course of development. In order for a diagnosis of disorder the \\nbehaviour pattern must be clearly observable in more than one setting. \\nInclusions: attention deficit disorder with hyperactivity \\nattention deficit syndrome with hyperactivity \\nExclusions: Autism spectrum disorder (6A02) \\nDisruptive behaviour or dissocial disorders (BlockL1‑6C9) \\n \\n6A05.0 Attention deficit hyperactivity disorder, predominantly inattentive \\npresentation \\nAll definitional requirements for attention deficit hyperactivity disorder are met and \\ninattentive symptoms are predominant in the clinical presentation. Inattentio n refers \\nto significant difficulty in sustaining attention to tasks that do not provi de a high level \\nof stimulation or frequent rewards, distractibility and problems with organization. \\nSome hyperactive-impulsive symptoms may also be present, but these are not \\nclinically significant in relation to the inattentive symptoms. \\n \\n6A05.1 Attention deficit hyperactivity disorder, predominantly hyperactive-impulsive \\npresentation \\nAll definitional requirements for attention deficit hyperactivity disorder are met and \\nhyperactive-impulsive symptoms are predominant in the clinical presentation. \\nHyperactivity refers to excessive motor activity and difficulties with remai ning still, \\nmost evident in structured situations that require behavioural self-control. Impu lsivity \\nis a tendency to act in response to immediate stimuli, without deliberation or \\nconsideration of the risks and consequences. Some inattentive symptoms ma y also \\nbe present, but these are not clinically significant in relation to the hyperac tive-\\nimpulsive symptoms.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 12, 'page_label': '13'}, page_content='12  ICD-11 MMS - 2018 \\n \\n6A05.2 Attention deficit hyperactivity disorder, combined presentation \\nAll definitional requirements for attention deficit hyperactivity disorder are met. Both \\ninattentive and hyperactive-impulsive symptoms are clinically signi ficant, with \\nneither predominating in the clinical presentation. Inattention refers to signific ant \\ndifficulty in sustaining attention to tasks that do not provide a high level of \\nstimulation or frequent rewards, distractibility and problems with organization. \\nHyperactivity refers to excessive motor activity and difficulties with remai ning still, \\nmost evident in structured situations that require behavioural self-control. Impu lsivity \\nis a tendency to act in response to immediate stimuli, without deliberation or \\nconsideration of the risks and consequences. \\n \\n6A05.Y Attention deficit hyperactivity disorder, other specified presentation \\n \\n6A05.Z Attention deficit hyperactivity disorder, presentation unspecified \\n \\n  6A06   Stereotyped movement disorder \\nStereotyped movement disorder is characterized by voluntary, repetitive, \\nstereotyped, apparently purposeless (and often rhythmic) movements that arise \\nduring the early developmental period, are not caused by the direct physiologi cal \\neffects of a substance or medication (including withdrawal), and markedly inte rfere \\nwith normal activities or result in self-inflicted bodily injury. Stereoty ped movements \\nthat are non-injurious can include body rocking, head rocking, finger-flicki ng \\nmannerisms, and hand flapping. Stereotyped self-injurious behaviours can incl ude \\nrepetitive head banging, face slapping, eye poking, and biting of the hands, l ips, or \\nother body parts. \\nExclusions: Tic disorders (8A05) \\nTrichotillomania (6B25.0) \\nAbnormal involuntary movements (MB46) \\n \\n6A06.0 Stereotyped movement disorder without self-injury \\nThis category should be applied to forms of Stereotyped movement disorder in \\nwhich stereotyped behaviours markedly interfere with normal activities, but do not \\nresult in self-inflicted bodily injury. Stereotyped movement disorder without s elf-\\ninjury is characterized by voluntary, repetitive, stereotyped, apparently purpos eless \\n(and often rhythmic) movements that arise during the early developmental period, \\nare not caused by the direct physiological effects of a substance or medication \\n(including withdrawal), and markedly interfere with normal activities. Stereotyp ed \\nmovements that are non-injurious can include body rocking, head rocking, finger-\\nflicking mannerisms, and hand flapping. \\n \\n6A06.1 Stereotyped movement disorder with self-injury \\nThis category should be applied to forms of Stereotyped movement disorder in \\nwhich stereotyped behaviours result in self-inflicted bodily injury that is s ignificant \\nenough to require medical treatment, or would result in such injury if protective \\nmeasures (e.g., helmet to prevent head injury) were not employed. Stereotyped \\nmovement disorder with self-injury is characterized by voluntary, repetitive,  \\nstereotyped, apparently purposeless (and often rhythmic) movements that arise \\nduring the early developmental period, are not caused by the direct physiologi cal \\neffects of a substance or medication (including withdrawal). Stereotyped \\nmovements that are self-injurious can include head banging, face slapping, ey e \\npoking, and biting of the hands, lips, or other body parts.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 13, 'page_label': '14'}, page_content=\"INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   13 \\n \\n6A06.Z Stereotyped movement disorder, unspecified \\n \\n  6A0Y   Other specified neurodevelopmental disorders \\n \\n  6A0Z   Neurodevelopmental disorders, unspecified \\n \\nSchizophrenia or other primary psychotic disorders (BlockL1‑6A2) \\nSchizophrenia and other primary psychotic disorders are characterized by signif icant impairments in \\nreality testing and alterations in behavior manifest in positive symptoms such as persistent delusions, \\npersistent hallucinations, disorganized thinking (typically manifest as disorganized speech), grossly \\ndisorganized behavior, and experiences of passivity and control, negative sy mptoms such as blunted \\nor flat affect and avolition, and psychomotor disturbances. The symptoms occur with suf ficient \\nfrequency and intensity to deviate from expected cultural or subcultural norms. These symptoms do \\nnot arise as a feature of another mental and behavioural disorder (e.g., a mood disorder , delirium, or \\na disorder due to substance use). The categories in this grouping should not be used to classify the \\nexpression of ideas, beliefs, or behaviours that are culturally sanctioned. \\nCoded Elsewhere: Substance-induced psychotic disorders \\nSecondary psychotic syndrome (6E61) \\n  6A20   Schizophrenia \\nSchizophrenia is characterized by disturbances in multiple mental modalities, \\nincluding thinking (e.g., delusions, disorganization in the form of thought), \\nperception (e.g., hallucinations), self-experience (e.g., the experience that on e's \\nfeelings, impulses, thoughts, or behaviour are under the control of an external \\nforce), cognition (e.g., impaired attention, verbal memory, and social cognition) , \\nvolition (e.g., loss of motivation), affect (e.g., blunted emotional expression), an d \\nbehaviour (e.g.,behaviour that appears bizarre or purposeless, unpredictable or \\ninappropriate emotional responses that interfere with the organization of behaviour). \\nPsychomotor disturbances, including catatonia, may be present. Persistent \\ndelusions, persistent hallucinations, thought disorder, and experiences of inf luence, \\npassivity, or control are considered core symptoms. Symptoms must have pers isted \\nfor at least one month in order for a diagnosis of schizophrenia to be assigned. The  \\nsymptoms are not a manifestation of another health condition (e.g., a brain tumour) \\nand are not due to the effect of a substance or medication on the central nervous \\nsystem (e.g., corticosteroids), including withdrawal (e.g., alcohol withdrawal). \\nExclusions: Schizotypal disorder (6A22) \\nschizophrenic reaction (6A22) \\nAcute and transient psychotic disorder (6A23) \\n \\n6A20.0 Schizophrenia, first episode \\nSchizophrenia, first episode should be used to identify individuals experi encing \\nsymptoms that meet the diagnostic requirements for Schizophrenia (including \\nduration) but who have never before experienced an episode during which \\ndiagnostic requirements for Schizophrenia were met. \\n \\n6A20.00 Schizophrenia, first episode, currently symptomatic \\nAll definitional requirements for Schizophrenia, first episode in terms  of symptoms \\nand duration are currently met, or have been met within the past one month.\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 14, 'page_label': '15'}, page_content='14  ICD-11 MMS - 2018 \\n \\n6A20.01 Schizophrenia, first episode, in partial remission \\nAll definitional requirements for Schizophrenia, first episode in terms  of symptoms \\nand duration were previously met. Symptoms have ameliorated such that the \\ndiagnostic requirements for the disorder have not been met for at least one month, \\nbut some clinically significant symptoms remain, which may or may not  be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A20.02 Schizophrenia, first episode, in full remission \\nAll definitional requirements for Schizophrenia, first episode in terms  of symptoms \\nand duration were previously met. Symptoms have ameliorated such that no \\nsignificant symptoms remain. The remission may have occurred in res ponse to \\nmedication or other treatment. \\n \\n6A20.0Z Schizophrenia, first episode, unspecified \\n \\n6A20.1 Schizophrenia, multiple episodes \\nSchizophrenia, multiple episode should be used to identify individuals exp eriencing \\nsymptoms that meet the diagnostic requirements for Schizophrenia (including \\nduration) and who have also previously experienced episodes during which \\ndiagnostic requirements were met, with substantial remission of symptoms between \\nepisodes. Some attenuated symptoms may remain during periods of remission, and \\nremissions may have occurred in response to medication or other treatment. \\n \\n6A20.10 Schizophrenia, multiple episodes, currently symptomatic \\nAll definitional requirements for Schizophrenia, multiple episodes in terms  of \\nsymptoms and duration are currently met, or have been met within the past one \\nmonth. \\n \\n6A20.11 Schizophrenia, multiple episodes, in partial remission \\nAll definitional requirements for Schizophrenia, multiple episodes in terms  of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nthe diagnostic requirements for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or ma y not be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A20.12 Schizophrenia, multiple episodes, in full remission \\nAll definitional requirements for Schizophrenia, multiple episodes in terms  of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nno significant symptoms remain. The remission may have occurred in res ponse to \\nmedication or other treatment. \\n \\n6A20.1Z Schizophrenia, multiple episodes, unspecified \\n \\n6A20.2 Schizophrenia, continuous \\nSymptoms fulfilling all definitional requirements of Schizophrenia have been present \\nfor almost all of the illness course over a period of at least one year, with periods of \\nsubthreshold symptoms being very brief relative to the overall course.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 15, 'page_label': '16'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   15 \\n \\n6A20.20 Schizophrenia, continuous, currently symptomatic \\nAll definitional requirements for Schizophrenia, continuous in terms of sy mptoms \\nand duration are currently met, or have been met within the past one month. \\n \\n6A20.21 Schizophrenia, continuous, in partial remission \\nAll definitional requirements for Schizophrenia, continuous in terms of sy mptoms \\nand duration were previously met. Symptoms have ameliorated such that the \\ndiagnostic requirements for the disorder have not been met for at least one month, \\nbut some clinically significant symptoms remain, which may or may not  be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A20.22 Schizophrenia, continuous, in full remission \\nAll definitional requirements for Schizophrenia, continuous in terms of sy mptoms \\nand duration were previously met. Symptoms have ameliorated such that no \\nsignificant symptoms remain. The remission may have occurred in res ponse to \\nmedication or other treatment. \\n \\n6A20.2Z Schizophrenia, continuous, unspecified \\n \\n6A20.Y Other specified schizophrenia \\n \\n6A20.Z Schizophrenia, unspecified \\n \\n  6A21   Schizoaffective disorder \\nSchizoaffective disorder is an episodic disorder in which the diagnostic \\nrequirements of schizophrenia and a manic, mixed, or moderate or severe \\ndepressive episode are met within the same episode of illness, either \\nsimultaneously or within a few days of each other. Prominent symptoms of \\nschizophrenia (e.g. delusions, hallucinations, disorganization in the form of thought, \\nexperiences of influence, passivity and control) are accompanied by typi cal \\nsymptoms of a depressive episode (e.g. depressed mood, loss of interest, reduced \\nenergy), a manic episode (e.g., elevated mood, increase in the quality and sp eed of \\nphysical and mental activity) or a mixed episode. Psychomotor disturbances , \\nincluding catatonia, may be present. Symptoms must have persisted for at least one  \\nmonth. The symptoms are not a manifestation of another health condition (e.g., a \\nbrain tumor) and are not due to the effect of a substance or medication on the \\ncentral nervous system (e.g., corticosteroids), including withdrawal (e.g., alcoh ol \\nwithdrawal). \\n \\n6A21.0 Schizoaffective disorder, first episode \\nSchizoaffective disorder, first episode should be used to identify individual s \\nexperiencing symptoms that meet the diagnostic requirements for Schizoaffective  \\ndisorder (including duration) but who have never before experienced an episode \\nduring which diagnostic requirements for Schizoaffective disorder or Schi zophrenia \\nwere met. \\n \\n6A21.00 Schizoaffective disorder, first episode, currently symptomatic \\nAll definitional requirements for Schizoaffective disorder, first episode  in terms of \\nsymptoms and duration are currently met, or have been met within the past one \\nmonth.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 16, 'page_label': '17'}, page_content='16  ICD-11 MMS - 2018 \\n \\n6A21.01 Schizoaffective disorder, first episode, in partial remission \\nAll definitional requirements for Schizoaffective disorder, first episode  in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such th at \\nthe diagnostic requirements for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or ma y not be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A21.02 Schizoaffective disorder, first episode, in full remission \\nAll definitional requirements for Schizoaffective disorder, first episode  in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nno significant symptoms remain. The remission may have occurred in res ponse to \\nmedication or other treatment. \\n \\n6A21.0Z Schizoaffective disorder, first episode, unspecified \\n \\n6A21.1 Schizoaffective disorder, multiple episodes \\nSchizoaffective disorder, multiple episodes should be used to identify indiv iduals \\nexperiencing symptoms that meet the diagnostic requirements for Schizoaffective  \\ndisorder (including duration) and who have also previously experienced episodes  \\nduring which diagnostic requirements for Schizoaffective disorder or Schi zophrenia \\nwere met, with substantial remission of symptoms between episodes. Some \\nattenuated symptoms may remain during period of remission, and remissions may \\nhave occurred in response to medication or other treatment. \\n \\n6A21.10 Schizoaffective disorder, multiple episodes, currently symptomatic \\nAll definitional requirements for Schizoaffective disorder, multiple episod es in terms \\nof symptoms and duration are currently met, or have been met within the past one \\nmonth. \\n \\n6A21.11 Schizoaffective disorder, multiple episodes, in partial remission \\nAll definitional requirements for Schizoaffective disorder, multiple episod es in terms \\nof symptoms and duration were previously met. Symptoms have ameliorated such \\nthat the diagnostic requirements for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or ma y not be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A21.12 Schizoaffective disorder, multiple episodes, in full remission \\nAll definitional requirements for Schizoaffective disorder, multiple episod es in terms \\nof symptoms and duration were previously met. Symptoms have ameliorated such \\nthat no significant symptoms remain. The remission may have occurred in r esponse \\nto medication or other treatment. \\n \\n6A21.1Z Schizoaffective disorder, multiple episodes, unspecified \\n \\n6A21.2 Schizoaffective disorder, continuous \\nSymptoms fulfilling all definitional requirements of Schizoaffective d isorder have \\nbeen present for almost all of the illness course over a period of at least one y ear, \\nwith periods of subthreshold symptoms being very brief relative to the overall \\ncourse.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 17, 'page_label': '18'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   17 \\n \\n6A21.20 Schizoaffective disorder, continuous, currently symptomatic \\nAll definitional requirements for Schizoaffective disorder, continuous in terms of \\nsymptoms and duration are currently met, or have been met within the past one \\nmonth. \\n \\n6A21.21 Schizoaffective disorder, continuous, in partial remission \\nAll definitional requirements for Schizoaffective disorder, continuous in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nthe diagnostic requirements for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or ma y not be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A21.22 Schizoaffective disorder, continuous, in full remission \\nAll definitional requirements for Schizoaffective disorder, continuous in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nno significant symptoms remain. The remission may have occurred in res ponse to \\nmedication or other treatment. \\n \\n6A21.2Z Schizoaffective disorder, continuous, unspecified \\n \\n6A21.Y Other specified schizoaffective disorder \\n \\n6A21.Z Schizoaffective disorder, unspecified \\n \\n  6A22   Schizotypal disorder \\nSchizotypal disorder is characterized by an enduring pattern (i.e., characteristi c of \\nthe person’s functioning over a period of at least several years) of eccentricities in \\nbehavior, appearance and speech, accompanied by cognitive and perceptual \\ndistortions, unusual beliefs, and discomfort with — and often reduced capacity for — \\ninterpersonal relationships. Symptoms may include constricted or inappropr iate \\naffect and anhedonia (negative schizotypy). Paranoid ideas, ideas of reference, or  \\nother psychotic symptoms, including hallucinations in any modality, may occur \\n(positive schizotypy), but are not of sufficient intensity or duration to meet the  \\ndiagnostic requirements of schizophrenia, schizoaffective disorder, or delusional \\ndisorder. The symptoms cause distress or impairment in personal, family, soc ial, \\neducational, occupational or other important areas of functioning. \\nInclusions: Schizotypal personality disorder \\nExclusions: Autism spectrum disorder (6A02) \\nPersonality disorder (6D10)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 18, 'page_label': '19'}, page_content='18  ICD-11 MMS - 2018 \\n \\n  6A23   Acute and transient psychotic disorder \\nAcute and transient psychotic disorder is characterized by acute onset of psych otic \\nsymptoms that emerge without a prodrome and reach their maximal severity within \\ntwo weeks. Symptoms may include delusions, hallucinations, disorganization of \\nthought processes, perplexity or confusion, and disturbances of affect and mood. \\nCatatonia-like psychomotor disturbances may be present. Symptoms typically \\nchange rapidly, both in nature and intensity, from day to day, or even  within a single \\nday. The duration of the episode does not exceed 3 months, and most commonly \\nlasts from a few days to 1 month. The symptoms are not a manifestation of anot her \\nhealth condition (e.g., a brain tumor) and are not due to the effect of a substance or  \\nmedication on the central nervous system (e.g., corticosteroids), including \\nwithdrawal (e.g., alcohol withdrawal). \\n \\n6A23.0 Acute and transient psychotic disorder, first episode \\nAcute and transient psychotic disorder, first episode should be used to iden tify \\nindividuals experiencing symptoms that meet the diagnostic requirements for acute \\nand transient psychotic disorder but who have never before experienced a sim ilar \\nepisode. \\n \\n6A23.00 Acute and transient psychotic disorder, first episode, currently symptomatic  \\nAll definitional requirements for Acute and transient psychotic disorder, first episode \\nin terms of symptoms and duration are currently met, or have been met within the  \\npast one month. \\n \\n6A23.01 Acute and transient psychotic disorder, first episode, in partial remission \\nAll definitional requirements for Acute and transient psychotic disorder, first episode \\nin terms of symptoms and duration were previously met. Symptoms have \\nameliorated such that the diagnostic requirements for the disorder have not been \\nmet for at least one month, but some clinically significant symptoms rem ain, which \\nmay or may not be associated with functional impairment. The partial remission may \\nhave occurred in response to medication or other treatment. \\n \\n6A23.02 Acute and transient psychotic disorder, first episode, in full remission \\nAll definitional requirements for Acute and transient psychotic disorder, first episode \\nin terms of symptoms and duration were previously met. Symptoms have \\nameliorated such that no significant symptoms remain. The remission may have \\noccurred in response to medication or other treatment. \\n \\n6A23.0Z Acute and transient psychotic disorder, first episode, unspecified \\n \\n6A23.1 Acute and transient psychotic disorder, multiple episodes \\nAcute and transient psychotic disorder, multiple episodes should be used to identify  \\nindividuals experiencing symptoms that meet the diagnostic requirements for acute \\nand transient psychotic disorder and who have experienced similar episodes in t he \\npast. \\n \\n6A23.10 Acute and transient psychotic disorder, multiple episodes, currently symptomatic  \\nAll definitional requirements for Acute and transient psychotic disorder, m ultiple \\nepisodes in terms of symptoms and duration are currently met, or have been met \\nwithin the past one month.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 19, 'page_label': '20'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   19 \\n \\n6A23.11 Acute and transient psychotic disorder, multiple episodes, in partial remission  \\nAll definitional requirements for Acute and transient psychotic disorder, m ultiple \\nepisodes in terms of symptoms and duration were previously met. Symptoms ha ve \\nameliorated such that the diagnostic requirements for the disorder have not been \\nmet for at least one month, but some clinically significant symptoms re main, which \\nmay or may not be associated with functional impairment. The partial remission may \\nhave occurred in response to medication or other treatment. \\n \\n6A23.12 Acute and transient psychotic disorder, multiple episodes, in full remission  \\nAll definitional requirements for Acute and transient psychotic disorder, m ultiple \\nepisodes in terms of symptoms and duration were previously met. Symptoms ha ve \\nameliorated such that no significant symptoms remain. The remission may hav e \\noccurred in response to medication or other treatment. \\n \\n6A23.1Z Acute and transient psychotic disorder, multiple episodes, unspecified \\n \\n6A23.Y Other specified acute and transient psychotic disorder \\n \\n6A23.Z Acute and transient psychotic disorder, unspecified \\n \\n  6A24   Delusional disorder \\nDelusional disorder is characterized by the development of a delusion or set of \\nrelated delusions that persist for at least 3 months (usually much longer), which \\noccur in the absence of a Depressive, Manic, or Mixed mood episode. Other \\ncharacteristic symptoms of Schizophrenia (e.g. persistent auditory hallucinat ions, \\ndisorganized thinking, negative symptoms) are not present, although various forms \\nof perceptual disturbances (e.g., hallucinations, illusions, misidentificati ons of \\npersons) thematically related to the delusion are still consistent with the diag nosis. \\nApart from actions and attitudes directly related to the delusion or delus ional \\nsystem, affect, speech, and behavior are typically unaffected. The symptoms ar e \\nnot a manifestation of another disorder or disease that is not classified under \\nMental, behavioural or neurodevelopmental disorders (e.g., a brain tumor) and are \\nnot due to the effect of a substance or medication on the central nervous system  \\n(e.g., corticosteroids), including withdrawal effects (e.g., alcohol withdrawal). \\n \\n6A24.0 Delusional disorder, currently symptomatic \\nAll definitional requirements for Delusional disorder in terms of symptoms an d \\nduration are currently met, or have been met within the past one month. \\n \\n6A24.1 Delusional disorder, in partial remission \\nAll definitional requirements for Delusional disorder in terms of symptoms an d \\nduration were previously met. Symptoms have ameliorated such that the diagnos tic \\nrequirements for the disorder have not been met for at least one month, but some \\nclinically significant symptoms remain, which may or may not be assoc iated with \\nfunctional impairment. The partial remission may have occurred in res ponse to \\nmedication or other treatment.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 20, 'page_label': '21'}, page_content=\"20  ICD-11 MMS - 2018 \\n \\n6A24.2 Delusional disorder, in full remission \\nAll definitional requirements for Delusional disorder in terms of symptoms an d \\nduration were previously met. Symptoms have ameliorated such that no signific ant \\nsymptoms remain. The remission may have occurred in response to medication or \\nother treatment. \\n \\n6A24.Z Delusional disorder, unspecified \\n \\n  6A25   Symptomatic manifestations of primary psychotic disorders \\nThese categories may be used to characterize the current clinical presentation in \\nindividuals diagnosed with Schizophrenia or another primary psychotic disorder, \\nand should not be used in individuals without such a diagnosis. Multiple c ategories \\nmay be applied. Symptoms attributable to the direct pathophysiological \\nconsequences of a health condition or injury not classified under Mental, \\nbehavioural or neurodevelopmental disorders (e.g., a brain tumour or traumatic \\nbrain injury), or to the direct effects of a substance or medication on the central  \\nnervous system, including withdrawal effects, should not be considered as \\nexamples of the respective types of symptoms. \\nNote: These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of these symptoms in primary psychotic disorders. \\n \\n6A25.0 Positive symptoms in primary psychotic disorders \\nPositive symptoms in primary psychotic disorders include persistent delusion s, \\npersistent hallucinations (most commonly verbal auditory hallucinatio ns), \\ndisorganized thinking (formal thought disorder such as loose associations, thought \\nderailment, or incoherence), grossly disorganized behavior (behaviour that appears \\nbizarre, purposeless and not goal-directed) and experiences of passivity and control \\n(the experience that one's feelings, impulses, or thoughts are under the control of \\nan external force). The rating should be made based on the severity of positive \\nsymptoms during the past week. \\nNote: Code also the underlying condition \\n \\n6A25.1 Negative symptoms in primary psychotic disorders \\nNegative symptoms in primary psychotic disorders include constricted, blunted, or  \\nflat affect, alogia or paucity of speech, avolition (general lack of drive, or lack  of \\nmotivation to pursue meaningful goals), asociality (reduced or absent engagemen t \\nwith others and interest in social interaction) and anhedonia (inability to experie nce \\npleasure from normally pleasurable activities). To be considered negative psyc hotic \\nsymptoms, relevant symptoms should not be entirely attributable to antipsych otic \\ndrug treatment, a depressive disorder, or an under-stimulating environment, and \\nshould not be a direct consequence of a positive symptom (e.g., persecutory \\ndelusions causing a person to become socially isolated due to fear of harm). The \\nrating should be made based on the severity of negative symptoms during the past \\nweek. \\nNote: Code also the underlying condition\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 21, 'page_label': '22'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   21 \\n \\n6A25.2 Depressive symptoms in primary psychotic disorders \\nDepressive symptoms in primary psychotic disorders refer to depressed mood as \\nreported by the individual (feeling down, sad) or manifested as a sign (e.g. tearf ul, \\ndowntrodden appearance). If only non-mood symptoms of a depressive episode are \\npresent (e.g., anhedonia, psychomotor slowing), this descriptor should not be us ed. \\nThis descriptor may be used whether or not depressive symptoms meet the \\ndiagnostic requirements of a separately diagnosed Depressive disorder. The rating \\nshould be made based on the severity of depressive mood symptoms during the \\npast week. \\nNote: Code also the underlying condition \\n \\n6A25.3 Manic symptoms in primary psychotic disorders \\nManic symptoms in primary psychotic disorders refer to elevated, euphoric, ir ritable, \\nor expansive mood states, including rapid changes among different mood states \\n(i.e., mood lability) accompanied by increased energy or activity, when thes e \\nrepresent a significant change from the individual ’s typical mood and energy or \\nactivity level. This descriptor may be used whether or not the manic sym ptoms meet \\nthe diagnostic requirements of a separately diagnosed bipolar disorder. The rati ng \\nshould be made based on the severity of manic mood symptoms during the past \\nweek. \\nNote: Code also the underlying condition \\n \\n6A25.4 Psychomotor symptoms in primary psychotic disorders \\nPsychomotor symptoms in primary psychotic disorders include psychomotor  \\nagitation or excessive motor activity, usually manifested by purposeless beha viors \\nsuch as fidgeting, shifting, fiddling, inability to sit or stand still, wringing of the hands, \\npsychomotor retardation, or a visible generalized slowing of movements and  \\nspeech, and catatonic symptoms such as excitement, posturing, waxy flexibili ty, \\nnegativism, mutism, or stupor. The rating should be made based on the severit y of \\npsychomotor symptoms during the past week. \\nNote: Code also the underlying condition \\n \\n6A25.5 Cognitive symptoms in primary psychotic disorders \\nCognitive symptoms in primary psychotic disorders refer to cognitive impairmen t in \\nany of the following domains: speed of processing, attention/concentration, \\norientation, judgment, abstraction, verbal or visual learning, and working memory. \\nThe cognitive impairment is not attributable to a neurodevelopmental disorder, a \\ndelirium or other neurocognitive disorder, or the direct effects of a substance or \\nmedication on the central nervous system, including withdrawal effects. Ideally , use \\nof this category should be based on the results of locally validated, standardi zed \\nneuropsychological assessments, although such measures may not be available  in \\nall settings. The rating should be made based on the severity of cognitive sy mptoms \\nduring the past week. \\nNote: Code also the underlying condition \\nExclusions: Neurocognitive disorders  (BlockL1‑6D7) \\nNeurodevelopmental disorders (BlockL1‑6A0) \\n \\n  6A2Y   Other specified schizophrenia or other primary psychotic disorders'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 22, 'page_label': '23'}, page_content='22  ICD-11 MMS - 2018 \\n \\n  6A2Z   Schizophrenia or other primary psychotic disorders, unspecified \\n \\nCatatonia (BlockL1‑6A4) \\nCatatonia is a marked disturbance in the voluntary control of movements characterized  by several of \\nthe following: extreme slowing or absence of motor activity, mutism, purposeless m otor activity \\nunrelated to external stimuli, assumption and maintenance of rigid, unusual or bizarre  postures, \\nresistance to instructions or attempts to be moved, or automatic compliance with instruction s. \\nCatatonia may be diagnosed in the context of certain specific mental disorders, inc luding Mood \\ndisorders, Schizophrenia, and Autism spectrum disorder. Catatonia may also be caused by disorders \\nor diseases classified elsewhere. \\nNote: Use additional code, if desired, for any associated disorder or diseases if known. \\nExclusions: Harmful effects of drugs, medicaments or biological substances, not elsewhere \\nclassified (NE60) \\nCoded Elsewhere: Secondary catatonia syndrome (6E69) \\n  6A40   Catatonia associated with another mental disorder \\nCatatonia associated with another mental disorder is a marked disturbance in the \\nvoluntary control of movements characterized by several of the following: ex treme \\nslowing or absence of motor activity, mutism, purposeless motor activity un related \\nto external stimuli, assumption and maintenance of rigid, unusual or bizarre \\npostures, resistance to instructions or attempts to be moved, or automatic \\ncompliance with instructions. Catatonia associated with another mental disorder \\nmay be diagnosed in the context of certain specific conditions, including Mood  \\ndisorders, Schizophrenia, and Autism spectrum disorder. \\nNote: Code also the underlying condition \\n \\n  6A41   Catatonia induced by psychoactive substances, including medications \\nCatatonia induced by psychoactive substances, including medications is a marked  \\ndisturbance in the voluntary control of movements characterized by several of the \\nfollowing: extreme slowing or absence of motor activity, mutism, purposeless m otor \\nactivity unrelated to external stimuli, assumption and maintenance of rigid, unusual \\nor bizarre postures, resistance to instructions or attempts to be moved, or automatic \\ncompliance with instructions that occurs during or shortly after the consumption of a \\npsychoactive substance or during use of a psychoactive medication. \\n \\n  6A4Z   Catatonia, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 23, 'page_label': '24'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   23 \\n \\nMood disorders (BlockL1‑6A6) \\nMood Disorders refers to a superordinate grouping of Bipolar and Depressive Disorders. Moo d \\ndisorders are defined according to particular types of mood episodes and their patt ern over time. The \\nprimary types of mood episodes are Depressive episode, Manic episode, Mixed epi sode, and \\nHypomanic episode. Mood episodes are not independently diagnosable entities, an d therefore do not \\nhave their own diagnostic codes. Rather, mood episodes make up the primary com ponents of most of \\nthe Depressive and Bipolar Disorders. \\nCoded Elsewhere: Substance-induced mood disorders \\nSecondary mood syndrome (6E62) \\nBipolar or related disorders (BlockL2‑6A6) \\nBipolar and related disorders are episodic mood disorders defined by the occurr ence of Manic, Mixed \\nor Hypomanic episodes or symptoms. These episodes typically alternate o ver the course of these \\ndisorders with Depressive episodes or periods of depressive symptoms. \\n  6A60   Bipolar type I disorder \\nBipolar type I disorder is an episodic mood disorder defined by the occurr ence of \\none or more manic or mixed episodes. A manic episode is an extreme mood state \\nlasting at least one week unless shortened by a treatment intervention \\ncharacterized by euphoria, irritability, or expansiveness, and by increased acti vity or \\na subjective experience of increased energy, accompanied by other characteristic  \\nsymptoms such as rapid or pressured speech, flight of ideas, increased self-esteem \\nor grandiosity, decreased need for sleep, distractibility, impulsive or reckless  \\nbehavior, and rapid changes among different mood states (i.e., mood lability). A \\nmixed episode is characterized by either a mixture or very rapid alternation between \\nprominent manic and depressive symptoms on most days during a period of at leas t \\n2 weeks. Although the diagnosis can be made based on evidence of a single m anic \\nor mixed episode, typically manic or mixed episodes alternate with depressive  \\nepisodes over the course of the disorder. \\nExclusions: cyclothymia (6A62) \\nBipolar type II disorder (6A61) \\n \\n6A60.0 Bipolar type I disorder, current episode manic, without psychotic symptoms  \\nBipolar type I disorder, current episode manic, without psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar type I disorder are met, the \\ncurrent episode is manic, and there are no delusions or hallucinations present \\nduring the episode. A manic episode is an extreme mood state lasting at l east one \\nweek unless shortened by a treatment intervention characterized by euphoria, \\nirritability, or expansiveness, and by increased activity or a subjective ex perience of \\nincreased energy, accompanied by other characteristic symptoms such as rapid or \\npressured speech, flight of ideas, increased self-esteem or grandiosity, decreased \\nneed for sleep, distractibility, impulsive or reckless behavior, and rapid c hanges \\namong different mood states (i.e., mood lability).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 24, 'page_label': '25'}, page_content='24  ICD-11 MMS - 2018 \\n \\n6A60.1 Bipolar type I disorder, current episode manic, with psychotic symptoms  \\nBipolar type I disorder, current episode manic with psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar type I Disorder have b een \\nmet, the current episode is Manic and there are delusions or hallucinations present \\nduring the episode. A manic episode is an extreme mood state lasting at l east one \\nweek unless shortened by a treatment intervention characterized by euphoria, \\nirritability, or expansiveness, and by increased activity or a subjective ex perience of \\nincreased energy, accompanied by other characteristic symptoms such as rapid  or \\npressured speech, flight of ideas, increased self-esteem or grandiosity, decreased \\nneed for sleep, distractibility, impulsive or reckless behavior, and rapid c hanges \\namong different mood states (i.e., mood lability). \\n \\n6A60.2 Bipolar type I disorder, current episode hypomanic \\nBipolar type I disorder, current episode hypomanic is diagnosed when the \\ndefinitional requirements for Bipolar type I disorder have been met and the c urrent \\nepisode is hypomanic. A hypomanic episode is a persistent mood state las ting at \\nleast several days characterized by mild elevation of mood or increased  irritability \\nand increased activity or a subjective experience of increased energy, accompani ed \\nby other characteristic symptoms such as rapid speech, rapid or racing thoughts , \\nincreased self-esteem, an increase in sexual drive or sociability, decrease d need for \\nsleep, distractibility, or impulsive or reckless behavior. The symptoms are not \\nsevere enough to cause marked impairment in occupational functioning or in usual \\nsocial activities or relationships with others, does not necessitate hospitalization , \\nand there are no accompanying delusions or hallucinations. \\n \\n6A60.3 Bipolar type I disorder, current episode depressive, mild \\nBipolar type I disorder, current episode depressive, mild is diagnosed when the \\ndefinitional requirements for Bipolar type I disorder have been met and the c urrent \\nepisode is depressive at a mild level of severity. A depressive ep isode is \\ncharacterized by a period of almost daily depressed mood or diminished interes t in \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a mild \\ndepressive episode, none of the symptoms are present to an intense degree. An \\nindividual with a mild depressive episode typically has some, but not cons iderable, \\ndifficulty in continuing with ordinary work, social, or domestic activiti es and there are \\nno delusions or hallucinations.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 25, 'page_label': '26'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   25 \\n \\n6A60.4 Bipolar type I disorder, current episode depressive, moderate without \\npsychotic symptoms \\nBipolar type I disorder, current episode depressive, moderate, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type I \\ndisorder have been met and the current episode is depressive at a moderate level \\nof severity and there are no delusions or hallucinations during the episode.  A \\ndepressive episode is characterized by a period of almost daily depressed mood or \\ndiminished interest in activities lasting at least two weeks accompanied by oth er \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a moderate depressive episode, several symptoms of a depressive \\nepisode are present to a marked degree, or a large number of depressive \\nsymptoms of lesser severity are present overall. An individual with a mod erate \\ndepressive episode typically has considerable difficulty in continui ng with work, \\nsocial, or domestic activities, but is still able to function in at least some areas. \\n \\n6A60.5 Bipolar type I disorder, current episode depressive, moderate with psychotic \\nsymptoms \\nBipolar type I disorder, current episode depressive, moderate, with psychotic \\nsymptoms diagnosed when the definitional requirements for Bipolar type I disor der \\nhave been met and the current episode is depressive at a moderate level of severity \\nand there are delusions or hallucinations during the episode. A depressive episode \\nis characterized by a period of almost daily depressed mood or diminished interest \\nin activities lasting at least two weeks accompanied by other symptoms s uch as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a moderate \\ndepressive episode, several symptoms of a depressive episode are present to a \\nmarked degree, or a large number of depressive symptoms of lesser severity are \\npresent overall. An individual with a moderate depressive episode typically has \\nconsiderable difficulty in continuing with work, social, or domestic activities, but is \\nstill able to function in at least some areas. \\n \\n6A60.6 Bipolar type I disorder, current episode depressive, severe without psychotic \\nsymptoms \\nBipolar type I disorder, current episode depressive, severe, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type I \\ndisorder are met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period \\nof almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating, \\nfeelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked  \\ndegree, or a smaller number of symptoms are present and manifest to an intense \\ndegree, and the individual is unable to function in personal, family, social, \\neducational, occupational, or other important domains, except to a very limited \\ndegree.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 26, 'page_label': '27'}, page_content='26  ICD-11 MMS - 2018 \\n \\n6A60.7 Bipolar type I disorder, current episode depressive, severe with psychotic \\nsymptoms \\nBipolar type I disorder, current episode depressive, severe, with psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type I \\ndisorder are met and the current episode is severe and there are delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period \\nof almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating, \\nfeelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked  \\ndegree, or a smaller number of symptoms are present and manifest to an intense \\ndegree and the individual is unable to function in personal, family, social, \\neducational, occupational, or other important domains, except to a very limited \\ndegree. \\n \\n6A60.8 Bipolar type I disorder, current episode depressive, unspecified severity  \\nBipolar type I disorder, current episode depressive, unspecified severity is \\ndiagnosed when the definitional requirements for Bipolar type I disorder have been  \\nmet and the current episode is depressive, but there is insufficient information to \\ndetermine the severity of the current depressive episode. A depressive episode is \\ncharacterized by a period of almost daily depressed mood or diminished interest i n \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. The symptoms \\nare associated with at least some difficulty in continuing with ordinary work, s ocial, \\nor domestic activities. \\n \\n6A60.9 Bipolar type I disorder, current episode mixed, without psychotic symptoms  \\nBipolar type I disorder, current episode mixed, without psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar type I disorder are met and \\nthe current episode is mixed and there are no delusions or hallucinations pres ent \\nduring the episode. A mixed episode is characterized by either a mixture or very \\nrapid alternation between prominent manic and depressive symptoms on most days \\nduring a period of at least one week. \\n \\n6A60.A Bipolar type I disorder, current episode mixed, with psychotic symptoms  \\nBipolar type I disorder, current episode mixed, with psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar type I disorder are met and \\nthe current episode is mixed and there are delusions or hallucinations present \\nduring the episode. A mixed episode is characterized by either a mixture or very \\nrapid alternation between prominent manic and depressive symptoms on most days \\nduring a period of at least one week.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 27, 'page_label': '28'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   27 \\n \\n6A60.B Bipolar type I disorder, currently in partial remission, most recent episode \\nmanic or hypomanic \\nBipolar type I disorder, currently in partial remission, most recent episode man ic or \\nhypomanic is diagnosed when the definitional requirements for Bipolar type I \\ndisorder have been met and the most recent episode was a manic or hypomanic \\nepisode. The full definitional requirements for a manic or hypomanic epis ode are no \\nlonger met but some significant mood symptoms remain. In some cases, resi dual \\nmood symptoms may be depressive rather than manic or hypomanic, but do not \\nsatisfy the definitional requirements for a depressive episode. \\n \\n6A60.C Bipolar type I disorder, currently in partial remission, most recent episode \\ndepressive \\nBipolar type I disorder, currently in partial remission, most recent episode  \\ndepressive is diagnosed when the definitional requirements for Bipolar type I \\ndisorder have been met and the most recent episode was a depressive episode. \\nThe full definitional requirements for the episode are no longer met but so me \\nsignificant depressive symptoms remain. \\n \\n6A60.D Bipolar type I disorder, currently in partial remission, most recent episode \\nmixed \\nBipolar type I disorder, currently in partial remission, most recent episo de mixed is \\ndiagnosed when the definitional requirements for Bipolar type I disorder have be en \\nmet and the most recent episode was a mixed episode. The full definitional \\nrequirements for the episode are no longer met but some significant mood \\nsymptoms remain. \\n \\n6A60.E Bipolar type I disorder, currently in partial remission, most recent episode \\nunspecified \\nBipolar type I disorder, currently in partial remission, most recent episode  \\nunspecified is diagnosed when the definitional requirements for Bipolar t ype II \\ndisorder have been met but there is insufficient information to determine the nature \\nof the most recent mood episode. The full definitional requirements for a mood \\nepisode are no longer met but some significant mood symptoms remain. \\n \\n6A60.F Bipolar type I disorder, currently in full remission \\nBipolar type I disorder, currently in full remission is diagnosed when the f ull \\ndefinitional requirements for Bipolar I disorder have been met in the past but th ere \\nare no longer any significant mood symptoms. \\n \\n6A60.Y Other specified bipolar type I disorder \\n \\n6A60.Z Bipolar type I disorder, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 28, 'page_label': '29'}, page_content='28  ICD-11 MMS - 2018 \\n \\n  6A61   Bipolar type II disorder \\nBipolar type II disorder is an episodic mood disorder defined by the occ urrence of \\none or more hypomanic episodes and at least one depressive episode. A \\nhypomanic episode is a persistent mood state characterized by euphoria, irr itability, \\nor expansiveness, and excessive psychomotor activation or increased energy, \\naccompanied by other characteristic symptoms such as grandiosity, decreased \\nneed for sleep, pressured speech, flight of ideas, distractibility, and impulsive or \\nreckless behavior lasting for at least several days. The symptoms represent a  \\nchange from the individual ’s typical behavior and are not severe enough to cause \\nmarked impairment in functioning. A depressive episode is characterized by a \\nperiod of almost daily depressed mood or diminished interest in activities lasti ng at \\nleast 2 weeks accompanied by other symptoms such as changes in appetite  or \\nsleep, psychomotor agitation or retardation, fatigue, feelings of worthless or \\nexcessive or inappropriate guilt, feelings or hopelessness, difficulty conc entrating, \\nand suicidality. There is no history of manic or mixed Episodes. \\n \\n6A61.0 Bipolar type II disorder, current episode hypomanic \\nBipolar type II disorder, current episode hypomanic is diagnosed when the \\ndefinitional requirements for Bipolar type II disorder have been met and the c urrent \\nepisode is hypomanic. A hypomanic episode is a persistent mood state las ting at \\nleast several days characterized by mild elevation of mood or increased  irritability \\nand increased activity or a subjective experience of increased energy, accompan ied \\nby other characteristic symptoms such as rapid speech, rapid or racing thoughts , \\nincreased self-esteem, an increase in sexual drive or sociability, decrease d need for \\nsleep, distractibility, or impulsive or reckless behavior. The symptoms are not \\nsevere enough to cause marked impairment in occupational functioning or in usual \\nsocial activities or relationships with others, does not necessitate hospitalization , \\nand there are no accompanying delusions or hallucinations. \\n \\n6A61.1 Bipolar type II disorder, current episode depressive, mild \\nBipolar type II disorder, current episode depressive, mild is diagnosed when the \\ndefinitional requirements for Bipolar type II disorder have been met and the c urrent \\nepisode is depressive at a mild level of severity. A depressive ep isode is \\ncharacterized by a period of almost daily depressed mood or diminished interest i n \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a mild \\ndepressive episode, none of the symptoms are present to an intense degree. An \\nindividual with a mild depressive episode typically has some, but not cons iderable, \\ndifficulty in continuing with ordinary work, social, or domestic activiti es and there are \\nno delusions or hallucinations.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 29, 'page_label': '30'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   29 \\n \\n6A61.2 Bipolar type II disorder, current episode depressive, moderate without \\npsychotic symptoms \\nBipolar type II disorder, current episode depressive, moderate, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type II  \\ndisorder have been met and the current episode is depressive at a moderate level \\nof severity and there are no delusions or hallucinations during the episode.  A \\ndepressive episode is characterized by a period of almost daily depressed mood or \\ndiminished interest in activities lasting at least two weeks accompanied by o ther \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a moderate depressive episode, several symptoms of a depressive \\nepisode are present to a marked degree, or a large number of depressive \\nsymptoms of lesser severity are present overall. An individual with a mod erate \\ndepressive episode typically has considerable difficulty in continui ng with work, \\nsocial, or domestic activities, but is still able to function in at least some areas. \\n \\n6A61.3 Bipolar type II disorder, current episode depressive, moderate with psychotic \\nsymptoms \\nBipolar type II disorder, current episode depressive, moderate, with psychotic \\nsymptoms diagnosed when the definitional requirements for Bipolar type II dis order \\nhave been met and the current episode is depressive at a moderate level of severity \\nand there are delusions or hallucinations during the episode. A depressive episode \\nis characterized by a period of almost daily depressed mood or diminished interest \\nin activities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a moderate \\ndepressive episode, several symptoms of a depressive episode are present to a \\nmarked degree, or a large number of depressive symptoms of lesser severity are \\npresent overall. An individual with a moderate depressive episode typically has \\nconsiderable difficulty in continuing with work, social, or domestic activities, but is \\nstill able to function in at least some areas. \\n \\n6A61.4 Bipolar type II disorder, current episode depressive, severe without psychotic \\nsymptoms \\nBipolar type II disorder, current episode depressive, severe, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type II  \\ndisorder are met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period \\nof almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating, \\nfeelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked  \\ndegree, or a smaller number of symptoms are present and manifest to an intense \\ndegree, and the individual is unable to function in personal, family, social, \\neducational, occupational, or other important domains, except to a very limited \\ndegree.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 30, 'page_label': '31'}, page_content='30  ICD-11 MMS - 2018 \\n \\n6A61.5 Bipolar type II disorder, current episode depressive, severe with psychotic \\nsymptoms \\nBipolar type II disorder, current episode depressive, severe, with psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type II  \\ndisorder are met and the current episode is severe and there are delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period \\nof almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating, \\nfeelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked  \\ndegree, or a smaller number of symptoms are present and manifest to an intense \\ndegree and the individual is unable to function in personal, family, social,  \\neducational, occupational, or other important domains, except to a very limited \\ndegree. \\n \\n6A61.6 Bipolar type II disorder, current episode depressive, unspecified severity  \\nBipolar type II disorder, current episode depressive, unspecified severity is \\ndiagnosed when the definitional requirements for Bipolar type II disorder hav e been \\nmet and the current episode is depressive, but there is insufficient information to \\ndetermine the severity of the current depressive episode. A depressive episode is \\ncharacterized by a period of almost daily depressed mood or diminished interest i n \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate  guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. The symptoms \\nare associated with at least some difficulty in continuing with ordinary work, s ocial, \\nor domestic activities. \\n \\n6A61.7 Bipolar type II disorder, currently in partial remission, most recent episode \\nhypomanic \\nBipolar type II disorder, currently in partial remission, most recent episo de \\nhypomanic is diagnosed when the definitional requirements for Bipolar typ e II \\ndisorder have been met and the most recent episode was a hypomanic episode. \\nThe full definitional requirements for a hypomanic episode are no longer m et but \\nsome significant mood symptoms remain. In some cases, residual mood symptom s \\nmay be depressive rather than hypomanic, but do not satisfy the definitiona l \\nrequirements for a depressive episode. \\n \\n6A61.8 Bipolar type II disorder, currently in partial remission, most recent episode \\ndepressive \\nBipolar type II disorder, currently in partial remission, most recent episode \\ndepressive is diagnosed when the definitional requirements for Bipolar type II \\ndisorder have been met and the most recent episode was a depressive episode. \\nThe full definitional requirements for the episode are no longer met but so me \\nsignificant depressive symptoms remain.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 31, 'page_label': '32'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   31 \\n \\n6A61.9 Bipolar type II disorder, currently in partial remission, most recent episode \\nunspecified \\nBipolar type II disorder, currently in partial remission, most recent episode \\nunspecified is diagnosed when the definitional requirements for Bipolar t ype II \\ndisorder have been met but there is insufficient information to determine the nature \\nof the most recent mood episode. The full definitional requirements for a mood \\nepisode are no longer met but some significant mood symptoms remain. \\n \\n6A61.A Bipolar type II disorder, currently in full remission \\nBipolar type II disorder, currently in full remission, is diagnosed when the defi nitional \\nrequirements for Bipolar type II disorder have been met but there are no longer any \\nsignificant mood symptoms. \\n \\n6A61.Y Other specified bipolar type II disorder \\n \\n6A61.Z Bipolar type II disorder, unspecified \\n \\n  6A62   Cyclothymic disorder \\nCyclothymic disorder is characterized by a persistent instability of m ood over a \\nperiod of at least 2 years, involving numerous periods of hypomanic (e.g., euph oria, \\nirritability, or expansiveness, psychomotor activation) and depressive (e.g., f eeling \\ndown, diminished interest in activities, fatigue) symptoms that are present during \\nmore of the time than not. The hypomanic symptomatology may or may not be \\nsufficiently severe or prolonged to meet the full definitional requirements of a \\nhypomanic episode (see Bipolar type II disorder), but there is no history  of manic or \\nmixed episodes (see Bipolar type I disorder). The depressive symptomatolog y has \\nnever been sufficiently severe or prolonged to meet the diagnostic requirements for \\na depressive episode (see Bipolar type II disorder). The symptoms result in \\nsignificant distress or significant impairment in personal, family, social, educational, \\noccupational or other important areas of functioning. \\nInclusions: Cycloid personality \\nCyclothymic personality \\n \\n  6A6Y   Other specified bipolar or related disorders \\n \\n  6A6Z   Bipolar or related disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 32, 'page_label': '33'}, page_content='32  ICD-11 MMS - 2018 \\n \\nDepressive disorders (BlockL2‑6A7) \\nDepressive disorders are characterized by depressive mood (e.g., sad, irritable, empty)  or loss of \\npleasure accompanied by other cognitive, behavioural, or neurovegetative symptoms that significantly \\naffect the individual’s ability to function. A depressive disorder should not be diagnosed in individuals \\nwho have ever experienced a manic, mixed or hypomanic episode, which would indicate th e presence \\nof a bipolar disorder. \\nCoded Elsewhere: Premenstrual dysphoric disorder (GA34.41) \\n  6A70   Single episode depressive disorder \\nSingle episode depressive disorder is characterized by the presence or history of \\none depressive episode when there is no history of prior depressive episodes. A \\ndepressive episode is characterized by a period of almost daily depressed mood or \\ndiminished interest in activities lasting at least two weeks accompanied by oth er \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. There have never been any prior manic, hypomanic, or mixed episodes, \\nwhich would indicate the presence of a bipolar disorder. \\nExclusions: recurrent depressive disorder (6A71) \\nAdjustment disorder (6B43) \\nBipolar or related disorders (BlockL2‑6A6) \\n \\n6A70.0 Single episode depressive disorder, mild \\nSingle episode depressive disorder, mild, is diagnosed when the definitional \\nrequirements of a Depressive episode are met and the episode is of mild severity . \\nNone of the symptoms of the Depressive episode should be present to an intens e \\ndegree. An individual with a Mild depressive episode typically has some, but not \\nconsiderable, difficulty in continuing with ordinary work, social, or domestic ac tivities \\nand there are no delusions or hallucinations. \\n \\n6A70.1 Single episode depressive disorder, moderate, without psychotic symptoms \\nSingle episode depressive disorder, moderate, without psychotic symptoms is \\ndiagnosed when the definitional requirements of a depressive episode have been \\nmet, there is no history of prior depressive episodes, the episode is of moderate  \\nseverity, and there are no delusions or hallucinations during the episode. A \\ndepressive episode is characterized by a period of almost daily depressed mood or \\ndiminished interest in activities lasting at least two weeks accompanied by oth er \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a moderate depressive episode, several symptoms of a depressive \\nepisode are present to a marked degree, or a large number of depressive \\nsymptoms of lesser severity are present overall. An individual with a mod erate \\ndepressive episode typically has considerable difficulty in continui ng with work, \\nsocial, or domestic activities, but is still able to function in at least some areas.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 33, 'page_label': '34'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   33 \\n \\n6A70.2 Single episode depressive disorder, moderate, with psychotic symptoms  \\nSingle episode depressive disorder, moderate, with psychotic symptoms is \\ndiagnosed when the definitional requirements of a depressive episode have been \\nmet, there is no history of prior depressive episodes, the episode is of moderate \\nseverity, and there are delusions or hallucinations during the episode. A depr essive \\nepisode is characterized by a period of almost daily depressed mood or dimini shed \\ninterest in activities lasting at least two weeks accompanied by other symptoms \\nsuch as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a moderate depressive episode, several symptoms of a depressive \\nepisode are present to a marked degree, or a large number of depressive \\nsymptoms of lesser severity are present overall. An individual with a mod erate \\ndepressive episode typically has considerable difficulty in continui ng with work, \\nsocial, or domestic activities, but is still able to function in at least some areas. \\n \\n6A70.3 Single episode depressive disorder, severe, without psychotic symptoms  \\nSingle episode depressive disorder, severe, without psychotic symptoms is \\ndiagnosed when the definitional requirements for Single episode depressive \\ndisorder are met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period \\nof almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating, \\nfeelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked  \\ndegree, or a smaller number of symptoms are present and manifest to an intense \\ndegree, and the individual is unable to function in personal, family, social, \\neducational, occupational, or other important domains, except to a very limited \\ndegree. \\nInclusions: Agitated depression single episode without psychotic \\nsymptoms \\nMajor depression single episode without psychotic symptoms \\nVital depression single episode without psychotic symptoms \\n \\n6A70.4 Single episode depressive disorder, severe, with psychotic symptoms \\nSingle episode depressive disorder, severe, with psychotic symptoms is diagno sed \\nwhen the definitional requirements for Single episode depressive disorder are met \\nand the current episode is severe and there are delusions or hallucinations during \\nthe episode. A depressive episode is characterized by a period of almost dail y \\ndepressed mood or diminished interest in activities lasting at least two weeks \\naccompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. In a severe depressive episode, many \\nor most symptoms of a depressive episode are present to a marked degree, or a \\nsmaller number of symptoms are present and manifest to an intense degree and the \\nindividual is unable to function in personal, family, social, educational, oc cupational, \\nor other important domains, except to a very limited degree.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 34, 'page_label': '35'}, page_content='34  ICD-11 MMS - 2018 \\n \\n6A70.5 Single episode depressive disorder, unspecified severity \\nSingle episode depressive disorder, unspecified severity is diagnosed when the  \\ndefinitional requirements of a depressive episode have been met, there is no history \\nof prior depressive episodes, and there is insufficient information to determine the \\nseverity of the current depressive episode. A depressive episode is characteri zed \\nby a period of almost daily depressed mood or diminished interest in activi ties \\nlasting at least two weeks accompanied by other symptoms such as difficult y \\nconcentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. The symptoms \\nare associated with at least some difficulty in continuing with ordinary work, s ocial, \\nor domestic activities. \\n \\n6A70.6 Single episode depressive disorder, currently in partial remission \\nSingle episode depressive disorder, currently in partial remission, is diagnose d \\nwhen the full definitional requirements for a depressive episode have been met and \\nthere is no history of prior depressive episodes. The full definitional requi rements for \\na depressive episode are no longer met but some significant mood symptoms \\nremain. \\n \\n6A70.7 Single episode depressive disorder, currently in full remission \\nSingle episode depressive disorder, currently in full remission is diagnosed  when \\nthe full definitional requirements for one depressive episode have been met i n the \\npast and there are no longer any significant mood symptoms. There is no histor y of \\ndepressive episodes preceding the episode under consideration. \\n \\n6A70.Y Other specified single episode depressive disorder \\n \\n6A70.Z Single episode depressive disorder, unspecified \\n \\n  6A71   Recurrent depressive disorder \\nRecurrent depressive disorder is characterized by a history or at least two \\ndepressive episodes separated by at least several months without significant  mood \\ndisturbance. A depressive episode is characterized by a period of almost daily \\ndepressed mood or diminished interest in activities lasting at least two weeks \\naccompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. There have never been any prior manic, \\nhypomanic, or mixed episodes, which would indicate the presence of a Bipolar \\ndisorder. \\nInclusions: seasonal depressive disorder \\nExclusions: Adjustment disorder (6B43) \\nBipolar or related disorders (BlockL2‑6A6) \\nSingle episode depressive disorder (6A70)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 35, 'page_label': '36'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   35 \\n \\n6A71.0 Recurrent depressive disorder, current episode mild \\nRecurrent depressive disorder, current episode mild is diagnosed when the \\ndefinitional requirements for Recurrent depressive disorder have been met and \\nthere is currently a depressive episode of mild severity. A depressive epis ode is \\ncharacterized by a period of almost daily depressed mood or diminished interest i n \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a mild \\ndepressive episode, none of the symptoms are present to an intense degree. An \\nindividual with a mild depressive episode typically has some, but not cons iderable, \\ndifficulty in continuing with ordinary work, social, or domestic activiti es and there are \\nno delusions or hallucinations. \\n \\n6A71.1 Recurrent depressive disorder, current episode moderate, without psychotic \\nsymptoms \\nRecurrent depressive disorder, current episode moderate, without psychotic \\nsymptoms is diagnosed when the definitional requirements for recurrent depr essive \\ndisorder have been met and there is currently a depressive episode of moderate \\nseverity, and there are no delusions or hallucinations during the episode. A \\ndepressive episode is characterized by a period of almost daily depressed mood or  \\ndiminished interest in activities lasting at least two weeks accompanied by oth er \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a moderate depressive episode, several symptoms of a depressive \\nepisode are present to a marked degree, or a large number of depressive \\nsymptoms of lesser severity are present overall. An individual with a mod erate \\ndepressive episode typically has considerable difficulty in continui ng with work, \\nsocial, or domestic activities, but is still able to function in at least some areas. \\n \\n6A71.2 Recurrent depressive disorder, current episode moderate, with psychotic \\nsymptoms \\nRecurrent depressive disorder, current episode moderate, with psychotic symptoms \\nis diagnosed when the definitional requirements for Recurrent depressive disorder \\nhave been met and there is currently a depressive episode of moderate severity, \\nand there are delusions or hallucinations during the episode. A depressive episode \\nis characterized by a period of almost daily depressed mood or diminished interest \\nin activities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a moderate \\ndepressive episode, several symptoms of a depressive episode are present to a \\nmarked degree, or a large number of depressive symptoms of lesser severity are \\npresent overall. An individual with a moderate depressive episode typically has \\nconsiderable difficulty in continuing with work, social, or domestic activities, but is \\nstill able to function in at least some areas.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 36, 'page_label': '37'}, page_content='36  ICD-11 MMS - 2018 \\n \\n6A71.3 Recurrent depressive disorder, current episode severe, without psychotic \\nsymptoms \\nRecurrent depressive disorder, current episode severe, without psychotic symptoms  \\nis diagnosed when the definitional requirements for Recurrent depressive disorder \\nare met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period \\nof almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating, \\nfeelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked  \\ndegree, or a smaller number of symptoms are present and manifest to an intense \\ndegree, and the individual is unable to function in personal, family, social, \\neducational, occupational, or other important domains, except to a very limited \\ndegree. \\nInclusions: Endogenous depression without psychotic symptoms \\nMajor depression, recurrent without psychotic symptoms \\nManic-depressive psychosis, depressed type without psychotic \\nsymptoms \\nVital depression, recurrent without psychotic symptoms \\n \\n6A71.4 Recurrent depressive disorder, current episode severe, with psychotic \\nsymptoms \\nRecurrent depressive disorder, current episode severe, with psychotic symptoms is \\ndiagnosed when the definitional requirements for Recurrent depressive disorder are \\nmet and the current episode is severe and there are delusions or hallucinations \\nduring the episode. A depressive episode is characterized by a period of a lmost \\ndaily depressed mood or diminished interest in activities lasting at least two week s \\naccompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. In a severe depressive episode, many \\nor most symptoms of a depressive episode are present to a marked degree, or a \\nsmaller number of symptoms are present and manifest to an intense degree and the \\nindividual is unable to function in personal, family, social, educational, oc cupational, \\nor other important domains, except to a very limited degree. \\nInclusions: Endogenous depression with psychotic symptoms \\nManic-depressive psychosis, depressed type with psychotic \\nsymptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 37, 'page_label': '38'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   37 \\n \\n6A71.5 Recurrent depressive disorder, current episode, unspecified severity  \\nRecurrent depressive disorder current episode, unspecified severity is dia gnosed \\nwhen the definitional requirements of a depressive episode have been met and \\nthere is a history of prior depressive episodes, but there is insufficient inf ormation to \\ndetermine the severity of the current depressive episode. A depressive episode is \\ncharacterized by a period of almost daily depressed mood or diminished interest i n \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. The symptoms \\nare associated with at least some difficulty in continuing with ordinary work, social, \\nor domestic activities. \\n \\n6A71.6 Recurrent depressive disorder, currently in partial remission \\nRecurrent depressive disorder, currently in partial remission, is diagnosed when t he \\ndefinitional requirements for Recurrent depressive disorder have been met; the full \\ndefinitional requirements for a depressive episode are no longer met but some \\nsignificant mood symptoms remain. \\n \\n6A71.7 Recurrent depressive disorder, currently in full remission \\nRecurrent depressive disorder, currently in full remission is diagnosed w hen the \\ndefinitional requirements for recurrent depressive disorder have been met but \\ncurrently there are no significant mood symptoms. \\n \\n6A71.Y Other specified recurrent depressive disorder \\n \\n6A71.Z Recurrent depressive disorder, unspecified \\n \\n  6A72   Dysthymic disorder \\nDysthymic disorder is characterized by a persistent depressive mood (i.e., las ting 2 \\nyears or more), for most of the day, for more days than not. In children and \\nadolescents depressed mood can manifest as pervasive irritability.The d epressed \\nmood is accompanied by additional symptoms such as markedly diminish ed interest \\nor pleasure in activities, reduced concentration and attention or indecisive ness, low \\nself-worth or excessive or inappropriate guilt, hopelessness about the future, \\ndisturbed sleep or increased sleep, diminished or increased appetite, or low energy  \\nor fatigue. During the first 2 years of the disorder, there has never been a 2-week \\nperiod during which the number and duration of symptoms were sufficient to mee t \\nthe diagnostic requirements for a Depressive Episode. There is no history of Mani c, \\nMixed, or Hypomanic Episodes. \\nInclusions: Dysthymia \\nExclusions: anxiety depression (mild or not persistent) (6A73)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 38, 'page_label': '39'}, page_content='38  ICD-11 MMS - 2018 \\n \\n  6A73   Mixed depressive and anxiety disorder \\nMixed depressive and anxiety disorder is characterized by symptoms of both \\nanxiety and depression more days than not for a period of two weeks or more. \\nNeither set of symptoms, considered separately, is sufficiently severe, num erous, or \\npersistent to justify a diagnosis of a depressive episode, dysthymia or an a nxiety \\nand fear-related disorder. Depressed mood or diminished interest in activities must \\nbe present accompanied by additional depressive symptoms as well as multiple \\nsymptoms of anxiety. The symptoms result in significant distress or si gnificant \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning. There have never been any prior manic, hypomanic, or mixed  \\nepisodes, which would indicate the presence of a bipolar disorder. \\n \\n  6A7Y   Other specified depressive disorders \\n \\n  6A7Z   Depressive disorders, unspecified \\n \\n  6A80   Symptomatic and course presentations for mood episodes in mood \\ndisorders \\nThese categories may be applied to describe the presentation and characteristics of \\nmood episodes in the context of single episode depressive disorder, recurrent \\nrepressive disorder, bipolar type I disorder, or bipolar type II disorder. These \\ncategories indicate the presence of specific, important features of the clin ical \\npresentation or of the course, onset, and pattern of mood episodes. These \\ncategories are not mutually exclusive, and as many may be added as apply. \\nNote: These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify specific \\nclinically important features of mood episodes in mood disorders. \\nCoded Elsewhere: Mental or behavioural disorders associated with pregnancy, \\nchildbirth and the puerperium, without psychotic \\nsymptoms (6E20) \\nMental or behavioural disorders associated with pregnancy, \\nchildbirth or the puerperium, with psychotic symptoms \\n(6E21) \\n \\n6A80.0 Prominent anxiety symptoms in mood episodes \\nIn the context of a current depressive, manic, mixed, or hypomanic episode, \\nprominent and clinically significant anxiety symptoms (e.g., feeling nervo us, anxious \\nor on edge, not being able to control worrying thoughts, fear that something awf ul \\nwill happen, having trouble relaxing, motor tension, autonomic symptoms) have \\nbeen present for most of the time during the past 2 weeks. If there have been panic \\nattacks during a current depressive or mixed episode, these should be recorded \\nseparately.  \\nWhen the diagnostic requirements for both a mood disorder and an anxiety or fear-\\nrelated disorder are met, the anxiety or fear-related disorder should also be \\ndiagnosed. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 39, 'page_label': '40'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   39 \\n \\n6A80.1 Panic attacks in mood episodes \\nIn the context of a current mood episode (manic, depressive, mixed, or hypomanic) , \\nthere have been recurrent panic attacks (i.e., at least two) during the past mon th \\nthat occur specifically in response to anxiety-provoking cognitions that are fea tures \\nof the mood episode. If panic attacks occur exclusively in response to such \\nthoughts, panic attacks should be recorded using this qualifier rather than assigni ng \\nan additional co-occurring diagnosis of panic disorder. \\nIf some panic attacks over the course of the depressive or mixed episode have \\nbeen unexpected and not exclusively in response to depressive or anxiety-\\nprovoking thoughts, a separate diagnosis of panic disorder should be assigned. \\nNote: Code also the underlying condition \\nExclusions: Panic disorder (6B01) \\n \\n6A80.2 Current depressive episode persistent \\nThe diagnostic requirements for a depressive episode are currently met and hav e \\nbeen met continuously for at least the past 2 years. \\n \\n6A80.3 Current depressive episode with melancholia \\nIn the context of a current Depressive Episode, several of the following symptoms \\nhave been present during worst period within the past month: loss of interest or \\npleasure in most activities that are normally enjoyable to the individual (i.e.,  \\npervasive anhedonia); lack of emotional reactivity to normally pleasurable stim uli or \\ncircumstances (i.e., mood does not lift even transiently with exposure); termina l \\ninsomnia (i.e., waking in the morning two hours or more before the usual time); \\ndepressive symptoms are worse in the morning; marked psychomotor retardation or \\nagitation; marked loss of appetite or loss of weight. \\n \\n6A80.4 Seasonal pattern of mood episode onset \\nIn the context of recurrent depressive disorder, bipolar type I or bipolar type II \\ndisorder, there has been a regular seasonal pattern of onset and remission of at \\nleast one type of episode (i.e., depressive, manic, mixed, or hypomanic epis odes), \\nwith a substantial majority of the relevant mood episodes corresponding to the \\nseasonal pattern. (In bipolar type I and bipolar type II disorder, all types of mood \\nepisodes may not follow this pattern.) A seasonal pattern should be differentia ted \\nfrom an episode that is coincidental with a particular season but predominantl y \\nrelated to a psychological stressor that regularly occurs at that time of the year (e.g., \\nseasonal unemployment). \\n \\n6A80.5 Rapid cycling \\nIn the context of bipolar type I or bipolar type II disorder, there has been a hig h \\nfrequency of mood episodes (at least four) over the past 12 months. There may be \\na switch from one polarity of mood to the other, or the mood episodes may be \\ndemarcated by a period of remission. In individuals with a high frequency of  mood \\nepisodes, some may have a shorter duration than those usually observed in bipolar \\ntype I or bipolar type II disorder. In particular, depressive periods may only last \\nseveral days. If depressive and manic symptoms alternate very rapidly (i.e. , from \\nday to day or within the same day), a mixed episode should be diagnosed r ather \\nthan rapid cycling. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 40, 'page_label': '41'}, page_content='40  ICD-11 MMS - 2018 \\n \\n  6A8Y   Other specified mood disorders \\n \\n  6A8Z   Mood disorders, unspecified \\n \\nAnxiety or fear-related disorders (BlockL1‑6B0) \\nAnxiety and fear-related disorders are characterized by excessive fear and anxi ety and related \\nbehavioural disturbances, with symptoms that are severe enough to result in sign ificant distress or \\nsignificant impairment in personal, family, social, educational, occupati onal, or other important areas \\nof functioning. Fear and anxiety are closely related phenomena; fear represents a reaction to \\nperceived imminent threat in the present, whereas anxiety is more future-orien ted, referring to \\nperceived anticipated threat. A key differentiating feature among the Anxiety and fea r-related \\ndisorders are disorder-specific foci of apprehension, that is, the stimulus or situation  that triggers the \\nfear or anxiety. The clinical presentation of Anxiety and fear-related di sorders typically includes \\nspecific associated cognitions that can assist in differentiating among the disorder s by clarifying the \\nfocus of apprehension. \\nCoded Elsewhere: Substance-induced anxiety disorders \\nHypochondriasis (6B23) \\nSecondary anxiety syndrome (6E63) \\n  6B00   Generalised anxiety disorder \\nGeneralised anxiety disorder is characterized by marked symptoms of anxi ety that \\npersist for at least several months, for more days than not, manifested by either \\ngeneral apprehension (i.e. ‘free-floating anxiety ’) or excessive worry focused on \\nmultiple everyday events, most often concerning family, health, finances, and \\nschool or work, together with additional symptoms such as muscular tension or \\nmotor restlessness, sympathetic autonomic over-activity, subjective experien ce of \\nnervousness, difficulty maintaining concentration, irritability, or sl eep disturbance. \\nThe symptoms result in significant distress or significant impairment i n personal, \\nfamily, social, educational, occupational, or other important areas of functioni ng. \\nThe symptoms are not a manifestation of another health condition and are not due \\nto the effects of a substance or medication on the central nervous system. \\n \\n  6B01   Panic disorder \\nPanic disorder is characterized by recurrent unexpected panic attacks that are not \\nrestricted to particular stimuli or situations. Panic attacks are discrete episode s of \\nintense fear or apprehension accompanied by the rapid and concurrent onset of \\nseveral characteristic symptoms (e.g., palpitations or increased heart rate, \\nsweating, trembling, shortness of breath, chest pain, dizziness or lightheadedness,  \\nchills, hot flushes, fear of imminent death). In addition, panic disorder is \\ncharacterized by persistent concern about the recurrence or significance of panic  \\nattacks, or behaviors intended to avoid their recurrence, that results in signifi cant \\nimpairment in personal, family, social, educational, occupational, or other i mportant \\nareas of functioning. The symptoms are not a manifestation of another health \\ncondition and are not due to the effects of a substance or medication on the central \\nnervous system. \\nExclusions: Panic attack (MB23.H)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 41, 'page_label': '42'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   41 \\n \\n  6B02   Agoraphobia \\nAgoraphobia is characterized by marked and excessive fear or anxiety that oc curs \\nin response to multiple situations where escape might be difficult or help migh t not \\nbe available, such as using public transportation, being in crowds, being outs ide the \\nhome alone (e.g., in shops, theatres, standing in line). The individual is con sistently \\nanxious about these situations due to a fear of specific negative outc omes (e.g., \\npanic attacks, other incapacitating or embarrassing physical symptoms). The \\nsituations are actively avoided, entered only under specific circumstances s uch as \\nin the presence of a trusted companion, or endured with intense fear or anxiety. The \\nsymptoms persist for least several months, and are sufficiently severe to resu lt in \\nsignificant distress or significant impairment in personal, family, soc ial, educational, \\noccupational, or other important areas of functioning. \\n \\n  6B03   Specific phobia \\nSpecific phobia is characterized by a marked and excessive fear or anxiety that \\nconsistently occurs when exposed to one or more specific objects or situatio ns \\n(e.g., proximity to certain animals, flying, heights, closed spaces, sight of bloo d or \\ninjury) and that is out of proportion to actual danger. The phobic objects or \\nsituations are avoided or else endured with intense fear or anxiety. Symptoms  \\npersist for at least several months and are sufficiently severe to result in signi ficant \\ndistress or significant impairment in personal, family, social, educationa l, \\noccupational, or other important areas of functioning. \\nInclusions: Simple phobia \\nAcrophobia \\nClaustrophobia \\nExclusions: Body dysmorphic disorder (6B21) \\nHypochondriasis (6B23) \\n \\n  6B04   Social anxiety disorder \\nSocial anxiety disorder is characterized by marked and excessive fear or anx iety \\nthat consistently occurs in one or more social situations such as social interacti ons \\n(e.g., having a conversation), being observed (e.g., eating or drinking), or \\nperforming in front of others (e.g., giving a speech). The individual is con cerned that \\nhe or she will act in a way, or show anxiety symptoms, that will be negativ ely \\nevaluated by others. The social situations are consistently avoided or else e ndured \\nwith intense fear or anxiety. The symptoms persist for at least several months and \\nare sufficiently severe to result in significant distress or significant impa irment in \\npersonal, family, social, educational, occupational, or other important areas of \\nfunctioning. \\nInclusions: Anthropophobia'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 42, 'page_label': '43'}, page_content='42  ICD-11 MMS - 2018 \\n \\n  6B05   Separation anxiety disorder \\nSeparation anxiety disorder is characterized by marked and excessive fear or \\nanxiety about separation from specific attachment figures. In children, separat ion \\nanxiety typically focuses on caregivers, parents or other family member s; in adults it \\nis typically a romantic partner or children. Manifestations of separation anxie ty may \\ninclude thoughts of harm or untoward events befalling the attachment figure, \\nreluctance to go to school or work, recurrent excessive distress upon separation, \\nreluctance or refusal to sleep away from the attachment figure, and recurrent \\nnightmares about separation. The symptoms persist for at least several months and \\nare sufficiently severe to result in significant distress or significant im pairment in \\npersonal, family, social, educational, occupational, or other important areas of \\nfunctioning. \\nExclusions: mood [affective] disorders  (BlockL1‑6A6) \\nSelective mutism (6B06) \\nSocial anxiety disorder (6B04) \\n \\n  6B06   Selective mutism \\nSelective mutism is characterized consistent selectivity in speaking, s uch that a \\nchild demonstrates adequate language competence in specific social situations, \\ntypically at home, but consistently fails to speak in others, typical ly at school. The \\ndisturbance lasts for at least one month, is not limited to the first month of school , \\nand is of sufficient severity to interfere with educational or occupational \\nachievement or with social communication. Failure to speak is not due to  a lack of \\nknowledge of, or comfort with, the spoken language required in the social si tuation \\n(e.g., a different language spoken at school than at home). \\nExclusions: Schizophrenia (6A20) \\ntransient mutism as part of separation anxiety in young \\nchildren (6B05) \\nAutism spectrum disorder (6A02) \\n \\n  6B0Y   Other specified anxiety or fear-related disorders \\n \\n  6B0Z   Anxiety or fear-related disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 43, 'page_label': '44'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   43 \\n \\nObsessive-compulsive or related disorders (BlockL1‑6B2) \\nObsessive-compulsive and related disorders is a group of disorders characterize d by repetitive \\nthoughts and behaviours that are believed to share similarities in etiology and k ey diagnostic \\nvalidators. Cognitive phenomena such as obsessions, intrusive thoughts and preoccup ations are \\ncentral to a subset of these conditions (i.e., obsessive-compulsive disorder, body dysmorphic \\ndisorder, hypochondriasis, and olfactory reference disorder) and are accompanied by r elated \\nrepetitive behaviours. Hoarding Disorder is not associated with intrusive unwanted thou ghts but rather \\nis characterized by a compulsive need to accumulate possessions and distr ess related to discarding \\nthem. Also included in the grouping are body-focused repetitive behaviour disorders, which are \\nprimarily characterized by recurrent and habitual actions directed at the integument ( e.g., hair-pulling, \\nskin-picking) and lack a prominent cognitive aspect. The symptoms result in s ignificant distress or \\nsignificant impairment in personal, family, social, educational, occupati onal, or other important areas \\nof functioning. \\nCoded Elsewhere: Substance-induced obsessive-compulsive or related disorders \\nSecondary obsessive-compulsive or related syndrome (6E64) \\nTourette syndrome (8A05.00) \\n  6B20   Obsessive-compulsive disorder \\nObsessive-Compulsive Disorder is characterized by the presence of persistent \\nobsessions or compulsions, or most commonly both. Obsessions are repetitive and \\npersistent thoughts, images, or impulses/urges that are intrusive, unwanted, and are \\ncommonly associated with anxiety. The individual attempts to ignore or suppress  \\nobsessions or to neutralize them by performing compulsions. Compulsions are \\nrepetitive behaviors including repetitive mental acts that the individual feels driven to \\nperform in response to an obsession, according to rigid rules, or to achieve a  sense \\nof ‘completeness’. In order for obsessive-compulsive disorder to be diagnosed, \\nobsessions and compulsions must be time consuming (e.g., taking more than an \\nhour per day), and result in significant distress or significant impairm ent in personal, \\nfamily, social, educational, occupational or other important areas of functioning. \\nInclusions: anankastic neurosis \\nobsessive-compulsive neurosis \\nExclusions: obsessive compulsive behaviour (MB23.4) \\n \\n6B20.0 Obsessive-compulsive disorder with fair to good insight \\nAll definitional requirements of obsessive-compulsive disorder are met. Muc h of the \\ntime, the individual is able to entertain the possibility that his or her dis order-specific \\nbeliefs may not be true and is willing to accept an alternative explanati on for his or \\nher experience. At circumscribed times (e.g., when highly anxious), the indi vidual \\nmay demonstrate no insight. \\n \\n6B20.1 Obsessive-compulsive disorder with poor to absent insight \\nAll definitional requirements of obsessive-compulsive disorder are met. Mo st or all \\nof the time, the individual is convinced that the disorder-specific beli efs are true and \\ncannot accept an alternative explanation for their experience. The lack of insight \\nexhibited by the individual does not vary markedly as a function of anxiety level. \\n \\n6B20.Z Obsessive-compulsive disorder, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 44, 'page_label': '45'}, page_content='44  ICD-11 MMS - 2018 \\n \\n  6B21   Body dysmorphic disorder \\nBody Dysmorphic Disorder is characterized by persistent preoccupation with one or \\nmore perceived defects or flaws in appearance that are either unnoticeable or only  \\nslightly noticeable to others. Individuals experience excessive self-con sciousness, \\noften with ideas of reference (i.e., the conviction that people are taking notic e, \\njudging, or talking about the perceived defect or flaw). In response to thei r \\npreoccupation, individuals engage in repetitive and excessive behaviours that \\ninclude repeated examination of the appearance or severity of the perceived defect \\nor flaw, excessive attempts to camouflage or alter the perceived defect, or m arked \\navoidance of social situations or triggers that increase distress about the perc eived \\ndefect or flaw. The symptoms are sufficiently severe to result in significan t distress \\nor significant impairment in personal, family, social, educational, occupat ional or \\nother important areas of functioning. \\nExclusions: Anorexia Nervosa (6B80) \\nBodily distress disorder (6C20) \\nConcern about body appearance (BlockL2‑QD3) \\n \\n6B21.0 Body dysmorphic disorder with fair to good insight \\nAll definitional requirements of body dysmorphic disorder are met. Much of the time, \\nthe individual is able to entertain the possibility that his or her disorder-spe cific \\nbeliefs may not be true and is willing to accept an alternative explanati on for his or \\nher experience. At circumscribed times (e.g., when highly anxious), the ind ividual \\nmay demonstrate no insight. \\n \\n6B21.1 Body dysmorphic disorder with poor to absent insight \\nAll definitional requirements of body dysmorphic disorder are met. Most or all  of the \\ntime, the individual is convinced that the disorder-specific beliefs are tr ue and \\ncannot accept an alternative explanation for their experience. The lack of insight \\nexhibited by the individual does not vary markedly as a function of anxiety level. \\n \\n6B21.Z Body dysmorphic disorder, unspecified \\n \\n  6B22   Olfactory reference disorder \\nOlfactory Reference Disorder is characterized by persistent preoccupation with the \\nbelief that one is emitting a perceived foul or offensive body odour or breath  that is \\neither unnoticeable or only slightly noticeable to others. Individuals experi ence \\nexcessive self-consciousness about the perceived odour, often with ideas of \\nreference (i.e., the conviction that people are taking notice, judging, or talki ng about \\nthe odour). In response to their preoccupation, individuals engage in repetitive a nd \\nexcessive behaviours such as repeatedly checking for body odour or chec king the \\nperceived source of the smell, or repeatedly seeking reassurance, excessive \\nattempts to camouflage, alter, or prevent the perceived odour, or marked avoidance \\nof social situations or triggers that increase distress about the perceived fou l or \\noffensive odour. The symptoms are sufficiently severe to result in significan t \\ndistress or significant impairment in personal, family, social, educationa l, \\noccupational or other important areas of functioning.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 45, 'page_label': '46'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   45 \\n \\n6B22.0 Olfactory reference disorder with fair to good insight \\nAll definitional requirements of olfactory reference disorder are met. Much of the \\ntime, the individual is able to entertain the possibility that his or her dis order-specific \\nbeliefs may not be true and is willing to accept an alternative explanati on for his or \\nher experience. At circumscribed times (e.g., when highly anxious), the indi vidual \\nmay demonstrate no insight. \\n \\n6B22.1 Olfactory reference disorder with poor to absent insight \\nAll definitional requirements of olfactory reference disorder are met. Most or all of \\nthe time, the individual is convinced that the disorder-specific beliefs  are true and \\ncannot accept an alternative explanation for their experience. The lack of insight \\nexhibited by the individual does not vary markedly as a function of anxiety level. \\n \\n6B22.Z Olfactory reference disorder, unspecified \\n \\n  6B23   Hypochondriasis \\nHypochondriasis is characterized by persistent preoccupation with or fear a bout the \\npossibility of having one or more serious, progressive or life-threatening diseases . \\nThe preoccupation is associated with catastrophic misinterpretation of bodily  signs \\nor symptoms, including normal or commonplace sensations, and is manifest either \\nin repetitive and excessive health-related behaviours or in maladaptive avoidance \\nbehaviours related to health. The preoccupation or fear is not simply a reas onable \\nconcern related to a specific context of the patient, and persists or reoccurs de spite \\nappropriate medical evaluation and reassurance. The symptoms result in signif icant \\ndistress or significant impairment in personal, family, social, educationa l, \\noccupational or other important areas of functioning. \\nInclusions: Hypochondriacal neurosis \\nNosophobia \\nIllness anxiety disorder \\nExclusions: Body dysmorphic disorder (6B21) \\nBodily distress disorder (6C20) \\nFear of cancer (MG24.0) \\n \\n6B23.0 Hypochondriasis with fair to good insight \\nAll definitional requirements of hypochondriasis are met. Much of the ti me, the \\nindividual is able to entertain the possibility that his or her disord er-specific beliefs \\nmay not be true and is willing to accept an alternative explanation for his or her \\nexperience. At circumscribed times (e.g., when highly anxious), the indivi dual may \\ndemonstrate no insight. \\n \\n6B23.1 Hypochondriasis with poor to absent insight \\nAll definitional requirements of hypochondriasis are met. Most or all of the  time, the \\nindividual is convinced that the disorder-specific beliefs are true and c annot accept \\nan alternative explanation for their experience. The lack of insight exhibited by  t he \\nindividual does not vary markedly as a function of anxiety level. \\n \\n6B23.Z Hypochondriasis, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 46, 'page_label': '47'}, page_content='46  ICD-11 MMS - 2018 \\n \\n  6B24   Hoarding disorder \\nHoarding disorder is characterised by accumulation of possessions due to \\nexcessive acquisition of or difficulty discarding possessions, regardless  of their \\nactual value. Excessive acquisition is characterized by repetitive urges  or \\nbehaviours related to amassing or buying items. Difficulty discarding possess ions is \\ncharacterized by a perceived need to save items and distress associated with \\ndiscarding them. Accumulation of possessions results in living spaces becomi ng \\ncluttered to the point that their use or safety is compromised. The symptoms result \\nin significant distress or significant impairment in personal, family, social, \\neducational, occupational or other important areas of functioning. \\n \\n6B24.0 Hoarding disorder with fair to good insight \\nAll definitional requirements of hoarding disorder are met. The individual recog nizes \\nthat hoarding-related beliefs and behaviours (pertaining to excessive acquisiti on, \\ndifficulty discarding, or clutter) are problematic. This qualifier level may s till be \\napplied if, at circumscribed times (e.g., when being forced to discard items), the  \\nindividual demonstrates no insight. \\n \\n6B24.1 Hoarding disorder with poor to absent insight \\nAll definitional requirements of hoarding disorder are met. Most or all of the time, the \\nindividual is convinced that that hoarding-related beliefs and behaviou rs (pertaining \\nto excessive acquisition, difficulty discarding, or clutter) are not problematic, des pite \\nevidence to the contrary. The lack of insight exhibited by the individual d oes not \\nvary markedly as a function of anxiety level. \\n \\n6B24.Z Hoarding disorder, unspecified \\n \\n  6B25   Body-focused repetitive behaviour disorders \\nBody focused repetitive behavior disorders are characterized by recurrent and \\nhabitual actions directed at the integument (e.g. hair-pulling, skin-picking , lip-biting), \\ntypically accompanied by unsuccessful attempts to decrease or stop the behavi our \\ninvolved, and which lead to dermatological sequelae (e.g., hair loss, sk in lesions, lip \\nabrasions). The behaviour may occur in brief episodes scattered throughout the day \\nor in less frequent but more sustained periods. The symptoms result in signific ant \\ndistress or significant impairment in personal, family, social, educationa l, \\noccupational or other important areas of functioning. \\n \\n6B25.0 Trichotillomania \\nTrichotillomania is characterized by recurrent pulling of one ’s own hair leading to \\nsignificant hair loss, accompanied by unsuccessful attempts to decrease or stop  the \\nbehaviour. Hair pulling may occur from any region of the body in which hai r grows \\nbut the most common sites are the scalp, eyebrows, and eyelids. Hair pulling  may \\noccur in brief episodes scattered throughout the day or in less frequent but more \\nsustained periods. The symptoms result in significant distress or signific ant \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning. \\nInclusions: Compulsive hair plucking \\nExclusions: stereotyped movement disorder with hair-plucking (6A06)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 47, 'page_label': '48'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   47 \\n \\n6B25.1 Excoriation disorder \\nExcoriation disorder is characterized by recurrent picking of one ’s own skin leading \\nto skin lesions, accompanied by unsuccessful attempts to decrease or stop the  \\nbehaviour. The most commonly picked sites are the face, arms and hands, but \\nmany individuals pick from multiple body sites. Skin picking may  occur in brief \\nepisodes scattered throughout the day or in less frequent but more sustained \\nperiods. The symptoms result in significant distress or significant im pairment in \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning. \\nInclusions: skin picking disorder \\nExclusions: Stereotyped movement disorder (6A06) \\nAcute excoriation of skin (ME62.9) \\nChronic excoriation of skin (ME63.7) \\n \\n6B25.Y Other specified body-focused repetitive behaviour disorders \\n \\n6B25.Z Body-focused repetitive behaviour disorders, unspecified \\n \\n  6B2Y   Other specified obsessive-compulsive or related disorders \\n \\n  6B2Z   Obsessive-compulsive or related disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 48, 'page_label': '49'}, page_content='48  ICD-11 MMS - 2018 \\n \\nDisorders specifically associated with stress (BlockL1‑6B4) \\nDisorders specifically associated with stress are directly related to ex posure to a stressful or traumatic \\nevent, or a series of such events or adverse experiences. For each of the disorders in t his grouping, \\nan identifiable stressor is a necessary, though not sufficient, causal factor. A lthough not all individuals \\nexposed to an identified stressor will develop a disorder, the disorders in thi s grouping would not have \\noccurred without experiencing the stressor. Stressful events for some disorders in thi s grouping are \\nwithin the normal range of life experiences (e.g., divorce, socio-economic problem s, bereavement). \\nOther disorders require the experience of a stressor of an extremely threatening or horrific n ature (i.e., \\npotentially traumatic events). With all disorders in this grouping, it is the nature, p attern, and duration \\nof the symptoms that arise in response to the stressful events —together with associated functional \\nimpairment—that distinguishes the disorders. \\nExclusions: Burn-out (QD85) \\nAcute stress reaction (QE84) \\n  6B40   Post traumatic stress disorder \\nPost-traumatic stress disorder (PTSD) is a syndrome that develops following  \\nexposure to an extremely threatening or horrific event or series of events that is \\ncharacterized by all of the following: 1) re-experiencing the traumatic even t or \\nevents in the present in the form of vivid intrusive memories, flashbacks, or  \\nnightmares, which are typically accompanied by strong and overwhelming emotions \\nsuch as fear or horror and strong physical sensations, or feelings of being \\noverwhelmed or immersed in the same intense emotions that were experienced \\nduring the traumatic event; 2) avoidance of thoughts and memories of the event or \\nevents, or avoidance of activities, situations, or people reminiscent of the even t or \\nevents; and 3) persistent perceptions of heightened current threat, for example as \\nindicated by hypervigilance or an enhanced startle reaction to stimuli such as \\nunexpected noises. The symptoms must persist for at least several weeks and \\ncause significant impairment in personal, family, social, educati onal, occupational or \\nother important areas of functioning. \\nInclusions: Traumatic neurosis \\nExclusions: Acute stress reaction (QE84) \\nComplex post traumatic stress disorder (6B41) \\n \\n  6B41   Complex post traumatic stress disorder \\nComplex post-traumatic stress disorder (Complex PTSD) is a disorder that may \\ndevelop following exposure to an event or series of events of an extremely \\nthreatening or horrific nature, most commonly prolonged or repetitive events fro m \\nwhich escape is difficult or impossible (e.g., torture, slavery, genocide campaigns, \\nprolonged domestic violence, repeated childhood sexual or physical abuse). T he \\ndisorder is characterized by the core symptoms of PTSD; that is, all diagnostic \\nrequirements for PTSD have been met at some point during the course of the \\ndisorder. In addition, Complex PTSD is characterized by 1) severe and pervasive \\nproblems in affect regulation; 2) persistent beliefs about oneself as diminished, \\ndefeated or worthless, accompanied by deep and pervasive feelings of shame, gu ilt \\nor failure related to the traumatic event; and 3) persistent difficulties in sustai ning \\nrelationships and in feeling close to others. The disturbance causes signif icant \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning. \\nExclusions: Post traumatic stress disorder (6B40)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 49, 'page_label': '50'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   49 \\n \\n  6B42   Prolonged grief disorder \\nProlonged grief disorder is a disturbance in which, following the death of a par tner, \\nparent, child, or other person close to the bereaved, there is persistent and \\npervasive grief response characterized by longing for the deceased or persis tent \\npreoccupation with the deceased accompanied by intense emotional pain (e.g. \\nsadness, guilt, anger, denial, blame, difficulty accepting the death, feeli ng one has \\nlost a part of one ’s self, an inability to experience positive mood, emotional \\nnumbness, difficulty in engaging with social or other activities). The grief r esponse \\nhas persisted for an atypically long period of time following the loss ( more than 6 \\nmonths at a minimum) and clearly exceeds expected social, cultural or religious  \\nnorms for the individual’s culture and context. Grief reactions that have persisted for \\nlonger periods that are within a normative period of grieving given the person ’s \\ncultural and religious context are viewed as normal bereavement responses and are \\nnot assigned a diagnosis. The disturbance causes significant impairment in \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning. \\n \\n  6B43   Adjustment disorder \\nAdjustment disorder is a maladaptive reaction to an identifiable psychosoc ial \\nstressor or multiple stressors (e.g., divorce, illness or disability, socio-econom ic \\nproblems, conflicts at home or work) that usually emerges within a month of the \\nstressor. The disorder is characterized by preoccupation with the stressor or its \\nconsequences, including excessive worry, recurrent and distressing thoughts abou t \\nthe stressor, or constant rumination about its implications, as well as by f ailure to \\nadapt to the stressor that causes significant impairment in personal, family, soc ial, \\neducational, occupational or other important areas of functioning. The symptoms \\nare not of sufficient specificity or severity to justify the diagnosis of another Mental \\nand Behavioural Disorder and typically resolve within 6 months, unless the stressor \\npersists for a longer duration. \\nExclusions: separation anxiety disorder of childhood (6B05) \\nRecurrent depressive disorder (6A71) \\nSingle episode depressive disorder (6A70) \\nProlonged grief disorder (6B42) \\nUncomplicated bereavement (QE62) \\nBurn-out (QD85) \\nAcute stress reaction (QE84)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 50, 'page_label': '51'}, page_content='50  ICD-11 MMS - 2018 \\n \\n  6B44   Reactive attachment disorder \\nReactive attachment disorder is characterized by grossly abnormal attachment \\nbehaviours in early childhood, occurring in the context of a history of gros sly \\ninadequate child care (e.g., severe neglect, maltreatment, institutional deprivation). \\nEven when an adequate primary caregiver is newly available, the child does  not \\nturn to the primary caregiver for comfort, support and nurture, rarely displays \\nsecurity-seeking behaviours towards any adult, and does not respond when com fort \\nis offered. Reactive attachment disorder can only be diagnosed in children, and \\nfeatures of the disorder develop within the first 5 years of life. However, the disord er \\ncannot be diagnosed before the age of 1 year (or a developmental age of less than \\n9 months), when the capacity for selective attachments may not be fully devel oped, \\nor in the context of Autism spectrum disorder. \\nExclusions: Asperger syndrome (6A02) \\ndisinhibited attachment disorder of childhood (6B45) \\n \\n  6B45   Disinhibited social engagement disorder \\nDisinhibited social engagement disorder is characterized by grossly abnormal social \\nbehaviour, occurring in the context of a history of grossly inadequate child care \\n(e.g., severe neglect, institutional deprivation). The child approaches adults \\nindiscriminately, lacks reticence to approach, will go away with unfamili ar adults, \\nand exhibits overly familiar behaviour towards strangers. Disinhibited soci al \\nengagement disorder can only be diagnosed in children, and features of the \\ndisorder develop within the first 5 years of life. However, the disorder cannot be \\ndiagnosed before the age of 1 year (or a developmental age of less than 9 month s), \\nwhen the capacity for selective attachments may not be fully developed, or in the \\ncontext of Autism spectrum disorder. \\nExclusions: Asperger syndrome (6A02) \\nAdjustment disorder (6B43) \\nAttention deficit hyperactivity disorder (6A05) \\nreactive attachment disorder of childhood (6B44) \\n \\n  6B4Y   Other specified disorders specifically associated with stress \\n \\n  6B4Z   Disorders specifically associated with stress, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 51, 'page_label': '52'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   51 \\n \\nDissociative disorders (BlockL1‑6B6) \\nDissociative disorders are characterized by involuntary disruption or discon tinuity in the normal \\nintegration of one or more of the following: identity, sensations, perceptions, aff ects, thoughts, \\nmemories, control over bodily movements, or behaviour. Disruption or dis continuity may be complete, \\nbut is more commonly partial, and can vary from day to day or even from hour to hour. The symptoms \\nof dissociative disorders are not due the direct effects of a medication or sub stance, including \\nwithdrawal effects, are not better explained by another Mental, behavioural, or neurodev elopmental \\ndisorder, a Sleep-wake disorder, a Disease of the nervous system or other health conditio n, and are \\nnot part of an accepted cultural, religious, or spiritual practice. Dissociative s ymptoms in dissociativ e \\ndisorders are sufficiently severe to result in significant impairment in p ersonal, family, social, \\neducational, occupational or other important areas of functioning. \\nCoded Elsewhere: Secondary dissociative syndrome (6E65) \\n  6B60   Dissociative neurological symptom disorder \\nDissociative neurological symptom disorder is characterized by the presentati on of \\nmotor, sensory, or cognitive symptoms that imply an involuntary discontinu ity in the \\nnormal integration of motor, sensory, or cognitive functions and are not consisten t \\nwith a recognized disease of the nervous system, other mental or behavioural \\ndisorder, or other health condition. The symptoms do not occur exclusively duri ng \\nanother dissociative disorder and are not due to the effects of a substance or \\nmedication on the central nervous system, including withdrawal effects, or a Slee p-\\nWake disorder. \\nExclusions: Factitious disorders  (BlockL1‑6D5) \\n \\n6B60.0 Dissociative neurological symptom disorder, with visual disturbance \\nDissociative neurological symptom disorder, with visual disturbance is characteriz ed \\nby visual symptoms such as blindness, tunnel vision, diplopia, visual distortions or \\nhallucinations that are not consistent with a recognized disease of the nerv ous \\nsystem, other mental or behavioural disorder, or other health condition and do not \\noccur exclusively during another dissociative disorder. \\n \\n6B60.1 Dissociative neurological symptom disorder, with auditory disturbance \\nDissociative neurological symptom disorder, with auditory disturbance is \\ncharacterized by auditory symptoms such as loss of hearing or auditory \\nhallucinations that are not consistent with a recognized disease of the nerv ous \\nsystem, other mental or behavioural disorder, or other health condition and do not \\noccur exclusively during another dissociative disorder. \\n \\n6B60.2 Dissociative neurological symptom disorder, with vertigo or dizziness  \\nDissociative neurological symptom disorder, with vertigo or dizziness is \\ncharacterized by a sensation of spinning while stationary (vertigo) or dizziness  that \\nis not consistent with a recognized disease of the nervous system, mental or \\nbehavioural disorder, or other health condition and does not occur exclusively \\nduring another dissociative disorder.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 52, 'page_label': '53'}, page_content='52  ICD-11 MMS - 2018 \\n \\n6B60.3 Dissociative neurological symptom disorder, with other sensory disturbance  \\nDissociative neurological symptom disorder, with other sensory disturbance is \\ncharacterized by sensory symptoms not identified in other specific categ ories in this \\ngrouping such as numbness, tightness, tingling, burning, pain, or other symptoms \\nrelated to touch, smell, taste, balance, proprioception, kinesthesia, or \\nthermoception. The symptoms are not consistent with a recognized disease of the \\nnervous system, other mental or behavioural disorder, or other health condition and \\ndo not occur exclusively during another dissociative disorder. \\n \\n6B60.4 Dissociative neurological symptom disorder, with non-epileptic seizures  \\nDissociative neurological symptom disorder, with non-epileptic seizures is \\ncharacterized by a symptomatic presentation of seizures or convulsions that are no t \\nconsistent with a recognized disease of the nervous system, other mental or \\nbehavioural disorder, or other health condition and do not occur exclusively durin g \\nanother dissociative disorder. \\n \\n6B60.5 Dissociative neurological symptom disorder, with speech disturbance  \\nDissociative neurological symptom disorder, with speech disturbance is \\ncharacterized by symptoms such as difficulty with speaking (dysphonia), loss  of the \\nability to speak (aphonia) or difficult or unclear articulation of speech (dysarthr ia) \\nthat are not consistent with a recognized disease of the nervous system, a \\nneurodevelopmental or neurocognitive disorder, other mental or behavioural \\ndisorder, or other health condition and do not occur exclusively during another \\ndissociative disorder. \\n \\n6B60.6 Dissociative neurological symptom disorder, with paresis or weakness \\nDissociative neurological symptom disorder, with paresis or weakness is \\ncharacterized by a difficulty or inability to intentionally move parts of the  body or to \\ncoordinate movements that is not consistent with a recognized disease of the \\nnervous system, other mental and behavioural disorder, other health condition and \\ndoes not occur exclusively during another dissociative disorder. \\n \\n6B60.7 Dissociative neurological symptom disorder, with gait disturbance \\nDissociative neurological symptom disorder, with gait disturbance is characterized  \\nby symptoms involving the individual ’s ability or manner of walking, including ataxia \\nand the inability to stand unaided, that are not consistent with a recognized diseas e \\nof the nervous system, other mental and behavioural disorder, or other health \\ncondition and do not occur exclusively during another dissociative disorder. \\n \\n6B60.8 Dissociative neurological symptom disorder, with movement disturbance  \\nDissociative neurological symptom disorder, with movement disturbance is \\ncharacterized by symptoms such as chorea, myoclonus, tremor, dystonia, facial \\nspasm, parkinsonism, or dyskinesia that are not consistent with a recognized \\ndisease of the nervous system, other mental and behavioural disorder, or other \\nhealth condition and do not occur exclusively during another dissociative disorder.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 53, 'page_label': '54'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   53 \\n \\n6B60.80 Dissociative neurological symptom disorder, with chorea \\nDissociative neurological symptom disorder, with chorea is characterized by \\nirregular, non-repetitive, brief, jerky, flowing movements that move randomly f rom \\none part of the body to another that are not consistent with a recognized disease of \\nthe nervous system, other mental and behavioural disorder, or other health \\ncondition and do not occur exclusively during another dissociative disorder. \\n \\n6B60.81 Dissociative neurological symptom disorder, with myoclonus \\nDissociative neurological symptom disorder, with myoclonus is characterized by  \\nsudden rapid jerks that may be focal, multifocal or generalized that are not \\nconsistent with a recognized disease of the nervous system, other mental and  \\nbehavioural disorder, or other health condition and do not occur exclusively durin g \\nanother dissociative disorder. \\n \\n6B60.82 Dissociative neurological symptom disorder, with tremor \\nDissociative neurological symptom disorder, with tremor is characterized by \\ninvoluntary oscillation of a body part that is not consistent with a recogn ized disease \\nof the nervous system, other mental and behavioural disorder, or other health \\ncondition and does not occur exclusively during another dissociative disorder. \\n \\n6B60.83 Dissociative neurological symptom disorder, with dystonia \\nDissociative neurological symptom disorder, with dystonia is characterized by  \\nsustained muscle contractions that frequently causing twisting and repetitive  \\nmovements or abnormal postures that are not consistent with a recognized disease \\nof the nervous system, other mental and behavioural disorder, or other health \\ncondition and do not occur exclusively during another dissociative disorder. \\n \\n6B60.84 Dissociative neurological symptom disorder, with facial spasm \\nDissociative neurological symptom disorder, with facial spasm is characteriz ed by \\ninvoluntary muscle contractions or twitching of the face that is not consi stent with a \\nrecognized disease of the nervous system, other mental and behavioural dis order, \\nor other health condition and does not occur exclusively during another dissociati ve \\ndisorder. \\n \\n6B60.85 Dissociative neurological symptom disorder, with Parkinsonism \\nDissociative neurological symptom disorder, with Parkinsonism is characterized b y \\na symptomatic presentation of a Parkinson-like syndrome in the absence of \\nconfirmed Parkinson disease that does not occur exclusively during another \\ndissociative disorder. Dissociative neurological symptom disorder, with \\nParkinsonism can be distinguished from Parkinson disease by features such as  \\nbrupt onset, early disability, bilateral shaking and slowness, nondecremental \\nslowness when performing repetitive movements, voluntary resistance against \\npassive movement without cogwheel rigidity, distractibility, ‘give-way’ weakness, \\nstuttering speech, bizarre gait, and a variety of behavioral symptoms. \\n \\n6B60.8Y Dissociative neurological symptom disorder, with other specified movement \\ndisturbance \\n \\n6B60.8Z Dissociative neurological symptom disorder, with unspecified movement \\ndisturbance'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 54, 'page_label': '55'}, page_content='54  ICD-11 MMS - 2018 \\n \\n6B60.9 Dissociative neurological symptom disorder, with cognitive symptoms  \\nDissociative neurological symptom disorder, with cognitive symptoms is \\ncharacterized by impaired cognitive performance in memory, language or othe r \\ncognitive domains that is internal inconsistent and not consistent with a recogni zed \\ndisease of the nervous system, a neurodevelopmental or neurocognitive disorder, \\nother mental and behavioural disorder, or another health condition and does not \\noccur exclusively during another dissociative disorder. \\nExclusions: Dissociative amnesia (6B61) \\n \\n6B60.Y Dissociative neurological symptom disorder, with other specified symptoms  \\n \\n6B60.Z Dissociative neurological symptom disorder, with unspecified symptoms  \\n \\n  6B61   Dissociative amnesia \\nDissociative amnesia is characterized by an inability to recall impo rtant \\nautobiographical memories, typically of recent traumatic or stressful events, th at is \\ninconsistent with ordinary forgetting. The amnesia does not occur exclusively dur ing \\nanother dissociative disorder and is not better explained by another mental, \\nbehavioural or neurodevelopmental disorder. The amnesia is not due to the direc t \\neffects of a substance or medication on the central nervous system, including  \\nwithdrawal effects, and is not due to a disease of the nervous system or to head \\ntrauma. The amnesia results in significant impairment in personal, f amily, social, \\neducational, occupational or other important areas of functioning. \\nExclusions: amnesia NOS (MB21.1) \\nAmnestic disorder due to use of alcohol (6D72.10) \\nAnterograde amnesia (MB21.10) \\nRetrograde amnesia (MB21.11) \\nnonalcoholic organic amnesic syndrome (6D72.0) \\npostictal amnesia in epilepsy (BlockL1‑8A6) \\n \\n  6B62   Trance disorder \\nTrance disorder is characterized by trance states in which there is a marked \\nalteration in the individual ’s state of consciousness or a loss of the individual ’s \\ncustomary sense of personal identity in which the individual experiences a \\nnarrowing of awareness of immediate surroundings or unusually narrow and \\nselective focusing on environmental stimuli and restriction of movements, po stures, \\nand speech to repetition of a small repertoire that is experienced as being outside of \\none’s control. The trance state is not characterized by the experience of being \\nreplaced by an alternate identity. Trance episodes are recurrent or, if the diagnosi s \\nis based on a single episode, the episode has lasted for at least several day s. The \\ntrance state is involuntary and unwanted and is not accepted as a part of a \\ncollective cultural or religious practice. The symptoms do not occur exclusivel y \\nduring another dissociative disorder and are not better explained by another mental, \\nbehavioural or neurodevelopmental disorder. The symptoms are not due to the \\ndirect effects of a substance or medication on the central nervous system, incl uding \\nwithdrawal effects, exhaustion, or to hypnagogic or hypnopompic states, and are \\nnot due to a disease of the nervous system, head trauma, or a sleep-wake disorder. \\nThe symptoms result in significant distress or significant impairment i n personal, \\nfamily, social, educational, occupational or other important areas of functioning.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 55, 'page_label': '56'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   55 \\n \\n  6B63   Possession trance disorder \\nPossession trance disorder is characterized by trance states in which there is a  \\nmarked alteration in the individual ’s state of consciousness and the individual ’s \\ncustomary sense of personal identity is replaced by an external ‘possessing’ identity \\nand in which the individual ’s behaviours or movements are experienced as being \\ncontrolled by the possessing agent. Possession trance episodes are recurrent or, if \\nthe diagnosis is based on a single episode, the episode has lasted for at lea st \\nseveral days. The possession trance state is involuntary and unwanted and is n ot \\naccepted as a part of a collective cultural or religious practice. The symptoms do not \\noccur exclusively during another dissociative disorder and are not better explained \\nby another mental, behavioural or neurodevelopmental disorder. The symptoms are \\nnot due to the direct effects of a substance or medication on the central nervo us \\nsystem, including withdrawal effects, exhaustion, or to hypnagogic or hypnopompic \\nstates, and are not due to a disease of the nervous system or a sleep-wake \\ndisorder. The symptoms result in significant distress or significant impa irment in \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning. \\nExclusions: Schizophrenia (6A20) \\nDisorders due to use of other specified psychoactive \\nsubstances, including medications (6C4E) \\nAcute and transient psychotic disorder (6A23) \\nSecondary personality change (6E68) \\n \\n  6B64   Dissociative identity disorder \\nDissociative identity disorder is characterized by disruption of identity in which there \\nare two or more distinct personality states (dissociative identities) associated w ith \\nmarked discontinuities in the sense of self and agency. Each personality state  \\nincludes its own pattern of experiencing, perceiving, conceiving, and relati ng to self, \\nthe body, and the environment. At least two distinct personality states recurr ently \\ntake executive control of the individual ’s consciousness and functioning in \\ninteracting with others or with the environment, such as in the performance of \\nspecific aspects of daily life such as parenting, or work, or in response to specific \\nsituations (e.g., those that are perceived as threatening). Changes in personality \\nstate are accompanied by related alterations in sensation, perception, affect, \\ncognition, memory, motor control, and behaviour. There are typically epis odes of \\namnesia, which may be severe. The symptoms are not better explained by anot her \\nmental, behavioural or neurodevelopmental disorder and are not due to the direct \\neffects of a substance or medication on the central nervous system, includi ng \\nwithdrawal effects, and are not due to a disease of the nervous system or a sl eep-\\nwake disorder. The symptoms result in significant impairment in personal, fami ly, \\nsocial, educational, occupational or other important areas of functioning.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 56, 'page_label': '57'}, page_content='56  ICD-11 MMS - 2018 \\n \\n  6B65   Partial dissociative identity disorder \\nPartial dissociative identity disorder is characterized by disruption of iden tity in \\nwhich there are two or more distinct personality states (dissociative identiti es) \\nassociated with marked discontinuities in the sense of self and agency. Ea ch \\npersonality state includes its own pattern of experiencing, perceiving, conceiv ing, \\nand relating to self, the body, and the environment. One personality state is \\ndominant and normally functions in daily life, but is intruded upon by on e or more \\nnon-dominant personality states (dissociative intrusions). These intrusions may be \\ncognitive, affective, perceptual, motor, or behavioral. They are experienced as \\ninterfering with the functioning of the dominant personality state and are typical ly \\naversive. The non-dominant personality states do not recurrently take executive \\ncontrol of the individual ’s consciousness and functioning, but there may be \\noccasional, limited and transient episodes in which a distinct personality  state \\nassumes executive control to engage in circumscribed behaviours, such as in \\nresponse to extreme emotional states or during episodes of self-harm or the \\nreenactment of traumatic memories. The symptoms are not better explained by \\nanother mental, behavioural or neurodevelopmental disorder and are not due to the \\ndirect effects of a substance or medication on the central nervous system, incl uding \\nwithdrawal effects, and are not due to a disease of the nervous system or a sl eep-\\nwake disorder. The symptoms result in significant impairment in personal, fami ly, \\nsocial, educational, occupational or other important areas of functioning. \\n \\n  6B66   Depersonalization-derealization disorder \\nDepersonalization-derealization disorder is characterized by persistent or recurrent \\nexperiences of depersonalization, derealization, or both. Depersonalization is \\ncharacterized by experiencing the self as strange or unreal, or feeling detach ed \\nfrom, or as though one were an outside observer of, one ’s thoughts, feelings, \\nsensations, body, or actions. Derealization is characterized by experiencing othe r \\npersons, objects, or the world as strange or unreal (e.g., dreamlike, distant, foggy, \\nlifeless, colorless, or visually distorted) or feeling detached from one ’s surroundings. \\nDuring experiences of depersonalization or derealization, reality testing remai ns \\nintact. The experiences of depersonalization or derealization do not occur \\nexclusively during another dissociative disorder and are not better explained by \\nanother mental, behavioural or neurodevelopmental disorder. The experiences of \\ndepersonalization or derealization are not due to the direct effects of a substance or \\nmedication on the central nervous system, including withdrawal effects, and are not  \\ndue to a disease of the nervous system or to head trauma. The symptoms result in \\nsignificant distress or impairment in personal, family, social, educationa l, \\noccupational or other important areas of functioning. \\n \\n  6B6Y   Other specified dissociative disorders \\n \\n  6B6Z   Dissociative disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 57, 'page_label': '58'}, page_content=\"INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   57 \\n \\nFeeding or eating disorders (BlockL1‑6B8) \\nFeeding and Eating Disorders involve abnormal eating or feeding behaviours that are  not explained \\nby another health condition and are not developmentally appropriate or culturally sanctioned. Feeding \\ndisorders involve behavioural disturbances that are not related to body weight and shape concerns, \\nsuch as eating of non-edible substances or voluntary regurgitation of foods. Eatin g disorders include \\nabnormal eating behaviour and preoccupation with food as well as prominent body weight an d shape \\nconcerns. \\n  6B80   Anorexia Nervosa \\nAnorexia Nervosa is characterized by significantly low body weight for t he \\nindividual’s height, age and developmental stage (body mass index (BMI) less than \\n18.5 kg/m2 in adults and BMI-for-age under fifth percentile in children and \\nadolescents) that is not due to another health condition or to the unavailabili ty of \\nfood. Low body weight is accompanied by a persistent pattern of behaviours to \\nprevent restoration of normal weight, which may include behaviours aimed at  \\nreducing energy intake (restricted eating), purging behaviours (e.g., self -induced \\nvomiting, misuse of laxatives), and behaviours aimed at increasing energy  \\nexpenditure (e.g., excessive exercise), typically associated with a fear of wei ght \\ngain. Low body weight or shape is central to the person's self-evaluation or is \\ninaccurately perceived to be normal or even excessive. \\n \\n6B80.0 Anorexia Nervosa with significantly low body weight \\nAnorexia Nervosa with significantly low body weight meets all definitional  \\nrequirements for Anorexia Nervosa, with BMI between 18.5 kg/m2 and 14.0 kg/m² \\nfor adults or between the fifth percentile and the 0.3 percentile for BMI-for- age in \\nchildren and adolescents). \\n \\n6B80.00 Anorexia Nervosa with significantly low body weight, restricting pattern  \\nAnorexia Nervosa with significantly low body weight, restricting pattern refers  to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\nsignificantly low body weight and who induce weight loss and maintain l ow body \\nweight through restricted food intake or fasting alone or in combination with \\nincreased energy expenditure (such as through excessive exercise) but who do not \\nengage in binge eating or purging behaviours. \\n \\n6B80.01 Anorexia Nervosa with significantly low body weight, binge-purge pattern  \\nAnorexia Nervosa with significantly low body weight, binge-purge pattern ref ers to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\nsignificantly low body weight and who present with episodes of binge eating or \\npurging behaviours. These individuals induce weight loss and maintain low b ody \\nweight through restricted food intake, commonly accompanied by significant purgi ng \\nbehaviours aimed at getting rid of ingested food (e.g. self-induced vomiting, laxative \\nabuse or enemas). This pattern also includes individuals who exhibit binge eating \\nepisodes but do not purge. \\n \\n6B80.0Z Anorexia Nervosa with significantly low body weight, unspecified\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 58, 'page_label': '59'}, page_content='58  ICD-11 MMS - 2018 \\n \\n6B80.1 Anorexia Nervosa with dangerously low body weight \\nAnorexia Nervosa with dangerously low body weight meets all definitional \\nrequirements for Anorexia Nervosa, with BMI under 14.0 kg/m² in adults or under \\nthe 0.3rd percentile for BMI-for-age in children and adolescents. In the context of \\nAnorexia Nervosa, severe underweight status is an important prognostic factor that \\nis associated with high risk of physical complications and substanti ally increased \\nmortality. \\n \\n6B80.10 Anorexia Nervosa with dangerously low body weight, restricting pattern \\nAnorexia Nervosa with dangerously low body weight, restricting pattern refers to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\ndangerously low body weight and who induce weight loss and maintain low body  \\nweight through restricted food intake or fasting alone or in combination with \\nincreased energy expenditure (such as through excessive exercise) but who do not \\nengage in binge eating or purging behaviours. \\n \\n6B80.11 Anorexia Nervosa with dangerously low body weight, binge-purge pattern \\nAnorexia Nervosa with dangerously low body weight, binge-purge pattern refers to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\ndangerously low body weight and who present with episodes of binge eating or \\npurging behaviours. These individuals induce weight loss and maintain low body \\nweight through restricted food intake, commonly accompanied by significant purgi ng \\nbehaviours aimed at getting rid of ingested food (e.g. self-induced vomiting, laxative \\nabuse or enemas). This pattern also includes individuals who exhibit binge ea ting \\nepisodes but do not purge. \\n \\n6B80.1Z Anorexia Nervosa with dangerously low body weight, unspecified \\n \\n6B80.2 Anorexia Nervosa in recovery with normal body weight \\nAmong individuals who are recovering from Anorexia Nervosa and whose body \\nweight is more than 18.5 kg/m2 for adults or over the fifth percentile for BMI-for- age \\nfor children and adolescents, the diagnosis should be retained until a full and lasting \\nrecovery is achieved, as indicated by the maintenance of a healthy weight and t he \\ncessation of behaviours aimed at reducing body weight independent of the provision \\nof treatment (e.g., for at least 1 year after intensive treatment is withdrawn). \\n \\n6B80.Y Other specified anorexia Nervosa \\n \\n6B80.Z Anorexia Nervosa, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 59, 'page_label': '60'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   59 \\n \\n  6B81   Bulimia Nervosa \\nBulimia Nervosa is characterized by frequent, recurrent episodes of binge eating  \\n(e.g., once a week or more over a period of at least one month). A binge eating \\nepisode is a distinct period of time during which the individual expe riences a \\nsubjective loss of control over eating, eating notably more or differently than usua l, \\nand feels unable to stop eating or limit the type or amount of food eaten. Binge \\neating is accompanied by repeated inappropriate compensatory behaviours aim ed \\nat preventing weight gain (e.g., self-induced vomiting, misuse of laxatives or \\nenemas, strenuous exercise). The individual is preoccupied with body shape or \\nweight, which strongly influences self-evaluation. The individual is not significantly \\nunderweight and therefore does not meet the diagnostic requirements of Anorexia \\nNervosa. \\nExclusions: Binge eating disorder (6B82) \\n \\n  6B82   Binge eating disorder \\nBinge eating disorder is characterized by frequent, recurrent episodes of binge  \\neating (e.g., once a week or more over a period of several months). A binge eating \\nepisode is a distinct period of time during which the individual expe riences a \\nsubjective loss of control over eating, eating notably more or differently than us ual, \\nand feels unable to stop eating or limit the type or amount of food eaten. Binge \\neating is experienced as very distressing, and is often accompanied by negati ve \\nemotions such as guilt or disgust. However, unlike in Bulimia Nervosa, binge eating \\nepisodes are not regularly followed by inappropriate compensatory behaviours \\naimed at preventing weight gain (e.g., self-induced vomiting, misuse of laxatives  or \\nenemas, strenuous exercise). \\nExclusions: Bulimia Nervosa (6B81) \\n \\n  6B83   Avoidant-restrictive food intake disorder \\nAvoidant-restrictive food intake disorder (ARFID) is characterized by abnormal \\neating or feeding behaviours that result in the intake of an insufficient quantity  or \\nvariety of food to meet adequate energy or nutritional requirements. The pattern of \\nrestricted eating has caused significant weight loss, failure to gain weight as \\nexpected in childhood or pregnancy, clinically significant nutritional def iciencies, \\ndependence on oral nutritional supplements or tube feeding, or has otherwise \\nnegatively affected the health of the individual or resulted in significant functional \\nimpairment. The pattern of eating behaviour does not reflect concerns about body \\nweight or shape. Restricted food intake and its effects on weight, other aspects of \\nhealth, or functioning is not better accounted for by lack of food availability , the \\neffects of a medication or substance, or another health condition. \\nExclusions: Anorexia Nervosa (6B80) \\nFeeding problem of infant (MG43.30) \\nFeeding problems of newborn (KD32)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 60, 'page_label': '61'}, page_content='60  ICD-11 MMS - 2018 \\n \\n  6B84   Pica \\nPica is characterized by the regular consumption of non-nutritive substances , such \\nas non-food objects and materials (e.g., clay, soil, chalk, plaster, pl astic, metal and \\npaper) or raw food ingredients (e.g., large quantities of salt or corn flour) that is \\npersistent or severe enough to require clinical attention in an individual  who has \\nreached a developmental age at which they would be expected to distinguish  \\nbetween edible and non-edible substances (approximately 2 years). That is, t he \\nbehavior causes damage to health, impairment in functioning, or significant  risk due \\nto the frequency, amount or nature of the substances or objects ingested. \\n \\n  6B85   Rumination-regurgitation disorder \\nRumination-regurgitation disorder is characterized by the intentional and repeated \\nbringing up of previously swallowed food back to the mouth (i.e., regurgitation) , \\nwhich may be re-chewed and re-swallowed (i.e., rumination), or may be de liberately \\nspat out (but not as in vomiting). The regurgitation behaviour is frequent (at l east \\nseveral times per week) and sustained over a period of at least several weeks. T he \\nregurgitation behaviour is not fully accounted for by another health condition t hat \\ndirectly causes regurgitation (e.g., oesophageal strictures or neuromuscular \\ndisorders affecting oesophageal functioning) or causes nausea or vomiting (e.g., \\npyloric stenosis). Rumination-regurgitation disorder should only be diagnosed in \\nindividuals who have reached a developmental age of at least 2 years. \\nExclusions: Adult rumination syndrome (DD90.6) \\nNausea or vomiting (MD90) \\n \\n  6B8Y   Other specified feeding or eating disorders \\n \\n  6B8Z   Feeding or eating disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 61, 'page_label': '62'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   61 \\n \\nElimination disorders (BlockL1‑6C0) \\nElimination disorders include the repeated voiding of urine into clothes or bed (enuresis) and the \\nrepeated passage of feces in inappropriate places (encopresis). Elimination d isorders should only be \\ndiagnosed after the individual has reached a developmental age when continence  is ordinarily \\nexpected (5 years for enuresis and 4 years for encopresis). The urinary or fecal incontinence may \\nhave been present from birth (i.e., an atypical extension of normal infantile incontinenc e), or may have \\narisen following a period of acquired bladder or bowel control. An Elimina tion disorder should not be \\ndiagnosed if the behaviour is fully attributable to another health condition that causes incontinence, \\ncongenital or acquired abnormalities of the urinary tract or bowel, or excessive use of laxatives or \\ndiuretics. \\n  6C00   Enuresis \\nEnuresis is the repeated voiding of urine into clothes or bed, which may occ ur \\nduring the day or at night, in an individual who has reached a developmental  age \\nwhen urinary continence is ordinarily expected (5 years). The urinary incontine nce \\nmay have been present from birth (i.e., an atypical extension of normal infantile \\nincontinence), or may have arisen following a period of acquired bladder contr ol. In \\nmost cases, the behaviour is involuntary but in some cases it appears intent ional. \\nEnuresis should not be diagnosed if unintentional voiding of urine is due to a health \\ncondition that interferes with continence (e.g., diseases of the nervous system  or \\nmusculoskeletal disorders) or by congenital or acquired abnormalities of the urinary \\ntract. \\nInclusions: Functional enuresis \\nPsychogenic enuresis \\nUrinary incontinence of nonorganic origin \\nExclusions: Stress incontinence (MF50.20) \\nUrge Incontinence (MF50.21) \\nFunctional urinary incontinence (MF50.23) \\nOverflow Incontinence (MF50.2) \\nReflex incontinence (MF50.24) \\nExtraurethral urinary incontinence (MF50.2) \\n \\n6C00.0 Nocturnal enuresis \\nNocturnal enuresis refers to repeated voiding of urine into clothes or bed that occurs \\nonly during sleep (i.e., during the night) in an individual who has reac hed a \\ndevelopmental age when urinary continence is ordinarily expected (5 years). The \\nurinary incontinence may have been present from birth (i.e., an atypical extension of \\nnormal infantile incontinence), or may have arisen following a period of acquired \\nbladder control. In most cases, the behaviour is involuntary but in some cases it \\nappears intentional. \\n \\n6C00.1 Diurnal enuresis \\nDiurnal enuresis refers to repeated voiding of urine into clothes that occurs only  \\nduring waking hours in an individual who has reached a developmental age when \\nurinary continence is ordinarily expected (5 years). The urinary incontinence may \\nhave been present from birth (i.e., an atypical extension of normal infantile \\nincontinence), or may have arisen following a period of acquired bladder contr ol. In \\nmost cases, the behaviour is involuntary but in some cases it appears intentional.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 62, 'page_label': '63'}, page_content='62  ICD-11 MMS - 2018 \\n \\n6C00.2 Nocturnal and diurnal enuresis \\nNocturnal and diurnal enuresis refers to repeated voiding of urine into clothes or \\nbed that occurs both during sleep (i.e., during the night) and during waking hours in \\nan individual who has reached a developmental age when urinary continence is \\nordinarily expected (5 years). The urinary incontinence may have been present from \\nbirth (i.e., an atypical extension of normal infantile incontinence), or may have \\narisen following a period of acquired bladder control. In most cases, the behavio ur \\nis involuntary but in some cases it appears intentional. \\n \\n6C00.Z Enuresis, unspecified \\n \\n  6C01   Encopresis \\nEncopresis is the repeated passage of feces in inappropriate places. Encopres is \\nshould be diagnosed if inappropriate passage of feces occurs repeatedly (e.g., at \\nleast once per month over a period of several months) in an individual wh o has \\nreached the developmental age when fecal continence is ordinarily expected (4 \\nyears). The fecal incontinence may have been present from birth (i.e., an atypi cal \\nextension of normal infantile incontinence), or may have arisen following a period  of \\nacquired bowel control. Encopresis should not be diagnosed if fecal soi ling is fully \\nattributable to another health condition (e.g., aganglionic megacolon, spina bifida, \\ndementia), congenital or acquired abnormalities of the bowel, gastrointestinal \\ninfection, or excessive use of laxatives. \\n \\n6C01.0 Encopresis with constipation or overflow incontinence \\nEncopresis is the repeated passage of feces in inappropriate places occurring \\nrepeatedly (e.g., at least once per month over a period of several months) in an \\nindividual who has reached the developmental age when fecal continence is \\nordinarily expected (4 years). The fecal incontinence may have been present from \\nbirth (i.e., an atypical extension of normal infantile incontinence), or may have \\narisen following a period of acquired bowel control. Encopresis with constipa tion \\nand overflow incontinence is the most common form of fecal soiling, and in volves \\nretention and impaction of feces. Stools are typically — but not always — poorly \\nformed (loose or liquid) and leakage may range from occasional to continuou s. \\nThere is often a history of toilet avoidance leading to constipation. \\n \\n6C01.1 Encopresis without constipation or overflow incontinence \\nEncopresis is the repeated passage of feces in inappropriate places occurring \\nrepeatedly (e.g., at least once per month over a period of several months) in an \\nindividual who has reached the developmental age when fecal continence is \\nordinarily expected (4 years). The fecal incontinence may have been present from \\nbirth (i.e., an atypical extension of normal infantile incontinence), or may have \\narisen following a period of acquired bowel control. Encopresis without con stipation \\nand overflow is not associated with retention and impaction of feces, but r ather \\nreflects reluctance, resistance or failure to conform to social norms in defecating i n \\nacceptable places in the context of normal physiological control over defecatio n. \\nStools are typically of normal consistency and inappropriate defecation is likely to \\nbe intermittent. \\n \\n6C01.Z Encopresis, unspecified \\n \\n  6C0Z   Elimination disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 63, 'page_label': '64'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   63 \\n \\nDisorders of bodily distress or bodily experience (BlockL1‑6C2) \\nDisorders of bodily distress and bodily experience are characterized by disturb ances in the person ’s \\nexperience of his or her body. Bodily distress disorder involves bodily  symptoms that the individual \\nfinds distressing and to which excessive attention is directed. Body integrity  dysphoria involves a \\ndisturbance in the person ’s experience of the body manifested by the persistent desire to have a \\nspecific physical disability accompanied by persistent discomfort, or i ntense feelings of \\ninappropriateness concerning current non-disabled body configuration. \\nExclusions: Dissociative neurological symptom disorder (6B60) \\nConcern about body appearance (BlockL2‑QD3) \\n  6C20   Bodily distress disorder \\nBodily distress disorder is characterized by the presence of bodily symptoms  that \\nare distressing to the individual and excessive attention directed toward t he \\nsymptoms, which may be manifest by repeated contact with health care providers. If \\nanother health condition is causing or contributing to the symptoms, the degree of \\nattention is clearly excessive in relation to its nature and progression. Excess ive \\nattention is not alleviated by appropriate clinical examination and invest igations and \\nappropriate reassurance. Bodily symptoms are persistent, being present on most \\ndays for at least several months. Typically, bodily distress disorder involv es multiple \\nbodily symptoms that may vary over time. Occasionally there is a single s ymptom—\\nusually pain or fatigue—that is associated with the other features of the disorder. \\nExclusions: Tourette syndrome (8A05.00) \\nHair pulling disorder (6B25.0) \\nDissociative disorders (BlockL1‑6B6) \\nhair-plucking (6B25.0) \\nHypochondriasis (6B23) \\nBody dysmorphic disorder (6B21) \\nExcoriation disorder (6B25.1) \\nGender incongruence (BlockL1‑HA6) \\nSexual dysfunctions (BlockL1‑HA0) \\nTic disorders (8A05) \\nFeigning of symptoms (MB23.B) \\nSexual pain-penetration disorder (HA20) \\n \\n6C20.0 Mild bodily distress disorder \\nAll definitional requirements of bodily distress disorder are present. Ther e is \\nexcessive attention to distressing symptoms and their consequences, which may \\nresult in frequent medical visits, but the person is not preoccupied with the \\nsymptoms (e.g., the individual spends less than an hour per day focusing on t hem). \\nAlthough the individual expresses distress about the symptoms and they m ay have \\nsome impact on his or her life (e.g., strain in relationships, less effective ac ademic \\nor occupational functioning, abandonment of specific leisure activities), ther e is no \\nsubstantial impairment in the person ’s personal, family, social, educational, \\noccupational, or other important areas of functioning.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 64, 'page_label': '65'}, page_content='64  ICD-11 MMS - 2018 \\n \\n6C20.1 Moderate bodily distress disorder \\nAll definitional requirements of bodily distress disorder are present. The re is \\npersistent preoccupation with the distressing symptoms and their consequences \\n(e.g., the individual spends more than an hour a day thinking about them), ty pically \\nassociated with frequent medical visits. The person devotes much of his or her \\nenergy to focusing on the symptoms and their consequences. The symptoms and \\nassociated distress and preoccupation cause moderate impairment in personal, \\nfamily, social, educational, occupational, or other important areas of fun ctioning \\n(e.g., relationship conflict, performance problems at work, abandonment of a range \\nof social and leisure activities). \\n \\n6C20.2 Severe bodily distress disorder \\nAll definitional requirements of Bodily distress disorder are present. Ther e is \\npervasive and persistent preoccupation with the symptoms and their consequ ences \\nto the extent that these may become the focal point of the person ’s life, typically \\nresulting in extensive interactions with the health care system. The symptoms an d \\nassociated distress and preoccupation cause serious impairment in personal, \\nfamily, social, educational, occupational, or other important areas of fun ctioning \\n(e.g., unable to work, alienation of friends and family, abandonment of nearly al l \\nsocial and leisure activities). The person ’s interests may become so narrow so as to \\nfocus almost exclusively on his or her bodily symptoms and their negative \\nconsequences. \\n \\n6C20.Z Bodily distress disorder, unspecified \\n \\n  6C21   Body integrity dysphoria \\nBody integrity dysphoria is characterized by an intense and persistent desire to \\nbecome physically disabled in a significant way (e.g., major limb amputee,  \\nparaplegic, blind), with onset by early adolescence accompanied by persiste nt \\ndiscomfort, or intense feelings of inappropriateness concerning current non-disabled \\nbody configuration. The desire to become physically disabled results in harmful \\nconsequences, as manifested by either the preoccupation with the desire (including \\ntime spent pretending to be disabled) significantly interfering with productivity, wit h \\nleisure activities, or with social functioning (e.g., person is unwilling t o have a close \\nrelationships because it would make it difficult to pretend) or by attempts to actual ly \\nbecome disabled have resulted in the person putting his or her health or life in \\nsignificant jeopardy. \\n \\n  6C2Y   Other specified disorders of bodily distress or bodily experience \\n \\n  6C2Z   Disorders of bodily distress or bodily experience, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 65, 'page_label': '66'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   65 \\n \\nDisorders due to substance use or addictive behaviours (BlockL1‑6C4) \\nDisorders due to substance use and addictive behaviours are mental and beha vioural disorders that \\ndevelop as a result of the use of predominantly psychoactive substances, includi ng medications, or \\nspecific repetitive rewarding and reinforcing behaviours. \\nDisorders due to substance use (BlockL2‑6C4) \\nDisorders due to substance use include single episodes of harmful substance use, s ubstance use \\ndisorders (harmful substance use and substance dependence), and substan ce-induced disorders \\nsuch as substance intoxication, substance withdrawal and substance-induced mental di sorders, \\nsexual dysfunctions and sleep-wake disorders. \\nCoded Elsewhere: Catatonia induced by psychoactive substances, including medications (6A41) \\n  6C40   Disorders due to use of alcohol \\nDisorders due to use of alcohol are characterised by the pattern and consequences \\nof alcohol use. In addition to Alcohol intoxication, alcohol has dependenc e-inducing \\nproperties, resulting in Alcohol dependence in some people and Alcohol withdra wal \\nwhen use is reduced or discontinued. Alcohol is implicated in a wide range of  harms \\naffecting most organs and systems of the body, which may be classified as Si ngle \\nepisode of harmful use of alcohol and Harmful pattern of use of alcohol. Harm to \\nothers resulting from behaviour during Alcohol intoxication is included in the \\ndefinitions of Harmful use of alcohol. Several alcohol-induced mental disorders and \\nalcohol-related forms of neurocognitive impairment are recognised. \\nNote: Code also the underlying condition \\nExclusions: Hazardous alcohol use (QE10) \\n \\n6C40.0 Single episode of harmful use of alcohol \\nA single episode of use of alcohol that has caused damage to a person ’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of other s. \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behavior due to alcohol intoxication on the part of the \\nperson to whom the diagnosis of single episode of harmful use applies. Thi s \\ndiagnosis should not be made if the harm is attributed to a known pattern of alcohol \\nuse. \\nExclusions: Harmful pattern of use of alcohol (6C40.1) \\nAlcohol dependence (6C40.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 66, 'page_label': '67'}, page_content='66  ICD-11 MMS - 2018 \\n \\n6C40.1 Harmful pattern of use of alcohol \\nA pattern of alcohol use that has caused damage to a person ’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of alcohol use is evident over a period of at least 12 months if sub stance \\nuse is episodic or at least one month if use is continuous. Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to alcohol intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of alcohol applies. \\nExclusions: Alcohol dependence (6C40.2) \\nSingle episode of harmful use of alcohol (6C40.0) \\n \\n6C40.10 Harmful pattern of use of alcohol, episodic \\nA pattern of episodic or intermittent alcohol use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic alcohol use is evident over a period of \\nat least 12 months. Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm  \\nto health of others includes any form of physical harm, including trauma, or mental  \\ndisorder that is directly attributable to behaviour related to alcohol intoxicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of alcohol \\napplies. \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nAlcohol dependence (6C40.2) \\n \\n6C40.11 Harmful pattern of use of alcohol, continuous \\nA pattern of continuous (daily or almost daily) alcohol use that has caused da mage \\nto a person’s physical or mental health or has resulted in behaviour leading to harm  \\nto the health of others. The pattern of continuous alcohol use is evident over a \\nperiod of at least one month. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondar y \\ntoxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to alcohol \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern  of \\nuse of alcohol applies. \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nAlcohol dependence (6C40.2) \\n \\n6C40.1Z Harmful pattern of use of alcohol, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 67, 'page_label': '68'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   67 \\n \\n6C40.2 Alcohol dependence \\nAlcohol dependence is a disorder of regulation of alcohol use arising from rep eated \\nor continuous use of alcohol. The characteristic feature is a strong internal driv e to \\nuse alcohol, which is manifested by impaired ability to control use, inc reasing \\npriority given to use over other activities and persistence of use despite harm or \\nnegative consequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use alcohol. Physiological features of depe ndence \\nmay also be present, including tolerance to the effects of alcohol, withdrawal \\nsymptoms following cessation or reduction in use of alcohol, or repeated use of \\nalcohol or pharmacologically similar substances to prevent or alleviate withdrawal \\nsymptoms. The features of dependence are usually evident over a period of at least \\n12 months but the diagnosis may be made if alcohol use is continuous (dail y or \\nalmost daily) for at least 1 month. \\nInclusions: Chronic alcoholism \\nDipsomania \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1) \\n \\n6C40.20 Alcohol dependence, current use, continuous \\nAlcohol dependence with continuous consumption of alcohol (daily or almost dail y) \\nover a period of at least 1 month. \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1) \\n \\n6C40.21 Alcohol dependence, current use, episodic \\nDuring the past 12 months, there has been alcohol dependence with intermittent \\nheavy drinking, with periods of abstinence from alcohol. If current use is con tinuous \\n(daily or almost daily over at least the past 1 month), the diagnosis of Alcoh ol \\ndependence, current use, continuous should be made instead. \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1) \\n \\n6C40.22 Alcohol dependence, early full remission \\nAfter a diagnosis of alcohol dependence, and often following a treatment episode or \\nother intervention (including self-help intervention), the individual has been  \\nabstinent from alcohol during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1) \\n \\n6C40.23 Alcohol dependence, sustained partial remission \\nAfter a diagnosis of alcohol dependence, and often following a treatment episode or \\nother intervention (including self-help intervention), there is a significant reduction in \\nalcohol consumption for more than 12 months, such that even though intermittent or \\ncontinuing drinking has occurred during this period, the definitional requir ements for \\ndependence have not been met. \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 68, 'page_label': '69'}, page_content='68  ICD-11 MMS - 2018 \\n \\n6C40.24 Alcohol dependence, sustained full remission \\nAfter a diagnosis of alcohol dependence, and often following a treatment episode or \\nother intervention (including self-intervention), the person has been abstinent fr om \\nalcohol for 12 months or longer. \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1) \\n \\n6C40.2Z Alcohol dependence, unspecified \\n \\n6C40.3 Alcohol intoxication \\nAlcohol intoxication is a clinically significant transient condition t hat develops during \\nor shortly after the consumption of alcohol that is characterized by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. Thes e \\ndisturbances are caused by the known pharmacological effects of alcohol and their \\nintensity is closely related to the amount of alcohol consumed. They are time- limited \\nand abate as alcohol is cleared from the body. Presenting features may include \\nimpaired attention, inappropriate or aggressive behaviour, lability of mood, impair ed \\njudgment, poor coordination, unsteady gait, and slurred speech. At more severe \\nlevels of intoxication, stupor or coma may occur. \\nNote: Code also the underlying condition \\nExclusions: alcohol poisoning (NE61) \\nPossession trance disorder (6B63) \\n \\n6C40.4 Alcohol withdrawal \\nAlcohol withdrawal is a clinically significant cluster of symptom s, behaviours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of alcohol in individuals who have developed Al cohol \\ndependence or have used alcohol for a prolonged period or in large amounts. \\nPresenting features of Alcohol withdrawal may include autonomic hyperacti vity, \\nincreased hand tremor, nausea, retching or vomiting, insomnia, anxiety, \\npsychomotor agitation, transient visual, tactile or auditory hallucinations , and \\ndistractibility. Less commonly, the withdrawal state is complicated by  seizures. The \\nwithdrawal state may progress to a very severe form of delirium characterized by  \\nconfusion and disorientation, delusions, and prolonged visual, tactile or auditory  \\nhallucinations. In such cases, a separate diagnosis of Alcohol-induced delirium \\nshould also be assigned. \\nNote: Code also the underlying condition \\n \\n6C40.40 Alcohol withdrawal, uncomplicated \\nAll diagnostic requirements for Alcohol Withdrawal are met and the withdrawa l state \\nis not accompanied by perceptual disturbances or seizures. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 69, 'page_label': '70'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   69 \\n \\n6C40.41 Alcohol withdrawal with perceptual disturbances \\nAll diagnostic requirements for Alcohol withdrawal are met and the withdrawal s tate \\nis accompanied by perceptual disturbances (e.g., visual or tactile hallucinati ons or \\nillusions) with intact reality testing. There is no evidence of confusion and other \\ndiagnostic requirements for Delirium are not met. The withdrawal state is not \\naccompanied by seizures. \\nNote: Code also the underlying condition \\n \\n6C40.42 Alcohol withdrawal with seizures \\nAll diagnostic requirements for Alcohol withdrawal are met and the withdrawal s tate \\nis accompanied by seizures (i.e., generalized tonic-clonic seizures) but not by \\nperceptual disturbances. \\nNote: Code also the underlying condition \\n \\n6C40.43 Alcohol withdrawal with perceptual disturbances and seizures \\nAll diagnostic requirements for Alcohol withdrawal are met and the withdrawal s tate \\nis accompanied by both seizures (i.e., generalized tonic-clonic seizures) a nd \\nperceptual disturbances (e.g., visual or tactile hallucinations or illusions) with  intact \\nreality testing. Diagnostic requirements for Delirium are not met. \\nNote: Code also the underlying condition \\n \\n6C40.4Z Alcohol withdrawal, unspecified \\nNote: Code also the underlying condition \\n \\n6C40.5 Alcohol-induced delirium \\nAlcohol-induced delirium is characterized by an acute state of disturbed attenti on \\nand awareness with specific features of delirium that develops during or soon af ter \\nsubstance intoxication or withdrawal or during the use of alcohol. The amount and \\nduration of alcohol use must be capable of producing delirium. Specific f eatures of \\nalcohol-induced delirium may include impaired consciousness with disorien tation, \\nvivid hallucinations and illusions, insomnia, delusions, agitation, disturbances of \\nattention, and accompanying tremor and physiological symptoms of alcohol \\nwithdrawal. In some cases of alcohol withdrawal, the withdrawal state may progress \\nto a very severe form of Alcohol-induced delirium. The symptoms are not better \\nexplained by a primary mental disorder, by use of or withdrawal from a diff erent \\nsubstance, or by another health condition that is not classified under Mental, \\nbehavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\nInclusions: Delirium tremens (alcohol-induced) \\nDelirium induced by alcohol withdrawal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 70, 'page_label': '71'}, page_content='70  ICD-11 MMS - 2018 \\n \\n6C40.6 Alcohol-induced psychotic disorder \\nAlcohol-induced psychotic disorder is characterized by psychotic symptoms  (e.g., \\ndelusions, hallucinations, disorganized thinking, grossly disorganized behav iour) \\nthat develop during or soon after intoxication with or withdrawal from alcohol. The \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of Alcohol  \\nintoxication or Alcohol withdrawal. The amount and duration of alcohol use must be  \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe alcohol use, if the symptoms persist for a substantial period of time after \\ncessation of the alcohol use or withdrawal, or if there is other evidence of a p re-\\nexisting primary mental disorder with psychotic symptoms (e.g., a history of pri or \\nepisodes not associated with alcohol use). \\nNote: Code also the underlying condition \\nInclusions: alcoholic jealousy \\n \\n6C40.60 Alcohol-induced psychotic disorder with hallucinations \\nAlcohol-induced psychotic disorder with hallucinations is characterized by the \\npresence of hallucinations that are judged to be the direct consequence of alcohol \\nuse. Neither delusions nor other psychotic symptoms are present. The symptoms \\ndo not occur exclusively during hypnogogic or hypnopompic states, are not better \\naccounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms). \\nNote: Code also the underlying condition \\n \\n6C40.61 Alcohol-induced psychotic disorder with delusions \\nAlcohol-induced psychotic disorder with delusions is characterized by the presenc e \\nof delusions that are judged to be the direct consequence of alcohol use. Neither \\nhallucinations nor other psychotic symptoms are present. The symptoms do not  \\noccur exclusively during hypnogogic or hypnopompic states, are not better \\naccounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms). \\nNote: Code also the underlying condition \\n \\n6C40.62 Alcohol-induced psychotic disorder with mixed psychotic symptoms \\nAlcohol-induced psychotic disorder with mixed psychotic symptoms is char acterized \\nby the presence of multiple psychotic symptoms, primarily hallucinations and \\ndelusions, when these are judged to be the direct consequence of alcohol use. The \\nsymptoms do not occur exclusively during hypnogogic or hypnopompic states, are \\nnot better accounted for by another mental and behavioural disorder (e.g., \\nschizophrenia), and are not due to another disorder or disease classified elsewh ere \\n(e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C40.6Z Alcohol-induced psychotic disorder, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 71, 'page_label': '72'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   71 \\n \\n6C40.7 Other alcohol-induced disorders \\nNote: Code also the underlying condition \\nCoded Elsewhere: Amnestic disorder due to use of alcohol (6D72.10) \\nDementia due to use of alcohol (6D84.0) \\n \\n6C40.70 Alcohol-induced mood disorder \\nAlcohol-induced mood disorder is characterized by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intox ication \\nwith or withdrawal from alcohol. The intensity or duration of the symptoms is \\nsubstantially in excess of mood disturbances that are characteristic of Alcohol \\nintoxication or Alcohol withdrawal. The amount and duration of alcohol use must be \\ncapable of producing mood symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, \\nSchizoaffective disorder), as might be the case if the mood symptoms precede d the \\nonset of the alcohol use, if the symptoms persist for a substantial period of time \\nafter cessation of the alcohol use or withdrawal, or if there is other evidence of a \\npre-existing primary mental disorder with mood symptoms (e.g., a history of prio r \\nepisodes not associated with alcohol use). \\nNote: Code also the underlying condition \\n \\n6C40.71 Alcohol-induced anxiety disorder \\nAlcohol-induced anxiety disorder is characterized by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic  \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from alcohol. The intensity or duration of the symptoms is substantially in  \\nexcess of anxiety symptoms that are characteristic of Alcohol intoxication or Alc ohol \\nwithdrawal. The amount and duration of alcohol use must be capable of producing \\nanxiety symptoms. The symptoms are not better explained by a primary mental \\ndisorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with \\nprominent anxiety symptoms), as might be the case if the anxiety symptoms \\npreceded the onset of the alcohol use, if the symptoms persist for a substantial \\nperiod of time after cessation of the alcohol use or withdrawal, or if there is oth er \\nevidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with alcohol use). \\nNote: Code also the underlying condition \\n \\n6C40.Y Other specified disorders due to use of alcohol \\nNote: Code also the underlying condition \\n \\n6C40.Z Disorders due to use of alcohol, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 72, 'page_label': '73'}, page_content='72  ICD-11 MMS - 2018 \\n \\n  6C41   Disorders due to use of cannabis \\nDisorders due to use of cannabis are characterised by the pattern and \\nconsequences of cannabis use. In addition to Cannabis intoxication, cannabis has \\ndependence-inducing properties, resulting in Cannabis dependence in some people \\nand Cannabis withdrawal when use is reduced or discontinued. Cannabis is \\nimplicated in a wide range of harms affecting most organs and systems of the bo dy, \\nwhich may be classified as Single episode of harmful use of cannabis an d Harmful \\npattern of use of cannabis. Harm to others resulting from behaviour during \\nCannabis intoxication is included in the definitions of Harmful use of cannabi s. \\nSeveral cannabis-induced mental disorders are recognised. \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of synthetic cannabinoids (6C42) \\nHazardous use of cannabis (QE11.1) \\n \\n6C41.0 Single episode of harmful use of cannabis \\nA single episode of use of cannabis that has caused damage to a person ’s physical \\nor mental health or has resulted in behaviour leading to harm to the health of others. \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behavior due to cannabis intoxication on the par t of the \\nperson to whom the diagnosis of single episode of harmful use applies. Thi s \\ndiagnosis should not be made if the harm is attributed to a known pattern of \\ncannabis use. \\nExclusions: Cannabis dependence (6C41.2) \\nHarmful pattern of use of cannabis (6C41.1) \\n \\n6C41.1 Harmful pattern of use of cannabis \\nA pattern of cannabis use that has caused damage to a person ’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of cannabis use is evident over a period of at least 12 months if substan ce \\nuse is episodic or at least one month if use is continuous (i.e., daily or a lmost daily). \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behaviour related to cannabis intoxication on th e part of the \\nperson to whom the diagnosis of Harmful pattern of use of cannabis applies. \\nExclusions: Cannabis dependence (6C41.2) \\nSingle episode of harmful use of cannabis (6C41.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 73, 'page_label': '74'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   73 \\n \\n6C41.10 Harmful pattern of use of cannabis, episodic \\nA pattern of episodic or intermittent cannabis use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic cannabis use is evident over a period of \\nat least 12 months. Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm  \\nto health of others includes any form of physical harm, including trauma, or mental  \\ndisorder that is directly attributable to behaviour related to cannabis intoxicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of cannabi s \\napplies. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nCannabis dependence (6C41.2) \\n \\n6C41.11 Harmful pattern of use of cannabis, continuous \\nA pattern of continuous (daily or almost daily) cannabis use that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous cannabis use is eviden t \\nover a period of at least one month. Harm to health of the individual occurs due to \\none or more of the following: (1) behaviour related to intoxication; (2) direct  or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto cannabis intoxication on the part of the person to whom the diagnosis of Harmful \\npattern of use of cannabis applies. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nCannabis dependence (6C41.2) \\n \\n6C41.1Z Harmful pattern of use of cannabis, unspecified \\n \\n6C41.2 Cannabis dependence \\nCannabis dependence is a disorder of regulation of cannabis use arising from  \\nrepeated or continuous use of cannabis. The characteristic feature is a strong \\ninternal drive to use cannabis, which is manifested by impaired ability t o control use, \\nincreasing priority given to use over other activities and persistence of use despi te \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use cannabis. Physiological f eatures of \\ndependence may also be present, including tolerance to the effects of cannabis, \\nwithdrawal symptoms following cessation or reduction in use of cannabis, or \\nrepeated use of cannabis or pharmacologically similar substances to prevent or \\nalleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months but the diagnosis may be made if cannabis use \\nis continuous (daily or almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nHarmful pattern of use of cannabis (6C41.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 74, 'page_label': '75'}, page_content='74  ICD-11 MMS - 2018 \\n \\n6C41.20 Cannabis dependence, current use \\nCurrent cannabis dependence with use of cannabis within the past month. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nHarmful pattern of use of cannabis (6C41.1) \\n \\n6C41.21 Cannabis dependence, early full remission \\nAfter a diagnosis of cannabis dependence, and often following a treatment episode  \\nor other intervention (including self-help intervention), the individual has been  \\nabstinent from cannabis during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nHarmful pattern of use of cannabis (6C41.1) \\n \\n6C41.22 Cannabis dependence, sustained partial remission \\nAfter a diagnosis of cannabis dependence, and often following a treatment episode  \\nor other intervention (including self-help intervention), there is a signific ant reduction \\nin cannabis consumption for more than 12 months, such that even though cannabis \\nuse has occurred during this period, the definitional requirements for dependence  \\nhave not been met. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nHarmful pattern of use of cannabis (6C41.1) \\n \\n6C41.23 Cannabis dependence, sustained full remission \\nAfter a diagnosis of cannabis dependence, and often following a treatment episode  \\nor other intervention (including self-intervention), the person has been abs tinent \\nfrom cannabis for 12 months or longer. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nHarmful pattern of use of cannabis (6C41.1) \\n \\n6C41.2Z Cannabis dependence, unspecified \\n \\n6C41.3 Cannabis intoxication \\nCannabis intoxication is a clinically significant transient conditi on that develops \\nduring or shortly after the consumption of cannabis that is characterized by \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof cannabis and their intensity is closely related to the amount of cannabis  \\nconsumed. They are time-limited and abate as cannabis is cleared from the bo dy. \\nPresenting features may include inappropriate euphoria, impaired attention, \\nimpaired judgment, perceptual alterations (such as the sensation of floating, a ltered \\nperception of time), changes in sociability, increased appetite, anxiety, \\nintensification of ordinary experiences, impaired short-term memory, and \\nsluggishness. Physical signs include conjunctival injection (red or bloodshot eyes) \\nand tachycardia. \\nNote: Code also the underlying condition \\nInclusions: \"Bad trips\" (cannabinoids) \\nExclusions: cannabinoid poisoning (NE60) \\nPossession trance disorder (6B63)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 75, 'page_label': '76'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   75 \\n \\n6C41.4 Cannabis withdrawal \\nCannabis withdrawal is a clinically significant cluster of symptoms, be haviours \\nand/or physiological features, varying in degree of severity and duration, that occurs \\nupon cessation or reduction of use of cannabis in individuals who have dev eloped \\nCannabis dependence or have used cannabis for a prolonged period or in large \\namounts. Presenting features of Cannabis withdrawal may include irritability, anger, \\nshakiness, insomnia, restlessness, anxiety, dysphoric mood, appetite disturbance, \\nabdominal cramps and muscle aches. \\nNote: Code also the underlying condition \\n \\n6C41.5 Cannabis-induced delirium \\nCannabis-induced delirium is characterized by an acute state of disturbed attention \\nand awareness with specific features of delirium that develops during or soon af ter \\nsubstance intoxication or withdrawal or during the use of cannabis. The amount and \\nduration of cannabis use must be capable of producing delirium. The symptoms are \\nnot better explained by a primary mental disorder, by use of or withdrawal from a  \\ndifferent substance, or by another health condition that is not classified unde r \\nMental, behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C41.6 Cannabis-induced psychotic disorder \\nCannabis-induced psychotic disorder is characterized by psychotic symptoms (e.g., \\ndelusions, hallucinations, disorganized thinking, grossly disorganized behav iour) \\nthat develop during or soon after intoxication with or withdrawal from cannabis. The \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nCannabis intoxication or Cannabis withdrawal. The amount and duration of \\ncannabis use must be capable of producing psychotic symptoms. The symptoms \\nare not better explained by a primary mental disorder (e.g., Schizophrenia, a Mood \\ndisorder with psychotic symptoms), as might be the case if the psychotic sym ptoms \\npreceded the onset of the cannabis use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cannabis use or withdrawal, or if there is o ther \\nevidence of a pre-existing primary mental disorder with psychotic symptoms (e.g ., a \\nhistory of prior episodes not associated with cannabis use). \\nNote: Code also the underlying condition \\n \\n6C41.7 Other cannabis-induced disorders \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 76, 'page_label': '77'}, page_content='76  ICD-11 MMS - 2018 \\n \\n6C41.70 Cannabis-induced mood disorder \\nCannabis-induced mood disorder is characterized by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxi cation \\nwith or withdrawal from cannabis. The intensity or duration of the symptoms is \\nsubstantially in excess of mood disturbances that are characteristic of Cannabi s \\nintoxication or Cannabis withdrawal. The amount and duration of cannabis use must \\nbe capable of producing mood symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, \\nSchizoaffective disorder), as might be the case if the mood symptoms preceded  the \\nonset of the cannabis use, if the symptoms persist for a substantial period of  time \\nafter cessation of the cannabis use or withdrawal, or if there is other evidence of a \\npre-existing primary mental disorder with mood symptoms (e.g., a history of prior \\nepisodes not associated with cannabis use). \\nNote: Code also the underlying condition \\n \\n6C41.71 Cannabis-induced anxiety disorder \\nCannabis-induced anxiety disorder is characterized by anxiety symptoms (e.g.,  \\napprehension or worry, fear, physiological symptoms of excessive autonomic  \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from cannabis. The intensity or duration of the symptoms is sub stantially \\nin excess of anxiety symptoms that are characteristic of Cannabis intoxication or \\nCannabis withdrawal. The amount and duration of cannabis use must be capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety sympto ms \\npreceded the onset of the cannabis use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cannabis use or withdrawal, or if there is o ther \\nevidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with cannabis use). \\nNote: Code also the underlying condition \\n \\n6C41.Y Other specified disorders due to use of cannabis \\nNote: Code also the underlying condition \\n \\n6C41.Z Disorders due to use of cannabis, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 77, 'page_label': '78'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   77 \\n \\n  6C42   Disorders due to use of synthetic cannabinoids \\nDisorders due to use of synthetic cannabinoids are characterised by the pattern and \\nconsequences of synthetic cannabinoid use. In addition to Synthetic cannabinoid  \\nintoxication, synthetic cannabinoids have dependence-inducing properties, result ing \\nin Synthetic cannabinoid dependence in some people and Synthetic cannabinoid \\nwithdrawal when use is reduced or discontinued. Synthetic cannabinoids are \\nimplicated in a wide range of harms affecting most organs and systems of the bo dy, \\nwhich may be classified as Single episode of harmful use of synthetic cannabinoid \\nand Harmful pattern of use of synthetic cannabinoid. Harm to others resulting fro m \\nbehaviour during Synthetic cannabinoid intoxication is included in the definiti ons of \\nHarmful use of synthetic cannabinoids. Several Synthetic cannabinoid- induced \\nmental disorders are recognised. \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of cannabis (6C41) \\n \\n6C42.0 Single episode of harmful use of synthetic cannabinoids \\nA single episode of use of a synthetic cannabinoid that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm  \\nto health of others includes any form of physical harm, including trauma, or men tal \\ndisorder that is directly attributable to behavior due to synthetic cannabinoid \\nintoxication on the part of the person to whom the diagnosis of single episo de of \\nharmful use applies. This diagnosis should not be made if the harm is attri buted to a \\nknown pattern of synthetic cannabinoid use. \\nExclusions: Harmful pattern of use of synthetic cannabinoids (6C42.1) \\nSynthetic cannabinoid dependence (6C42.2) \\n \\n6C42.1 Harmful pattern of use of synthetic cannabinoids \\nA pattern of use of synthetic cannabinoids that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health \\nof others. The pattern of synthetic cannabinoid use is evident over a period of  at \\nleast 12 months if substance use is episodic or at least one month if use i s \\ncontinuous (i.e., daily or almost daily). Harm to health of the individual oc curs due to \\none or more of the following: (1) behaviour related to intoxication; (2) direct  or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto synthetic cannabinoid intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of synthetic cannabinoids applies. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nSynthetic cannabinoid dependence (6C42.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 78, 'page_label': '79'}, page_content='78  ICD-11 MMS - 2018 \\n \\n6C42.10 Harmful pattern of use of synthetic cannabinoids, episodic \\nA pattern of episodic or intermittent use of synthetic cannabinoids that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of episodic synthetic cannabinoid use i s \\nevident over a period of at least 12 months. Harm to health of the individual occur s \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto synthetic cannabinoid intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of synthetic cannabinoids applies. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nSynthetic cannabinoid dependence (6C42.2) \\n \\n6C42.11 Harmful pattern of use of synthetic cannabinoids, continuous \\nA pattern of continuous (daily or almost daily) use of synthetic cannabinoi ds that \\nhas caused damage to a person ’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. The pattern of continuous \\nsynthetic cannabinoid use is evident over a period of at least one month. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behavi our \\nrelated to intoxication; (2) direct or secondary toxic effects on body organs and \\nsystems; or (3) a harmful route of administration. Harm to health of others includes \\nany form of physical harm, including trauma, or mental disorder that is directl y \\nattributable to behaviour related to synthetic cannabinoid intoxication o n the part of \\nthe person to whom the diagnosis of Harmful pattern of use of synthetic \\ncannabinoids applies. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nSynthetic cannabinoid dependence (6C42.2) \\n \\n6C42.1Y Other specified harmful pattern of use of synthetic cannabinoids \\n \\n6C42.1Z Harmful pattern of use of synthetic cannabinoids, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 79, 'page_label': '80'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   79 \\n \\n6C42.2 Synthetic cannabinoid dependence \\nSynthetic cannabinoid dependence is a disorder of regulation of synthetic  \\ncannabinoid use arising from repeated or continuous use of synthetic cannabinoi ds. \\nThe characteristic feature is a strong internal drive to use synthetic cannab inoids, \\nwhich is manifested by impaired ability to control use, increasing priority gi ven to \\nuse over other activities and persistence of use despite harm or negative \\nconsequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use synthetic cannabinoids. Physiological features of \\ndependence may also be present, including tolerance to the effects of synthetic \\ncannabinoids, withdrawal symptoms following cessation or reduction in use of \\nsynthetic cannabinoids, or repeated use of synthetic cannabinoids or \\npharmacologically similar substances to prevent or alleviate withdrawal symptoms.  \\nThe features of dependence are usually evident over a period of at least 12 months \\nbut the diagnosis may be made if synthetic cannabinoid use is continu ous (daily or \\nalmost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nHarmful pattern of use of synthetic cannabinoids (6C42.1) \\n \\n6C42.20 Synthetic cannabinoid dependence, current use \\nCurrent synthetic cannabinoid dependence with use of synthetic cannabinoids \\nwithin the past month. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nHarmful pattern of use of synthetic cannabinoids (6C42.1) \\n \\n6C42.21 Synthetic cannabinoid dependence, early full remission \\nAfter a diagnosis of synthetic cannabinoid dependence, and often following a \\ntreatment episode or other intervention (including self-help intervention), the \\nindividual has been abstinent from synthetic cannabinoid use during a period lasting \\nfrom between 1 and 12 months. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nHarmful pattern of use of synthetic cannabinoids (6C42.1) \\n \\n6C42.22 Synthetic cannabinoid dependence, sustained partial remission \\nAfter a diagnosis of synthetic cannabinoid dependence, and often following a \\ntreatment episode or other intervention (including self-help intervention), ther e is a \\nsignificant reduction in synthetic cannabinoid consumption for more than 12 months, \\nsuch that even though synthetic cannabinoid use has occurred during this perio d, \\nthe definitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nHarmful pattern of use of synthetic cannabinoids (6C42.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 80, 'page_label': '81'}, page_content='80  ICD-11 MMS - 2018 \\n \\n6C42.23 Synthetic cannabinoid dependence, sustained full remission \\nAfter a diagnosis of synthetic cannabinoid dependence, and often following a \\ntreatment episode or other intervention (including self-intervention), the person has \\nbeen abstinent from synthetic cannabinoid use for 12 months or longer. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nHarmful pattern of use of synthetic cannabinoids (6C42.1) \\n \\n6C42.2Y Other specified synthetic cannabinoid dependence \\n \\n6C42.2Z Synthetic cannabinoid dependence, unspecified \\n \\n6C42.3 Synthetic cannabinoid intoxication \\nSynthetic cannabinoid intoxication is a clinically significant transien t condition that \\ndevelops during or shortly after the consumption of synthetic cannabinoids that is \\ncharacterized by disturbances in consciousness, cognition, perception, affect, \\nbehaviour, or coordination. These disturbances are caused by the known \\npharmacological effects of synthetic cannabinoids and their intensity is closely \\nrelated to the amount of synthetic cannabinoid consumed. They are time-limited and \\nabate as synthetic cannabinoid is cleared from the body. Presenting features m ay \\ninclude inappropriate euphoria, impaired attention, impaired judgment, perceptual  \\nalterations (such as the sensation of floating, altered perception of time), changes in  \\nsociability, increased appetite, anxiety, intensification of ordinary ex periences, \\nimpaired short-term memory, and sluggishness. Physical signs include c onjunctival \\ninjection (red or bloodshot eyes) and tachycardia. Intoxication with syntheti c \\ncannabinoids may also cause delirium or acute psychosis. \\nNote: Code also the underlying condition \\n \\n6C42.4 Synthetic cannabinoid withdrawal \\nSynthetic cannabinoid withdrawal is a clinically significant clus ter of symptoms, \\nbehaviours and/or physiological features, varying in degree of severity and durati on, \\nthat occurs upon cessation or reduction of use of synthetic cannabinoids in \\nindividuals who have developed Synthetic cannabinoid dependence or have used \\nsynthetic cannabinoids for a prolonged period or in large amounts. Presenting \\nfeatures of Synthetic cannabinoid withdrawal may include irritability, ang er, \\naggression, shakiness, insomnia and disturbing dreams, restlessness, anxiety , \\ndepressed mood and appetite disturbance. In the early phase, Synthetic \\ncannabinoid withdrawal may be accompanied by residual features of intoxi cation \\nfrom the drug, such as paranoid ideation and auditory and visual hallucinations. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 81, 'page_label': '82'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   81 \\n \\n6C42.5 Synthetic cannabinoid-induced delirium \\nSynthetic cannabinoid-induced delirium is characterized by an acute state  of \\ndisturbed attention and awareness with specific features of delirium that develo ps \\nduring or soon after substance intoxication or withdrawal or during the use of \\nsynthetic cannabinoids. The amount and duration of synthetic cannabinoid use must \\nbe capable of producing delirium. The symptoms are not better explained by a \\nprimary mental disorder, by use of or withdrawal from a different substance, or by \\nanother health condition that is not classified under Mental, behavioural and \\nneurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C42.6 Synthetic cannabinoid-induced psychotic disorder \\nSynthetic cannabinoid-induced psychotic disorder is characterized by psyc hotic \\nsymptoms (e.g., delusions, hallucinations, disorganized thinking, grossly \\ndisorganized behaviour) that develop during or soon after intoxication with or \\nwithdrawal from synthetic cannabinoids. The intensity or duration of the symptom s \\nis substantially in excess of psychotic-like disturbances of perception , cognition, or \\nbehaviour that are characteristic of Synthetic cannabinoid intoxication or Synth etic \\ncannabinoid withdrawal. The amount and duration of synthetic cannabinoid use \\nmust be capable of producing psychotic symptoms. The symptoms are not better \\nexplained by a primary mental disorder (e.g., Schizophrenia, a Mood disorder with \\npsychotic symptoms), as might be the case if the psychotic symptoms preceded  the \\nonset of the synthetic cannabinoid use, if the symptoms persist for a s ubstantial \\nperiod of time after cessation of the synthetic cannabinoid use or withdrawal, or i f \\nthere is other evidence of a pre-existing primary mental disorder with psycho tic \\nsymptoms (e.g., a history of prior episodes not associated with synthetic \\ncannabinoid use). \\nNote: Code also the underlying condition \\n \\n6C42.7 Other synthetic cannabinoids-induced disorders \\nNote: Code also the underlying condition \\n \\n6C42.70 Synthetic cannabinoid-induced mood disorder \\nSynthetic cannabinoid-induced mood disorder is characterized by mood sympto ms \\n(e.g., depressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intox ication \\nwith or withdrawal from synthetic cannabinoids. The intensity or duration of  the \\nsymptoms is substantially in excess of mood disturbances that are characteristic of \\nSynthetic cannabinoid intoxication or Synthetic cannabinoid withdrawal. The amount \\nand duration of synthetic cannabinoid use must be capable of producing mood \\nsymptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), as migh t \\nbe the case if the mood symptoms preceded the onset of the synthetic cannabinoi d \\nuse, if the symptoms persist for a substantial period of time after cessation of  the \\nsynthetic cannabinoid use or withdrawal, or if there is other evidence of a pre-\\nexisting primary mental disorder with mood symptoms (e.g., a history of prior \\nepisodes not associated with synthetic cannabinoid use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 82, 'page_label': '83'}, page_content='82  ICD-11 MMS - 2018 \\n \\n6C42.71 Synthetic cannabinoid-induced anxiety disorder \\nSynthetic cannabinoid-induced anxiety disorder is characterized by anxiety  \\nsymptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive \\nautonomic arousal, avoidance behaviour) that develop during or soon after \\nintoxication with or withdrawal from synthetic cannabinoids. The intensity or duration  \\nof the symptoms is substantially in excess of anxiety symptoms that are \\ncharacteristic of Synthetic cannabinoid intoxication or Synthetic cannabinoid \\nwithdrawal. The amount and duration of synthetic cannabinoid use must be capable \\nof producing anxiety symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive \\nDisorder with prominent anxiety symptoms), as might be the case if the anxiety \\nsymptoms preceded the onset of the synthetic cannabinoid use, if the symptoms \\npersist for a substantial period of time after cessation of the synthetic cann abinoid \\nuse or withdrawal, or if there is other evidence of a pre-existing primary mental \\ndisorder with anxiety symptoms (e.g., a history of prior episodes not associated  with \\nsynthetic cannabinoid use). \\nNote: Code also the underlying condition \\n \\n  6C43   Disorders due to use of opioids \\nDisorders due to use of opioids are characterised by the pattern and consequences \\nof opioid use. In addition to Opioid intoxication, opioids have dependence-induc ing \\nproperties, resulting in Opioid dependence in some people and Opioid withdra wal \\nwhen use is reduced or discontinued. Opioids are implicated in a wide range  of \\nharms affecting most organs and systems of the body, which may be classifi ed as \\nSingle episode of harmful use of opioids and Harmful pattern of use of opioids.  \\nHarm to others resulting from behaviour during Opioid intoxication is included i n the \\ndefinitions of Harmful use of opioids. Several opioid-induced mental disorders a re \\nrecognised. \\nNote: Code also the underlying condition \\nExclusions: Hazardous use of opioids (QE11.0) \\n \\n6C43.0 Single episode of harmful use of opioids \\nA single episode of opioid use that has caused damage to a person ’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of other s. \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on bod y \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behavior due to opioid intoxication on the part of the pers on \\nto whom the diagnosis of single episode of harmful use applies. This diag nosis \\nshould not be made if the harm is attributed to a known pattern of opioid use. \\nExclusions: Harmful pattern of use of opioids (6C43.1) \\nOpioid dependence (6C43.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 83, 'page_label': '84'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   83 \\n \\n6C43.1 Harmful pattern of use of opioids \\nA pattern of use of opioids that has caused damage to a person’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of opioid use is evident over a period of at least 12 months if sub stance use \\nis episodic or at least one month if use is continuous (i.e., daily or alm ost daily). \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body  \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behaviour related to opioid intoxication on the part of the \\nperson to whom the diagnosis of Harmful pattern of use of opioids applies. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nOpioid dependence (6C43.2) \\n \\n6C43.10 Harmful pattern of use of opioids, episodic \\nA pattern of episodic or intermittent use of opioids that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic opioid use is evident over a period of at \\nleast 12 months. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to opioid intoxic ation on the \\npart of the person to whom the diagnosis of Harmful pattern of use of opioids \\napplies. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nOpioid dependence (6C43.2) \\n \\n6C43.11 Harmful pattern of use of opioids, continuous \\nA pattern of continuous (daily or almost daily) use of opioids that has cau sed \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous opioid use is evident over \\na period of at least one month. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to opioid intoxication \\non the part of the person to whom the diagnosis of Harmful pattern of use of opioids \\napplies. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nOpioid dependence (6C43.2) \\n \\n6C43.1Z Harmful pattern of use of opioids, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 84, 'page_label': '85'}, page_content='84  ICD-11 MMS - 2018 \\n \\n6C43.2 Opioid dependence \\nOpioid dependence is a disorder of regulation of opioid use arising from r epeated or \\ncontinuous use of opioids. The characteristic feature is a strong internal drive to use \\nopioids, which is manifested by impaired ability to control use, increasin g priority \\ngiven to use over other activities and persistence of use despite harm or negativ e \\nconsequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use opioids. Physiological features of depend ence \\nmay also be present, including tolerance to the effects of opioids, withdrawal \\nsymptoms following cessation or reduction in use of opioids, or repeated use of \\nopioids or pharmacologically similar substances to prevent or alleviate withdrawal \\nsymptoms. The features of dependence are usually evident over a period of at least \\n12 months but the diagnosis may be made if opioid use is continuous (da ily or \\nalmost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nHarmful pattern of use of opioids (6C43.1) \\n \\n6C43.20 Opioid dependence, current use \\nOpioid dependence, with use of an opioid within the past month. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nHarmful pattern of use of opioids (6C43.1) \\n \\n6C43.21 Opioid dependence, early full remission \\nAfter a diagnosis of opioid dependence, and often following a treatment episode or \\nother intervention (including self-help intervention), the individual has be en \\nabstinent from opioid use during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nHarmful pattern of use of opioids (6C43.1) \\n \\n6C43.22 Opioid dependence, sustained partial remission \\nAfter a diagnosis of Opioid dependence, and often following a treatment episode or \\nother intervention (including self-help intervention), there is a significant r eduction in \\nopioid consumption for more than 12 months, such that even though opioid use has \\noccurred during this period, the definitional requirements for dependence have not \\nbeen met. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nHarmful pattern of use of opioids (6C43.1) \\n \\n6C43.23 Opioid dependence, sustained full remission \\nAfter a diagnosis of Opioid dependence, and often following a treatment episode or \\nother intervention (including self-intervention), the person has been abstinent fr om \\nopioids for 12 months or longer. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nHarmful pattern of use of opioids (6C43.1) \\n \\n6C43.2Z Opioid dependence, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 85, 'page_label': '86'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   85 \\n \\n6C43.3 Opioid intoxication \\nOpioid intoxication is a clinically significant transient condition th at develops during \\nor shortly after the consumption of opioids that is characterized by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. These \\ndisturbances are caused by the known pharmacological effects of opioids and their \\nintensity is closely related to the amount of opioids consumed. They are time- limited \\nand abate as opioids are cleared from the body. Presenting features may incl ude \\nsomnolence, mood changes (e.g., inappropriate euphoria followed by apathy and \\ndysphoria), reduced movement, impaired judgment, respiratory depression, slurred  \\nspeech, and impairment of memory and attention. In severe intoxication coma may \\nensue. A characteristic physical sign is pupillary constriction but this s ign may be \\nabsent when intoxication is due to synthetic opioids. Severe opioid i ntoxication can \\nlead to death due to excessive respiratory depression. \\nNote: Code also the underlying condition \\nExclusions: opioid poisoning (NE60) \\nPossession trance disorder (6B63) \\n \\n6C43.4 Opioid withdrawal \\nOpioid withdrawal is a clinically significant cluster of symptoms, be haviours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of opioids in individuals who have developed Opioi d \\ndependence or have used opioids for a prolonged period or in large amounts. \\nOpioid withdrawal can also occur when prescribed opioids have been used in \\nstandard therapeutic doses. Presenting features of Opioid withdrawal may inc lude \\ndysphoric mood, craving for an opioid, anxiety, nausea or vomiting, abdomi nal \\ncramps, muscle aches, yawning, perspiration, hot and cold flushes, lacrimation, \\nrhinorrhea, hypersomnia (typically in the initial phase) or insomnia, diarrhoe a and \\npiloerection. \\nNote: Code also the underlying condition \\n \\n6C43.5 Opioid-induced delirium \\nOpioid-induced delirium is characterized by an acute state of disturbed attention  \\nand awareness with specific features of delirium that develops during or soon af ter \\nsubstance intoxication or withdrawal or during the use of opioids. The amount and \\nduration of opioid use must be capable of producing delirium. The symptoms are \\nnot better explained by a primary mental disorder, by use of or withdrawal from a  \\ndifferent substance, or by another health condition that is not classified un der \\nMental, Behavioural, and Neurodevelopmental Disorders. \\nNote: Code also the underlying condition \\nInclusions: Delirium induced by opioid withdrawal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 86, 'page_label': '87'}, page_content='86  ICD-11 MMS - 2018 \\n \\n6C43.6 Opioid-induced psychotic disorder \\nOpioid-induced psychotic disorder is characterized by psychotic symptoms  (e.g., \\ndelusions, hallucinations, disorganized thinking, grossly disorganized behavi our) \\nthat develop during or soon after intoxication with or withdrawal from opioids. The \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of Opioid \\nintoxication or Opioid withdrawal. The amount and duration of opioid use must  be \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe opioid use, if the symptoms persist for a substantial period of time after \\ncessation of the opioid use or withdrawal, or if there is other evidence of a pre-\\nexisting primary mental disorder with psychotic symptoms (e.g., a history of pri or \\nepisodes not associated with opioid use). \\nNote: Code also the underlying condition \\n \\n6C43.7 Other opioid-induced disorders \\nNote: Code also the underlying condition \\n \\n6C43.70 Opioid-induced mood disorder \\nOpioid-induced mood disorder is characterized by mood symptoms (e.g., depressed  \\nor elevated mood, decreased engagement in pleasurable activities, increased or \\ndecreased energy levels) that develop during or soon after intoxication with or \\nwithdrawal from opioids. The intensity or duration of the symptoms is substantially in \\nexcess of mood disturbances that are characteristic of Opioid intoxication or Opioid \\nwithdrawal. The amount and duration of opioid use must be capable of producing \\nmood symptoms. The symptoms are not better explained by a primary mental \\ndisorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disord er), \\nas might be the case if the mood symptoms preceded the onset of the opioid use, if \\nthe symptoms persist for a substantial period of time after cessation of the opi oid \\nuse or withdrawal, or if there is other evidence of a pre-existing primary mental \\ndisorder with mood symptoms (e.g., a history of prior episodes not associated with \\nopioid use). \\n \\n6C43.71 Opioid-induced anxiety disorder \\nOpioid-induced anxiety disorder is characterized by anxiety symptoms (e. g., \\napprehension or worry, fear, physiological symptoms of excessive autonomi c \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from opioids. The intensity or duration of the symptoms is substantially in \\nexcess of anxiety symptoms that are characteristic of Opioid intoxication or Opioid \\nwithdrawal. The amount and duration of opioid use must be capable of producing \\nanxiety symptoms. The symptoms are not better explained by a primary mental \\ndisorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with \\nprominent anxiety symptoms), as might be the case if the anxiety symptoms \\npreceded the onset of the opioid use, if the symptoms persist for a substantial \\nperiod of time after cessation of the opioid use or withdrawal, or if there is oth er \\nevidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with opioid use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 87, 'page_label': '88'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   87 \\n \\n6C43.Y Other specified disorders due to use of opioids \\nNote: Code also the underlying condition \\n \\n6C43.Z Disorders due to use of opioids, unspecified \\nNote: Code also the underlying condition \\n \\n  6C44   Disorders due to use of sedatives, hypnotics or anxiolytics \\nDisorders due to use of sedatives, hypnotics or anxiolytics are characterized b y the \\npattern and consequences of sedative use. In addition to Sedative, hypnotic or  \\nanxiolytic intoxication, sedatives have dependence-inducing properties, resulti ng in \\nSedative, hypnotic or anxiolytic dependence in some people and Sedative, hyp notic \\nor anxiolytic withdrawal when use is reduced or discontinued. Sedatives are \\nimplicated in a wide range of harms affecting most organs and systems of the bo dy, \\nwhich may be classified as Single episode of harmful use of sedatives , hypnotics or \\nanxiolytics and Harmful pattern of use of sedatives, hypnotics or anxiolyti cs. Harm \\nto others resulting from behaviour during Sedative, hypnotic or anxiolytic \\nintoxication is included in the definitions of Harmful use of sedatives,  hypnotics or \\nanxiolytics. Several sedative-induced mental disorders and sedative-rel ated forms \\nof neurocognitive impairment are recognised. \\nNote: Code also the underlying condition \\nExclusions: Hazardous use of sedatives, hypnotics or anxiolytics (QE11.2) \\n \\n6C44.0 Single episode of harmful use of sedatives, hypnotics or anxiolytics  \\nA single episode of use of a sedative, hypnotic or anxiolytic that has c aused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administratio n. \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behavior due to sedative, hypnot ic or \\nanxiolytic intoxication on the part of the person to whom the diagnosis of  single \\nepisode of harmful use applies. This diagnosis should not be made if the harm  is \\nattributed to a known pattern of sedative, hypnotic or anxiolytic use. \\nExclusions: Sedative, hypnotic or anxiolytic dependence (6C44.2) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1) \\n \\n6C44.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics \\nA pattern of sedative, hypnotic, or anxiolytic use that has caused clinical ly \\nsignificant harm to a person ’s physical or mental health or in which behaviour \\ninduced by sedatives, hypnotics or anxiolytics has caused clinicall y significant harm \\nto the health of other people. The pattern of sedative, hypnotic, or anxiolytic use is  \\nevident over a period of at least 12 months if use is episodic and at least  one month \\nif use is continuous (i.e., daily or almost daily). Harm may be caused  by the \\nintoxicating effects of sedatives, hypnotics or anxiolytics, the direct or secondary \\ntoxic effects on body organs and systems, or a harmful route of administration. \\nExclusions: Sedative, hypnotic or anxiolytic dependence (6C44.2) \\nSingle episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 88, 'page_label': '89'}, page_content='88  ICD-11 MMS - 2018 \\n \\n6C44.10 Harmful pattern of use of sedatives, hypnotics or anxiolytics, episodic \\nA pattern of episodic or intermittent use of sedatives, hypnotics or anxiolytics that \\nhas caused clinically significant harm to a person ’s physical or mental health or in \\nwhich behaviour induced by sedatives, hypnotics or anxiolytics has caused c linically \\nsignificant harm to the health of other people. The pattern of episodic or intermitte nt \\nuse of sedatives, hypnotics or anxiolytics is evident over a period of at least 12 \\nmonths. Harm may be caused by the intoxicating effects of sedatives, hypnotic s or \\nanxiolytics, the direct or secondary toxic effects on body organs and systems, or a \\nharmful route of administration. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nSedative, hypnotic or anxiolytic dependence (6C44.2) \\n \\n6C44.11 Harmful pattern of use of sedatives, hypnotics or anxiolytics, continuous  \\nA pattern of continuous use of sedatives, hypnotics or anxiolytics (daily or almost \\ndaily) that has caused clinically significant harm to a person ’s physical or mental \\nhealth or in which behaviour induced by sedatives, hypnotics or anxiolyt ics has \\ncaused clinically significant harm to the health of other people. The patter n of \\ncontinuous use of sedatives, hypnotics or anxiolytics is evident over a perio d of at \\nleast one month. Harm may be caused by the intoxicating effects of sedatives, \\nhypnotics or anxiolytics, the direct or secondary toxic effects on body organs  and \\nsystems, or a harmful route of administration. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nSedative, hypnotic or anxiolytic dependence (6C44.2) \\n \\n6C44.1Z Harmful pattern of use of sedatives, hypnotics or anxiolytics, unspecified \\n \\n6C44.2 Sedative, hypnotic or anxiolytic dependence \\nSedative, hypnotic or anxiolytic dependence is a disorder of regulation of s edative \\nuse arising from repeated or continuous use of these substances. The characteristic  \\nfeature is a strong internal drive to use sedatives, hypnotics, or anxiolytics, which  is \\nmanifested by impaired ability to control use, increasing priority give n to use over \\nother activities and persistence of use despite harm or negative consequences. \\nThese experiences are often accompanied by a subjective sensation of urge or \\ncraving to use these substances. Physiological features of dependence may als o be \\npresent, including tolerance to the effects of sedatives, hypnotics or anxiolytics , \\nwithdrawal symptoms following cessation or reduction in use, or repeated use of \\nsedatives or pharmacologically similar substances to prevent or alleviate withdr awal \\nsymptoms. The features of dependence are usually evident over a period of at least \\n12 months but the diagnosis may be made if sedative use is continuous (daily or \\nalmost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 89, 'page_label': '90'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   89 \\n \\n6C44.20 Sedative, hypnotic or anxiolytic dependence, current use \\nCurrent Sedative, hypnotic or anxiolytic dependence with use of a sedative, \\nhypnotic or anxiolytic drug within the past month. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1) \\n \\n6C44.21 Sedative, hypnotic or anxiolytic dependence, early full remission \\nAfter a diagnosis of Sedative, hypnotic or anxiolytic dependence, and often  \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthe individual has been abstinent from sedatives, hypnotics or anxiolytics during a \\nperiod lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1) \\n \\n6C44.22 Sedative, hypnotic or anxiolytic dependence, sustained partial remission  \\nAfter a diagnosis of Sedative, hypnotic or anxiolytic dependence, and often  \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthere is a significant reduction in sedative, hypnotic or anxiolytic c onsumption for \\nmore than 12 months, such that even though sedative, hypnotic or anxiolytic use \\nhas occurred during this period, the definitional requirements for dependence hav e \\nnot been met. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1) \\n \\n6C44.23 Sedative, hypnotic or anxiolytic dependence, sustained full remission \\nAfter a diagnosis of Sedative, hypnotic or anxiolytic dependence, and often  \\nfollowing a treatment episode or other intervention (including self-interventi on), the \\nperson has been abstinent from alcohol for 12 months or longer. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1) \\n \\n6C44.2Z Sedative, hypnotic or anxiolytic dependence, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 90, 'page_label': '91'}, page_content='90  ICD-11 MMS - 2018 \\n \\n6C44.3 Sedative, hypnotic or anxiolytic intoxication \\nSedative, hypnotic or anxiolytic intoxication is a clinically signific ant transien t \\ncondition that develops during or shortly after the consumption of sedatives, \\nhypnotics or anxiolytics that is characterized by disturbances in consci ousness, \\ncognition, perception, affect, behaviour, or coordination. These disturbances a re \\ncaused by the known pharmacological effects of sedatives, hypnotics or anxioly tics \\nand their intensity is closely related to the amount of sedatives, hypnotics  or \\nanxiolytics consumed. They are time-limited and abate as sedatives, hypno tics or \\nanxiolytics are cleared from the body. Presenting features may incl ude somnolence, \\nimpaired judgment, slurred speech, impaired motor coordination, unsteady gait, \\nmood changes, as well as impaired memory, attention and concentration. \\nNystagmus (repetitive, uncontrolled eye movements) is a common physical sign. \\nNote: Code also the underlying condition \\nInclusions: \"Bad trips\" (Sedatives, hypnotics or anxiolytics) \\nExclusions: sedative, hypnotic drugs and other CNS depressants \\npoisoning (NE60) \\nPossession trance disorder (6B63) \\n \\n6C44.4 Sedative, hypnotic or anxiolytic withdrawal \\nSedative, hypnotic or anxiolytic withdrawal is a clinically significant cluster of \\nsymptoms, behaviours and/or physiological features, varying in degree of severit y \\nand duration, that occurs upon cessation or reduction of use of sedatives, hypnotics \\nor anxiolytics in individuals who have developed dependence or have used \\nsedatives, hypnotics or anxiolytics for a prolonged period or in large amounts. \\nSedative, hypnotic or anxiolytic withdrawal can also occur when prescribed  \\nsedatives, hypnotics or anxiolytics have been used in standard therapeutic dos es. \\nPresenting features of Sedative, hypnotic or anxiolytic withdrawal may incl ude \\nanxiety, psychomotor agitation, insomnia, increased hand tremor, nausea or \\nvomiting, and transient visual, tactile or auditory illusions or hallucinations . There \\nmay be signs of autonomic hyperactivity, or postural hypotension. The withdra wal \\nstate may be complicated by seizures. Less commonly there may be progressi on to \\na more severe form of delirium characterized by confusion and disorientation, \\ndelusions, and more prolonged visual, tactile or auditory hallucinations. In such \\ncases, a separate diagnosis of Sedative, hypnotic, or anxiolytic-induced deli rium \\nshould be assigned. \\nNote: Code also the underlying condition \\n \\n6C44.40 Sedative, hypnotic or anxiolytic withdrawal, uncomplicated \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic Wi thdrawal are met \\nand the withdrawal state is not accompanied by perceptual disturbances or \\nseizures. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 91, 'page_label': '92'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   91 \\n \\n6C44.41 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic withdraw al are met \\nand the withdrawal state is accompanied by perceptual disturbances (e.g., vi sual or \\ntactile hallucinations or illusions) with intact reality testing. There is no  evidence of \\nconfusion and other diagnostic requirements for Delirium are not met. The \\nwithdrawal state is not accompanied by seizures. \\nNote: Code also the underlying condition \\n \\n6C44.42 Sedative, hypnotic or anxiolytic withdrawal, with seizures \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic withdraw al are met \\nand the withdrawal state is accompanied by seizures (i.e., generalized tonic- clonic \\nseizures) but not by perceptual disturbances. \\nNote: Code also the underlying condition \\n \\n6C44.43 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances and \\nseizures \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic withdraw al are met \\nand the withdrawal state is accompanied by both seizures (i.e., generalized tonic -\\nclonic seizures) and perceptual disturbances (e.g., visual or tactile hallucina tions or \\nillusions) with intact reality testing. Diagnostic requirements for Delirium are not met. \\nNote: Code also the underlying condition \\n \\n6C44.4Z Sedative, hypnotic or anxiolytic withdrawal, unspecified \\nNote: Code also the underlying condition \\n \\n6C44.5 Sedative, hypnotic or anxiolytic-induced delirium \\nSedative, hypnotic or anxiolytic-induced delirium is characterized by an ac ute state \\nof disturbed attention and awareness with specific features of delirium that develops \\nduring or soon after substance intoxication or withdrawal or during the use of \\nsedatives, hypnotics, or anxiolytics. Specific features of Sedative, hypno tic or \\nanxiolytic-induced delirium may include confusion and disorientation, pa ranoid \\ndelusions, and recurrent visual, tactile or auditory hallucinations. The amount and \\nduration of sedative, hypnotic, or anxiolytic use must be capable of producing \\ndelirium. The symptoms are not better explained by a primary mental disorder, by \\nuse of or withdrawal from a different substance, or by another health condition t hat \\nis not classified under Mental, behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\nInclusions: Delirium induced by sedative, hypnotic or anxiolytic withdrawal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 92, 'page_label': '93'}, page_content='92  ICD-11 MMS - 2018 \\n \\n6C44.6 Sedative, hypnotic or anxiolytic-induced psychotic disorder \\nSedative, hypnotic or anxiolytic-induced psychotic disorder is characterized b y \\npsychotic symptoms (e.g., delusions, hallucinations, disorganized thinking, grossly \\ndisorganized behaviour) that develop during or soon after intoxication with or \\nwithdrawal from sedatives, hypnotics or anxiolytics. The intensity or d uration of the \\nsymptoms is substantially in excess of psychotic-like disturbances of per ception, \\ncognition, or behaviour that are characteristic of intoxication or withdrawal due t o \\nsedatives, hypnotics or anxiolytics. The amount and duration of sedative, hypnoti c \\nor anxiolytic use must be capable of producing psychotic symptoms. The symptoms  \\nare not better explained by a primary mental disorder (e.g., Schizophrenia, a Mood \\ndisorder with psychotic symptoms), as might be the case if the psychotic sym ptoms \\npreceded the onset of the sedative, hypnotic or anxiolytic use, if the symptoms \\npersist for a substantial period of time after cessation of the sedative, hypno tic or \\nanxiolytic use or withdrawal, or if there is other evidence of a pre-existin g primary \\nmental disorder with psychotic symptoms (e.g., a history of prior episodes not \\nassociated with sedative, hypnotic or anxiolytic use). \\nNote: Code also the underlying condition \\n \\n6C44.7 Other sedatives, hypnotics or anxiolytic-induced disorders \\nNote: Code also the underlying condition \\nCoded Elsewhere: Amnestic disorder due to use of sedatives, hypnotics or \\nanxiolytics (6D72.11) \\nDementia due to use of sedatives, hypnotics or anxiolytics \\n(6D84.1) \\n \\n6C44.70 Sedative, hypnotic or anxiolytic-induced mood disorder \\nSedative, hypnotic or anxiolytic-induced mood disorder is characterized by mood \\nsymptoms (e.g., depressed or elevated mood, decreased engagement in \\npleasurable activities, increased or decreased energy levels) that develop during or \\nsoon after intoxication with or withdrawal from sedatives, hypnotics or anxioly tics. \\nThe intensity or duration of the symptoms is substantially in excess of mood \\ndisturbances that are characteristic of intoxication or withdrawal due to sedatives, \\nhypnotics or anxiolytics. The amount and duration of sedative, hypnotic or anxiolytic \\nuse must be capable of producing mood symptoms. The symptoms are not better \\nexplained by a primary mental disorder (e.g., a Depressive disorder, a Bip olar \\ndisorder, Schizoaffective disorder), as might be the case if the mood symptoms  \\npreceded the onset of the sedative, hypnotic or anxiolytic use, if the symptoms \\npersist for a substantial period of time after cessation of the sedative, hypno tic or \\nanxiolytic use or withdrawal, or if there is other evidence of a pre-existin g primary \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with sedative, hypnotic or anxiolytic use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 93, 'page_label': '94'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   93 \\n \\n6C44.71 Sedative, hypnotic or anxiolytic-induced anxiety disorder \\nSedative, hypnotic or anxiolytic-induced anxiety disorder is characterize d by anxiety \\nsymptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive \\nautonomic arousal, avoidance behaviour) that develop during or soon after \\nintoxication with or withdrawal from sedatives, hypnotics or anxiolytics. T he intensity \\nor duration of the symptoms is substantially in excess of anxiety sym ptoms that are \\ncharacteristic of intoxication or withdrawal due to sedatives, hypnotics or anxioly tics. \\nThe amount and duration of sedative, hypnotic or anxiolytic use must be capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety symptom s \\npreceded the onset of the sedative, hypnotic or anxiolytic use, if the symptoms \\npersist for a substantial period of time after cessation of the sedative, hypno tic or \\nanxiolytic use or withdrawal, or if there is other evidence of a pre-existin g primary \\nmental disorder with anxiety symptoms (e.g., a history of prior episodes not \\nassociated with sedative, hypnotic or anxiolytic use). \\nNote: Code also the underlying condition \\n \\n6C44.Y Other specified disorders due to use of sedatives, hypnotics or anxiolytics  \\nNote: Code also the underlying condition \\n \\n6C44.Z Disorders due to use of sedatives, hypnotics or anxiolytics, unspecified  \\nNote: Code also the underlying condition \\n \\n  6C45   Disorders due to use of cocaine \\nDisorders due to use of cocaine are characterized by the pattern and consequences \\nof cocaine use. In addition to Cocaine intoxication, cocaine has dependence-\\ninducing properties, resulting in Cocaine dependence in some people and Cocaine \\nwithdrawal when use is reduced or discontinued. Cocaine is implicated in a wide \\nrange of harms affecting most organs and systems of the body, which may be \\nclassified as Single episode of harmful use of cocaine and Harmful pattern of  use of \\ncocaine. Harm to others resulting from behaviour during Cocaine intoxicatio n is \\nincluded in the definitions of Harmful use of cocaine. Several cocaine-induced  \\nmental disorders are recognised. \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46) \\nHazardous use of cocaine (QE11.3)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 94, 'page_label': '95'}, page_content='94  ICD-11 MMS - 2018 \\n \\n6C45.0 Single episode of harmful use of cocaine \\nA single episode of use of cocaine that has caused damage to a person ’s physical \\nor mental health or has resulted in behaviour leading to harm to the health of others. \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behavior due to cocaine intoxication on the part of  the \\nperson to whom the diagnosis of single episode of harmful use applies. Thi s \\ndiagnosis should not be made if the harm is attributed to a known pattern of cocain e \\nuse. \\nExclusions: Cocaine dependence (6C45.2) \\nHarmful pattern of use of cocaine (6C45.1) \\n \\n6C45.1 Harmful pattern of use of cocaine \\nA pattern of use of cocaine that has caused damage to a person ’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of other s. \\nThe pattern of cocaine use is evident over a period of at least 12 months if \\nsubstance use is episodic or at least one month if use is continuous (i.e., dai ly or \\nalmost daily). Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to cocaine intoxicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of cocaine \\napplies. \\nExclusions: Cocaine dependence (6C45.2) \\nSingle episode of harmful use of cocaine (6C45.0) \\n \\n6C45.10 Harmful pattern of use of cocaine, episodic \\nA pattern of episodic or intermittent cocaine use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic cocaine use is evident over a period of \\nat least 12 months. Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm  \\nto health of others includes any form of physical harm, including trauma, or mental  \\ndisorder that is directly attributable to behaviour related to cocaine intoxicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of cocaine \\napplies. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nCocaine dependence (6C45.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 95, 'page_label': '96'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   95 \\n \\n6C45.11 Harmful pattern of use of cocaine, continuous \\nA pattern of continuous (daily or almost daily) cocaine use that has caused  damage \\nto a person’s physical or mental health or has resulted in behaviour leading to harm \\nto the health of others. The pattern of continuous cocaine use is evident over a \\nperiod of at least one month. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administratio n. \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to cocaine \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern  of \\nuse of cocaine applies. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nCocaine dependence (6C45.2) \\n \\n6C45.1Z Harmful pattern of use of cocaine, unspecified \\n \\n6C45.2 Cocaine dependence \\nCocaine dependence is a disorder of regulation of cocaine use arising from \\nrepeated or continuous use of cocaine. The characteristic feature is a strong \\ninternal drive to use cocaine, which is manifested by impaired ability to control use, \\nincreasing priority given to use over other activities and persistence of use despite  \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use cocaine. Physiological fea tures of \\ndependence may also be present, including tolerance to the effects of cocaine, \\nwithdrawal symptoms following cessation or reduction in use of cocaine, or \\nrepeated use of cocaine or pharmacologically similar substances to prevent or \\nalleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months but the diagnosis may be made if cocaine use is \\ncontinuous (daily or almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nHarmful pattern of use of cocaine (6C45.1) \\n \\n6C45.20 Cocaine dependence, current use \\nCurrent cocaine dependence with cocaine use within the past month. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nHarmful pattern of use of cocaine (6C45.1) \\n \\n6C45.21 Cocaine dependence, early full remission \\nAfter a diagnosis of Cocaine dependence, and often following a treatment episode \\nor other intervention (including self-help intervention), the individual has been  \\nabstinent from cocaine during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nHarmful pattern of use of cocaine (6C45.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 96, 'page_label': '97'}, page_content='96  ICD-11 MMS - 2018 \\n \\n6C45.22 Cocaine dependence, sustained partial remission \\nAfter a diagnosis of Cocaine dependence, and often following a treatment episode \\nor other intervention (including self-help intervention), there is a signific ant reduction \\nin cocaine consumption for more than 12 months, such that even though cocaine \\nuse has occurred during this period, the definitional requirements for dependence \\nhave not been met. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nHarmful pattern of use of cocaine (6C45.1) \\n \\n6C45.23 Cocaine dependence, sustained full remission \\nAfter a diagnosis of cocaine dependence, and often following a treatment episode \\nor other intervention (including self-intervention), the person has been abs tinent \\nfrom cocaine for 12 months or longer. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nHarmful pattern of use of cocaine (6C45.1) \\n \\n6C45.2Z Cocaine dependence, unspecified \\n \\n6C45.3 Cocaine intoxication \\nCocaine intoxication is a clinically significant transient condition that develops during \\nor shortly after the consumption of cocaine that is characterized by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. These \\ndisturbances are caused by the known pharmacological effects of cocaine and their \\nintensity is closely related to the amount of cocaine consumed. They are tim e-\\nlimited and abate as cocaine is cleared from the body. Presenting features  may \\ninclude inappropriate euphoria, anxiety, anger, impaired attention, hypervigilanc e, \\npsychomotor agitation, paranoid ideation (sometimes of delusional intensity),  \\nauditory hallucinations, confusion, and changes in sociability. Perspi ration or chills, \\nnausea or vomiting, and palpitations and chest pain may be experienced. Physic al \\nsigns may include tachycardia, elevated blood pressure, and pupillary di latation. In \\nrare instances, usually in severe intoxication, cocaine use can result in seizures, \\nmuscle weakness, dyskinesia, or dystonia. \\nNote: Code also the underlying condition \\nExclusions: cocaine poisoning (NE60) \\nPossession trance disorder (6B63) \\n \\n6C45.4 Cocaine withdrawal \\nCocaine withdrawal is a clinically significant cluster of symptoms, behavi ours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of cocaine in individuals who have developed Cocaine \\ndependence or have used cocaine for a prolonged period or in large amounts. \\nPresenting features of Cocaine withdrawal may include dysphoric mood, irritabili ty, \\nfatigue, inertia, vivid unpleasant dreams, insomnia or hypersomnia, increased \\nappetite, anxiety, psychomotor agitation or retardation, and craving for cocaine. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 97, 'page_label': '98'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   97 \\n \\n6C45.5 Cocaine-induced delirium \\nCocaine-induced delirium is characterized by an acute state of disturbed attenti on \\nand awareness with specific features of delirium that develops during or soon af ter \\nsubstance intoxication or withdrawal or during the use of cocaine. The amount and \\nduration of cocaine use must be capable of producing delirium. The symptoms are \\nnot better explained by a primary mental disorder, by use of or withdrawal from a  \\ndifferent substance, or by another health condition that is not classified unde r \\nMental, behavioural, and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C45.6 Cocaine-induced psychotic disorder \\nCocaine-induced psychotic disorder is characterized by psychotic symptoms  (e.g., \\ndelusions, hallucinations, disorganized thinking, grossly disorganized behavi our) \\nthat develop during or soon after intoxication with or withdrawal from cocaine. The \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nCocaine intoxication or Cocaine withdrawal. The amount and duration of cocaine \\nuse must be capable of producing psychotic symptoms. The symptoms are no t \\nbetter explained by a primary mental disorder (e.g., Schizophrenia, a Mood disorder \\nwith psychotic symptoms), as might be the case if the psychotic sympto ms \\npreceded the onset of the cocaine use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cocaine use or withdrawal, or if there is oth er \\nevidence of a pre-existing primary mental disorder with psychotic symptoms ( e.g., a \\nhistory of prior episodes not associated with cocaine use). \\nNote: Code also the underlying condition \\n \\n6C45.60 Cocaine-induced psychotic disorder with hallucinations \\nCocaine-induced psychotic disorder with hallucinations is characterized by the by \\nthe presence of hallucinations that are judged to be the direct consequence of \\ncocaine use. Neither delusions nor other psychotic symptoms are present. The \\nsymptoms do not occur exclusively during hypnogogic or hypnopompic states, are \\nnot better accounted for by another mental and behavioural disorder (e.g., \\nschizophrenia), and are not due to another disorder or disease classified elsewh ere \\n(e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C45.61 Cocaine-induced psychotic disorder with delusions \\nCocaine-induced psychotic disorder with delusions is characterized by the by the \\npresence of delusions that are judged to be the direct consequence of cocaine use . \\nNeither hallucinations nor other psychotic symptoms are present. The symptoms  do \\nnot occur exclusively during hypnogogic or hypnopompic states, are not better \\naccounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 98, 'page_label': '99'}, page_content='98  ICD-11 MMS - 2018 \\n \\n6C45.62 Cocaine-induced psychotic disorder with mixed psychotic symptoms \\nCocaine-induced psychotic disorder with mixed psychotic symptoms is \\ncharacterized by the presence of multiple psychotic symptoms, primarily \\nhallucinations and delusions, when these are judged to be the direct con sequence \\nof cocaine use. The symptoms do not occur exclusively during hypnogogic or \\nhypnopompic states, are not better accounted for by another mental and \\nbehavioural disorder (e.g., Schizophrenia), and are not due to another disorder or \\ndisease classified elsewhere (e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C45.6Z Cocaine-induced psychotic disorder, unspecified \\nNote: Code also the underlying condition \\n \\n6C45.7 Other cocaine-induced disorders \\nNote: Code also the underlying condition \\n \\n6C45.70 Cocaine-induced mood disorder \\nCocaine-induced mood disorder is characterized by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxi cation \\nwith or withdrawal from cocaine. The intensity or duration of the symptoms is  \\nsubstantially in excess of mood disturbances that are characteristic of Cocaine \\nintoxication or Cocaine withdrawal. The amount and duration of cocaine use must \\nbe capable of producing mood symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, \\nSchizoaffective disorder), as might be the case if the mood symptoms preceded  the \\nonset of the cocaine use, if the symptoms persist for a substantial period of time \\nafter cessation of the cocaine use or withdrawal, or if there is other evidence of a \\npre-existing primary mental disorder with mood symptoms (e.g., a history of prior \\nepisodes not associated with cocaine use). \\nNote: Code also the underlying condition \\n \\n6C45.71 Cocaine-induced anxiety disorder \\nCocaine-induced anxiety disorder is characterized by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic  \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from cocaine. The intensity or duration of the symptoms is subs tantially \\nin excess of anxiety symptoms that are characteristic of Cocaine intoxication or \\nCocaine withdrawal. The amount and duration of cocaine use must be capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety symptom s \\npreceded the onset of the cocaine use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cocaine use or withdrawal, or if there is oth er \\nevidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with cocaine use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 99, 'page_label': '100'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   99 \\n \\n6C45.72 Cocaine-induced obsessive-compulsive or related disorder \\nCocaine-induced obsessive-compulsive or related disorder is characterized by \\neither repetitive intrusive thoughts or preoccupations, normally associated with \\nanxiety and typically accompanied by repetitive behaviours performed in response, \\nor by recurrent and habitual actions directed at the integument (e.g., hair pulling, \\nskin picking) that develop during or soon after intoxication with or withdrawal f rom \\ncocaine. The intensity or duration of the symptoms is substantially in excess  of \\nanalogous disturbances that are characteristic of Cocaine intoxication or Cocaine \\nwithdrawal. The amount and duration of cocaine use must be capable of producing \\nobsessive-compulsive or related symptoms. The symptoms are not better explain ed \\nby a primary mental disorder (in particular an Obsessive-compulsive or rela ted \\ndisorder), as might be the case if the symptoms preceded the onset of the cocaine \\nuse, if the symptoms persist for a substantial period of time after cessation of  the \\ncocaine use or withdrawal, or if there is other evidence of a pre-existing primary  \\nmental disorder with obsessive-compulsive or related symptoms (e.g., a history of \\nprior episodes not associated with cocaine use). \\nNote: Code also the underlying condition \\n \\n6C45.73 Cocaine-induced impulse control disorder \\nCocaine-induced impulse control disorder is characterized by persistently r epeated \\nbehaviours in which there is recurrent failure to resist an impulse, drive, or urg e to \\nperform an act that is rewarding to the person, at least in the short-term, des pite \\nlonger-term harm either to the individual or to others (e.g., fire setting or steali ng \\nwithout apparent motive, repetitive sexual behaviour, aggressive outbursts) that \\ndevelop during or soon after intoxication with or withdrawal from cocaine. The \\nintensity or duration of the symptoms is substantially in excess of di sturbances of \\nimpulse control that are characteristic of Cocaine intoxication or Cocaine \\nwithdrawal. The amount and duration of cocaine use must be capable of producing \\ndisturbances of impulse control. The symptoms are not better explained by a \\nprimary mental disorder (e.g., an Impulse control disorder, a Disorder due to \\naddictive behaviours), as might be the case if the impulse control disturbances  \\npreceded the onset of the cocaine use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cocaine use or withdrawal, or if there is oth er \\nevidence of a pre-existing primary mental disorder with impulse control symptoms \\n(e.g., a history of prior episodes not associated with cocaine use). \\nNote: Code also the underlying condition \\n \\n6C45.Y Other specified disorders due to use of cocaine \\nNote: Code also the underlying condition \\n \\n6C45.Z Disorders due to use of cocaine, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 100, 'page_label': '101'}, page_content='100  ICD-11 MMS - 2018 \\n \\n  6C46   Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone \\nDisorders due to use of stimulants including amphetamines, methamphetamine or \\nmethcathinone are characterized by the pattern and consequences of stimulant use. \\nIn addition to Stimulant intoxication including amphetamines, methamphetamine or \\nmethcathinone, stimulants have dependence-inducing properties, resulting in \\nStimulant dependence including amphetamines, methamphetamine or \\nmethcathinone in some people and Stimulant withdrawal including amphetamines, \\nmethamphetamine or methcathinone when use is reduced or discontinued. \\nStimulants are implicated in a wide range of harms affecting most organs and \\nsystems of the body, which may be classified as Single episode of  harmful use of \\nstimulants including amphetamines, methamphetamine or methcathinone and \\nHarmful pattern of use of stimulants including amphetamines, methamphetamine or \\nmethcathinone. Harm to others resulting from behaviour during Stimulant \\nintoxication including amphetamines, methamphetamine or methcathinone is \\nincluded in the definitions of Harmful use of stimulants including amphetami nes, \\nmethamphetamine or methcathinone. Several stimulant-induced mental disorders \\nare recognised. \\nExclusions: Disorders due to use of synthetic cathinones (6C47) \\nDisorders due to use of caffeine (6C48) \\nDisorders due to use of cocaine (6C45) \\nHazardous use of stimulants including amphetamines or \\nmethamphetamine (QE11.4) \\n \\n6C46.0 Single episode of harmful use of stimulants including amphetamines, \\nmethamphetamine or methcathinone \\nA single episode of use of a stimulant including amphetamines, methamphetamine \\nand methcathinone that has caused damage to a person ’s physical or mental health \\nor has resulted in behaviour leading to harm to the health of others. Harm to health \\nof the individual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehavior due to stimulant intoxication on the part of the person to whom the \\ndiagnosis of single episode of harmful use applies. This diagnosis shou ld not be \\nmade if the harm is attributed to a known pattern of stimulant including \\namphetamines, methamphetamine and methcathinone use. \\nExclusions: Harmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1) \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 101, 'page_label': '102'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   101 \\n \\n6C46.1 Harmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone \\nA pattern of use of stimulants including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour \\nleading to harm to the health of others. The pattern of stimulant use is evident over \\na period of at least 12 months if substance use is episodic or at least one mon th if \\nuse is continuous. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to stimulant intoxicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of stimulants \\nincluding amphetamines, methamphetamine and methcathinone applies. \\nExclusions: Harmful pattern of use of caffeine (6C48.1) \\nHarmful pattern of use of cocaine (6C45.1) \\nHarmful pattern of use of synthetic cathinones (6C47.1) \\nSingle episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2) \\n \\n6C46.10 Harmful pattern of use of stimulants including amphetamines, methamphetamine or \\nmethcathinone, episodic \\nA pattern of episodic or intermittent use of stimulants including amphetamines, \\nmethamphetamine and methcathinone but excluding caffeine, cocaine and synthetic \\ncathinones that has caused damage to a person ’s physical or mental health or has \\nresulted in behaviour leading to harm to the health of others. The pattern of episodic \\nstimulant use is evident over a period of at least 12 months. Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to stimulant intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of stimulants including amphetamines, \\nmethamphetamine and methcathinone applies. \\nExclusions: Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 102, 'page_label': '103'}, page_content='102  ICD-11 MMS - 2018 \\n \\n6C46.11 Harmful pattern of use of stimulants including amphetamines, methamphetamine or \\nmethcathinone, continuous \\nA pattern of use of stimulants including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour \\nleading to harm to the health of others. The pattern of stimulant use is evident over \\na period of at least 12 months if substance use is episodic or at least one month if \\nuse is continuous (i.e., daily or almost daily). Harm to health of the indiv idual occurs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto stimulant intoxication on the part of the person to whom the diagnosis of Harmful  \\npattern of use of stimulants including amphetamines, methamphetamine and \\nmethcathinone applies. \\nExclusions: Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2) \\n \\n6C46.1Z Harmful pattern of use of stimulants including amphetamines, methamphetamine \\nand methcathinone, unspecified \\n \\n6C46.2 Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant dependence including amphetamines, methamphetamine or \\nmethcathinone is a disorder of regulation of stimulant use arising from repeated or \\ncontinuous use of stimulants. The characteristic feature is a strong internal driv e to \\nuse stimulants, which is manifested by impaired ability to control use, inc reasing \\npriority given to use over other activities and persistence of use despite harm or \\nnegative consequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use stimulants. Physiological features of \\ndependence may also be present, including tolerance to the effects of stimulants, \\nwithdrawal symptoms following cessation or reduction in use of stimulants, or \\nrepeated use of stimulants or pharmacologically similar substances to prevent or \\nalleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months but the diagnosis may be made if stimulant us e \\nis continuous (daily or almost daily) for at least 1 month. \\nExclusions: Cocaine dependence (6C45.2) \\nSynthetic cathinone dependence (6C47.2) \\nSingle episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 103, 'page_label': '104'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   103 \\n \\n6C46.20 Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, current use \\nStimulant dependence including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones refers to  \\namphetamine or other stimulant use within the past month. \\nExclusions: Harmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1) \\nSingle episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\n \\n6C46.21 Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, early full remission \\nAfter a diagnosis of Stimulant dependence including amphetamines, \\nmethamphetamine and methcathinone but excluding caffeine, cocaine and synthetic \\ncathinones, and often following a treatment episode or other intervention (incl uding \\nself-help intervention), the individual has been abstinent from stimulants during a \\nperiod lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1) \\n \\n6C46.22 Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, sustained partial remission \\nAfter a diagnosis of Stimulant dependence including amphetamines, \\nmethamphetamine and methcathinone but excluding caffeine, cocaine and synthetic \\ncathinones, and often following a treatment episode or other intervention (incl uding \\nself-help intervention), there is a significant reduction in amphetamine or ot her \\nstimulant consumption for more than 12 months, such that even though \\namphetamine or other stimulant use has occurred during this period, the definitional \\nrequirements for dependence have not been met. \\nExclusions: Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1) \\n \\n6C46.23 Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, sustained full remission \\nAfter a diagnosis of Stimulant dependence including amphetamines, \\nmethamphetamine and methcathinone but excluding caffeine, cocaine and synthetic \\ncathinones, and often following a treatment episode or other intervention (incl uding \\nself-intervention), the person has been abstinent from amphetamine or othe r \\nstimulants for 12 months or longer. \\nExclusions: Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 104, 'page_label': '105'}, page_content='104  ICD-11 MMS - 2018 \\n \\n6C46.2Z Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, unspecified \\n \\n6C46.3 Stimulant intoxication including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant intoxication including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones is a \\nclinically significant transient condition that develops during or shor tly after the \\nconsumption of amphetamine or other stimulants that is characterized by \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof amphetamine or other stimulants and their intensity is closely related t o the \\namount of amphetamine or other stimulant consumed. They are time-limited and \\nabate as amphetamine or another stimulant is cleared from the body. Presenti ng \\nfeatures may include anxiety, anger, impaired attention, hypervigilance, \\npsychomotor agitation, paranoid ideation (often of delusional intensity), audi tory \\nhallucinations, confusion, and changes in sociability. Perspiration or chi lls, nausea \\nor vomiting, and palpitations may be experienced. Physical signs may i nclude \\ntachycardia, elevated blood pressure, pupillary dilatation, dyskinesias and \\ndystonias, and skin sores may be evident. In rare instances, usually in seve re \\nintoxication, use of stimulants including amphetamines, methamphetamine and \\nmethcathinone can result in seizures. \\nNote: Code also the underlying condition \\nInclusions: \"Bad trips\" (Stimulants including amphetamines but excluding \\ncaffeine and cocaine) \\nTrance and possession disorders in stimulant intoxication \\nincluding amphetamines but excluding caffeine and \\ncocaine intoxication \\nExclusions: amphetamine poisoning (NE60) \\nCaffeine intoxication (6C48.2) \\nCocaine intoxication (6C45.3) \\nSynthetic cathinone intoxication (6C47.3) \\nPossession trance disorder (6B63)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 105, 'page_label': '106'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   105 \\n \\n6C46.4 Stimulant withdrawal including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant withdrawal including amphetamines, methamphetamine and \\nmethcathinone is a clinically significant cluster of symptoms, behaviours  and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of stimulants in individuals who have develo ped \\nStimulant dependence or have used stimulants for a prolonged period or in large  \\namounts. Stimulant withdrawal can also occur when prescribed stimulants have \\nbeen used in standard therapeutic doses. Presenting features of stimulant \\nwithdrawal may include dysphoric mood, irritability, fatigue, insomnia or (m ore \\ncommonly) hypersomnia, increased appetite, psychomotor agitation or retardati on, \\nand craving for amphetamine and related stimulants. \\nNote: Code also the underlying condition \\nExclusions: Cocaine withdrawal (6C45.4) \\nCaffeine withdrawal (6C48.3) \\nSynthetic cathinone withdrawal (6C47.4) \\n \\n6C46.5 Stimulant-induced delirium including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant-induced delirium including amphetamines, methamphetamine and \\nmethcathinone is characterized by an acute state of disturbed attention and \\nawareness with specific features of delirium that develops during or soon after \\nsubstance intoxication or withdrawal or during the use of stimulants. The amount \\nand duration of stimulants use must be capable of producing delirium. The \\nsymptoms are not better explained by a primary mental disorder, by use of or \\nwithdrawal from a different substance, or by another health condition that is not \\nclassified under Mental, behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\nExclusions: Cocaine-induced delirium (6C45.5) \\nSynthetic cathinone-induced delirium (6C47.5) \\nDisorders due to use of caffeine (6C48)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 106, 'page_label': '107'}, page_content='106  ICD-11 MMS - 2018 \\n \\n6C46.6 Stimulant-induced psychotic disorder including amphetamines, \\nmethamphetamine or methcathinone \\nStimulant-induced psychotic disorder including amphetamines, methamphetamine \\nand methcathinone is characterized by psychotic symptoms (e.g., delusions, \\nhallucinations, disorganized thinking, grossly disorganized behaviour) that develop  \\nduring or soon after intoxication or withdrawal due to stimulants. The intensity or \\nduration of the symptoms is substantially in excess of psychotic-lik e disturbances of \\nperception, cognition, or behaviour that are characteristic of Stimulant intoxication or \\nStimulant withdrawal. The amount and duration of stimulant use must be capable of \\nproducing psychotic symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe stimulant use, if the symptoms persist for a substantial period of time aft er \\ncessation of the stimulant use or withdrawal, or if there is other evidence of a pr e-\\nexisting primary mental disorder with psychotic symptoms (e.g., a history of pri or \\nepisodes not associated with use of stimulants). \\nNote: Code also the underlying condition \\nExclusions: Cocaine-induced psychotic disorder (6C45.6) \\nSynthetic cathinone-induced psychotic disorder (6C47.6) \\nDisorders due to use of caffeine (6C48) \\n \\n6C46.60 Stimulant-induced psychotic disorder including amphetamines, methamphetamine \\nor methcathinone with hallucinations \\nStimulant-induced psychotic disorder with hallucinations is characterized by  the \\npresence of hallucinations that are judged to be the direct consequence of stimula nt \\nuse. Neither delusions nor other psychotic symptoms are present. The symptoms \\ndo not occur exclusively during hypnogogic or hypnopompic states, are not better  \\naccounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms). \\nNote: Code also the underlying condition \\nExclusions: Cocaine-induced psychotic disorder with hallucinations \\n(6C45.60) \\nDisorders due to use of caffeine (6C48) \\nSynthetic cathinone-induced psychotic disorder with \\nhallucinations (6C47.60)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 107, 'page_label': '108'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   107 \\n \\n6C46.61 Stimulant-induced psychotic disorder including amphetamines, methamphetamine \\nor methcathinone with delusions \\nStimulant-induced psychotic disorder including amphetamines, methamphetamine \\nand methcathinone is characterized by psychotic symptoms (e.g., delusions, \\nhallucinations, disorganized thinking, grossly disorganized behaviour) that dev elop \\nduring or soon after intoxication or withdrawal due to stimulants. The intensity or \\nduration of the symptoms is substantially in excess of psychotic-lik e disturbances of \\nperception, cognition, or behaviour that are characteristic of Stimulant intoxication or  \\nStimulant withdrawal. The amount and duration of stimulant use must be capable of \\nproducing psychotic symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe stimulant use, if the symptoms persist for a substantial period of time aft er \\ncessation of the stimulant use or withdrawal, or if there is other evidence of a pr e-\\nexisting primary mental disorder with psychotic symptoms (e.g., a history of pri or \\nepisodes not associated with use of stimulants). \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of caffeine (6C48) \\nCocaine-induced psychotic disorder with delusions (6C45.61) \\nSynthetic cathinone-induced psychotic disorder with delusions \\n(6C47.61) \\n \\n6C46.62 Stimulant-induced psychotic disorder including amphetamines but excluding \\ncaffeine or cocaine with mixed psychotic symptoms \\nStimulant-induced psychotic disorder with mixed psychotic symptoms is \\ncharacterized by the presence of multiple psychotic symptoms, primarily \\nhallucinations and delusions, when these are judged to be the direct con sequence \\nof stimulant use. The symptoms do not occur exclusively during hypnogogic or \\nhypnopompic states, are not better accounted for by another mental and \\nbehavioural disorder (e.g., Schizophrenia), and are not due to another disorder or \\ndisease classified elsewhere (e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of caffeine (6C48) \\nCocaine-induced psychotic disorder with mixed psychotic \\nsymptoms (6C45.62) \\nSynthetic cathinone-induced psychotic disorder with mixed \\npsychotic symptoms (6C47.62) \\n \\n6C46.6Z Stimulant-induced psychotic disorder including amphetamines, methamphetamine \\nor methcathinone, unspecified \\nNote: Code also the underlying condition \\n \\n6C46.7 Other stimulant-induced disorders including amphetamines, \\nmethamphetamine or methcathinone \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 108, 'page_label': '109'}, page_content='108  ICD-11 MMS - 2018 \\n \\n6C46.70 Stimulant-induced mood disorder including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant-induced mood disorder including amphetamines, methamphetamine and \\nmethcathinone is characterized by mood symptoms (e.g., depressed or elevated \\nmood, decreased engagement in pleasurable activities, increased or decreased \\nenergy levels) that develop during or soon after intoxication or withdrawal due to \\nstimulants. The intensity or duration of the symptoms is substantially i n excess of \\nmood disturbances that are characteristic of Stimulant intoxication or Stimulant \\nwithdrawal. The amount and duration of stimulant use must be capable of producing \\nmood symptoms. The symptoms are not better explained by a primary mental \\ndisorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), \\nas might be the case if the mood symptoms preceded the onset of the stimulant \\nuse, if the symptoms persist for a substantial period of time after cessation of  the \\nstimulant use or withdrawal, or if there is other evidence of a pre-existing primar y \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with use of stimulants). \\nNote: Code also the underlying condition \\nExclusions: Synthetic cathinone-induced mood disorder (6C47.70) \\nCocaine-induced mood disorder (6C45.70) \\nDisorders due to use of caffeine (6C48) \\n \\n6C46.71 Stimulant-induced anxiety disorder including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant-induced anxiety disorder including amphetamines, methamphetamine and \\nmethcathinone is characterized by anxiety symptoms (e.g., apprehension or worry,  \\nfear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) \\nthat develop during or soon after intoxication or withdrawal due to stimulants. The \\nintensity or duration of the symptoms is substantially in excess of anxiety  symptoms \\nthat are characteristic of Stimulant intoxication or Stimulant withdrawal. The am ount \\nand duration of stimulant use must be capable of producing anxiety symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear-related disorder, a Depressive disorder with prominent anxiety symptoms), \\nas might be the case if the anxiety symptoms preceded the onset of the stim ulant \\nuse, if the symptoms persist for a substantial period of time after cessation of  the \\nstimulant use or withdrawal, or if there is other evidence of a pre-existing primar y \\nmental disorder with anxiety symptoms (e.g., a history of prior episodes not \\nassociated with use of stimulants). \\nNote: Code also the underlying condition \\nExclusions: Cocaine-induced anxiety disorder (6C45 .71) \\nCaffeine-induced anxiety disorder (6C48.40) \\nSynthetic cathinone-induced anxiety disorder (6C47.71)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 109, 'page_label': '110'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   109 \\n \\n6C46.72 Stimulant-induced obsessive-compulsive or related disorder including \\namphetamines, methamphetamine or methcathinone \\nStimulant-induced obsessive-compulsive or related disorder including \\namphetamines, methamphetamine and methcathinone is characterized by either \\nrepetitive intrusive thoughts or preoccupations, normally associated with anxiety \\nand typically accompanied by repetitive behaviours performed in response, or by \\nrecurrent and habitual actions directed at the integument (e.g., hair pulling, skin \\npicking) that develop during or soon after intoxication with or withdrawal fro m \\nstimulants. The intensity or duration of the symptoms is substantially i n excess of \\nanalogous disturbances that are characteristic of Stimulant intoxication or Stim ulant \\nwithdrawal. The amount and duration of stimulant use must be capable of producing \\nobsessive-compulsive or related symptoms. The symptoms are not better explain ed \\nby a primary mental disorder (in particular an Obsessive-compulsive or rela ted \\ndisorder), as might be the case if the symptoms preceded the onset of the stimulant \\nuse, if the symptoms persist for a substantial period of time after cessation of  the \\nstimulant use or withdrawal, or if there is other evidence of a pre-existing primar y \\nmental disorder with obsessive-compulsive or related symptoms (e.g., a history of \\nprior episodes not associated with stimulant use). \\nNote: Code also the underlying condition \\nExclusions: Cocaine-induced obsessive-compulsive or related disorder \\n(6C45.72) \\nSynthetic cathinone-induced obsessive-compulsive or related \\nsyndrome (6C47.72) \\nDisorders due to use of caffeine (6C48) \\n \\n6C46.73 Stimulant-induced impulse control disorder including amphetamines, \\nmethamphetamine or methcathinone \\nStimulant-induced impulse control disorder including amphetamines, \\nmethamphetamine and methcathinone is characterized by persistently repeat ed \\nbehaviours in which there is recurrent failure to resist an impulse, drive, or urg e to \\nperform an act that is rewarding to the person, at least in the short-term, des pite \\nlonger-term harm either to the individual or to others (e.g., fire setting or stealing  \\nwithout apparent motive, repetitive sexual behaviour, aggressive outbursts) that \\ndevelop during or soon after intoxication with or withdrawal from stimulants. The  \\nintensity or duration of the symptoms is substantially in excess of di sturbances of \\nimpulse control that are characteristic of Stimulant intoxication or Stimulant  \\nwithdrawal. The amount and duration of stimulant use must be capable of producing \\ndisturbances of impulse control. The symptoms are not better explained by a \\nprimary mental disorder (e.g., an Impulse control disorder, a Disorder due to \\naddictive behaviours), as might be the case if the impulse control disturbances  \\npreceded the onset of the stimulant use, if the symptoms persist for a substantial \\nperiod of time after cessation of the stimulant use or withdrawal, or if there is o ther \\nevidence of a pre-existing primary mental disorder with impulse control symptoms \\n(e.g., a history of prior episodes not associated with stimulant use). \\nNote: Code also the underlying condition \\n \\n6C46.Y Other specified disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone \\n \\n6C46.Z Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 110, 'page_label': '111'}, page_content='110  ICD-11 MMS - 2018 \\n \\n  6C47   Disorders due to use of synthetic cathinones \\nDisorders due to use of synthetic cathinones are characterised by the pattern and \\nconsequences of synthetic cathinone use. In addition to Synthetic cathinone \\nintoxication, synthetic cathinones have dependence-inducing properties, res ulting in \\nSynthetic cathinone dependence in some people and Synthetic cathinone \\nwithdrawal when use is reduced or discontinued. Synthetic cathinones are \\nimplicated in a wide range of harms affecting most organs and systems of the bo dy, \\nwhich may be classified as Single episode of harmful use of synthetic cathinones \\nand Harmful pattern of use of synthetic cathinones. Harm to others resulting from \\nbehaviour during Synthetic cathinone intoxication is included in the def initions of \\nHarmful use of synthetic cathinones. Several synthetic cathinone-induced mental  \\ndisorders are recognised. \\nNote: Code also the underlying condition \\n \\n6C47.0 Single episode of harmful use of synthetic cathinones \\nA single episode of synthetic cathinone use that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health \\nof others. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behavior due to synthetic cathinone \\nintoxication on the part of the person to whom the diagnosis of single episo de of \\nharmful use applies. This diagnosis should not be made if the harm is attri buted to a \\nknown pattern of synthetic cathinone use. \\nExclusions: Harmful pattern of use of synthetic cathinones (6C47.1) \\nSynthetic cathinone dependence (6C47.2) \\n \\n6C47.1 Harmful pattern of use of synthetic cathinones \\nA pattern of use of synthetic cathinones that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health \\nof others. The pattern of synthetic cathinone use is evident over a period of at  least \\n12 months if substance use is episodic or at least one month if use is cont inuous \\n(i.e., daily or almost daily). Harm to health of the individual occurs due to on e or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to synthetic \\ncathinone intoxication on the part of the person to whom the diagnosis of Harm ful \\npattern of use of synthetic cathinones applies. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nSynthetic cathinone dependence (6C47.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 111, 'page_label': '112'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   111 \\n \\n6C47.10 Harmful pattern of use of synthetic cathinones, episodic \\nA pattern of episodic or intermittent use of synthetic cathinones that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of episodic synthetic cathinone use is \\nevident over a period of at least 12 months. Harm to health of the individual occu rs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto synthetic cathinone intoxication on the part of the person to whom the diagnosis \\nof Harmful pattern of use of synthetic cathinones applies. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nSynthetic cathinone dependence (6C47.2) \\n \\n6C47.11 Harmful use of synthetic cathinones, continuous \\nA pattern of continuous (daily or almost daily) use of synthetic cathinones  that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour \\nleading to harm to the health of others. The pattern of continuous synthetic \\ncathinone use is evident over a period of at least one month. Harm to heal th of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to synthetic cathinone intoxication on the part of the person to \\nwhom the diagnosis of Harmful use of synthetic cathinones applies. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nSynthetic cathinone dependence (6C47.2) \\n \\n6C47.1Y Other specified harmful pattern of use of synthetic cathinones \\n \\n6C47.1Z Harmful pattern of use of synthetic cathinones, unspecified \\n \\n6C47.2 Synthetic cathinone dependence \\nSynthetic cathinone dependence is a disorder of regulation of synthetic cathinone \\nuse arising from repeated or continuous use of synthetic cathinones. The \\ncharacteristic feature is a strong internal drive to use synthetic cathinones, which is  \\nmanifested by impaired ability to control use, increasing priority given to use over \\nother activities and persistence of use despite harm or negative consequences. \\nThese experiences are often accompanied by a subjective sensation of urge or \\ncraving to use synthetic cathinones. Physiological features of dependence may  also \\nbe present, including tolerance to the effects of synthetic cathinones, withdrawal \\nsymptoms following cessation or reduction in use of synthetic cathinones, or \\nrepeated use of synthetic cathinones or pharmacologically similar substances to  \\nprevent or alleviate withdrawal symptoms. The features of dependence are usually \\nevident over a period of at least 12 months but the diagnosis may be made if \\nsynthetic cathinone use is continuous (daily or almost daily) for at least 1 month. \\nExclusions: Harmful pattern of use of synthetic cathinones (6C47.1) \\nSingle episode of harmful use of synthetic cathinones (6C47.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 112, 'page_label': '113'}, page_content='112  ICD-11 MMS - 2018 \\n \\n6C47.20 Synthetic cathinone dependence, current use \\nCurrent synthetic cathinone dependence with use of synthetic cathinones withi n the \\npast month. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nHarmful pattern of use of synthetic cathinones (6C47.1) \\n \\n6C47.21 Synthetic cathinone dependence, early full remission \\nAfter a diagnosis of synthetic cathinone dependence, and often following a \\ntreatment episode or other intervention (including self-help intervention), the \\nindividual has been abstinent from synthetic cathinone use during a period las ting \\nfrom between 1 and 12 months. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nHarmful pattern of use of synthetic cathinones (6C47.1) \\n \\n6C47.22 Synthetic cathinone dependence, sustained partial remission \\nAfter a diagnosis of synthetic cathinone dependence, and often following a \\ntreatment episode or other intervention (including self-help intervention), ther e is a \\nsignificant reduction in synthetic cathinone consumption for more than 12 months, \\nsuch that even though synthetic cathinone use has occurred during this period, the  \\ndefinitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nHarmful pattern of use of synthetic cathinones (6C47.1) \\n \\n6C47.23 Synthetic cathinone dependence, sustained full remission \\nAfter a diagnosis of synthetic cathinone dependence, and often following a \\ntreatment episode or other intervention (including self-intervention), the person has \\nbeen abstinent from synthetic cathinone use for 12 months or longer. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nHarmful pattern of use of synthetic cathinones (6C47.1) \\n \\n6C47.2Y Other specified synthetic cathinone dependence \\n \\n6C47.2Z Synthetic cathinone dependence, unspecified \\n \\n6C47.3 Synthetic cathinone intoxication \\nSynthetic cathinone intoxication is a clinically significant transient  condition that \\ndevelops during or shortly after the consumption of synthetic cathinones that is  \\ncharacterized by disturbances in consciousness, cognition, perception, affect, \\nbehaviour, or coordination. These disturbances are caused by the known \\npharmacological effects of synthetic cathinones and their intensity is close ly related \\nto the amount of synthetic cathinones consumed. They are time-limited and abate \\nas the synthetic cathinone is cleared from the body. Presenting features may \\ninclude anxiety, anger, hypervigilance, psychomotor agitation, panic, conf usion, \\nparanoid ideation, auditory hallucinations and changes in sociability, p erspiration or \\nchills, and nausea or vomiting. Physical signs may include tachycardia, el evated \\nblood pressure, pupillary dilatation, and hyperthermia. In rare instances, usually in \\nsevere intoxication, use of synthetic cathinones can result in seizures. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 113, 'page_label': '114'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   113 \\n \\n6C47.4 Synthetic cathinone withdrawal \\nSynthetic cathinone withdrawal is a clinically significant cluster of sy mptoms, \\nbehaviours and/or physiological features, varying in degree of severity and durati on, \\nthat occurs upon cessation or reduction of use of synthetic cathinones in individu als \\nwho have developed Synthetic cathinone dependence or have used synthetic \\ncathinones for a prolonged period or in large amounts. Presenting features of \\nSynthetic cathinone withdrawal may include dysphoric mood, irritabil ity, fatigue, \\ninsomnia or hypersomnia, increased appetite, anxiety, and craving for stimulants, \\nincluding cathinones. \\nNote: Code also the underlying condition \\n \\n6C47.5 Synthetic cathinone-induced delirium \\nSynthetic cathinone-induced delirium is characterized by an acute state of di sturbed \\nattention and awareness with specific features of delirium that develops during or \\nsoon after substance intoxication or withdrawal or during the use of synthetic \\ncathinones. The amount and duration of synthetic cathinone use must be capable of \\nproducing delirium. The symptoms are not better explained by a primary mental \\ndisorder, by use of or withdrawal from a different substance, or by another health \\ncondition that is not classified under Mental, behavioural and neurodevelopmental \\ndisorders. \\nNote: Code also the underlying condition \\n \\n6C47.6 Synthetic cathinone-induced psychotic disorder \\nSynthetic cathinone-induced psychotic disorder is characterized by psychotic \\nsymptoms (e.g., delusions, hallucinations, disorganized thinking, grossly \\ndisorganized behaviour) that develop during or soon after intoxication with or \\nwithdrawal from synthetic cathinones. The intensity or duration of the sy mptoms is \\nsubstantially in excess of psychotic-like disturbances of perception, cognit ion, or \\nbehaviour that are characteristic of Synthetic cathinone intoxication or Synthetic \\ncathinone withdrawal. The amount and duration of synthetic cathinone use must be \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe synthetic cathinone use, if the symptoms persist for a substantial period of time \\nafter cessation of the synthetic cathinone use or withdrawal, or if there is o ther \\nevidence of a pre-existing primary mental disorder with psychotic symptoms (e.g ., a \\nhistory of prior episodes not associated with synthetic cathinone use). \\nNote: Code also the underlying condition \\n \\n6C47.60 Synthetic cathinone-induced psychotic disorder with hallucinations  \\nSynthetic cathinone-induced psychotic disorder with hallucinations is characteriz ed \\nby the presence of hallucinations that are judged to be the direct consequenc e of \\nsynthetic cathinone use. Neither delusions nor other psychotic symptoms are \\npresent. The symptoms do not occur exclusively during hypnogogic or hypnopompic \\nstates, are not better accounted for by another mental and behavioural disorder \\n(e.g., schizophrenia), and are not due to another disorder or disease classified \\nelsewhere (e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 114, 'page_label': '115'}, page_content='114  ICD-11 MMS - 2018 \\n \\n6C47.61 Synthetic cathinone-induced psychotic disorder with delusions \\nSynthetic cathinone psychotic disorder with delusions is characterized by the \\npresence of delusions that are judged to be the direct consequence of syntheti c \\ncathinone use. Neither hallucinations nor other psychotic symptoms are present. \\nThe symptoms do not occur exclusively during hypnogogic or hypnopompic states , \\nare not better accounted for by another mental and behavioural disorder (e.g., \\nschizophrenia), and are not due to another disorder or disease classified elsewh ere \\n(e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C47.62 Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms  \\nSynthetic cathinone-induced psychotic disorder with mixed psychotic sy mptoms is \\ncharacterized by the presence of multiple psychotic symptoms, primarily \\nhallucinations and delusions, when these are judged to be the direct con sequence \\nof synthetic cathinone use. The symptoms do not occur exclusively during \\nhypnogogic or hypnopompic states, are not better accounted for by another mental \\nand behavioural disorder (e.g., Schizophrenia), and are not due to another disorder \\nor disease classified elsewhere (e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C47.6Z Synthetic cathinone-induced psychotic disorder, unspecified \\nNote: Code also the underlying condition \\n \\n6C47.7 Other synthetic cathinones-induced disorders \\nNote: Code also the underlying condition \\n \\n6C47.70 Synthetic cathinone-induced mood disorder \\nSynthetic cathinone-induced mood disorder is characterized by mood sympto ms \\n(e.g., depressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after into xication \\nwith or withdrawal from synthetic cathinones. The intensity or duration of the \\nsymptoms is substantially in excess of mood disturbances that are characteristic of \\nSynthetic cathinone intoxication or Synthetic cathinone withdrawal. The amount and \\nduration of synthetic cathinone use must be capable of producing mood symptoms. \\nThe symptoms are not better explained by a primary mental disorder (e.g., a \\nDepressive disorder, a Bipolar disorder, Schizoaffective disorder), as might be the  \\ncase if the mood symptoms preceded the onset of the synthetic cathinone use, if \\nthe symptoms persist for a substantial period of time after cessation of the synt hetic \\ncathinone use or withdrawal, or if there is other evidence of a pre-existing primary \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with synthetic cathinone use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 115, 'page_label': '116'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   115 \\n \\n6C47.71 Synthetic cathinone-induced anxiety disorder \\nSynthetic cathinone-induced anxiety disorder is characterized by anxiety symptoms \\n(e.g., apprehension or worry, fear, physiological symptoms of excessive auto nomic \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from synthetic cathinones. The intensity or duration of the sy mptoms is \\nsubstantially in excess of anxiety symptoms that are characteristic of Sy nthetic \\ncathinone intoxication or Synthetic cathinone withdrawal. The amount and durati on \\nof synthetic cathinone use must be capable of producing anxiety symptoms. T he \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear-related disorder, a Depressive disorder with prominent anxiety symptoms), \\nas might be the case if the anxiety symptoms preceded the onset of the synthe tic \\ncathinone use, if the symptoms persist for a substantial period of time after \\ncessation of the synthetic cathinone use or withdrawal, or if there is other evidenc e \\nof a pre-existing primary mental disorder with anxiety symptoms (e.g., a histor y of \\nprior episodes not associated with synthetic cathinone use). \\nNote: Code also the underlying condition \\n \\n6C47.72 Synthetic cathinone-induced obsessive-compulsive or related syndrome  \\nSynthetic cathinone-induced obsessi ve-compulsive or related disorder is \\ncharacterized by either repetitive intrusive thoughts or preoccupations, normally \\nassociated with anxiety and typically accompanied by repetitive behaviours \\nperformed in response, or by recurrent and habitual actions directed at the \\nintegument (e.g., hair pulling, skin picking) that develop during or soon after \\nintoxication with or withdrawal from synthetic cathinones. The intensity or duration \\nof the symptoms is substantially in excess of analogous disturbances that are  \\ncharacteristic of Synthetic cathinone intoxication or Synthetic cathinone withdrawal. \\nThe amount and duration of synthetic cathinone use must be capable of producing \\nobsessive-compulsive or related symptoms. The symptoms are not better explain ed \\nby a primary mental disorder (in particular an Obsessive-compulsive or rela ted \\ndisorder), as might be the case if the symptoms preceded the onset of the synthetic \\ncathinone use, if the symptoms persist for a substantial period of time after \\ncessation of the synthetic cathinone use or withdrawal, or if there is other eviden ce \\nof a pre-existing primary mental disorder with obsessive-compulsive or related  \\nsymptoms (e.g., a history of prior episodes not associated with synthetic cathino ne \\nuse). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 116, 'page_label': '117'}, page_content='116  ICD-11 MMS - 2018 \\n \\n6C47.73 Synthetic cathinone-induced impulse control disorder \\nSynthetic cathinone-induced impulse control disorder is characterized by \\npersistently repeated behaviours in which there is recurrent failure to resist an \\nimpulse, drive, or urge to perform an act that is rewarding to the person, at least in \\nthe short-term, despite longer-term harm either to the individual or to others  (e.g., \\nfire setting or stealing without apparent motive, repetitive sexual behaviour, \\naggressive outbursts) that develop during or soon after intoxication with or \\nwithdrawal from synthetic cathinones. The intensity or duration of the sy mptoms is \\nsubstantially in excess of disturbances of impulse control that are characteristic o f \\nSynthetic cathinone intoxication or Synthetic cathinone withdrawal. The amount and \\nduration of synthetic cathinone use must be capable of producing disturbances of \\nimpulse control. The symptoms are not better explained by a primary mental \\ndisorder (e.g., an Impulse control disorder, a Disorder due to addictive behaviours), \\nas might be the case if the impulse control disturbances preceded the onset of the  \\nsynthetic cathinone use, if the symptoms persist for a substantial period of time after \\ncessation of the synthetic cathinone use or withdrawal, or if there is other evidenc e \\nof a pre-existing primary mental disorder with impulse control symptoms (e.g., a \\nhistory of prior episodes not associated with synthetic cathinone use). \\nNote: Code also the underlying condition \\n \\n6C47.Y Other specified disorders due to use of synthetic cathinones \\nNote: Code also the underlying condition \\n \\n6C47.Z Disorders due to use of synthetic cathinones, unspecified \\nNote: Code also the underlying condition \\n \\n  6C48   Disorders due to use of caffeine \\nDisorders due to use of caffeine are characterised by the pattern and consequences \\nof caffeine use. In addition to Caffeine intoxication, Caffeine withdrawal may oc cur \\nupon cessation or reduction of use of caffeine in individuals who have used caffei ne \\nfor a prolonged period or in large amounts. Caffeine is implicated in harms affecti ng \\norgans and systems of the body, which may be classified as Single episode  of \\nharmful use of caffeine and Harmful pattern of use of caffeine. Caffeine-induced \\nanxiety disorder and caffeine-induced sleep-wake disorder are recognised. \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46) \\nHazardous use of caffeine (QE11.5) \\n \\n6C48.0 Single episode of harmful use of caffeine \\nA single episode of caffeine use that has caused damage to a person ’s physical or \\nmental health. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) direct or secondary toxic effects on body organs and systems; or (2) a \\nharmful route of administration. This diagnosis should not be made if the harm is \\nattributed to a known pattern of caffeine use. \\nExclusions: Harmful pattern of use of caffeine (6C48.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 117, 'page_label': '118'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   117 \\n \\n6C48.1 Harmful pattern of use of caffeine \\nA pattern of caffeine use that has caused clinically significant harm to a person ’s \\nphysical or mental health or in which caffeine-induced behaviour has caus ed \\nclinically significant harm to the health of other people. The pattern of caffeine use is \\nevident over a period of at least 12 months if use is episodic and at least  one month \\nif use is continuous (i.e., daily or almost daily). Harm may be caused  by the \\nintoxicating effects of caffeine, the direct or secondary toxic effects on body orga ns \\nand systems, or a harmful route of administration. \\nExclusions: Single episode of harmful use of caffeine (6C48.0) \\n \\n6C48.10 Harmful pattern of use of caffeine, episodic \\nA pattern of episodic or intermittent caffeine use that has caused damage to a \\nperson’s physical or mental health. The pattern of episodic caffeine use is ev ident \\nover a period of at least 12 months. Harm to health of the individual occurs due to \\none or more of the following: (1) direct or secondary toxic effects on body organs  \\nand systems; or (2) a harmful route of administration. \\nExclusions: Single episode of harmful use of caffeine (6C48.0) \\n \\n6C48.11 Harmful pattern of use of caffeine, continuous \\nA pattern of continuous (daily or almost daily) caffeine use that has caus ed damage \\nto a person ’s physical or mental health. The pattern of continuous caffeine use is \\nevident over a period of at least one month. Harm to health of the individual occurs  \\ndue to one or more of the following: (1) direct or secondary toxic effects on  body \\norgans and systems; or (2) a harmful route of administration. \\nExclusions: Single episode of harmful use of caffeine (6C48.0) \\n \\n6C48.1Z Harmful pattern of use of caffeine, unspecified \\n \\n6C48.2 Caffeine intoxication \\nCaffeine intoxication is a clinically significant transient conditi on that develops \\nduring or shortly after the consumption of caffeine that is characterized by \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof caffeine and their intensity is closely related to the amount of caffeine  consumed. \\nThey are time-limited and abate as caffeine is cleared from the body. Presen ting \\nfeatures may include restlessness, anxiety, excitement, insomnia, flushed face, \\ndiuresis, gastrointestinal disturbances, muscle twitching, psychomotor agitation, \\nperspiration or chills, and nausea or vomiting. Panic attacks may occur. \\nDisturbances typical of intoxication tend to occur at relatively higher doses ( e.g., > 1 \\ng per day). Very high doses of caffeine (e.g., > 5 g) can result in r espiratory distress \\nor seizures and can be fatal. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 118, 'page_label': '119'}, page_content='118  ICD-11 MMS - 2018 \\n \\n6C48.3 Caffeine withdrawal \\nCaffeine withdrawal is a clinically significant cluster of symptoms, behav iours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of caffeine (typically in the form of coffee, c affeinated \\ndrinks, or as an ingredient in certain over- the-counter medications) in individuals \\nwho have used caffeine for a prolonged period or in large amounts. Presenting \\nfeatures of Caffeine withdrawal may include headache, fatigue or drowsiness, \\nanxiety, dysphoric mood, nausea or vomiting, and difficulty concentrating. \\nNote: Code also the underlying condition \\n \\n6C48.4 Caffeine-induced disorders \\nNote: Code also the underlying condition \\n \\n6C48.40 Caffeine-induced anxiety disorder \\nCaffeine-induced anxiety disorder is characterized by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic  \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from caffeine. The intensity or duration of the symptoms is s ubstantially \\nin excess of anxiety symptoms that are characteristic of Caffeine intoxication or \\nCaffeine withdrawal. The amount and duration of caffeine use must be capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety symptom s \\npreceded the onset of the caffeine use, if the symptoms persist for a subs tantial \\nperiod of time after cessation of the caffeine use or withdrawal, or if there is ot her \\nevidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with caffeine use). \\nNote: Code also the underlying condition \\n \\n6C48.Y Other specified disorders due to use of caffeine \\nNote: Code also the underlying condition \\n \\n6C48.Z Disorders due to use of caffeine, unspecified \\nNote: Code also the underlying condition \\n \\n  6C49   Disorders due to use of hallucinogens \\nDisorders due to use of hallucinogens are characterised by the pattern and \\nconsequences of hallucinogen use. In addition to Hallucinogen intoxication, \\nhallucinogens have dependence-inducing properties, resulting in Hallucinogen \\ndependence in some people. Hallucinogens are implicated in a wide range of harms \\naffecting most organs and systems of the body, which may be classified as Si ngle \\nepisode of harmful use of hallucinogens and Harmful pattern of use of \\nhallucinogens. Harm to others resulting from behaviour during Hallucinog en \\nintoxication is included in the definitions of Harmful use of hallucinog ens. Several \\nhallucinogen-induced mental disorders are recognised. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 119, 'page_label': '120'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   119 \\n \\n6C49.0 Single episode of harmful use of hallucinogens \\nA single episode of hallucinogen use that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health \\nof others. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behavior due to hallucinogen intoxicati on on \\nthe part of the person to whom the diagnosis of single episode of harmful use \\napplies. This diagnosis should not be made if the harm is attributed to a known \\npattern of hallucinogen use. \\nExclusions: Hallucinogen dependence (6C49.2) \\nHarmful pattern of use of hallucinogens (6C49.1) \\n \\n6C49.1 Harmful pattern of use of hallucinogens \\nA pattern of use of hallucinogens that has caused damage to a person ’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of other s. \\nThe pattern of hallucinogen use is evident over a period of at least 12 months  if \\nsubstance use is episodic or at least one month if use is continuous (i.e., dai ly or \\nalmost daily). Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to hallucinogen intox ication \\non the part of the person to whom the diagnosis of Harmful pattern of use of \\nhallucinogens applies. \\nExclusions: Hallucinogen dependence (6C49.2) \\nSingle episode of harmful use of hallucinogens (6C49.0) \\n \\n6C49.10 Harmful pattern of use of hallucinogens, episodic \\nA pattern of episodic or intermittent use of hallucinogens that has caused damage \\nto a person’s physical or mental health or has resulted in behaviour leading to harm \\nto the health of others. The pattern of episodic hallucinogen use is evident over a \\nperiod of at least 12 months. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trau ma, or \\nmental disorder that is directly attributable to behaviour related to hallucinogen \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern  of \\nuse of hallucinogens applies. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHallucinogen dependence (6C49.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 120, 'page_label': '121'}, page_content='120  ICD-11 MMS - 2018 \\n \\n6C49.11 Harmful pattern of use of hallucinogens, continuous \\nA pattern of continuous (daily or almost daily) use of hallucinogens that has  caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous hallucinogen use is \\nevident over a period of at least one month. Harm to health of the individual occurs  \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour re lated \\nto hallucinogen intoxication on the part of the person to whom the diagnosis of \\nHarmful use of hallucinogens applies. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHallucinogen dependence (6C49.2) \\n \\n6C49.1Z Harmful pattern of use of hallucinogens, unspecified \\n \\n6C49.2 Hallucinogen dependence \\nHallucinogen dependence is a disorder of regulation of hallucinogen use aris ing \\nfrom repeated or continuous use of hallucinogens. The characteristic fea ture is a \\nstrong internal drive to use hallucinogens, which is manifested by impaired ab ility to \\ncontrol use, increasing priority given to use over other activities and persis tence of \\nuse despite harm or negative consequences. These experiences are often \\naccompanied by a subjective sensation of urge or craving to use hallucinogens. The  \\nfeatures of dependence are usually evident over a period of at least 12 months but \\nthe diagnosis may be made if hallucinogens use is continuous (daily or almost daily) \\nfor at least 1 month. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHarmful pattern of use of hallucinogens (6C49.1) \\n \\n6C49.20 Hallucinogen dependence, current use \\nCurrent hallucinogen dependence with hallucinogen use within the past month. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHarmful pattern of use of hallucinogens (6C49.1) \\n \\n6C49.21 Hallucinogen dependence, early full remission \\nAfter a diagnosis of Hallucinogen dependence, and often following a treatment \\nepisode or other intervention (including self-help intervention), the ind ividual has \\nbeen abstinent from hallucinogens during a period lasting from betwe en 1 and 12 \\nmonths. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHarmful pattern of use of hallucinogens (6C49.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 121, 'page_label': '122'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   121 \\n \\n6C49.22 Hallucinogen dependence, sustained partial remission \\nAfter a diagnosis of Hallucinogen dependence, and often following a treatment \\nepisode or other intervention (including self-help intervention), there is a  significant \\nreduction in hallucinogen consumption for more than 12 months, such that even \\nthough intermittent or continuing hallucinogen use has occurred during this period,  \\nthe definitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHarmful pattern of use of hallucinogens (6C49.1) \\n \\n6C49.23 Hallucinogen dependence, sustained full remission \\nAfter a diagnosis of Hallucinogen dependence, and often following a treatment \\nepisode or other intervention (including self-intervention), the person has  been \\nabstinent from hallucinogens for 12 months or longer. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHarmful pattern of use of hallucinogens (6C49.1) \\n \\n6C49.2Z Hallucinogen dependence, unspecified \\n \\n6C49.3 Hallucinogen intoxication \\nHallucinogen intoxication is a clinically significant transient conditio n that develops \\nduring or shortly after the consumption of hallucinogens that is characterized b y \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof hallucinogens and their intensity is closely related to the amount of hal lucinogen \\nconsumed. They are time-limited and abate as the hallucinogen is cleared from the \\nbody. Presenting features may include hallucinations, illusions, perceptual  changes \\n(such as depersonalization, derealization, synesthesias (blending of senses, su ch \\nas a visual stimulus evoking a smell), anxiety or depression, ideas of reference, \\nparanoid ideation, impaired judgment, palpitations, sweating, blurred vision, tremors  \\nand incoordination. Physical signs may include tachycardia, elevated blood \\npressure, and pupillary dilatation. In rare instances, hallucinogen intoxication may  \\nincrease suicidal behaviour. \\nNote: Code also the underlying condition \\nExclusions: hallucinogens poisoning (NE60) \\nPossession trance disorder (6B63) \\n \\n6C49.4 Hallucinogen-induced delirium \\nHallucinogen-induced delirium is characterized by an acute state of disturbed  \\nattention and awareness with specific features of delirium that develops during or \\nsoon after substance intoxication or during the use of hallucinogens. The amount \\nand duration of hallucinogen use must be capable of producing delirium. The \\nsymptoms are not better explained by a primary mental disorder, by use of or \\nwithdrawal from a different substance, or by another health condition that is not \\nclassified under Mental, behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 122, 'page_label': '123'}, page_content='122  ICD-11 MMS - 2018 \\n \\n6C49.5 Hallucinogen-induced psychotic disorder \\nHallucinogen-induced psychotic disorder is characterized by psychotic sym ptoms \\n(e.g., delusions, hallucinations, disorganized thinking, grossly disorganized \\nbehaviour) that develop during or soon after intoxication with hallucinogens. The \\nintensity or duration of the symptoms is substantially in excess of psy chotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nhallucinogen intoxication. The amount and duration of hallucinogen use must be  \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe hallucinogen use, if the symptoms persist for a substantial period of time after \\ncessation of the hallucinogen use, or if there is other evidence of a pre-exi sting \\nprimary mental disorder with psychotic symptoms (e.g., a history of prior episodes \\nnot associated with hallucinogen use). \\nNote: Code also the underlying condition \\nExclusions: Psychotic disorder induced by other specified psychoactive \\nsubstance (6C4E.6) \\nAlcohol-induced psychotic disorder (6C40.6) \\n \\n6C49.6 Other hallucinogen-induced disorders \\nNote: Code also the underlying condition \\n \\n6C49.60 Hallucinogen-induced mood disorder \\nHallucinogen-induced mood disorder is characterized by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxi cation \\nwith hallucinogens. The intensity or duration of the symptoms is substant ially in \\nexcess of mood disturbances that are characteristic of hallucinogen intoxication. \\nThe amount and duration of hallucinogen use must be capable of producing mood \\nsymptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), as migh t \\nbe the case if the mood symptoms preceded the onset of the hallucinogen use, if \\nthe symptoms persist for a substantial period of time after cessation of the \\nhallucinogen use, or if there is other evidence of a pre-existing primary mental \\ndisorder with mood symptoms (e.g., a history of prior episodes not associated with \\nhallucinogen use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 123, 'page_label': '124'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   123 \\n \\n6C49.61 Hallucinogen-induced anxiety disorder \\nHallucinogen-induced anxiety disorder is characterized by anxiety symptoms  (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic  \\narousal, avoidance behaviour) that develop during or soon after intoxication with \\nhallucinogens. The intensity or duration of the symptoms is substantially i n excess \\nof anxiety symptoms that are characteristic of hallucinogen intoxication. The amou nt \\nand duration of hallucinogen use must be capable of producing anxiety symptoms. \\nThe symptoms are not better explained by a primary mental disorder (e.g., an \\nAnxiety and Fear-Related Disorder, a Depressive Disorder with prominent anxiety \\nsymptoms), as might be the case if the anxiety symptoms preceded the onset of the \\nhallucinogen use, if the symptoms persist for a substantial period of time aft er \\ncessation of the hallucinogen use, or if there is other evidence of a pre-exi sting \\nprimary mental disorder with anxiety symptoms (e.g., a history of prior episodes not  \\nassociated with hallucinogen use). \\nNote: Code also the underlying condition \\n \\n6C49.Y Other specified disorders due to use of hallucinogens \\nNote: Code also the underlying condition \\n \\n6C49.Z Disorders due to use of hallucinogens, unspecified \\nNote: Code also the underlying condition \\n \\n  6C4A   Disorders due to use of nicotine \\nDisorders due to use of nicotine are characterised by the pattern and consequences \\nof nicotine use. In addition to Nicotine intoxication, nicotine has dependence-\\ninducing properties, resulting in Nicotine dependence in some people and Nicotine  \\nwithdrawal when use is reduced or discontinued. Nicotine is implicated in a wide \\nrange of harms affecting most organs and systems of the body, which may be \\nclassified as Single episode of harmful use of nicotine and Harmful pattern of use of \\nnicotine. Nicotine-induced sleep-wake disorder is recognised. \\nNote: Code also the underlying condition \\n \\n6C4A.0 Single episode of harmful use of nicotine \\nA single episode of nicotine use that has caused damage to a person ’s physical or \\nmental health. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) direct or secondary toxic effects on body organs and systems; or (2) a \\nharmful route of administration. This diagnosis should not be made if the harm is \\nattributed to a known pattern of nicotine use. \\nExclusions: Nicotine dependence (6C4A.2) \\nHarmful pattern of use of nicotine (6C4A.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 124, 'page_label': '125'}, page_content='124  ICD-11 MMS - 2018 \\n \\n6C4A.1 Harmful pattern of use of nicotine \\nA pattern of nicotine use that has caused damage to a person ’s physical or mental \\nhealth. The pattern of nicotine use is evident over a period of at least 12 months if \\nsubstance use is episodic or at least one month if use is continuous (i.e., dai ly or \\nalmost daily). Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) direct or secondary toxic effects on body organs and systems; or (2) a \\nharmful route of administration. \\nExclusions: Nicotine dependence (6C4A.2) \\nSingle episode of harmful use of nicotine (6C4A.0) \\n \\n6C4A.10 Harmful pattern of use of nicotine, episodic \\nA pattern of episodic or intermittent nicotine use that has caused damage to a \\nperson’s physical or mental health. The pattern of episodic nicotine use is evi dent \\nover a period of at least 12 months. Harm to health of the individual occurs due to \\none or more of the following: (1) direct or secondary toxic effects on body organs \\nand systems; or (2) a harmful route of administration. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nNicotine dependence (6C4A.2) \\n \\n6C4A.11 Harmful pattern of use of nicotine, continuous \\nA pattern of continuous (daily or almost daily) nicotine use that has caus ed damage \\nto a person ’s physical or mental health. The pattern of continuous nicotine use is \\nevident over a period of at least one month. Harm to health of the individual occurs  \\ndue to one or more of the following: (1) direct or secondary toxic effects on  body \\norgans and systems; or (2) a harmful route of administration. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nNicotine dependence (6C4A.2) \\n \\n6C4A.1Z Harmful pattern of use of nicotine, unspecified \\n \\n6C4A.2 Nicotine dependence \\nNicotine dependence is a disorder of regulation of nicotine use arising from \\nrepeated or continuous use of nicotine. The characteristic feature is a strong \\ninternal drive to use nicotine, which is manifested by impaired ability to control use, \\nincreasing priority given to use over other activities and persistence of use despite  \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use nicotine. Physiological f eatures of \\ndependence may also be present, including tolerance to the effects of nicotine, \\nwithdrawal symptoms following cessation or reduction in use of nicotine, or \\nrepeated use of nicotine or pharmacologically similar substances to prevent or \\nalleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nHarmful pattern of use of nicotine (6C4A.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 125, 'page_label': '126'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   125 \\n \\n6C4A.20 Nicotine dependence, current use \\nCurrent nicotine dependence with nicotine use within the past month. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nHarmful pattern of use of nicotine (6C4A.1) \\n \\n6C4A.21 Nicotine dependence, early full remission \\nAfter a diagnosis of nicotine dependence, and often following a treatment episode  \\nor other intervention (including self-help intervention), the individual has been  \\nabstinent from nicotine during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nHarmful pattern of use of nicotine (6C4A.1) \\n \\n6C4A.22 Nicotine dependence, sustained partial remission \\nAfter a diagnosis of nicotine dependence, and often following a treatment episode  \\nor other intervention (including self-help intervention), there is a signific ant reduction \\nin nicotine consumption for more than 12 months, such that even though \\nintermittent or continuing nicotine use has occurred during this period, the \\ndefinitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nHarmful pattern of use of nicotine (6C4A.1) \\n \\n6C4A.23 Nicotine dependence, sustained full remission \\nAfter a diagnosis of nicotine dependence, and often following a treatment episode  \\nor other intervention (including self-intervention), the person has been abs tinent \\nfrom nicotine for 12 months or longer. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nHarmful pattern of use of nicotine (6C4A.1) \\n \\n6C4A.2Z Nicotine dependence, unspecified \\n \\n6C4A.3 Nicotine intoxication \\nNicotine intoxication is a clinically significant transient condition that de velops during \\nor shortly after the consumption of nicotine that is characterized by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. These \\ndisturbances are caused by the known pharmacological effects of nicotine and their \\nintensity is closely related to the amount of nicotine consumed. They are ti me-\\nlimited and abate as nicotine is cleared from the body. Presenting fea tures may \\ninclude restlessness, psychomotor agitation, anxiety, cold sweats, head ache, \\ninsomnia, palpitations, paresthesias, nausea or vomiting, abdominal cramps, \\nconfusion, bizarre dreams, burning sensations in the mouth, and salivation. In rare \\ninstances, paranoid ideation, perceptual disturbances, convulsions or coma and \\nmay occur. Nicotine intoxication occurs most commonly in naïve (non-tolerant) \\nusers or among those taking higher than accustomed doses. \\nNote: Code also the underlying condition \\nInclusions: \"Bad trips\" (nicotine) \\nExclusions: intoxication meaning poisoning (NE61) \\nPossession trance disorder (6B63)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 126, 'page_label': '127'}, page_content='126  ICD-11 MMS - 2018 \\n \\n6C4A.4 Nicotine withdrawal \\nNicotine withdrawal is a clinically significant cluster of symptoms, behavi ours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon  \\ncessation or reduction of use of nicotine (typically used as a constituent of  tobacco) \\nin individuals who have developed Nicotine dependence or have used nicotine  for a \\nprolonged period or in large amounts. Presenting features of Nicotine withdrawal \\nmay include dysphoric or depressed mood, insomnia, irritability, frustration, anger, \\nanxiety, difficulty concentrating, restlessness, bradycardia, increased appet ite, and \\nweight gain and craving for tobacco (or other nicotine-containing products). Other \\nphysical symptoms may include increased cough and mouth ulceration. \\nNote: Code also the underlying condition \\n \\n6C4A.Y Other specified disorders due to use of nicotine \\nNote: Code also the underlying condition \\n \\n6C4A.Z Disorders due to use of nicotine, unspecified \\nNote: Code also the underlying condition \\n \\n  6C4B   Disorders due to use of volatile inhalants \\nDisorders due to use of volatile inhalants are characterised by the pattern and \\nconsequences of volatile inhalant use. In addition to Volatile inhalant intoxication, \\nvolatile inhalants have dependence-inducing properties, resulting in Volati le inhalant \\ndependence in some people and Volatile inhalant withdrawal when use is reduced \\nor discontinued. Volatile inhalants are implicated in a wide range of harms affec ting \\nmost organs and systems of the body, which may be classified as Single epi sode of \\nharmful use of volatile inhalants and Harmful pattern of use of volatile inhalants. \\nHarm to others resulting from behaviour during Volatile inhalant intoxic ation is \\nincluded in the definitions of Harmful use of volatile inhalants. Several volatile \\ninhalant-induced mental disorders are recognised. \\nNote: Code also the underlying condition \\n \\n6C4B.0 Single episode of harmful use of volatile inhalants \\nA single episode of volatile inhalant use or unintentional exposure (e.g., \\noccupational exposure) that has caused damage to a person ’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behavi our \\nrelated to intoxication; (2) direct or secondary toxic effects on body organs and \\nsystems; or (3) a harmful route of administration. Harm to health of others includes \\nany form of physical harm, including trauma, or mental disorder that is dire ctly \\nattributable to behavior due to volatile inhalant intoxication on the part of the person \\nto whom the diagnosis of single episode of harmful use applies. This diag nosis \\nshould not be made if the harm is attributed to a known pattern of volatile inhalant \\nuse. \\nExclusions: Harmful pattern of use of volatile inhalants (6C4B.1) \\nVolatile inhalant dependence (6C4B.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 127, 'page_label': '128'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   127 \\n \\n6C4B.1 Harmful pattern of use of volatile inhalants \\nA pattern of volatile inhalant use of that has caused damage to a person ’s physical \\nor mental health. The pattern of volatile inhalant use is evident over a period of at \\nleast 12 months if substance use is episodic or at least one month if use i s \\ncontinuous (i.e., daily or almost daily). Harm to health of the individual occurs due to \\none or more of the following: (1) behaviour related to intoxication; (1) direct  or \\nsecondary toxic effects on body organs and systems; or (2) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto volatile inhalant intoxication on the part of the person to whom the diag nosis of \\nHarmful pattern of use of volatile inhalants applies. \\nExclusions: Volatile inhalant dependence (6C4B.2) \\nSingle episode of harmful use of volatile inhalants (6C4B.0) \\n \\n6C4B.10 Harmful pattern of use of volatile inhalants, episodic \\nA pattern of episodic or intermittent volatile inhalant use that has caused damag e to \\na person’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic volatile inhalant use is evident over  a \\nperiod of at least 12 months. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to volatile inhalant \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern  of \\nuse of volatile inhalants applies. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nVolatile inhalant dependence (6C4B.2) \\n \\n6C4B.11 Harmful pattern of use of volatile inhalants, continuous \\nA pattern of continuous (daily or almost daily) volatile inhalant use that ha s caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous volatile inhalant use is \\nevident over a period of at least one month. Harm to health of the individual occurs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto volatile inhalant intoxication on the part of the person to whom the diag nosis of \\nHarmful pattern of use of volatile inhalants applies. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nVolatile inhalant dependence (6C4B.2) \\n \\n6C4B.1Z Harmful pattern of use of volatile inhalants, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 128, 'page_label': '129'}, page_content='128  ICD-11 MMS - 2018 \\n \\n6C4B.2 Volatile inhalant dependence \\nVolatile inhalant dependence is a disorder of regulation of volatile inhala nt use \\narising from repeated or continuous use of volatile inhalants. The characteristic  \\nfeature is a strong internal drive to use volatile inhalants, which is manifested  by \\nimpaired ability to control use, increasing priority given to use over other ac tivities \\nand persistence of use despite harm or negative consequences. These experiences \\nare often accompanied by a subjective sensation of urge or craving to use vol atile \\ninhalants. Physiological features of dependence may also be present, including \\ntolerance to the effects of volatile inhalants, withdrawal symptoms following  \\ncessation or reduction in use of volatile inhalants, or repeated use of volatil e \\ninhalants or pharmacologically similar substances to prevent or alleviate withdra wal \\nsymptoms. The features of dependence are usually evident over a period of at least \\n12 months but the diagnosis may be made if volatile inhalant use is c ontinuous \\n(daily or almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nHarmful pattern of use of volatile inhalants (6C4B.1) \\n \\n6C4B.20 Volatile inhalant dependence, current use \\nCurrent volatile inhalant dependence with volatile inhalant use within the past \\nmonth. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nHarmful pattern of use of volatile inhalants (6C4B.1) \\n \\n6C4B.21 Volatile inhalant dependence, early full remission \\nAfter a diagnosis of volatile inhalant dependence, and often following a treatm ent \\nepisode or other intervention (including self-help intervention), the ind ividual has \\nbeen abstinent from volatile inhalants during a period lasting from between 1 and 12 \\nmonths. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nHarmful pattern of use of volatile inhalants (6C4B.1) \\n \\n6C4B.22 Volatile inhalant dependence, sustained partial remission \\nAfter a diagnosis of Volatile inhalant dependence, and often following a treatment \\nepisode or other intervention (including self-help intervention), there is a significant \\nreduction in volatile inhalant consumption for more than 12 months, such that even \\nthough intermittent or continuing volatile inhalant use has occurred during this \\nperiod, the definitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nHarmful pattern of use of volatile inhalants (6C4B.1) \\n \\n6C4B.23 Volatile inhalant dependence, sustained full remission \\nAfter a diagnosis of Volatile inhalant dependence, and often following a treatment \\nepisode or other intervention (including self-intervention), the person has  been \\nabstinent from volatile inhalants for 12 months or longer. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nHarmful pattern of use of volatile inhalants (6C4B.1) \\n \\n6C4B.2Z Volatile inhalant dependence, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 129, 'page_label': '130'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   129 \\n \\n6C4B.3 Volatile inhalant intoxication \\nVolatile inhalant intoxication is a clinically significant transient cond ition that \\ndevelops during or shortly after the consumption of a volatile inhalant that is  \\ncharacterized by disturbances in consciousness, cognition, perception, affect, \\nbehaviour, or coordination. These disturbances are caused by the known \\npharmacological effects of volatile inhalants and their intensity is clos ely related to \\nthe amount of volatile inhalant consumed. They are time-limited and abate as the \\nvolatile inhalant is cleared from the body. Presenting features may incl ude \\ninappropriate euphoria, impaired judgment, aggression, somnolence, coma, \\ndizziness, tremor, lack of coordination, slurred speech, unsteady gait, letharg y and \\napathy, psychomotor retardation, and visual disturbance. Muscle weakness and \\ndiplopia may occur. Use of volatile inhalants may cause cardiac arrthymi as, cardiac \\narrest, and death. Inhalants containing lead (e.g. some forms of petrol/gasoline)  \\nmay cause confusion, irritability, coma and seizures. \\nNote: Code also the underlying condition \\nExclusions: Possession trance disorder (6B63) \\n \\n6C4B.4 Volatile inhalant withdrawal \\nVolatile inhalant withdrawal is a clinically significant cluster of symptom s, \\nbehaviours and/or physiological features, varying in degree of severity and durati on, \\nthat occurs upon cessation or reduction of use of volatile inhalants in individual s \\nwho have developed Volatile inhalant dependence or have used volatile inhalants \\nfor a prolonged period or in large amounts. Presenting features of Volatile inhalant \\nwithdrawal may include insomnia, anxiety, irritability, dysphoric mood, shakiness, \\nperspiration, nausea, and transient illusions. \\nNote: Code also the underlying condition \\n \\n6C4B.5 Volatile inhalant-induced delirium \\nVolatile inhalant-induced delirium is characterized by an acute state of distur bed \\nattention and awareness with specific features of delirium that develops during or \\nsoon after substance intoxication or withdrawal or during the use of volatile \\ninhalants. The amount and duration of volatile inhalant use must be capable of \\nproducing delirium. The symptoms are not better explained by a primary mental \\ndisorder, by use of or withdrawal from a different substance, or by another health \\ncondition that is not classified under Mental, behavioural and neurodevelopmental \\ndisorders. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 130, 'page_label': '131'}, page_content='130  ICD-11 MMS - 2018 \\n \\n6C4B.6 Volatile inhalant-induced psychotic disorder \\nVolatile inhalant-induced psychotic disorder is characterized by psychoti c symptoms \\n(e.g., delusions, hallucinations, disorganized thinking, grossly disorganized \\nbeha1viour) that develop during or soon after intoxication with or withdrawal from \\nvolatile inhalants. The intensity or duration of the symptoms is substantial ly in \\nexcess of psychotic-like disturbances of perception, cognition, or behaviour tha t are \\ncharacteristic of Volatile inhalant intoxication or Volatile inhalant withdrawa l. The \\namount and duration of volatile inhalant use must be capable of producing psychotic \\nsymptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be the \\ncase if the psychotic symptoms preceded the onset of the volatile inhalant use, if \\nthe symptoms persist for a substantial period of time after cessation of the vo latile \\ninhalant use or withdrawal, or if there is other evidence of a pre-existing prim ary \\nmental disorder with psychotic symptoms (e.g., a history of prior episodes not \\nassociated with volatile inhalant use). \\nNote: Code also the underlying condition \\n \\n6C4B.7 Other volatile inhalants-induced disorders \\nNote: Code also the underlying condition \\n \\n6C4B.70 Volatile inhalant-induced mood disorder \\nVolatile inhalant-induced mood disorder is characterized by mood symptoms (e.g ., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intox ication \\nwith or withdrawal from volatile inhalants. The intensity or duration of the symptom s \\nis substantially in excess of mood disturbances that are characteristic of Volatil e \\ninhalant intoxication or Volatile inhalant withdrawal. The amount and durati on of \\nvolatile inhalant use must be capable of producing mood symptoms. The symptoms  \\nare not better explained by a primary mental disorder (e.g., a Depressive disorder, a \\nBipolar disorder, Schizoaffective disorder), as might be the case if the mood \\nsymptoms preceded the onset of the volatile inhalant use, if the symptoms pers ist \\nfor a substantial period of time after cessation of the volatile inhalant use or \\nwithdrawal, or if there is other evidence of a pre-existing primary mental di sorder \\nwith mood symptoms (e.g., a history of prior episodes not associated with vol atile \\ninhalant use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 131, 'page_label': '132'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   131 \\n \\n6C4B.71 Volatile inhalant-induced anxiety disorder \\nVolatile inhalant-induced anxiety disorder is characterized by anxiety sy mptoms \\n(e.g., apprehension or worry, fear, physiological symptoms of excessive auto nomic \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from volatile inhalants. The intensity or duration of the symptoms i s \\nsubstantially in excess of anxiety symptoms that are characteristic of Vol atile \\ninhalant intoxication or Volatile inhalant withdrawal. The amount and duration  of \\nvolatile inhalant use must be capable of producing anxiety symptoms. The  \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand Fear-Related Disorder, a Depressive Disorder with prominent anxiety \\nsymptoms), as might be the case if the anxiety symptoms preceded the onset of the \\nvolatile inhalant use, if the symptoms persist for a substantial period of  time after \\ncessation of the volatile inhalant use or withdrawal, or if there is other ev idence of a \\npre-existing primary mental disorder with anxiety symptoms (e.g., a history of pri or \\nepisodes not associated with volatile inhalant use). \\nNote: Code also the underlying condition \\n \\n6C4B.Y Other specified disorders due to use of volatile inhalants \\nNote: Code also the underlying condition \\n \\n6C4B.Z Disorders due to use of volatile inhalants, unspecified \\nNote: Code also the underlying condition \\n \\n  6C4C   Disorders due to use of MDMA or related drugs, including MDA \\nDisorders due to use of MDMA or related drugs, including MDA are characterised \\nby the pattern and consequences of MDMA or related drug use. In addition to \\nMDMA or related drug intoxication, including MDA, MDMA or related drugs have \\ndependence-inducing properties, resulting in MDMA or related drug dependence, \\nincluding MDA in some people and MDMA or related drug withdrawal, including  \\nMDA when use is reduced or discontinued. MDMA or related drugs are implicated in \\na wide range of harms affecting most organs and systems of the body, which ma y \\nbe classified as Single episode of harmful use of MDMA or related drugs, i ncluding \\nMDA and Harmful pattern of use of MDMA or related drugs, including MDA. Harm to \\nothers resulting from behaviour during MDMA or related drug intoxication, including \\nMDA is included in the definitions of Harmful use of MDMA or related drugs, \\nincluding MDA. Several MDMA or related drug-induced mental disorders and are \\nrecognised. \\nNote: Code also the underlying condition \\nExclusions: Hazardous use of MDMA or related drugs (QE11.6)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 132, 'page_label': '133'}, page_content='132  ICD-11 MMS - 2018 \\n \\n6C4C.0 Single episode of harmful use of MDMA or related drugs, including MDA  \\nA single episode of use of MDMA or related drugs, including MDA, that has caus ed \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behavior due to intoxication with \\nMDMA or related drugs, including MDA, on the part of the person to whom the \\ndiagnosis of single episode of harmful use applies. This diagnosis shou ld not be \\nmade if the harm is attributed to a known pattern of use of MDMA or related drugs, \\nincluding MDA. \\nExclusions: Harmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1) \\nMDMA or related drug dependence, including MDA (6C4C.2) \\n \\n6C4C.1 Harmful pattern of use of MDMA or related drugs, including MDA \\nA pattern of use of MDMA or related drugs, including MDA, that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of use of MDMA or related drugs is \\nevident over a period of at least 12 months if use is episodic or at least one mon th if \\nuse is continuous (i.e., daily or almost daily). Harm to health of the indivi dual occurs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto MDMA or related drug intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of MDMA or related drugs, including MDA \\napplies. \\nExclusions: MDMA or related drug dependence, including MDA (6C4C.2) \\nSingle episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\n \\n6C4C.10 Harmful use of MDMA or related drugs, including MDA, episodic \\nA pattern of episodic or intermittent use of MDMA or related drugs, including MDA, \\nthat has caused damage to a person ’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. The pattern of episodic use of \\nMDMA or related drugs is evident over a period of at least 12 months. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behavi our \\nrelated to intoxication; (2) direct or secondary toxic effects on body organs and \\nsystems; or (3) a harmful route of administration. Harm to health of others includes \\nany form of physical harm, including trauma, or mental disorder that is directl y \\nattributable to behaviour related to MDMA or related drug intoxication on the part of \\nthe person to whom the diagnosis of Harmful pattern of use of MDMA or related \\ndrugs, including MDA applies. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nMDMA or related drug dependence, including MDA (6C4C.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 133, 'page_label': '134'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   133 \\n \\n6C4C.11 Harmful use of MDMA or related drugs, including MDA, continuous \\nA pattern of continuous (daily or almost daily) use of MDMA or related drugs, \\nincluding MDA, that has caused damage to a person ’s physical or mental health or \\nhas resulted in behaviour leading to harm to the health of others. The pattern of \\ncontinuous use of MDMA or related drugs is evident over a period of at least one \\nmonth. Harm to health of the individual occurs due to one or more of the followi ng: \\n(1) behaviour related to intoxication; (2) direct or secondary toxic effects on bod y \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behaviour related to MDMA or related drug intoxic ation on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of MDMA or \\nrelated drugs, including MDA applies. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nMDMA or related drug dependence, including MDA (6C4C.2) \\n \\n6C4C.1Z Harmful pattern of use of MDMA or related drugs, including MDA, unspecified  \\n \\n6C4C.2 MDMA or related drug dependence, including MDA \\nMDMA or related drug dependence, including MDA is a disorder of regulation of \\nMDMA or related drug use arising from repeated or continuous use of MDMA or \\nrelated drugs. The characteristic feature is a strong internal drive to use MDMA or \\nrelated drugs, which is manifested by impaired ability to control use, increas ing \\npriority given to use over other activities and persistence of use despite harm or \\nnegative consequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use MDMA or related drugs. Physiological features \\nof dependence may also be present, including tolerance to the effects of MDMA or \\nrelated drugs, withdrawal symptoms following cessation or reduction in use of \\nMDMA or related drugs, or repeated use of MDMA or pharmacologically similar \\nsubstances to prevent or alleviate withdrawal symptoms. The features of \\ndependence are usually evident over a period of at least 12 months but the \\ndiagnosis may be made if MDMA or related drug use is continuous (daily or almost \\ndaily) for at least 1 month. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1) \\n \\n6C4C.20 MDMA or related drug dependence, including MDA, current use \\nCurrent MDMA or related drug dependence, including MDA, with MDMA or related \\ndrug use within the past month. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 134, 'page_label': '135'}, page_content='134  ICD-11 MMS - 2018 \\n \\n6C4C.21 MDMA or related drug dependence, including MDA, early full remission  \\nAfter a diagnosis of MDMA or related drug dependence, including MDA, and often \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthe individual has been abstinent from MDMA or related drug dependence, \\nincluding MDA, during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1) \\n \\n6C4C.22 MDMA or related drug dependence, including MDA, sustained partial remission  \\nAfter a diagnosis of MDMA or related drug dependence, including MDA, and often \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthere is a significant reduction in consumption of MDMA or related drugs, inc luding \\nMDA, for more than 12 months, such that even though intermittent or continuing use \\nof MDMA or related drugs, including MDA, has occurred during this period, the \\ndefinitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1) \\n \\n6C4C.23 MDMA or related drug dependence, including MDA, sustained full remission  \\nAfter a diagnosis of MDMA or related drug dependence, including MDA, and often \\nfollowing a treatment episode or other intervention (including self-intervent ion), the \\nperson has been abstinent from MDMA or related drugs, including MDA, for 12 \\nmonths or longer. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1) \\n \\n6C4C.2Z MDMA or related drug dependence, including MDA, unspecified \\n \\n6C4C.3 MDMA or related drug intoxication, including MDA \\nMDMA or related drug intoxication, including MDA is a clinically significan t transient \\ncondition that develops during or shortly after the consumption of MDMA or related  \\ndrugs that is characterized by disturbances in consciousness, cognition, percepti on, \\naffect, behaviour, or coordination. These disturbances are caused by the known \\npharmacological effects of MDMA or related drugs and their intensity is closely \\nrelated to the amount of MDMA or a related drug consumed. They are time-limited \\nand abate as MDMA or a related drug is cleared from the body. Presenting features \\nmay include increased or inappropriate sexual interest and activity, anxiety, \\nrestlessness, agitation, and sweating. In rare instances, usually in severe \\nintoxication, use of MDMA or related drugs, including MDA can result in dyst onia \\nand seizures. Sudden death is a rare but recognized complication. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 135, 'page_label': '136'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   135 \\n \\n6C4C.4 MDMA or related drug withdrawal, including MDA \\nMDMA or related drug withdrawal, including MDA is a clinically signific ant cluster of \\nsymptoms, behaviours and/or physiological features, varying in degree of severit y \\nand duration, that occurs upon cessation or reduction of use of MDMA or related \\ndrugs in individuals who have developed MDMA or related drug dependence or \\nhave used MDMA or related drugs for a prolonged period or in large amounts. \\nPresenting features of MDMA or related drug withdrawal may include fatigue, \\nlethargy, hypersomnia or insomnia, depressed mood, anxiety, irritability, cravi ng, \\ndifficulty in concentrating, and appetite disturbance. \\nNote: Code also the underlying condition \\n \\n6C4C.5 MDMA or related drug-induced delirium, including MDA \\nMDMA or related drug-induced delirium, including MDA is characterized by an acute \\nstate of disturbed attention and awareness with specific features of delirium that \\ndevelops during or soon after substance intoxication or during the use of MDMA or \\nrelated drugs. The amount and duration of MDMA or related drug use must be \\ncapable of producing delirium. The symptoms are not better explained by a primary \\nmental disorder, by use of or withdrawal from a different substance, or by another \\nhealth condition that is not classified under Mental, behavioural and \\nneurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C4C.6 MDMA or related drug-induced psychotic disorder, including MDA \\nMDMA or related drug-induced psychotic disorder, including MDA is characterized \\nby psychotic symptoms (e.g., delusions, hallucinations, disorganized th inking, \\ngrossly disorganized behaviour) that develop during or soon after intoxication with \\nMDMA or related drugs. The intensity or duration of the symptoms is substantiall y in \\nexcess of psychotic-like disturbances of perception, cognition, or behaviour tha t are \\ncharacteristic of MDMA or related drug intoxication. The amount and duration of \\nMDMA or related drug use must be capable of producing psychotic symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., \\nSchizophrenia, a Mood disorder with psychotic symptoms), as might be the case if  \\nthe psychotic symptoms preceded the onset of the MDMA or related drug use, if the \\nsymptoms persist for a substantial period of time after cessation of the MDMA or \\nrelated drug use, or if there is other evidence of a pre-existing primary mental \\ndisorder with psychotic symptoms (e.g., a history of prior episodes not associated \\nwith MDMA or related drug use, including MDA). \\nNote: Code also the underlying condition \\n \\n6C4C.7 Other MDMA or related drugs, including MDA-induced disorders \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 136, 'page_label': '137'}, page_content='136  ICD-11 MMS - 2018 \\n \\n6C4C.70 MDMA or related drug-induced mood disorder, including MDA \\nMDMA or related drug-induced mood disorder, including MDA is characterized by \\nmood symptoms (e.g., depressed or elevated mood, decreased engagement in \\npleasurable activities, increased or decreased energy levels) that develop during or \\nsoon after intoxication with MDMA or related drugs. The intensity or duration of the \\nsymptoms is substantially in excess of mood disturbances that are characteristic of \\nMDMA or related drug intoxication, including MDA. The amount and duration of \\nMDMA or related drug use must be capable of producing mood symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., a Depressive \\ndisorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if t he \\nmood symptoms preceded the onset of the MDMA or related drug use, if the \\nsymptoms persist for a substantial period of time after cessation of the MDMA or \\nrelated drug use, or if there is other evidence of a pre-existing primary mental \\ndisorder with mood symptoms (e.g., a history of prior episodes not associated with \\nMDMA or related drug use). \\nNote: Code also the underlying condition \\n \\n6C4C.71 MDMA or related drug-induced anxiety disorder \\nMDMA or related drug-induced anxiety disorder, including MDA is characterized b y \\nanxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms  of \\nexcessive autonomic arousal, avoidance behaviour) that develop during or soon \\nafter intoxication with MDMA or related drugs. The intensity or duration of the \\nsymptoms is substantially in excess of anxiety symptoms that are characteristic  of \\nMDMA or related drug intoxication, including MDA. The amount and duration of \\nMDMA or related drug use must be capable of producing anxiety symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear-related disorder, a Depressive disorder with prominent anxiety symptoms), \\nas might be the case if the anxiety symptoms preceded the onset of the MDMA  or \\nrelated drug use, if the symptoms persist for a substantial period of time after \\ncessation of the MDMA or related drug use, or if there is other evidence of a pre-\\nexisting primary mental disorder with anxiety symptoms (e.g., a history of prior \\nepisodes not associated with MDMA or related drug use). \\nNote: Code also the underlying condition \\n \\n6C4C.Y Other specified disorders due to use of MDMA or related drugs, including \\nMDA \\nNote: Code also the underlying condition \\n \\n6C4C.Z Disorders due to use of MDMA or related drugs, including MDA, unspecified  \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 137, 'page_label': '138'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   137 \\n \\n  6C4D   Disorders due to use of dissociative drugs including ketamine and \\nphencyclidine [PCP] \\nDisorders due to use of dissociative drugs including ketamine and phencyclidine \\n[PCP] are characterised by the pattern and consequences of dissociative drug use. \\nIn addition to Dissociative drug intoxication including Ketamine or PCP, dissociati ve \\ndrugs have dependence-inducing properties, resulting in Dissociative drug \\ndependence including ketamine or PCP in some people. Dissociative drugs are \\nimplicated in a wide range of harms affecting most organs and systems of the bo dy, \\nwhich may be classified as Single episode of harmful use of dissociati ve drugs \\nincluding ketamine or PCP and Harmful pattern of use of dissociative drugs \\nincluding ketamine or PCP. Harm to others resulting from behaviour during \\nDissociative drug intoxication including Ketamine or PCP is included in the \\ndefinitions of Harmful use of dissociative drugs. Several dissociative drug -induced \\nmental disorders are recognised. \\nNote: Code also the underlying condition \\nExclusions: Hazardous use of dissociative drugs including ketamine or \\nPCP (QE11.7) \\n \\n6C4D.0 Single episode of harmful use of dissociative drugs including ketamine or \\nPCP \\nA single episode of use of a dissociative drug, including Ketamine and PCP, that \\nhas caused damage to a person ’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. Harm to health of the individual \\noccurs due to one or more of the following: (1) behaviour related to intoxication; (2) \\ndirect or secondary toxic effects on body organs and systems; or (3) a harmful route \\nof administration. Harm to health of others includes any form of physical harm , \\nincluding trauma, or mental disorder that is directly attributable to behavior d ue to \\nintoxication with a dissociative drug, including Ketamine and PCP, on the par t of the \\nperson to whom the diagnosis of single episode of harmful use applies. Thi s \\ndiagnosis should not be made if the harm is attributed to a known pattern  of use of \\ndissociative drugs, including Ketamine and PCP. \\nExclusions: Dissociative drug dependence including ketamine or PCP \\n(6C4D.2) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 138, 'page_label': '139'}, page_content='138  ICD-11 MMS - 2018 \\n \\n6C4D.1 Harmful pattern of use of dissociative drugs, including ketamine or PCP \\nA pattern of use of dissociative drugs, including ketamine and phencyclidine (PCP), \\nthat has caused damage to a person ’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. The pattern of dissociative drug \\nuse is evident over a period of at least 12 months if use is episodic or at leas t one \\nmonth if use is continuous (i.e., daily or almost daily). Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to dissociative drug intoxication on the part of the person t o whom \\nthe diagnosis of Harmful pattern of use of dissociative drugs, including ketam ine \\nand PCP applies. \\nExclusions: Dissociative drug dependence including ketamine or PCP \\n(6C4D.2) \\nSingle episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\n \\n6C4D.10 Harmful pattern of use of dissociative drugs including ketamine or PCP, episodic  \\nA pattern of episodic or intermittent use of dissociative drugs, including ketami ne \\nand phencyclidine (PCP), that has caused damage to a person ’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of episodic use of dissociative drugs is evident over a period of at least 12 \\nmonths. Harm to health of the individual occurs due to one or more of the follow ing: \\n(1) behaviour related to intoxication; (2) direct or secondary toxic effects on bod y \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behaviour related to dissociative drug intoxication on the \\npart of the person to whom the diagnosis of Harmful pattern of use of dissociati ve \\ndrugs, including ketamine and PCP applies. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nDissociative drug dependence including ketamine or PCP \\n(6C4D.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 139, 'page_label': '140'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   139 \\n \\n6C4D.11 Harmful pattern of use of dissociative drugs including ketamine or PCP, continuous  \\nA pattern of continuous (daily or almost daily) use of dissociative drugs, including \\nketamine and phencyclidine (PCP), that has caused damage to a person ’s physical \\nor mental health or has resulted in behaviour leading to harm to the health of others. \\nThe pattern of continuous use of dissociative drugs is evident over a period of at \\nleast one month. Harm to health of the individual occurs due to one or more of t he \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental  \\ndisorder that is directly attributable to behaviour related to dissociative drug \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern  of \\nuse of dissociative drugs, including ketamine and PCP applies. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nDissociative drug dependence including ketamine or PCP \\n(6C4D.2) \\n \\n6C4D.1Z Harmful pattern of use of dissociative drugs, including ketamine or PCP, unspecified  \\n \\n6C4D.2 Dissociative drug dependence including ketamine or PCP \\nDissociative drug dependence including ketamine or PCP is a disorder of regulation  \\nof dissociative drug use arising from repeated or continuous use of dis sociative \\ndrugs. The characteristic feature is a strong internal drive to use dissociative drugs, \\nwhich is manifested by impaired ability to control use, increasing priority gi ven to \\nuse over other activities and persistence of use despite harm or negative \\nconsequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use dissociative drugs. The features of dependence \\nare usually evident over a period of at least 12 months but the diagnosis may be \\nmade if dissociative drugs use is continuous (daily or almost daily) for at  least 1 \\nmonth. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1) \\n \\n6C4D.20 Dissociative drug dependence including Ketamine or PCP, current use  \\nDissociative drug dependence including Ketamine and PCP, current use refers to \\nuse of dissociative drugs within the past month. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 140, 'page_label': '141'}, page_content='140  ICD-11 MMS - 2018 \\n \\n6C4D.21 Dissociative drug dependence including Ketamine or PCP, early full remission  \\nAfter a diagnosis of Dissociative drug dependence including Ketamine and PCP, \\nand often following a treatment episode or other intervention (including self-h elp \\nintervention), the individual has been abstinent from dissociative drugs duri ng a \\nperiod lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1) \\n \\n6C4D.22 Dissociative drug dependence including Ketamine or PCP, sustained partial \\nremission \\nAfter a diagnosis of Dissociative drug dependence including Ketamine and PCP, \\nand often following a treatment episode or other intervention (including self-h elp \\nintervention), there is a significant reduction in dissociative drug consumption for \\nmore than 12 months, such that even though intermittent or continuing dissociative \\ndrug use has occurred during this period, the definitional requirements for \\ndependence have not been met. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1) \\n \\n6C4D.23 Dissociative drug dependence including Ketamine or PCP, sustained full remission  \\nAfter a diagnosis of Dissociative drug dependence including Ketamine and PCP, \\nand often following a treatment episode or other intervention (including self-\\nintervention), the person has been abstinent from dissociative drugs for 12 months \\nor longer. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1) \\n \\n6C4D.2Z Dissociative drug dependence including ketamine or PCP, unspecified \\n \\n6C4D.3 Dissociative drug intoxication including Ketamine or PCP \\nDissociative drug intoxication including Ketamine and PCP is a clinica lly significant \\ntransient condition that develops during or shortly after the consumption of a \\ndissociative drug that is characterized by disturbances in consciousness, cogni tion, \\nperception, affect, behaviour, or coordination. These disturbances are caused by \\nthe known pharmacological effects of a dissociative drug and their intensity  is \\nclosely related to the amount of the dissociative drug consumed. They are time-\\nlimited and abate as the dissociative drug is cleared from the body. Pres enting \\nfeatures may include aggression, impulsiveness, unpredictability, anxiety, \\npsychomotor agitation, impaired judgment, numbness or diminished responsiveness \\nto pain, slurred speech, and dystonia. Physical signs include nystagmus (r epetitive, \\nuncontrolled eye movements), tachycardia, elevated blood pressure, numbness, \\nataxia, dysarthria, and muscle rigidity. In rare instances, use of dissociative drug s \\nincluding Ketamine and PCP can result in seizures. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 141, 'page_label': '142'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   141 \\n \\n6C4D.4 Dissociative drug-induced delirium including ketamine or PCP \\nDissociative drug-induced delirium including Ketamine or PCP is characterized by \\nan acute state of disturbed attention and awareness with specific features of \\ndelirium that develops during or soon after substance intoxication or during the  use \\nof dissociative drugs. The amount and duration of dissociative drug use must be \\ncapable of producing delirium. The symptoms are not better explained by a primary \\nmental disorder, by use of or withdrawal from a different substance, or by another \\nhealth condition that is not classified under Mental, behavioural and \\nneurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C4D.5 Dissociative drug-induced psychotic disorder including Ketamine or PCP  \\nDissociative drug-induced psychotic disorder including Ketamine or PCP is \\ncharacterized by psychotic symptoms (e.g., delusions, hallucinations, disorgani zed \\nthinking, grossly disorganized behaviour) that develop during or soon after \\nintoxication with dissociative drugs. The intensity or duration of the symptoms  is \\nsubstantially in excess of psychotic-like disturbances of perception, cognit ion, or \\nbehaviour that are characteristic of Dissociative drug intoxication. The amount and  \\nduration of Dissociative drug use must be capable of producing psychotic \\nsymptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be  the \\ncase if the psychotic symptoms preceded the onset of the dissociative drug use , if \\nthe symptoms persist for a substantial period of time after cessation of the \\ndissociative drug use, or if there is other evidence of a pre-existing primary men tal \\ndisorder with psychotic symptoms (e.g., a history of prior episodes not associated \\nwith dissociative drug use). \\nNote: Code also the underlying condition \\n \\n6C4D.6 Other dissociative drugs including ketamine and phencyclidine [PCP]-\\ninduced disorders \\nNote: Code also the underlying condition \\n \\n6C4D.60 Dissociative drug-induced mood disorder including Ketamine or PCP \\nDissociative drug-induced mood disorder including Ketamine or PCP is \\ncharacterized by mood symptoms (e.g., depressed or elevated mood, decreased \\nengagement in pleasurable activities, increased or decreased energy levels) that \\ndevelop during or soon after intoxication with dissociative drugs. The intensity or \\nduration of the symptoms is substantially in excess of mood disturbances that are \\ncharacteristic of Dissociative drug intoxication. The amount and duration of \\nDissociative drug use must be capable of producing mood symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., a Depressive \\ndisorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if t he \\nmood symptoms preceded the onset of the dissociative drug use, if the symptoms \\npersist for a substantial period of time after cessation of the dissociative dru g use, \\nor if there is other evidence of a pre-existing primary mental disorder with mood  \\nsymptoms (e.g., a history of prior episodes not associated with dissociative drug \\nuse). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 142, 'page_label': '143'}, page_content='142  ICD-11 MMS - 2018 \\n \\n6C4D.61 Dissociative drug-induced anxiety disorder including Ketamine or PCP \\nDissociative drug-induced anxiety disorder including Ketamine or PCP is \\ncharacterized by anxiety symptoms (e.g., apprehension or worry, fear, physiol ogical \\nsymptoms of excessive autonomic arousal, avoidance behaviour) that develop \\nduring or soon after intoxication with dissociative drugs. The intensity or duration of  \\nthe symptoms is substantially in excess of anxiety symptoms that are ch aracteristic \\nof Dissociative drug intoxication. The amount and duration of Dissociative drug use \\nmust be capable of producing anxiety symptoms. The symptoms are not better \\nexplained by a primary mental disorder (e.g., an Anxiety and Fear- Related Disorder, \\na Depressive Disorder with prominent anxiety symptoms), as might be the case i f \\nthe anxiety symptoms preceded the onset of the dissociative drug use, if the \\nsymptoms persist for a substantial period of time after cessation of the dissoci ative \\ndrug use, or if there is other evidence of a pre-existing primary mental disorder with \\nanxiety symptoms (e.g., a history of prior episodes not associated with diss ociative \\ndrug use). \\nNote: Code also the underlying condition \\n \\n6C4D.Y Other specified disorders due to use of dissociative drugs including ketamine \\nand phencyclidine [PCP] \\nNote: Code also the underlying condition \\n \\n6C4D.Z Disorders due to use of dissociative drugs including ketamine and \\nphencyclidine [PCP], unspecified \\nNote: Code also the underlying condition \\n \\n  6C4E   Disorders due to use of other specified psychoactive substances, \\nincluding medications \\nDisorders due to use of other specified psychoactive substances, including \\nmedications are characterised by the pattern and consequences of other specified \\npsychoactive substance use. In addition to Other specified psychoactive substa nce \\nintoxication, other specified substances have dependence-inducing properties, \\nresulting in Other specified psychoactive substance dependence in some peopl e \\nand Other specified psychoactive substance withdrawal when use is reduced or \\ndiscontinued. Other specified substances are implicated in a wide range of harms \\naffecting most organs and systems of the body, which may be classified as Si ngle \\nepisode of harmful use of other specified psychoactive substance and Harmful \\npattern of use of other specified psychoactive substance. Harm to others resulting  \\nfrom behaviour during Other specified psychoactive substance intoxication  is \\nincluded in the definitions of Harmful use of other specified substances. S everal \\nother specified substance-induced mental disorders and other specified sub stance-\\nrelated forms of neurocognitive impairment are recognised. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 143, 'page_label': '144'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   143 \\n \\n6C4E.0 Single episode of harmful use of other specified psychoactive substance  \\nA single episode of use of a specified psychoactive substance or medication that is \\nnot included in the other substance classes specifically identified under Dis orders \\nDue to Substance Use that has caused damage to a person ’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behavi our \\nrelated to substance intoxication or psychoactive medication use; (2) direct or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto substance intoxication or psychoactive medication use on the part of the per son \\nto whom the diagnosis of single episode of harmful use of other specified \\npsychoactive substance applies. This diagnosis should not be made if the har m is \\nattributed to a known pattern of use of the specified psychoactive substance. \\nExclusions: Harmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1) \\nOther specified psychoactive substance dependence (6C4E.2) \\n \\n6C4E.1 Harmful pattern of use of other specified psychoactive substance \\nA pattern of use of a specified psychoactive substance or medication that is not \\nincluded in the other substance classes specifically identified under Dis orders Due \\nto Substance Use that has caused damage to a person ’s physical or mental health \\nor has resulted in behaviour leading to harm to the health of others. The pattern of \\nsubstance use is evident over a period of at least 12 months if use is episod ic or at \\nleast one month if use is continuous (i.e., daily or almost daily). Harm  to health of \\nthe individual occurs due to one or more of the following: (1) behaviour related  to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to intoxication due to the specified substance or medicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of other \\nspecified psychoactive substance applies. \\nExclusions: Other specified psychoactive substance dependence (6C4E.2) \\nSingle episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 144, 'page_label': '145'}, page_content='144  ICD-11 MMS - 2018 \\n \\n6C4E.10 Harmful pattern of use of other specified psychoactive substance, episodic  \\nA pattern of episodic or intermittent use of a specified psychoactive substance or \\nmedication that is not included in the other substance classes specificall y identified \\nunder Disorders Due to Substance Abuse that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health \\nof others. The pattern of episodic substance use is evident over a period of at lea st \\n12 months. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental  \\ndisorder that is directly attributable to behaviour related to intoxication due to the \\nspecified substance or medication on the part of the person to whom the diagnosis \\nof Harmful pattern of use of other specified psychoactive substance applies. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nOther specified psychoactive substance dependence (6C4E.2) \\n \\n6C4E.11 Harmful pattern of use of other specified psychoactive substance, continuous  \\nA pattern of continuous (daily or almost daily) use of a specified psyc hoactive \\nsubstance or medication that is not included in the other substance classes \\nspecifically identified under Disorders Due to Substance Use that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous substance use is evi dent \\nover a period of at least one month. Harm to health of the individual occurs due to \\none or more of the following: (1) behaviour related to intoxication; (2) direct  or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto intoxication due to the specified substance or medication on the part of the \\nperson to whom the diagnosis of Harmful pattern of use of other specified \\npsychoactive substance applies. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nOther specified psychoactive substance dependence (6C4E.2) \\n \\n6C4E.1Z Harmful pattern of use of other specified psychoactive substance, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 145, 'page_label': '146'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   145 \\n \\n6C4E.2 Other specified psychoactive substance dependence \\nOther specified psychoactive substance dependence is a disorder of regul ation of \\nuse of a specified substance arising from repeated or continuous use of the  \\nspecified substance. The characteristic feature is a strong internal drive to use the \\nspecified substance, which is manifested by impaired ability to contro l use, \\nincreasing priority given to use over other activities and persistence of use despite  \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use the specified substance. Physiological \\nfeatures of dependence may also be present, including tolerance to the effects of \\nthe specified substance, withdrawal symptoms following cessation or reduction in \\nuse of the specified substance, or repeated use of the specified substance or \\npharmacologically similar substances to prevent or alleviate withdrawal symptoms.  \\nThe features of dependence are usually evident over a period of at least 12 months \\nbut the diagnosis may be made if use of the specified substance is continuous (daily \\nor almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1) \\n \\n6C4E.20 Other specified psychoactive substance dependence, current use \\nCurrent Other specified psychoactive substance dependence, with use of the \\nspecified psychoactive substance within the past month. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1) \\n \\n6C4E.21 Other specified psychoactive substance dependence, early full remission  \\nAfter a diagnosis of Other specified psychoactive substance dependence, and  often \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthe individual has been abstinent from the specified substance during a per iod \\nlasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1) \\n \\n6C4E.22 Other specified psychoactive substance dependence, sustained partial remission  \\nAfter a diagnosis of Other specified psychoactive substance dependence, and  often \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthere is a significant reduction in consumption of the specified substanc e for more \\nthan 12 months, such that even though intermittent or continuing substance use has \\noccurred during this period, the definitional requirements for dependence have not \\nbeen met. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 146, 'page_label': '147'}, page_content='146  ICD-11 MMS - 2018 \\n \\n6C4E.23 Other specified psychoactive substance dependence, sustained full remission  \\nAfter a diagnosis of Other specified psychoactive substance dependence, and  often \\nfollowing a treatment episode or other intervention (including self-intervent ion), the \\nperson has been abstinent from the specified substance for 12 months or longer. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1) \\n \\n6C4E.2Z Other specified psychoactive substance dependence, unspecified \\n \\n6C4E.3 Other specified psychoactive substance intoxication \\nOther specified psychoactive substance intoxication is a clinically si gnificant \\ntransient condition that develops during or shortly after the consumption of a \\nspecified psychoactive substance or medication that is characterized by \\ndisturbances in level of consciousness, cognition, perception, affect, behaviour,  or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof the specified psychoactive substance and their intensity is closely related to the \\namount of the specified psychoactive substance consumed. They are time-limi ted \\nand abate as the specified substance is cleared from the body. \\nNote: Code also the underlying condition \\n \\n6C4E.4 Other specified psychoactive substance withdrawal \\nOther specified psychoactive substance withdrawal is a clinically s ignificant cluster \\nof symptoms, behaviours and/or physiological features, varying in degree of severity \\nand duration, that occurs upon cessation or reduction of use of the specified \\nsubstance in individuals who have developed dependence or have used the \\nspecified substance for a prolonged period or in large amounts. Other specified \\npsychoactive substance withdrawal can also occur when prescribed psychoactive \\nmedications have been used in standard therapeutic doses. The specific features  of \\nthe withdrawal state depend on the pharmacological properties of the specified \\nsubstance. \\nNote: Code also the underlying condition \\n \\n6C4E.40 Other specified psychoactive substance withdrawal, uncomplicated \\nThe development of a withdrawal state not accompanied by perceptual \\ndisturbances or seizures following cessation or reduction of use of the specified \\nsubstance. \\nNote: Code also the underlying condition \\n \\n6C4E.41 Other specified psychoactive substance withdrawal, with perceptual disturbances  \\nThe development of a withdrawal state accompanied by perceptual disturbances \\nbut not by seizures following cessation or reduction of use of the specified \\nsubstance. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 147, 'page_label': '148'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   147 \\n \\n6C4E.42 Other specified psychoactive substance withdrawal, with seizures \\nThe development of a withdrawal state accompanied by seizures but not by \\nperceptual disturbances following cessation or reduction of use of the specified \\nsubstance. \\nNote: Code also the underlying condition \\n \\n6C4E.43 Other specified psychoactive substance withdrawal, with perceptual disturbances \\nand seizures \\nThe development of a withdrawal state accompanied by both perceptual \\ndisturbances and seizures following cessation or reduction of use of the specified \\nsubstance. \\nNote: Code also the underlying condition \\n \\n6C4E.4Z Other specified psychoactive substance withdrawal, unspecified \\nNote: Code also the underlying condition \\n \\n6C4E.5 Delirium induced by other specified psychoactive substance including \\nmedications \\nDelirium induced by other specified psychoactive substance is characterize d by an \\nacute state of disturbed attention and awareness with specific features of deliri um \\nthat develops during or soon after substance intoxication or withdrawal or during the \\nuse of a specified psychoactive substance. The amount and duration of use of the \\nspecified substance must be capable of producing delirium. The symptoms are not \\nbetter explained by a primary mental disorder, by use of or withdrawal from a \\ndifferent substance, or by another health condition that is not classified unde r \\nMental, behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C4E.6 Psychotic disorder induced by other specified psychoactive substance  \\nPsychotic disorder induced by other specified psychoactive substance is  \\ncharacterized by psychotic symptoms (e.g., delusions, hallucinations, disorgani zed \\nthinking, grossly disorganized behaviour) that develop during or soon after \\nintoxication with or withdrawal from a specified psychoactive substance. The  \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nintoxication with or withdrawal from a specified psychoactive substance. The  \\namount and duration of use of the specified psychoactive substance must be \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe use of the specified psychoactive substance, if the symptoms persist for a \\nsubstantial period of time after cessation of the use of the specified psychoacti ve \\nsubstance or withdrawal from the specified psychoactive substance, or if there is \\nother evidence of a pre-existing primary mental disorder with psychotic symptoms \\n(e.g., a history of prior episodes not associated with the use of the specified \\npsychoactive substance). \\nNote: Code also the underlying condition \\n \\n6C4E.7 Other specified psychoactive substance-induced disorders \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 148, 'page_label': '149'}, page_content='148  ICD-11 MMS - 2018 \\n \\n6C4E.70 Mood disorder induced by other specified psychoactive substance \\nMood disorder induced by other specified psychoactive substance is characteri zed \\nby mood symptoms (e.g., depressed or elevated mood, decreased engagement in \\npleasurable activities, increased or decreased energy levels) that develop during or \\nsoon after intoxication with or withdrawal from a specified psychoactive subs tance. \\nThe intensity or duration of the symptoms is substantially in excess of mood \\ndisturbances that are characteristic of intoxication with or withdrawal from a \\nspecified psychoactive substance. The amount and duration of use of the specified \\npsychoactive substance must be capable of producing mood symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., a Depressive \\ndisorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if the \\nmood symptoms preceded the onset of the use of the specified psychoactive \\nsubstance, if the symptoms persist for a substantial period of time after cessation  of \\nthe use of the specified psychoactive substance or withdrawal from the speci fied \\npsychoactive substance, or if there is other evidence of a pre-existing primary \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with the use of the specified psychoactive substance). \\nNote: Code also the underlying condition \\n \\n6C4E.71 Anxiety disorder induced by other specified psychoactive substance \\nAnxiety disorder induced by other specified psychoactive substance i s \\ncharacterized by anxiety symptoms (e.g., apprehension or worry, fear, physiol ogical \\nsymptoms of excessive autonomic arousal, avoidance behaviour) that develop \\nduring or soon after intoxication with or withdrawal from a specified psychoactiv e \\nsubstance. The intensity or duration of the symptoms is substantially in exc ess of \\nanxiety symptoms that are characteristic of intoxication with or withdrawal  from a \\nspecified psychoactive substance. The amount and duration of use of the specified \\npsychoactive substance must be capable of producing anxiety symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear-related disorder, a Depressive disorder with prominent anxiety symptoms), \\nas might be the case if the anxiety symptoms preceded the onset of the use of the  \\nspecified psychoactive substance, if the symptoms persist for a substanti al period of \\ntime after cessation of the use of the specified psychoactive substance or \\nwithdrawal from the specified psychoactive substance, or if there is other ev idence \\nof a pre-existing primary mental disorder with anxiety symptoms (e.g., a histor y of \\nprior episodes not associated with the use of the specified psychoactive substance). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 149, 'page_label': '150'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   149 \\n \\n6C4E.72 Obsessive-compulsive or related disorder induced by other specified psychoactive \\nsubstance \\nObsessive-compulsive or related disorder induced by other specified psychoacti ve \\nsubstance is characterized by either repetitive intrusive thoughts or preoccupat ions, \\nnormally associated with anxiety and typically accompanied by repetitive behaviours \\nperformed in response, or by recurrent and habitual actions directed at the \\nintegument (e.g., hair pulling, skin picking) that develop during or soon after \\nintoxication with or withdrawal from a specified psychoactive substance. The  \\nintensity or duration of the symptoms is substantially in excess of analogo us \\ndisturbances that are characteristic of intoxication with or withdrawal from the \\nspecified psychoactive substance. The amount and duration of the specified \\npsychoactive substance use must be capable of producing obsessive-compulsive or \\nrelated symptoms. The symptoms are not better explained by a primary mental \\ndisorder (in particular an Obsessive-compulsive or related disorder), as might be the \\ncase if the symptoms preceded the onset of the specified psychoactive substance \\nuse, if the symptoms persist for a substantial period of time after cessation of use or \\nwithdrawal of the specified psychoactive substance, or if there is other evidence of a \\npre-existing primary mental disorder with obsessive-compulsive or related \\nsymptoms (e.g., a history of prior episodes not associated with specified \\npsychoactive substance use). \\nNote: Code also the underlying condition \\n \\n6C4E.73 Impulse control disorder induced by other specified psychoactive substance  \\nImpulse control disorder induced by other specified psychoactive substance is \\ncharacterized by persistently repeated behaviours in which there is rec urrent failure \\nto resist an impulse, drive, or urge to perform an act that is rewarding to the person, \\nat least in the short-term, despite longer-term harm either to the individual or to \\nothers (e.g., fire setting or stealing without apparent motive, repetitive sexual  \\nbehaviour, aggressive outbursts) that develop during or soon after intoxication with \\nor withdrawal from a specified psychoactive substance. The intensity or duration of \\nthe symptoms is substantially in excess of disturbances of impulse control that are \\ncharacteristic of intoxication with or withdrawal from the specified psycho active \\nsubstance. The amount and duration of the specified psychoactive substance u se \\nmust be capable of producing disturbances of impulse control. The symptoms ar e \\nnot better explained by a primary mental disorder (e.g., an Impulse control disorder , \\na Disorder due to addictive behaviours), as might be the case if the impul se control \\ndisturbances preceded the onset of the specified psychoactive substance use, if  the \\nsymptoms persist for a substantial period of time after cessation of use or \\nwithdrawal of the specified psychoactive substance, or if there is other evidence o f a \\npre-existing primary mental disorder with impulse control symptoms (e.g., a histor y \\nof prior episodes not associated with specified psychoactive substance use). \\nNote: Code also the underlying condition \\n \\n6C4E.Y Other specified disorders due to use of other specified psychoactive \\nsubstances, including medications \\nNote: Code also the underlying condition \\n \\n6C4E.Z Disorders due to use of other specified psychoactive substances, including \\nmedications, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 150, 'page_label': '151'}, page_content='150  ICD-11 MMS - 2018 \\n \\n  6C4F   Disorders due to use of multiple specified psychoactive substances, \\nincluding medications \\nDisorders due to use of multiple specified psychoactive substances, including \\nmedications are characterised by the pattern and consequences of multiple \\nspecified psychoactive substance use. In addition to Intoxication due to multipl e \\nspecified psychoactive substances, multiple specified substances have \\ndependence-inducing properties, resulting in Multiple specified psychoactiv e \\nsubstances dependence in some people and Multiple specified psychoactive \\nsubstances withdrawal when use is reduced or discontinued. Multiple specified  \\npsychoactive substances are implicated in a wide range of harms affecting most \\norgans and systems of the body, which may be classified as Single episode  of \\nharmful use of multiple specified psychoactive substances and Harmful patt ern of \\nuse of multiple specified psychoactive substances. Harm to others resulting fro m \\nbehaviour during Intoxication due to multiple specified psychoactive substan ces is \\nincluded in the definitions of Harmful use of multiple specified psychoac tive \\nsubstances. Several multiple specified psychoactive substances-induced ment al \\ndisorders are recognised. \\nNote: Code also the underlying condition \\n \\n6C4F.0 Single episode of harmful use of multiple specified psychoactive substances  \\nA single episode of use of multiple specified psychoactive substances or \\nmedications that are not included in the other substance classes specifically  \\nidentified under Disorder Due to Substance Use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to multiple substance intoxication or \\npsychoactive medication use (2) direct or secondary toxic effects on body organs  \\nand systems; or (3) a harmful route of administration. Harm to health of others \\nincludes any form of physical harm, including trauma, or mental disorder that is \\ndirectly attributable to behavior due to multiple substance intoxication or \\npsychoactive medication use on the part of the person to whom the diagnosis of \\nsingle episode of harmful use of multiple specified psychoactive substances appli es. \\nThis diagnosis should not be made if the harm is attributed to a known pattern  of \\nuse of the multiple psychoactive substances. \\nExclusions: Harmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1) \\nMultiple specified psychoactive substances dependence \\n(6C4F.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 151, 'page_label': '152'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   151 \\n \\n6C4F.1 Harmful pattern of use of multiple specified psychoactive substances  \\nA pattern of use of a multiple specified psychoactive substances or medications that \\nare not included in the other substance classes specifically identified under \\nDisorders Due to Substance Use that has caused damage to a person ’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of other s. \\nThe pattern of substance use is evident over a period of at least 12 months i f use is \\nepisodic or at least one month if use is continuous (i.e., daily or almost dail y). Harm \\nto health of the individual occurs due to one or more of the following: (1) beha viour \\nrelated to multiple substance intoxication or psychoactive medication use; (2) direc t \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto multiple substance intoxication or psychoactive medication use on the part of the \\nperson to whom the diagnosis of Harmful pattern of use of multiple specified \\npsychoactive substances applies. \\nExclusions: Single episode of harmful use of multiple specified \\npsychoactive substances (6C4F.0) \\nMultiple specified psychoactive substances dependence \\n(6C4F.2) \\n \\n6C4F.10 Harmful pattern of use of multiple specified psychoactive substances, episodic  \\nA pattern of episodic or intermittent use of a specified psychoactive substance or \\nmedication that is not included in the other substance classes specificall y identified \\nunder Disorders Due to Substance Use that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health \\nof others. The pattern of episodic substance use is evident over a period of at lea st \\n12 months. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to intoxication due to the \\nspecified substance or medication on the part of the person to whom the diagnosis \\nof Harmful pattern of use of other specified psychoactive substance applies. \\nExclusions: Single episode of harmful use of multiple specified \\npsychoactive substances (6C4F.0) \\nMultiple specified psychoactive substances dependence \\n(6C4F.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 152, 'page_label': '153'}, page_content='152  ICD-11 MMS - 2018 \\n \\n6C4F.11 Harmful pattern of use of multiple specified psychoactive substances, continuous  \\nA pattern of continuous (daily or almost daily) use of a multiple specified \\npsychoactive substance or medication that is not included in the other substanc e \\nclasses specifically identified under Disorders Due to Substance Use that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour \\nleading to harm to the health of others. The pattern of continuous substance use i s \\nevident over a period of at least one month. Harm to health of the individual occurs  \\ndue to one or more of the following: (1) behaviour related to multiple substance \\nintoxication or psychoactive medication use; (2) direct or secondary toxic effect s on \\nbody organs and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behaviour related to multiple substance intoxication or \\npsychoactive medication use on the part of the person to whom the diagnosis of \\nHarmful pattern of multiple specified psychoactive substances applies. \\nExclusions: Single episode of harmful use of multiple specified \\npsychoactive substances (6C4F.0) \\nMultiple specified psychoactive substances dependence \\n(6C4F.2) \\n \\n6C4F.1Z Harmful pattern of use of multiple specified psychoactive substances, unspecified  \\n \\n6C4F.2 Multiple specified psychoactive substances dependence \\nMultiple specified psychoactive substances dependence is a disorder of regul ation \\nof use of multiple specified substances arising from repeated or continuous use of \\nthe specified substances. The characteristic feature is a strong internal drive t o use \\nthe specified substances, which is manifested by impaired ability to co ntrol use, \\nincreasing priority given to use over other activities and persistence of use despite  \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use the specified substances. \\nPhysiological features of dependence may also be present, including toleranc e to \\nthe effects of the specified substances, withdrawal symptoms following ces sation or \\nreduction in use of the specified substances, or repeated use of the specified \\nsubstances or pharmacologically similar substances to prevent or alleviate \\nwithdrawal symptoms. The features of dependence are usually evident over a \\nperiod of at least 12 months but the diagnosis may be made if use of the  specified \\nsubstances is continuous (daily or almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of multiple specified \\npsychoactive substances (6C4F.0) \\nHarmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1) \\n \\n6C4F.20 Multiple specified psychoactive substances dependence, current use \\nExclusions: Single episode of harmful use of multiple specified \\npsychoactive substances (6C4F.0) \\nHarmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 153, 'page_label': '154'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   153 \\n \\n6C4F.21 Multiple specified psychoactive substances dependence, early full remission  \\nExclusions: Single episode of harmful use of multiple specified \\npsychoactive substances (6C4F.0) \\nHarmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1) \\n \\n6C4F.22 Multiple specified psychoactive substances dependence, sustained partial \\nremission \\nExclusions: Single episode of harmful use of multiple specified \\npsychoactive substances (6C4F.0) \\nHarmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1) \\n \\n6C4F.23 Multiple specified psychoactive substances dependence, sustained full remission  \\nExclusions: Single episode of harmful use of multiple specified \\npsychoactive substances (6C4F.0) \\nHarmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1) \\n \\n6C4F.2Z Multiple specified psychoactive substances dependence, unspecified \\n \\n6C4F.3 Intoxication due to multiple specified psychoactive substances \\nIntoxication due to multiple specified psychoactive substances is a clin ically \\nsignificant transient condition that develops during or shortly after the consumption  \\nof multiple specified substances or medications that is characterized by \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof the multiple specified psychoactive substances and their intensity is closely \\nrelated to the amount of the substances consumed. They are time-limited and abate \\nas the multiple specified substances are cleared from the body. \\nNote: Code also the underlying condition \\n \\n6C4F.4 Multiple specified psychoactive substances withdrawal \\nMultiple specified psychoactive substance withdrawal is a clinically significant \\ncluster of symptoms, behaviours and physiological features, varying in degree of \\nseverity and duration, that occurs upon cessation or reduction of use of multiple \\nspecified substances in individuals who have developed dependence or have used \\nthe specified substances for a prolonged period or in large amounts. Multiple \\nspecified psychoactive substance withdrawal can also occur when prescribed \\npsychoactive medications have been used in standard therapeutic doses. T he \\nspecific features of the withdrawal state depend on the pharmacological properties \\nof the specified substances and their interactions. \\nNote: Code also the underlying condition \\n \\n6C4F.40 Multiple specified psychoactive substances withdrawal, uncomplicated \\nNote: Code also the underlying condition \\n \\n6C4F.41 Multiple specified psychoactive substances withdrawal, with perceptual \\ndisturbances \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 154, 'page_label': '155'}, page_content='154  ICD-11 MMS - 2018 \\n \\n6C4F.42 Multiple specified psychoactive substances withdrawal, with seizures \\nNote: Code also the underlying condition \\n \\n6C4F.43 Multiple specified psychoactive substances withdrawal, with perceptual \\ndisturbances and seizures \\nNote: Code also the underlying condition \\n \\n6C4F.4Y Other specified multiple specified psychoactive substances withdrawal  \\nNote: Code also the underlying condition \\n \\n6C4F.4Z Multiple specified psychoactive substances withdrawal, unspecified \\nNote: Code also the underlying condition \\n \\n6C4F.5 Delirium induced by multiple specified psychoactive substances including \\nmedications \\nDelirium induced by multiple specified psychoactive substances is characteriz ed by \\nan acute state of disturbed attention and awareness with specific features of \\ndelirium that develops during or soon after substance intoxication or withdraw al or \\nduring the use of multiple specified substances. The amount and duration of use of \\nthe multiple specified substances must be capable of producing delirium. The \\nsymptoms are not better explained by a primary mental disorder, by use of or \\nwithdrawal from a substance other than those specified, or by another health \\ncondition that is not classified under Mental, behavioural and neurodevelopmental \\ndisorders. \\nNote: Code also the underlying condition \\n \\n6C4F.6 Psychotic disorder induced by multiple specified psychoactive substances  \\nPsychotic disorder induced by multiple specified psychoactive substanc es is \\ncharacterized by psychotic symptoms (e.g., delusions, hallucinations, disorgani zed \\nthinking, grossly disorganized behaviour) that develop during or soon after \\nintoxication with or withdrawal from multiple specified psychoactive substances. The \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nintoxication with or withdrawal from multiple specified psychoactive substances. The \\namount and duration of use of the multiple specified psychoactive substances mu st \\nbe capable of producing psychotic symptoms. The symptoms are not better \\nexplained by a primary mental disorder (e.g., Schizophrenia, a Mood disorder with \\npsychotic symptoms), as might be the case if the psychotic symptoms preceded the \\nonset of the use of the multiple specified psychoactive substances, if the sy mptoms \\npersist for a substantial period of time after cessation of the use of the multiple \\nspecified psychoactive substances or withdrawal from the multiple specif ied \\npsychoactive substances, or if there is other evidence of a pre-existing primary \\nmental disorder with psychotic symptoms (e.g., a history of prior episodes not \\nassociated with the use of the multiple specified psychoactive substances). \\nNote: Code also the underlying condition \\n \\n6C4F.7 Other multiple specified psychoactive substances-induced disorders \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 155, 'page_label': '156'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   155 \\n \\n6C4F.70 Mood disorder induced by multiple specified psychoactive substances \\nMood disorder induced by multiple specified psychoactive substances is \\ncharacterized by mood symptoms (e.g., depressed or elevated mood, decreased \\nengagement in pleasurable activities, increased or decreased energy levels) that \\ndevelop during or soon after intoxication with or withdrawal from multiple specified \\npsychoactive substances. The intensity or duration of the symptoms is sub stantially \\nin excess of mood disturbances that are characteristic of intoxication with or \\nwithdrawal from multiple specified psychoactive substances. The amount and \\nduration of use of the multiple specified psychoactive substances must be capabl e \\nof producing mood symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffectiv e \\ndisorder), as might be the case if the mood symptoms preceded the onset of the \\nuse of the multiple specified psychoactive substances, if the symptoms persi st for a \\nsubstantial period of time after cessation of the use of the multiple specified \\npsychoactive substances or withdrawal from the multiple specified psychoac tive \\nsubstances, or if there is other evidence of a pre-existing primary mental dis order \\nwith mood symptoms (e.g., a history of prior episodes not associated with the use of \\nthe multiple specified psychoactive substances). \\nNote: Code also the underlying condition \\n \\n6C4F.71 Anxiety disorder induced by multiple specified psychoactive substances \\nAnxiety disorder induced by multiple specified psychoactive substances is  \\ncharacterized by anxiety symptoms (e.g., apprehension or worry, fear, physiol ogical \\nsymptoms of excessive autonomic arousal, avoidance behaviour) that develop \\nduring or soon after intoxication with or withdrawal from multiple specified \\npsychoactive substances. The intensity or duration of the symptoms is sub stantially \\nin excess of anxiety symptoms that are characteristic of intoxication with or \\nwithdrawal from multiple specified psychoactive substances. The amount and \\nduration of use of the multiple specified psychoactive substances must be capabl e \\nof producing anxiety symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive \\ndisorder with prominent anxiety symptoms), as might be the case if the anxiety \\nsymptoms preceded the onset of the use of the multiple specified psychoactive \\nsubstances, if the symptoms persist for a substantial period of time after ces sation \\nof the use of the multiple specified psychoactive substances or withdrawal from the \\nmultiple specified psychoactive substances, or if there is other evidence of a pre -\\nexisting primary mental disorder with anxiety symptoms (e.g., a history of prior \\nepisodes not associated with the use of the multiple specified psychoactive \\nsubstances). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 156, 'page_label': '157'}, page_content='156  ICD-11 MMS - 2018 \\n \\n6C4F.72 Obsessive-compulsive or related disorder induced by multiple specified \\npsychoactive substances \\nObsessive-compulsive or related disorder induced by multiple specified \\npsychoactive substances is characterized by either repetitive intrusive t houghts or \\npreoccupations, normally associated with anxiety and typically accompanied by  \\nrepetitive behaviours performed in response, or by recurrent and habitual actions \\ndirected at the integument (e.g., hair pulling, skin picking) that develop during or \\nsoon after intoxication with or withdrawal from multiple specified psychoacti ve \\nsubstances. The intensity or duration of the symptoms is substantially in  excess of \\nanalogous disturbances that are characteristic of intoxication with or withdrawal  \\nfrom the multiple specified psychoactive substances. The amount and durati on of \\nthe multiple specified psychoactive substances use must be capable of produci ng \\nobsessive-compulsive or related symptoms. The symptoms are not better explain ed \\nby a primary mental disorder (in particular an Obsessive-compulsive or rela ted \\ndisorder), as might be the case if the symptoms preceded the onset of the use of \\nmultiple specified psychoactive substances, if the symptoms persist for a substantia l \\nperiod of time after cessation of the multiple specified psychoactive substance use \\nor withdrawal, or if there is other evidence of a pre-existing primary mental  disorder \\nwith obsessive-compulsive or related symptoms (e.g., a history of prior episodes no t \\nassociated with multiple specified psychoactive substances use). \\nNote: Code also the underlying condition \\n \\n6C4F.73 Impulse control syndrome induced by multiple specified psychoactive substances  \\nImpulse control disorder induced by multiple specified psychoactive substanc es is \\ncharacterized by persistently repeated behaviours in which there is rec urrent failure \\nto resist an impulse, drive, or urge to perform an act that is rewarding to the person, \\nat least in the short-term, despite longer-term harm either to the individual or to \\nothers (e.g., fire setting or stealing without apparent motive, repetitive sexual  \\nbehaviour, aggressive outbursts) that develop during or soon after intoxication with \\nor withdrawal from multiple specified psychoactive substances. The intensity  or \\nduration of the symptoms is substantially in excess of disturbances of impulse  \\ncontrol that are characteristic of intoxication with or withdrawal from the mul tiple \\nspecified psychoactive substances. The amount and duration of the multiple \\nspecified psychoactive substances use must be capable of producing disturbances \\nof impulse control. The symptoms are not better explained by a primary mental \\ndisorder (e.g., an Impulse control disorder, a Disorder due to addictive behaviours), \\nas might be the case if the impulse control disturbances preceded the onset of the  \\nuse of multiple specified psychoactive substances, if the symptoms pers ist for a \\nsubstantial period of time after cessation of the multiple specified psychoactiv e \\nsubstance use or withdrawal, or if there is other evidence of a pre-existing primary \\nmental disorder with impulse control symptoms (e.g., a history of prior epi sodes not \\nassociated with multiple specified psychoactive substances use). \\nNote: Code also the underlying condition \\n \\n6C4F.Y Other specified disorders due to use of multiple specified psychoactive \\nsubstances, including medications \\nNote: Code also the underlying condition \\n \\n6C4F.Z Disorders due to use of multiple specified psychoactive substances, \\nincluding medications, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 157, 'page_label': '158'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   157 \\n \\n  6C4G   Disorders due use of unknown or unspecified psychoactive \\nsubstances \\nDisorders due to use of unknown or unspecified psychoactive substances are \\ncharacterized by the pattern and consequences of unknown or unspecified \\npsychoactive substance use. In addition to Intoxication due to unknown or \\nunspecified psychoactive substance, unknown or unspecified psychoactive \\nsubstances have dependence-inducing properties, resulting in Unknown or \\nunspecified psychoactive substance dependence in some people and Withdrawal \\ndue to unknown or unspecified psychoactive substance when use is reduced or \\ndiscontinued. Unknown or unspecified psychoactive substances are implicated in a  \\nwide range of harms affecting most organs and systems of the body, which ma y be \\nclassified as Single episode of harmful use of unknown or unspecified psyc hoactive \\nsubstances and Harmful pattern of use of unknown or unspecified psychoacti ve \\nsubstance. Harm to others resulting from behaviour during Intoxication due to \\nunknown or unspecified psychoactive substance is included in the definit ions of \\nHarmful use of unknown or unspecified psychoactive substance. Several \\nunspecified psychoactive substance-induced mental disorders are recognised. \\nNote: Code also the underlying condition \\n \\n6C4G.0 Single episode of harmful use of unknown or unspecified psychoactive \\nsubstances \\nA single episode of use of an unknown or unspecified psychoactive substance th at \\nhas caused damage to a person ’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. Harm to health of the individual \\noccurs due to one or more of the following: (1) behaviour related to intoxication or \\nwithdrawal; (2) direct or secondary toxic effects on body organs and system s; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehavior due to substance intoxication or withdrawal on the part of the person t o \\nwhom the diagnosis of single episode of harmful use applies. This diagnosis s hould \\nnot be made if the harm is attributed to a known pattern of use of the unknown or \\nunspecified psychoactive substance. \\nExclusions: Harmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1) \\nUnknown or unspecified psychoactive substance dependence \\n(6C4G.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 158, 'page_label': '159'}, page_content='158  ICD-11 MMS - 2018 \\n \\n6C4G.1 Harmful pattern of use of unknown or unspecified psychoactive substance  \\nA pattern of use of an unknown or unspecified psychoactive substance that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour \\nleading to harm to the health of others. The pattern of substance use is evident over \\na period of at least 12 months if use is episodic or at least one month if use is \\ncontinuous (i.e., daily or almost daily). Harm to health of the individual occurs due to \\none or more of the following: (1) behaviour related to intoxication; (2) direct  or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto substance intoxication on the part of the person to whom the diagnosis of \\nHarmful pattern of use of unknown or unspecified psychoactive substance applies. \\nExclusions: Single episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0) \\nUnknown or unspecified psychoactive substance dependence \\n(6C4G.2) \\n \\n6C4G.10 Harmful pattern of use of unknown or unspecified psychoactive substance, episodic  \\nA pattern of episodic or intermittent use of an unknown or unspecified psychoactiv e \\nsubstance that has caused damage to a person ’s physical or mental health or has \\nresulted in behaviour leading to harm to the health of others. The pattern of episodic \\nsubstance use is evident over a period of at least 12 months. Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to substance intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of unknown or unspecified psychoactive \\nsubstance applies. \\nExclusions: Single episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0) \\nUnknown or unspecified psychoactive substance dependence \\n(6C4G.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 159, 'page_label': '160'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   159 \\n \\n6C4G.11 Harmful pattern of use of unknown or unspecified psychoactive substance, \\ncontinuous \\nA pattern of continuous (daily or almost daily) use of an unknown or unspecifi ed \\npsychoactive substance that has caused damage to a person ’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of continuous substance use is evident over a period of at least one month.  \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder that \\nis directly attributable to behaviour related to substance intoxication on  the part of \\nthe person to whom the diagnosis of Harmful pattern of use of unknown or \\nunspecified psychoactive substance applies. \\nExclusions: Single episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0) \\nUnknown or unspecified psychoactive substance dependence \\n(6C4G.2) \\n \\n6C4G.1Z Harmful pattern of use of unknown or unspecified psychoactive substance, \\nunspecified \\n \\n6C4G.2 Unknown or unspecified psychoactive substance dependence \\nUnknown or unspecified psychoactive substance dependence is a disorder of \\nregulation of use of an unknown or unspecified substance arising from repeated or \\ncontinuous use of the substance. The characteristic feature is a strong internal dri ve \\nto use the unknown or unspecified substance, which is manifested by impaired \\nability to control use, increasing priority given to use over other activities a nd \\npersistence of use despite harm or negative consequences. These experiences are \\noften accompanied by a subjective sensation of urge or craving to use the unknown \\nor unspecified substance. The features of dependence are usually evident over a \\nperiod of at least 12 months but the diagnosis may be made if use of the u nknown \\nor unspecified substance is continuous (daily or almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0) \\nHarmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1) \\n \\n6C4G.20 Unknown or unspecified psychoactive substance dependence, current use  \\nCurrent dependence on an unknown or unspecified psychoactive substance, with \\nuse of the substance within the past month. \\nExclusions: Single episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0) \\nHarmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 160, 'page_label': '161'}, page_content='160  ICD-11 MMS - 2018 \\n \\n6C4G.21 Unknown or unspecified psychoactive substance dependence, early full remission  \\nAfter a diagnosis of Unknown or unspecified psychoactive substance dependence, \\nand often following a treatment episode or other intervention (including self-h elp \\nintervention), the individual has been abstinent from the substance during a pe riod \\nlasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0) \\nHarmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1) \\n \\n6C4G.22 Unknown or unspecified psychoactive substance dependence, sustained partial \\nremission \\nAfter a diagnosis of Unknown or unspecified psychoactive substance dependence, \\nand often following a treatment episode or other intervention (including self-h elp \\nintervention), there is a significant reduction in consumption of the substa nce for \\nmore than 12 months, such that even though intermittent or continuing use of the \\nsubstance has occurred during this period, the definitional requirements for \\ndependence have not been met. \\nExclusions: Single episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0) \\nHarmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1) \\n \\n6C4G.23 Unknown or unspecified psychoactive substance dependence, sustained full \\nremission \\nAfter a diagnosis of Unknown or unspecified psychoactive substance dependence, \\nsustained full remission, and often following a treatment episode or other \\nintervention (including self-intervention), the person has been abstinent fr om the \\nsubstance for 12 months or longer. \\nExclusions: Single episode of harmful use of unknown or unspecified \\npsychoactive substances (6C4G.0) \\nHarmful pattern of use of unknown or unspecified psychoactive \\nsubstance (6C4G.1) \\n \\n6C4G.2Z Unknown or unspecified psychoactive substance dependence, substance and state \\nof remission unspecified \\n \\n6C4G.3 Intoxication due to unknown or unspecified psychoactive substance \\nIntoxication due to unknown or unspecified psychoactive substance is a transien t \\ncondition that develops during or shortly after the administration of an unknown  or \\nunspecified psychoactive substance that is characterized by disturbances in le vel of \\nconsciousness, cognition, perception, affect or behavior, or other \\npsychophysiological functions and responses. This diagnosis should be m ade only \\nwhen there is strong evidence that an unidentified substance has been taken and  \\nthe features cannot be accounted for by another disorder or disease. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 161, 'page_label': '162'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   161 \\n \\n6C4G.4 Withdrawal due to unknown or unspecified psychoactive substance  \\nWithdrawal due to unknown or unspecified psychoactive substance is a clinicall y \\nsignificant cluster of symptoms, behaviours and/or physiological features, var ying in \\ndegree of severity and duration, that occurs upon cessation or reduction of use of \\nan unknown or unspecified substance in individuals who have developed \\ndependence or have used the unknown or unspecified substance for a prolonged \\nperiod or in large amounts. Withdrawal due to unknown or unspecified psychoactive \\nsubstance can also occur when prescribed psychoactive medications have been \\nused in standard therapeutic doses. The specific features of the withdrawal s tate \\ndepend on the pharmacological properties of the unknown or unspecified \\nsubstance. \\nNote: Code also the underlying condition \\n \\n6C4G.40 Withdrawal due to unknown or unspecified psychoactive substance, uncomplicated  \\nAll diagnostic requirements for Withdrawal due to unknown or unspecified \\npsychoactive substance are met and the withdrawal state is not accompanied by \\nperceptual disturbances or seizures. \\nNote: Code also the underlying condition \\n \\n6C4G.41 Withdrawal due to unknown or unspecified psychoactive substance, with perceptual \\ndisturbances \\nAll diagnostic requirements for Withdrawal due to unknown or unspecified \\npsychoactive substance are met and the withdrawal state is accompanied by \\nperceptual disturbances (e.g., visual or tactile hallucinations or illusions) with  intact \\nreality testing. There is no evidence of confusion and other diagnostic requirem ents \\nfor Delirium are not met. The withdrawal state is not accompanied by seizures. \\nNote: Code also the underlying condition \\n \\n6C4G.42 Withdrawal due to unknown or unspecified psychoactive substance, with seizures  \\nAll diagnostic requirements for Withdrawal due to unknown or unspecified \\npsychoactive substance are met and the withdrawal state is accompanied by \\nseizures (i.e., generalized tonic-clonic seizures) but not by perceptual disturbances. \\nNote: Code also the underlying condition \\n \\n6C4G.43 Withdrawal due to unknown or unspecified psychoactive, with perceptual \\ndisturbances and seizures \\nThe development of a withdrawal syndrome accompanied by both perceptual \\ndisturbances and seizures following cessation or reduction of use of the unknown or \\nunspecified substance. \\nNote: Code also the underlying condition \\n \\n6C4G.4Z Withdrawal due to unknown or unspecified psychoactive substance, unspecified  \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 162, 'page_label': '163'}, page_content='162  ICD-11 MMS - 2018 \\n \\n6C4G.5 Delirium induced by unknown or unspecified psychoactive substance  \\nDelirium induced by unknown or unspecified psychoactive substance is \\ncharacterized by an acute state of disturbed attention and awareness with specific  \\nfeatures of delirium that develops during or soon after substance intoxication or  \\nwithdrawal or during the use of an unknown or unspecified substance. The \\nsymptoms are not better explained by a primary mental disorder, by use of or \\nwithdrawal from another substance, or by another health condition that is not \\nclassified under Mental, behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C4G.6 Psychotic disorder induced by unknown or unspecified psychoactive \\nsubstance \\nPsychotic disorder induced by unknown or unspecified psychoactive substance is \\ncharacterized by psychotic symptoms (e.g., delusions, hallucinations, disorgani zed \\nthinking, grossly disorganized behaviour) that develop during or soon after \\nintoxication with or withdrawal from an unknown or unspecified psychoactive \\nsubstance. The symptoms are not better explained by a primary mental disorder \\n(e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be the \\ncase if the psychotic symptoms preceded the onset of the use of the unknown or \\nunspecified psychoactive substance, if the symptoms persist for a substantial period \\nof time after cessation of the use of the unknown or unspecified psychoactive \\nsubstance or withdrawal from the unknown or unspecified psychoactive substa nce, \\nor if there is other evidence of a pre-existing primary mental disorder with psych otic \\nsymptoms (e.g., a history of prior episodes not associated with the use of the \\nunknown or unspecified psychoactive substance). \\nNote: Code also the underlying condition \\n \\n6C4G.7 Other unknown or unspecified psychoactive substance-induced disorders  \\nNote: Code also the underlying condition \\n \\n6C4G.70 Mood disorder induced by unknown or unspecified psychoactive substance  \\nMood disorder induced by unknown or unspecified psychoactive substance is  \\ncharacterized by mood symptoms (e.g., depressed or elevated mood, decreased \\nengagement in pleasurable activities, increased or decreased energy levels) that \\ndevelop during or soon after intoxication with or withdrawal from a specified \\npsychoactive substance. The symptoms are not better explained by a primary \\nmental disorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffectiv e \\ndisorder), as might be the case if the mood symptoms preceded the onset of the \\nuse of the unknown or unspecified psychoactive substance, if the symptoms per sist \\nfor a substantial period of time after cessation of the use of the unknown or \\nunspecified psychoactive substance or withdrawal from the unknown or unspecifi ed \\npsychoactive substance, or if there is other evidence of a pre-existing primary  \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with the use of the unknown or unspecified psychoactive substance). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 163, 'page_label': '164'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   163 \\n \\n6C4G.71 Anxiety disorder induced by unknown or unspecified psychoactive substance  \\nAnxiety disorder induced by unknown or unspecified psychoactive substance i s \\ncharacterized by anxiety symptoms (e.g., apprehension or worry, fear, physiol ogical \\nsymptoms of excessive autonomic arousal, avoidance behaviour) that develop \\nduring or soon after intoxication with or withdrawal from an unknown or unspecified \\npsychoactive substance. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety symptom s \\npreceded the onset of the use of the unknown or unspecified psychoactive \\nsubstance, if the symptoms persist for a substantial period of time after cessation  of \\nthe use of the unknown or unspecified psychoactive substance or withdrawal from  \\nthe unknown or unspecified psychoactive substance, or if there is other ev idence of \\na pre-existing primary mental disorder with anxiety symptoms (e.g., a history of prior \\nepisodes not associated with the use of the unknown or unspecified psychoa ctive \\nsubstance). \\nNote: Code also the underlying condition \\n \\n6C4G.72 Obsessive-compulsive or related disorder induced by unknown or unspecified \\npsychoactive substance \\nObsessive-compulsive or related disorder induced by unknown or unspecified \\npsychoactive substance is characterized by either repetitive intrusive thoughts or  \\npreoccupations, normally associated with anxiety and typically accompanied by  \\nrepetitive behaviours performed in response, or by recurrent and habitual actions \\ndirected at the integument (e.g., hair pulling, skin picking) that develop during or \\nsoon after intoxication with or withdrawal from an unknown or unspecified \\npsychoactive substance. The symptoms are not better explained by a primary \\nmental disorder (in particular an Obsessive-compulsive or related disorder ), as \\nmight be the case if the symptoms preceded the onset of the unknown or \\nunspecified psychoactive substance use, if the symptoms persist for a substantial \\nperiod of time after cessation of use or withdrawal of the unknown or unspecified \\npsychoactive substance, or if there is other evidence of a pre-existing primary \\nmental disorder with obsessive-compulsive or related symptoms (e.g., a history of \\nprior episodes not associated with the unknown or unspecified psychoactive \\nsubstance use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 164, 'page_label': '165'}, page_content='164  ICD-11 MMS - 2018 \\n \\n6C4G.73 Impulse control disorder induced by unknown or unspecified psychoactive \\nsubstance \\nImpulse control disorder induced by unknown or unspecified psychoactive \\nsubstance is characterized by persistently repeated behaviours in which th ere is \\nrecurrent failure to resist an impulse, drive, or urge to perform an act that is \\nrewarding to the person, at least in the short-term, despite longer-term harm either \\nto the individual or to others (e.g., fire setting or stealing without apparent motive, \\nrepetitive sexual behaviour, aggressive outbursts) that develop during or soon af ter \\nintoxication with or withdrawal from an unknown or unspecified psychoactive \\nsubstance. The symptoms are not better explained by a primary mental disorder \\n(e.g., an Impulse control disorder, a Disorder due to addictive behaviours), as mi ght \\nbe the case if the impulse control disturbances preceded the onset of the unknown \\nor unspecified psychoactive substance use, if the symptoms persist for a substanti al \\nperiod of time after cessation of use or withdrawal of the unknown or unspecified \\npsychoactive substance, or if there is other evidence of a pre-existing primar y \\nmental disorder with impulse control symptoms (e.g., a history of prior epis odes not \\nassociated with the unknown or unspecified psychoactive substance use). \\nNote: Code also the underlying condition \\n \\n6C4G.Y Other specified disorders due use of unknown or unspecified psychoactive \\nsubstances \\nNote: Code also the underlying condition \\n \\n6C4G.Z Disorders due use of unknown or unspecified psychoactive substances, \\nunspecified \\nNote: Code also the underlying condition \\n \\n  6C4H   Disorders due to use of non-psychoactive substances \\nDisorders due to use of non-psychoactive substances are characterized by the \\npattern and consequences of non-psychoactive substance use. Non-psychoactiv e \\nsubstances are implicated in a wide range of harms affecting most organs and \\nsystems of the body, which may be classified as Single episode of harmful non-\\npsychoactive substance use and Harmful pattern of non-psychoactive substan ce \\nuse. \\n \\n6C4H.0 Single episode of harmful use of non-psychoactive substances \\nA single episode of use of a non-psychoactive substance that has caused damage \\nto a person’s physical or mental health. Harm to health of the individual occurs due \\nto direct or secondary toxic effects on body organs and systems or a harmful r oute \\nof administration. This diagnosis should not be made if the harm is attribu ted to a \\nknown pattern of non-psychoactive substance use. \\nExclusions: Harmful pattern of use of non-psychoactive substances \\n(6C4H.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 165, 'page_label': '166'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   165 \\n \\n6C4H.1 Harmful pattern of use of non-psychoactive substances \\nA pattern of use of non-psychoactive substances that has caused clinically  \\nsignificant harm to a person ’s physical or mental health. The pattern of use is \\nevident over a period of at least 12 months if use is episodic and at least one month \\nif use is continuous (i.e., daily or almost daily). Harm may be caused by  the direct or \\nsecondary toxic effects of the substance on body organs and systems, or a harmful  \\nroute of administration. \\nInclusions: abuse of antacids \\nabuse of herbal or folk remedies \\nabuse of hormones \\nabuse of vitamins \\nlaxative habit \\nExclusions: Harmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1) \\nSingle episode of harmful use of non-psychoactive substances \\n(6C4H.0) \\n \\n6C4H.10 Harmful pattern of use of non-psychoactive substances, episodic \\nA pattern of episodic or intermittent use of a non-psychoactive substance that has \\ncaused damage to a person ’s physical or mental health. The pattern of episodic or \\nintermittent use of the non-psychoactive substance is evident over a period of at \\nleast 12 months. Harm may be caused by the direct or secondary toxic effects  on \\nbody organs and systems, or a harmful route of administration. \\n \\n6C4H.11 Harmful pattern of use of non-psychoactive substances, continuous \\nA pattern of continuous use of a non-psychoactive substance (daily or almost daily) \\nthat has caused damage to a person ’s physical or mental health. The pattern of \\ncontinuous use of the non-psychoactive substance is evident over a period of at  \\nleast one month. Harm may be caused by the direct or secondary toxic effects  on \\nbody organs and systems, or a harmful route of administration. \\n \\n6C4H.1Z Harmful pattern of use of non-psychoactive substances, unspecified \\n \\n6C4H.Y Other specified disorders due to use of non-psychoactive substances  \\n \\n6C4H.Z Disorders due to use of non-psychoactive substances, unspecified \\n \\n  6C4Y   Other specified disorders due to substance use \\n \\n  6C4Z   Disorders due to substance use, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 166, 'page_label': '167'}, page_content='166  ICD-11 MMS - 2018 \\n \\nDisorders due to addictive behaviours (BlockL2‑6C5) \\nDisorders due to addictive behaviours are recognizable and clinically signi ficant syndromes \\nassociated with distress or interference with personal functions that develop as a result of repetitive \\nrewarding behaviours other than the use of dependence-producing substances. Disorders d ue to \\naddictive behaviors include gambling disorder and gaming disorder, which may i nvolve both online \\nand offline behaviour. \\n  6C50   Gambling disorder \\nGambling disorder is characterized by a pattern of persistent or recurrent gambling \\nbehaviour, which may be online (i.e., over the internet) or offline, manif ested by: 1) \\nimpaired control over gambling (e.g., onset, frequency, intensity, duration,  \\ntermination, context); 2) increasing priority given to gambling to the extent that \\ngambling takes precedence over other life interests and daily activities; and 3) \\ncontinuation or escalation of gambling despite the occurrence of negative \\nconsequences. The behaviour pattern is of sufficient severity to result in signif icant \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning. The pattern of gambling behaviour may be continuous or \\nepisodic and recurrent. The gambling behaviour and other features are normally \\nevident over a period of at least 12 months in order for a diagnosis to be ass igned, \\nalthough the required duration may be shortened if all diagnostic requir ements are \\nmet and symptoms are severe. \\nInclusions: Compulsive gambling \\nExclusions: Bipolar type I disorder (6A60) \\nBipolar type II disorder (6A61) \\nHazardous gambling or betting (QE21) \\n \\n6C50.0 Gambling disorder, predominantly offline \\nGambling disorder, predominantly offline is characterized by a pattern of persistent \\nor recurrent gambling behaviour that is not primarily conducted over the internet and \\nis manifested by: 1) impaired control over gambling (e.g., onset, frequenc y, \\nintensity, duration, termination, context); 2) increasing priority given to g ambling to \\nthe extent that gambling takes precedence over other life interests and daily \\nactivities; and 3) continuation or escalation of gambling despite the occurrence of \\nnegative consequences. The behaviour pattern is of sufficient severity to result in \\nsignificant impairment in personal, family, social, educational, occupationa l or other \\nimportant areas of functioning. The pattern of gambling behaviour may be \\ncontinuous or episodic and recurrent. The gambling behaviour and other features \\nare normally evident over a period of at least 12 months in order for a diagnosis to  \\nbe assigned, although the required duration may be shortened if all di agnostic \\nrequirements are met and symptoms are severe. \\nExclusions: Hazardous gambling or betting (QE21)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 167, 'page_label': '168'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   167 \\n \\n6C50.1 Gambling disorder, predominantly online \\nGambling disorder, predominantly online is characterized by a pattern of persistent \\nor recurrent gambling behaviour that is primarily conducted over the internet and is \\nmanifested by: 1) impaired control over gambling (e.g., onset, frequency, inten sity, \\nduration, termination, context); 2) increasing priority given to gambling to the extent \\nthat gambling takes precedence over other life interests and daily activities; and 3) \\ncontinuation or escalation of gambling despite the occurrence of negative \\nconsequences. The behaviour pattern is of sufficient severity to result in signif icant \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning. The pattern of gambling behaviour may be continuous or \\nepisodic and recurrent. The gambling behaviour and other features are normally \\nevident over a period of at least 12 months in order for a diagnosis to be assi gned, \\nalthough the required duration may be shortened if all diagnostic requir ements are \\nmet and symptoms are severe. \\nExclusions: Hazardous gambling or betting (QE21) \\n \\n6C50.Z Gambling disorder, unspecified \\n \\n  6C51   Gaming disorder \\nGaming disorder is characterized by a pattern of persistent or recurrent gaming \\nbehaviour ( ‘digital gaming ’ or ‘video-gaming’), which may be online (i.e., over the \\ninternet) or offline, manifested by: 1) impaired control over gaming (e.g., onset, \\nfrequency, intensity, duration, termination, context); 2) increasing priority given to \\ngaming to the extent that gaming takes precedence over other life interests and \\ndaily activities; and 3) continuation or escalation of gaming despite the occ urrence \\nof negative consequences. The behaviour pattern is of sufficient severity to result in \\nsignificant impairment in personal, family, social, educational, occupationa l or other \\nimportant areas of functioning. The pattern of gaming behaviour may be continuous  \\nor episodic and recurrent. The gaming behaviour and other features are normally \\nevident over a period of at least 12 months in order for a diagnosis to be assi gned, \\nalthough the required duration may be shortened if all diagnostic requir ements are \\nmet and symptoms are severe. \\nExclusions: Hazardous gaming (QE22) \\nBipolar type I disorder (6A60) \\nBipolar type II disorder (6A61) \\n \\n6C51.0 Gaming disorder, predominantly online \\nGaming disorder, predominantly online is characterized by a pattern of persistent or \\nrecurrent gaming behaviour ( ‘digital gaming ’ or ‘video-gaming’) that is primarily \\nconducted over the internet and is manifested by: 1) impaired control over ga ming \\n(e.g., onset, frequency, intensity, duration, termination, context); 2) increasing \\npriority given to gaming to the extent that gaming takes precedence over other life \\ninterests and daily activities; and 3) continuation or escalation of gaming des pite the \\noccurrence of negative consequences. The behaviour pattern is of sufficient \\nseverity to result in significant impairment in personal, family, social, e ducational, \\noccupational or other important areas of functioning. The pattern of gaming \\nbehaviour may be continuous or episodic and recurrent. The gaming behaviour and \\nother features are normally evident over a period of at least 12 months in order for a \\ndiagnosis to be assigned, although the required duration may be shortened if  all \\ndiagnostic requirements are met and symptoms are severe.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 168, 'page_label': '169'}, page_content='168  ICD-11 MMS - 2018 \\n \\n6C51.1 Gaming disorder, predominantly offline \\nGaming disorder, predominantly offline is characterized by a pattern of persistent  or \\nrecurrent gaming behaviour ( ‘digital gaming’ or ‘video-gaming’) that is not primarily \\nconducted over the internet and is manifested by: 1) impaired control over ga ming \\n(e.g., onset, frequency, intensity, duration, termination, context); 2) increasing  \\npriority given to gaming to the extent that gaming takes precedence over other life \\ninterests and daily activities; and 3) continuation or escalation of gaming des pite the \\noccurrence of negative consequences. The behaviour pattern is of sufficient \\nseverity to result in significant impairment in personal, family, social, e ducational, \\noccupational or other important areas of functioning. The pattern of gaming \\nbehaviour may be continuous or episodic and recurrent. The gaming behaviour and \\nother features are normally evident over a period of at least 12 months in order for a \\ndiagnosis to be assigned, although the required duration may be shortened if  all \\ndiagnostic requirements are met and symptoms are severe. \\n \\n6C51.Z Gaming disorder, unspecified \\n \\n  6C5Y   Other specified disorders due to addictive behaviours \\n \\n  6C5Z   Disorders due to addictive behaviours, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 169, 'page_label': '170'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   169 \\n \\nImpulse control disorders (BlockL1‑6C7) \\nImpulse control disorders are characterized by the repeated failure to resist an impulse, drive, or urge \\nto perform an act that is rewarding to the person, at least in the short-term , despite consequences \\nsuch as longer-term harm either to the individual or to others, marked distres s about the behaviour \\npattern, or significant impairment in personal, family, social, educ ational, occupational, or other \\nimportant areas of functioning. Impulse Control Disorders involve a range of s pecific behaviours, \\nincluding fire-setting, stealing, sexual behaviour, and explosive outbursts. \\nCoded Elsewhere: Substance-induced impulse control disorders \\nGambling disorder (6C50) \\nGaming disorder (6C51) \\nSecondary impulse control syndrome (6E66) \\nBody-focused repetitive behaviour disorders (6B25) \\n  6C70   Pyromania \\nPyromania is characterized by a recurrent failure to control strong impulses to set \\nfires, resulting in multiple acts of, or attempts at, setting fire to property or other \\nobjects, in the absence of an intelligible motive (e.g., monetary gain, reveng e, \\nsabotage, political statement, attracting attention or recognition). There is an \\nincreasing sense of tension or affective arousal prior to instances of fire setti ng, \\npersistent fascination or preoccupation with fire and related stimuli (e.g., w atching \\nfires, building fires, fascination with firefighting equipment), and a sense of pleasure, \\nexcitement, relief or gratification during, and immediately after the act of setti ng the \\nfire, witnessing its effects, or participating in its aftermath. The behaviour i s not \\nbetter explained by intellectual impairment, another mental and behavioural \\ndisorder, or substance intoxication. \\nInclusions: pathological fire-setting \\nExclusions: Conduct-dissocial disorder (6C91) \\nBipolar type I disorder (6A60) \\nSchizophrenia or other primary psychotic disorders \\n(BlockL1‑6A2) \\nFire-setting as the reason for observation for suspected mental \\nor behavioural disorders, ruled out (QA02.3) \\n \\n  6C71   Kleptomania \\nKleptomania is characterized by a recurrent failure to control strong impulses  to \\nsteal objects in the absence of an intelligible motive (e.g., objects are not acqui red \\nfor personal use or monetary gain). There is an increasing sense of tension or \\naffective arousal before instances of theft and a sense of pleasure, excitement, \\nrelief, or gratification during and immediately after the act of stealing. The behavi our \\nis not better explained by intellectual impairment, another mental and behavio ural \\ndisorder, or substance intoxication. \\nNote: If stealing occurs within the context of conduct-dissocial disorder or a manic \\nepisode, Kleptomania should not be diagnosed separately. \\nInclusions: pathological stealing \\nExclusions: shoplifting as the reason for observation for suspected mental \\ndisorder, ruled out (QA02.3)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 170, 'page_label': '171'}, page_content='170  ICD-11 MMS - 2018 \\n \\n  6C72   Compulsive sexual behaviour disorder \\nCompulsive sexual behaviour disorder is characterized by a persistent pat tern of \\nfailure to control intense, repetitive sexual impulses or urges resulting in r epetitive \\nsexual behaviour. Symptoms may include repetitive sexual activities becom ing a \\ncentral focus of the person ’s life to the point of neglecting health and personal care \\nor other interests, activities and responsibilities; numerous unsuccessful efforts to \\nsignificantly reduce repetitive sexual behaviour; and continued repetitive sexual \\nbehaviour despite adverse consequences or deriving little or no satisfaction f rom it. \\nThe pattern of failure to control intense, sexual impulses or urges and resulting \\nrepetitive sexual behaviour is manifested over an extended period of time (e.g., 6 \\nmonths or more), and causes marked distress or significant impairment in perso nal, \\nfamily, social, educational, occupational, or other important areas of functioni ng. \\nDistress that is entirely related to moral judgments and disapproval about s exual \\nimpulses, urges, or behaviours is not sufficient to meet this requirement. \\nExclusions: Paraphilic disorders  (BlockL1‑6D3) \\n \\n  6C73   Intermittent explosive disorder \\nIntermittent explosive disorder is characterized by repeated brief episodes of verbal \\nor physical aggression or destruction of property that represent a failure to c ontrol \\naggressive impulses, with the intensity of the outburst or degree of aggressiveness \\nbeing grossly out of proportion to the provocation or precipitating psychosocial \\nstressors. The symptoms are not better explained by another mental, behavioural, \\nor neurodevelopmental disorder and are not part of a pattern of chronic anger and \\nirritability (e.g., in oppositional defiant disorder). The behaviour pattern i s of \\nsufficient severity to result in significant impairment in personal, family, social, \\neducational, occupational or other important areas of functioning. \\nExclusions: Oppositional defiant disorder (6C90) \\n \\n  6C7Y   Other specified impulse control disorders \\n \\n  6C7Z   Impulse control disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 171, 'page_label': '172'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   171 \\n \\nDisruptive behaviour or dissocial disorders (BlockL1‑6C9) \\nDisruptive behaviour and dissocial disorders are characterized by persistent beh aviour problems that \\nrange from markedly and persistently defiant, disobedient, provocative or spit eful (i.e., disruptive) \\nbehaviours to those that persistently violate the basic rights of others or major age-appropriate \\nsocietal norms, rules, or laws (i.e., dissocial). Onset of Disruptive and dissocial disorders is \\ncommonly, though not always, during childhood. \\n  6C90   Oppositional defiant disorder \\nOppositional defiant disorder is a persistent pattern (e.g., 6 months or more) of \\nmarkedly defiant, disobedient, provocative or spiteful behaviour that occurs more \\nfrequently than is typically observed in individuals of comparable ag e and \\ndevelopmental level and that is not restricted to interaction with siblings. \\nOppositional defiant disorder may be manifest in prevailing, persistent angry or \\nirritable mood, often accompanied by severe temper outbursts or in headstrong , \\nargumentative and defiant behaviour. The behavior pattern is of sufficient severity to \\nresult in significant impairment in personal, family, social, educationa l, occupational \\nor other important areas of functioning \\n \\n6C90.0 Oppositional defiant disorder with chronic irritability-anger \\nAll definitional requirements for oppositional defiant disorder are met. This  form of \\noppositional defiant disorder is characterized by prevailing, persistent angry or \\nirritable mood that may be present independent of any apparent provocation. The \\nnegative mood is often accompanied by regularly occurring severe temper outbursts \\nthat are grossly out of proportion in intensity or duration to the provocation. Chronic \\nirritability and anger are characteristic of the individual ’s functioning nearly every \\nday, are observable across multiple settings or domains of functioning (e.g., home,  \\nschool, social relationships), and are not restricted to the individual ’s relationship \\nwith his/her parents or guardians. The pattern of chronic irritability and anger i s not \\nlimited to occasional episodes (e.g., developmentally typical irritabili ty) or discrete \\nperiods (e.g., irritable mood in the context of manic or depressive episodes). \\n \\n6C90.00 Oppositional defiant disorder with chronic irritability-anger with limited prosoci al \\nemotions \\nAll definitional requirements for oppositional defiant disorder with chronic i rritability-\\nanger are met. In addition, the individual exhibits characteristics that are sometimes \\nreferred to as ‘callous and unemotional ’. These characteristics include a lack of \\nempathy or sensitivity to the feelings of others and a lack of concern for others’ \\ndistress; a lack of remorse, shame or guilt over their own behaviour (unless \\nprompted by being apprehended), a relative indifference to the probability of \\npunishment; a lack of concern over poor performance in school or work; and limited \\nexpression of emotions, particularly positive or loving feelings toward others, or only \\ndoing so in ways that seem shallow, insincere, or instrumental. \\n \\n6C90.01 Oppositional defiant disorder with chronic irritability-anger with typical prosocial \\nemotions \\nAll definitional requirements for oppositional defiant disorder with chronic irritability-\\nanger are met. The individual does not exhibit characteristics referred to as ‘callous \\nand unemotional ’, such as lack of empathy or sensitivity to the feelings of others \\nand a lack of concern for others’ distress. \\n \\n6C90.0Z Oppositional defiant disorder with chronic irritability-anger, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 172, 'page_label': '173'}, page_content='172  ICD-11 MMS - 2018 \\n \\n6C90.1 Oppositional defiant disorder without chronic irritability-anger \\nMeets all definitional requirements for oppositional defiant disorder. This form of \\noppositional defiant disorder is not characterized by prevailing, persistent, angr y or \\nirritable mood, but does feature headstrong, argumentative, and defiant behavior. \\n \\n6C90.10 Oppositional defiant disorder without chronic irritability-anger with limited pros ocial \\nemotions \\nAll definitional requirements for oppositional defiant disorder without chronic  \\nirritability-anger are met. In addition, the individual exhibits characteristic s that are \\nsometimes referred to as ‘callous and unemotional’. These characteristics include a \\nlack of empathy or sensitivity to the feelings of others and a lack of c oncern for \\nothers’ distress; a lack of remorse, shame or guilt over their own behaviour (u nless \\nprompted by being apprehended), a relative indifference to the probability of \\npunishment; a lack of concern over poor performance in school or work; and limited \\nexpression of emotions, particularly positive or loving feelings toward others, or only \\ndoing so in ways that seem shallow, insincere, or instrumental. This pattern is \\npervasive across situations and relationships (i.e., the qualifier should no t be \\napplied based on a single characteristic, a single relationship, or a single instance of \\nbehaviour) and is pattern is persistent over time (e.g., at least 1 year). \\n \\n6C90.11 Oppositional defiant disorder without chronic irritability-anger with typical prosocial \\nemotions \\nAll definitional requirements for oppositional defiant disorder without chronic  \\nirritability-anger are met. The individual does not exhibit characteristics referred to \\nas ‘callous and unemotional ’, such as lack of empathy or sensitivity to the feelings \\nof others and a lack of concern for others’ distress. \\n \\n6C90.1Z Oppositional defiant disorder without chronic irritability-anger, unspecified  \\n \\n6C90.Z Oppositional defiant disorder, unspecified \\n \\n  6C91   Conduct-dissocial disorder \\nConduct-dissocial disorder is characterized by a repetitive and persistent pattern of \\nbehaviour in which the basic rights of others or major age-appropriate socie tal \\nnorms, rules, or laws are violated such as aggression towards people or animals; \\ndestruction of property; deceitfulness or theft; and serious violations of r ules. The \\nbehaviour pattern is of sufficient severity to result in significant im pairment in \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning. To be diagnosed, the behaviour pattern must be enduring over a \\nsignificant period of time (e.g., 12 months or more). Isolated dissocial or crimina l \\nacts are thus not in themselves grounds for the diagnosis. \\n \\n6C91.0 Conduct-dissocial disorder, childhood onset \\nConduct-dissocial disorder, childhood onset is characterized by a repetitive and \\npersistent pattern of behaviour in which the basic rights of others or major age -\\nappropriate societal norms, rules, or laws are violated such as aggression towards \\npeople or animals; destruction of property; deceitfulness or theft; and serious \\nviolations of rules. To be diagnosed, features of the disorder must be present during \\nchildhood prior to adolescence (e.g., before 10 years of age) and the behaviour \\npattern must be enduring over a significant period of time (e.g., 12 months or more). \\nIsolated dissocial or criminal acts are thus not in themselves grounds for the \\ndiagnosis.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 173, 'page_label': '174'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   173 \\n \\n6C91.00 Conduct-dissocial disorder, childhood onset with limited prosocial emotions  \\nMeets all definitional requirements for Conduct-dissocial disorder, childhood ons et. \\nIn addition, the individual exhibits characteristics that are sometimes referred to as \\n‘callous and unemotional ’. These characteristics include a lack of empathy or \\nsensitivity to the feelings of others and a lack of concern for others ’ distress; a lack \\nof remorse, shame or guilt over their own behaviour (unless prompted by being \\napprehended), a relative indifference to the probability of punishment; a lack of \\nconcern over poor performance in school or work; and limited expression of \\nemotions, particularly positive or loving feelings toward others, or only doing so in \\nways that seem shallow, insincere, or instrumental. \\n \\n6C91.01 Conduct-dissocial disorder, childhood onset with typical prosocial emotions  \\nAll definitional requirements for conduct-dissocial disorder, childhoo d onset are met. \\nThe individual does not exhibit characteristics referred to as ‘callous and \\nunemotional’, such as lack of empathy or sensitivity to the feelings of others and a \\nlack of concern for others’ distress. \\n \\n6C91.0Z Conduct-dissocial disorder, childhood onset, unspecified \\n \\n6C91.1 Conduct-dissocial disorder, adolescent onset \\nConduct-dissocial disorder, adolescent onset is characterized by a repetitive a nd \\npersistent pattern of behaviour in which the basic rights of others or major ag e-\\nappropriate societal norms, rules, or laws are violated such as aggression towards \\npeople or animals; destruction of property; deceitfulness or theft; and serious \\nviolations of rules. No features of the disorder are present during childhood prior to \\nadolescence (e.g., before 10 years of age). To be diagnosed, the behaviour pattern \\nmust be enduring over a significant period of time (e.g., 12 months or more). \\nIsolated dissocial or criminal acts are thus not in themselves grounds for the \\ndiagnosis. \\n \\n6C91.10 Conduct-dissocial disorder, adolescent onset with limited prosocial emotions  \\nAll definitional requirements for conduct-dissocial disorder, adolescent on set are \\nmet. In addition, the individual exhibits characteristics that are sometimes referred \\nto as ‘callous and unemotional ’. These characteristics include a lack of empathy or \\nsensitivity to the feelings of others and a lack of concern for others ’ distress; a lack \\nof remorse, shame or guilt over their own behaviour (unless prompted by being \\napprehended), a relative indifference to the probability of punishment; a lack of \\nconcern over poor performance in school or work; and limited expression of \\nemotions, particularly positive or loving feelings toward others, or only doing so in \\nways that seem shallow, insincere, or instrumental. \\n \\n6C91.11 Conduct-dissocial disorder, adolescent onset with typical prosocial emotions  \\nAll definitional requirements for conduct-dissocial disorder, adolescent on set are \\nmet. The individual does not exhibit characteristics referred to as ‘callous and \\nunemotional’, such as lack of empathy or sensitivity to the feelings of others and a \\nlack of concern for others’ distress. \\n \\n6C91.1Y Other specified conduct-dissocial disorder, adolescent onset \\n \\n6C91.Z Conduct-dissocial disorder, unspecified \\n \\n  6C9Y   Other specified disruptive behaviour or dissocial disorders'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 174, 'page_label': '175'}, page_content='174  ICD-11 MMS - 2018 \\n \\n  6C9Z   Disruptive behaviour or dissocial disorders, unspecified \\n \\nPersonality disorders and related traits (BlockL1‑6D1) \\nCoded Elsewhere: Secondary personality change (6E68) \\n  6D10   Personality disorder \\nPersonality disorder is characterized by problems in functioning of aspects of the \\nself (e.g., identity, self-worth, accuracy of self-view, self-direction), and /or \\ninterpersonal dysfunction (e.g., ability to develop and maintain close and mutually \\nsatisfying relationships, ability to understand others ’ perspectives and to manage \\nconflict in relationships) that have persisted over an extended period of tim e (e.g., 2 \\nyears or more). The disturbance is manifest in patterns of cognition, emotional \\nexperience, emotional expression, and behaviour that are maladaptive (e.g., \\ninflexible or poorly regulated) and is manifest across a range of personal and  social \\nsituations (i.e., is not limited to specific relationships or social roles). The patterns of \\nbehaviour characterizing the disturbance are not developmentally appropriate and \\ncannot be explained primarily by social or cultural factors, including soci o-political \\nconflict. The disturbance is associated with substantial distress or signif icant \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning. \\n \\n6D10.0 Mild personality disorder \\nAll general diagnostic requirements for Personality Disorder are met. Disturbances  \\naffect some areas of personality functioning but not others (e.g., problems with sel f-\\ndirection in the absence of problems with stability and coherence of identity or self-\\nworth), and may not be apparent in some contexts. There are problems in many \\ninterpersonal relationships and/or in performance of expected occupational and \\nsocial roles, but some relationships are maintained and/or some roles carried out. \\nSpecific manifestations of personality disturbances are generally of mil d severity. \\nMild Personality Disorder is typically not associated with substantial harm to self or \\nothers, but may be associated with substantial distress or with impairment in  \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning that is either limited to circumscribed areas (e.g., romantic relatio nships; \\nemployment) or present in more areas but milder.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 175, 'page_label': '176'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   175 \\n \\n6D10.1 Moderate personality disorder \\nAll general diagnostic requirements for Personality Disorder are met. Disturbances  \\naffect multiple areas of personality functioning (e.g., identity or sense of s elf, ability \\nto form intimate relationships, ability to control impulses and modulate behaviou r). \\nHowever, some areas of personality functioning may be relatively less af fected. \\nThere are marked problems in most interpersonal relationships and the \\nperformance of most expected social and occupational roles are compromised to \\nsome degree. Relationships are likely to be characterized by conflict, av oidance, \\nwithdrawal, or extreme dependency (e.g., few friendships maintained, persistent \\nconflict in work relationships and consequent occupational problems, romantic \\nrelationships characterized by serious disruption or inappropriate submissiven ess). \\nSpecific manifestations of personality disturbance are generally of moderate \\nseverity. Moderate Personality Disorder is sometimes associated with harm to self \\nor others, and is associated with marked impairment in personal, family, soci al, \\neducational, occupational or other important areas of functioning, although \\nfunctioning in circumscribed areas may be maintained. \\n \\n6D10.2 Severe personality disorder \\nAll general diagnostic requirements for Personality Disorder are met. There are \\nsevere disturbances in functioning of the self (e.g., sense of self may be so unstable \\nthat individuals report not having a sense of who they are or so rigid that they refus e \\nto participate in any but an extremely narrow range of situations; self vi ew may be \\ncharacterized by self-contempt or be grandiose or highly eccentric). Problems in \\ninterpersonal functioning seriously affect virtually all relationships and the ability and \\nwillingness to perform expected social and occupational roles is absent or s everely \\ncompromised. Specific manifestations of personality disturbance are severe and \\naffect most, if not all, areas of personality functioning. Severe Personalit y Disorder \\nis often associated with harm to self or others, and is associated with severe \\nimpairment in all or nearly all areas of life, including personal, fami ly, social, \\neducational, occupational, and other important areas of functioning. \\n \\n6D10.Z Personality disorder, severity unspecified \\n \\n  6D11   Prominent personality traits or patterns \\nTrait domain qualifiers may be applied to Personality Disorders or Personali ty \\nDifficulty to describe the characteristics of the individual ’s personality that are most \\nprominent and that contribute to personality disturbance. Trait domains are \\ncontinuous with normal personality characteristics in individuals who do not have \\nPersonality Disorder or Personality Difficulty. Trait domains are not diagnostic  \\ncategories, but rather represent a set of dimensions that correspond to the \\nunderlying structure of personality. As many trait domain qualifiers may be applied \\nas necessary to describe personality functioning. Individuals with more severe \\npersonality disturbance tend to have a greater number of prominent trait domains.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 176, 'page_label': '177'}, page_content=\"176  ICD-11 MMS - 2018 \\n \\n6D11.0 Negative affectivity in personality disorder or personality difficulty \\nThe core feature of the Negative Affectivity trait domain is the tendency to \\nexperience a broad range of negative emotions. Common manifestations of \\nNegative Affectivity, not all of which may be present in a given individu al at a given \\ntime, include: experiencing a broad range of negative emotions with a frequency \\nand intensity out of proportion to the situation; emotional lability and poor emotion \\nregulation; negativistic attitudes; low self-esteem and self-confidence; and  \\nmistrustfulness. \\nNote: This category should ONLY be used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty. \\n \\n6D11.1 Detachment in personality disorder or personality difficulty \\nThe core feature of the Detachment trait domain is the tendency to maintain \\ninterpersonal distance (social detachment) and emotional distance (emotional \\ndetachment). Common manifestations of Detachment, not all of which may be \\npresent in a given individual at a given time, include: social detachment (avoida nce \\nof social interactions, lack of friendships, and avoidance of intimacy); and em otional \\ndetachment (reserve, aloofness, and limited emotional expression and experience). \\nNote: This category should ONLY be used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty. \\n \\n6D11.2 Dissociality in personality disorder or personality difficulty \\nThe core feature of the Dissociality trait domain is disregard for the rights and \\nfeelings of others, encompassing both self-centeredness and lack of empathy. \\nCommon manifestations of Dissociality, not all of which may be present in a gi ven \\nindividual at a given time, include: self-centeredness (e.g., sense of entitlem ent, \\nexpectation of others’ admiration, positive or negative attention-seeking behaviours, \\nconcern with one's own needs, desires and comfort and not those of others); and \\nlack of empathy (i.e., indifference to whether one ’s actions inconvenience hurt \\nothers, which may include being deceptive, manipulative, and exploitative of oth ers, \\nbeing mean and physically aggressive, callousness in response to others' suffering, \\nand ruthlessness in obtaining one’s goals). \\nNote: This category should ONLY be used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty. \\n \\n6D11.3 Disinhibition in personality disorder or personality difficulty \\nThe core feature of the Disinhibition trait domain is the tendency to act r ashly based \\non immediate external or internal stimuli (i.e., sensations, emotions, thoughts) , \\nwithout consideration of potential negative consequences. Common manifestations \\nof Disinhibition, not all of which may be present in a given individual at a given time, \\ninclude: impulsivity; distractibility; irresponsibility; recklessnes s; and lack of \\nplanning. \\nNote: This category should ONLY be used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty.\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 177, 'page_label': '178'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   177 \\n \\n6D11.4 Anankastia in personality disorder or personality difficulty \\nThe core feature of the Anankastia trait domain is a narrow focus on one ’s rigid \\nstandard of perfection and of right and wrong, and on controlling one ’s own and \\nothers’ behaviour and controlling situations to ensure conformity to these standards. \\nCommon manifestations of Anankastia, not all of which may be present in a given \\nindividual at a given time, include: perfectionism (e.g., concern with social rules, \\nobligations, and norms of right and wrong, scrupulous attention to detail, rigid,  \\nsystematic, day- to-day routines, hyper-scheduling and planfulness, emphasis on \\norganization, orderliness, and neatness); and emotional and behavioral constraint \\n(e.g., rigid control over emotional expression, stubbornness and inflexibility, risk-\\navoidance, perseveration, and deliberativeness). \\nNote: This category should ONLY be used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty. \\n \\n6D11.5 Borderline pattern \\nThe Borderline pattern descriptor may be applied to individuals whose pattern of \\npersonality disturbance is characterized by a pervasive pattern of instabili ty of \\ninterpersonal relationships, self-image, and affects, and marked impulsiv ity, as \\nindicated by many of the following: Frantic efforts to avoid real or imagin ed \\nabandonment; A pattern of unstable and intense interpersonal relationships; Identity \\ndisturbance, manifested in markedly and persistently unstable self-image or sense \\nof self; A tendency to act rashly in states of high negative affect, leading to \\npotentially self-damaging behaviours; Recurrent episodes of self-harm; Emotion al \\ninstability due to marked reactivity of mood; Chronic feelings of emptiness ; \\nInappropriate intense anger or difficulty controlling anger; Transient dissociative \\nsymptoms or psychotic-like features in situations of high affective arousal. \\nNote: This category should ONLY be used in combination with a Personality disorder \\ncategory (Mild, Moderate, or Severe) or Personality difficulty. \\n \\nParaphilic disorders (BlockL1‑6D3) \\nParaphilic disorders are characterized by persistent and intense patterns of atypical  sexual arousal, \\nmanifested by sexual thoughts, fantasies, urges, or behaviours, the focus of which i nvolves others \\nwhose age or status renders them unwilling or unable to consent and on which the person has acted \\nor by which he or she is markedly distressed. Paraphilic disorders may include arousal patterns \\ninvolving solitary behaviours or consenting individuals only when these are associated with marked \\ndistress that is not simply a result of rejection or feared rejection of the  arousal pattern by others or \\nwith significant risk of injury or death. \\nInclusions: paraphilias \\n  6D30   Exhibitionistic disorder \\nExhibitionistic disorder is characterized by a sustained, focused and intense p attern \\nof sexual arousal—as manifested by persistent sexual thoughts, fantasies, urges, or \\nbehaviors—that involves exposing one ’s genitals to an unsuspecting individual in \\npublic places, usually without inviting or intending closer contact. In addition, in  \\norder for Exhibitionistic Disorder to be diagnosed, the individual must have acted on \\nthese thoughts, fantasies or urges or be markedly distressed by them. \\nExhibitionistic Disorder specifically excludes consensual exhibition istic behaviours \\nthat occur with the consent of the person or persons involved as well as soc ially \\nsanctioned forms of exhibitionism.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 178, 'page_label': '179'}, page_content='178  ICD-11 MMS - 2018 \\n \\n  6D31   Voyeuristic disorder \\nVoyeuristic disorder is characterized by a sustained, focused and intense pa ttern of \\nsexual arousal —as manifested by persistent sexual thoughts, fantasies, urges, or \\nbehaviours—that involves observing an unsuspecting individual who is naked, in the \\nprocess of disrobing, or engaging in sexual activity. In addition, in order for \\nVoyeuristic Disorder to be diagnosed, the individual must have acted on these \\nthoughts, fantasies or urges or be markedly distressed by them. Voyeuristic  \\nDisorder specifically excludes consensual voyeuristic behaviours that oc cur with the \\nconsent of the person or persons being observed. \\n \\n  6D32   Pedophilic disorder \\nPedophilic disorder is characterized by a sustained, focused, and intense pattern of \\nsexual arousal —as manifested by persistent sexual thoughts, fantasies, urges, o r \\nbehaviours—involving pre-pubertal children. In addition, in order for Pedophilic \\nDisorder to be diagnosed, the individual must have acted on these thoughts, \\nfantasies or urges or be markedly distressed by them. This diagnosis does not \\napply to sexual behaviours among pre- or post-pubertal children with peers who are \\nclose in age. \\n \\n  6D33   Coercive sexual sadism disorder \\nCoercive sexual sadism disorder is characterized by a sustained, focused and \\nintense pattern of sexual arousal —as manifested by persistent sexual thoughts, \\nfantasies, urges or behaviours —that involves the infliction of physical or \\npsychological suffering on a non-consenting person. In addition, in order for \\nCoercive Sexual Sadism Disorder to be diagnosed, the individual must have acted  \\non these thoughts, fantasies or urges or be markedly distressed by them. Coercive \\nSexual Sadism Disorder specifically excludes consensual sexual sadism and \\nmasochism. \\n \\n  6D34   Frotteuristic disorder \\nFrotteuristic disorder is characterized by a sustained, focused and intense pattern  of \\nsexual arousal— as manifested by persistent sexual thoughts, fantasies, urges, or \\nbehaviours— that involves touching or rubbing against a non-consenting person in \\ncrowded public places. In addition, in order for Frotteuristic Disorder to be \\ndiagnosed, the individual must have acted on these thoughts, fantasies or urges or \\nbe markedly distressed by them. Frotteuristic Disorder specifically ex cludes \\nconsensual touching or rubbing that occur with the consent of the person or persons \\ninvolved. \\n \\n  6D35   Other paraphilic disorder involving non-consenting individuals \\nOther paraphilic disorder involving non-consenting individuals is charac terized by a \\npersistent and intense pattern of atypical sexual arousal — manifested by sexual \\nthoughts, fantasies, urges, or behaviours — in which the focus of the arousal pattern \\ninvolves others who are unwilling or unable to consent but that is not specific ally \\ndescribed in any of the other named Paraphilic Disorders categories (e.g., arousal  \\npatterns involving corpses or animals). The individual must have acted on th ese \\nthoughts, fantasies or urges or be markedly distressed by them. The disorder \\nspecifically excludes sexual behaviours that occur with the consent of the person or \\npersons involved, provided that they are considered able to provide such consent.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 179, 'page_label': '180'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   179 \\n \\n  6D36   Paraphilic disorder involving solitary behaviour or consenting \\nindividuals \\nParaphilic disorder involving solitary behaviour or consenting individua ls is \\ncharacterized by a persistent and intense pattern of atypical sexual arousal — \\nmanifested by sexual thoughts, fantasies, urges, or behaviours — that involves \\nconsenting adults or solitary behaviours. One of the following two elements mus t be \\npresent: 1) the person is markedly distressed by the nature of the arousal pattern \\nand the distress is not simply a consequence of rejection or feared rejection of the \\narousal pattern by others; or 2) the nature of the paraphilic behaviour involves \\nsignificant risk of injury or death either to the individual or to the partner  (e.g., \\nasphyxophilia). \\n \\n  6D3Z   Paraphilic disorders, unspecified \\n \\nFactitious disorders (BlockL1‑6D5) \\nFactitious disorders are characterized by intentionally feigning, falsifying, ind ucing, or aggravating \\nmedical, psychological, or behavioural signs and symptoms or injury in ones elf or in another person, \\nmost commonly a child dependent, associated with identified deception. A pre-exis ting disorder or \\ndisease may be present, but the individual intentionally aggravates existing sy mptoms or falsifies or \\ninduces additional symptoms. Individuals with factitious disorder seek treatmen t or otherwise present \\nthemselves or another person as ill, injured, or impaired based on the feigned, fal sified, or self-\\ninduced signs, symptoms, or injuries. The deceptive behaviour is not solel y motivated by obvious \\nexternal rewards or incentives (e.g., obtaining disability payments or evading cr iminal prosecution). \\nThis is in contrast to Malingering, in which obvious external rewards or incentives motivate the \\nbehaviour. \\nExclusions: Malingering (QC30) \\n  6D50   Factitious disorder imposed on self \\nFactitious disorder imposed on self is characterized by feigning, falsify ing, or \\ninducing medical, psychological, or behavioural signs and symptoms or injury \\nassociated with identified deception. If a pre-existing disorder or disease is prese nt, \\nthe individual intentionally aggravates existing symptoms or falsifies or i nduces \\nadditional symptoms. The individual seeks treatment or otherwise presents hi mself \\nor herself as ill, injured, or impaired based on the feigned, falsified, or s elf-induced \\nsigns, symptoms, or injuries. The deceptive behavior is not solely motivated by \\nobvious external rewards or incentives (e.g., obtaining disability payments or \\nevading criminal prosecution). This is in contrast to Malingering, in whic h obvious \\nexternal rewards or incentives motivate the behaviour \\nInclusions: Münchhausen syndrome \\nExclusions: Excoriation disorder (6B25.1) \\nMalingering (QC30)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 180, 'page_label': '181'}, page_content='180  ICD-11 MMS - 2018 \\n \\n  6D51   Factitious disorder imposed on another \\nFactitious disorder imposed on another is characterized by feigning, falsifying,  or \\ninducing, medical, psychological, or behavioural signs and symptoms or injury in \\nanother person, most commonly a child dependent, associated with identified \\ndeception. If a pre-existing disorder or disease is present in the other person, the  \\nindividual intentionally aggravates existing symptoms or falsifies or induc es \\nadditional symptoms. The individual seeks treatment for the other person or \\notherwise presents him or her as ill, injured, or impaired based on the feigned, \\nfalsified, or induced signs, symptoms, or injuries. The deceptive behavior is not \\nsolely motivated by obvious external rewards or incentives (e.g., obtaining disabi lity \\npayments or avoiding criminal prosecution for child or elder abuse). \\nNote: The diagnosis of Factitious Disorder Imposed on Another is assigned to the \\nindividual who is feigning, falsifying or inducing the symptoms in another person, not \\nto the person who is presented as having the symptoms. Occasionally the individual \\ninduces or falsifies symptoms in a pet rather than in another person. \\nExclusions: Malingering (QC30) \\n \\n  6D5Z   Factitious disorders, unspecified \\n \\nNeurocognitive disorders (BlockL1‑6D7) \\nNeurocognitive disorders are characterized by primary clinical deficits in c ognitive functioning that are \\nacquired rather than developmental. That is, neurocognitive disorders do not include d isorders \\ncharacterized by deficits in cognitive function that are present from bir th or that arise during the \\ndevelopmental period, which are classified in the grouping neurodevelopmental dis orders. Rather, \\nneurocognitive disorders represent a decline from a previously attained level of functioning. Although \\ncognitive deficits are present in many mental disorders (e.g., schizophrenia, bipol ar disorders), only \\ndisorders whose core features are cognitive are included in the neurocognitive Disorders group ing. In \\ncases where the underlying pathology and etiology for neurocognitive disorders c an be determined, \\nthe identified etiology should be classified separately. \\nCoded Elsewhere: Secondary neurocognitive syndrome (6E67) \\n  6D70   Delirium \\nDelirium is characterized by disturbed attention (i.e., reduced ability to di rect, focus, \\nsustain, and shift attention) and awareness (i.e., reduced orientation to the \\nenvironment) that develops over a short period of time and tends to fluctuate during \\nthe course of a day, accompanied by other cognitive impairment such as memory \\ndeficit, disorientation, or impairment in language, visuospatial ability,  or perception. \\nDisturbance of the sleep-wake cycle (reduced arousal of acute onset or total sleep \\nloss with reversal of the sleep-wake cycle) may also be present. The sympto ms are \\nattributable to a disorder or disease not classified under mental and behavioural \\ndisorders or to substance intoxication or withdrawal or to a medication. \\n \\n6D70.0 Delirium due to disease classified elsewhere \\nAll definitional requirements for delirium are met. There is evidence from  history, \\nphysical examination, or laboratory findings that Delirium is caused by the d irect \\nphysiological consequences of a disorder or disease classified elsewhere. \\nNote: Identified etiology should be classified separately.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 181, 'page_label': '182'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   181 \\n \\n6D70.1 Delirium due to psychoactive substances including medications \\nAll definitional requirements for delirium are met. There is evidence from  history, \\nphysical examination, or laboratory findings that the delirium is caused by the direct \\nphysiological effects of a substance or medication (including withdrawal). If th e \\nspecific substance inducing the delirium has been identified, it should be classified \\nusing the appropriate subcategory (e.g., alcohol-induced delirium). \\nCoded Elsewhere: Alcohol-induced delirium (6C40.5) \\nCannabis-induced delirium (6C41.5) \\nSynthetic cannabinoid-induced delirium (6C42.5) \\nOpioid-induced delirium (6C43.5) \\nSedative, hypnotic or anxiolytic-induced delirium (6C44.5) \\nCocaine-induced delirium (6C45.5) \\nStimulant-induced delirium including amphetamines, \\nmethamphetamine or methcathinone (6C46.5) \\nSynthetic cathinone-induced delirium (6C47.5) \\nHallucinogen-induced delirium (6C49.4) \\nVolatile inhalant-induced delirium (6C4B.5) \\nMDMA or related drug-induced delirium, including MDA \\n(6C4C.5) \\nDissociative drug-induced delirium including ketamine or PCP \\n(6C4D.4) \\nDelirium induced by other specified psychoactive substance \\nincluding medications (6C4E.5) \\nDelirium induced by unknown or unspecified psychoactive \\nsubstance (6C4G.5) \\nDelirium induced by multiple specified psychoactive \\nsubstances including medications (6C4F.5) \\n \\n6D70.2 Delirium due to multiple etiological factors \\nAll definitional requirements for delirium are met. There is evidence from  history, \\nphysical examination, or laboratory findings that the delirium is attributable to \\nmultiple etiological factors, which may include disorders or diseases not classifi ed \\nunder mental and behavioural disorders, substance intoxication or withdrawal, or a \\nmedication. \\nNote: Identified etiologies should be classified separately. \\n \\n6D70.3 Delirium due to unknown or unspecified aetiological factors \\nAll definitional requirements for delirium are met. The specific aetiol ogy of the \\ndelirium is unspecified or cannot be determined.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 182, 'page_label': '183'}, page_content='182  ICD-11 MMS - 2018 \\n \\n  6D71   Mild neurocognitive disorder \\nMild neurocognitive disorder is characterized by the subjective experience of a \\ndecline from a previous level of cognitive functioning, accompanied by objec tive \\nevidence of impairment in performance on one or more cognitive domains relat ive \\nto that expected given the individual ’s age and general level of intellectual \\nfunctioning that is not sufficiently severe to significantly interfere w ith independence \\nin the person ’s performance of activities of daily living. The cognitive impairment  is \\nnot entirely attributable to normal aging. The cognitive impairment may be \\nattributable to an underlying disease of the nervous system, a trauma, an i nfection \\nor other disease process affecting specific areas of the brain, or to chronic use of \\nspecific substances or medications, or the etiology may be undetermined. \\nNote: Code also the underlying condition \\n \\n  6D72   Amnestic disorder \\nAmnestic disorder is characterized by severe memory impairment relative to the  \\nindividual’s age and general level of intellectual functioning that is disproportio nate \\nto impairment in other cognitive domains. It is manifest by a severe deficit in \\nacquiring memories or learning new information or the inability to recall previou sly \\nlearned information, without disturbance of consciousness or generalized cognitive  \\nimpairment. Recent memory is typically more disturbed than remote memory and  \\nimmediate recall is usually preserved. The memory impairment is not attribu table to \\nsubstance intoxication or substance withdrawal, and is presumed to be attributable \\nto an underlying neurological condition, trauma, infection, tumour or other disease \\nprocess affecting specific areas of the brain or to chronic use of specific substances \\nor medications. \\nExclusions: Delirium (6D70) \\nDementia (BlockL2‑6D8) \\nMild neurocognitive disorder (6D71) \\n \\n6D72.0 Amnestic disorder due to diseases classified elsewhere \\nAll definitional requirements for amnestic disorder are met. There is evi dence from \\nhistory, physical examination, or laboratory findings that the disturbance i s caused \\nby the direct physiological consequences of a disorder or disease classified \\nelsewhere. Identified etiology should be classified separately. \\nExclusions: amnesia: retrograde (MB21.11) \\nKorsakoff syndrome, alcohol-induced or unspecified (8D44) \\nDissociative amnesia (6B61) \\nAnterograde amnesia (MB21.10) \\namnesia NOS (MB21.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 183, 'page_label': '184'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   183 \\n \\n6D72.1 Amnestic disorder due to psychoactive substances including medications  \\nAll definitional requirements for amnestic disorder are met, and memory im pairment \\npersists beyond the usual duration of substance intoxication or withdrawal. T here is \\nevidence from history, physical examination, or laboratory findings that the \\ndisturbance is caused by the direct physiologic consequences of use of a substan ce \\nor medication. If the specific substance inducing the amnestic disorder has been \\nidentified, it should be classified using the appropriate subcategory (e.g., amne stic \\ndisorder use of alcohol). \\n \\n6D72.10 Amnestic disorder due to use of alcohol \\nAmnestic disorder due to alcohol use is characterized by the development of \\namnestic symptoms that share primary clinical features with Amnestic disorder, bu t \\nwhich are judged to be the direct consequence of alcohol use. Symptoms of \\namnestic disorder due to alcohol use develop during or soon after substance \\nintoxication or withdrawal but their intensity and duration are substantially i n excess \\nof disturbances of memory normally associated with these conditions. The i ntensity \\nand duration of alcohol use must be known to be capable of producing memor y \\nimpairment. The symptoms are not better accounted for by Amnestic Disorder, as \\nmight be the case if the amnestic symptoms preceded the onset of the substanc e \\nuse or if the symptoms persist for a substantial period of time after cessation of \\nsubstance use. \\nNote: This category should not be used to describe cognitive changes due to thiamine \\ndeficiency associated with chronic alcohol use. \\nExclusions: Korsakoff syndrome (5B5A.11) \\nWernicke-Korsakoff Syndrome (5B5A.1) \\n \\n6D72.11 Amnestic disorder due to use of sedatives, hypnotics or anxiolytics \\nAmnestic disorder due to use of sedatives, hypnotics or anxiolytics is characteriz ed \\nby the development of a syndrome of memory impairment with specific features  of \\namnestic disorder that is judged to be the direct consequence of sedative, hyp notic, \\nor anxiolytic use that persists beyond the usual duration of sedative, hypnotic  or \\nanxiolytic intoxication or withdrawal. The amount and duration of sedative, h ypnotic, \\nor anxiolytic use must be sufficient to be capable of producing memory impair ment. \\nMoreover, the memory impairment is not better accounted for by a disorder that is \\nnot due to use of sedatives, hypnotics, or anxiolytics, such as a dementia or \\namnestic disorder due to causes other than substances including medications. \\nNote: Code also the underlying condition \\n \\n6D72.12 Amnestic disorder due to other specified psychoactive substance including \\nmedications \\nAmnestic disorder due to other specified psychoactive substance including \\nmedications is characterized by the development of a syndrome of memory \\nimpairment with specific features of amnestic disorder that is judged to be the direct \\nconsequence of use of a specified psychoactive substance that persists beyond the \\nusual duration of intoxication with or withdrawal from that substance. The am ount \\nand duration of the specified substance use must be sufficient to be capable of \\nproducing memory impairment. Moreover, the memory impairment is not better \\naccounted for by a disorder that is not due to use of the specified psychoactive \\nsubstance, such as a Dementia or Amnestic disorder due to causes other than \\nsubstances including medications.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 184, 'page_label': '185'}, page_content='184  ICD-11 MMS - 2018 \\n \\n6D72.13 Amnestic disorder due to use of volatile inhalants \\nAmnestic disorder due to use of volatile inhalants is characterized by the \\ndevelopment of a syndrome of memory impairment with specific features of \\namnestic disorder that is judged to be the direct consequence of volatile inhalant \\nuse that persists beyond the usual duration of volatile inhalant intoxication  or \\nwithdrawal. The amount and duration of volatile inhalant use must be sufficient to be \\ncapable of producing memory impairment. Moreover, the memory impairment is no t \\nbetter accounted for by a disorder that is not due to use of volatile inhalants, s uch \\nas a dementia or amnestic disorder due to causes other than substances including \\nmedications. \\n \\n6D72.2 Amnestic disorder due to unknown or unspecified aetiological factors  \\nAll definitional requirements for amnestic disorder are met. The specific  etiology of \\nthe disorder is unspecified or cannot be determined. \\n \\n6D72.Y Other specified amnestic disorder \\n \\n6D72.Z Amnestic disorder, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 185, 'page_label': '186'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   185 \\n \\nDementia (BlockL2‑6D8) \\nDementia is an acquired brain syndrome characterized by a decline from a previ ous level of cognitive \\nfunctioning with impairment in two or more cognitive domains (such as memor y, executive functions, \\nattention, language, social cognition and judgment, psychomotor speed, visuoperc eptual or \\nvisuospatial abilities). The cognitive impairment is not entirely attri butable to normal aging and \\nsignificantly interferes with independence in the person ’s performance of activities of daily living. \\nBased on available evidence, the cognitive impairment is attributed or assumed  to be attributable to a \\nneurological or medical condition that affects the brain, trauma, nutritional def iciency, chronic use of \\nspecific substances or medications, or exposure to heavy metals or other toxins. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\nInclusions: Dementia NOS \\nExclusions: Coma (MB20.1) \\nDelirium (6D70) \\nDisorders of intellectual development (6A00) \\nNeurodevelopmental disorders (BlockL1‑6A0) \\nStupor (MB20.0) \\nOld age (senility) (MG2A) \\n  6D80   Dementia due to Alzheimer disease \\nDementia due to Alzheimer disease is the most common form of dementia. Onset is \\ninsidious with memory impairment typically reported as the initial presenti ng \\ncomplaint. The characteristic course is a slow but steady decline f rom a previous \\nlevel of cognitive functioning with impairment in additional cognitive dom ains (such \\nas executive functions, attention, language, social cognition and judgment, \\npsychomotor speed, visuoperceptual or visuospatial abilities) emerging with di sease \\nprogression. Dementia due to Alzheimer disease is often accompanied by mental \\nand behavioural symptoms such as depressed mood and apathy in the initial stag es \\nof the disease and may be accompanied by psychotic symptoms, irritabil ity, \\naggression, confusion, abnormalities of gait and mobility, and seizures at la ter \\nstages. Positive genetic testing, family history and gradual cognitive dec line are \\nhighly suggestive of Dementia due to Alzheimer disease. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 186, 'page_label': '187'}, page_content='186  ICD-11 MMS - 2018 \\n \\n6D80.0 Dementia due to Alzheimer disease with early onset \\nDementia due to Alzheimer disease in which symptoms emerge before the age of \\n65 years. It is relatively rare, representing less than 5% of all cases, and may be \\ngenetically determined (autosomal dominant Alzheimer disease). Clinical \\npresentation may be similar to cases with later onset, but a significant proportio n of \\ncases manifest atypical symptoms, with relatively less severe memory deficits. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D80.1 Dementia due to Alzheimer disease with late onset \\nDementia due to Alzheimer disease that develops at the age of 65 years or above. \\nThis is the most common pattern, representing more than 95% of all cases. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D80.2 Alzheimer disease dementia, mixed type, with cerebrovascular disease  \\nDementia due to Alzheimer disease and concomitant cerebrovascular disease. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D80.3 Alzheimer disease dementia, mixed type, with other nonvascular aetiologies  \\nDementia due to Alzheimer disease with other concomitant pathology, not includ ing \\ncerebrovascular disease. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D80.Z Dementia due to Alzheimer disease, onset unknown or unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 187, 'page_label': '188'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   187 \\n \\n  6D81   Vascular dementia \\nVascular dementia is due to significant brain parenchyma injury resulting from  \\ncerebrovascular disease (ischemic or haemorrhagic). The onset of the cognitive \\ndeficits is temporally related to one or more vascular events. Cognitive decline is \\ntypically most prominent in speed of information processing, complex attention, and \\nfrontal-executive functioning. There is evidence of the presence of cerebrovascular \\ndisease considered to be sufficient to account for the neurocognitive deficits from  \\nhistory, physical examination and neuroimaging. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nExclusions: Alzheimer disease dementia, mixed type, with cerebrovascular \\ndisease (6D80.2) \\n \\n  6D82   Dementia due to Lewy body disease \\nDementia due to Lewy body disease is the second most common form of dementia \\nin the elderly after Alzheimer disease. The precise etiology is unknown but  involves \\nabnormal alpha-synuclein protein folding and aggregation with Lewy body form ation \\nprimarily in the cortex and brainstem. Onset is insidious with attentional and \\nexecutive functioning deficits typically reported as the initial presenting c omplaint. \\nThese cognitive deficits are often accompanied by visual hallucinations and  \\nsymptoms of REM sleep behaviour disorder. Hallucinations in other sensor y \\nmodalities, depressive symptoms, and delusions may also be present. The \\nsymptom presentation usually varies significantly over the course of days \\nnecessitating longitudinal assessment and differentiation from Delirium. \\nSpontaneous onset of Parkinsonism within approximately 1 year of the onset of \\ncognitive symptoms is characteristic of the disease. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n  6D83   Frontotemporal dementia \\nFrontotemporal dementia (FTD) is a group of primary neurodegenerative disorders \\nprimarily affecting the frontal and temporal lobes. Onset is typically insidi ous with a \\ngradual and worsening course. Several syndromic variants (some with an identi fied \\ngenetic basis or familiality) are described that include presentations with \\npredominantly marked personality and behavioral changes (such as executive \\ndysfunction, apathy, deterioration of social cognition, repetitive behaviours, a nd \\ndietary changes) or with predominantly language deficits (that include semanti c, \\nagrammatic/nonfluent, and logopenic forms), or with a combination of these defici ts. \\nMemory function, psychomotor speed, as well as visuoperceptual and visuospatial  \\nabilities often remain relatively intact, particularly during the early stag es of the \\ndisorder. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 188, 'page_label': '189'}, page_content='188  ICD-11 MMS - 2018 \\n \\n  6D84   Dementia due to psychoactive substances including medications \\nDementia due to psychoactive substances including medications includes forms of  \\ndementia that are judged to be a direct consequence of substance use and that \\npersist beyond the usual duration of action or withdrawal syndrome associated with \\nthe substance. The amount and duration of substance use must be sufficient to \\nproduce the cognitive impairment. The cognitive impairment is not better accou nted \\nfor by a disorder that is not induced by substances such as a dementia due to \\nanother medical condition. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\nExclusions: Dementia due to exposure to heavy metals and other toxins \\n(6D85.2) \\n \\n6D84.0 Dementia due to use of alcohol \\nDementia due to use of alcohol is characterized by the development of persistent \\ncognitive impairments (e.g., memory problems, language impairment, and an \\ninability to perform complex motor tasks) that meet the definitional requir ements of \\nDementia that are judged to be a direct consequence of alcohol use and that persist \\nbeyond the usual duration of alcohol intoxication or acute withdrawal. The inten sity \\nand duration of alcohol use must have been sufficient to produce the cognitive \\nimpairment. The cognitive impairment is not better accounted for by a disorder  or \\ndisease that is not induced by alcohol such as a dementia due to another d isorder \\nor disease classified elsewhere. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply.  \\nThis category should not be used to describe cognitive changes due to thiamine \\ndeficiency associated with chronic alcohol use. \\nInclusions: Alcohol-induced dementia \\nExclusions: Wernicke-Korsakoff Syndrome (5B5A.1) \\nKorsakoff syndrome (5B5A.11)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 189, 'page_label': '190'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   189 \\n \\n6D84.1 Dementia due to use of sedatives, hypnotics or anxiolytics \\nDementia due to use of sedatives, hypnotics or anxiolytics is characterized by  the \\ndevelopment of persistent cognitive impairments (e.g., memory problems, language \\nimpairment, and an inability to perform complex motor tasks) that meet the \\ndefinitional requirements of Dementia that are judged to be a direct consequence of \\nsedative, hypnotic, or anxiolytic use and that persist beyond the usual dur ation of \\naction or withdrawal syndrome associated with the substance. The amount and \\nduration of sedative, hypnotic, or anxiolytic use must be sufficient to produce the  \\ncognitive impairment. The cognitive impairment is not better accounted for b y a \\ndisorder that is not induced by sedatives, hypnotics, or anxiolytics such as  a \\ndementia due to another medical condition. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\nInclusions: Late-onset psychoactive substance-induced psychotic disorder \\nPosthallucinogen perception disorder \\n \\n6D84.2 Dementia due to use of volatile inhalants \\nDementia due to use of volatile inhalants is characterized by the development of \\npersistent cognitive impairments (e.g., memory problems, language impairmen t, \\nand an inability to perform complex motor tasks) that meet the definitional \\nrequirements of Dementia that are judged to be a direct consequence of inhalant \\nuse or exposure and that persist beyond the usual duration of action or withdrawal \\nsyndrome associated with the substance. The amount and duration of inhalant us e \\nor exposure must be sufficient to be capable of producing the cognitive impairment.  \\nThe cognitive impairment is not better accounted for by a disorder that is not \\ninduced by volatile inhalants such as a dementia due to another medical condition. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D84.Y Dementia due to other specified psychoactive substance \\nNote: Code also the underlying condition \\n \\n  6D85   Dementia due to diseases classified elsewhere \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 190, 'page_label': '191'}, page_content='190  ICD-11 MMS - 2018 \\n \\n6D85.0 Dementia due to Parkinson disease \\nDementia due to Parkinson disease develops among individuals with idiopathi c \\nParkinson disease and is characterized by impairment in attention, memory, \\nexecutive and visuo-spatial functions as well as behavioral and psychiatr ic \\nsymptoms such as changes in affect, apathy and hallucinations. Onset is insid ious \\nand the course is one of gradual worsening of symptoms. The primary pathologic al \\ncorrelate is Lewy Body-type degeneration predominantly in the basal ganglia rather \\nthan in the cortex as is typical of Dementia due to Lewy body disease. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D85.1 Dementia due to Huntington disease \\nDementia due to Huntington disease occurs as part of a widespread degeneration \\nof the brain due to a trinucleotide repeat expansion in the HTT gene, which is \\ntransmitted through autosomal dominance. Onset of symptoms is insidious typi cally \\nin the third and fourth decade of life with gradual and slow progression. Initial  \\nsymptoms typically include impairments in executive functions with relative sparing \\nof memory, prior to the onset of motor deficits (bradykinesia and chorea) \\ncharacteristic of Huntington disease. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\nInclusions: Dementia in Huntington chor ea \\n \\n6D85.2 Dementia due to exposure to heavy metals and other toxins \\nDementia due to exposure to heavy metals and other toxins caused by toxic \\nexposure to specific heavy metals such as aluminum from dialysis water, lea d, \\nmercury or manganese. The characteristic cognitive impairments in Dementia d ue \\nto exposure to heavy metals and other toxins depend on the specific heavy metal or \\ntoxin that the individual has been exposed to but can affect all cognitive domai ns. \\nOnset of symptoms is related to exposure and progression can be rapid especially  \\nwith acute exposure. In many cases, symptoms are reversible when exposure is \\nidentified and ceases. Investigations such as brain imaging or neurophysiologic al \\ntesting may be abnormal. Lead poisoning is associated with abnormalities on brai n \\nimaging including widespread calcification and increased signal on MRI T 2-\\nweighted images of periventricular white matter, basal ganglia hypothalamus and \\npons. Dementia due to aluminum toxicity may demonstrate characteristic \\nparoxysmal high-voltage delta EEG changes. Examination may make evident other \\nfeatures such as peripheral neuropathy in the case of lead, arsenic, or mercury. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\nExclusions: Dementia due to psychoactive substances including \\nmedications (6D84)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 191, 'page_label': '192'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   191 \\n \\n6D85.3 Dementia due to human immunodeficiency virus \\nDementia due to human immunodeficiency virus develops during the course o f \\nconfirmed HIV disease, in the absence of a concurrent illness or conditi on other \\nthan HIV infection that could explain the clinical features. Although a variety of \\npatterns of cognitive deficit are possible depending on where the HIV pathoge nic \\nprocesses have occurred, typically deficits follow a subcortical pattern with \\nimpairments in executive function, processing speed, attention, and learning new \\ninformation. The course of Dementia due to human immunodeficiency virus varies \\nincluding resolution of symptoms, gradual decline in functioning, improvement, or \\nfluctuation in symptoms. Rapid decline in cognitive functioning is rare with the  \\nadvent of antiretroviral medications. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D85.4 Dementia due to multiple sclerosis \\nDementia due to multiple sclerosis is a neurodegenerative disease due to the  \\ncerebral effects of multiple sclerosis, a demyelinating disease. Onset of symptom s \\nis insidious and not related to the progression or functional impairment attributabl e \\nto the primary disease (i.e., multiple sclerosis). Cognitive impairments vary \\naccording to the location of demyelination but typically include deficits in processing \\nspeed, memory, attention, and aspects of executive functioning. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D85.5 Dementia due to prion disease \\nDementia due to prion disease is a primary neurodegenerative disease caused by a  \\ngroup of spongiform encephalopathies resulting from abnormal prion protei n \\naccumulation in the brain. These can be sporadic, genetic (caused by mutations  in \\nthe prion-protein gene), or transmissible (acquired from an infected individu al). \\nOnset is insidious and there is a rapid progression of symptoms and impair ment \\ncharacterized by cognitive deficits, ataxia, and motor symptoms (myoclonus , \\nchorea, or dystonia). Diagnosis is typically made on the basis of brain  imaging \\nstudies, presence of characteristic proteins in spinal fluid, EEG, or genetic testing. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 192, 'page_label': '193'}, page_content='192  ICD-11 MMS - 2018 \\n \\n6D85.6 Dementia due to normal pressure hydrocephalus \\nDementia due to normal pressure hydrocephalus results from excess accumulation \\nof cerebrospinal fluid in the brain as a result of idiopathic, non-obstructive causes  \\nbut can also be secondary to haemorrhage, infection or inflammation. Progression \\nis gradual but intervention (e.g., shunt) can result in significant improvement of \\nsymptoms. Typically, cognitive impairments include reduced processing s peed, \\ndeficits in executive functioning and attention, as well as personality chan ges. \\nThese symptoms are also typically accompanied by gait abnormalities and urinar y \\nincontinence. Brain imaging to reveal ventricular volume and brain displacement is  \\noften necessary to confirm the diagnosis. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D85.7 Dementia due to injury to the head \\nDementia due to injury to the head is caused by damage inflicted on the tis sues of \\nthe brain as the direct or indirect result of an external force. Trauma to the brain is \\nknown to have resulted in loss of consciousness, amnesia, disorientation and \\nconfusion, or neurological signs. The symptoms characteristic of Dementia due to \\ninjury to the head must arise immediately following the trauma or after the individ ual \\ngains consciousness and must persist beyond the acute post-injury period. \\nCognitive deficits vary depending on the specific brain areas affected and the \\nseverity of the injury but can include impairments in attention, memory, execut ive \\nfunctioning, personality, processing speed, social cognition, and language abilities. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D85.8 Dementia due to pellagra \\nDementia due to pellagra is caused by persistent lack of vitamin B3 (niacin) or \\ntryptophan either in the diet or due to poor absorption in the gastrointestinal tract \\ndue to disease (e.g., Crohn disease) or due to the effects of some medications \\n(e.g., isoniazid). Core signs of pellagra include dermatological changes (sens itivity \\nto sunlight, lesions, alopecia, and edema) and diarrheoa. With prolonged nutritional \\ndeficiency cognitive symptoms that include aggressivity, motor disturbanc es (ataxia \\nand restlessness), confusion, and weakness are observed. Treatment with \\nnutritional supplementation (e.g., niacin) typically results in reversal of symptoms.  \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 193, 'page_label': '194'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   193 \\n \\n6D85.9 Dementia due to Down syndrome \\nDementia due to Down syndrome is a neurodegenerative disorder related to the \\nimpact of abnormal increased production and accumulation of amyloid precursor \\nprotein (APP) leading to formation of beta-amyloid plaques and tau tangles. APP \\ngene expression is increased due to its location on chromosome 21, which is \\nabnormally triplicated in Down syndrome. Cognitive deficits and neuropathologi cal \\nfeatures are similar to those observed in Alzheimer disease. Onset is typical ly after \\nthe fourth decade of life with a gradual decline in functioning. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply. \\n \\n6D85.Y Dementia due to other specified diseases classified elsewhere \\nNote: Code also the underlying condition \\n \\n  6D86   Behavioural or psychological disturbances in dementia \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant behavioral or psycholog ical \\ndisturbances. \\nNote: These categories should never be used in primary tabulation. The codes are \\nprovided for use as supplementary or additional codes when it is desired to identify \\nthe presence of behavioural or psychological disturbance in dementia. \\nCode all that apply. \\nExclusions: Secondary mental or behavioural syndromes associated wit h \\ndisorders or diseases classified elsewhere \\n(BlockL1‑6E6) \\n \\n6D86.0 Psychotic symptoms in dementia \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant delusions or hallucinations. \\nExclusions: Schizophrenia or other primary psychotic disorders  \\n(BlockL1‑6A2) \\nSecondary psychotic syndrome (6E61) \\n \\n6D86.1 Mood symptoms in dementia \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant mood symptoms such as depressed \\nmood, elevated mood, or irritable mood. \\nExclusions: Mood disorders  (BlockL1‑6A6) \\nSecondary mood syndrome (6E62)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 194, 'page_label': '195'}, page_content='194  ICD-11 MMS - 2018 \\n \\n6D86.2 Anxiety symptoms in dementia \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant symptoms of anxiety or worry. \\nExclusions: Anxiety or fear-related disorders  (BlockL1‑6B0) \\nSecondary anxiety syndrome (6E63) \\n \\n6D86.3 Apathy in dementia \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant indifference or lack of interest. \\nExclusions: Mood disorders  (BlockL1‑6A6) \\nSecondary mood syndrome (6E62) \\n \\n6D86.4 Agitation or aggression in dementia \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes: 1) clinically significant excessive psychom otor activity \\naccompanied by increased tension; or 2) hostile or violent behaviour. \\n \\n6D86.5 Disinhibition in dementia \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant lack of restraint m anifested in disregard \\nfor social conventions, impulsivity, and poor risk assessment. \\n \\n6D86.6 Wandering in dementia \\nIn addition to the cognitive disturbances characteristic of dementia, the current \\nclinical picture includes clinically significant wandering that put the pe rson at risk of \\nharm. \\n \\n6D86.Y Other specified behavioural or psychological disturbances in dementia  \\nNote: Code also the underlying condition \\n \\n6D86.Z Behavioural or psychological disturbances in dementia, unspecified  \\nNote: Code also the underlying condition \\n \\n  6D8Z   Dementia, unknown or unspecified cause \\nNote: Code also the underlying condition \\n \\n  6E0Y   Other specified neurocognitive disorders \\n \\n  6E0Z   Neurocognitive disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 195, 'page_label': '196'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   195 \\n \\nMental or behavioural disorders associated with pregnancy, childbirth and the \\npuerperium (BlockL1‑6E2) \\nSyndromes associated with pregnancy or the puerperium (commencing within about 6 week s after \\ndelivery) that involve significant mental and behavioural features. If the symptoms meet the diagnostic \\nrequirements for a specific mental disorder, that diagnosis should also be assigned. \\nCoded Elsewhere: Psychological disorder related to obstetric fistula (GC04.1Y) \\n  6E20   Mental or behavioural disorders associated with pregnancy, childbirth \\nand the puerperium, without psychotic symptoms \\nA syndrome associated with pregnancy or the puerperium (commencing within \\nabout 6 weeks after delivery) that involves significant mental and behavioural \\nfeatures, most commonly depressive symptoms. The syndrome does not include \\ndelusions, hallucinations, or other psychotic symptoms. If the symptoms mee t the \\ndiagnostic requirements for a specific mental disorder, that diagnosis shoul d also be \\nassigned. This designation should not be used to describe mild and transien t \\ndepressive symptoms that do not meet the diagnostic requirements for a depressive \\nepisode, which may occur soon after delivery (so-called postpartum blues). \\nNote: Code also the underlying condition \\n \\n6E20.0 Postpartum depression NOS \\n \\n6E20.Y Other specified mental or behavioural disorders associated with pregnancy, \\nchildbirth and the puerperium, without psychotic symptoms \\nNote: Code also the underlying condition \\n \\n6E20.Z Mental or behavioural disorders associated with pregnancy, childbirth and the \\npuerperium, without psychotic symptoms, unspecified \\nNote: Code also the underlying condition \\n \\n  6E21   Mental or behavioural disorders associated with pregnancy, childbirth \\nor the puerperium, with psychotic symptoms \\nA syndrome associated with pregnancy or the puerperium (commencing within \\nabout 6 weeks after delivery) that involves significant mental and behavioural \\nfeatures, including delusions, hallucinations, or other psychotic symptoms. Mood \\nsymptoms (depressive and/or manic) are also typically present. If the symptom s \\nmeet the diagnostic requirements for a specific mental disorder, that diagnosi s \\nshould also be assigned. \\nNote: Code also the underlying condition \\n \\n  6E2Z   Mental or behavioural disorders associated with pregnancy, childbirth \\nand the puerperium, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 196, 'page_label': '197'}, page_content='196  ICD-11 MMS - 2018 \\n \\n  6E40   Psychological or behavioural factors affecting disorders or diseases \\nclassified elsewhere \\nPsychological and behavioural factors affecting disorders or diseases classifi ed \\nelsewhere are those that may adversely affect the manifestation, treatment, or \\ncourse of a condition classified in another chapter of the ICD. These factors may \\nadversely affect the manifestation, treatment, or course of the disorder or disease \\nclassified in another chapter by: interfering with the treatment of the disorder or \\ndisease by affecting treatment adherence or care seeking; constituting an additional  \\nhealth risk; or influencing the underlying pathophysiology to precipitate or \\nexacerbate symptoms or otherwise necessitate medical attention. This diagnosis \\nshould be assigned only when the factors increase the risk of suffering, disability , or \\ndeath and represent a focus of clinical attention, and should be assigned tog ether \\nwith the diagnosis for the relevant other condition. \\nNote: Code also the underlying condition \\nInclusions: Psychological factors affecting physical conditions \\nExclusions: Tension-type headache (8A81) \\nMental or behavioural disorders associated with pregnancy, \\nchildbirth and the puerperium (BlockL1‑6E2) \\n \\n6E40.0 Mental disorder affecting disorders or diseases classified elsewhere  \\nAll diagnostic requirements for Psychological or behavioural factors affecting  \\ndisorders or diseases classified elsewhere are met. The individual is diagnosed with \\na mental, behavioural, or neurodevelopmental disorder that adversely affects the \\nmanifestation, treatment, or course of a disorder or disease classified in another \\nchapter. \\n \\n6E40.1 Psychological symptoms affecting disorders or diseases classified elsewhere  \\nAll diagnostic requirements for Psychological or behavioural factors affecting  \\ndisorders or diseases classified elsewhere are met. The individual exhibits \\npsychological symptoms that do not meet the diagnostic requirements for a mental, \\nbehavioural, or neurodevelopmental disorder that adversely affect the \\nmanifestation, treatment, or course of a disorder or disease classified in another \\nchapter. \\n \\n6E40.2 Personality traits or coping style affecting disorders or diseases classified \\nelsewhere \\nAll diagnostic requirements for Psychological or behavioural factors affecting  \\ndisorders or diseases classified elsewhere are met. The individual exhibits \\npersonality traits or coping styles that do not meet the diagnostic requirem ents for a \\nmental, behavioural, or neurodevelopmental disorder that adversely affect the \\nmanifestation, treatment, or course of a disorder or disease classified in another \\nchapter.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 197, 'page_label': '198'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   197 \\n \\n6E40.3 Maladaptive health behaviours affecting disorders or diseases classified \\nelsewhere \\nAll diagnostic requirements for Psychological or behavioural factors affecting  \\ndisorders or diseases classified elsewhere are met. The individual exhibits \\nmaladaptive health behaviours that adversely affect the manifestation, treatment, or \\ncourse of a disorder or disease classified in another chapter (e.g., overe ating, lack \\nof exercise). \\n \\n6E40.4 Stress-related physiological response affecting disorders or diseases \\nclassified elsewhere \\nAll diagnostic requirements for Psychological or behavioural factors affecting  \\ndisorders or diseases classified elsewhere are met. The individual exhibits stress -\\nrelated physiological responses that adversely affect the manifestation, treatment,  \\nor course of a disorder or disease classified in another chapter (e.g., stress-rela ted \\nexacerbation of ulcer, hypertension, arrhythmia, or tension headache). \\n \\n6E40.Y Other specified psychological or behavioural factors affecting disorders or \\ndiseases classified elsewhere \\nNote: Code also the underlying condition \\n \\n6E40.Z Psychological or behavioural factors affecting disorders or diseases \\nclassified elsewhere, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 198, 'page_label': '199'}, page_content='198  ICD-11 MMS - 2018 \\n \\nSecondary mental or behavioural syndromes associated with disorders or diseases \\nclassified elsewhere (BlockL1‑6E6) \\nThis grouping includes syndromes characterized by the presence of prominent psychologic al or \\nbehavioural symptoms judged to be direct pathophysiological consequences  of a health condition not \\nclassified under mental and behavioural disorders, based on evidence from the hi story, physical \\nexamination, or laboratory findings. The symptoms are not accounted for by deliri um or by another \\nmental and behavioural disorder, and are not a psychologically mediated response to a severe \\nmedical condition (e.g., adjustment disorder or anxiety symptoms in response to b eing diagnosed with \\na life-threatening illness). These categories should be used in addition to the diagnosis for the \\npresumed underlying disorder or disease when the psychological and behavioural s ymptoms are \\nsufficiently severe to warrant specific clinical attention. \\nCoded Elsewhere: Delirium due to disease classified elsewhere (6D70.0) \\n  6E60   Secondary neurodevelopmental syndrome \\nA syndrome that involves significant neurodevelopmental features that do not fulfi ll \\nthe diagnostic requirements of any of the specific neurodevelopmental disorders  \\nthat is judged to be a direct pathophysiological consequence of a health condit ion \\nnot classified under mental and behavioural disorders (e.g., autistic-like f eatures in \\nRetts syndrome; aggression and self-mutilation in Lesch-Nyhan syndrome, \\nabnormalities in language development in Williams syndrome), based on evide nce \\nfrom the history, physical examination, or laboratory findings.  \\nThis category should be used in addition to the diagnosis for the presumed \\nunderlying disorder or disease when the neurodevelopmental problems are \\nsufficiently severe to warrant specific clinical attention. \\nNote: Code also the underlying condition \\n \\n6E60.0 Secondary speech or language syndrome \\nA syndrome that involves significant features related to speech or language \\ndevelopment that do not fulfill the diagnostic requirements of any of the s pecific \\ndevelopmental speech or language disorders that is judged to be a direct \\npathophysiological consequence of a health condition not classified under m ental \\nand behavioural disorders, based on evidence from the history, physical \\nexamination, or laboratory findings. Possible etiologies include a diseas e of the \\nnervous system, sensory impairment, brain injury or infection. \\nNote: This diagnosis should be assigned in addition to the diagnosis for the presumed \\nunderlying disorder or disease when the neurodevelopmental problems are \\nsufficiently severe to warrant specific clinical attention. \\n \\n6E60.Y Other specified secondary neurodevelopmental syndrome \\nNote: Code also the underlying condition \\n \\n6E60.Z Secondary neurodevelopmental syndrome, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 199, 'page_label': '200'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   199 \\n \\n  6E61   Secondary psychotic syndrome \\nA syndrome characterized by the presence of prominent hallucinations or delusions \\njudged to be a direct pathophysiological consequence of a health condition n ot \\nclassified under mental and behavioural disorders, based on evidence from the \\nhistory, physical examination, or laboratory findings. The symptoms are not \\naccounted for by delirium or by another mental and behavioural disorder, and are \\nnot a psychologically mediated response to a severe medical condition (e. g., an \\nacute stress reaction in response to a life-threatening diagnosis). This categor y \\nshould be used in addition to the diagnosis for the presumed underlying disorder  or \\ndisease when the psychotic symptoms are sufficiently severe to warrant specifi c \\nclinical attention. \\nNote: Code also the underlying condition \\nExclusions: Acute and transient psychotic disorder (6A23) \\nDelirium (6D70) \\nMood disorders (BlockL1‑6A6) \\n \\n6E61.0 Secondary psychotic syndrome, with hallucinations \\nA syndrome characterized by the presence of prominent hallucinations that is \\njudged to be a direct pathophysiological consequence of a health condition n ot \\nclassified under mental and behavioural disorders, based on evidence from the \\nhistory, physical examination, or laboratory findings. Delusions are not a prominent  \\naspect of the clinical presentation. The symptoms are not accounted for by deli rium \\nor by another mental and behavioural disorder, and are not a psychologically \\nmediated response to a severe medical condition (e.g., an acute stress reaction in \\nresponse to a life-threatening diagnosis). This category should be used in additi on \\nthe diagnosis for the presumed underlying disorder or disease when the psychoti c \\nsymptoms are sufficiently severe to warrant specific clinical attention. \\nNote: Code also the underlying condition \\nExclusions: Delirium (6D70) \\nMood disorders (BlockL1‑6A6) \\n \\n6E61.1 Secondary psychotic syndrome, with delusions \\nA syndrome characterized by the presence of prominent delusions that is judged to \\nbe a direct pathophysiological consequence of a health condition not classi fied \\nunder mental and behavioural disorders, based on evidence from the history, \\nphysical examination, or laboratory findings. Hallucinations are not a prominent \\naspect of the clinical presentation. The symptoms are not accounted for by deli rium \\nor by another mental and behavioural disorder, and are not a psychologically \\nmediated response to a severe medical condition (e.g., an acute stress reaction in \\nresponse to a life-threatening diagnosis). This category should be used in additi on \\nthe diagnosis for the presumed underlying disorder or disease when the psychoti c \\nsymptoms are sufficiently severe to warrant specific clinical attention. \\nNote: Code also the underlying condition \\nExclusions: Delirium (6D70) \\nMood disorders (BlockL1‑6A6)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 200, 'page_label': '201'}, page_content='200  ICD-11 MMS - 2018 \\n \\n6E61.2 Secondary psychotic syndrome, with hallucinations and delusions  \\nA syndrome characterized by the presence of both prominent hallucinations and \\nprominent delusions that is judged to be a direct pathophysiological consequence of \\na health condition not classified under mental and behavioural disorders, based on  \\nevidence from the history, physical examination, or laboratory findings. T he \\nsymptoms are not accounted for by delirium or by another mental and behavioural \\ndisorder, and are not a psychologically mediated response to a severe medical \\ncondition (e.g., an acute stress reaction in response to a life-threatening diagnosi s). \\nThis category should be used in addition the diagnosis for the presumed underlyi ng \\ndisorder or disease when the psychotic symptoms are sufficiently severe to warrant  \\nspecific clinical attention. \\nNote: Code also the underlying condition \\nExclusions: Delirium (6D70) \\nMood disorders (BlockL1‑6A6) \\n \\n6E61.3 Secondary psychotic syndrome, with unspecified symptoms \\nNote: Code also the underlying condition \\n \\n  6E62   Secondary mood syndrome \\nA syndrome characterized by the presence of prominent mood symptoms (i.e., \\ndepression, elevated mood, irritability) judged to be a direct pathophysiologi cal \\nconsequence of a health condition not classified under mental and behavioural \\ndisorders, based on evidence from the history, physical examination, or laborat ory \\nfindings. The symptoms are not accounted for by delirium or by another mental a nd \\nbehavioural disorder, and are not a psychologically mediated response to a severe \\nmedical condition (e.g., depressive symptoms in response to a life-threateni ng \\ndiagnosis). This category should be used in addition to the diagnosis f or the \\npresumed underlying disorder or disease when the mood symptoms are sufficiently \\nsevere to warrant specific clinical attention. \\nNote: Code also the underlying condition \\nExclusions: Adjustment disorder (6B43) \\nDelirium (6D70)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 201, 'page_label': '202'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   201 \\n \\n6E62.0 Secondary mood syndrome, with depressive symptoms \\nA syndrome characterized by the presence of prominent depressive symptoms such \\nas persistently depressed mood, loss of interest in previously enjoyable activities, or \\nsigns such as tearful and downtrodden appearance that is judged to be a direct \\npathophysiological consequence of a health condition not classified under m ental \\nand behavioural disorders based on evidence from the history, physical \\nexamination, or laboratory findings. The symptoms are not accounted for by \\ndelirium or by another mental and behavioural disorder, and are not a \\npsychologically mediated response to a severe medical condition (e.g., d epressive \\nsymptoms in response to a life-threatening diagnosis). This category should be \\nused in addition to the diagnosis for the presumed underlying disorder or disease \\nwhen the mood symptoms are sufficiently severe to warrant specific clinical \\nattention. \\nNote: Code also the underlying condition \\nExclusions: Adjustment disorder (6B43) \\nDelirium (6D70) \\n \\n6E62.1 Secondary mood syndrome, with manic symptoms \\nA syndrome characterized by the presence of prominent manic symptoms such as \\nelevated, euphoric, irritable, or expansive mood states, rapid changes among \\ndifferent mood states (i.e., mood lability), or increased energy or activity that  is \\njudged to be a direct pathophysiological consequence of a health condition n ot \\nclassified under mental and behavioural disorders based on evidence from the \\nhistory, physical examination, or laboratory findings. \\nNote: Code also the underlying condition \\nInclusions: mood syndrome due to disorders or diseases not classified \\nunder Mental and behavioural disorders, with manic \\nsymptoms \\nExclusions: Adjustment disorder (6B43) \\nDelirium (6D70)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 202, 'page_label': '203'}, page_content='202  ICD-11 MMS - 2018 \\n \\n6E62.2 Secondary mood syndrome, with mixed symptoms \\nA syndrome characterized by the presence of both manic and depressive \\nsymptoms, either occurring together or alternating from day to day or over the \\ncourse of a day that is judged to be a direct pathophysiological conse quence of a \\nhealth condition not classified under mental and behavioural disorders based on \\nevidence from the history, physical examination, or laboratory findings. Mani c \\nsymptoms may include elevated, euphoric, irritable, or expansive mood states, rapid \\nchanges among different mood states (i.e., mood lability), or increased energy or \\nactivity. Depressive symptoms may include persistently depressed mood, l oss of \\ninterest in previously enjoyable activities, or signs such as tearful or  downtrodden \\nappearance. The symptoms are not accounted for by delirium or by another mental \\nand behavioural disorder, and are not a psychologically mediated response t o a \\nsevere medical condition (e.g., depressive symptoms in response to a life-\\nthreatening diagnosis). This category should be used in addition to the diagnosis  for \\nthe presumed underlying disorder or disease when the mood symptoms are \\nsufficiently severe to warrant specific clinical attention. \\nNote: Code also the underlying condition \\nExclusions: Adjustment disorder (6B43) \\nDelirium (6D70) \\n \\n6E62.3 Secondary mood syndrome, with unspecified symptoms \\nNote: Code also the underlying condition \\nExclusions: Adjustment disorder (6B43) \\nDelirium (6D70) \\n \\n  6E63   Secondary anxiety syndrome \\nA syndrome characterized by the presence of prominent anxiety symptoms judged \\nto be a direct pathophysiological consequence of a health condition not classi fied \\nunder mental and behavioural disorders, based on evidence from the history, \\nphysical examination, or laboratory findings. The symptoms are not accounted for  \\nby delirium or by another mental and behavioural disorder, and are not a \\npsychologically mediated response to a severe medical condition (e.g., anxiety  \\nsymptoms or panic attacks in response to a life-threatening diagnosis). This \\ncategory should be used in addition to the diagnosis for the presumed underlying \\ndisorder or disease when the anxiety symptoms are sufficiently severe to warrant \\nspecific clinical attention. \\nNote: Code also the underlying condition \\nExclusions: Adjustment disorder (6B43) \\nDelirium (6D70)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 203, 'page_label': '204'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   203 \\n \\n  6E64   Secondary obsessive-compulsive or related syndrome \\nA syndrome characterized by the presence of prominent obsessions, compulsions, \\npreoccupations with appearance, hoarding, skin picking, hair pulling, other  body-\\nfocused repetitive behaviors, or other symptoms characteristic of obsessive-\\ncompulsive and related disorder that is judged to be the direct pathophysiological  \\nconsequence of a disorder or disease not classified under Mental and behavioural \\ndisorders, based on evidence from the history, physical examination, or laborat ory \\nfindings. The symptoms are not accounted for by Delirium or by another Mental and \\nbehavioural disorder, and are not a psychologically mediated response to a severe \\nmedical condition (e.g., repetitive ruminations in response to a life-threatening \\ndiagnosis). This category should be used in addition to the diagnosis f or the \\npresumed underlying disorder or disease when the obsessive-compulsive or relat ed \\nsymptoms are sufficiently severe to warrant specific clinical attention. \\nNote: Code also the underlying condition \\nExclusions: Delirium (6D70) \\nObsessive-compulsive or related disorder induced by other \\nspecified psychoactive substance (6C4E.72) \\n \\n  6E65   Secondary dissociative syndrome \\nA syndrome characterized by the presence of prominent dissociative symptoms \\n(e.g., depersonalization, derealization) that is judged to be the direct \\npathophysiological consequence of a health condition not classified under m ental \\nand behavioural disorders, based on evidence from the history, physical \\nexamination, or laboratory findings. The symptoms are not accounted for by \\ndelirium or by another mental and behavioural disorder, and are not a \\npsychologically mediated response to a severe medical condition (e.g., as pa rt of an \\nacute stress reaction in response to a life-threatening diagnosis). This categor y \\nshould be used in addition to the diagnosis for the presumed underlying disorder  or \\ndisease when the dissociative symptoms are sufficiently severe to warrant spec ific \\nclinical attention. \\nNote: Code also the underlying condition \\nExclusions: Delirium (6D70) \\nAcute stress reaction (QE84) \\n \\n  6E66   Secondary impulse control syndrome \\nA syndrome characterized by the presence of prominent symptoms of disordered \\nimpulse control (e.g., excessive gambling, stealing, fire-setting, agg ressive outburst, \\ncompulsive sexual behavior) that is judged to be a direct pathophysiological \\nconsequence of a health condition not classified under mental and behavioural \\ndisorders, based on evidence from the history, physical examination, or laborat ory \\nfindings. The symptoms are not accounted for by delirium or by another mental a nd \\nbehavioural disorder, and are not a psychologically mediated response to a severe \\nmedical condition (e.g., as part of an adjustment disorder in response to a life-\\nthreatening diagnosis). This category should be used in addition to the diagnosis  for \\nthe presumed underlying disorder or disease when the impulse control symptom s \\nare sufficiently severe to warrant specific clinical attention. \\nNote: Code also the underlying condition \\nExclusions: Delirium (6D70)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 204, 'page_label': '205'}, page_content='204  ICD-11 MMS - 2018 \\n \\n  6E67   Secondary neurocognitive syndrome \\nA syndrome that involves significant cognitive features that do not fulfill the \\ndiagnostic requirements of any of the specific neurocognitive disorders and are \\njudged to be a direct pathophysiological consequence of a health condition or injury \\nnot classified under mental and behavioural disorders (e.g., cognitive cha nges due \\nto a brain tumor), based on evidence from the history, physical examination, or \\nlaboratory findings. This category should be used in addition to the diagnosis  for the \\npresumed underlying disorder or disease when the cognitive symptoms are \\nsufficiently severe to warrant specific clinical attention. \\nNote: Code also the underlying condition \\nExclusions: Disorders with neurocognitive impairment as a major feature  \\n(BlockL1‑8A2) \\nCoded Elsewhere: Delirium (6D70) \\n \\n  6E68   Secondary personality change \\nA syndrome characterized by a persistent personality disturbance that represents a \\nchange from the individual ’s previous characteristic personality pattern that is \\njudged to be a direct pathophysiological consequence of a health condition n ot \\nclassified under Mental and behavioural disorders, based on evidence from the \\nhistory, physical examination, or laboratory findings. The symptoms are not \\naccounted for by delirium or by another mental and behavioural disorder, and are \\nnot a psychologically mediated response to a severe medical condition (e. g., social \\nwithdrawal, avoidance, or dependence in response to a life-threatening diagnosis).  \\nThis category should be used in addition to the diagnosis for the presumed \\nunderlying disorder or disease when the personality symptoms are sufficiently \\nsevere to warrant specific clinical attention. \\nNote: Code also the underlying condition \\nExclusions: Personality difficulty (QE50.7) \\nPersonality disorder (6D10) \\nDelirium (6D70) \\n \\n  6E69   Secondary catatonia syndrome \\nSecondary catatonia syndrome is a marked disturbance in the voluntary control of \\nmovements judged to be a direct pathophysiological consequence of a health \\ncondition not classified under mental and behavioural disorders, based on evidenc e \\nfrom the history, physical examination, or laboratory findings. The sym ptoms are not \\naccounted for by delirium or by another mental and behavioural disorder, and are \\nnot a psychologically mediated response to a severe medical condition (e.g ., an \\nacute stress reaction in response to a life-threatening diagnosis). Secondary \\ncatatonia syndrome is characterized by several of the following: extreme slowing or \\nabsence of motor activity, mutism, purposeless motor activity unrelated t o external \\nstimuli, assumption and maintenance of rigid, unusual or bizarre postures, \\nresistance to instructions or attempts to be moved, or automatic compliance with \\ninstructions. \\nNote: Use additional code, if desired, for any underlying disorder if known. \\n \\n  6E6Y   Other specified secondary mental or behavioural syndrome \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 205, 'page_label': '206'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   205 \\n \\n  6E6Z   Secondary mental or behavioural syndrome, unspecified \\nNote: Code also the underlying condition \\n \\n  6E8Y   Other specified mental, behavioural or neurodevelopmental disorders \\n \\n  6E8Z   Mental, behavioural or neurodevelopmental disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 206, 'page_label': '207'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   1 \\n \\nCHAPTER 07 \\nSleep-wake disorders \\nThis chapter has 42 four-character categories. \\nCode range starts with 7A00 \\nThis chapter contains the following top level blocks: \\n\\uf0b7 Insomnia disorders \\n\\uf0b7 Hypersomnolence disorders \\n\\uf0b7 Sleep-related breathing disorders \\n\\uf0b7 Circadian rhythm sleep-wake disorders \\n\\uf0b7 Sleep-related movement disorders \\n\\uf0b7 Parasomnia disorders \\n \\nInsomnia disorders (BlockL1‑7A0) \\nInsomnia disorders are characterized by the complaint of persistent difficulty with sl eep initiation, \\nduration, consolidation, or quality that occurs despite adequate opportunity and cir cumstances for \\nsleep, and results in some form of daytime impair¬ment. Daytime sympto ms typically include fatigue, \\ndecreased mood or irritability, general malaise, and cognitive impairment. Ind ividuals who report sleep \\nrelated symptoms in the absence of daytime impairment are not regarded as having an insomnia \\ndisorder. \\n  7A00   Chronic insomnia \\nChronic insomnia disorder is a frequent and persistent difficulty initiating or \\nmaintaining sleep that occurs despite adequate opportunity and circumstances for \\nsleep and that results in general sleep dissatisfaction and some form of day time \\nimpairment. Daytime symptoms typically include fatigue, decreased moo d or \\nirritability, general malaise, and cognitive impairment. The sleep disturba nce and \\nassociated daytime symptoms occur at least several times per week and are  \\nassociated with daytime symptoms that have been present for at least several \\nmonths. Some individuals with chronic insomnia may show a more episodic cou rse, \\nwith recurrent episodes of sleep/wake difficulties lasting several weeks at a tim e \\nover several years. Individuals who report sleep related symptoms in the absence of \\ndaytime impairment are not regarded as having an insomnia disorder. If the \\ninsomnia is due to another sleep-wake disorder, a mental disorder, another medical  \\ncondition, or a substance or medication, chronic insomnia should only be diagnosed \\nif the insomnia is an independent focus of clinical attention.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 207, 'page_label': '208'}, page_content='2  ICD-11 MMS - 2018 \\n \\n  7A01   Short-term insomnia \\nShort-term insomnia disorder is characterized by difficulty ini¬tiating or mai ntaining \\nsleep that occurs despite adequate opportunity and circumstances for sleep and  \\nthat has lasted for less than 3 months duration that results in general sleep \\ndissatisfaction and some form of daytime impairment. Daytime symptoms typic ally \\ninclude fatigue, decreased mood or irritability, general malaise, and cognit ive \\nimpairment. Individuals who report sleep related symptoms in the absence of \\ndaytime impairment are not regarded as having an insomnia disorder. If the \\ninsomnia is due to another sleep-wake disorder, a mental disorder, another medical  \\ncondition, or a substance or medication, chronic insomnia should only be diagnosed \\nif the insomnia is an independent focus of clinical attention. Insomnia attributab le to \\nuse of substances or medications should be diagnosed as substance-induced \\ninsomnia according to the particular substance involved. \\n \\n  7A0Z   Insomnia disorders, unspecified \\n \\nHypersomnolence disorders (BlockL1‑7A2) \\n  7A20   Narcolepsy \\n \\n7A20.0 Narcolepsy, Type 1 \\n \\n7A20.1 Narcolepsy, Type 2 \\nNarcolepsy without cataplexy is a sleep disorder characterized by excessive day-\\ntime sleepiness associated with uncontrollable sleep urges and sometimes \\nparalysis at sleep, hypnagogic hallucinations and automatic behavior. \\n \\n7A20.Z Narcolepsy, unspecified \\n \\n  7A21   Idiopathic hypersomnia \\nIdiopathic hypersomnia is a sleep disorder classified in two forms: idiop athic \\nhypersomnia with long sleep time and idiopathic hypersomnia without long sleep \\ntime. \\n \\n  7A22   Kleine-Levin syndrome \\nKleine-Levin syndrome is a rare neurological disorder of unknown origin \\ncharacterised by relapsing-remitting episodes of hypersomnia in association w ith \\ncognitive and behavioural disturbances. \\nInclusions: recurrent hypersomnolence \\n \\n  7A23   Hypersomnia due to a medical condition \\n \\n  7A24   Hypersomnia due to a medication or substance \\nInclusions: Hypersomnia due to substances including medications \\n \\n  7A25   Hypersomnolence associated with a mental disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 208, 'page_label': '209'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   3 \\n \\n  7A26   Insufficient sleep syndrome \\nInclusions: Behaviourally induced hypersomnia \\nExclusions: Narcolepsy, Type 2 (7A20.1) \\nNarcolepsy (7A20) \\n \\n  7A2Y   Other specified hypersomnolence disorders \\n \\n  7A2Z   Hypersomnolence disorders, unspecified \\n \\nSleep-related breathing disorders (BlockL1‑7A4) \\nExclusions: Apnoea of newborn (KB2A) \\nCoded Elsewhere: Sleep related Cheyne-Stokes respiration (MD11.4) \\n  7A40   Central sleep apnoeas \\nExclusions: Central neonatal apnoea (KB2A.0) \\n \\n7A40.0 Primary central sleep apnoea \\nExclusions: Primary central sleep apnoea of infancy (7A40.1) \\nPrimary central sleep apnoea of prematurity (7A40.2) \\n \\n7A40.1 Primary central sleep apnoea of infancy \\nA paediatric condition characterized by an unexplained episode of cessation of \\nbreathing for 20 seconds or longer, or a shorter respiratory pause associated with \\nbradycardia, cyanosis, pallor, and/or marked hypotonia, in an infant. \\nExclusions: Primary central sleep apnoea of prematurity (7A40.2) \\n \\n7A40.2 Primary central sleep apnoea of prematurity \\nInclusions: Primary sleep apnea of prematurity \\n \\n7A40.3 Central sleep apnoea due to a medical condition with Cheyne-Stokes \\nbreathing \\nInclusions: Certain specified central sleep apneas with Cheynes-Stokes \\nrespiration \\n \\n7A40.4 Central sleep apnoea due to a medical condition without Cheyne-Stokes \\nbreathing \\nInclusions: Certain specified central sleep apneas without Cheynes-\\nStokes respiration \\n \\n7A40.5 Central sleep apnoea due to high-altitude periodic breathing \\n \\n7A40.6 Central sleep apnoea due to a medication or substance \\n \\n7A40.7 Treatment-emergent central sleep apnoea \\n \\n7A40.Y Other specified central sleep apnoeas \\n \\n7A40.Z Central sleep apnoeas, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 209, 'page_label': '210'}, page_content='4  ICD-11 MMS - 2018 \\n \\n  7A41   Obstructive sleep apnoea \\nCharacterised by repetitive episodes of complete (apnoea) or partial (hypopno ea) \\nupper airway obstruction occurring during sleep. These events often result in \\nreductions in blood oxygen saturation and are usually terminated by brief arousal s \\nfrom sleep. \\nExclusions: Obstructive neonatal apnoea (KB2A.1) \\n \\n  7A42   Sleep-related hypoventilation or hypoxemia disorders \\nSleep related hypoventilation disorders are characterized by an abnormal increa se \\nin the arterial PCO2(PaCO2) during sleep. \\n \\n7A42.0 Obesity hypoventilation syndrome \\nExtreme obesity associated with alveolar hypoventilation; a Pickwickian  \\nsyndrome“[1] is a breathing disorder that affects some obese people. Poor \\nbreathing results in too much carbon dioxide (hypoventilation) and too little oxy gen \\nin the blood (hypoxemia). These changes can lead to serious health problems, such \\nas leg edema, pulmonary hypertension, cor pulmonale, and secondary \\nerythrocytosis(Obesity hypoventilation syndrome :OHS). If left untreated, OHS  can \\neven be fatal. Many people who have OHS also have obstructive sleep apnea. [2] \\nThe central features of OHS, as currently accepted, include obesity (BMI >30 \\nkg/m2), chronic alveolar hypoventilation leading to daytime hypercapnia and \\nhypoxia (PaCO2 >45 mm Hg and PaO2 < 70 mm Hg), and sleep-disordered \\nbreathing. Essential to the diagnosis is exclusion of other causes of alveolar \\nhypoventilation such as severe obstructive or restrictive pulmonary disea se, \\nsignificant kyphoscoliosis, severe hypothyroidism, neuromuscular diseases, or other \\ncentral hypoventilation syndromes.[3] \\nInclusions: Pickwickian syndrome \\n \\n7A42.1 Congenital central alveolar sleep-related hypoventilation \\n \\n7A42.2 Late onset central hypoventilation with hypothalamic abnormalities  \\n \\n7A42.3 Idiopathic central alveolar hypoventilation \\n \\n7A42.4 Sleep-related hypoventilation due to a medication or substance  \\n \\n7A42.5 Sleep-related hypoventilation due to medical condition \\nSleep related hypoventilation due to lung parenchymal or airway disease, \\npulmonary vascular pathology, chest wall disorder, neurologic disorder, or muscle \\nweakness is believed to be the primary cause of hypoventilation. Hypov entilation is \\nnot primarily due to obesity hypoventilation syndrome, medication use, or a known  \\ncongenital central alveolar hypoventilation syndrome. \\nExclusions: Obesity hypoventilation syndrome (7A42.0) \\nCongenital central alveolar sleep-related hypoventilation \\n(7A42.1) \\n \\n7A42.6 Sleep-related hypoxemia \\n \\n7A42.Y Other specified sleep-related hypoventilation or hypoxemia disorders  \\n \\n7A42.Z Sleep-related hypoventilation or hypoxemia disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 210, 'page_label': '211'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   5 \\n \\n  7A4Y   Other specified sleep-related breathing disorders \\n \\n  7A4Z   Sleep-related breathing disorders, unspecified \\n \\nCircadian rhythm sleep-wake disorders (BlockL1‑7A6) \\nCircadian rhythm sleep-wake disorders are disturbances of the sleep-wake cycle (typically manifest \\nas insomnia, excessive sleepiness, or both) due to alterations of the circadian ti me-keeping system, \\nits entrainment mechanisms, or a misalignment of the endogenous circadian rhy thm and the external \\nenvironment. \\nInclusions: Delayed sleep phase syndrome \\nIrregular sleep-wake pattern \\n  7A60   Delayed sleep-wake phase disorder \\nDelayed sleep-wake phase disorder is a recurrent pattern of disturbance of the \\nsleep-wake schedule characterized by persistent delay in the major sleep period  \\ncompared to conventional or desired sleep times. The disorder results in di fficulty \\nfalling asleep and difficulty awakening at desired or required times. W hen sleep is \\nallowed to occur on the delayed schedule, it is essentially normal in qual ity and \\nduration. The condition results in significant distress or mental, physi cal, social, \\noccupational or academic impairment. \\n \\n  7A61   Advanced sleep-wake phase disorder \\nAdvanced sleep-wake phase disorder is a recurrent pattern of disturbance of the \\nsleep-wake schedule characterized by persistent advance (to an earlier time) of the \\nmajor sleep period compared to conventional or desired sleep times. The dis order \\nresults in evening sleepiness (prior to the desired bedtime) and awakening  earlier \\nthan the desired or required times. When sleep is allowed to occur on the adv anced \\nschedule, it is essentially normal in quality and duration. The condition  results in \\nsignificant distress or mental, physical, social, occupational or academ ic \\nimpairment. \\n \\n  7A62   Irregular sleep-wake rhythm disorder \\nIrregular sleep-wake rhythm disorder is characterized by absence of a clearl y-\\ndefined cycle of sleep and wake. Sleep becomes distributed in multiple episodes of \\nvariable duration throughout the 24-hour period. Patients typically complain of \\ninsomnia and/or excessive daytime sleepiness as a result of the condition. \\n \\n  7A63   Non-24 hour sleep-wake rhythm disorder \\nNon-24 hour sleep-wake rhythm disorder is characterized by periods of insom nia \\nand/or daytime sleepiness, alternating with periods of relatively normal sleep, due to \\na lack of entrainment of the circadian clock to the 24-hour environmental cyc le. The \\nperiod length of the circadian/sleep-wake cycle may be shorter or, more typi cally, \\nlonger than 24 hours. Symptoms occur as the circadian-controlled sleep-wa ke \\npropensity cycles in and out of phase with the environmental day-night cycle.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 211, 'page_label': '212'}, page_content='6  ICD-11 MMS - 2018 \\n \\n  7A64   Circadian rhythm sleep-wake disorder, shift work type \\nCircadian rhythm sleep-wake disorder, shift work type is characterized by \\ncomplaints of insomnia and/or excessive sleepiness that occur as a result of wo rk \\nshifts that overlap with all or a portion of conventional nighttime sleep perio ds. The \\ndisorder is also typically associated with a reduction in total sleep time. \\n \\n  7A65   Circadian rhythm sleep-wake disorder, jet lag type \\nCircadian rhythm sleep-wake disorder, jet lag type is characterized by a tem porary \\nmismatch between the timing of the sleep and wake cycle generated by the \\nendogenous circadian clock and that of the sleep and wake pattern required by  a \\nchange in time zone. Individuals complain of disturbed sleep, sleepiness and \\nfatigue, and impaired daytime function. The severity and duration of symptoms is  \\ndependent on the number of time zones traveled, the ability to sleep while trave ling, \\nexposure to appropriate circadian times cues in the new environment, tolerance to \\ncircadian misalignment when awake during the biological night, and the direct ion of \\nthe travel. \\n \\n  7A6Z   Circadian rhythm sleep-wake disorders, unspecified \\n \\nSleep-related movement disorders (BlockL1‑7A8) \\nThis is a group of movement disorders which normally occur at night when the patient is at rest and/or \\nduring sleep. These disorders involve relatively simple, non-purposeful  and usually stereotyped \\nmovements. \\nCoded Elsewhere: REM sleep behaviour disorder (7B01.0) \\n  7A80   Restless legs syndrome \\n \\n  7A81   Periodic limb movement disorder \\nMovement disorder characterised by recurrent episodes of repetitive limb \\nmovements due to muscle contractions during sleep. Up to 90% of patients with \\nRestless legs syndrome have simple stereotyped non-volitional movements of the \\nlower limbs during sleep. Polysomnography with surface EMG is the gold standard  \\nfor diagnosis. \\n \\n  7A82   Sleep-related leg cramps \\nLeg cramps are painful contractions of muscles of the leg or foot with resultant \\ntightness or hardness. They occur most frequently at night, waking the patient from \\nsleep and are generally helped by stretching the affected muscle, often by standing. \\n \\n  7A83   Sleep-related bruxism \\nIn sleep-related bruxism there is tonic contraction of the masseter muscles lasting at \\nleast 2 seconds, or trains of rhythmic masseter contraction at about 1 Hz. It is seen \\nmost frequently in light non-REM (NREM) sleep but may occur in any stage. The  \\nconsequences may include damage to the teeth, jaw discomfort, fatigue or pain or \\ntemporal headaches on wakening.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 212, 'page_label': '213'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   7 \\n \\n  7A84   Sleep-related rhythmic movement disorder \\nThe movements of rhythmic movement disorder (RMD) consist of stereotyped \\ncontractions of large muscle groups at 0.5 Hz to 2 Hz during drowsiness or sleep. In \\norder for the movements to be classified as a disorder, they must cause \\ninterference with normal sleep, impairment in daytime functioning, or bodily injury . \\nRMD is common in infancy and early childhood. \\n \\n  7A85   Benign sleep myoclonus of infancy \\nBenign sleep myoclonus in infancy is a disorder of quiet sleep, which oc curs from \\nthe first day of life up to age 3 years. Its main features are rhythmic myoclonic  jerks \\nwhen drowsy or asleep, which stop if the child is woken, and normal \\nencephalograms during or after the episodes. \\n \\n  7A86   Propriospinal myoclonus at sleep onset \\n \\n  7A87   Sleep-related movement disorder due to a medical conditoin \\nSleep-related movement disorders are known to occur secondary to various \\nmedical conditions such as iron deficiency, pregnancy, end-stage renal  disease, \\nand neuropathy. These usually occur later in the life and in the absence of a family \\nhistory of Sleep-related movement disorder. \\nNote: Code also the underlying condition \\n \\n  7A88   Sleep-related movement disorder due to a medication or substance \\n \\n  7A8Y   Other specified sleep-related movement disorders \\n \\n  7A8Z   Sleep-related movement disorders, unspecified \\n \\nParasomnia disorders (BlockL1‑7B0) \\nUndesirable physical events or experiences that occurs during entry into sleep , within sleep, or during \\narousal from sleep. \\n  7B00   Disorders of arousal from non-REM sleep \\n \\n7B00.0 Confusional arousals \\n \\n7B00.1 Sleepwalking disorder \\nA state of altered consciousness in which phenomena of sleep and wakefulness are \\ncombined. During a sleepwalking episode the individual arises from bed, usual ly \\nduring the first third of nocturnal sleep, and walks about, exhibiting low leve ls of \\nawareness, reactivity, and motor skill. Upon awakening, there is usually n o recall of \\nthe event. \\n \\n7B00.2 Sleep terrors \\nNocturnal episodes of extreme terror and panic associated with intense \\nvocalization, motility, and high levels of autonomic discharge. The individual sits up \\nor gets up, usually during the first third of nocturnal sleep, with a panic ky scream. \\nQuite often he or she rushes to the door as if trying to escape, although very seldom \\nleaves the room. Recall of the event, if any, is very limited (usually to on e or two \\nfragmentary mental images).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 213, 'page_label': '214'}, page_content='8  ICD-11 MMS - 2018 \\n \\n7B00.3 Sleep-related eating disorder \\n \\n7B00.Y Other specified disorders of arousal from non-REM sleep \\n \\n7B00.Z Disorders of arousal from non-REM sleep, unspecified \\n \\n  7B01   Parasomnias related to REM sleep \\n \\n7B01.0 REM sleep behaviour disorder \\nRapid eye movement (REM) sleep behavior disorder (RBD) is characterized by a \\nloss of normal muscle tone during REM sleep and motor activity associated with \\ndream content. RBD constitutes an increased risk of developing neurodegenerativ e \\ndiseases, such as multiple system atrophy (MSA), Parkinson disease (PD), and \\ndementia with Lewy bodies (DLB). \\n \\n7B01.1 Recurrent isolated sleep paralysis \\n \\n7B01.2 Nightmare disorder \\nDream experiences loaded with anxiety or fear. There is very detailed recal l of the \\ndream content. The dream experience is very vivid and usually includes them es \\ninvolving threats to survival, security, or self-esteem. Quite often there is a \\nrecurrence of the same or similar frightening nightmare themes. During a typical \\nepisode there is a degree of autonomic discharge but no appreciable vocalizat ion or \\nbody motility. Upon awakening the individual rapidly becomes alert and oriented. \\nInclusions: Dream anxiety disorder \\n \\n7B01.Y Other specified parasomnias related to REM sleep \\n \\n7B01.Z Parasomnias related to REM sleep, unspecified \\n \\n  7B02   Other parasomnias \\nCoded Elsewhere: Nocturnal enuresis (6C00.0) \\n \\n7B02.0 Hypnogogic exploding head syndrome \\nInclusions: Hypnogogic sensory disturbance \\n \\n7B02.1 Sleep-related hallucinations \\n \\n7B02.2 Parasomnia disorder due to a medical condition \\n \\n7B02.3 Parasomnia disorder due to a medication or substance \\n \\n  7B0Y   Other specified parasomnia disorders \\n \\n  7B0Z   Parasomnia disorders, unspecified \\n \\n \\n  7B2Y   Other specified sleep-wake disorders \\n \\n  7B2Z   Sleep-wake disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 214, 'page_label': '215'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   1 \\n \\nCHAPTER 17 \\nConditions related to sexual health \\nThis chapter has 15 four-character categories. \\nCode range starts with HA00 \\nCoded Elsewhere: Changes in female genital anatomy \\nChanges in male genital anatomy \\nParaphilic disorders (6D30-6D3Z) \\nAdrenogenital disorders (5A71) \\nPredominantly sexually transmitted infections (1A60-1A9Z) \\nContact with health services for contraceptive management (QA21) \\nThis chapter contains the following top level blocks: \\n\\uf0b7 Sexual dysfunctions \\n\\uf0b7 Sexual pain disorders \\n\\uf0b7 Gender incongruence \\n\\uf0b7 Changes in female genital anatomy \\n\\uf0b7 Changes in male genital anatomy \\n \\nSexual dysfunctions (BlockL1‑HA0) \\nSexual Dysfunctions are syndromes that comprise the various ways in which adult people may have \\ndifficulty experiencing personally satisfying, non-coercive sexual ac tivities. Sexual response is a \\ncomplex interaction of psychological, interpersonal, social, cultural and phy siological processes and \\none or more of these factors may affect any stage of the sexual response. In order to be  considered a \\nsexual dysfunction, the dysfunction must: 1) occur frequently, although it may  be absent on some \\noccasions; 2) have been present for at least several months; and 3) be associated wit h clinically \\nsignificant distress. \\nCoded Elsewhere: Sexual dysfunction associated with pelvic organ prolapse (GC42) \\n  HA00   Hypoactive sexual desire dysfunction \\nHypoactive Sexual Desire Dysfunction is characterized by absence or marked \\nreduction in desire or motivation to engage in sexual activity as manifested b y any \\nof the following: 1) reduced or absent spontaneous desire (sexual thoughts or \\nfantasies); 2) reduced or absent responsive desire to erotic cues and stimulation ; or \\n3) inability to sustain desire or interest in sexual activity once initiated. The pattern \\nof diminished or absent spontaneous or responsive desire or inability to sustai n \\ndesire or interest in sexual activity has occurred episodically or persistentl y over a \\nperiod at least several months, and is associated with clinically significant distress.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 215, 'page_label': '216'}, page_content='2  ICD-11 MMS - 2018 \\n \\nHA00.0 Hypoactive sexual desire dysfunction, lifelong, generalised \\nThe person has always experienced hypoactive sexual desire dysfunction  from the \\ntime of initiation of relevant sexual activity and the desired response is  currently \\nabsent or diminished in all circumstances, including masturbation. \\n \\nHA00.1 Hypoactive sexual desire dysfunction, lifelong, situational \\nThe person has always experienced hypoactive sexual desire dysfunc tion, from the \\ntime of initiation of relevant sexual activity and the desired response i s currently \\nabsent or diminished in some circumstances, with some partners, or in response to \\nsome stimuli, but not in other situations. \\n \\nHA00.2 Hypoactive sexual desire dysfunction, acquired, generalised \\nThe onset of hypoactive sexual desire dysfunction has followed a perio d of time \\nduring which the person did not experience it and the desired response is  currently \\nabsent or diminished in all circumstances, including masturbation. \\n \\nHA00.3 Hypoactive sexual desire dysfunction, acquired, situational \\nThe onset of hypoactive sexual desire dysfunction has followed a perio d of time \\nduring which the person did not experience it and the desired response is  currently \\nabsent or diminished in some circumstances, with some partners, or in response to \\nsome stimuli, but not in other situations. \\n \\nHA00.Z Hypoactive sexual desire dysfunction, unspecified \\n \\n  HA01   Sexual arousal dysfunctions \\nSexual arousal dysfunctions include difficulties with the physiological or t he \\nsubjective aspects of sexual arousal. \\n \\nHA01.0 Female sexual arousal dysfunction \\nFemale sexual arousal dysfunction is characterized by absence or marked \\nreduction in response to sexual stimulation in women, as manfested by any of the  \\nfollowing: 1) Absence or marked reduction in genital response, including \\nvulvovaginal lubrication, engorgement of the genitalia, and sensitivity of t he \\ngenitalia; 2) Absence or marked reduction in non-genital responses such as \\nhardening of the nipples, flushing of the skin, increased heart rate, increased blood \\npressure, and increased respiration rate; 3) Absence or marked reduction in \\nfeelings of sexual arousal (sexual excitement and sexual pleasure) from any ty pe of \\nsexual stimulation. The absence or marked reduction in response to sexual \\nstimulation occurs despite the desire for sexual activity and adequate sexua l \\nstimulation, has occurred episodically or persistently over a period at least sever al \\nmonths, and is associated with clinically significant distress. \\n \\nHA01.00 Female sexual arousal dysfunction, lifelong, generalised \\nThe person has always experienced female sexual arousal dysfunction from t he \\ntime of initiation of relevant sexual activity and the desired response is  currently \\nabsent or diminished in all circumstances, including masturbation.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 216, 'page_label': '217'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   3 \\n \\nHA01.01 Female sexual arousal dysfunction, lifelong, situational \\nThe person has always experienced female sexual arousal dysfunction from t he \\ntime of initiation of relevant sexual activity and the desired response is  currently \\nabsent or diminished in some circumstances, with some partners, or in response to \\nsome stimuli, but not in other situations. \\n \\nHA01.02 Female sexual arousal dysfunction, acquired, generalised \\nThe onset of female sexual arousal dysfunction has followed a period of time during \\nwhich the person did not experience it and the desired response is current ly absent \\nor diminished in all circumstances, including masturbation. \\n \\nHA01.03 Female sexual arousal dysfunction, acquired, situational \\nThe onset of female sexual arousal dysfunction has followed a period of time during \\nwhich the person did not experience it and the desired response is current ly absent \\nor diminished in some circumstances, with some partners, or in response to some \\nstimuli, but not in other situations. \\n \\nHA01.0Z Female sexual arousal dysfunction, unspecified \\n \\nHA01.1 Male erectile dysfunction \\nMale erectile dysfunction is characterized by inability or marked reduction in the \\nability in men to attain or sustain a penile erection of sufficient duration or rigidi ty to \\nallow for sexual activity. The pattern of erectile difficulty occurs despite th e desire \\nfor sexual activity and adequate sexual stimulation, has occurred episodicall y or \\npersistently over a period at least several months, and is associated with cl inically \\nsignificant distress. \\nNote: Code also the underlying condition \\n \\nHA01.10 Male erectile dysfunction, lifelong, generalised \\nThe person has always experienced male erectile dysfunction from the ti me of \\ninitiation of relevant sexual activity and the desired response is currentl y absent or \\ndiminished in all circumstances, including masturbation. \\n \\nHA01.11 Male erectile dysfunction, lifelong, situational \\nThe person has always experienced male erectile dysfunction from the ti me of \\ninitiation of relevant sexual activity and the desired response is currentl y absent or \\ndiminished in some circumstances, with some partners, or in response to some \\nstimuli, but not in other situations. \\n \\nHA01.12 Male erectile dysfunction, acquired, generalised \\nThe onset of male erectile dysfunction has followed a period of time during which \\nthe person did not experience it and the desired response is currently absent or \\ndiminished in all circumstances, including masturbation. \\n \\nHA01.13 Male erectile dysfunction, acquired, situational \\nThe onset of male erectile dysfunction has followed a period of time during which \\nthe person did not experience it and the desired response is currently absent or \\ndiminished in some circumstances, with some partners, or in response to some \\nstimuli, but not in other situation'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 217, 'page_label': '218'}, page_content='4  ICD-11 MMS - 2018 \\n \\nHA01.1Z Male erectile dysfunction, unspecified \\nNote: Code also the underlying condition \\n \\nHA01.Y Other specified sexual arousal dysfunctions \\n \\nHA01.Z Sexual arousal dysfunctions, unspecified \\n \\n  HA02   Orgasmic dysfunctions \\nOrgasmic dysfunctions refer to difficulties related to the subjective exper ience of \\norgasm. \\n \\nHA02.0 Anorgasmia \\nAnorgasmia is characterized by the absence or marked infrequency of the orgasm  \\nexperience or markedly diminished intensity of orgasmic sensations. In women, thi s \\nincludes a marked delay in orgasm, which in men would be diagnosed as Male \\nDelayed Ejaculation. The pattern of absence, delay, or diminished frequency or \\nintensity of orgasm occurs despite adequate sexual stimulation, including the de sire \\nfor sexual activity and orgasm, has occurred episodically or persistently o ver a \\nperiod at least several months, and is associated with clinically significant distress. \\nInclusions: Psychogenic anorgasmy \\n \\nHA02.00 Anorgasmia, lifelong, generalised \\nThe person has always experienced anorgasmia from the time of initiation of \\nrelevant sexual activity and the desired response is currently absent or di minished \\nin all circumstances, including masturbation. \\n \\nHA02.01 Anorgasmia, lifelong, situational \\nThe person has always experienced anorgasmia from the time of initiation of \\nrelevant sexual activity and the desired response is currently absent or di minished \\nin some circumstances, with some partners, or in response to some stimuli, but n ot \\nin other situations. \\n \\nHA02.02 Anorgasmia, acquired, generalised \\nThe onset of anorgasmia has followed a period of time during which the person did \\nnot experience it and the desired response is currently absent or diminished in  all \\ncircumstances, including masturbation. \\n \\nHA02.03 Anorgasmia, acquired, situational \\nThe onset of anorgasmia has followed a period of time during which the person did \\nnot experience it and the desired response is currently absent or diminis hed in \\nsome circumstances, with some partners, or in response to some stimuli, but no t in \\nother situations. \\n \\nHA02.0Z Anorgasmia, unspecified \\n \\nHA02.Y Other specified orgasmic dysfunctions \\n \\nHA02.Z Orgasmic dysfunctions, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 218, 'page_label': '219'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   5 \\n \\n  HA03   Ejaculatory dysfunctions \\nEjaculatory dysfunctions refer to difficulties with ejaculation in men, includ ing \\nejaculatory latencies that are experienced as too short (Male early ejaculati on) or \\ntoo long (Male delayed ejaculation). \\nCoded Elsewhere: Retrograde ejaculation (MF40.3) \\n \\nHA03.0 Male early ejaculation \\nMale early ejaculation is characterized by ejaculation that occurs prior to or within a \\nvery short duration of the initiation of vaginal penetration or other relevan t sexual \\nstimulation, with no or little perceived control over ejaculation. The pattern of ea rly \\nejaculation has occurred episodically or persistently over a period at least s everal \\nmonths, and is associated with clinically significant distress. \\n \\nHA03.00 Male early ejaculation, lifelong, generalised \\nThe person has always experienced early ejaculation from the time of ini tiation of \\nrelevant sexual activity and the desired response is currently absent or di minished \\nin all circumstances, including masturbation. \\n \\nHA03.01 Male early ejaculation, lifelong, situational \\nThe person has always experienced early ejaculation from the time of ini tiation of \\nrelevant sexual activity and the desired response is currently absent or di minished \\nin some circumstances, with some partners, or in response to some stimuli, but n ot \\nin other situations. \\n \\nHA03.02 Male early ejaculation, acquired, generalised \\nThe onset of early ejaculation has followed a period of time during which th e person \\ndid not experience it and the desired response is currently absent or diminished in \\nall circumstances, including masturbation. \\n \\nHA03.03 Male early ejaculation, acquired, situational \\nThe onset of early ejaculation has followed a period of time during which th e person \\ndid not experience it and the desired response is currently absent or diminished in \\nsome circumstances, with some partners, or in response to some stimuli, bu t not in \\nother situations. \\n \\nHA03.0Z Male early ejaculation, unspecified \\n \\nHA03.1 Male delayed ejaculation \\nMale delayed ejaculation is characterized by an inability to achieve ejacul ation or an \\nexcessive or increased latency of ejaculation, despite adequate sexual stim ulation \\nand the desire to ejaculate. The pattern of delayed ejaculation has occurred \\nepisodically or persistently over a period at least several months, and is assoc iated \\nwith clinically significant distress. \\n \\nHA03.10 Male delayed ejaculation, lifelong, generalised \\nThe person has always experienced delayed ejaculation from the time of init iation of \\nrelevant sexual activity and the desired response is currently absent or di minished \\nin all circumstances, including masturbation.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 219, 'page_label': '220'}, page_content='6  ICD-11 MMS - 2018 \\n \\nHA03.11 Male delayed ejaculation, lifelong, situational \\nThe person has always experienced delayed ejaculation from the time of init iation of \\nrelevant sexual activity and the desired response is currently absent or di minished \\nin some circumstances, with some partners, or in response to some stimuli, but n ot \\nin other situations. \\n \\nHA03.12 Male delayed ejaculation, acquired, generalised \\nThe onset of delayed ejaculation has followed a period of time during which the \\nperson did not experience it and the desired response is currently absent or \\ndiminished in all circumstances, including masturbation. \\n \\nHA03.13 Male delayed ejaculation, acquired, situational \\nThe onset of delayed ejaculation has followed a period of time during which the \\nperson did not experience it and the desired response is currently absent or \\ndiminished in some circumstances, with some partners, or in response to some \\nstimuli, but not in other situations. \\n \\nHA03.1Z Male delayed ejaculation, unspecified \\n \\nHA03.Y Other specified ejaculatory dysfunctions \\n \\nHA03.Z Ejaculatory dysfunctions, unspecified \\n \\n  HA0Y   Other specified sexual dysfunctions \\n \\n  HA0Z   Sexual dysfunctions, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 220, 'page_label': '221'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   7 \\n \\nSexual pain disorders (BlockL1‑HA2) \\nSexual pain disorders refer to marked and persistent or recurrent difficulties relat ed to the experience \\nof pain during sexual activity in adult people, which are not entirely at tributable to an underlying \\nmedical condition, insufficient lubrication in women, age-related chan ges, or changes associated with \\nmenopause in women and are associated with clinically significant distress. \\nInclusions: Psychogenic dyspareunia \\nCoded Elsewhere: Dyspareunia (GA12) \\n  HA20   Sexual pain-penetration disorder \\nSexual pain-penetration disorder is characterized by at least one of the follo wing: 1) \\nmarked and persistent or recurrent difficulties with penetration, including due to \\ninvoluntary tightening or tautness of the pelvic floor muscles during attempted \\npenetration; 2) marked and persistent or recurrent vulvovaginal or pelvic pain during \\npenetration; 3) marked and persistent or recurrent fear or anxiety about \\nvulvovaginal or pelvic pain in anticipation of, during, or as a result of pe netration. \\nThe symptoms are recurrent during sexual interactions involving or potentially \\ninvolving penetration, despite adequate sexual desire and stimulation, are not \\nentirely attributable to a medical condition that adversely affects the pelvic area and \\nresults in genital and/or penetrative pain or to a mental disorder, are not entirely \\nattributable to insufficient vaginal lubrication or post-menopausal/ age -related \\nchanges, and are associated with clinically significant distress. \\nExclusions: Dyspareunia (GA12) \\nPain related to vulva, vagina or pelvic floor (GA34.0) \\n \\nHA20.0 Sexual pain-penetration disorder, lifelong, generalised \\nThe person has always experienced genito-pelvic pain or penetration disorder  from \\nthe time of initiation of relevant sexual activity and the desired respons e is currently \\nabsent or diminished in all circumstances, including masturbation. \\n \\nHA20.1 Sexual pain-penetration disorder, lifelong, situational \\nThe person has always experienced genito-pelvic pain or penetration dis order from \\nthe time of initiation of relevant sexual activity and the desired response is currently \\nabsent or diminished in some circumstances, with some partners, or in response to \\nsome stimuli, but not in other situations. \\n \\nHA20.2 Sexual pain-penetration disorder, acquired, generalised \\nThe onset of genito-pelvic pain or penetration disorder has followed a period of time \\nduring which the person did not experience it and the desired response is  currently \\nabsent or diminished in all circumstances, including masturbation. \\n \\nHA20.3 Sexual pain-penetration disorder, acquired, situational \\nThe onset of genito-pelvic pain or penetration disorder has followed a period of time \\nduring which the person did not experience it and the desired response is  currently \\nabsent or diminished in some circumstances, with some partners, or in response to \\nsome stimuli, but not in other situations. \\n \\nHA20.Z Sexual pain-penetration disorder, unspecified \\n \\n  HA2Y   Other specified sexual pain disorders'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 221, 'page_label': '222'}, page_content='8  ICD-11 MMS - 2018 \\n \\n  HA2Z   Sexual pain disorders, unspecified \\n \\n  HA40   Aetiological considerations in sexual dysfunctions and sexual pain \\ndisorders \\n \\nHA40.0 Associated with a medical condition, injury, or the effects of surgery or \\nradiation treatment \\nThis category should be assigned when there is evidence that an underlying or co -\\noccurring health condition, including hormonal, neurological, and vascular \\nconditions, injuries, and consequences of surgical or radiation treatment is an \\nimportant contributing factor to a Sexual Dysfunction or a Sexual Pain Disorder.  In \\nsuch cases, the diagnosis corresponding to the underlying or co-occurring health \\ncondition should also be assigned. However, underlying or contributory mental \\ndisorders should be noted using the qualifier ‘Associated with psychological and \\nbehavioural factors, including mental disorders’, rather than using with this category. \\n \\nHA40.1 Associated with psychological or behavioural factors, including mental \\ndisorders \\nThis category should be assgned when psychological and behavioural factors or \\nsymptoms are important contributing factors to the Sexual Dysfunction or Sexual \\nPain Disorder. Examples include low self-esteem, negative attitudes toward sexual \\nactivity, adverse past sexual experiences, and behavioural patterns such as poor \\nsleep hygiene and overwork. Depressive, anxiety, or cognitive symptoms as  well as \\nother symptoms of Mental, Behavioural, or Neurodevelopmental Disorders may also \\ninterfere with sexual functioning. If the symptoms reach the level of constituti ng a \\ndiagnosable Mental and Behavioural Disorder and the Sexual Dysfunction or Sexual \\nPain Disorder is an independent focus of clinical attention, this category sho uld be \\nused and the appropriate Mental and Behavioural Disorder diagnosis should also be \\nassigned. However, underlying or contributory Disorders Due to Substance Use \\nshould be noted using the category ‘Associated with use of psychoactive substance \\nor medication’, rather than using this category. \\n \\nHA40.2 Associated with use of psychoactive substance or medication \\nThis category should be assigned when there is evidence that the direct \\nphysiological effects of a psychoactive substance or medication are an impor tant \\ncontributing factor to the Sexual Dysfunction or Sexual Pain Disorder. Examples \\ninclude selective serotonin reuptake inhibitors, histamine-2 receptor antagonists \\n(e.g., cimetidine), alcohol, opioids, and amphetamines. If the diagnostic \\nrequirements for a Disorder Due to Substance Use are met, the appropriate \\nDisorder Due to Substance Use diagnosis should also be assigned. \\n \\nHA40.3 Associated with lack of knowledge or experience \\nThis category should be assigned when, in the clinician ’s judgment, the individual ’s \\nlack of knowledge or experience of her or his own body, sexual functio ning, and \\nsexual response is an important contributing factor to the Sexual Dysfunction or \\nSexual Pain Disorder. This includes inaccurate information or myths about sexual  \\nfunctioning.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 222, 'page_label': '223'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   9 \\n \\nHA40.4 Associated with relationship factors \\nhis category should be assigned when, in the clinician ’s judgment, relationship \\nfactors are important contributing factors to the Sexual Dysfunction or Sexual Pain  \\nDisorder. Examples include relationship conflict or lack of romantic attachment. T his \\ncategory may also be used when the Sexual Dysfunction or Sexual Pain Dis order is \\nassociated with a Sexual Dysfunction or Sexual Pain Disorder in the sexual partner.  \\n \\nHA40.5 Associated with cultural factors \\nThis category should be assigned when, in the clinician ’s judgment, cultural factors \\nare important contributing factors to the Sexual Dysfunction or Sexual Pain \\nDisorder. Cultural factors may influence expectations or provoke inhibitions about \\nthe experience of sexual pleasure or other aspects of sexual activity. Other \\nexamples include strong culturally shared beliefs about sexual expression, for \\nexample a belief that loss of semen can lead to weakness, disease or death. \\n \\nHA40.Y Other specified aetiological considerations in sexual dysfunctions and sexual \\npain disorders \\n \\nGender incongruence (BlockL1‑HA6) \\nGender incongruence is characterized by a marked and persistent incongruence bet ween an \\nindividual’s experienced gender and the assigned sex. Gender variant behaviour and preferences \\nalone are not a basis for assigning the diagnoses in this group. \\nExclusions: Paraphilic disorders  (BlockL1‑6D3) \\n  HA60   Gender incongruence of adolescence or adulthood \\nGender incongruence of adolescence and adulthood is characterized by a marked \\nand persistent incongruence between an individual´s experienced gender and the \\nassigned sex, as manifested by at least two of the following: 1) a strong disl ike or \\ndiscomfort with the one ’s primary or secondary sex characteristics (in adolescents, \\nanticipated secondary sex characteristics) due to their incongruity with the \\nexperienced gender; 2) a strong desire to be rid of some or all of one ’s primary \\nand/or secondary sex characteristics (in adolescents, anticipated secondary s ex \\ncharacteristics) due to their incongruity with the experienced gender; 3) a strong \\ndesire to have the primary and/or secondary sex characteristics of the experienced  \\ngender. The individual experiences a strong desire to be treated (to live and be \\naccepted) as a person of the experienced gender. The experienced gender \\nincongruence must have been continuously present for at least several months. The \\ndiagnosis cannot be assigned prior the onset of puberty. Gender variant behaviour \\nand preferences alone are not a basis for assigning the diagnosis. \\nExclusions: Paraphilic disorders  (BlockL1‑6D3)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 223, 'page_label': '224'}, page_content='10  ICD-11 MMS - 2018 \\n \\n  HA61   Gender incongruence of childhood \\nGender incongruence of childhood is characterized by a marked incongruence \\nbetween an individual’s experienced/expressed gender and the assigned sex in pre-\\npubertal children. It includes a strong desire to be a different gender than the \\nassigned sex; a strong dislike on the child ’s part of his or her sexual anatomy or \\nanticipated secondary sex characteristics and/or a strong desire for the primary \\nand/or anticipated secondary sex characteristics that match the experienced \\ngender; and make-believe or fantasy play, toys, games, or activities and pl aymates \\nthat are typical of the experienced gender rather than the assigned sex. The \\nincongruence must have persisted for about 2 years. Gender variant behaviour and \\npreferences alone are not a basis for assigning the diagnosis. \\nExclusions: Paraphilic disorders  (BlockL1‑6D3) \\n \\n  HA6Z   Gender incongruence, unspecified \\n \\n  HA8Y   Other specified conditions related to sexual health \\n \\n  HA8Z   Conditions related to sexual health, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 224, 'page_label': '225'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   1 \\n \\nCHAPTER V \\nSupplementary section for functioning assessment \\nThis chapter has 73 four-character categories. \\nCode range starts with VA00 \\nThe section allows for creating functioning profiles and overall functioning  scores of individuals, which \\nare suitable to describe and quantify the level of functioning associated with a health conditions. \\nTo guide functioning assessment, the section includes two ICF-based instruments  developed by \\nWHO: the WHO Disability Assessment Schedule (WHODAS 2.0 36-item version ), and the Model \\nDisability Survey (MDS). \\nThis chapter contains the following top level blocks: \\n\\uf0b7 WHODAS 2.0 36-item version \\n\\uf0b7 Brief Model Disability Survey'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 225, 'page_label': '226'}, page_content='2  ICD-11 MMS - 2018 \\n \\nWHODAS 2.0 36-item version (BlockL1‑VA0) \\n!markdown \\nThis subsection includes the domains and questions for use with the WHO Disabi lity Assessment \\nSchedule 2.0 (WHODAS 2.0) 36 item version. The WHODAS 2.0 captures an individual ’s level of \\nfunctioning in six major life domains of the “activity and participati on” dimension: cognition, mobility, \\nself-care, getting along, life activities and participation in society. For all domains, the WHODAS 2.0 \\n36-item version provides domain-specific and overall summary score of functioning.  \\nThe table below provides the classification of severity of the functioning pro blem, based on the \\nresponse received to the question related to the relevant functioning category.  \\nFor coding, the relevant additional digit is added after the decimal point to th e code of the relevant \\nfunctioning category. \\n+:---------------------+:----------------------------------+ \\n|**additional digit**  |**Level of functioning problem**   | \\n+======================+===================================+ \\n| .0                   |   None  (no problem)              | \\n+----------------------+-----------------------------------+ \\n| .1                   |   Mild                            | \\n+----------------------+-----------------------------------+ \\n| .2                   |   Moderate                        | \\n+----------------------+-----------------------------------+ \\n| .3                   |   Severe                          | \\n+----------------------+-----------------------------------+ \\n| .4                   |   Extreme or cannot do            | \\n+----------------------+-----------------------------------+ \\nCognition (BlockL2‑VA0) \\n  VA00   Attention functions \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in concentrating on doing something for ten minutes? \\n \\n  VA01   Memory functions \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in remembering to do important things? \\n \\n  VA02   Solving problems \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in analysing and finding solutions to problems in day to day life?'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 226, 'page_label': '227'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   3 \\n \\n  VA03   Basic learning \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in learning a new task, for example, learning how to get a new place? \\n \\n  VA04   Communicating with - receiving - spoken messages \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in generally understanding what people say? \\n \\n  VA05   Conversation \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in starting and maintaining a conversation? \\n \\n  VA0Y   Other specified cognition \\n \\n  VA0Z   Cognition, unspecified \\n \\nMobility (BlockL2‑VA1) \\n  VA10   Maintaining a standing position \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in standing for long periods such as 30 minutes? \\n \\n  VA11   Changing body position - standing \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in standing up from sitting down? \\n \\n  VA12   Moving around within the home \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in moving around inside your home? \\n \\n  VA13   Moving around around outside the home and other buildings \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in getting out of your home? \\n \\n  VA14   Walking \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in walking a long distance such as a kilometre (or equivalent)? \\n \\n  VA1Y   Other specified mobility \\n \\n  VA1Z   Mobility, unspecified \\n \\nSelf-care WHODAS (BlockL2‑VA2) \\n  VA20   Washing oneself \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in washing your whole body?'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 227, 'page_label': '228'}, page_content='4  ICD-11 MMS - 2018 \\n \\n  VA21   Dressing \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in getting dressed? \\n \\n  VA22   Eating \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in eating? \\n \\n  VA23   Carrying out daily routine \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in staying by yourself for a few days? \\n \\n  VA2Y   Other specified self-care WHODAS \\n \\n  VA2Z   Self-care WHODAS, unspecified \\n \\nGetting along (BlockL2‑VA3) \\n  VA30   Relating with strangers \\nBecause of your health condition, in the past 30 days, how much difficulty  did y ou \\nhave in dealing with people you do not know? \\n \\n  VA31   Informal relationship with friends - maintaining \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in maintaining a friendship? \\n \\n  VA32   Family relationships \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in getting along with people who are close to you? \\n \\n  VA33   Informal relationship with friends - making new friends \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in making new friends? \\n \\n  VA34   Intimate relationships \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in sexual activities? \\n \\n  VA3Y   Other specified getting along \\n \\n  VA3Z   Getting along, unspecified \\n \\nLife activities (BlockL2‑VA4) \\n  VA40   Taking care of household responsabilities \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in taking care of your household responsibilities?'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 228, 'page_label': '229'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   5 \\n \\n  VA41   Doing most important household tasks \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in doing most important household tasks well? \\n \\n  VA42   Doing housework \\n \\nVA42.0 Getting all needed housework done \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in getting all the household work done that you need to do? \\n \\nVA42.1 Getting hosehold work done quickly \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in getting your household work done as quickly as needed? \\n \\nVA42.Y Other specified doing housework \\n \\nVA42.Z Doing housework, unspecified \\n \\n  VA43   Remunerative employment \\n \\nVA43.0 Difficulties in daily work or school \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in your day to day work/school? \\n \\nVA43.1 Doing most important work or school task \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in doing your most important work/school tasks well? \\n \\nVA43.2 Getting all needed work or school work done \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in getting all the work done that you need to do? \\n \\nVA43.3 Getting remunerative work or school work done quickly \\nBecause of your health condition, in the past 30 days, how much difficulty  did you \\nhave in getting your work done as quickly as needed? \\n \\nVA43.Y Other specified remunerative employment \\n \\nVA43.Z Remunerative employment, unspecified \\n \\n  VA4Y   Other specified life activities \\n \\n  VA4Z   Life activities, unspecified \\n \\nParticipation and impact of health problems (BlockL2‑VA5) \\n  VA50   Recreation and leisure \\nIn the past 30 days, how much of a problem did you have in joining in community  \\nactivities (for example: festivities, religious or other activities) in the same way as \\nanyone else can?'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 229, 'page_label': '230'}, page_content='6  ICD-11 MMS - 2018 \\n \\n  VA51   Problems by barriers \\nIn the past 30 days, how much of a problem did you have because of barriers or \\nhindrances in the world around you? \\n \\n  VA52   Human rights \\nIn the past 30 days, how much of a problem did you have living with dignity because \\nof the attitudes and actions of others? \\n \\n  VA53   Time spent on health condition \\nIn the past 30 days, how much time did you spend on your health condition,  or its \\nconsequences? \\n \\n  VA54   Emotional effect of health condition \\nIn the past 30 days, how much have you been emotionally affected by your health \\ncondition? \\n \\n  VA55   Health drain on financial resources \\nIn the past 30 days, how much has your health been a drain on the financial \\nresources of you or your family? \\n \\n  VA56   Health problems causing family problems \\nIn the past 30 days, how much of a problem did your family have because of your \\nhealth problems? \\n \\n  VA57   Problems in relaxation or pleasure \\nIn the past 30 days, how much of a problem did you have in doing things by yourself \\nfor relaxation or pleasure? \\n \\n  VA5Y   Other specified participation and impact of health problems \\n \\n  VA5Z   Participation and impact of health problems, unspecified \\n \\n  VA7Y   Other specified WHODAS 2.0 36-item version \\n \\n  VA7Z   WHODAS 2.0 36-item version, unspecified \\n \\nBrief Model Disability Survey (BlockL1‑VA9) \\nThis subsection includes the domains and questions for use with the WHO Model Di sability Survey \\n(MDS) brief version. The brief MDS includes body functions as well as activi ties and participation \\ncategories. The brief MDS allows to generate an overall summary score of functioning. \\n  VA90   Seeing and related functions \\nHow much difficulty do you have seeing things at a distance [without glasses]? \\n \\n  VA91   Hearing and vestibular functions \\nHow much difficulty do you have hearing [without hearing aids]?'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 230, 'page_label': '231'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   7 \\n \\nMental functions (BlockL2‑VB0) \\nCoded Elsewhere: Attention functions (VA00) \\nMemory functions (VA01) \\n  VB00   Energy and drive functions \\n \\n  VB01   Sleep functions \\n \\n  VB02   Emotional functions \\n \\nSensory functions and pain (BlockL2‑VB1) \\nCoded Elsewhere: Seeing and related functions (VA90) \\nHearing and vestibular functions (VA91) \\n  VB10   Sensation of pain \\n \\n  VB2Y   Other specified brief Model Disability Survey \\n \\n  VB2Z   Brief Model Disability Survey, unspecified \\n \\n  VB40   Generic functioning domains \\nThis subsection contains a generic set of functioning categories of high expl anatory \\npower derived from the ICF Annex 9. \\nCoded Elsewhere: Learning and applying knowledge \\nCommunication \\nMajor life areas \\nCommunity, social and civic life \\nMental functions (VB00-VB02) \\nSensory functions and pain (VB10-VB10) \\n \\nVoice and speech functions (BlockL2‑VB6) \\n  VB60   Voice and speech related functions \\n \\nFunctions of the cardiovascular, haematological, immunological and respiratory systems \\n(BlockL2‑VB7) \\n  VB70   Exercise tolerance functions \\n \\nFunctions of the digestive, metabolic and endocrine systems (BlockL2‑VB8) \\n  VB80   Functions related to the digestive system'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 231, 'page_label': '232'}, page_content=\"8  ICD-11 MMS - 2018 \\n \\nGenitourinary and reproductive functions (BlockL2‑VB9) \\n  VB90   Urination functions \\n \\n  VB91   Sexual functions \\n \\nNeuromusculoskeletal and movement-related functions (BlockL2‑VC0) \\n  VC00   Mobility of joint functions \\n \\n  VC01   Muscle power functions \\n \\nVB40.5 Functions of the skin and related structures \\n \\nGeneral tasks and demands (BlockL2‑VC1) \\nCoded Elsewhere: Carrying out daily routine (VA23) \\n  VC10   Handling stress and other psychological demands \\n \\nMobility (BlockL2‑VC2) \\nCoded Elsewhere: Changing body position - standing (VA11) \\nMaintaining a standing position (VA10) \\nWalking (VA14) \\nMoving around within the home (VA12) \\n  VC20   Transferring oneself \\n \\n  VC21   Carrying, moving and handling objects \\n \\n  VC22   Moving around using equipment \\n \\n  VC23   Using transportation \\n \\nSelf-care (BlockL2‑VC3) \\nCoded Elsewhere: Washing oneself (VA20) \\nDressing (VA21) \\nEating (VA22) \\n  VC30   Caring for body parts \\n \\n  VC31   Toileting \\n \\n  VC32   Looking after one's health\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 232, 'page_label': '233'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   9 \\n \\nDomestic life (BlockL2‑VC4) \\nCoded Elsewhere: Doing housework (VA42) \\nTaking care of household responsabilities (VA40) \\nDoing most important household tasks (VA41) \\n  VC40   Preparing meals \\n \\n  VC41   Assisting others \\n \\nInterpersonal interactions and relationships (BlockL2‑VC5) \\nCoded Elsewhere: Relating with strangers (VA30) \\nIntimate relationships (VA34) \\n  VC50   Basic interpersonal interactions \\n \\nVB40.Y Other specified generic functioning domains \\n \\nVB40.Z Generic functioning domains, unspecified')]"
      ]
     },
     "execution_count": 7,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# import necessary library for load the pdf file and make the chunking opreration\n",
    "from langchain.document_loaders import PyPDFLoader, DirectoryLoader\n",
    "from langchain.text_splitter import RecursiveCharacterTextSplitter\n",
    "\n",
    "# Extract  the data from PDF files.\n",
    "def load_pdf_file(data):\n",
    "    loader = DirectoryLoader(\n",
    "                             data,\n",
    "                             glob = \"*.pdf\",\n",
    "                             loader_cls= PyPDFLoader\n",
    "                            )\n",
    "\n",
    "    documents = loader.load()\n",
    "    return documents\n",
    "\n",
    "# print the extracted data\n",
    "extracted_data = load_pdf_file(data = \"Data/\")\n",
    "print(\"extracted_data\" )\n",
    "extracted_data\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "id": "a3d334ac",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "The length of text chunks is : 1475\n"
     ]
    }
   ],
   "source": [
    "# Now we have perform the chunking operation\n",
    "# Split the data into chunks\n",
    "def text_splitter(extracted_data):\n",
    "    text_splitter = RecursiveCharacterTextSplitter(chunk_size = 500, chunk_overlap = 20)\n",
    "    text_chunks = text_splitter.split_documents(extracted_data)\n",
    "    return text_chunks\n",
    "\n",
    "text_chunks = text_splitter(extracted_data)\n",
    "print(\"The length of text chunks is :\", len(text_chunks))\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 9,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 1, 'page_label': '2'}, page_content=\"INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   1 \\n \\nCHAPTER 06 \\nMental, behavioural or neurodevelopmental \\ndisorders \\nThis chapter has 161 four-character categories. \\nCode range starts with 6A00 \\nMental, behavioural and neurodevelopmental disorders are syndromes characterized by c linically \\nsignificant disturbance in an individual's cognition, emotional regulation, or b ehaviour that reflects a\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 1, 'page_label': '2'}, page_content='dysfunction in the psychological, biological, or developmental processes that un derlie mental and \\nbehavioural functioning. These disturbances are usually associated with distres s or impairment in \\npersonal, family, social, educational, occupational, or other important areas of functioning. \\nExclusions: Acute stress reaction (QE84) \\nUncomplicated bereavement (QE62) \\nCoded Elsewhere: Sleep-wake disorders (7A00-7B2Z) \\nSexual dysfunctions (HA00-HA0Z) \\nGender incongruence (HA60-HA6Z)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 1, 'page_label': '2'}, page_content='This chapter contains the following top level blocks: \\n\\uf0b7 Neurodevelopmental disorders \\n\\uf0b7 Schizophrenia or other primary psychotic disorders \\n\\uf0b7 Catatonia \\n\\uf0b7 Mood disorders \\n\\uf0b7 Anxiety or fear-related disorders \\n\\uf0b7 Obsessive-compulsive or related disorders \\n\\uf0b7 Disorders specifically associated with stress \\n\\uf0b7 Dissociative disorders \\n\\uf0b7 Feeding or eating disorders \\n\\uf0b7 Elimination disorders \\n\\uf0b7 Disorders of bodily distress or bodily experience \\n\\uf0b7 Disorders due to substance use or addictive behaviours'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 1, 'page_label': '2'}, page_content='\\uf0b7 Impulse control disorders \\n\\uf0b7 Disruptive behaviour or dissocial disorders \\n\\uf0b7 Personality disorders and related traits \\n\\uf0b7 Paraphilic disorders \\n\\uf0b7 Factitious disorders \\n\\uf0b7 Neurocognitive disorders'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 2, 'page_label': '3'}, page_content='2  ICD-11 MMS - 2018 \\n \\n\\uf0b7 Mental or behavioural disorders associated with pregnancy, childbirth and the puerperium \\n\\uf0b7 Secondary mental or behavioural syndromes associated with disorders or diseases classif ied \\nelsewhere \\n \\nNeurodevelopmental disorders (BlockL1‑6A0) \\nNeurodevelopmental disorders are behavioural and cognitive disorders that arise during th e \\ndevelopmental period that involve significant difficulties in the acquis ition and execution of specific'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 2, 'page_label': '3'}, page_content='intellectual, motor, or social functions. Although behavioural and cognitive defic its are present in many \\nmental and behavioural disorders that can arise during the developmental period (e.g., Schiz ophrenia, \\nBipolar disorder), only disorders whose core features are neurodevelopmental are include d in this \\ngrouping. The presumptive etiology for neurodevelopmental disorders is complex, and i n many \\nindividual cases is unknown. \\nCoded Elsewhere: Primary tics or tic disorders (8A05.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 2, 'page_label': '3'}, page_content='Secondary neurodevelopmental syndrome (6E60) \\n  6A00   Disorders of intellectual development \\nDisorders of intellectual development are a group of etiologically diverse conditions  \\noriginating during the developmental period characterized by significantly be low \\naverage intellectual functioning and adaptive behavior that are approximately two or \\nmore standard deviations below the mean (approximately less than the 2.3rd'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 2, 'page_label': '3'}, page_content='percentile), based on appropriately normed, individually administered standard ized \\ntests. Where appropriately normed and standardized tests are not available, \\ndiagnosis of disorders of intellectual development requires greater reliance on \\nclinical judgment based on appropriate assessment of comparable behavioural \\nindicators. \\nNote: Use additional code, if desired, to identify any known aetiology. \\n \\n6A00.0 Disorder of intellectual development, mild'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 2, 'page_label': '3'}, page_content='A mild disorder of intellectual development is a condition originating dur ing the \\ndevelopmental period characterized by significantly below average intellect ual \\nfunctioning and adaptive behaviour that are approximately two to three standard \\ndeviations below the mean (approximately 0.1 – 2.3 percentile), based on \\nappropriately normed, individually administered standardized tests or by \\ncomparable behavioural indicators when standardized testing is unavailab le.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 2, 'page_label': '3'}, page_content='Affected persons often exhibit difficulties in the acquisition and comprehensio n of \\ncomplex language concepts and academic skills. Most master basic self-care, \\ndomestic, and practical activities. Persons affected by a mild disorder of intellec tual \\ndevelopment can generally achieve relatively independent living and employme nt \\nas adults but may require appropriate support.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 3, 'page_label': '4'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   3 \\n \\n6A00.1 Disorder of intellectual development, moderate \\nA moderate disorder of intellectual development is a condition originating during  the \\ndevelopmental period characterized by significantly below average intellect ual \\nfunctioning and adaptive behaviour that are approximately three to four standard \\ndeviations below the mean (approximately 0.003 – 0.1 percentile), based on'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 3, 'page_label': '4'}, page_content='appropriately normed, individually administered standardized tests or by \\ncomparable behavioural indicators when standardized testing is unavailab le. \\nLanguage and capacity for acquisition of academic skills of persons affected by a \\nmoderate disorder of intellectual development vary but are generally limited t o basic \\nskills. Some may master basic self-care, domestic, and practical activities. Mos t \\naffected persons require considerable and consistent support in order to achieve'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 3, 'page_label': '4'}, page_content='independent living and employment as adults. \\n \\n6A00.2 Disorder of intellectual development, severe \\nA severe disorder of intellectual development is a condition originating during the \\ndevelopmental period characterized by significantly below average intellect ual \\nfunctioning and adaptive behaviour that are approximately four of more standard  \\ndeviations below the mean (less than approximately the 0.003rd percentile), based'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 3, 'page_label': '4'}, page_content='on appropriately normed, individually administered standardized tests or by  \\ncomparable behavioural indicators when standardized testing is unavailab le. \\nAffected persons exhibit very limited language and capacity for acquisit ion of \\nacademic skills. They may also have motor impairments and typicall y require daily \\nsupport in a supervised environment for adequate care, but may acquire basic sel f-\\ncare skills with intensive training. Severe and profound disorders of intellectual'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 3, 'page_label': '4'}, page_content='development are differentiated exclusively on the basis of adaptive behaviour \\ndifferences because existing standardized tests of intelligence cannot reliably or \\nvalidly distinguish among individuals with intellectual functioning below the 0.003rd \\npercentile. \\n \\n6A00.3 Disorder of intellectual development, profound \\nA profound disorder of intellectual development is a condition originatin g during the \\ndevelopmental period characterized by significantly below average intellect ual'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 3, 'page_label': '4'}, page_content='functioning and adaptive behaviour that are approximately four of more standard  \\ndeviations below the mean (approximately less than the 0.003rd percentile), based  \\non individually administered appropriately normed, standardized tests or by  \\ncomparable behavioural indicators when standardized testing is unavailab le. \\nAffected persons possess very limited communication abilities and capac ity for \\nacquisition of academic skills is restricted to basic concrete skill s. They may also'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 3, 'page_label': '4'}, page_content='have co-occurring motor and sensory impairments and typically require daily \\nsupport in a supervised environment for adequate care. Severe and profound \\ndisorders of intellectual development are differentiated exclusively on the basis  of \\nadaptive behaviour differences because existing standardized tests of intelligenc e \\ncannot reliably or validly distinguish among individuals with intellectual functioning \\nbelow the 0.003rd percentile.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 4, 'page_label': '5'}, page_content='4  ICD-11 MMS - 2018 \\n \\n6A00.4 Disorder of intellectual development, provisional \\nDisorder of intellectual development, provisional is assigned when there is evidence \\nof a disorder of intellectual development but the individual is an infant or child under \\nthe age of four or it is not possible to conduct a valid assessment of intellectual \\nfunctioning and adaptive behaviour because of sensory or physical impairm ents'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 4, 'page_label': '5'}, page_content='(e.g., blindness, pre-lingual deafness), locomotor disability, severe problem \\nbehaviours or co-occurring mental and behavioural disorders. \\n \\n6A00.Z Disorders of intellectual development, unspecified \\n \\n  6A01   Developmental speech or language disorders \\nDevelopmental speech or language disorders arise during the developmental period \\nand are characterized by difficulties in understanding or producing speech and \\nlanguage or in using language in context for the purposes of communication that'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 4, 'page_label': '5'}, page_content='are outside the limits of normal variation expected for age and level of intellec tual \\nfunctioning. The observed speech and language problems are not attributable to \\nsocial or cultural factors (e.g., regional dialects) and are not fully explained b y \\nanatomical or neurological abnormalities. The presumptive etiology for \\nDevelopmental speech or language disorders is complex, and in many individual \\ncases is unknown. \\n \\n6A01.0 Developmental speech sound disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 4, 'page_label': '5'}, page_content='Developmental speech sound disorder is characterized by difficulties in the \\nacquisition, production and perception of speech that result in errors of \\npronunciation, either in number or types of speech errors made or the overall qualit y \\nof speech production, that are outside the limits of normal variation expected for age \\nand level of intellectual functioning and result in reduced intelligibi lity and \\nsignificantly affect communication. The errors in pronunciation arise during the early'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 4, 'page_label': '5'}, page_content='developmental period and cannot be explained by social, cultural, and other \\nenvironmental variations (e.g., regional dialects). The speech errors are not full y \\nexplained by a hearing impairment or a structural or neurological abnormality. \\nInclusions: Functional speech articulation disorder \\nExclusions: Deafness not otherwise specified (AB52) \\nDiseases of the nervous system (chapter 08) \\nDysarthria (MA80.2) \\n \\n6A01.1 Developmental speech fluency disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 4, 'page_label': '5'}, page_content='Developmental speech fluency disorder is characterized by persistent and frequ ent \\nor pervasive disruption of the rhythmic flow of speech that arises during the  \\ndevelopmental period and is outside the limits of normal variation expected for age \\nand level of intellectual functioning and results in reduced intelligibil ity and \\nsignificantly affects communication. It can involve repetitions of sounds , syllables or \\nwords, prolongations, word breaks, blockage of production, excessive use of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 4, 'page_label': '5'}, page_content='interjections, and rapid short bursts of speech. \\nExclusions: Tic disorders (8A05)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 5, 'page_label': '6'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   5 \\n \\n6A01.2 Developmental language disorder \\nDevelopmental language disorder is characterized by persistent difficulties i n the \\nacquisition, understanding, production or use of language (spoken or signed), that \\narise during the developmental period, typically during early childhood, and cause \\nsignificant limitations in the individual ’s ability to communicate. The individual ’s'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 5, 'page_label': '6'}, page_content='ability to understand, produce or use language is markedly below what would be \\nexpected given the individual ’s age and level of intellectual functioning. The \\nlanguage deficits are not explained by another neurodevelopmental disorder or a \\nsensory impairment or neurological condition, including the effects of brain i njury or \\ninfection. \\nExclusions: Autism spectrum disorder (6A02) \\nDiseases of the nervous system (chapter 08) \\nDeafness not otherwise specified (AB52) \\nSelective mutism (6B06)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 5, 'page_label': '6'}, page_content='6A01.20 Developmental language disorder with impairment of receptive and expressive \\nlanguage \\nDevelopmental language disorder with impairment of receptive and expressive \\nlanguage is characterized by persistent difficulties in the acquisition, unde rstanding, \\nproduction, and use of language that arise during the developmental period, \\ntypically during early childhood, and cause significant limitations in the individual ’s'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 5, 'page_label': '6'}, page_content='ability to communicate. The ability to understand spoken or signed language (i.e., \\nreceptive language) is markedly below the expected level given the individual ’s age \\nand level of intellectual functioning, and is accompanied by persistent impairment in \\nthe ability to produce and use spoken or signed language (i.e., expressive \\nlanguage). \\nInclusions: developmental dysphasia or aphasia, receptive type \\ndevelopmental Wernicke aphasia'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 5, 'page_label': '6'}, page_content='Exclusions: acquired aphasia with epilepsy [Landau-Kleffner] (8A62.2) \\nAutism spectrum disorder (6A02) \\nSelective mutism (6B06) \\ndysphasia NOS (MA80.1) \\nDiseases of the nervous system (chapter 08) \\nDeafness not otherwise specified (AB52)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 6, 'page_label': '7'}, page_content='6  ICD-11 MMS - 2018 \\n \\n6A01.21 Developmental language disorder with impairment of mainly expressive language  \\nDevelopmental language disorder with impairment of mainly expressive language is  \\ncharacterized by persistent difficulties in the acquisition, production, and use of \\nlanguage that arise during the developmental period, typically during early \\nchildhood, and cause significant limitations in the individual ’s ability to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 6, 'page_label': '7'}, page_content='communicate. The ability to produce and use spoken or signed language (i. e., \\nexpressive language) is markedly below the expected level given the indi vidual’s \\nage and level of intellectual functioning, but the ability to understand spoken  or \\nsigned language (i.e., receptive language) is relatively intact. \\nInclusions: Developmental dysphasia or aphasia, expressive type \\nExclusions: acquired aphasia with epilepsy [Landau-Kleffner] (8A62.2) \\nSelective mutism (6B06)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 6, 'page_label': '7'}, page_content='dysphasia and aphasia: developmental, receptive type \\n(6A01.20) \\ndysphasia NOS (MA80.1) \\naphasia NOS (MA80.0) \\nDiseases of the nervous system (chapter 08) \\nDeafness not otherwise specified (AB52) \\n \\n6A01.22 Developmental language disorder with impairment of mainly pragmatic language  \\nDevelopmental language disorder with impairment of mainly pragmatic language is \\ncharacterized by persistent and marked difficulties with the understanding and  use'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 6, 'page_label': '7'}, page_content='of language in social contexts, for example making inferences, understanding verbal \\nhumour, and resolving ambiguous meaning. These difficulties arise during the \\ndevelopmental period, typically during early childhood, and cause signifi cant \\nlimitations in the individual ’s ability to communicate. Pragmatic language abilities \\nare markedly below the expected level given the individual ’s age and level of \\nintellectual functioning, but the other components of receptive and expressiv e'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 6, 'page_label': '7'}, page_content='language are relatively intact. This qualifier should not be used if the pragmatic \\nlanguage impairment is better explained by Autism Spectrum Disorder or by \\nimpairments in other components of receptive or expressive language. \\nExclusions: Autism spectrum disorder (6A02) \\nDiseases of the nervous system (chapter 08) \\nSelective mutism (6B06)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 7, 'page_label': '8'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   7 \\n \\n6A01.23 Developmental language disorder, with other specified language impairment  \\nDevelopmental language disorder with other specified language impairment is \\ncharacterized by persistent difficulties in the acquisition, understanding, pro duction \\nor use of language (spoken or signed), that arise during the developmental period'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 7, 'page_label': '8'}, page_content='and cause significant limitations in the individual ’s ability to communicate. The \\npattern of specific deficits in language abilities is not adequately cap tured by any of \\nthe other developmental language disorder categories. \\nExclusions: Autism spectrum disorder (6A02) \\nDiseases of the nervous system (chapter 08) \\nDisorders of intellectual development (6A00) \\nSelective mutism (6B06) \\n \\n6A01.Y Other specified developmental speech or language disorders'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 7, 'page_label': '8'}, page_content='6A01.Z Developmental speech or language disorders, unspecified \\n \\n  6A02   Autism spectrum disorder \\nAutism spectrum disorder is characterized by persistent deficits in the a bility to \\ninitiate and to sustain reciprocal social interaction and social communication, and  by \\na range of restricted, repetitive, and inflexible patterns of behaviour and i nterests. \\nThe onset of the disorder occurs during the developmental period, typically  in early'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 7, 'page_label': '8'}, page_content='childhood, but symptoms may not become fully manifest until later, when social  \\ndemands exceed limited capacities. Deficits are sufficiently severe to cause \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning and are usually a pervasive feature of the individual ’s \\nfunctioning observable in all settings, although they may vary according to social, \\neducational, or other context. Individuals along the spectrum exhibit a full rang e of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 7, 'page_label': '8'}, page_content='intellectual functioning and language abilities. \\nInclusions: Autistic disorder \\nPervasive developmental delay \\nExclusions: Developmental language disorder (6A01.2) \\nSchizophrenia or other primary psychotic disorders \\n(BlockL1‑6A2) \\n \\n6A02.0 Autism spectrum disorder without disorder of intellectual development and \\nwith mild or no impairment of functional language \\nAll definitional requirements for autism spectrum disorder are met, intellectual'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 7, 'page_label': '8'}, page_content=\"functioning and adaptive behaviour are found to be at least within the average  \\nrange (approximately greater than the 2.3rd percentile), and there is only mild or no \\nimpairment in the individual's capacity to use functional language ( spoken or \\nsigned) for instrumental purposes, such as to express personal needs and desires. \\n \\n6A02.1 Autism spectrum disorder with disorder of intellectual development and with \\nmild or no impairment of functional language\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 7, 'page_label': '8'}, page_content=\"All definitional requirements for both autism spectrum disorder and disorder of \\nintellectual development are met and there is only mild or no impairment in the  \\nindividual's capacity to use functional language (spoken or signed) for instrumental \\npurposes, such as to express personal needs and desires.\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 8, 'page_label': '9'}, page_content='8  ICD-11 MMS - 2018 \\n \\n6A02.2 Autism spectrum disorder without disorder of intellectual development and \\nwith impaired functional language \\nAll definitional requirements for autism spectrum disorder are met, intellectual  \\nfunctioning and adaptive behaviour are found to be at least within the average  \\nrange (approximately greater than the 2.3rd percentile), and there is marked \\nimpairment in functional language (spoken or signed) relative to the individual ’s age,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 8, 'page_label': '9'}, page_content='with the individual not able to use more than single words or simple phrases fo r \\ninstrumental purposes, such as to express personal needs and desires. \\n \\n6A02.3 Autism spectrum disorder with disorder of intellectual development and with \\nimpaired functional language \\nAll definitional requirements for both autism spectrum disorder and disorder of \\nintellectual development are met and there is marked impairment in functional'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 8, 'page_label': '9'}, page_content='language (spoken or signed) relative to the individual ’s age, with the individual not \\nable to use more than single words or simple phrases for instrumental purposes, \\nsuch as to express personal needs and desires. \\n \\n6A02.4 Autism spectrum disorder without disorder of intellectual development and \\nwith absence of functional language \\nAll definitional requirements for autism spectrum disorder are met, intellectual'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 8, 'page_label': '9'}, page_content='functioning and adaptive behaviour are found to be at least within the averag e \\nrange (approximately greater than the 2.3rd percentile), and there is complete, or \\nalmost complete, absence of ability relative to the individual ’s age to use functional \\nlanguage (spoken or signed) for instrumental purposes, such as to express \\npersonal needs and desires. \\n \\n6A02.5 Autism spectrum disorder with disorder of intellectual development and with \\nabsence of functional language'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 8, 'page_label': '9'}, page_content='All definitional requirements for both autism spectrum disorder and disorder of \\nintellectual development are met and there is complete, or almost complete, \\nabsence of ability relative to the individual ’s age to use functional language (spoken \\nor signed) for instrumental purposes, such as to express personal needs and \\ndesires \\n \\n6A02.Y Other specified autism spectrum disorder \\n \\n6A02.Z Autism spectrum disorder, unspecified \\n \\n  6A03   Developmental learning disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 8, 'page_label': '9'}, page_content='Developmental learning disorder is characterized by significant and persistent \\ndifficulties in learning academic skills, which may include reading, writing, or \\narithmetic. The individual ’s performance in the affected academic skill(s) is \\nmarkedly below what would be expected for chronological age and general level of \\nintellectual functioning, and results in significant impairment in the indiv idual’s \\nacademic or occupational functioning. Developmental learning disorder first'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 8, 'page_label': '9'}, page_content='manifests when academic skills are taught during the early school years. \\nDevelopmental learning disorder is not due to a disorder of intellectual \\ndevelopment, sensory impairment (vision or hearing), neurological or motor \\ndisorder, lack of availability of education, lack of proficiency in the lang uage of \\nacademic instruction, or psychosocial adversity. \\nExclusions: Symbolic dysfunctions (MB4B)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 9, 'page_label': '10'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   9 \\n \\n6A03.0 Developmental learning disorder with impairment in reading \\nDevelopmental learning disorder with impairment in reading is characterized by \\nsignificant and persistent difficulties in learning academic skills related to reading, \\nsuch as word reading accuracy, reading fluency, and reading comprehension. The'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 9, 'page_label': '10'}, page_content='individual’s performance in reading is markedly below what would be expected for \\nchronological age and level of intellectual functioning and results in signif icant \\nimpairment in the individual ’s academic or occupational functioning. Developmental \\nlearning disorder with impairment in reading is not due to a disorder of intellect ual \\ndevelopment, sensory impairment (vision or hearing), neurological disorder, l ack of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 9, 'page_label': '10'}, page_content='availability of education, lack of proficiency in the language of academic i nstruction, \\nor psychosocial adversity. \\nInclusions: Developmental dyslexia \\nExclusions: Disorders of intellectual development (6A00) \\n \\n6A03.1 Developmental learning disorder with impairment in written expression \\nDevelopmental learning disorder with impairment in written expression is \\ncharacterized by significant and persistent difficulties in learning academic  skills'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 9, 'page_label': '10'}, page_content='related to writing, such as spelling accuracy, grammar and punctuation accuracy, \\nand organization and coherence of ideas in writing. The individual ’s performance in \\nwritten expression is markedly below what would be expected for chronological age \\nand level of intellectual functioning and results in significant impair ment in the \\nindividual’s academic or occupational functioning. Developmental learning disorder \\nwith impairment in written expression is not due to a disorder of intellectual'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 9, 'page_label': '10'}, page_content='development, sensory impairment (vision or hearing), a neurological or motor \\ndisorder, lack of availability of education, lack of proficiency in the lang uage of \\nacademic instruction, or psychosocial adversity. \\nExclusions: Disorders of intellectual development (6A00) \\n \\n6A03.2 Developmental learning disorder with impairment in mathematics \\nDevelopmental learning disorder with impairment in mathematics is characterized'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 9, 'page_label': '10'}, page_content='by significant and persistent difficulties in learning academic ski lls related to \\nmathematics or arithmetic, such as number sense, memorization of number facts , \\naccurate calculation, fluent calculation, and accurate mathematic reasoning. The \\nindividual’s performance in mathematics or arithmetic is markedly below what would \\nbe expected for chronological or developmental age and level of intellectual \\nfunctioning and results in significant impairment in the individual ’s academic or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 9, 'page_label': '10'}, page_content='occupational functioning. Developmental learning disorder with impairment in \\nmathematics is not due to a disorder of intellectual development, sensory \\nimpairment (vision or hearing), a neurological disorder, lack of availability of \\neducation, lack of proficiency in the language of academic instruction, or \\npsychosocial adversity. \\nExclusions: Disorders of intellectual development (6A00)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 10, 'page_label': '11'}, page_content='10  ICD-11 MMS - 2018 \\n \\n6A03.3 Developmental learning disorder with other specified impairment of learning  \\nDevelopmental learning disorder with other specified impairment of learning is \\ncharacterized by significant and persistent difficulties in learning academic  skills \\nother than reading, mathematics, and written expression. The individual ’s \\nperformance in the relevant academic skill is markedly below what would be'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 10, 'page_label': '11'}, page_content='expected for chronological age and level of intellectual functioning and results  in \\nsignificant impairment in the individual ’s academic or occupational functioning. \\nDevelopmental learning disorder with other specified impairment of learning is no t \\ndue to a disorder of intellectual development, sensory impairment (vision or \\nhearing), neurological disorder, lack of availability of education, lack of profic iency in \\nthe language of academic instruction, or psychosocial adversity.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 10, 'page_label': '11'}, page_content='Exclusions: Disorders of intellectual development (6A00) \\n \\n6A03.Z Developmental learning disorder, unspecified \\n \\n  6A04   Developmental motor coordination disorder \\nDevelopmental motor coordination disorder is characterized by a significant d elay in \\nthe acquisition of gross and fine motor skills and impairment in the executio n of \\ncoordinated motor skills that manifest in clumsiness, slowness, or inaccurac y of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 10, 'page_label': '11'}, page_content=\"motor performance. Coordinated motor skills are substantially below that expected \\ngiven the individual's chronological age and level of intellectual functioning . Onset of \\ncoordinated motor skills difficulties occurs during the developmental period a nd is \\ntypically apparent from early childhood. Coordinated motor skills difficulti es cause \\nsignificant and persistent limitations in functioning (e.g., in activities  of daily living,\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 10, 'page_label': '11'}, page_content='school work, and vocational and leisure activities). Difficulties with coor dinated \\nmotor skills are not solely attributable to a Disease of the Nervous System, Disease \\nof the Musculoskeletal System or Connective Tissue, sensory impairment, and not \\nbetter explained by a Disorder of Intellectual Development. \\nExclusions: Abnormalities of gait and mobility (MB44) \\nDiseases of the musculoskeletal system or connective tissue \\n(chapter 15) \\nDiseases of the nervous system (chapter 08)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 11, 'page_label': '12'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   11 \\n \\n  6A05   Attention deficit hyperactivity disorder \\nAttention deficit hyperactivity disorder is characterized by a persistent patter n (at \\nleast 6 months) of inattention and/or hyperactivity-impulsivity, with onset du ring the \\ndevelopmental period, typically early to mid-childhood. The degree of inattention'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 11, 'page_label': '12'}, page_content='and hyperactivity-impulsivity is outside the limits of normal variation ex pected for \\nage and level of intellectual functioning and significantly interferes with academic, \\noccupational, or social functioning. Inattention refers to significant difficul ty in \\nsustaining attention to tasks that do not provide a high level of stimulation  or \\nfrequent rewards, distractibility and problems with organization. Hyperactivit y refers'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 11, 'page_label': '12'}, page_content='to excessive motor activity and difficulties with remaining still, most evi dent in \\nstructured situations that require behavioural self-control. Impulsivity is a ten dency \\nto act in response to immediate stimuli, without deliberation or consideration of  the \\nrisks and consequences. The relative balance and the specific manifestations  of \\ninattentive and hyperactive-impulsive characteristics varies across indiv iduals, and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 11, 'page_label': '12'}, page_content='may change over the course of development. In order for a diagnosis of disorder the \\nbehaviour pattern must be clearly observable in more than one setting. \\nInclusions: attention deficit disorder with hyperactivity \\nattention deficit syndrome with hyperactivity \\nExclusions: Autism spectrum disorder (6A02) \\nDisruptive behaviour or dissocial disorders (BlockL1‑6C9) \\n \\n6A05.0 Attention deficit hyperactivity disorder, predominantly inattentive \\npresentation'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 11, 'page_label': '12'}, page_content='presentation \\nAll definitional requirements for attention deficit hyperactivity disorder are met and \\ninattentive symptoms are predominant in the clinical presentation. Inattentio n refers \\nto significant difficulty in sustaining attention to tasks that do not provi de a high level \\nof stimulation or frequent rewards, distractibility and problems with organization. \\nSome hyperactive-impulsive symptoms may also be present, but these are not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 11, 'page_label': '12'}, page_content='clinically significant in relation to the inattentive symptoms. \\n \\n6A05.1 Attention deficit hyperactivity disorder, predominantly hyperactive-impulsive \\npresentation \\nAll definitional requirements for attention deficit hyperactivity disorder are met and \\nhyperactive-impulsive symptoms are predominant in the clinical presentation. \\nHyperactivity refers to excessive motor activity and difficulties with remai ning still,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 11, 'page_label': '12'}, page_content='most evident in structured situations that require behavioural self-control. Impu lsivity \\nis a tendency to act in response to immediate stimuli, without deliberation or \\nconsideration of the risks and consequences. Some inattentive symptoms ma y also \\nbe present, but these are not clinically significant in relation to the hyperac tive-\\nimpulsive symptoms.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 12, 'page_label': '13'}, page_content='12  ICD-11 MMS - 2018 \\n \\n6A05.2 Attention deficit hyperactivity disorder, combined presentation \\nAll definitional requirements for attention deficit hyperactivity disorder are met. Both \\ninattentive and hyperactive-impulsive symptoms are clinically signi ficant, with \\nneither predominating in the clinical presentation. Inattention refers to signific ant \\ndifficulty in sustaining attention to tasks that do not provide a high level of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 12, 'page_label': '13'}, page_content='stimulation or frequent rewards, distractibility and problems with organization. \\nHyperactivity refers to excessive motor activity and difficulties with remai ning still, \\nmost evident in structured situations that require behavioural self-control. Impu lsivity \\nis a tendency to act in response to immediate stimuli, without deliberation or \\nconsideration of the risks and consequences. \\n \\n6A05.Y Attention deficit hyperactivity disorder, other specified presentation'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 12, 'page_label': '13'}, page_content='6A05.Z Attention deficit hyperactivity disorder, presentation unspecified \\n \\n  6A06   Stereotyped movement disorder \\nStereotyped movement disorder is characterized by voluntary, repetitive, \\nstereotyped, apparently purposeless (and often rhythmic) movements that arise \\nduring the early developmental period, are not caused by the direct physiologi cal \\neffects of a substance or medication (including withdrawal), and markedly inte rfere'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 12, 'page_label': '13'}, page_content='with normal activities or result in self-inflicted bodily injury. Stereoty ped movements \\nthat are non-injurious can include body rocking, head rocking, finger-flicki ng \\nmannerisms, and hand flapping. Stereotyped self-injurious behaviours can incl ude \\nrepetitive head banging, face slapping, eye poking, and biting of the hands, l ips, or \\nother body parts. \\nExclusions: Tic disorders (8A05) \\nTrichotillomania (6B25.0) \\nAbnormal involuntary movements (MB46)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 12, 'page_label': '13'}, page_content='6A06.0 Stereotyped movement disorder without self-injury \\nThis category should be applied to forms of Stereotyped movement disorder in \\nwhich stereotyped behaviours markedly interfere with normal activities, but do not \\nresult in self-inflicted bodily injury. Stereotyped movement disorder without s elf-\\ninjury is characterized by voluntary, repetitive, stereotyped, apparently purpos eless \\n(and often rhythmic) movements that arise during the early developmental period,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 12, 'page_label': '13'}, page_content='are not caused by the direct physiological effects of a substance or medication \\n(including withdrawal), and markedly interfere with normal activities. Stereotyp ed \\nmovements that are non-injurious can include body rocking, head rocking, finger-\\nflicking mannerisms, and hand flapping. \\n \\n6A06.1 Stereotyped movement disorder with self-injury \\nThis category should be applied to forms of Stereotyped movement disorder in'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 12, 'page_label': '13'}, page_content='which stereotyped behaviours result in self-inflicted bodily injury that is s ignificant \\nenough to require medical treatment, or would result in such injury if protective \\nmeasures (e.g., helmet to prevent head injury) were not employed. Stereotyped \\nmovement disorder with self-injury is characterized by voluntary, repetitive,  \\nstereotyped, apparently purposeless (and often rhythmic) movements that arise \\nduring the early developmental period, are not caused by the direct physiologi cal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 12, 'page_label': '13'}, page_content='effects of a substance or medication (including withdrawal). Stereotyped \\nmovements that are self-injurious can include head banging, face slapping, ey e \\npoking, and biting of the hands, lips, or other body parts.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 13, 'page_label': '14'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   13 \\n \\n6A06.Z Stereotyped movement disorder, unspecified \\n \\n  6A0Y   Other specified neurodevelopmental disorders \\n \\n  6A0Z   Neurodevelopmental disorders, unspecified \\n \\nSchizophrenia or other primary psychotic disorders (BlockL1‑6A2) \\nSchizophrenia and other primary psychotic disorders are characterized by signif icant impairments in'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 13, 'page_label': '14'}, page_content='reality testing and alterations in behavior manifest in positive symptoms such as persistent delusions, \\npersistent hallucinations, disorganized thinking (typically manifest as disorganized speech), grossly \\ndisorganized behavior, and experiences of passivity and control, negative sy mptoms such as blunted \\nor flat affect and avolition, and psychomotor disturbances. The symptoms occur with suf ficient'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 13, 'page_label': '14'}, page_content='frequency and intensity to deviate from expected cultural or subcultural norms. These symptoms do \\nnot arise as a feature of another mental and behavioural disorder (e.g., a mood disorder , delirium, or \\na disorder due to substance use). The categories in this grouping should not be used to classify the \\nexpression of ideas, beliefs, or behaviours that are culturally sanctioned. \\nCoded Elsewhere: Substance-induced psychotic disorders \\nSecondary psychotic syndrome (6E61) \\n  6A20   Schizophrenia'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 13, 'page_label': '14'}, page_content=\"Schizophrenia is characterized by disturbances in multiple mental modalities, \\nincluding thinking (e.g., delusions, disorganization in the form of thought), \\nperception (e.g., hallucinations), self-experience (e.g., the experience that on e's \\nfeelings, impulses, thoughts, or behaviour are under the control of an external \\nforce), cognition (e.g., impaired attention, verbal memory, and social cognition) , \\nvolition (e.g., loss of motivation), affect (e.g., blunted emotional expression), an d\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 13, 'page_label': '14'}, page_content='behaviour (e.g.,behaviour that appears bizarre or purposeless, unpredictable or \\ninappropriate emotional responses that interfere with the organization of behaviour). \\nPsychomotor disturbances, including catatonia, may be present. Persistent \\ndelusions, persistent hallucinations, thought disorder, and experiences of inf luence, \\npassivity, or control are considered core symptoms. Symptoms must have pers isted'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 13, 'page_label': '14'}, page_content='for at least one month in order for a diagnosis of schizophrenia to be assigned. The  \\nsymptoms are not a manifestation of another health condition (e.g., a brain tumour) \\nand are not due to the effect of a substance or medication on the central nervous \\nsystem (e.g., corticosteroids), including withdrawal (e.g., alcohol withdrawal). \\nExclusions: Schizotypal disorder (6A22) \\nschizophrenic reaction (6A22) \\nAcute and transient psychotic disorder (6A23) \\n \\n6A20.0 Schizophrenia, first episode'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 13, 'page_label': '14'}, page_content='Schizophrenia, first episode should be used to identify individuals experi encing \\nsymptoms that meet the diagnostic requirements for Schizophrenia (including \\nduration) but who have never before experienced an episode during which \\ndiagnostic requirements for Schizophrenia were met. \\n \\n6A20.00 Schizophrenia, first episode, currently symptomatic \\nAll definitional requirements for Schizophrenia, first episode in terms  of symptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 13, 'page_label': '14'}, page_content='and duration are currently met, or have been met within the past one month.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 14, 'page_label': '15'}, page_content='14  ICD-11 MMS - 2018 \\n \\n6A20.01 Schizophrenia, first episode, in partial remission \\nAll definitional requirements for Schizophrenia, first episode in terms  of symptoms \\nand duration were previously met. Symptoms have ameliorated such that the \\ndiagnostic requirements for the disorder have not been met for at least one month, \\nbut some clinically significant symptoms remain, which may or may not  be \\nassociated with functional impairment. The partial remission may have occurred in'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 14, 'page_label': '15'}, page_content='response to medication or other treatment. \\n \\n6A20.02 Schizophrenia, first episode, in full remission \\nAll definitional requirements for Schizophrenia, first episode in terms  of symptoms \\nand duration were previously met. Symptoms have ameliorated such that no \\nsignificant symptoms remain. The remission may have occurred in res ponse to \\nmedication or other treatment. \\n \\n6A20.0Z Schizophrenia, first episode, unspecified \\n \\n6A20.1 Schizophrenia, multiple episodes'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 14, 'page_label': '15'}, page_content='Schizophrenia, multiple episode should be used to identify individuals exp eriencing \\nsymptoms that meet the diagnostic requirements for Schizophrenia (including \\nduration) and who have also previously experienced episodes during which \\ndiagnostic requirements were met, with substantial remission of symptoms between \\nepisodes. Some attenuated symptoms may remain during periods of remission, and \\nremissions may have occurred in response to medication or other treatment.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 14, 'page_label': '15'}, page_content='6A20.10 Schizophrenia, multiple episodes, currently symptomatic \\nAll definitional requirements for Schizophrenia, multiple episodes in terms  of \\nsymptoms and duration are currently met, or have been met within the past one \\nmonth. \\n \\n6A20.11 Schizophrenia, multiple episodes, in partial remission \\nAll definitional requirements for Schizophrenia, multiple episodes in terms  of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 14, 'page_label': '15'}, page_content='the diagnostic requirements for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or ma y not be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A20.12 Schizophrenia, multiple episodes, in full remission \\nAll definitional requirements for Schizophrenia, multiple episodes in terms  of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 14, 'page_label': '15'}, page_content='symptoms and duration were previously met. Symptoms have ameliorated such that \\nno significant symptoms remain. The remission may have occurred in res ponse to \\nmedication or other treatment. \\n \\n6A20.1Z Schizophrenia, multiple episodes, unspecified \\n \\n6A20.2 Schizophrenia, continuous \\nSymptoms fulfilling all definitional requirements of Schizophrenia have been present \\nfor almost all of the illness course over a period of at least one year, with periods of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 14, 'page_label': '15'}, page_content='subthreshold symptoms being very brief relative to the overall course.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 15, 'page_label': '16'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   15 \\n \\n6A20.20 Schizophrenia, continuous, currently symptomatic \\nAll definitional requirements for Schizophrenia, continuous in terms of sy mptoms \\nand duration are currently met, or have been met within the past one month. \\n \\n6A20.21 Schizophrenia, continuous, in partial remission \\nAll definitional requirements for Schizophrenia, continuous in terms of sy mptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 15, 'page_label': '16'}, page_content='and duration were previously met. Symptoms have ameliorated such that the \\ndiagnostic requirements for the disorder have not been met for at least one month, \\nbut some clinically significant symptoms remain, which may or may not  be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A20.22 Schizophrenia, continuous, in full remission \\nAll definitional requirements for Schizophrenia, continuous in terms of sy mptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 15, 'page_label': '16'}, page_content='and duration were previously met. Symptoms have ameliorated such that no \\nsignificant symptoms remain. The remission may have occurred in res ponse to \\nmedication or other treatment. \\n \\n6A20.2Z Schizophrenia, continuous, unspecified \\n \\n6A20.Y Other specified schizophrenia \\n \\n6A20.Z Schizophrenia, unspecified \\n \\n  6A21   Schizoaffective disorder \\nSchizoaffective disorder is an episodic disorder in which the diagnostic \\nrequirements of schizophrenia and a manic, mixed, or moderate or severe'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 15, 'page_label': '16'}, page_content='depressive episode are met within the same episode of illness, either \\nsimultaneously or within a few days of each other. Prominent symptoms of \\nschizophrenia (e.g. delusions, hallucinations, disorganization in the form of thought, \\nexperiences of influence, passivity and control) are accompanied by typi cal \\nsymptoms of a depressive episode (e.g. depressed mood, loss of interest, reduced \\nenergy), a manic episode (e.g., elevated mood, increase in the quality and sp eed of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 15, 'page_label': '16'}, page_content='physical and mental activity) or a mixed episode. Psychomotor disturbances , \\nincluding catatonia, may be present. Symptoms must have persisted for at least one  \\nmonth. The symptoms are not a manifestation of another health condition (e.g., a \\nbrain tumor) and are not due to the effect of a substance or medication on the \\ncentral nervous system (e.g., corticosteroids), including withdrawal (e.g., alcoh ol \\nwithdrawal). \\n \\n6A21.0 Schizoaffective disorder, first episode'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 15, 'page_label': '16'}, page_content='Schizoaffective disorder, first episode should be used to identify individual s \\nexperiencing symptoms that meet the diagnostic requirements for Schizoaffective  \\ndisorder (including duration) but who have never before experienced an episode \\nduring which diagnostic requirements for Schizoaffective disorder or Schi zophrenia \\nwere met. \\n \\n6A21.00 Schizoaffective disorder, first episode, currently symptomatic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 15, 'page_label': '16'}, page_content='All definitional requirements for Schizoaffective disorder, first episode  in terms of \\nsymptoms and duration are currently met, or have been met within the past one \\nmonth.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 16, 'page_label': '17'}, page_content='16  ICD-11 MMS - 2018 \\n \\n6A21.01 Schizoaffective disorder, first episode, in partial remission \\nAll definitional requirements for Schizoaffective disorder, first episode  in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such th at \\nthe diagnostic requirements for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or ma y not be'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 16, 'page_label': '17'}, page_content='associated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A21.02 Schizoaffective disorder, first episode, in full remission \\nAll definitional requirements for Schizoaffective disorder, first episode  in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nno significant symptoms remain. The remission may have occurred in res ponse to \\nmedication or other treatment.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 16, 'page_label': '17'}, page_content='6A21.0Z Schizoaffective disorder, first episode, unspecified \\n \\n6A21.1 Schizoaffective disorder, multiple episodes \\nSchizoaffective disorder, multiple episodes should be used to identify indiv iduals \\nexperiencing symptoms that meet the diagnostic requirements for Schizoaffective  \\ndisorder (including duration) and who have also previously experienced episodes  \\nduring which diagnostic requirements for Schizoaffective disorder or Schi zophrenia'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 16, 'page_label': '17'}, page_content='were met, with substantial remission of symptoms between episodes. Some \\nattenuated symptoms may remain during period of remission, and remissions may \\nhave occurred in response to medication or other treatment. \\n \\n6A21.10 Schizoaffective disorder, multiple episodes, currently symptomatic \\nAll definitional requirements for Schizoaffective disorder, multiple episod es in terms \\nof symptoms and duration are currently met, or have been met within the past one \\nmonth.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 16, 'page_label': '17'}, page_content='month. \\n \\n6A21.11 Schizoaffective disorder, multiple episodes, in partial remission \\nAll definitional requirements for Schizoaffective disorder, multiple episod es in terms \\nof symptoms and duration were previously met. Symptoms have ameliorated such \\nthat the diagnostic requirements for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or ma y not be'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 16, 'page_label': '17'}, page_content='associated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A21.12 Schizoaffective disorder, multiple episodes, in full remission \\nAll definitional requirements for Schizoaffective disorder, multiple episod es in terms \\nof symptoms and duration were previously met. Symptoms have ameliorated such \\nthat no significant symptoms remain. The remission may have occurred in r esponse \\nto medication or other treatment.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 16, 'page_label': '17'}, page_content='6A21.1Z Schizoaffective disorder, multiple episodes, unspecified \\n \\n6A21.2 Schizoaffective disorder, continuous \\nSymptoms fulfilling all definitional requirements of Schizoaffective d isorder have \\nbeen present for almost all of the illness course over a period of at least one y ear, \\nwith periods of subthreshold symptoms being very brief relative to the overall \\ncourse.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 17, 'page_label': '18'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   17 \\n \\n6A21.20 Schizoaffective disorder, continuous, currently symptomatic \\nAll definitional requirements for Schizoaffective disorder, continuous in terms of \\nsymptoms and duration are currently met, or have been met within the past one \\nmonth. \\n \\n6A21.21 Schizoaffective disorder, continuous, in partial remission \\nAll definitional requirements for Schizoaffective disorder, continuous in terms of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 17, 'page_label': '18'}, page_content='symptoms and duration were previously met. Symptoms have ameliorated such that \\nthe diagnostic requirements for the disorder have not been met for at least one \\nmonth, but some clinically significant symptoms remain, which may or ma y not be \\nassociated with functional impairment. The partial remission may have occurred in \\nresponse to medication or other treatment. \\n \\n6A21.22 Schizoaffective disorder, continuous, in full remission'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 17, 'page_label': '18'}, page_content='All definitional requirements for Schizoaffective disorder, continuous in terms of \\nsymptoms and duration were previously met. Symptoms have ameliorated such that \\nno significant symptoms remain. The remission may have occurred in res ponse to \\nmedication or other treatment. \\n \\n6A21.2Z Schizoaffective disorder, continuous, unspecified \\n \\n6A21.Y Other specified schizoaffective disorder \\n \\n6A21.Z Schizoaffective disorder, unspecified \\n \\n  6A22   Schizotypal disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 17, 'page_label': '18'}, page_content='Schizotypal disorder is characterized by an enduring pattern (i.e., characteristi c of \\nthe person’s functioning over a period of at least several years) of eccentricities in \\nbehavior, appearance and speech, accompanied by cognitive and perceptual \\ndistortions, unusual beliefs, and discomfort with — and often reduced capacity for — \\ninterpersonal relationships. Symptoms may include constricted or inappropr iate'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 17, 'page_label': '18'}, page_content='affect and anhedonia (negative schizotypy). Paranoid ideas, ideas of reference, or  \\nother psychotic symptoms, including hallucinations in any modality, may occur \\n(positive schizotypy), but are not of sufficient intensity or duration to meet the  \\ndiagnostic requirements of schizophrenia, schizoaffective disorder, or delusional \\ndisorder. The symptoms cause distress or impairment in personal, family, soc ial, \\neducational, occupational or other important areas of functioning.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 17, 'page_label': '18'}, page_content='Inclusions: Schizotypal personality disorder \\nExclusions: Autism spectrum disorder (6A02) \\nPersonality disorder (6D10)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 18, 'page_label': '19'}, page_content='18  ICD-11 MMS - 2018 \\n \\n  6A23   Acute and transient psychotic disorder \\nAcute and transient psychotic disorder is characterized by acute onset of psych otic \\nsymptoms that emerge without a prodrome and reach their maximal severity within \\ntwo weeks. Symptoms may include delusions, hallucinations, disorganization of \\nthought processes, perplexity or confusion, and disturbances of affect and mood. \\nCatatonia-like psychomotor disturbances may be present. Symptoms typically'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 18, 'page_label': '19'}, page_content='change rapidly, both in nature and intensity, from day to day, or even  within a single \\nday. The duration of the episode does not exceed 3 months, and most commonly \\nlasts from a few days to 1 month. The symptoms are not a manifestation of anot her \\nhealth condition (e.g., a brain tumor) and are not due to the effect of a substance or  \\nmedication on the central nervous system (e.g., corticosteroids), including \\nwithdrawal (e.g., alcohol withdrawal).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 18, 'page_label': '19'}, page_content='6A23.0 Acute and transient psychotic disorder, first episode \\nAcute and transient psychotic disorder, first episode should be used to iden tify \\nindividuals experiencing symptoms that meet the diagnostic requirements for acute \\nand transient psychotic disorder but who have never before experienced a sim ilar \\nepisode. \\n \\n6A23.00 Acute and transient psychotic disorder, first episode, currently symptomatic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 18, 'page_label': '19'}, page_content='All definitional requirements for Acute and transient psychotic disorder, first episode \\nin terms of symptoms and duration are currently met, or have been met within the  \\npast one month. \\n \\n6A23.01 Acute and transient psychotic disorder, first episode, in partial remission \\nAll definitional requirements for Acute and transient psychotic disorder, first episode \\nin terms of symptoms and duration were previously met. Symptoms have'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 18, 'page_label': '19'}, page_content='ameliorated such that the diagnostic requirements for the disorder have not been \\nmet for at least one month, but some clinically significant symptoms rem ain, which \\nmay or may not be associated with functional impairment. The partial remission may \\nhave occurred in response to medication or other treatment. \\n \\n6A23.02 Acute and transient psychotic disorder, first episode, in full remission \\nAll definitional requirements for Acute and transient psychotic disorder, first episode'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 18, 'page_label': '19'}, page_content='in terms of symptoms and duration were previously met. Symptoms have \\nameliorated such that no significant symptoms remain. The remission may have \\noccurred in response to medication or other treatment. \\n \\n6A23.0Z Acute and transient psychotic disorder, first episode, unspecified \\n \\n6A23.1 Acute and transient psychotic disorder, multiple episodes \\nAcute and transient psychotic disorder, multiple episodes should be used to identify'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 18, 'page_label': '19'}, page_content='individuals experiencing symptoms that meet the diagnostic requirements for acute \\nand transient psychotic disorder and who have experienced similar episodes in t he \\npast. \\n \\n6A23.10 Acute and transient psychotic disorder, multiple episodes, currently symptomatic  \\nAll definitional requirements for Acute and transient psychotic disorder, m ultiple \\nepisodes in terms of symptoms and duration are currently met, or have been met \\nwithin the past one month.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 19, 'page_label': '20'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   19 \\n \\n6A23.11 Acute and transient psychotic disorder, multiple episodes, in partial remission  \\nAll definitional requirements for Acute and transient psychotic disorder, m ultiple \\nepisodes in terms of symptoms and duration were previously met. Symptoms ha ve \\nameliorated such that the diagnostic requirements for the disorder have not been'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 19, 'page_label': '20'}, page_content='met for at least one month, but some clinically significant symptoms re main, which \\nmay or may not be associated with functional impairment. The partial remission may \\nhave occurred in response to medication or other treatment. \\n \\n6A23.12 Acute and transient psychotic disorder, multiple episodes, in full remission  \\nAll definitional requirements for Acute and transient psychotic disorder, m ultiple \\nepisodes in terms of symptoms and duration were previously met. Symptoms ha ve'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 19, 'page_label': '20'}, page_content='ameliorated such that no significant symptoms remain. The remission may hav e \\noccurred in response to medication or other treatment. \\n \\n6A23.1Z Acute and transient psychotic disorder, multiple episodes, unspecified \\n \\n6A23.Y Other specified acute and transient psychotic disorder \\n \\n6A23.Z Acute and transient psychotic disorder, unspecified \\n \\n  6A24   Delusional disorder \\nDelusional disorder is characterized by the development of a delusion or set of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 19, 'page_label': '20'}, page_content='related delusions that persist for at least 3 months (usually much longer), which \\noccur in the absence of a Depressive, Manic, or Mixed mood episode. Other \\ncharacteristic symptoms of Schizophrenia (e.g. persistent auditory hallucinat ions, \\ndisorganized thinking, negative symptoms) are not present, although various forms \\nof perceptual disturbances (e.g., hallucinations, illusions, misidentificati ons of \\npersons) thematically related to the delusion are still consistent with the diag nosis.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 19, 'page_label': '20'}, page_content='Apart from actions and attitudes directly related to the delusion or delus ional \\nsystem, affect, speech, and behavior are typically unaffected. The symptoms ar e \\nnot a manifestation of another disorder or disease that is not classified under \\nMental, behavioural or neurodevelopmental disorders (e.g., a brain tumor) and are \\nnot due to the effect of a substance or medication on the central nervous system  \\n(e.g., corticosteroids), including withdrawal effects (e.g., alcohol withdrawal).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 19, 'page_label': '20'}, page_content='6A24.0 Delusional disorder, currently symptomatic \\nAll definitional requirements for Delusional disorder in terms of symptoms an d \\nduration are currently met, or have been met within the past one month. \\n \\n6A24.1 Delusional disorder, in partial remission \\nAll definitional requirements for Delusional disorder in terms of symptoms an d \\nduration were previously met. Symptoms have ameliorated such that the diagnos tic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 19, 'page_label': '20'}, page_content='requirements for the disorder have not been met for at least one month, but some \\nclinically significant symptoms remain, which may or may not be assoc iated with \\nfunctional impairment. The partial remission may have occurred in res ponse to \\nmedication or other treatment.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 20, 'page_label': '21'}, page_content='20  ICD-11 MMS - 2018 \\n \\n6A24.2 Delusional disorder, in full remission \\nAll definitional requirements for Delusional disorder in terms of symptoms an d \\nduration were previously met. Symptoms have ameliorated such that no signific ant \\nsymptoms remain. The remission may have occurred in response to medication or \\nother treatment. \\n \\n6A24.Z Delusional disorder, unspecified \\n \\n  6A25   Symptomatic manifestations of primary psychotic disorders'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 20, 'page_label': '21'}, page_content='These categories may be used to characterize the current clinical presentation in \\nindividuals diagnosed with Schizophrenia or another primary psychotic disorder, \\nand should not be used in individuals without such a diagnosis. Multiple c ategories \\nmay be applied. Symptoms attributable to the direct pathophysiological \\nconsequences of a health condition or injury not classified under Mental, \\nbehavioural or neurodevelopmental disorders (e.g., a brain tumour or traumatic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 20, 'page_label': '21'}, page_content='brain injury), or to the direct effects of a substance or medication on the central  \\nnervous system, including withdrawal effects, should not be considered as \\nexamples of the respective types of symptoms. \\nNote: These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of these symptoms in primary psychotic disorders. \\n \\n6A25.0 Positive symptoms in primary psychotic disorders'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 20, 'page_label': '21'}, page_content=\"Positive symptoms in primary psychotic disorders include persistent delusion s, \\npersistent hallucinations (most commonly verbal auditory hallucinatio ns), \\ndisorganized thinking (formal thought disorder such as loose associations, thought \\nderailment, or incoherence), grossly disorganized behavior (behaviour that appears \\nbizarre, purposeless and not goal-directed) and experiences of passivity and control \\n(the experience that one's feelings, impulses, or thoughts are under the control of\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 20, 'page_label': '21'}, page_content='an external force). The rating should be made based on the severity of positive \\nsymptoms during the past week. \\nNote: Code also the underlying condition \\n \\n6A25.1 Negative symptoms in primary psychotic disorders \\nNegative symptoms in primary psychotic disorders include constricted, blunted, or  \\nflat affect, alogia or paucity of speech, avolition (general lack of drive, or lack  of \\nmotivation to pursue meaningful goals), asociality (reduced or absent engagemen t'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 20, 'page_label': '21'}, page_content='with others and interest in social interaction) and anhedonia (inability to experie nce \\npleasure from normally pleasurable activities). To be considered negative psyc hotic \\nsymptoms, relevant symptoms should not be entirely attributable to antipsych otic \\ndrug treatment, a depressive disorder, or an under-stimulating environment, and \\nshould not be a direct consequence of a positive symptom (e.g., persecutory \\ndelusions causing a person to become socially isolated due to fear of harm). The'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 20, 'page_label': '21'}, page_content='rating should be made based on the severity of negative symptoms during the past \\nweek. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 21, 'page_label': '22'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   21 \\n \\n6A25.2 Depressive symptoms in primary psychotic disorders \\nDepressive symptoms in primary psychotic disorders refer to depressed mood as \\nreported by the individual (feeling down, sad) or manifested as a sign (e.g. tearf ul, \\ndowntrodden appearance). If only non-mood symptoms of a depressive episode are \\npresent (e.g., anhedonia, psychomotor slowing), this descriptor should not be us ed.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 21, 'page_label': '22'}, page_content='This descriptor may be used whether or not depressive symptoms meet the \\ndiagnostic requirements of a separately diagnosed Depressive disorder. The rating \\nshould be made based on the severity of depressive mood symptoms during the \\npast week. \\nNote: Code also the underlying condition \\n \\n6A25.3 Manic symptoms in primary psychotic disorders \\nManic symptoms in primary psychotic disorders refer to elevated, euphoric, ir ritable,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 21, 'page_label': '22'}, page_content='or expansive mood states, including rapid changes among different mood states \\n(i.e., mood lability) accompanied by increased energy or activity, when thes e \\nrepresent a significant change from the individual ’s typical mood and energy or \\nactivity level. This descriptor may be used whether or not the manic sym ptoms meet \\nthe diagnostic requirements of a separately diagnosed bipolar disorder. The rati ng \\nshould be made based on the severity of manic mood symptoms during the past \\nweek.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 21, 'page_label': '22'}, page_content='week. \\nNote: Code also the underlying condition \\n \\n6A25.4 Psychomotor symptoms in primary psychotic disorders \\nPsychomotor symptoms in primary psychotic disorders include psychomotor  \\nagitation or excessive motor activity, usually manifested by purposeless beha viors \\nsuch as fidgeting, shifting, fiddling, inability to sit or stand still, wringing of the hands, \\npsychomotor retardation, or a visible generalized slowing of movements and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 21, 'page_label': '22'}, page_content='speech, and catatonic symptoms such as excitement, posturing, waxy flexibili ty, \\nnegativism, mutism, or stupor. The rating should be made based on the severit y of \\npsychomotor symptoms during the past week. \\nNote: Code also the underlying condition \\n \\n6A25.5 Cognitive symptoms in primary psychotic disorders \\nCognitive symptoms in primary psychotic disorders refer to cognitive impairmen t in \\nany of the following domains: speed of processing, attention/concentration,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 21, 'page_label': '22'}, page_content='orientation, judgment, abstraction, verbal or visual learning, and working memory. \\nThe cognitive impairment is not attributable to a neurodevelopmental disorder, a \\ndelirium or other neurocognitive disorder, or the direct effects of a substance or \\nmedication on the central nervous system, including withdrawal effects. Ideally , use \\nof this category should be based on the results of locally validated, standardi zed'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 21, 'page_label': '22'}, page_content='neuropsychological assessments, although such measures may not be available  in \\nall settings. The rating should be made based on the severity of cognitive sy mptoms \\nduring the past week. \\nNote: Code also the underlying condition \\nExclusions: Neurocognitive disorders  (BlockL1‑6D7) \\nNeurodevelopmental disorders (BlockL1‑6A0) \\n \\n  6A2Y   Other specified schizophrenia or other primary psychotic disorders'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 22, 'page_label': '23'}, page_content='22  ICD-11 MMS - 2018 \\n \\n  6A2Z   Schizophrenia or other primary psychotic disorders, unspecified \\n \\nCatatonia (BlockL1‑6A4) \\nCatatonia is a marked disturbance in the voluntary control of movements characterized  by several of \\nthe following: extreme slowing or absence of motor activity, mutism, purposeless m otor activity \\nunrelated to external stimuli, assumption and maintenance of rigid, unusual or bizarre  postures,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 22, 'page_label': '23'}, page_content='resistance to instructions or attempts to be moved, or automatic compliance with instruction s. \\nCatatonia may be diagnosed in the context of certain specific mental disorders, inc luding Mood \\ndisorders, Schizophrenia, and Autism spectrum disorder. Catatonia may also be caused by disorders \\nor diseases classified elsewhere. \\nNote: Use additional code, if desired, for any associated disorder or diseases if known.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 22, 'page_label': '23'}, page_content='Exclusions: Harmful effects of drugs, medicaments or biological substances, not elsewhere \\nclassified (NE60) \\nCoded Elsewhere: Secondary catatonia syndrome (6E69) \\n  6A40   Catatonia associated with another mental disorder \\nCatatonia associated with another mental disorder is a marked disturbance in the \\nvoluntary control of movements characterized by several of the following: ex treme \\nslowing or absence of motor activity, mutism, purposeless motor activity un related'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 22, 'page_label': '23'}, page_content='to external stimuli, assumption and maintenance of rigid, unusual or bizarre \\npostures, resistance to instructions or attempts to be moved, or automatic \\ncompliance with instructions. Catatonia associated with another mental disorder \\nmay be diagnosed in the context of certain specific conditions, including Mood  \\ndisorders, Schizophrenia, and Autism spectrum disorder. \\nNote: Code also the underlying condition \\n \\n  6A41   Catatonia induced by psychoactive substances, including medications'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 22, 'page_label': '23'}, page_content='Catatonia induced by psychoactive substances, including medications is a marked  \\ndisturbance in the voluntary control of movements characterized by several of the \\nfollowing: extreme slowing or absence of motor activity, mutism, purposeless m otor \\nactivity unrelated to external stimuli, assumption and maintenance of rigid, unusual \\nor bizarre postures, resistance to instructions or attempts to be moved, or automatic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 22, 'page_label': '23'}, page_content='compliance with instructions that occurs during or shortly after the consumption of a \\npsychoactive substance or during use of a psychoactive medication. \\n \\n  6A4Z   Catatonia, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 23, 'page_label': '24'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   23 \\n \\nMood disorders (BlockL1‑6A6) \\nMood Disorders refers to a superordinate grouping of Bipolar and Depressive Disorders. Moo d \\ndisorders are defined according to particular types of mood episodes and their patt ern over time. The \\nprimary types of mood episodes are Depressive episode, Manic episode, Mixed epi sode, and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 23, 'page_label': '24'}, page_content='Hypomanic episode. Mood episodes are not independently diagnosable entities, an d therefore do not \\nhave their own diagnostic codes. Rather, mood episodes make up the primary com ponents of most of \\nthe Depressive and Bipolar Disorders. \\nCoded Elsewhere: Substance-induced mood disorders \\nSecondary mood syndrome (6E62) \\nBipolar or related disorders (BlockL2‑6A6) \\nBipolar and related disorders are episodic mood disorders defined by the occurr ence of Manic, Mixed'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 23, 'page_label': '24'}, page_content='or Hypomanic episodes or symptoms. These episodes typically alternate o ver the course of these \\ndisorders with Depressive episodes or periods of depressive symptoms. \\n  6A60   Bipolar type I disorder \\nBipolar type I disorder is an episodic mood disorder defined by the occurr ence of \\none or more manic or mixed episodes. A manic episode is an extreme mood state \\nlasting at least one week unless shortened by a treatment intervention'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 23, 'page_label': '24'}, page_content='characterized by euphoria, irritability, or expansiveness, and by increased acti vity or \\na subjective experience of increased energy, accompanied by other characteristic  \\nsymptoms such as rapid or pressured speech, flight of ideas, increased self-esteem \\nor grandiosity, decreased need for sleep, distractibility, impulsive or reckless  \\nbehavior, and rapid changes among different mood states (i.e., mood lability). A'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 23, 'page_label': '24'}, page_content='mixed episode is characterized by either a mixture or very rapid alternation between \\nprominent manic and depressive symptoms on most days during a period of at leas t \\n2 weeks. Although the diagnosis can be made based on evidence of a single m anic \\nor mixed episode, typically manic or mixed episodes alternate with depressive  \\nepisodes over the course of the disorder. \\nExclusions: cyclothymia (6A62) \\nBipolar type II disorder (6A61)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 23, 'page_label': '24'}, page_content='6A60.0 Bipolar type I disorder, current episode manic, without psychotic symptoms  \\nBipolar type I disorder, current episode manic, without psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar type I disorder are met, the \\ncurrent episode is manic, and there are no delusions or hallucinations present \\nduring the episode. A manic episode is an extreme mood state lasting at l east one \\nweek unless shortened by a treatment intervention characterized by euphoria,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 23, 'page_label': '24'}, page_content='irritability, or expansiveness, and by increased activity or a subjective ex perience of \\nincreased energy, accompanied by other characteristic symptoms such as rapid or \\npressured speech, flight of ideas, increased self-esteem or grandiosity, decreased \\nneed for sleep, distractibility, impulsive or reckless behavior, and rapid c hanges \\namong different mood states (i.e., mood lability).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 24, 'page_label': '25'}, page_content='24  ICD-11 MMS - 2018 \\n \\n6A60.1 Bipolar type I disorder, current episode manic, with psychotic symptoms  \\nBipolar type I disorder, current episode manic with psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar type I Disorder have b een \\nmet, the current episode is Manic and there are delusions or hallucinations present \\nduring the episode. A manic episode is an extreme mood state lasting at l east one'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 24, 'page_label': '25'}, page_content='week unless shortened by a treatment intervention characterized by euphoria, \\nirritability, or expansiveness, and by increased activity or a subjective ex perience of \\nincreased energy, accompanied by other characteristic symptoms such as rapid  or \\npressured speech, flight of ideas, increased self-esteem or grandiosity, decreased \\nneed for sleep, distractibility, impulsive or reckless behavior, and rapid c hanges \\namong different mood states (i.e., mood lability).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 24, 'page_label': '25'}, page_content='6A60.2 Bipolar type I disorder, current episode hypomanic \\nBipolar type I disorder, current episode hypomanic is diagnosed when the \\ndefinitional requirements for Bipolar type I disorder have been met and the c urrent \\nepisode is hypomanic. A hypomanic episode is a persistent mood state las ting at \\nleast several days characterized by mild elevation of mood or increased  irritability \\nand increased activity or a subjective experience of increased energy, accompani ed'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 24, 'page_label': '25'}, page_content='by other characteristic symptoms such as rapid speech, rapid or racing thoughts , \\nincreased self-esteem, an increase in sexual drive or sociability, decrease d need for \\nsleep, distractibility, or impulsive or reckless behavior. The symptoms are not \\nsevere enough to cause marked impairment in occupational functioning or in usual \\nsocial activities or relationships with others, does not necessitate hospitalization , \\nand there are no accompanying delusions or hallucinations.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 24, 'page_label': '25'}, page_content='6A60.3 Bipolar type I disorder, current episode depressive, mild \\nBipolar type I disorder, current episode depressive, mild is diagnosed when the \\ndefinitional requirements for Bipolar type I disorder have been met and the c urrent \\nepisode is depressive at a mild level of severity. A depressive ep isode is \\ncharacterized by a period of almost daily depressed mood or diminished interes t in \\nactivities lasting at least two weeks accompanied by other symptoms such as'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 24, 'page_label': '25'}, page_content='difficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a mild \\ndepressive episode, none of the symptoms are present to an intense degree. An \\nindividual with a mild depressive episode typically has some, but not cons iderable,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 24, 'page_label': '25'}, page_content='difficulty in continuing with ordinary work, social, or domestic activiti es and there are \\nno delusions or hallucinations.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 25, 'page_label': '26'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   25 \\n \\n6A60.4 Bipolar type I disorder, current episode depressive, moderate without \\npsychotic symptoms \\nBipolar type I disorder, current episode depressive, moderate, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type I \\ndisorder have been met and the current episode is depressive at a moderate level'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 25, 'page_label': '26'}, page_content='of severity and there are no delusions or hallucinations during the episode.  A \\ndepressive episode is characterized by a period of almost daily depressed mood or \\ndiminished interest in activities lasting at least two weeks accompanied by oth er \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 25, 'page_label': '26'}, page_content='appetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a moderate depressive episode, several symptoms of a depressive \\nepisode are present to a marked degree, or a large number of depressive \\nsymptoms of lesser severity are present overall. An individual with a mod erate \\ndepressive episode typically has considerable difficulty in continui ng with work, \\nsocial, or domestic activities, but is still able to function in at least some areas.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 25, 'page_label': '26'}, page_content='6A60.5 Bipolar type I disorder, current episode depressive, moderate with psychotic \\nsymptoms \\nBipolar type I disorder, current episode depressive, moderate, with psychotic \\nsymptoms diagnosed when the definitional requirements for Bipolar type I disor der \\nhave been met and the current episode is depressive at a moderate level of severity \\nand there are delusions or hallucinations during the episode. A depressive episode'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 25, 'page_label': '26'}, page_content='is characterized by a period of almost daily depressed mood or diminished interest \\nin activities lasting at least two weeks accompanied by other symptoms s uch as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a moderate'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 25, 'page_label': '26'}, page_content='depressive episode, several symptoms of a depressive episode are present to a \\nmarked degree, or a large number of depressive symptoms of lesser severity are \\npresent overall. An individual with a moderate depressive episode typically has \\nconsiderable difficulty in continuing with work, social, or domestic activities, but is \\nstill able to function in at least some areas. \\n \\n6A60.6 Bipolar type I disorder, current episode depressive, severe without psychotic \\nsymptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 25, 'page_label': '26'}, page_content='symptoms \\nBipolar type I disorder, current episode depressive, severe, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type I \\ndisorder are met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period \\nof almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 25, 'page_label': '26'}, page_content='feelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked  \\ndegree, or a smaller number of symptoms are present and manifest to an intense \\ndegree, and the individual is unable to function in personal, family, social,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 25, 'page_label': '26'}, page_content='educational, occupational, or other important domains, except to a very limited \\ndegree.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 26, 'page_label': '27'}, page_content='26  ICD-11 MMS - 2018 \\n \\n6A60.7 Bipolar type I disorder, current episode depressive, severe with psychotic \\nsymptoms \\nBipolar type I disorder, current episode depressive, severe, with psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type I \\ndisorder are met and the current episode is severe and there are delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 26, 'page_label': '27'}, page_content='of almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating, \\nfeelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 26, 'page_label': '27'}, page_content='degree, or a smaller number of symptoms are present and manifest to an intense \\ndegree and the individual is unable to function in personal, family, social, \\neducational, occupational, or other important domains, except to a very limited \\ndegree. \\n \\n6A60.8 Bipolar type I disorder, current episode depressive, unspecified severity  \\nBipolar type I disorder, current episode depressive, unspecified severity is \\ndiagnosed when the definitional requirements for Bipolar type I disorder have been'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 26, 'page_label': '27'}, page_content='met and the current episode is depressive, but there is insufficient information to \\ndetermine the severity of the current depressive episode. A depressive episode is \\ncharacterized by a period of almost daily depressed mood or diminished interest i n \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 26, 'page_label': '27'}, page_content='hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. The symptoms \\nare associated with at least some difficulty in continuing with ordinary work, s ocial, \\nor domestic activities. \\n \\n6A60.9 Bipolar type I disorder, current episode mixed, without psychotic symptoms  \\nBipolar type I disorder, current episode mixed, without psychotic symptoms is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 26, 'page_label': '27'}, page_content='diagnosed when the definitional requirements for Bipolar type I disorder are met and \\nthe current episode is mixed and there are no delusions or hallucinations pres ent \\nduring the episode. A mixed episode is characterized by either a mixture or very \\nrapid alternation between prominent manic and depressive symptoms on most days \\nduring a period of at least one week. \\n \\n6A60.A Bipolar type I disorder, current episode mixed, with psychotic symptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 26, 'page_label': '27'}, page_content='Bipolar type I disorder, current episode mixed, with psychotic symptoms is \\ndiagnosed when the definitional requirements for Bipolar type I disorder are met and \\nthe current episode is mixed and there are delusions or hallucinations present \\nduring the episode. A mixed episode is characterized by either a mixture or very \\nrapid alternation between prominent manic and depressive symptoms on most days \\nduring a period of at least one week.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 27, 'page_label': '28'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   27 \\n \\n6A60.B Bipolar type I disorder, currently in partial remission, most recent episode \\nmanic or hypomanic \\nBipolar type I disorder, currently in partial remission, most recent episode man ic or \\nhypomanic is diagnosed when the definitional requirements for Bipolar type I \\ndisorder have been met and the most recent episode was a manic or hypomanic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 27, 'page_label': '28'}, page_content='episode. The full definitional requirements for a manic or hypomanic epis ode are no \\nlonger met but some significant mood symptoms remain. In some cases, resi dual \\nmood symptoms may be depressive rather than manic or hypomanic, but do not \\nsatisfy the definitional requirements for a depressive episode. \\n \\n6A60.C Bipolar type I disorder, currently in partial remission, most recent episode \\ndepressive \\nBipolar type I disorder, currently in partial remission, most recent episode'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 27, 'page_label': '28'}, page_content='depressive is diagnosed when the definitional requirements for Bipolar type I \\ndisorder have been met and the most recent episode was a depressive episode. \\nThe full definitional requirements for the episode are no longer met but so me \\nsignificant depressive symptoms remain. \\n \\n6A60.D Bipolar type I disorder, currently in partial remission, most recent episode \\nmixed \\nBipolar type I disorder, currently in partial remission, most recent episo de mixed is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 27, 'page_label': '28'}, page_content='diagnosed when the definitional requirements for Bipolar type I disorder have be en \\nmet and the most recent episode was a mixed episode. The full definitional \\nrequirements for the episode are no longer met but some significant mood \\nsymptoms remain. \\n \\n6A60.E Bipolar type I disorder, currently in partial remission, most recent episode \\nunspecified \\nBipolar type I disorder, currently in partial remission, most recent episode'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 27, 'page_label': '28'}, page_content='unspecified is diagnosed when the definitional requirements for Bipolar t ype II \\ndisorder have been met but there is insufficient information to determine the nature \\nof the most recent mood episode. The full definitional requirements for a mood \\nepisode are no longer met but some significant mood symptoms remain. \\n \\n6A60.F Bipolar type I disorder, currently in full remission \\nBipolar type I disorder, currently in full remission is diagnosed when the f ull'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 27, 'page_label': '28'}, page_content='definitional requirements for Bipolar I disorder have been met in the past but th ere \\nare no longer any significant mood symptoms. \\n \\n6A60.Y Other specified bipolar type I disorder \\n \\n6A60.Z Bipolar type I disorder, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 28, 'page_label': '29'}, page_content='28  ICD-11 MMS - 2018 \\n \\n  6A61   Bipolar type II disorder \\nBipolar type II disorder is an episodic mood disorder defined by the occ urrence of \\none or more hypomanic episodes and at least one depressive episode. A \\nhypomanic episode is a persistent mood state characterized by euphoria, irr itability, \\nor expansiveness, and excessive psychomotor activation or increased energy, \\naccompanied by other characteristic symptoms such as grandiosity, decreased'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 28, 'page_label': '29'}, page_content='need for sleep, pressured speech, flight of ideas, distractibility, and impulsive or \\nreckless behavior lasting for at least several days. The symptoms represent a  \\nchange from the individual ’s typical behavior and are not severe enough to cause \\nmarked impairment in functioning. A depressive episode is characterized by a \\nperiod of almost daily depressed mood or diminished interest in activities lasti ng at \\nleast 2 weeks accompanied by other symptoms such as changes in appetite  or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 28, 'page_label': '29'}, page_content='sleep, psychomotor agitation or retardation, fatigue, feelings of worthless or \\nexcessive or inappropriate guilt, feelings or hopelessness, difficulty conc entrating, \\nand suicidality. There is no history of manic or mixed Episodes. \\n \\n6A61.0 Bipolar type II disorder, current episode hypomanic \\nBipolar type II disorder, current episode hypomanic is diagnosed when the \\ndefinitional requirements for Bipolar type II disorder have been met and the c urrent'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 28, 'page_label': '29'}, page_content='episode is hypomanic. A hypomanic episode is a persistent mood state las ting at \\nleast several days characterized by mild elevation of mood or increased  irritability \\nand increased activity or a subjective experience of increased energy, accompan ied \\nby other characteristic symptoms such as rapid speech, rapid or racing thoughts , \\nincreased self-esteem, an increase in sexual drive or sociability, decrease d need for'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 28, 'page_label': '29'}, page_content='sleep, distractibility, or impulsive or reckless behavior. The symptoms are not \\nsevere enough to cause marked impairment in occupational functioning or in usual \\nsocial activities or relationships with others, does not necessitate hospitalization , \\nand there are no accompanying delusions or hallucinations. \\n \\n6A61.1 Bipolar type II disorder, current episode depressive, mild \\nBipolar type II disorder, current episode depressive, mild is diagnosed when the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 28, 'page_label': '29'}, page_content='definitional requirements for Bipolar type II disorder have been met and the c urrent \\nepisode is depressive at a mild level of severity. A depressive ep isode is \\ncharacterized by a period of almost daily depressed mood or diminished interest i n \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 28, 'page_label': '29'}, page_content='hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a mild \\ndepressive episode, none of the symptoms are present to an intense degree. An \\nindividual with a mild depressive episode typically has some, but not cons iderable, \\ndifficulty in continuing with ordinary work, social, or domestic activiti es and there are \\nno delusions or hallucinations.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 29, 'page_label': '30'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   29 \\n \\n6A61.2 Bipolar type II disorder, current episode depressive, moderate without \\npsychotic symptoms \\nBipolar type II disorder, current episode depressive, moderate, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type II  \\ndisorder have been met and the current episode is depressive at a moderate level'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 29, 'page_label': '30'}, page_content='of severity and there are no delusions or hallucinations during the episode.  A \\ndepressive episode is characterized by a period of almost daily depressed mood or \\ndiminished interest in activities lasting at least two weeks accompanied by o ther \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 29, 'page_label': '30'}, page_content='appetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. In a moderate depressive episode, several symptoms of a depressive \\nepisode are present to a marked degree, or a large number of depressive \\nsymptoms of lesser severity are present overall. An individual with a mod erate \\ndepressive episode typically has considerable difficulty in continui ng with work, \\nsocial, or domestic activities, but is still able to function in at least some areas.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 29, 'page_label': '30'}, page_content='6A61.3 Bipolar type II disorder, current episode depressive, moderate with psychotic \\nsymptoms \\nBipolar type II disorder, current episode depressive, moderate, with psychotic \\nsymptoms diagnosed when the definitional requirements for Bipolar type II dis order \\nhave been met and the current episode is depressive at a moderate level of severity \\nand there are delusions or hallucinations during the episode. A depressive episode'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 29, 'page_label': '30'}, page_content='is characterized by a period of almost daily depressed mood or diminished interest \\nin activities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a moderate'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 29, 'page_label': '30'}, page_content='depressive episode, several symptoms of a depressive episode are present to a \\nmarked degree, or a large number of depressive symptoms of lesser severity are \\npresent overall. An individual with a moderate depressive episode typically has \\nconsiderable difficulty in continuing with work, social, or domestic activities, but is \\nstill able to function in at least some areas. \\n \\n6A61.4 Bipolar type II disorder, current episode depressive, severe without psychotic \\nsymptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 29, 'page_label': '30'}, page_content='symptoms \\nBipolar type II disorder, current episode depressive, severe, without psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type II  \\ndisorder are met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period \\nof almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 29, 'page_label': '30'}, page_content='feelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked  \\ndegree, or a smaller number of symptoms are present and manifest to an intense \\ndegree, and the individual is unable to function in personal, family, social,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 29, 'page_label': '30'}, page_content='educational, occupational, or other important domains, except to a very limited \\ndegree.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 30, 'page_label': '31'}, page_content='30  ICD-11 MMS - 2018 \\n \\n6A61.5 Bipolar type II disorder, current episode depressive, severe with psychotic \\nsymptoms \\nBipolar type II disorder, current episode depressive, severe, with psychotic \\nsymptoms is diagnosed when the definitional requirements for Bipolar type II  \\ndisorder are met and the current episode is severe and there are delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 30, 'page_label': '31'}, page_content='of almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating, \\nfeelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 30, 'page_label': '31'}, page_content='degree, or a smaller number of symptoms are present and manifest to an intense \\ndegree and the individual is unable to function in personal, family, social,  \\neducational, occupational, or other important domains, except to a very limited \\ndegree. \\n \\n6A61.6 Bipolar type II disorder, current episode depressive, unspecified severity  \\nBipolar type II disorder, current episode depressive, unspecified severity is \\ndiagnosed when the definitional requirements for Bipolar type II disorder hav e been'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 30, 'page_label': '31'}, page_content='met and the current episode is depressive, but there is insufficient information to \\ndetermine the severity of the current depressive episode. A depressive episode is \\ncharacterized by a period of almost daily depressed mood or diminished interest i n \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate  guilt,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 30, 'page_label': '31'}, page_content='hopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. The symptoms \\nare associated with at least some difficulty in continuing with ordinary work, s ocial, \\nor domestic activities. \\n \\n6A61.7 Bipolar type II disorder, currently in partial remission, most recent episode \\nhypomanic \\nBipolar type II disorder, currently in partial remission, most recent episo de'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 30, 'page_label': '31'}, page_content='hypomanic is diagnosed when the definitional requirements for Bipolar typ e II \\ndisorder have been met and the most recent episode was a hypomanic episode. \\nThe full definitional requirements for a hypomanic episode are no longer m et but \\nsome significant mood symptoms remain. In some cases, residual mood symptom s \\nmay be depressive rather than hypomanic, but do not satisfy the definitiona l \\nrequirements for a depressive episode.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 30, 'page_label': '31'}, page_content='6A61.8 Bipolar type II disorder, currently in partial remission, most recent episode \\ndepressive \\nBipolar type II disorder, currently in partial remission, most recent episode \\ndepressive is diagnosed when the definitional requirements for Bipolar type II \\ndisorder have been met and the most recent episode was a depressive episode. \\nThe full definitional requirements for the episode are no longer met but so me \\nsignificant depressive symptoms remain.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 31, 'page_label': '32'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   31 \\n \\n6A61.9 Bipolar type II disorder, currently in partial remission, most recent episode \\nunspecified \\nBipolar type II disorder, currently in partial remission, most recent episode \\nunspecified is diagnosed when the definitional requirements for Bipolar t ype II \\ndisorder have been met but there is insufficient information to determine the nature'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 31, 'page_label': '32'}, page_content='of the most recent mood episode. The full definitional requirements for a mood \\nepisode are no longer met but some significant mood symptoms remain. \\n \\n6A61.A Bipolar type II disorder, currently in full remission \\nBipolar type II disorder, currently in full remission, is diagnosed when the defi nitional \\nrequirements for Bipolar type II disorder have been met but there are no longer any \\nsignificant mood symptoms. \\n \\n6A61.Y Other specified bipolar type II disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 31, 'page_label': '32'}, page_content='6A61.Z Bipolar type II disorder, unspecified \\n \\n  6A62   Cyclothymic disorder \\nCyclothymic disorder is characterized by a persistent instability of m ood over a \\nperiod of at least 2 years, involving numerous periods of hypomanic (e.g., euph oria, \\nirritability, or expansiveness, psychomotor activation) and depressive (e.g., f eeling \\ndown, diminished interest in activities, fatigue) symptoms that are present during \\nmore of the time than not. The hypomanic symptomatology may or may not be'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 31, 'page_label': '32'}, page_content='sufficiently severe or prolonged to meet the full definitional requirements of a \\nhypomanic episode (see Bipolar type II disorder), but there is no history  of manic or \\nmixed episodes (see Bipolar type I disorder). The depressive symptomatolog y has \\nnever been sufficiently severe or prolonged to meet the diagnostic requirements for \\na depressive episode (see Bipolar type II disorder). The symptoms result in'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 31, 'page_label': '32'}, page_content='significant distress or significant impairment in personal, family, social, educational, \\noccupational or other important areas of functioning. \\nInclusions: Cycloid personality \\nCyclothymic personality \\n \\n  6A6Y   Other specified bipolar or related disorders \\n \\n  6A6Z   Bipolar or related disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 32, 'page_label': '33'}, page_content='32  ICD-11 MMS - 2018 \\n \\nDepressive disorders (BlockL2‑6A7) \\nDepressive disorders are characterized by depressive mood (e.g., sad, irritable, empty)  or loss of \\npleasure accompanied by other cognitive, behavioural, or neurovegetative symptoms that significantly \\naffect the individual’s ability to function. A depressive disorder should not be diagnosed in individuals \\nwho have ever experienced a manic, mixed or hypomanic episode, which would indicate th e presence \\nof a bipolar disorder.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 32, 'page_label': '33'}, page_content='Coded Elsewhere: Premenstrual dysphoric disorder (GA34.41) \\n  6A70   Single episode depressive disorder \\nSingle episode depressive disorder is characterized by the presence or history of \\none depressive episode when there is no history of prior depressive episodes. A \\ndepressive episode is characterized by a period of almost daily depressed mood or \\ndiminished interest in activities lasting at least two weeks accompanied by oth er'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 32, 'page_label': '33'}, page_content='symptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or \\nfatigue. There have never been any prior manic, hypomanic, or mixed episodes, \\nwhich would indicate the presence of a bipolar disorder. \\nExclusions: recurrent depressive disorder (6A71) \\nAdjustment disorder (6B43)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 32, 'page_label': '33'}, page_content='Bipolar or related disorders (BlockL2‑6A6) \\n \\n6A70.0 Single episode depressive disorder, mild \\nSingle episode depressive disorder, mild, is diagnosed when the definitional \\nrequirements of a Depressive episode are met and the episode is of mild severity . \\nNone of the symptoms of the Depressive episode should be present to an intens e \\ndegree. An individual with a Mild depressive episode typically has some, but not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 32, 'page_label': '33'}, page_content='considerable, difficulty in continuing with ordinary work, social, or domestic ac tivities \\nand there are no delusions or hallucinations. \\n \\n6A70.1 Single episode depressive disorder, moderate, without psychotic symptoms \\nSingle episode depressive disorder, moderate, without psychotic symptoms is \\ndiagnosed when the definitional requirements of a depressive episode have been \\nmet, there is no history of prior depressive episodes, the episode is of moderate'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 32, 'page_label': '33'}, page_content='severity, and there are no delusions or hallucinations during the episode. A \\ndepressive episode is characterized by a period of almost daily depressed mood or \\ndiminished interest in activities lasting at least two weeks accompanied by oth er \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 32, 'page_label': '33'}, page_content='fatigue. In a moderate depressive episode, several symptoms of a depressive \\nepisode are present to a marked degree, or a large number of depressive \\nsymptoms of lesser severity are present overall. An individual with a mod erate \\ndepressive episode typically has considerable difficulty in continui ng with work, \\nsocial, or domestic activities, but is still able to function in at least some areas.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 33, 'page_label': '34'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   33 \\n \\n6A70.2 Single episode depressive disorder, moderate, with psychotic symptoms  \\nSingle episode depressive disorder, moderate, with psychotic symptoms is \\ndiagnosed when the definitional requirements of a depressive episode have been \\nmet, there is no history of prior depressive episodes, the episode is of moderate'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 33, 'page_label': '34'}, page_content='severity, and there are delusions or hallucinations during the episode. A depr essive \\nepisode is characterized by a period of almost daily depressed mood or dimini shed \\ninterest in activities lasting at least two weeks accompanied by other symptoms \\nsuch as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 33, 'page_label': '34'}, page_content='fatigue. In a moderate depressive episode, several symptoms of a depressive \\nepisode are present to a marked degree, or a large number of depressive \\nsymptoms of lesser severity are present overall. An individual with a mod erate \\ndepressive episode typically has considerable difficulty in continui ng with work, \\nsocial, or domestic activities, but is still able to function in at least some areas. \\n \\n6A70.3 Single episode depressive disorder, severe, without psychotic symptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 33, 'page_label': '34'}, page_content='Single episode depressive disorder, severe, without psychotic symptoms is \\ndiagnosed when the definitional requirements for Single episode depressive \\ndisorder are met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period \\nof almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 33, 'page_label': '34'}, page_content='feelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked  \\ndegree, or a smaller number of symptoms are present and manifest to an intense \\ndegree, and the individual is unable to function in personal, family, social,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 33, 'page_label': '34'}, page_content='educational, occupational, or other important domains, except to a very limited \\ndegree. \\nInclusions: Agitated depression single episode without psychotic \\nsymptoms \\nMajor depression single episode without psychotic symptoms \\nVital depression single episode without psychotic symptoms \\n \\n6A70.4 Single episode depressive disorder, severe, with psychotic symptoms \\nSingle episode depressive disorder, severe, with psychotic symptoms is diagno sed'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 33, 'page_label': '34'}, page_content='when the definitional requirements for Single episode depressive disorder are met \\nand the current episode is severe and there are delusions or hallucinations during \\nthe episode. A depressive episode is characterized by a period of almost dail y \\ndepressed mood or diminished interest in activities lasting at least two weeks \\naccompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 33, 'page_label': '34'}, page_content='of death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. In a severe depressive episode, many \\nor most symptoms of a depressive episode are present to a marked degree, or a \\nsmaller number of symptoms are present and manifest to an intense degree and the \\nindividual is unable to function in personal, family, social, educational, oc cupational, \\nor other important domains, except to a very limited degree.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 34, 'page_label': '35'}, page_content='34  ICD-11 MMS - 2018 \\n \\n6A70.5 Single episode depressive disorder, unspecified severity \\nSingle episode depressive disorder, unspecified severity is diagnosed when the  \\ndefinitional requirements of a depressive episode have been met, there is no history \\nof prior depressive episodes, and there is insufficient information to determine the \\nseverity of the current depressive episode. A depressive episode is characteri zed'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 34, 'page_label': '35'}, page_content='by a period of almost daily depressed mood or diminished interest in activi ties \\nlasting at least two weeks accompanied by other symptoms such as difficult y \\nconcentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. The symptoms \\nare associated with at least some difficulty in continuing with ordinary work, s ocial,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 34, 'page_label': '35'}, page_content='or domestic activities. \\n \\n6A70.6 Single episode depressive disorder, currently in partial remission \\nSingle episode depressive disorder, currently in partial remission, is diagnose d \\nwhen the full definitional requirements for a depressive episode have been met and \\nthere is no history of prior depressive episodes. The full definitional requi rements for \\na depressive episode are no longer met but some significant mood symptoms \\nremain.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 34, 'page_label': '35'}, page_content='remain. \\n \\n6A70.7 Single episode depressive disorder, currently in full remission \\nSingle episode depressive disorder, currently in full remission is diagnosed  when \\nthe full definitional requirements for one depressive episode have been met i n the \\npast and there are no longer any significant mood symptoms. There is no histor y of \\ndepressive episodes preceding the episode under consideration. \\n \\n6A70.Y Other specified single episode depressive disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 34, 'page_label': '35'}, page_content='6A70.Z Single episode depressive disorder, unspecified \\n \\n  6A71   Recurrent depressive disorder \\nRecurrent depressive disorder is characterized by a history or at least two \\ndepressive episodes separated by at least several months without significant  mood \\ndisturbance. A depressive episode is characterized by a period of almost daily \\ndepressed mood or diminished interest in activities lasting at least two weeks \\naccompanied by other symptoms such as difficulty concentrating, feelings of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 34, 'page_label': '35'}, page_content='worthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. There have never been any prior manic, \\nhypomanic, or mixed episodes, which would indicate the presence of a Bipolar \\ndisorder. \\nInclusions: seasonal depressive disorder \\nExclusions: Adjustment disorder (6B43) \\nBipolar or related disorders (BlockL2‑6A6)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 34, 'page_label': '35'}, page_content='Single episode depressive disorder (6A70)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 35, 'page_label': '36'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   35 \\n \\n6A71.0 Recurrent depressive disorder, current episode mild \\nRecurrent depressive disorder, current episode mild is diagnosed when the \\ndefinitional requirements for Recurrent depressive disorder have been met and \\nthere is currently a depressive episode of mild severity. A depressive epis ode is \\ncharacterized by a period of almost daily depressed mood or diminished interest i n'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 35, 'page_label': '36'}, page_content='activities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a mild \\ndepressive episode, none of the symptoms are present to an intense degree. An \\nindividual with a mild depressive episode typically has some, but not cons iderable,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 35, 'page_label': '36'}, page_content='difficulty in continuing with ordinary work, social, or domestic activiti es and there are \\nno delusions or hallucinations. \\n \\n6A71.1 Recurrent depressive disorder, current episode moderate, without psychotic \\nsymptoms \\nRecurrent depressive disorder, current episode moderate, without psychotic \\nsymptoms is diagnosed when the definitional requirements for recurrent depr essive \\ndisorder have been met and there is currently a depressive episode of moderate'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 35, 'page_label': '36'}, page_content='severity, and there are no delusions or hallucinations during the episode. A \\ndepressive episode is characterized by a period of almost daily depressed mood or  \\ndiminished interest in activities lasting at least two weeks accompanied by oth er \\nsymptoms such as difficulty concentrating, feelings of worthlessness or excessive or \\ninappropriate guilt, hopelessness, recurrent thoughts of death or suicide, changes in \\nappetite or sleep, psychomotor agitation or retardation, and reduced energy or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 35, 'page_label': '36'}, page_content='fatigue. In a moderate depressive episode, several symptoms of a depressive \\nepisode are present to a marked degree, or a large number of depressive \\nsymptoms of lesser severity are present overall. An individual with a mod erate \\ndepressive episode typically has considerable difficulty in continui ng with work, \\nsocial, or domestic activities, but is still able to function in at least some areas. \\n \\n6A71.2 Recurrent depressive disorder, current episode moderate, with psychotic \\nsymptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 35, 'page_label': '36'}, page_content='symptoms \\nRecurrent depressive disorder, current episode moderate, with psychotic symptoms \\nis diagnosed when the definitional requirements for Recurrent depressive disorder \\nhave been met and there is currently a depressive episode of moderate severity, \\nand there are delusions or hallucinations during the episode. A depressive episode \\nis characterized by a period of almost daily depressed mood or diminished interest'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 35, 'page_label': '36'}, page_content='in activities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep, \\npsychomotor agitation or retardation, and reduced energy or fatigue. In a moderate \\ndepressive episode, several symptoms of a depressive episode are present to a \\nmarked degree, or a large number of depressive symptoms of lesser severity are'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 35, 'page_label': '36'}, page_content='present overall. An individual with a moderate depressive episode typically has \\nconsiderable difficulty in continuing with work, social, or domestic activities, but is \\nstill able to function in at least some areas.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 36, 'page_label': '37'}, page_content='36  ICD-11 MMS - 2018 \\n \\n6A71.3 Recurrent depressive disorder, current episode severe, without psychotic \\nsymptoms \\nRecurrent depressive disorder, current episode severe, without psychotic symptoms  \\nis diagnosed when the definitional requirements for Recurrent depressive disorder \\nare met and the current episode is severe and there are no delusions or \\nhallucinations during the episode. A depressive episode is characterized by a period'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 36, 'page_label': '37'}, page_content='of almost daily depressed mood or diminished interest in activities lasting at le ast \\ntwo weeks accompanied by other symptoms such as difficulty concentrating, \\nfeelings of worthlessness or excessive or inappropriate guilt, hopelessness, \\nrecurrent thoughts of death or suicide, changes in appetite or sleep, psychomotor \\nagitation or retardation, and reduced energy or fatigue. In a severe depressive \\nepisode, many or most symptoms of a depressive episode are present to a marked'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 36, 'page_label': '37'}, page_content='degree, or a smaller number of symptoms are present and manifest to an intense \\ndegree, and the individual is unable to function in personal, family, social, \\neducational, occupational, or other important domains, except to a very limited \\ndegree. \\nInclusions: Endogenous depression without psychotic symptoms \\nMajor depression, recurrent without psychotic symptoms \\nManic-depressive psychosis, depressed type without psychotic \\nsymptoms \\nVital depression, recurrent without psychotic symptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 36, 'page_label': '37'}, page_content='6A71.4 Recurrent depressive disorder, current episode severe, with psychotic \\nsymptoms \\nRecurrent depressive disorder, current episode severe, with psychotic symptoms is \\ndiagnosed when the definitional requirements for Recurrent depressive disorder are \\nmet and the current episode is severe and there are delusions or hallucinations \\nduring the episode. A depressive episode is characterized by a period of a lmost'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 36, 'page_label': '37'}, page_content='daily depressed mood or diminished interest in activities lasting at least two week s \\naccompanied by other symptoms such as difficulty concentrating, feelings of \\nworthlessness or excessive or inappropriate guilt, hopelessness, recurrent thoughts \\nof death or suicide, changes in appetite or sleep, psychomotor agitation or \\nretardation, and reduced energy or fatigue. In a severe depressive episode, many \\nor most symptoms of a depressive episode are present to a marked degree, or a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 36, 'page_label': '37'}, page_content='smaller number of symptoms are present and manifest to an intense degree and the \\nindividual is unable to function in personal, family, social, educational, oc cupational, \\nor other important domains, except to a very limited degree. \\nInclusions: Endogenous depression with psychotic symptoms \\nManic-depressive psychosis, depressed type with psychotic \\nsymptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 37, 'page_label': '38'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   37 \\n \\n6A71.5 Recurrent depressive disorder, current episode, unspecified severity  \\nRecurrent depressive disorder current episode, unspecified severity is dia gnosed \\nwhen the definitional requirements of a depressive episode have been met and \\nthere is a history of prior depressive episodes, but there is insufficient inf ormation to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 37, 'page_label': '38'}, page_content='determine the severity of the current depressive episode. A depressive episode is \\ncharacterized by a period of almost daily depressed mood or diminished interest i n \\nactivities lasting at least two weeks accompanied by other symptoms such as \\ndifficulty concentrating, feelings of worthlessness or excessive or inappropriate guilt, \\nhopelessness, recurrent thoughts of death or suicide, changes in appetite or sleep,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 37, 'page_label': '38'}, page_content='psychomotor agitation or retardation, and reduced energy or fatigue. The symptoms \\nare associated with at least some difficulty in continuing with ordinary work, social, \\nor domestic activities. \\n \\n6A71.6 Recurrent depressive disorder, currently in partial remission \\nRecurrent depressive disorder, currently in partial remission, is diagnosed when t he \\ndefinitional requirements for Recurrent depressive disorder have been met; the full'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 37, 'page_label': '38'}, page_content='definitional requirements for a depressive episode are no longer met but some \\nsignificant mood symptoms remain. \\n \\n6A71.7 Recurrent depressive disorder, currently in full remission \\nRecurrent depressive disorder, currently in full remission is diagnosed w hen the \\ndefinitional requirements for recurrent depressive disorder have been met but \\ncurrently there are no significant mood symptoms. \\n \\n6A71.Y Other specified recurrent depressive disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 37, 'page_label': '38'}, page_content='6A71.Z Recurrent depressive disorder, unspecified \\n \\n  6A72   Dysthymic disorder \\nDysthymic disorder is characterized by a persistent depressive mood (i.e., las ting 2 \\nyears or more), for most of the day, for more days than not. In children and \\nadolescents depressed mood can manifest as pervasive irritability.The d epressed \\nmood is accompanied by additional symptoms such as markedly diminish ed interest'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 37, 'page_label': '38'}, page_content='or pleasure in activities, reduced concentration and attention or indecisive ness, low \\nself-worth or excessive or inappropriate guilt, hopelessness about the future, \\ndisturbed sleep or increased sleep, diminished or increased appetite, or low energy  \\nor fatigue. During the first 2 years of the disorder, there has never been a 2-week \\nperiod during which the number and duration of symptoms were sufficient to mee t'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 37, 'page_label': '38'}, page_content='the diagnostic requirements for a Depressive Episode. There is no history of Mani c, \\nMixed, or Hypomanic Episodes. \\nInclusions: Dysthymia \\nExclusions: anxiety depression (mild or not persistent) (6A73)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 38, 'page_label': '39'}, page_content='38  ICD-11 MMS - 2018 \\n \\n  6A73   Mixed depressive and anxiety disorder \\nMixed depressive and anxiety disorder is characterized by symptoms of both \\nanxiety and depression more days than not for a period of two weeks or more. \\nNeither set of symptoms, considered separately, is sufficiently severe, num erous, or \\npersistent to justify a diagnosis of a depressive episode, dysthymia or an a nxiety \\nand fear-related disorder. Depressed mood or diminished interest in activities must'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 38, 'page_label': '39'}, page_content='be present accompanied by additional depressive symptoms as well as multiple \\nsymptoms of anxiety. The symptoms result in significant distress or si gnificant \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning. There have never been any prior manic, hypomanic, or mixed  \\nepisodes, which would indicate the presence of a bipolar disorder. \\n \\n  6A7Y   Other specified depressive disorders \\n \\n  6A7Z   Depressive disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 38, 'page_label': '39'}, page_content='6A80   Symptomatic and course presentations for mood episodes in mood \\ndisorders \\nThese categories may be applied to describe the presentation and characteristics of \\nmood episodes in the context of single episode depressive disorder, recurrent \\nrepressive disorder, bipolar type I disorder, or bipolar type II disorder. These \\ncategories indicate the presence of specific, important features of the clin ical \\npresentation or of the course, onset, and pattern of mood episodes. These'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 38, 'page_label': '39'}, page_content='categories are not mutually exclusive, and as many may be added as apply. \\nNote: These categories should never be used in primary coding. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify specific \\nclinically important features of mood episodes in mood disorders. \\nCoded Elsewhere: Mental or behavioural disorders associated with pregnancy, \\nchildbirth and the puerperium, without psychotic \\nsymptoms (6E20)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 38, 'page_label': '39'}, page_content='symptoms (6E20) \\nMental or behavioural disorders associated with pregnancy, \\nchildbirth or the puerperium, with psychotic symptoms \\n(6E21) \\n \\n6A80.0 Prominent anxiety symptoms in mood episodes \\nIn the context of a current depressive, manic, mixed, or hypomanic episode, \\nprominent and clinically significant anxiety symptoms (e.g., feeling nervo us, anxious \\nor on edge, not being able to control worrying thoughts, fear that something awf ul'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 38, 'page_label': '39'}, page_content='will happen, having trouble relaxing, motor tension, autonomic symptoms) have \\nbeen present for most of the time during the past 2 weeks. If there have been panic \\nattacks during a current depressive or mixed episode, these should be recorded \\nseparately.  \\nWhen the diagnostic requirements for both a mood disorder and an anxiety or fear-\\nrelated disorder are met, the anxiety or fear-related disorder should also be \\ndiagnosed. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 39, 'page_label': '40'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   39 \\n \\n6A80.1 Panic attacks in mood episodes \\nIn the context of a current mood episode (manic, depressive, mixed, or hypomanic) , \\nthere have been recurrent panic attacks (i.e., at least two) during the past mon th \\nthat occur specifically in response to anxiety-provoking cognitions that are fea tures \\nof the mood episode. If panic attacks occur exclusively in response to such'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 39, 'page_label': '40'}, page_content='thoughts, panic attacks should be recorded using this qualifier rather than assigni ng \\nan additional co-occurring diagnosis of panic disorder. \\nIf some panic attacks over the course of the depressive or mixed episode have \\nbeen unexpected and not exclusively in response to depressive or anxiety-\\nprovoking thoughts, a separate diagnosis of panic disorder should be assigned. \\nNote: Code also the underlying condition \\nExclusions: Panic disorder (6B01)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 39, 'page_label': '40'}, page_content='6A80.2 Current depressive episode persistent \\nThe diagnostic requirements for a depressive episode are currently met and hav e \\nbeen met continuously for at least the past 2 years. \\n \\n6A80.3 Current depressive episode with melancholia \\nIn the context of a current Depressive Episode, several of the following symptoms \\nhave been present during worst period within the past month: loss of interest or \\npleasure in most activities that are normally enjoyable to the individual (i.e.,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 39, 'page_label': '40'}, page_content='pervasive anhedonia); lack of emotional reactivity to normally pleasurable stim uli or \\ncircumstances (i.e., mood does not lift even transiently with exposure); termina l \\ninsomnia (i.e., waking in the morning two hours or more before the usual time); \\ndepressive symptoms are worse in the morning; marked psychomotor retardation or \\nagitation; marked loss of appetite or loss of weight. \\n \\n6A80.4 Seasonal pattern of mood episode onset'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 39, 'page_label': '40'}, page_content='In the context of recurrent depressive disorder, bipolar type I or bipolar type II \\ndisorder, there has been a regular seasonal pattern of onset and remission of at \\nleast one type of episode (i.e., depressive, manic, mixed, or hypomanic epis odes), \\nwith a substantial majority of the relevant mood episodes corresponding to the \\nseasonal pattern. (In bipolar type I and bipolar type II disorder, all types of mood'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 39, 'page_label': '40'}, page_content='episodes may not follow this pattern.) A seasonal pattern should be differentia ted \\nfrom an episode that is coincidental with a particular season but predominantl y \\nrelated to a psychological stressor that regularly occurs at that time of the year (e.g., \\nseasonal unemployment). \\n \\n6A80.5 Rapid cycling \\nIn the context of bipolar type I or bipolar type II disorder, there has been a hig h \\nfrequency of mood episodes (at least four) over the past 12 months. There may be'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 39, 'page_label': '40'}, page_content='a switch from one polarity of mood to the other, or the mood episodes may be \\ndemarcated by a period of remission. In individuals with a high frequency of  mood \\nepisodes, some may have a shorter duration than those usually observed in bipolar \\ntype I or bipolar type II disorder. In particular, depressive periods may only last \\nseveral days. If depressive and manic symptoms alternate very rapidly (i.e. , from \\nday to day or within the same day), a mixed episode should be diagnosed r ather'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 39, 'page_label': '40'}, page_content='than rapid cycling. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 40, 'page_label': '41'}, page_content='40  ICD-11 MMS - 2018 \\n \\n  6A8Y   Other specified mood disorders \\n \\n  6A8Z   Mood disorders, unspecified \\n \\nAnxiety or fear-related disorders (BlockL1‑6B0) \\nAnxiety and fear-related disorders are characterized by excessive fear and anxi ety and related \\nbehavioural disturbances, with symptoms that are severe enough to result in sign ificant distress or \\nsignificant impairment in personal, family, social, educational, occupati onal, or other important areas'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 40, 'page_label': '41'}, page_content='of functioning. Fear and anxiety are closely related phenomena; fear represents a reaction to \\nperceived imminent threat in the present, whereas anxiety is more future-orien ted, referring to \\nperceived anticipated threat. A key differentiating feature among the Anxiety and fea r-related \\ndisorders are disorder-specific foci of apprehension, that is, the stimulus or situation  that triggers the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 40, 'page_label': '41'}, page_content='fear or anxiety. The clinical presentation of Anxiety and fear-related di sorders typically includes \\nspecific associated cognitions that can assist in differentiating among the disorder s by clarifying the \\nfocus of apprehension. \\nCoded Elsewhere: Substance-induced anxiety disorders \\nHypochondriasis (6B23) \\nSecondary anxiety syndrome (6E63) \\n  6B00   Generalised anxiety disorder \\nGeneralised anxiety disorder is characterized by marked symptoms of anxi ety that'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 40, 'page_label': '41'}, page_content='persist for at least several months, for more days than not, manifested by either \\ngeneral apprehension (i.e. ‘free-floating anxiety ’) or excessive worry focused on \\nmultiple everyday events, most often concerning family, health, finances, and \\nschool or work, together with additional symptoms such as muscular tension or \\nmotor restlessness, sympathetic autonomic over-activity, subjective experien ce of \\nnervousness, difficulty maintaining concentration, irritability, or sl eep disturbance.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 40, 'page_label': '41'}, page_content='The symptoms result in significant distress or significant impairment i n personal, \\nfamily, social, educational, occupational, or other important areas of functioni ng. \\nThe symptoms are not a manifestation of another health condition and are not due \\nto the effects of a substance or medication on the central nervous system. \\n \\n  6B01   Panic disorder \\nPanic disorder is characterized by recurrent unexpected panic attacks that are not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 40, 'page_label': '41'}, page_content='restricted to particular stimuli or situations. Panic attacks are discrete episode s of \\nintense fear or apprehension accompanied by the rapid and concurrent onset of \\nseveral characteristic symptoms (e.g., palpitations or increased heart rate, \\nsweating, trembling, shortness of breath, chest pain, dizziness or lightheadedness,  \\nchills, hot flushes, fear of imminent death). In addition, panic disorder is \\ncharacterized by persistent concern about the recurrence or significance of panic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 40, 'page_label': '41'}, page_content='attacks, or behaviors intended to avoid their recurrence, that results in signifi cant \\nimpairment in personal, family, social, educational, occupational, or other i mportant \\nareas of functioning. The symptoms are not a manifestation of another health \\ncondition and are not due to the effects of a substance or medication on the central \\nnervous system. \\nExclusions: Panic attack (MB23.H)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 41, 'page_label': '42'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   41 \\n \\n  6B02   Agoraphobia \\nAgoraphobia is characterized by marked and excessive fear or anxiety that oc curs \\nin response to multiple situations where escape might be difficult or help migh t not \\nbe available, such as using public transportation, being in crowds, being outs ide the \\nhome alone (e.g., in shops, theatres, standing in line). The individual is con sistently'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 41, 'page_label': '42'}, page_content='anxious about these situations due to a fear of specific negative outc omes (e.g., \\npanic attacks, other incapacitating or embarrassing physical symptoms). The \\nsituations are actively avoided, entered only under specific circumstances s uch as \\nin the presence of a trusted companion, or endured with intense fear or anxiety. The \\nsymptoms persist for least several months, and are sufficiently severe to resu lt in'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 41, 'page_label': '42'}, page_content='significant distress or significant impairment in personal, family, soc ial, educational, \\noccupational, or other important areas of functioning. \\n \\n  6B03   Specific phobia \\nSpecific phobia is characterized by a marked and excessive fear or anxiety that \\nconsistently occurs when exposed to one or more specific objects or situatio ns \\n(e.g., proximity to certain animals, flying, heights, closed spaces, sight of bloo d or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 41, 'page_label': '42'}, page_content='injury) and that is out of proportion to actual danger. The phobic objects or \\nsituations are avoided or else endured with intense fear or anxiety. Symptoms  \\npersist for at least several months and are sufficiently severe to result in signi ficant \\ndistress or significant impairment in personal, family, social, educationa l, \\noccupational, or other important areas of functioning. \\nInclusions: Simple phobia \\nAcrophobia \\nClaustrophobia \\nExclusions: Body dysmorphic disorder (6B21)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 41, 'page_label': '42'}, page_content='Hypochondriasis (6B23) \\n \\n  6B04   Social anxiety disorder \\nSocial anxiety disorder is characterized by marked and excessive fear or anx iety \\nthat consistently occurs in one or more social situations such as social interacti ons \\n(e.g., having a conversation), being observed (e.g., eating or drinking), or \\nperforming in front of others (e.g., giving a speech). The individual is con cerned that \\nhe or she will act in a way, or show anxiety symptoms, that will be negativ ely'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 41, 'page_label': '42'}, page_content='evaluated by others. The social situations are consistently avoided or else e ndured \\nwith intense fear or anxiety. The symptoms persist for at least several months and \\nare sufficiently severe to result in significant distress or significant impa irment in \\npersonal, family, social, educational, occupational, or other important areas of \\nfunctioning. \\nInclusions: Anthropophobia'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 42, 'page_label': '43'}, page_content='42  ICD-11 MMS - 2018 \\n \\n  6B05   Separation anxiety disorder \\nSeparation anxiety disorder is characterized by marked and excessive fear or \\nanxiety about separation from specific attachment figures. In children, separat ion \\nanxiety typically focuses on caregivers, parents or other family member s; in adults it \\nis typically a romantic partner or children. Manifestations of separation anxie ty may \\ninclude thoughts of harm or untoward events befalling the attachment figure,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 42, 'page_label': '43'}, page_content='reluctance to go to school or work, recurrent excessive distress upon separation, \\nreluctance or refusal to sleep away from the attachment figure, and recurrent \\nnightmares about separation. The symptoms persist for at least several months and \\nare sufficiently severe to result in significant distress or significant im pairment in \\npersonal, family, social, educational, occupational, or other important areas of \\nfunctioning. \\nExclusions: mood [affective] disorders  (BlockL1‑6A6)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 42, 'page_label': '43'}, page_content='Selective mutism (6B06) \\nSocial anxiety disorder (6B04) \\n \\n  6B06   Selective mutism \\nSelective mutism is characterized consistent selectivity in speaking, s uch that a \\nchild demonstrates adequate language competence in specific social situations, \\ntypically at home, but consistently fails to speak in others, typical ly at school. The \\ndisturbance lasts for at least one month, is not limited to the first month of school ,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 42, 'page_label': '43'}, page_content='and is of sufficient severity to interfere with educational or occupational \\nachievement or with social communication. Failure to speak is not due to  a lack of \\nknowledge of, or comfort with, the spoken language required in the social si tuation \\n(e.g., a different language spoken at school than at home). \\nExclusions: Schizophrenia (6A20) \\ntransient mutism as part of separation anxiety in young \\nchildren (6B05) \\nAutism spectrum disorder (6A02)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 42, 'page_label': '43'}, page_content='6B0Y   Other specified anxiety or fear-related disorders \\n \\n  6B0Z   Anxiety or fear-related disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 43, 'page_label': '44'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   43 \\n \\nObsessive-compulsive or related disorders (BlockL1‑6B2) \\nObsessive-compulsive and related disorders is a group of disorders characterize d by repetitive \\nthoughts and behaviours that are believed to share similarities in etiology and k ey diagnostic \\nvalidators. Cognitive phenomena such as obsessions, intrusive thoughts and preoccup ations are'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 43, 'page_label': '44'}, page_content='central to a subset of these conditions (i.e., obsessive-compulsive disorder, body dysmorphic \\ndisorder, hypochondriasis, and olfactory reference disorder) and are accompanied by r elated \\nrepetitive behaviours. Hoarding Disorder is not associated with intrusive unwanted thou ghts but rather \\nis characterized by a compulsive need to accumulate possessions and distr ess related to discarding \\nthem. Also included in the grouping are body-focused repetitive behaviour disorders, which are'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 43, 'page_label': '44'}, page_content='primarily characterized by recurrent and habitual actions directed at the integument ( e.g., hair-pulling, \\nskin-picking) and lack a prominent cognitive aspect. The symptoms result in s ignificant distress or \\nsignificant impairment in personal, family, social, educational, occupati onal, or other important areas \\nof functioning. \\nCoded Elsewhere: Substance-induced obsessive-compulsive or related disorders \\nSecondary obsessive-compulsive or related syndrome (6E64) \\nTourette syndrome (8A05.00)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 43, 'page_label': '44'}, page_content='6B20   Obsessive-compulsive disorder \\nObsessive-Compulsive Disorder is characterized by the presence of persistent \\nobsessions or compulsions, or most commonly both. Obsessions are repetitive and \\npersistent thoughts, images, or impulses/urges that are intrusive, unwanted, and are \\ncommonly associated with anxiety. The individual attempts to ignore or suppress  \\nobsessions or to neutralize them by performing compulsions. Compulsions are'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 43, 'page_label': '44'}, page_content='repetitive behaviors including repetitive mental acts that the individual feels driven to \\nperform in response to an obsession, according to rigid rules, or to achieve a  sense \\nof ‘completeness’. In order for obsessive-compulsive disorder to be diagnosed, \\nobsessions and compulsions must be time consuming (e.g., taking more than an \\nhour per day), and result in significant distress or significant impairm ent in personal,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 43, 'page_label': '44'}, page_content='family, social, educational, occupational or other important areas of functioning. \\nInclusions: anankastic neurosis \\nobsessive-compulsive neurosis \\nExclusions: obsessive compulsive behaviour (MB23.4) \\n \\n6B20.0 Obsessive-compulsive disorder with fair to good insight \\nAll definitional requirements of obsessive-compulsive disorder are met. Muc h of the \\ntime, the individual is able to entertain the possibility that his or her dis order-specific'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 43, 'page_label': '44'}, page_content='beliefs may not be true and is willing to accept an alternative explanati on for his or \\nher experience. At circumscribed times (e.g., when highly anxious), the indi vidual \\nmay demonstrate no insight. \\n \\n6B20.1 Obsessive-compulsive disorder with poor to absent insight \\nAll definitional requirements of obsessive-compulsive disorder are met. Mo st or all \\nof the time, the individual is convinced that the disorder-specific beli efs are true and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 43, 'page_label': '44'}, page_content='cannot accept an alternative explanation for their experience. The lack of insight \\nexhibited by the individual does not vary markedly as a function of anxiety level. \\n \\n6B20.Z Obsessive-compulsive disorder, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 44, 'page_label': '45'}, page_content='44  ICD-11 MMS - 2018 \\n \\n  6B21   Body dysmorphic disorder \\nBody Dysmorphic Disorder is characterized by persistent preoccupation with one or \\nmore perceived defects or flaws in appearance that are either unnoticeable or only  \\nslightly noticeable to others. Individuals experience excessive self-con sciousness, \\noften with ideas of reference (i.e., the conviction that people are taking notic e, \\njudging, or talking about the perceived defect or flaw). In response to thei r'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 44, 'page_label': '45'}, page_content='preoccupation, individuals engage in repetitive and excessive behaviours that \\ninclude repeated examination of the appearance or severity of the perceived defect \\nor flaw, excessive attempts to camouflage or alter the perceived defect, or m arked \\navoidance of social situations or triggers that increase distress about the perc eived \\ndefect or flaw. The symptoms are sufficiently severe to result in significan t distress'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 44, 'page_label': '45'}, page_content='or significant impairment in personal, family, social, educational, occupat ional or \\nother important areas of functioning. \\nExclusions: Anorexia Nervosa (6B80) \\nBodily distress disorder (6C20) \\nConcern about body appearance (BlockL2‑QD3) \\n \\n6B21.0 Body dysmorphic disorder with fair to good insight \\nAll definitional requirements of body dysmorphic disorder are met. Much of the time, \\nthe individual is able to entertain the possibility that his or her disorder-spe cific'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 44, 'page_label': '45'}, page_content='beliefs may not be true and is willing to accept an alternative explanati on for his or \\nher experience. At circumscribed times (e.g., when highly anxious), the ind ividual \\nmay demonstrate no insight. \\n \\n6B21.1 Body dysmorphic disorder with poor to absent insight \\nAll definitional requirements of body dysmorphic disorder are met. Most or all  of the \\ntime, the individual is convinced that the disorder-specific beliefs are tr ue and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 44, 'page_label': '45'}, page_content='cannot accept an alternative explanation for their experience. The lack of insight \\nexhibited by the individual does not vary markedly as a function of anxiety level. \\n \\n6B21.Z Body dysmorphic disorder, unspecified \\n \\n  6B22   Olfactory reference disorder \\nOlfactory Reference Disorder is characterized by persistent preoccupation with the \\nbelief that one is emitting a perceived foul or offensive body odour or breath  that is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 44, 'page_label': '45'}, page_content='either unnoticeable or only slightly noticeable to others. Individuals experi ence \\nexcessive self-consciousness about the perceived odour, often with ideas of \\nreference (i.e., the conviction that people are taking notice, judging, or talki ng about \\nthe odour). In response to their preoccupation, individuals engage in repetitive a nd \\nexcessive behaviours such as repeatedly checking for body odour or chec king the \\nperceived source of the smell, or repeatedly seeking reassurance, excessive'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 44, 'page_label': '45'}, page_content='attempts to camouflage, alter, or prevent the perceived odour, or marked avoidance \\nof social situations or triggers that increase distress about the perceived fou l or \\noffensive odour. The symptoms are sufficiently severe to result in significan t \\ndistress or significant impairment in personal, family, social, educationa l, \\noccupational or other important areas of functioning.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 45, 'page_label': '46'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   45 \\n \\n6B22.0 Olfactory reference disorder with fair to good insight \\nAll definitional requirements of olfactory reference disorder are met. Much of the \\ntime, the individual is able to entertain the possibility that his or her dis order-specific \\nbeliefs may not be true and is willing to accept an alternative explanati on for his or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 45, 'page_label': '46'}, page_content='her experience. At circumscribed times (e.g., when highly anxious), the indi vidual \\nmay demonstrate no insight. \\n \\n6B22.1 Olfactory reference disorder with poor to absent insight \\nAll definitional requirements of olfactory reference disorder are met. Most or all of \\nthe time, the individual is convinced that the disorder-specific beliefs  are true and \\ncannot accept an alternative explanation for their experience. The lack of insight'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 45, 'page_label': '46'}, page_content='exhibited by the individual does not vary markedly as a function of anxiety level. \\n \\n6B22.Z Olfactory reference disorder, unspecified \\n \\n  6B23   Hypochondriasis \\nHypochondriasis is characterized by persistent preoccupation with or fear a bout the \\npossibility of having one or more serious, progressive or life-threatening diseases . \\nThe preoccupation is associated with catastrophic misinterpretation of bodily  signs'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 45, 'page_label': '46'}, page_content='or symptoms, including normal or commonplace sensations, and is manifest either \\nin repetitive and excessive health-related behaviours or in maladaptive avoidance \\nbehaviours related to health. The preoccupation or fear is not simply a reas onable \\nconcern related to a specific context of the patient, and persists or reoccurs de spite \\nappropriate medical evaluation and reassurance. The symptoms result in signif icant'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 45, 'page_label': '46'}, page_content='distress or significant impairment in personal, family, social, educationa l, \\noccupational or other important areas of functioning. \\nInclusions: Hypochondriacal neurosis \\nNosophobia \\nIllness anxiety disorder \\nExclusions: Body dysmorphic disorder (6B21) \\nBodily distress disorder (6C20) \\nFear of cancer (MG24.0) \\n \\n6B23.0 Hypochondriasis with fair to good insight \\nAll definitional requirements of hypochondriasis are met. Much of the ti me, the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 45, 'page_label': '46'}, page_content='individual is able to entertain the possibility that his or her disord er-specific beliefs \\nmay not be true and is willing to accept an alternative explanation for his or her \\nexperience. At circumscribed times (e.g., when highly anxious), the indivi dual may \\ndemonstrate no insight. \\n \\n6B23.1 Hypochondriasis with poor to absent insight \\nAll definitional requirements of hypochondriasis are met. Most or all of the  time, the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 45, 'page_label': '46'}, page_content='individual is convinced that the disorder-specific beliefs are true and c annot accept \\nan alternative explanation for their experience. The lack of insight exhibited by  t he \\nindividual does not vary markedly as a function of anxiety level. \\n \\n6B23.Z Hypochondriasis, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 46, 'page_label': '47'}, page_content='46  ICD-11 MMS - 2018 \\n \\n  6B24   Hoarding disorder \\nHoarding disorder is characterised by accumulation of possessions due to \\nexcessive acquisition of or difficulty discarding possessions, regardless  of their \\nactual value. Excessive acquisition is characterized by repetitive urges  or \\nbehaviours related to amassing or buying items. Difficulty discarding possess ions is \\ncharacterized by a perceived need to save items and distress associated with'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 46, 'page_label': '47'}, page_content='discarding them. Accumulation of possessions results in living spaces becomi ng \\ncluttered to the point that their use or safety is compromised. The symptoms result \\nin significant distress or significant impairment in personal, family, social, \\neducational, occupational or other important areas of functioning. \\n \\n6B24.0 Hoarding disorder with fair to good insight \\nAll definitional requirements of hoarding disorder are met. The individual recog nizes'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 46, 'page_label': '47'}, page_content='that hoarding-related beliefs and behaviours (pertaining to excessive acquisiti on, \\ndifficulty discarding, or clutter) are problematic. This qualifier level may s till be \\napplied if, at circumscribed times (e.g., when being forced to discard items), the  \\nindividual demonstrates no insight. \\n \\n6B24.1 Hoarding disorder with poor to absent insight \\nAll definitional requirements of hoarding disorder are met. Most or all of the time, the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 46, 'page_label': '47'}, page_content='individual is convinced that that hoarding-related beliefs and behaviou rs (pertaining \\nto excessive acquisition, difficulty discarding, or clutter) are not problematic, des pite \\nevidence to the contrary. The lack of insight exhibited by the individual d oes not \\nvary markedly as a function of anxiety level. \\n \\n6B24.Z Hoarding disorder, unspecified \\n \\n  6B25   Body-focused repetitive behaviour disorders \\nBody focused repetitive behavior disorders are characterized by recurrent and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 46, 'page_label': '47'}, page_content='habitual actions directed at the integument (e.g. hair-pulling, skin-picking , lip-biting), \\ntypically accompanied by unsuccessful attempts to decrease or stop the behavi our \\ninvolved, and which lead to dermatological sequelae (e.g., hair loss, sk in lesions, lip \\nabrasions). The behaviour may occur in brief episodes scattered throughout the day \\nor in less frequent but more sustained periods. The symptoms result in signific ant'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 46, 'page_label': '47'}, page_content='distress or significant impairment in personal, family, social, educationa l, \\noccupational or other important areas of functioning. \\n \\n6B25.0 Trichotillomania \\nTrichotillomania is characterized by recurrent pulling of one ’s own hair leading to \\nsignificant hair loss, accompanied by unsuccessful attempts to decrease or stop  the \\nbehaviour. Hair pulling may occur from any region of the body in which hai r grows \\nbut the most common sites are the scalp, eyebrows, and eyelids. Hair pulling  may'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 46, 'page_label': '47'}, page_content='occur in brief episodes scattered throughout the day or in less frequent but more \\nsustained periods. The symptoms result in significant distress or signific ant \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning. \\nInclusions: Compulsive hair plucking \\nExclusions: stereotyped movement disorder with hair-plucking (6A06)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 47, 'page_label': '48'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   47 \\n \\n6B25.1 Excoriation disorder \\nExcoriation disorder is characterized by recurrent picking of one ’s own skin leading \\nto skin lesions, accompanied by unsuccessful attempts to decrease or stop the  \\nbehaviour. The most commonly picked sites are the face, arms and hands, but \\nmany individuals pick from multiple body sites. Skin picking may  occur in brief'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 47, 'page_label': '48'}, page_content='episodes scattered throughout the day or in less frequent but more sustained \\nperiods. The symptoms result in significant distress or significant im pairment in \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning. \\nInclusions: skin picking disorder \\nExclusions: Stereotyped movement disorder (6A06) \\nAcute excoriation of skin (ME62.9) \\nChronic excoriation of skin (ME63.7) \\n \\n6B25.Y Other specified body-focused repetitive behaviour disorders'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 47, 'page_label': '48'}, page_content='6B25.Z Body-focused repetitive behaviour disorders, unspecified \\n \\n  6B2Y   Other specified obsessive-compulsive or related disorders \\n \\n  6B2Z   Obsessive-compulsive or related disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 48, 'page_label': '49'}, page_content='48  ICD-11 MMS - 2018 \\n \\nDisorders specifically associated with stress (BlockL1‑6B4) \\nDisorders specifically associated with stress are directly related to ex posure to a stressful or traumatic \\nevent, or a series of such events or adverse experiences. For each of the disorders in t his grouping, \\nan identifiable stressor is a necessary, though not sufficient, causal factor. A lthough not all individuals'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 48, 'page_label': '49'}, page_content='exposed to an identified stressor will develop a disorder, the disorders in thi s grouping would not have \\noccurred without experiencing the stressor. Stressful events for some disorders in thi s grouping are \\nwithin the normal range of life experiences (e.g., divorce, socio-economic problem s, bereavement). \\nOther disorders require the experience of a stressor of an extremely threatening or horrific n ature (i.e.,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 48, 'page_label': '49'}, page_content='potentially traumatic events). With all disorders in this grouping, it is the nature, p attern, and duration \\nof the symptoms that arise in response to the stressful events —together with associated functional \\nimpairment—that distinguishes the disorders. \\nExclusions: Burn-out (QD85) \\nAcute stress reaction (QE84) \\n  6B40   Post traumatic stress disorder \\nPost-traumatic stress disorder (PTSD) is a syndrome that develops following'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 48, 'page_label': '49'}, page_content='exposure to an extremely threatening or horrific event or series of events that is \\ncharacterized by all of the following: 1) re-experiencing the traumatic even t or \\nevents in the present in the form of vivid intrusive memories, flashbacks, or  \\nnightmares, which are typically accompanied by strong and overwhelming emotions \\nsuch as fear or horror and strong physical sensations, or feelings of being \\noverwhelmed or immersed in the same intense emotions that were experienced'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 48, 'page_label': '49'}, page_content='during the traumatic event; 2) avoidance of thoughts and memories of the event or \\nevents, or avoidance of activities, situations, or people reminiscent of the even t or \\nevents; and 3) persistent perceptions of heightened current threat, for example as \\nindicated by hypervigilance or an enhanced startle reaction to stimuli such as \\nunexpected noises. The symptoms must persist for at least several weeks and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 48, 'page_label': '49'}, page_content='cause significant impairment in personal, family, social, educati onal, occupational or \\nother important areas of functioning. \\nInclusions: Traumatic neurosis \\nExclusions: Acute stress reaction (QE84) \\nComplex post traumatic stress disorder (6B41) \\n \\n  6B41   Complex post traumatic stress disorder \\nComplex post-traumatic stress disorder (Complex PTSD) is a disorder that may \\ndevelop following exposure to an event or series of events of an extremely'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 48, 'page_label': '49'}, page_content='threatening or horrific nature, most commonly prolonged or repetitive events fro m \\nwhich escape is difficult or impossible (e.g., torture, slavery, genocide campaigns, \\nprolonged domestic violence, repeated childhood sexual or physical abuse). T he \\ndisorder is characterized by the core symptoms of PTSD; that is, all diagnostic \\nrequirements for PTSD have been met at some point during the course of the \\ndisorder. In addition, Complex PTSD is characterized by 1) severe and pervasive'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 48, 'page_label': '49'}, page_content='problems in affect regulation; 2) persistent beliefs about oneself as diminished, \\ndefeated or worthless, accompanied by deep and pervasive feelings of shame, gu ilt \\nor failure related to the traumatic event; and 3) persistent difficulties in sustai ning \\nrelationships and in feeling close to others. The disturbance causes signif icant \\nimpairment in personal, family, social, educational, occupational or o ther important \\nareas of functioning. \\nExclusions: Post traumatic stress disorder (6B40)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 49, 'page_label': '50'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   49 \\n \\n  6B42   Prolonged grief disorder \\nProlonged grief disorder is a disturbance in which, following the death of a par tner, \\nparent, child, or other person close to the bereaved, there is persistent and \\npervasive grief response characterized by longing for the deceased or persis tent \\npreoccupation with the deceased accompanied by intense emotional pain (e.g.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 49, 'page_label': '50'}, page_content='sadness, guilt, anger, denial, blame, difficulty accepting the death, feeli ng one has \\nlost a part of one ’s self, an inability to experience positive mood, emotional \\nnumbness, difficulty in engaging with social or other activities). The grief r esponse \\nhas persisted for an atypically long period of time following the loss ( more than 6 \\nmonths at a minimum) and clearly exceeds expected social, cultural or religious'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 49, 'page_label': '50'}, page_content='norms for the individual’s culture and context. Grief reactions that have persisted for \\nlonger periods that are within a normative period of grieving given the person ’s \\ncultural and religious context are viewed as normal bereavement responses and are \\nnot assigned a diagnosis. The disturbance causes significant impairment in \\npersonal, family, social, educational, occupational or other important areas of \\nfunctioning. \\n \\n  6B43   Adjustment disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 49, 'page_label': '50'}, page_content='Adjustment disorder is a maladaptive reaction to an identifiable psychosoc ial \\nstressor or multiple stressors (e.g., divorce, illness or disability, socio-econom ic \\nproblems, conflicts at home or work) that usually emerges within a month of the \\nstressor. The disorder is characterized by preoccupation with the stressor or its \\nconsequences, including excessive worry, recurrent and distressing thoughts abou t'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 49, 'page_label': '50'}, page_content='the stressor, or constant rumination about its implications, as well as by f ailure to \\nadapt to the stressor that causes significant impairment in personal, family, soc ial, \\neducational, occupational or other important areas of functioning. The symptoms \\nare not of sufficient specificity or severity to justify the diagnosis of another Mental \\nand Behavioural Disorder and typically resolve within 6 months, unless the stressor \\npersists for a longer duration.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 49, 'page_label': '50'}, page_content='Exclusions: separation anxiety disorder of childhood (6B05) \\nRecurrent depressive disorder (6A71) \\nSingle episode depressive disorder (6A70) \\nProlonged grief disorder (6B42) \\nUncomplicated bereavement (QE62) \\nBurn-out (QD85) \\nAcute stress reaction (QE84)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 50, 'page_label': '51'}, page_content='50  ICD-11 MMS - 2018 \\n \\n  6B44   Reactive attachment disorder \\nReactive attachment disorder is characterized by grossly abnormal attachment \\nbehaviours in early childhood, occurring in the context of a history of gros sly \\ninadequate child care (e.g., severe neglect, maltreatment, institutional deprivation). \\nEven when an adequate primary caregiver is newly available, the child does  not \\nturn to the primary caregiver for comfort, support and nurture, rarely displays'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 50, 'page_label': '51'}, page_content='security-seeking behaviours towards any adult, and does not respond when com fort \\nis offered. Reactive attachment disorder can only be diagnosed in children, and \\nfeatures of the disorder develop within the first 5 years of life. However, the disord er \\ncannot be diagnosed before the age of 1 year (or a developmental age of less than \\n9 months), when the capacity for selective attachments may not be fully devel oped, \\nor in the context of Autism spectrum disorder.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 50, 'page_label': '51'}, page_content='Exclusions: Asperger syndrome (6A02) \\ndisinhibited attachment disorder of childhood (6B45) \\n \\n  6B45   Disinhibited social engagement disorder \\nDisinhibited social engagement disorder is characterized by grossly abnormal social \\nbehaviour, occurring in the context of a history of grossly inadequate child care \\n(e.g., severe neglect, institutional deprivation). The child approaches adults \\nindiscriminately, lacks reticence to approach, will go away with unfamili ar adults,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 50, 'page_label': '51'}, page_content='and exhibits overly familiar behaviour towards strangers. Disinhibited soci al \\nengagement disorder can only be diagnosed in children, and features of the \\ndisorder develop within the first 5 years of life. However, the disorder cannot be \\ndiagnosed before the age of 1 year (or a developmental age of less than 9 month s), \\nwhen the capacity for selective attachments may not be fully developed, or in the \\ncontext of Autism spectrum disorder. \\nExclusions: Asperger syndrome (6A02)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 50, 'page_label': '51'}, page_content='Adjustment disorder (6B43) \\nAttention deficit hyperactivity disorder (6A05) \\nreactive attachment disorder of childhood (6B44) \\n \\n  6B4Y   Other specified disorders specifically associated with stress \\n \\n  6B4Z   Disorders specifically associated with stress, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 51, 'page_label': '52'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   51 \\n \\nDissociative disorders (BlockL1‑6B6) \\nDissociative disorders are characterized by involuntary disruption or discon tinuity in the normal \\nintegration of one or more of the following: identity, sensations, perceptions, aff ects, thoughts, \\nmemories, control over bodily movements, or behaviour. Disruption or dis continuity may be complete,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 51, 'page_label': '52'}, page_content='but is more commonly partial, and can vary from day to day or even from hour to hour. The symptoms \\nof dissociative disorders are not due the direct effects of a medication or sub stance, including \\nwithdrawal effects, are not better explained by another Mental, behavioural, or neurodev elopmental \\ndisorder, a Sleep-wake disorder, a Disease of the nervous system or other health conditio n, and are'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 51, 'page_label': '52'}, page_content='not part of an accepted cultural, religious, or spiritual practice. Dissociative s ymptoms in dissociativ e \\ndisorders are sufficiently severe to result in significant impairment in p ersonal, family, social, \\neducational, occupational or other important areas of functioning. \\nCoded Elsewhere: Secondary dissociative syndrome (6E65) \\n  6B60   Dissociative neurological symptom disorder \\nDissociative neurological symptom disorder is characterized by the presentati on of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 51, 'page_label': '52'}, page_content='motor, sensory, or cognitive symptoms that imply an involuntary discontinu ity in the \\nnormal integration of motor, sensory, or cognitive functions and are not consisten t \\nwith a recognized disease of the nervous system, other mental or behavioural \\ndisorder, or other health condition. The symptoms do not occur exclusively duri ng \\nanother dissociative disorder and are not due to the effects of a substance or \\nmedication on the central nervous system, including withdrawal effects, or a Slee p-'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 51, 'page_label': '52'}, page_content='Wake disorder. \\nExclusions: Factitious disorders  (BlockL1‑6D5) \\n \\n6B60.0 Dissociative neurological symptom disorder, with visual disturbance \\nDissociative neurological symptom disorder, with visual disturbance is characteriz ed \\nby visual symptoms such as blindness, tunnel vision, diplopia, visual distortions or \\nhallucinations that are not consistent with a recognized disease of the nerv ous \\nsystem, other mental or behavioural disorder, or other health condition and do not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 51, 'page_label': '52'}, page_content='occur exclusively during another dissociative disorder. \\n \\n6B60.1 Dissociative neurological symptom disorder, with auditory disturbance \\nDissociative neurological symptom disorder, with auditory disturbance is \\ncharacterized by auditory symptoms such as loss of hearing or auditory \\nhallucinations that are not consistent with a recognized disease of the nerv ous \\nsystem, other mental or behavioural disorder, or other health condition and do not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 51, 'page_label': '52'}, page_content='occur exclusively during another dissociative disorder. \\n \\n6B60.2 Dissociative neurological symptom disorder, with vertigo or dizziness  \\nDissociative neurological symptom disorder, with vertigo or dizziness is \\ncharacterized by a sensation of spinning while stationary (vertigo) or dizziness  that \\nis not consistent with a recognized disease of the nervous system, mental or \\nbehavioural disorder, or other health condition and does not occur exclusively \\nduring another dissociative disorder.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 52, 'page_label': '53'}, page_content='52  ICD-11 MMS - 2018 \\n \\n6B60.3 Dissociative neurological symptom disorder, with other sensory disturbance  \\nDissociative neurological symptom disorder, with other sensory disturbance is \\ncharacterized by sensory symptoms not identified in other specific categ ories in this \\ngrouping such as numbness, tightness, tingling, burning, pain, or other symptoms \\nrelated to touch, smell, taste, balance, proprioception, kinesthesia, or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 52, 'page_label': '53'}, page_content='thermoception. The symptoms are not consistent with a recognized disease of the \\nnervous system, other mental or behavioural disorder, or other health condition and \\ndo not occur exclusively during another dissociative disorder. \\n \\n6B60.4 Dissociative neurological symptom disorder, with non-epileptic seizures  \\nDissociative neurological symptom disorder, with non-epileptic seizures is \\ncharacterized by a symptomatic presentation of seizures or convulsions that are no t'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 52, 'page_label': '53'}, page_content='consistent with a recognized disease of the nervous system, other mental or \\nbehavioural disorder, or other health condition and do not occur exclusively durin g \\nanother dissociative disorder. \\n \\n6B60.5 Dissociative neurological symptom disorder, with speech disturbance  \\nDissociative neurological symptom disorder, with speech disturbance is \\ncharacterized by symptoms such as difficulty with speaking (dysphonia), loss  of the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 52, 'page_label': '53'}, page_content='ability to speak (aphonia) or difficult or unclear articulation of speech (dysarthr ia) \\nthat are not consistent with a recognized disease of the nervous system, a \\nneurodevelopmental or neurocognitive disorder, other mental or behavioural \\ndisorder, or other health condition and do not occur exclusively during another \\ndissociative disorder. \\n \\n6B60.6 Dissociative neurological symptom disorder, with paresis or weakness \\nDissociative neurological symptom disorder, with paresis or weakness is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 52, 'page_label': '53'}, page_content='characterized by a difficulty or inability to intentionally move parts of the  body or to \\ncoordinate movements that is not consistent with a recognized disease of the \\nnervous system, other mental and behavioural disorder, other health condition and \\ndoes not occur exclusively during another dissociative disorder. \\n \\n6B60.7 Dissociative neurological symptom disorder, with gait disturbance \\nDissociative neurological symptom disorder, with gait disturbance is characterized'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 52, 'page_label': '53'}, page_content='by symptoms involving the individual ’s ability or manner of walking, including ataxia \\nand the inability to stand unaided, that are not consistent with a recognized diseas e \\nof the nervous system, other mental and behavioural disorder, or other health \\ncondition and do not occur exclusively during another dissociative disorder. \\n \\n6B60.8 Dissociative neurological symptom disorder, with movement disturbance  \\nDissociative neurological symptom disorder, with movement disturbance is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 52, 'page_label': '53'}, page_content='characterized by symptoms such as chorea, myoclonus, tremor, dystonia, facial \\nspasm, parkinsonism, or dyskinesia that are not consistent with a recognized \\ndisease of the nervous system, other mental and behavioural disorder, or other \\nhealth condition and do not occur exclusively during another dissociative disorder.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 53, 'page_label': '54'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   53 \\n \\n6B60.80 Dissociative neurological symptom disorder, with chorea \\nDissociative neurological symptom disorder, with chorea is characterized by \\nirregular, non-repetitive, brief, jerky, flowing movements that move randomly f rom \\none part of the body to another that are not consistent with a recognized disease of \\nthe nervous system, other mental and behavioural disorder, or other health'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 53, 'page_label': '54'}, page_content='condition and do not occur exclusively during another dissociative disorder. \\n \\n6B60.81 Dissociative neurological symptom disorder, with myoclonus \\nDissociative neurological symptom disorder, with myoclonus is characterized by  \\nsudden rapid jerks that may be focal, multifocal or generalized that are not \\nconsistent with a recognized disease of the nervous system, other mental and  \\nbehavioural disorder, or other health condition and do not occur exclusively durin g'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 53, 'page_label': '54'}, page_content='another dissociative disorder. \\n \\n6B60.82 Dissociative neurological symptom disorder, with tremor \\nDissociative neurological symptom disorder, with tremor is characterized by \\ninvoluntary oscillation of a body part that is not consistent with a recogn ized disease \\nof the nervous system, other mental and behavioural disorder, or other health \\ncondition and does not occur exclusively during another dissociative disorder. \\n \\n6B60.83 Dissociative neurological symptom disorder, with dystonia'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 53, 'page_label': '54'}, page_content='Dissociative neurological symptom disorder, with dystonia is characterized by  \\nsustained muscle contractions that frequently causing twisting and repetitive  \\nmovements or abnormal postures that are not consistent with a recognized disease \\nof the nervous system, other mental and behavioural disorder, or other health \\ncondition and do not occur exclusively during another dissociative disorder. \\n \\n6B60.84 Dissociative neurological symptom disorder, with facial spasm'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 53, 'page_label': '54'}, page_content='Dissociative neurological symptom disorder, with facial spasm is characteriz ed by \\ninvoluntary muscle contractions or twitching of the face that is not consi stent with a \\nrecognized disease of the nervous system, other mental and behavioural dis order, \\nor other health condition and does not occur exclusively during another dissociati ve \\ndisorder. \\n \\n6B60.85 Dissociative neurological symptom disorder, with Parkinsonism'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 53, 'page_label': '54'}, page_content='Dissociative neurological symptom disorder, with Parkinsonism is characterized b y \\na symptomatic presentation of a Parkinson-like syndrome in the absence of \\nconfirmed Parkinson disease that does not occur exclusively during another \\ndissociative disorder. Dissociative neurological symptom disorder, with \\nParkinsonism can be distinguished from Parkinson disease by features such as  \\nbrupt onset, early disability, bilateral shaking and slowness, nondecremental'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 53, 'page_label': '54'}, page_content='slowness when performing repetitive movements, voluntary resistance against \\npassive movement without cogwheel rigidity, distractibility, ‘give-way’ weakness, \\nstuttering speech, bizarre gait, and a variety of behavioral symptoms. \\n \\n6B60.8Y Dissociative neurological symptom disorder, with other specified movement \\ndisturbance \\n \\n6B60.8Z Dissociative neurological symptom disorder, with unspecified movement \\ndisturbance'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 54, 'page_label': '55'}, page_content='54  ICD-11 MMS - 2018 \\n \\n6B60.9 Dissociative neurological symptom disorder, with cognitive symptoms  \\nDissociative neurological symptom disorder, with cognitive symptoms is \\ncharacterized by impaired cognitive performance in memory, language or othe r \\ncognitive domains that is internal inconsistent and not consistent with a recogni zed \\ndisease of the nervous system, a neurodevelopmental or neurocognitive disorder,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 54, 'page_label': '55'}, page_content='other mental and behavioural disorder, or another health condition and does not \\noccur exclusively during another dissociative disorder. \\nExclusions: Dissociative amnesia (6B61) \\n \\n6B60.Y Dissociative neurological symptom disorder, with other specified symptoms  \\n \\n6B60.Z Dissociative neurological symptom disorder, with unspecified symptoms  \\n \\n  6B61   Dissociative amnesia \\nDissociative amnesia is characterized by an inability to recall impo rtant'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 54, 'page_label': '55'}, page_content='autobiographical memories, typically of recent traumatic or stressful events, th at is \\ninconsistent with ordinary forgetting. The amnesia does not occur exclusively dur ing \\nanother dissociative disorder and is not better explained by another mental, \\nbehavioural or neurodevelopmental disorder. The amnesia is not due to the direc t \\neffects of a substance or medication on the central nervous system, including  \\nwithdrawal effects, and is not due to a disease of the nervous system or to head'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 54, 'page_label': '55'}, page_content='trauma. The amnesia results in significant impairment in personal, f amily, social, \\neducational, occupational or other important areas of functioning. \\nExclusions: amnesia NOS (MB21.1) \\nAmnestic disorder due to use of alcohol (6D72.10) \\nAnterograde amnesia (MB21.10) \\nRetrograde amnesia (MB21.11) \\nnonalcoholic organic amnesic syndrome (6D72.0) \\npostictal amnesia in epilepsy (BlockL1‑8A6) \\n \\n  6B62   Trance disorder \\nTrance disorder is characterized by trance states in which there is a marked'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 54, 'page_label': '55'}, page_content='alteration in the individual ’s state of consciousness or a loss of the individual ’s \\ncustomary sense of personal identity in which the individual experiences a \\nnarrowing of awareness of immediate surroundings or unusually narrow and \\nselective focusing on environmental stimuli and restriction of movements, po stures, \\nand speech to repetition of a small repertoire that is experienced as being outside of \\none’s control. The trance state is not characterized by the experience of being'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 54, 'page_label': '55'}, page_content='replaced by an alternate identity. Trance episodes are recurrent or, if the diagnosi s \\nis based on a single episode, the episode has lasted for at least several day s. The \\ntrance state is involuntary and unwanted and is not accepted as a part of a \\ncollective cultural or religious practice. The symptoms do not occur exclusivel y \\nduring another dissociative disorder and are not better explained by another mental, \\nbehavioural or neurodevelopmental disorder. The symptoms are not due to the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 54, 'page_label': '55'}, page_content='direct effects of a substance or medication on the central nervous system, incl uding \\nwithdrawal effects, exhaustion, or to hypnagogic or hypnopompic states, and are \\nnot due to a disease of the nervous system, head trauma, or a sleep-wake disorder. \\nThe symptoms result in significant distress or significant impairment i n personal, \\nfamily, social, educational, occupational or other important areas of functioning.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 55, 'page_label': '56'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   55 \\n \\n  6B63   Possession trance disorder \\nPossession trance disorder is characterized by trance states in which there is a  \\nmarked alteration in the individual ’s state of consciousness and the individual ’s \\ncustomary sense of personal identity is replaced by an external ‘possessing’ identity \\nand in which the individual ’s behaviours or movements are experienced as being'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 55, 'page_label': '56'}, page_content='controlled by the possessing agent. Possession trance episodes are recurrent or, if \\nthe diagnosis is based on a single episode, the episode has lasted for at lea st \\nseveral days. The possession trance state is involuntary and unwanted and is n ot \\naccepted as a part of a collective cultural or religious practice. The symptoms do not \\noccur exclusively during another dissociative disorder and are not better explained'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 55, 'page_label': '56'}, page_content='by another mental, behavioural or neurodevelopmental disorder. The symptoms are \\nnot due to the direct effects of a substance or medication on the central nervo us \\nsystem, including withdrawal effects, exhaustion, or to hypnagogic or hypnopompic \\nstates, and are not due to a disease of the nervous system or a sleep-wake \\ndisorder. The symptoms result in significant distress or significant impa irment in \\npersonal, family, social, educational, occupational or other important areas of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 55, 'page_label': '56'}, page_content='functioning. \\nExclusions: Schizophrenia (6A20) \\nDisorders due to use of other specified psychoactive \\nsubstances, including medications (6C4E) \\nAcute and transient psychotic disorder (6A23) \\nSecondary personality change (6E68) \\n \\n  6B64   Dissociative identity disorder \\nDissociative identity disorder is characterized by disruption of identity in which there \\nare two or more distinct personality states (dissociative identities) associated w ith'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 55, 'page_label': '56'}, page_content='marked discontinuities in the sense of self and agency. Each personality state  \\nincludes its own pattern of experiencing, perceiving, conceiving, and relati ng to self, \\nthe body, and the environment. At least two distinct personality states recurr ently \\ntake executive control of the individual ’s consciousness and functioning in \\ninteracting with others or with the environment, such as in the performance of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 55, 'page_label': '56'}, page_content='specific aspects of daily life such as parenting, or work, or in response to specific \\nsituations (e.g., those that are perceived as threatening). Changes in personality \\nstate are accompanied by related alterations in sensation, perception, affect, \\ncognition, memory, motor control, and behaviour. There are typically epis odes of \\namnesia, which may be severe. The symptoms are not better explained by anot her \\nmental, behavioural or neurodevelopmental disorder and are not due to the direct'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 55, 'page_label': '56'}, page_content='effects of a substance or medication on the central nervous system, includi ng \\nwithdrawal effects, and are not due to a disease of the nervous system or a sl eep-\\nwake disorder. The symptoms result in significant impairment in personal, fami ly, \\nsocial, educational, occupational or other important areas of functioning.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 56, 'page_label': '57'}, page_content='56  ICD-11 MMS - 2018 \\n \\n  6B65   Partial dissociative identity disorder \\nPartial dissociative identity disorder is characterized by disruption of iden tity in \\nwhich there are two or more distinct personality states (dissociative identiti es) \\nassociated with marked discontinuities in the sense of self and agency. Ea ch \\npersonality state includes its own pattern of experiencing, perceiving, conceiv ing, \\nand relating to self, the body, and the environment. One personality state is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 56, 'page_label': '57'}, page_content='dominant and normally functions in daily life, but is intruded upon by on e or more \\nnon-dominant personality states (dissociative intrusions). These intrusions may be \\ncognitive, affective, perceptual, motor, or behavioral. They are experienced as \\ninterfering with the functioning of the dominant personality state and are typical ly \\naversive. The non-dominant personality states do not recurrently take executive \\ncontrol of the individual ’s consciousness and functioning, but there may be'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 56, 'page_label': '57'}, page_content='occasional, limited and transient episodes in which a distinct personality  state \\nassumes executive control to engage in circumscribed behaviours, such as in \\nresponse to extreme emotional states or during episodes of self-harm or the \\nreenactment of traumatic memories. The symptoms are not better explained by \\nanother mental, behavioural or neurodevelopmental disorder and are not due to the \\ndirect effects of a substance or medication on the central nervous system, incl uding'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 56, 'page_label': '57'}, page_content='withdrawal effects, and are not due to a disease of the nervous system or a sl eep-\\nwake disorder. The symptoms result in significant impairment in personal, fami ly, \\nsocial, educational, occupational or other important areas of functioning. \\n \\n  6B66   Depersonalization-derealization disorder \\nDepersonalization-derealization disorder is characterized by persistent or recurrent \\nexperiences of depersonalization, derealization, or both. Depersonalization is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 56, 'page_label': '57'}, page_content='characterized by experiencing the self as strange or unreal, or feeling detach ed \\nfrom, or as though one were an outside observer of, one ’s thoughts, feelings, \\nsensations, body, or actions. Derealization is characterized by experiencing othe r \\npersons, objects, or the world as strange or unreal (e.g., dreamlike, distant, foggy, \\nlifeless, colorless, or visually distorted) or feeling detached from one ’s surroundings.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 56, 'page_label': '57'}, page_content='During experiences of depersonalization or derealization, reality testing remai ns \\nintact. The experiences of depersonalization or derealization do not occur \\nexclusively during another dissociative disorder and are not better explained by \\nanother mental, behavioural or neurodevelopmental disorder. The experiences of \\ndepersonalization or derealization are not due to the direct effects of a substance or \\nmedication on the central nervous system, including withdrawal effects, and are not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 56, 'page_label': '57'}, page_content='due to a disease of the nervous system or to head trauma. The symptoms result in \\nsignificant distress or impairment in personal, family, social, educationa l, \\noccupational or other important areas of functioning. \\n \\n  6B6Y   Other specified dissociative disorders \\n \\n  6B6Z   Dissociative disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 57, 'page_label': '58'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   57 \\n \\nFeeding or eating disorders (BlockL1‑6B8) \\nFeeding and Eating Disorders involve abnormal eating or feeding behaviours that are  not explained \\nby another health condition and are not developmentally appropriate or culturally sanctioned. Feeding \\ndisorders involve behavioural disturbances that are not related to body weight and shape concerns,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 57, 'page_label': '58'}, page_content='such as eating of non-edible substances or voluntary regurgitation of foods. Eatin g disorders include \\nabnormal eating behaviour and preoccupation with food as well as prominent body weight an d shape \\nconcerns. \\n  6B80   Anorexia Nervosa \\nAnorexia Nervosa is characterized by significantly low body weight for t he \\nindividual’s height, age and developmental stage (body mass index (BMI) less than \\n18.5 kg/m2 in adults and BMI-for-age under fifth percentile in children and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 57, 'page_label': '58'}, page_content='adolescents) that is not due to another health condition or to the unavailabili ty of \\nfood. Low body weight is accompanied by a persistent pattern of behaviours to \\nprevent restoration of normal weight, which may include behaviours aimed at  \\nreducing energy intake (restricted eating), purging behaviours (e.g., self -induced \\nvomiting, misuse of laxatives), and behaviours aimed at increasing energy  \\nexpenditure (e.g., excessive exercise), typically associated with a fear of wei ght'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 57, 'page_label': '58'}, page_content=\"gain. Low body weight or shape is central to the person's self-evaluation or is \\ninaccurately perceived to be normal or even excessive. \\n \\n6B80.0 Anorexia Nervosa with significantly low body weight \\nAnorexia Nervosa with significantly low body weight meets all definitional  \\nrequirements for Anorexia Nervosa, with BMI between 18.5 kg/m2 and 14.0 kg/m² \\nfor adults or between the fifth percentile and the 0.3 percentile for BMI-for- age in \\nchildren and adolescents).\"),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 57, 'page_label': '58'}, page_content='6B80.00 Anorexia Nervosa with significantly low body weight, restricting pattern  \\nAnorexia Nervosa with significantly low body weight, restricting pattern refers  to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\nsignificantly low body weight and who induce weight loss and maintain l ow body \\nweight through restricted food intake or fasting alone or in combination with \\nincreased energy expenditure (such as through excessive exercise) but who do not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 57, 'page_label': '58'}, page_content='engage in binge eating or purging behaviours. \\n \\n6B80.01 Anorexia Nervosa with significantly low body weight, binge-purge pattern  \\nAnorexia Nervosa with significantly low body weight, binge-purge pattern ref ers to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\nsignificantly low body weight and who present with episodes of binge eating or \\npurging behaviours. These individuals induce weight loss and maintain low b ody'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 57, 'page_label': '58'}, page_content='weight through restricted food intake, commonly accompanied by significant purgi ng \\nbehaviours aimed at getting rid of ingested food (e.g. self-induced vomiting, laxative \\nabuse or enemas). This pattern also includes individuals who exhibit binge eating \\nepisodes but do not purge. \\n \\n6B80.0Z Anorexia Nervosa with significantly low body weight, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 58, 'page_label': '59'}, page_content='58  ICD-11 MMS - 2018 \\n \\n6B80.1 Anorexia Nervosa with dangerously low body weight \\nAnorexia Nervosa with dangerously low body weight meets all definitional \\nrequirements for Anorexia Nervosa, with BMI under 14.0 kg/m² in adults or under \\nthe 0.3rd percentile for BMI-for-age in children and adolescents. In the context of \\nAnorexia Nervosa, severe underweight status is an important prognostic factor that \\nis associated with high risk of physical complications and substanti ally increased'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 58, 'page_label': '59'}, page_content='mortality. \\n \\n6B80.10 Anorexia Nervosa with dangerously low body weight, restricting pattern \\nAnorexia Nervosa with dangerously low body weight, restricting pattern refers to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\ndangerously low body weight and who induce weight loss and maintain low body  \\nweight through restricted food intake or fasting alone or in combination with \\nincreased energy expenditure (such as through excessive exercise) but who do not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 58, 'page_label': '59'}, page_content='engage in binge eating or purging behaviours. \\n \\n6B80.11 Anorexia Nervosa with dangerously low body weight, binge-purge pattern \\nAnorexia Nervosa with dangerously low body weight, binge-purge pattern refers to \\nindividuals who meet the definitional requirements of Anorexia Nervosa with \\ndangerously low body weight and who present with episodes of binge eating or \\npurging behaviours. These individuals induce weight loss and maintain low body'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 58, 'page_label': '59'}, page_content='weight through restricted food intake, commonly accompanied by significant purgi ng \\nbehaviours aimed at getting rid of ingested food (e.g. self-induced vomiting, laxative \\nabuse or enemas). This pattern also includes individuals who exhibit binge ea ting \\nepisodes but do not purge. \\n \\n6B80.1Z Anorexia Nervosa with dangerously low body weight, unspecified \\n \\n6B80.2 Anorexia Nervosa in recovery with normal body weight \\nAmong individuals who are recovering from Anorexia Nervosa and whose body'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 58, 'page_label': '59'}, page_content='weight is more than 18.5 kg/m2 for adults or over the fifth percentile for BMI-for- age \\nfor children and adolescents, the diagnosis should be retained until a full and lasting \\nrecovery is achieved, as indicated by the maintenance of a healthy weight and t he \\ncessation of behaviours aimed at reducing body weight independent of the provision \\nof treatment (e.g., for at least 1 year after intensive treatment is withdrawn). \\n \\n6B80.Y Other specified anorexia Nervosa'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 58, 'page_label': '59'}, page_content='6B80.Z Anorexia Nervosa, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 59, 'page_label': '60'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   59 \\n \\n  6B81   Bulimia Nervosa \\nBulimia Nervosa is characterized by frequent, recurrent episodes of binge eating  \\n(e.g., once a week or more over a period of at least one month). A binge eating \\nepisode is a distinct period of time during which the individual expe riences a \\nsubjective loss of control over eating, eating notably more or differently than usua l,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 59, 'page_label': '60'}, page_content='and feels unable to stop eating or limit the type or amount of food eaten. Binge \\neating is accompanied by repeated inappropriate compensatory behaviours aim ed \\nat preventing weight gain (e.g., self-induced vomiting, misuse of laxatives or \\nenemas, strenuous exercise). The individual is preoccupied with body shape or \\nweight, which strongly influences self-evaluation. The individual is not significantly \\nunderweight and therefore does not meet the diagnostic requirements of Anorexia \\nNervosa.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 59, 'page_label': '60'}, page_content='Nervosa. \\nExclusions: Binge eating disorder (6B82) \\n \\n  6B82   Binge eating disorder \\nBinge eating disorder is characterized by frequent, recurrent episodes of binge  \\neating (e.g., once a week or more over a period of several months). A binge eating \\nepisode is a distinct period of time during which the individual expe riences a \\nsubjective loss of control over eating, eating notably more or differently than us ual,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 59, 'page_label': '60'}, page_content='and feels unable to stop eating or limit the type or amount of food eaten. Binge \\neating is experienced as very distressing, and is often accompanied by negati ve \\nemotions such as guilt or disgust. However, unlike in Bulimia Nervosa, binge eating \\nepisodes are not regularly followed by inappropriate compensatory behaviours \\naimed at preventing weight gain (e.g., self-induced vomiting, misuse of laxatives  or \\nenemas, strenuous exercise). \\nExclusions: Bulimia Nervosa (6B81)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 59, 'page_label': '60'}, page_content='6B83   Avoidant-restrictive food intake disorder \\nAvoidant-restrictive food intake disorder (ARFID) is characterized by abnormal \\neating or feeding behaviours that result in the intake of an insufficient quantity  or \\nvariety of food to meet adequate energy or nutritional requirements. The pattern of \\nrestricted eating has caused significant weight loss, failure to gain weight as \\nexpected in childhood or pregnancy, clinically significant nutritional def iciencies,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 59, 'page_label': '60'}, page_content='dependence on oral nutritional supplements or tube feeding, or has otherwise \\nnegatively affected the health of the individual or resulted in significant functional \\nimpairment. The pattern of eating behaviour does not reflect concerns about body \\nweight or shape. Restricted food intake and its effects on weight, other aspects of \\nhealth, or functioning is not better accounted for by lack of food availability , the \\neffects of a medication or substance, or another health condition.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 59, 'page_label': '60'}, page_content='Exclusions: Anorexia Nervosa (6B80) \\nFeeding problem of infant (MG43.30) \\nFeeding problems of newborn (KD32)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 60, 'page_label': '61'}, page_content='60  ICD-11 MMS - 2018 \\n \\n  6B84   Pica \\nPica is characterized by the regular consumption of non-nutritive substances , such \\nas non-food objects and materials (e.g., clay, soil, chalk, plaster, pl astic, metal and \\npaper) or raw food ingredients (e.g., large quantities of salt or corn flour) that is \\npersistent or severe enough to require clinical attention in an individual  who has \\nreached a developmental age at which they would be expected to distinguish'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 60, 'page_label': '61'}, page_content='between edible and non-edible substances (approximately 2 years). That is, t he \\nbehavior causes damage to health, impairment in functioning, or significant  risk due \\nto the frequency, amount or nature of the substances or objects ingested. \\n \\n  6B85   Rumination-regurgitation disorder \\nRumination-regurgitation disorder is characterized by the intentional and repeated \\nbringing up of previously swallowed food back to the mouth (i.e., regurgitation) ,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 60, 'page_label': '61'}, page_content='which may be re-chewed and re-swallowed (i.e., rumination), or may be de liberately \\nspat out (but not as in vomiting). The regurgitation behaviour is frequent (at l east \\nseveral times per week) and sustained over a period of at least several weeks. T he \\nregurgitation behaviour is not fully accounted for by another health condition t hat \\ndirectly causes regurgitation (e.g., oesophageal strictures or neuromuscular'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 60, 'page_label': '61'}, page_content='disorders affecting oesophageal functioning) or causes nausea or vomiting (e.g., \\npyloric stenosis). Rumination-regurgitation disorder should only be diagnosed in \\nindividuals who have reached a developmental age of at least 2 years. \\nExclusions: Adult rumination syndrome (DD90.6) \\nNausea or vomiting (MD90) \\n \\n  6B8Y   Other specified feeding or eating disorders \\n \\n  6B8Z   Feeding or eating disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 61, 'page_label': '62'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   61 \\n \\nElimination disorders (BlockL1‑6C0) \\nElimination disorders include the repeated voiding of urine into clothes or bed (enuresis) and the \\nrepeated passage of feces in inappropriate places (encopresis). Elimination d isorders should only be \\ndiagnosed after the individual has reached a developmental age when continence  is ordinarily'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 61, 'page_label': '62'}, page_content='expected (5 years for enuresis and 4 years for encopresis). The urinary or fecal incontinence may \\nhave been present from birth (i.e., an atypical extension of normal infantile incontinenc e), or may have \\narisen following a period of acquired bladder or bowel control. An Elimina tion disorder should not be \\ndiagnosed if the behaviour is fully attributable to another health condition that causes incontinence,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 61, 'page_label': '62'}, page_content='congenital or acquired abnormalities of the urinary tract or bowel, or excessive use of laxatives or \\ndiuretics. \\n  6C00   Enuresis \\nEnuresis is the repeated voiding of urine into clothes or bed, which may occ ur \\nduring the day or at night, in an individual who has reached a developmental  age \\nwhen urinary continence is ordinarily expected (5 years). The urinary incontine nce \\nmay have been present from birth (i.e., an atypical extension of normal infantile'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 61, 'page_label': '62'}, page_content='incontinence), or may have arisen following a period of acquired bladder contr ol. In \\nmost cases, the behaviour is involuntary but in some cases it appears intent ional. \\nEnuresis should not be diagnosed if unintentional voiding of urine is due to a health \\ncondition that interferes with continence (e.g., diseases of the nervous system  or \\nmusculoskeletal disorders) or by congenital or acquired abnormalities of the urinary \\ntract. \\nInclusions: Functional enuresis \\nPsychogenic enuresis'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 61, 'page_label': '62'}, page_content='Urinary incontinence of nonorganic origin \\nExclusions: Stress incontinence (MF50.20) \\nUrge Incontinence (MF50.21) \\nFunctional urinary incontinence (MF50.23) \\nOverflow Incontinence (MF50.2) \\nReflex incontinence (MF50.24) \\nExtraurethral urinary incontinence (MF50.2) \\n \\n6C00.0 Nocturnal enuresis \\nNocturnal enuresis refers to repeated voiding of urine into clothes or bed that occurs \\nonly during sleep (i.e., during the night) in an individual who has reac hed a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 61, 'page_label': '62'}, page_content='developmental age when urinary continence is ordinarily expected (5 years). The \\nurinary incontinence may have been present from birth (i.e., an atypical extension of \\nnormal infantile incontinence), or may have arisen following a period of acquired \\nbladder control. In most cases, the behaviour is involuntary but in some cases it \\nappears intentional. \\n \\n6C00.1 Diurnal enuresis \\nDiurnal enuresis refers to repeated voiding of urine into clothes that occurs only'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 61, 'page_label': '62'}, page_content='during waking hours in an individual who has reached a developmental age when \\nurinary continence is ordinarily expected (5 years). The urinary incontinence may \\nhave been present from birth (i.e., an atypical extension of normal infantile \\nincontinence), or may have arisen following a period of acquired bladder contr ol. In \\nmost cases, the behaviour is involuntary but in some cases it appears intentional.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 62, 'page_label': '63'}, page_content='62  ICD-11 MMS - 2018 \\n \\n6C00.2 Nocturnal and diurnal enuresis \\nNocturnal and diurnal enuresis refers to repeated voiding of urine into clothes or \\nbed that occurs both during sleep (i.e., during the night) and during waking hours in \\nan individual who has reached a developmental age when urinary continence is \\nordinarily expected (5 years). The urinary incontinence may have been present from \\nbirth (i.e., an atypical extension of normal infantile incontinence), or may have'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 62, 'page_label': '63'}, page_content='arisen following a period of acquired bladder control. In most cases, the behavio ur \\nis involuntary but in some cases it appears intentional. \\n \\n6C00.Z Enuresis, unspecified \\n \\n  6C01   Encopresis \\nEncopresis is the repeated passage of feces in inappropriate places. Encopres is \\nshould be diagnosed if inappropriate passage of feces occurs repeatedly (e.g., at \\nleast once per month over a period of several months) in an individual wh o has'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 62, 'page_label': '63'}, page_content='reached the developmental age when fecal continence is ordinarily expected (4 \\nyears). The fecal incontinence may have been present from birth (i.e., an atypi cal \\nextension of normal infantile incontinence), or may have arisen following a period  of \\nacquired bowel control. Encopresis should not be diagnosed if fecal soi ling is fully \\nattributable to another health condition (e.g., aganglionic megacolon, spina bifida,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 62, 'page_label': '63'}, page_content='dementia), congenital or acquired abnormalities of the bowel, gastrointestinal \\ninfection, or excessive use of laxatives. \\n \\n6C01.0 Encopresis with constipation or overflow incontinence \\nEncopresis is the repeated passage of feces in inappropriate places occurring \\nrepeatedly (e.g., at least once per month over a period of several months) in an \\nindividual who has reached the developmental age when fecal continence is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 62, 'page_label': '63'}, page_content='ordinarily expected (4 years). The fecal incontinence may have been present from \\nbirth (i.e., an atypical extension of normal infantile incontinence), or may have \\narisen following a period of acquired bowel control. Encopresis with constipa tion \\nand overflow incontinence is the most common form of fecal soiling, and in volves \\nretention and impaction of feces. Stools are typically — but not always — poorly \\nformed (loose or liquid) and leakage may range from occasional to continuou s.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 62, 'page_label': '63'}, page_content='There is often a history of toilet avoidance leading to constipation. \\n \\n6C01.1 Encopresis without constipation or overflow incontinence \\nEncopresis is the repeated passage of feces in inappropriate places occurring \\nrepeatedly (e.g., at least once per month over a period of several months) in an \\nindividual who has reached the developmental age when fecal continence is \\nordinarily expected (4 years). The fecal incontinence may have been present from'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 62, 'page_label': '63'}, page_content='birth (i.e., an atypical extension of normal infantile incontinence), or may have \\narisen following a period of acquired bowel control. Encopresis without con stipation \\nand overflow is not associated with retention and impaction of feces, but r ather \\nreflects reluctance, resistance or failure to conform to social norms in defecating i n \\nacceptable places in the context of normal physiological control over defecatio n.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 62, 'page_label': '63'}, page_content='Stools are typically of normal consistency and inappropriate defecation is likely to \\nbe intermittent. \\n \\n6C01.Z Encopresis, unspecified \\n \\n  6C0Z   Elimination disorders, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 63, 'page_label': '64'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   63 \\n \\nDisorders of bodily distress or bodily experience (BlockL1‑6C2) \\nDisorders of bodily distress and bodily experience are characterized by disturb ances in the person ’s \\nexperience of his or her body. Bodily distress disorder involves bodily  symptoms that the individual \\nfinds distressing and to which excessive attention is directed. Body integrity  dysphoria involves a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 63, 'page_label': '64'}, page_content='disturbance in the person ’s experience of the body manifested by the persistent desire to have a \\nspecific physical disability accompanied by persistent discomfort, or i ntense feelings of \\ninappropriateness concerning current non-disabled body configuration. \\nExclusions: Dissociative neurological symptom disorder (6B60) \\nConcern about body appearance (BlockL2‑QD3) \\n  6C20   Bodily distress disorder \\nBodily distress disorder is characterized by the presence of bodily symptoms  that'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 63, 'page_label': '64'}, page_content='are distressing to the individual and excessive attention directed toward t he \\nsymptoms, which may be manifest by repeated contact with health care providers. If \\nanother health condition is causing or contributing to the symptoms, the degree of \\nattention is clearly excessive in relation to its nature and progression. Excess ive \\nattention is not alleviated by appropriate clinical examination and invest igations and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 63, 'page_label': '64'}, page_content='appropriate reassurance. Bodily symptoms are persistent, being present on most \\ndays for at least several months. Typically, bodily distress disorder involv es multiple \\nbodily symptoms that may vary over time. Occasionally there is a single s ymptom—\\nusually pain or fatigue—that is associated with the other features of the disorder. \\nExclusions: Tourette syndrome (8A05.00) \\nHair pulling disorder (6B25.0) \\nDissociative disorders (BlockL1‑6B6) \\nhair-plucking (6B25.0) \\nHypochondriasis (6B23)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 63, 'page_label': '64'}, page_content='Body dysmorphic disorder (6B21) \\nExcoriation disorder (6B25.1) \\nGender incongruence (BlockL1‑HA6) \\nSexual dysfunctions (BlockL1‑HA0) \\nTic disorders (8A05) \\nFeigning of symptoms (MB23.B) \\nSexual pain-penetration disorder (HA20) \\n \\n6C20.0 Mild bodily distress disorder \\nAll definitional requirements of bodily distress disorder are present. Ther e is \\nexcessive attention to distressing symptoms and their consequences, which may'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 63, 'page_label': '64'}, page_content='result in frequent medical visits, but the person is not preoccupied with the \\nsymptoms (e.g., the individual spends less than an hour per day focusing on t hem). \\nAlthough the individual expresses distress about the symptoms and they m ay have \\nsome impact on his or her life (e.g., strain in relationships, less effective ac ademic \\nor occupational functioning, abandonment of specific leisure activities), ther e is no'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 63, 'page_label': '64'}, page_content='substantial impairment in the person ’s personal, family, social, educational, \\noccupational, or other important areas of functioning.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 64, 'page_label': '65'}, page_content='64  ICD-11 MMS - 2018 \\n \\n6C20.1 Moderate bodily distress disorder \\nAll definitional requirements of bodily distress disorder are present. The re is \\npersistent preoccupation with the distressing symptoms and their consequences \\n(e.g., the individual spends more than an hour a day thinking about them), ty pically \\nassociated with frequent medical visits. The person devotes much of his or her \\nenergy to focusing on the symptoms and their consequences. The symptoms and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 64, 'page_label': '65'}, page_content='associated distress and preoccupation cause moderate impairment in personal, \\nfamily, social, educational, occupational, or other important areas of fun ctioning \\n(e.g., relationship conflict, performance problems at work, abandonment of a range \\nof social and leisure activities). \\n \\n6C20.2 Severe bodily distress disorder \\nAll definitional requirements of Bodily distress disorder are present. Ther e is \\npervasive and persistent preoccupation with the symptoms and their consequ ences'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 64, 'page_label': '65'}, page_content='to the extent that these may become the focal point of the person ’s life, typically \\nresulting in extensive interactions with the health care system. The symptoms an d \\nassociated distress and preoccupation cause serious impairment in personal, \\nfamily, social, educational, occupational, or other important areas of fun ctioning \\n(e.g., unable to work, alienation of friends and family, abandonment of nearly al l'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 64, 'page_label': '65'}, page_content='social and leisure activities). The person ’s interests may become so narrow so as to \\nfocus almost exclusively on his or her bodily symptoms and their negative \\nconsequences. \\n \\n6C20.Z Bodily distress disorder, unspecified \\n \\n  6C21   Body integrity dysphoria \\nBody integrity dysphoria is characterized by an intense and persistent desire to \\nbecome physically disabled in a significant way (e.g., major limb amputee,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 64, 'page_label': '65'}, page_content='paraplegic, blind), with onset by early adolescence accompanied by persiste nt \\ndiscomfort, or intense feelings of inappropriateness concerning current non-disabled \\nbody configuration. The desire to become physically disabled results in harmful \\nconsequences, as manifested by either the preoccupation with the desire (including \\ntime spent pretending to be disabled) significantly interfering with productivity, wit h'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 64, 'page_label': '65'}, page_content='leisure activities, or with social functioning (e.g., person is unwilling t o have a close \\nrelationships because it would make it difficult to pretend) or by attempts to actual ly \\nbecome disabled have resulted in the person putting his or her health or life in \\nsignificant jeopardy. \\n \\n  6C2Y   Other specified disorders of bodily distress or bodily experience \\n \\n  6C2Z   Disorders of bodily distress or bodily experience, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 65, 'page_label': '66'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   65 \\n \\nDisorders due to substance use or addictive behaviours (BlockL1‑6C4) \\nDisorders due to substance use and addictive behaviours are mental and beha vioural disorders that \\ndevelop as a result of the use of predominantly psychoactive substances, includi ng medications, or \\nspecific repetitive rewarding and reinforcing behaviours. \\nDisorders due to substance use (BlockL2‑6C4)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 65, 'page_label': '66'}, page_content='Disorders due to substance use include single episodes of harmful substance use, s ubstance use \\ndisorders (harmful substance use and substance dependence), and substan ce-induced disorders \\nsuch as substance intoxication, substance withdrawal and substance-induced mental di sorders, \\nsexual dysfunctions and sleep-wake disorders. \\nCoded Elsewhere: Catatonia induced by psychoactive substances, including medications (6A41) \\n  6C40   Disorders due to use of alcohol'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 65, 'page_label': '66'}, page_content='Disorders due to use of alcohol are characterised by the pattern and consequences \\nof alcohol use. In addition to Alcohol intoxication, alcohol has dependenc e-inducing \\nproperties, resulting in Alcohol dependence in some people and Alcohol withdra wal \\nwhen use is reduced or discontinued. Alcohol is implicated in a wide range of  harms \\naffecting most organs and systems of the body, which may be classified as Si ngle'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 65, 'page_label': '66'}, page_content='episode of harmful use of alcohol and Harmful pattern of use of alcohol. Harm to \\nothers resulting from behaviour during Alcohol intoxication is included in the \\ndefinitions of Harmful use of alcohol. Several alcohol-induced mental disorders and \\nalcohol-related forms of neurocognitive impairment are recognised. \\nNote: Code also the underlying condition \\nExclusions: Hazardous alcohol use (QE10) \\n \\n6C40.0 Single episode of harmful use of alcohol'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 65, 'page_label': '66'}, page_content='A single episode of use of alcohol that has caused damage to a person ’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of other s. \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 65, 'page_label': '66'}, page_content='others includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behavior due to alcohol intoxication on the part of the \\nperson to whom the diagnosis of single episode of harmful use applies. Thi s \\ndiagnosis should not be made if the harm is attributed to a known pattern of alcohol \\nuse. \\nExclusions: Harmful pattern of use of alcohol (6C40.1) \\nAlcohol dependence (6C40.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 66, 'page_label': '67'}, page_content='66  ICD-11 MMS - 2018 \\n \\n6C40.1 Harmful pattern of use of alcohol \\nA pattern of alcohol use that has caused damage to a person ’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of alcohol use is evident over a period of at least 12 months if sub stance \\nuse is episodic or at least one month if use is continuous. Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 66, 'page_label': '67'}, page_content='intoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to alcohol intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of alcohol applies. \\nExclusions: Alcohol dependence (6C40.2) \\nSingle episode of harmful use of alcohol (6C40.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 66, 'page_label': '67'}, page_content='6C40.10 Harmful pattern of use of alcohol, episodic \\nA pattern of episodic or intermittent alcohol use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic alcohol use is evident over a period of \\nat least 12 months. Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to intoxication; (2) direct or secondary toxic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 66, 'page_label': '67'}, page_content='effects on body organs and systems; or (3) a harmful route of administration. Harm  \\nto health of others includes any form of physical harm, including trauma, or mental  \\ndisorder that is directly attributable to behaviour related to alcohol intoxicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of alcohol \\napplies. \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nAlcohol dependence (6C40.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 66, 'page_label': '67'}, page_content='6C40.11 Harmful pattern of use of alcohol, continuous \\nA pattern of continuous (daily or almost daily) alcohol use that has caused da mage \\nto a person’s physical or mental health or has resulted in behaviour leading to harm  \\nto the health of others. The pattern of continuous alcohol use is evident over a \\nperiod of at least one month. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondar y'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 66, 'page_label': '67'}, page_content='toxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to alcohol \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern  of \\nuse of alcohol applies. \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nAlcohol dependence (6C40.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 66, 'page_label': '67'}, page_content='6C40.1Z Harmful pattern of use of alcohol, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 67, 'page_label': '68'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   67 \\n \\n6C40.2 Alcohol dependence \\nAlcohol dependence is a disorder of regulation of alcohol use arising from rep eated \\nor continuous use of alcohol. The characteristic feature is a strong internal driv e to \\nuse alcohol, which is manifested by impaired ability to control use, inc reasing \\npriority given to use over other activities and persistence of use despite harm or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 67, 'page_label': '68'}, page_content='negative consequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use alcohol. Physiological features of depe ndence \\nmay also be present, including tolerance to the effects of alcohol, withdrawal \\nsymptoms following cessation or reduction in use of alcohol, or repeated use of \\nalcohol or pharmacologically similar substances to prevent or alleviate withdrawal \\nsymptoms. The features of dependence are usually evident over a period of at least'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 67, 'page_label': '68'}, page_content='12 months but the diagnosis may be made if alcohol use is continuous (dail y or \\nalmost daily) for at least 1 month. \\nInclusions: Chronic alcoholism \\nDipsomania \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1) \\n \\n6C40.20 Alcohol dependence, current use, continuous \\nAlcohol dependence with continuous consumption of alcohol (daily or almost dail y) \\nover a period of at least 1 month.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 67, 'page_label': '68'}, page_content='Exclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1) \\n \\n6C40.21 Alcohol dependence, current use, episodic \\nDuring the past 12 months, there has been alcohol dependence with intermittent \\nheavy drinking, with periods of abstinence from alcohol. If current use is con tinuous \\n(daily or almost daily over at least the past 1 month), the diagnosis of Alcoh ol \\ndependence, current use, continuous should be made instead.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 67, 'page_label': '68'}, page_content='Exclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1) \\n \\n6C40.22 Alcohol dependence, early full remission \\nAfter a diagnosis of alcohol dependence, and often following a treatment episode or \\nother intervention (including self-help intervention), the individual has been  \\nabstinent from alcohol during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of alcohol (6C40.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 67, 'page_label': '68'}, page_content='Harmful pattern of use of alcohol (6C40.1) \\n \\n6C40.23 Alcohol dependence, sustained partial remission \\nAfter a diagnosis of alcohol dependence, and often following a treatment episode or \\nother intervention (including self-help intervention), there is a significant reduction in \\nalcohol consumption for more than 12 months, such that even though intermittent or \\ncontinuing drinking has occurred during this period, the definitional requir ements for \\ndependence have not been met.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 67, 'page_label': '68'}, page_content='Exclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 68, 'page_label': '69'}, page_content='68  ICD-11 MMS - 2018 \\n \\n6C40.24 Alcohol dependence, sustained full remission \\nAfter a diagnosis of alcohol dependence, and often following a treatment episode or \\nother intervention (including self-intervention), the person has been abstinent fr om \\nalcohol for 12 months or longer. \\nExclusions: Single episode of harmful use of alcohol (6C40.0) \\nHarmful pattern of use of alcohol (6C40.1) \\n \\n6C40.2Z Alcohol dependence, unspecified \\n \\n6C40.3 Alcohol intoxication'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 68, 'page_label': '69'}, page_content='Alcohol intoxication is a clinically significant transient condition t hat develops during \\nor shortly after the consumption of alcohol that is characterized by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. Thes e \\ndisturbances are caused by the known pharmacological effects of alcohol and their \\nintensity is closely related to the amount of alcohol consumed. They are time- limited'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 68, 'page_label': '69'}, page_content='and abate as alcohol is cleared from the body. Presenting features may include \\nimpaired attention, inappropriate or aggressive behaviour, lability of mood, impair ed \\njudgment, poor coordination, unsteady gait, and slurred speech. At more severe \\nlevels of intoxication, stupor or coma may occur. \\nNote: Code also the underlying condition \\nExclusions: alcohol poisoning (NE61) \\nPossession trance disorder (6B63) \\n \\n6C40.4 Alcohol withdrawal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 68, 'page_label': '69'}, page_content='Alcohol withdrawal is a clinically significant cluster of symptom s, behaviours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of alcohol in individuals who have developed Al cohol \\ndependence or have used alcohol for a prolonged period or in large amounts. \\nPresenting features of Alcohol withdrawal may include autonomic hyperacti vity, \\nincreased hand tremor, nausea, retching or vomiting, insomnia, anxiety,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 68, 'page_label': '69'}, page_content='psychomotor agitation, transient visual, tactile or auditory hallucinations , and \\ndistractibility. Less commonly, the withdrawal state is complicated by  seizures. The \\nwithdrawal state may progress to a very severe form of delirium characterized by  \\nconfusion and disorientation, delusions, and prolonged visual, tactile or auditory  \\nhallucinations. In such cases, a separate diagnosis of Alcohol-induced delirium \\nshould also be assigned. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 68, 'page_label': '69'}, page_content='6C40.40 Alcohol withdrawal, uncomplicated \\nAll diagnostic requirements for Alcohol Withdrawal are met and the withdrawa l state \\nis not accompanied by perceptual disturbances or seizures. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 69, 'page_label': '70'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   69 \\n \\n6C40.41 Alcohol withdrawal with perceptual disturbances \\nAll diagnostic requirements for Alcohol withdrawal are met and the withdrawal s tate \\nis accompanied by perceptual disturbances (e.g., visual or tactile hallucinati ons or \\nillusions) with intact reality testing. There is no evidence of confusion and other \\ndiagnostic requirements for Delirium are not met. The withdrawal state is not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 69, 'page_label': '70'}, page_content='accompanied by seizures. \\nNote: Code also the underlying condition \\n \\n6C40.42 Alcohol withdrawal with seizures \\nAll diagnostic requirements for Alcohol withdrawal are met and the withdrawal s tate \\nis accompanied by seizures (i.e., generalized tonic-clonic seizures) but not by \\nperceptual disturbances. \\nNote: Code also the underlying condition \\n \\n6C40.43 Alcohol withdrawal with perceptual disturbances and seizures'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 69, 'page_label': '70'}, page_content='All diagnostic requirements for Alcohol withdrawal are met and the withdrawal s tate \\nis accompanied by both seizures (i.e., generalized tonic-clonic seizures) a nd \\nperceptual disturbances (e.g., visual or tactile hallucinations or illusions) with  intact \\nreality testing. Diagnostic requirements for Delirium are not met. \\nNote: Code also the underlying condition \\n \\n6C40.4Z Alcohol withdrawal, unspecified \\nNote: Code also the underlying condition \\n \\n6C40.5 Alcohol-induced delirium'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 69, 'page_label': '70'}, page_content='Alcohol-induced delirium is characterized by an acute state of disturbed attenti on \\nand awareness with specific features of delirium that develops during or soon af ter \\nsubstance intoxication or withdrawal or during the use of alcohol. The amount and \\nduration of alcohol use must be capable of producing delirium. Specific f eatures of \\nalcohol-induced delirium may include impaired consciousness with disorien tation,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 69, 'page_label': '70'}, page_content='vivid hallucinations and illusions, insomnia, delusions, agitation, disturbances of \\nattention, and accompanying tremor and physiological symptoms of alcohol \\nwithdrawal. In some cases of alcohol withdrawal, the withdrawal state may progress \\nto a very severe form of Alcohol-induced delirium. The symptoms are not better \\nexplained by a primary mental disorder, by use of or withdrawal from a diff erent \\nsubstance, or by another health condition that is not classified under Mental,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 69, 'page_label': '70'}, page_content='behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\nInclusions: Delirium tremens (alcohol-induced) \\nDelirium induced by alcohol withdrawal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 70, 'page_label': '71'}, page_content='70  ICD-11 MMS - 2018 \\n \\n6C40.6 Alcohol-induced psychotic disorder \\nAlcohol-induced psychotic disorder is characterized by psychotic symptoms  (e.g., \\ndelusions, hallucinations, disorganized thinking, grossly disorganized behav iour) \\nthat develop during or soon after intoxication with or withdrawal from alcohol. The \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of Alcohol'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 70, 'page_label': '71'}, page_content='intoxication or Alcohol withdrawal. The amount and duration of alcohol use must be  \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe alcohol use, if the symptoms persist for a substantial period of time after \\ncessation of the alcohol use or withdrawal, or if there is other evidence of a p re-'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 70, 'page_label': '71'}, page_content='existing primary mental disorder with psychotic symptoms (e.g., a history of pri or \\nepisodes not associated with alcohol use). \\nNote: Code also the underlying condition \\nInclusions: alcoholic jealousy \\n \\n6C40.60 Alcohol-induced psychotic disorder with hallucinations \\nAlcohol-induced psychotic disorder with hallucinations is characterized by the \\npresence of hallucinations that are judged to be the direct consequence of alcohol'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 70, 'page_label': '71'}, page_content='use. Neither delusions nor other psychotic symptoms are present. The symptoms \\ndo not occur exclusively during hypnogogic or hypnopompic states, are not better \\naccounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms). \\nNote: Code also the underlying condition \\n \\n6C40.61 Alcohol-induced psychotic disorder with delusions'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 70, 'page_label': '71'}, page_content='Alcohol-induced psychotic disorder with delusions is characterized by the presenc e \\nof delusions that are judged to be the direct consequence of alcohol use. Neither \\nhallucinations nor other psychotic symptoms are present. The symptoms do not  \\noccur exclusively during hypnogogic or hypnopompic states, are not better \\naccounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 70, 'page_label': '71'}, page_content='visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C40.62 Alcohol-induced psychotic disorder with mixed psychotic symptoms \\nAlcohol-induced psychotic disorder with mixed psychotic symptoms is char acterized \\nby the presence of multiple psychotic symptoms, primarily hallucinations and \\ndelusions, when these are judged to be the direct consequence of alcohol use. The \\nsymptoms do not occur exclusively during hypnogogic or hypnopompic states, are'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 70, 'page_label': '71'}, page_content='not better accounted for by another mental and behavioural disorder (e.g., \\nschizophrenia), and are not due to another disorder or disease classified elsewh ere \\n(e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C40.6Z Alcohol-induced psychotic disorder, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 71, 'page_label': '72'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   71 \\n \\n6C40.7 Other alcohol-induced disorders \\nNote: Code also the underlying condition \\nCoded Elsewhere: Amnestic disorder due to use of alcohol (6D72.10) \\nDementia due to use of alcohol (6D84.0) \\n \\n6C40.70 Alcohol-induced mood disorder \\nAlcohol-induced mood disorder is characterized by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 71, 'page_label': '72'}, page_content='increased or decreased energy levels) that develop during or soon after intox ication \\nwith or withdrawal from alcohol. The intensity or duration of the symptoms is \\nsubstantially in excess of mood disturbances that are characteristic of Alcohol \\nintoxication or Alcohol withdrawal. The amount and duration of alcohol use must be \\ncapable of producing mood symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., a Depressive disorder, a Bipolar disorder,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 71, 'page_label': '72'}, page_content='Schizoaffective disorder), as might be the case if the mood symptoms precede d the \\nonset of the alcohol use, if the symptoms persist for a substantial period of time \\nafter cessation of the alcohol use or withdrawal, or if there is other evidence of a \\npre-existing primary mental disorder with mood symptoms (e.g., a history of prio r \\nepisodes not associated with alcohol use). \\nNote: Code also the underlying condition \\n \\n6C40.71 Alcohol-induced anxiety disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 71, 'page_label': '72'}, page_content='Alcohol-induced anxiety disorder is characterized by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic  \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from alcohol. The intensity or duration of the symptoms is substantially in  \\nexcess of anxiety symptoms that are characteristic of Alcohol intoxication or Alc ohol \\nwithdrawal. The amount and duration of alcohol use must be capable of producing'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 71, 'page_label': '72'}, page_content='anxiety symptoms. The symptoms are not better explained by a primary mental \\ndisorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with \\nprominent anxiety symptoms), as might be the case if the anxiety symptoms \\npreceded the onset of the alcohol use, if the symptoms persist for a substantial \\nperiod of time after cessation of the alcohol use or withdrawal, or if there is oth er \\nevidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 71, 'page_label': '72'}, page_content='history of prior episodes not associated with alcohol use). \\nNote: Code also the underlying condition \\n \\n6C40.Y Other specified disorders due to use of alcohol \\nNote: Code also the underlying condition \\n \\n6C40.Z Disorders due to use of alcohol, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 72, 'page_label': '73'}, page_content='72  ICD-11 MMS - 2018 \\n \\n  6C41   Disorders due to use of cannabis \\nDisorders due to use of cannabis are characterised by the pattern and \\nconsequences of cannabis use. In addition to Cannabis intoxication, cannabis has \\ndependence-inducing properties, resulting in Cannabis dependence in some people \\nand Cannabis withdrawal when use is reduced or discontinued. Cannabis is \\nimplicated in a wide range of harms affecting most organs and systems of the bo dy,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 72, 'page_label': '73'}, page_content='which may be classified as Single episode of harmful use of cannabis an d Harmful \\npattern of use of cannabis. Harm to others resulting from behaviour during \\nCannabis intoxication is included in the definitions of Harmful use of cannabi s. \\nSeveral cannabis-induced mental disorders are recognised. \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of synthetic cannabinoids (6C42) \\nHazardous use of cannabis (QE11.1) \\n \\n6C41.0 Single episode of harmful use of cannabis'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 72, 'page_label': '73'}, page_content='A single episode of use of cannabis that has caused damage to a person ’s physical \\nor mental health or has resulted in behaviour leading to harm to the health of others. \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 72, 'page_label': '73'}, page_content='others includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behavior due to cannabis intoxication on the par t of the \\nperson to whom the diagnosis of single episode of harmful use applies. Thi s \\ndiagnosis should not be made if the harm is attributed to a known pattern of \\ncannabis use. \\nExclusions: Cannabis dependence (6C41.2) \\nHarmful pattern of use of cannabis (6C41.1) \\n \\n6C41.1 Harmful pattern of use of cannabis'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 72, 'page_label': '73'}, page_content='A pattern of cannabis use that has caused damage to a person ’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of cannabis use is evident over a period of at least 12 months if substan ce \\nuse is episodic or at least one month if use is continuous (i.e., daily or a lmost daily). \\nHarm to health of the individual occurs due to one or more of the following: (1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 72, 'page_label': '73'}, page_content='behaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behaviour related to cannabis intoxication on th e part of the \\nperson to whom the diagnosis of Harmful pattern of use of cannabis applies. \\nExclusions: Cannabis dependence (6C41.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 72, 'page_label': '73'}, page_content='Single episode of harmful use of cannabis (6C41.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 73, 'page_label': '74'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   73 \\n \\n6C41.10 Harmful pattern of use of cannabis, episodic \\nA pattern of episodic or intermittent cannabis use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic cannabis use is evident over a period of \\nat least 12 months. Harm to health of the individual occurs due to one or more of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 73, 'page_label': '74'}, page_content='the following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm  \\nto health of others includes any form of physical harm, including trauma, or mental  \\ndisorder that is directly attributable to behaviour related to cannabis intoxicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of cannabi s \\napplies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 73, 'page_label': '74'}, page_content='applies. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nCannabis dependence (6C41.2) \\n \\n6C41.11 Harmful pattern of use of cannabis, continuous \\nA pattern of continuous (daily or almost daily) cannabis use that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous cannabis use is eviden t \\nover a period of at least one month. Harm to health of the individual occurs due to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 73, 'page_label': '74'}, page_content='one or more of the following: (1) behaviour related to intoxication; (2) direct  or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto cannabis intoxication on the part of the person to whom the diagnosis of Harmful \\npattern of use of cannabis applies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 73, 'page_label': '74'}, page_content='Exclusions: Single episode of harmful use of cannabis (6C41.0) \\nCannabis dependence (6C41.2) \\n \\n6C41.1Z Harmful pattern of use of cannabis, unspecified \\n \\n6C41.2 Cannabis dependence \\nCannabis dependence is a disorder of regulation of cannabis use arising from  \\nrepeated or continuous use of cannabis. The characteristic feature is a strong \\ninternal drive to use cannabis, which is manifested by impaired ability t o control use,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 73, 'page_label': '74'}, page_content='increasing priority given to use over other activities and persistence of use despi te \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use cannabis. Physiological f eatures of \\ndependence may also be present, including tolerance to the effects of cannabis, \\nwithdrawal symptoms following cessation or reduction in use of cannabis, or \\nrepeated use of cannabis or pharmacologically similar substances to prevent or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 73, 'page_label': '74'}, page_content='alleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months but the diagnosis may be made if cannabis use \\nis continuous (daily or almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nHarmful pattern of use of cannabis (6C41.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 74, 'page_label': '75'}, page_content='74  ICD-11 MMS - 2018 \\n \\n6C41.20 Cannabis dependence, current use \\nCurrent cannabis dependence with use of cannabis within the past month. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nHarmful pattern of use of cannabis (6C41.1) \\n \\n6C41.21 Cannabis dependence, early full remission \\nAfter a diagnosis of cannabis dependence, and often following a treatment episode  \\nor other intervention (including self-help intervention), the individual has been'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 74, 'page_label': '75'}, page_content='abstinent from cannabis during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nHarmful pattern of use of cannabis (6C41.1) \\n \\n6C41.22 Cannabis dependence, sustained partial remission \\nAfter a diagnosis of cannabis dependence, and often following a treatment episode  \\nor other intervention (including self-help intervention), there is a signific ant reduction'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 74, 'page_label': '75'}, page_content='in cannabis consumption for more than 12 months, such that even though cannabis \\nuse has occurred during this period, the definitional requirements for dependence  \\nhave not been met. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nHarmful pattern of use of cannabis (6C41.1) \\n \\n6C41.23 Cannabis dependence, sustained full remission \\nAfter a diagnosis of cannabis dependence, and often following a treatment episode'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 74, 'page_label': '75'}, page_content='or other intervention (including self-intervention), the person has been abs tinent \\nfrom cannabis for 12 months or longer. \\nExclusions: Single episode of harmful use of cannabis (6C41.0) \\nHarmful pattern of use of cannabis (6C41.1) \\n \\n6C41.2Z Cannabis dependence, unspecified \\n \\n6C41.3 Cannabis intoxication \\nCannabis intoxication is a clinically significant transient conditi on that develops \\nduring or shortly after the consumption of cannabis that is characterized by'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 74, 'page_label': '75'}, page_content='disturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof cannabis and their intensity is closely related to the amount of cannabis  \\nconsumed. They are time-limited and abate as cannabis is cleared from the bo dy. \\nPresenting features may include inappropriate euphoria, impaired attention, \\nimpaired judgment, perceptual alterations (such as the sensation of floating, a ltered'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 74, 'page_label': '75'}, page_content='perception of time), changes in sociability, increased appetite, anxiety, \\nintensification of ordinary experiences, impaired short-term memory, and \\nsluggishness. Physical signs include conjunctival injection (red or bloodshot eyes) \\nand tachycardia. \\nNote: Code also the underlying condition \\nInclusions: \"Bad trips\" (cannabinoids) \\nExclusions: cannabinoid poisoning (NE60) \\nPossession trance disorder (6B63)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 75, 'page_label': '76'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   75 \\n \\n6C41.4 Cannabis withdrawal \\nCannabis withdrawal is a clinically significant cluster of symptoms, be haviours \\nand/or physiological features, varying in degree of severity and duration, that occurs \\nupon cessation or reduction of use of cannabis in individuals who have dev eloped \\nCannabis dependence or have used cannabis for a prolonged period or in large'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 75, 'page_label': '76'}, page_content='amounts. Presenting features of Cannabis withdrawal may include irritability, anger, \\nshakiness, insomnia, restlessness, anxiety, dysphoric mood, appetite disturbance, \\nabdominal cramps and muscle aches. \\nNote: Code also the underlying condition \\n \\n6C41.5 Cannabis-induced delirium \\nCannabis-induced delirium is characterized by an acute state of disturbed attention \\nand awareness with specific features of delirium that develops during or soon af ter'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 75, 'page_label': '76'}, page_content='substance intoxication or withdrawal or during the use of cannabis. The amount and \\nduration of cannabis use must be capable of producing delirium. The symptoms are \\nnot better explained by a primary mental disorder, by use of or withdrawal from a  \\ndifferent substance, or by another health condition that is not classified unde r \\nMental, behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C41.6 Cannabis-induced psychotic disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 75, 'page_label': '76'}, page_content='Cannabis-induced psychotic disorder is characterized by psychotic symptoms (e.g., \\ndelusions, hallucinations, disorganized thinking, grossly disorganized behav iour) \\nthat develop during or soon after intoxication with or withdrawal from cannabis. The \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nCannabis intoxication or Cannabis withdrawal. The amount and duration of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 75, 'page_label': '76'}, page_content='cannabis use must be capable of producing psychotic symptoms. The symptoms \\nare not better explained by a primary mental disorder (e.g., Schizophrenia, a Mood \\ndisorder with psychotic symptoms), as might be the case if the psychotic sym ptoms \\npreceded the onset of the cannabis use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cannabis use or withdrawal, or if there is o ther'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 75, 'page_label': '76'}, page_content='evidence of a pre-existing primary mental disorder with psychotic symptoms (e.g ., a \\nhistory of prior episodes not associated with cannabis use). \\nNote: Code also the underlying condition \\n \\n6C41.7 Other cannabis-induced disorders \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 76, 'page_label': '77'}, page_content='76  ICD-11 MMS - 2018 \\n \\n6C41.70 Cannabis-induced mood disorder \\nCannabis-induced mood disorder is characterized by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxi cation \\nwith or withdrawal from cannabis. The intensity or duration of the symptoms is \\nsubstantially in excess of mood disturbances that are characteristic of Cannabi s'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 76, 'page_label': '77'}, page_content='intoxication or Cannabis withdrawal. The amount and duration of cannabis use must \\nbe capable of producing mood symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, \\nSchizoaffective disorder), as might be the case if the mood symptoms preceded  the \\nonset of the cannabis use, if the symptoms persist for a substantial period of  time \\nafter cessation of the cannabis use or withdrawal, or if there is other evidence of a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 76, 'page_label': '77'}, page_content='pre-existing primary mental disorder with mood symptoms (e.g., a history of prior \\nepisodes not associated with cannabis use). \\nNote: Code also the underlying condition \\n \\n6C41.71 Cannabis-induced anxiety disorder \\nCannabis-induced anxiety disorder is characterized by anxiety symptoms (e.g.,  \\napprehension or worry, fear, physiological symptoms of excessive autonomic  \\narousal, avoidance behaviour) that develop during or soon after intoxication with or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 76, 'page_label': '77'}, page_content='withdrawal from cannabis. The intensity or duration of the symptoms is sub stantially \\nin excess of anxiety symptoms that are characteristic of Cannabis intoxication or \\nCannabis withdrawal. The amount and duration of cannabis use must be capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety sympto ms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 76, 'page_label': '77'}, page_content='preceded the onset of the cannabis use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cannabis use or withdrawal, or if there is o ther \\nevidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with cannabis use). \\nNote: Code also the underlying condition \\n \\n6C41.Y Other specified disorders due to use of cannabis \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 76, 'page_label': '77'}, page_content='6C41.Z Disorders due to use of cannabis, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 77, 'page_label': '78'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   77 \\n \\n  6C42   Disorders due to use of synthetic cannabinoids \\nDisorders due to use of synthetic cannabinoids are characterised by the pattern and \\nconsequences of synthetic cannabinoid use. In addition to Synthetic cannabinoid  \\nintoxication, synthetic cannabinoids have dependence-inducing properties, result ing \\nin Synthetic cannabinoid dependence in some people and Synthetic cannabinoid'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 77, 'page_label': '78'}, page_content='withdrawal when use is reduced or discontinued. Synthetic cannabinoids are \\nimplicated in a wide range of harms affecting most organs and systems of the bo dy, \\nwhich may be classified as Single episode of harmful use of synthetic cannabinoid \\nand Harmful pattern of use of synthetic cannabinoid. Harm to others resulting fro m \\nbehaviour during Synthetic cannabinoid intoxication is included in the definiti ons of \\nHarmful use of synthetic cannabinoids. Several Synthetic cannabinoid- induced'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 77, 'page_label': '78'}, page_content='mental disorders are recognised. \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of cannabis (6C41) \\n \\n6C42.0 Single episode of harmful use of synthetic cannabinoids \\nA single episode of use of a synthetic cannabinoid that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. Harm to health of the individual occurs due to one or more of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 77, 'page_label': '78'}, page_content='the following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm  \\nto health of others includes any form of physical harm, including trauma, or men tal \\ndisorder that is directly attributable to behavior due to synthetic cannabinoid \\nintoxication on the part of the person to whom the diagnosis of single episo de of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 77, 'page_label': '78'}, page_content='harmful use applies. This diagnosis should not be made if the harm is attri buted to a \\nknown pattern of synthetic cannabinoid use. \\nExclusions: Harmful pattern of use of synthetic cannabinoids (6C42.1) \\nSynthetic cannabinoid dependence (6C42.2) \\n \\n6C42.1 Harmful pattern of use of synthetic cannabinoids \\nA pattern of use of synthetic cannabinoids that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 77, 'page_label': '78'}, page_content='of others. The pattern of synthetic cannabinoid use is evident over a period of  at \\nleast 12 months if substance use is episodic or at least one month if use i s \\ncontinuous (i.e., daily or almost daily). Harm to health of the individual oc curs due to \\none or more of the following: (1) behaviour related to intoxication; (2) direct  or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 77, 'page_label': '78'}, page_content='including trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto synthetic cannabinoid intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of synthetic cannabinoids applies. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nSynthetic cannabinoid dependence (6C42.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 78, 'page_label': '79'}, page_content='78  ICD-11 MMS - 2018 \\n \\n6C42.10 Harmful pattern of use of synthetic cannabinoids, episodic \\nA pattern of episodic or intermittent use of synthetic cannabinoids that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of episodic synthetic cannabinoid use i s \\nevident over a period of at least 12 months. Harm to health of the individual occur s'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 78, 'page_label': '79'}, page_content='due to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto synthetic cannabinoid intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of synthetic cannabinoids applies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 78, 'page_label': '79'}, page_content='Exclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nSynthetic cannabinoid dependence (6C42.2) \\n \\n6C42.11 Harmful pattern of use of synthetic cannabinoids, continuous \\nA pattern of continuous (daily or almost daily) use of synthetic cannabinoi ds that \\nhas caused damage to a person ’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. The pattern of continuous'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 78, 'page_label': '79'}, page_content='synthetic cannabinoid use is evident over a period of at least one month. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behavi our \\nrelated to intoxication; (2) direct or secondary toxic effects on body organs and \\nsystems; or (3) a harmful route of administration. Harm to health of others includes \\nany form of physical harm, including trauma, or mental disorder that is directl y'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 78, 'page_label': '79'}, page_content='attributable to behaviour related to synthetic cannabinoid intoxication o n the part of \\nthe person to whom the diagnosis of Harmful pattern of use of synthetic \\ncannabinoids applies. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nSynthetic cannabinoid dependence (6C42.2) \\n \\n6C42.1Y Other specified harmful pattern of use of synthetic cannabinoids \\n \\n6C42.1Z Harmful pattern of use of synthetic cannabinoids, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 79, 'page_label': '80'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   79 \\n \\n6C42.2 Synthetic cannabinoid dependence \\nSynthetic cannabinoid dependence is a disorder of regulation of synthetic  \\ncannabinoid use arising from repeated or continuous use of synthetic cannabinoi ds. \\nThe characteristic feature is a strong internal drive to use synthetic cannab inoids, \\nwhich is manifested by impaired ability to control use, increasing priority gi ven to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 79, 'page_label': '80'}, page_content='use over other activities and persistence of use despite harm or negative \\nconsequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use synthetic cannabinoids. Physiological features of \\ndependence may also be present, including tolerance to the effects of synthetic \\ncannabinoids, withdrawal symptoms following cessation or reduction in use of \\nsynthetic cannabinoids, or repeated use of synthetic cannabinoids or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 79, 'page_label': '80'}, page_content='pharmacologically similar substances to prevent or alleviate withdrawal symptoms.  \\nThe features of dependence are usually evident over a period of at least 12 months \\nbut the diagnosis may be made if synthetic cannabinoid use is continu ous (daily or \\nalmost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nHarmful pattern of use of synthetic cannabinoids (6C42.1) \\n \\n6C42.20 Synthetic cannabinoid dependence, current use'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 79, 'page_label': '80'}, page_content='Current synthetic cannabinoid dependence with use of synthetic cannabinoids \\nwithin the past month. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nHarmful pattern of use of synthetic cannabinoids (6C42.1) \\n \\n6C42.21 Synthetic cannabinoid dependence, early full remission \\nAfter a diagnosis of synthetic cannabinoid dependence, and often following a \\ntreatment episode or other intervention (including self-help intervention), the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 79, 'page_label': '80'}, page_content='individual has been abstinent from synthetic cannabinoid use during a period lasting \\nfrom between 1 and 12 months. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nHarmful pattern of use of synthetic cannabinoids (6C42.1) \\n \\n6C42.22 Synthetic cannabinoid dependence, sustained partial remission \\nAfter a diagnosis of synthetic cannabinoid dependence, and often following a \\ntreatment episode or other intervention (including self-help intervention), ther e is a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 79, 'page_label': '80'}, page_content='significant reduction in synthetic cannabinoid consumption for more than 12 months, \\nsuch that even though synthetic cannabinoid use has occurred during this perio d, \\nthe definitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nHarmful pattern of use of synthetic cannabinoids (6C42.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 80, 'page_label': '81'}, page_content='80  ICD-11 MMS - 2018 \\n \\n6C42.23 Synthetic cannabinoid dependence, sustained full remission \\nAfter a diagnosis of synthetic cannabinoid dependence, and often following a \\ntreatment episode or other intervention (including self-intervention), the person has \\nbeen abstinent from synthetic cannabinoid use for 12 months or longer. \\nExclusions: Single episode of harmful use of synthetic cannabinoids \\n(6C42.0) \\nHarmful pattern of use of synthetic cannabinoids (6C42.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 80, 'page_label': '81'}, page_content='6C42.2Y Other specified synthetic cannabinoid dependence \\n \\n6C42.2Z Synthetic cannabinoid dependence, unspecified \\n \\n6C42.3 Synthetic cannabinoid intoxication \\nSynthetic cannabinoid intoxication is a clinically significant transien t condition that \\ndevelops during or shortly after the consumption of synthetic cannabinoids that is \\ncharacterized by disturbances in consciousness, cognition, perception, affect, \\nbehaviour, or coordination. These disturbances are caused by the known'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 80, 'page_label': '81'}, page_content='pharmacological effects of synthetic cannabinoids and their intensity is closely \\nrelated to the amount of synthetic cannabinoid consumed. They are time-limited and \\nabate as synthetic cannabinoid is cleared from the body. Presenting features m ay \\ninclude inappropriate euphoria, impaired attention, impaired judgment, perceptual  \\nalterations (such as the sensation of floating, altered perception of time), changes in'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 80, 'page_label': '81'}, page_content='sociability, increased appetite, anxiety, intensification of ordinary ex periences, \\nimpaired short-term memory, and sluggishness. Physical signs include c onjunctival \\ninjection (red or bloodshot eyes) and tachycardia. Intoxication with syntheti c \\ncannabinoids may also cause delirium or acute psychosis. \\nNote: Code also the underlying condition \\n \\n6C42.4 Synthetic cannabinoid withdrawal \\nSynthetic cannabinoid withdrawal is a clinically significant clus ter of symptoms,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 80, 'page_label': '81'}, page_content='behaviours and/or physiological features, varying in degree of severity and durati on, \\nthat occurs upon cessation or reduction of use of synthetic cannabinoids in \\nindividuals who have developed Synthetic cannabinoid dependence or have used \\nsynthetic cannabinoids for a prolonged period or in large amounts. Presenting \\nfeatures of Synthetic cannabinoid withdrawal may include irritability, ang er, \\naggression, shakiness, insomnia and disturbing dreams, restlessness, anxiety ,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 80, 'page_label': '81'}, page_content='depressed mood and appetite disturbance. In the early phase, Synthetic \\ncannabinoid withdrawal may be accompanied by residual features of intoxi cation \\nfrom the drug, such as paranoid ideation and auditory and visual hallucinations. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 81, 'page_label': '82'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   81 \\n \\n6C42.5 Synthetic cannabinoid-induced delirium \\nSynthetic cannabinoid-induced delirium is characterized by an acute state  of \\ndisturbed attention and awareness with specific features of delirium that develo ps \\nduring or soon after substance intoxication or withdrawal or during the use of \\nsynthetic cannabinoids. The amount and duration of synthetic cannabinoid use must'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 81, 'page_label': '82'}, page_content='be capable of producing delirium. The symptoms are not better explained by a \\nprimary mental disorder, by use of or withdrawal from a different substance, or by \\nanother health condition that is not classified under Mental, behavioural and \\nneurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C42.6 Synthetic cannabinoid-induced psychotic disorder \\nSynthetic cannabinoid-induced psychotic disorder is characterized by psyc hotic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 81, 'page_label': '82'}, page_content='symptoms (e.g., delusions, hallucinations, disorganized thinking, grossly \\ndisorganized behaviour) that develop during or soon after intoxication with or \\nwithdrawal from synthetic cannabinoids. The intensity or duration of the symptom s \\nis substantially in excess of psychotic-like disturbances of perception , cognition, or \\nbehaviour that are characteristic of Synthetic cannabinoid intoxication or Synth etic \\ncannabinoid withdrawal. The amount and duration of synthetic cannabinoid use'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 81, 'page_label': '82'}, page_content='must be capable of producing psychotic symptoms. The symptoms are not better \\nexplained by a primary mental disorder (e.g., Schizophrenia, a Mood disorder with \\npsychotic symptoms), as might be the case if the psychotic symptoms preceded  the \\nonset of the synthetic cannabinoid use, if the symptoms persist for a s ubstantial \\nperiod of time after cessation of the synthetic cannabinoid use or withdrawal, or i f \\nthere is other evidence of a pre-existing primary mental disorder with psycho tic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 81, 'page_label': '82'}, page_content='symptoms (e.g., a history of prior episodes not associated with synthetic \\ncannabinoid use). \\nNote: Code also the underlying condition \\n \\n6C42.7 Other synthetic cannabinoids-induced disorders \\nNote: Code also the underlying condition \\n \\n6C42.70 Synthetic cannabinoid-induced mood disorder \\nSynthetic cannabinoid-induced mood disorder is characterized by mood sympto ms \\n(e.g., depressed or elevated mood, decreased engagement in pleasurable activities,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 81, 'page_label': '82'}, page_content='increased or decreased energy levels) that develop during or soon after intox ication \\nwith or withdrawal from synthetic cannabinoids. The intensity or duration of  the \\nsymptoms is substantially in excess of mood disturbances that are characteristic of \\nSynthetic cannabinoid intoxication or Synthetic cannabinoid withdrawal. The amount \\nand duration of synthetic cannabinoid use must be capable of producing mood \\nsymptoms. The symptoms are not better explained by a primary mental disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 81, 'page_label': '82'}, page_content='(e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), as migh t \\nbe the case if the mood symptoms preceded the onset of the synthetic cannabinoi d \\nuse, if the symptoms persist for a substantial period of time after cessation of  the \\nsynthetic cannabinoid use or withdrawal, or if there is other evidence of a pre-\\nexisting primary mental disorder with mood symptoms (e.g., a history of prior \\nepisodes not associated with synthetic cannabinoid use).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 81, 'page_label': '82'}, page_content='Note: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 82, 'page_label': '83'}, page_content='82  ICD-11 MMS - 2018 \\n \\n6C42.71 Synthetic cannabinoid-induced anxiety disorder \\nSynthetic cannabinoid-induced anxiety disorder is characterized by anxiety  \\nsymptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive \\nautonomic arousal, avoidance behaviour) that develop during or soon after \\nintoxication with or withdrawal from synthetic cannabinoids. The intensity or duration  \\nof the symptoms is substantially in excess of anxiety symptoms that are'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 82, 'page_label': '83'}, page_content='characteristic of Synthetic cannabinoid intoxication or Synthetic cannabinoid \\nwithdrawal. The amount and duration of synthetic cannabinoid use must be capable \\nof producing anxiety symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive \\nDisorder with prominent anxiety symptoms), as might be the case if the anxiety \\nsymptoms preceded the onset of the synthetic cannabinoid use, if the symptoms'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 82, 'page_label': '83'}, page_content='persist for a substantial period of time after cessation of the synthetic cann abinoid \\nuse or withdrawal, or if there is other evidence of a pre-existing primary mental \\ndisorder with anxiety symptoms (e.g., a history of prior episodes not associated  with \\nsynthetic cannabinoid use). \\nNote: Code also the underlying condition \\n \\n  6C43   Disorders due to use of opioids \\nDisorders due to use of opioids are characterised by the pattern and consequences'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 82, 'page_label': '83'}, page_content='of opioid use. In addition to Opioid intoxication, opioids have dependence-induc ing \\nproperties, resulting in Opioid dependence in some people and Opioid withdra wal \\nwhen use is reduced or discontinued. Opioids are implicated in a wide range  of \\nharms affecting most organs and systems of the body, which may be classifi ed as \\nSingle episode of harmful use of opioids and Harmful pattern of use of opioids.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 82, 'page_label': '83'}, page_content='Harm to others resulting from behaviour during Opioid intoxication is included i n the \\ndefinitions of Harmful use of opioids. Several opioid-induced mental disorders a re \\nrecognised. \\nNote: Code also the underlying condition \\nExclusions: Hazardous use of opioids (QE11.0) \\n \\n6C43.0 Single episode of harmful use of opioids \\nA single episode of opioid use that has caused damage to a person ’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of other s.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 82, 'page_label': '83'}, page_content='Harm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on bod y \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behavior due to opioid intoxication on the part of the pers on'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 82, 'page_label': '83'}, page_content='to whom the diagnosis of single episode of harmful use applies. This diag nosis \\nshould not be made if the harm is attributed to a known pattern of opioid use. \\nExclusions: Harmful pattern of use of opioids (6C43.1) \\nOpioid dependence (6C43.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 83, 'page_label': '84'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   83 \\n \\n6C43.1 Harmful pattern of use of opioids \\nA pattern of use of opioids that has caused damage to a person’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of opioid use is evident over a period of at least 12 months if sub stance use \\nis episodic or at least one month if use is continuous (i.e., daily or alm ost daily).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 83, 'page_label': '84'}, page_content='Harm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body  \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behaviour related to opioid intoxication on the part of the \\nperson to whom the diagnosis of Harmful pattern of use of opioids applies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 83, 'page_label': '84'}, page_content='Exclusions: Single episode of harmful use of opioids (6C43.0) \\nOpioid dependence (6C43.2) \\n \\n6C43.10 Harmful pattern of use of opioids, episodic \\nA pattern of episodic or intermittent use of opioids that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic opioid use is evident over a period of at \\nleast 12 months. Harm to health of the individual occurs due to one or more of the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 83, 'page_label': '84'}, page_content='following: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to opioid intoxic ation on the \\npart of the person to whom the diagnosis of Harmful pattern of use of opioids \\napplies. \\nExclusions: Single episode of harmful use of opioids (6C43.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 83, 'page_label': '84'}, page_content='Opioid dependence (6C43.2) \\n \\n6C43.11 Harmful pattern of use of opioids, continuous \\nA pattern of continuous (daily or almost daily) use of opioids that has cau sed \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous opioid use is evident over \\na period of at least one month. Harm to health of the individual occurs due to one or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 83, 'page_label': '84'}, page_content='more of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to opioid intoxication \\non the part of the person to whom the diagnosis of Harmful pattern of use of opioids \\napplies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 83, 'page_label': '84'}, page_content='applies. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nOpioid dependence (6C43.2) \\n \\n6C43.1Z Harmful pattern of use of opioids, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 84, 'page_label': '85'}, page_content='84  ICD-11 MMS - 2018 \\n \\n6C43.2 Opioid dependence \\nOpioid dependence is a disorder of regulation of opioid use arising from r epeated or \\ncontinuous use of opioids. The characteristic feature is a strong internal drive to use \\nopioids, which is manifested by impaired ability to control use, increasin g priority \\ngiven to use over other activities and persistence of use despite harm or negativ e \\nconsequences. These experiences are often accompanied by a subjective'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 84, 'page_label': '85'}, page_content='sensation of urge or craving to use opioids. Physiological features of depend ence \\nmay also be present, including tolerance to the effects of opioids, withdrawal \\nsymptoms following cessation or reduction in use of opioids, or repeated use of \\nopioids or pharmacologically similar substances to prevent or alleviate withdrawal \\nsymptoms. The features of dependence are usually evident over a period of at least \\n12 months but the diagnosis may be made if opioid use is continuous (da ily or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 84, 'page_label': '85'}, page_content='almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nHarmful pattern of use of opioids (6C43.1) \\n \\n6C43.20 Opioid dependence, current use \\nOpioid dependence, with use of an opioid within the past month. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nHarmful pattern of use of opioids (6C43.1) \\n \\n6C43.21 Opioid dependence, early full remission \\nAfter a diagnosis of opioid dependence, and often following a treatment episode or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 84, 'page_label': '85'}, page_content='other intervention (including self-help intervention), the individual has be en \\nabstinent from opioid use during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nHarmful pattern of use of opioids (6C43.1) \\n \\n6C43.22 Opioid dependence, sustained partial remission \\nAfter a diagnosis of Opioid dependence, and often following a treatment episode or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 84, 'page_label': '85'}, page_content='other intervention (including self-help intervention), there is a significant r eduction in \\nopioid consumption for more than 12 months, such that even though opioid use has \\noccurred during this period, the definitional requirements for dependence have not \\nbeen met. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nHarmful pattern of use of opioids (6C43.1) \\n \\n6C43.23 Opioid dependence, sustained full remission'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 84, 'page_label': '85'}, page_content='After a diagnosis of Opioid dependence, and often following a treatment episode or \\nother intervention (including self-intervention), the person has been abstinent fr om \\nopioids for 12 months or longer. \\nExclusions: Single episode of harmful use of opioids (6C43.0) \\nHarmful pattern of use of opioids (6C43.1) \\n \\n6C43.2Z Opioid dependence, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 85, 'page_label': '86'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   85 \\n \\n6C43.3 Opioid intoxication \\nOpioid intoxication is a clinically significant transient condition th at develops during \\nor shortly after the consumption of opioids that is characterized by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. These \\ndisturbances are caused by the known pharmacological effects of opioids and their'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 85, 'page_label': '86'}, page_content='intensity is closely related to the amount of opioids consumed. They are time- limited \\nand abate as opioids are cleared from the body. Presenting features may incl ude \\nsomnolence, mood changes (e.g., inappropriate euphoria followed by apathy and \\ndysphoria), reduced movement, impaired judgment, respiratory depression, slurred  \\nspeech, and impairment of memory and attention. In severe intoxication coma may \\nensue. A characteristic physical sign is pupillary constriction but this s ign may be'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 85, 'page_label': '86'}, page_content='absent when intoxication is due to synthetic opioids. Severe opioid i ntoxication can \\nlead to death due to excessive respiratory depression. \\nNote: Code also the underlying condition \\nExclusions: opioid poisoning (NE60) \\nPossession trance disorder (6B63) \\n \\n6C43.4 Opioid withdrawal \\nOpioid withdrawal is a clinically significant cluster of symptoms, be haviours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 85, 'page_label': '86'}, page_content='cessation or reduction of use of opioids in individuals who have developed Opioi d \\ndependence or have used opioids for a prolonged period or in large amounts. \\nOpioid withdrawal can also occur when prescribed opioids have been used in \\nstandard therapeutic doses. Presenting features of Opioid withdrawal may inc lude \\ndysphoric mood, craving for an opioid, anxiety, nausea or vomiting, abdomi nal \\ncramps, muscle aches, yawning, perspiration, hot and cold flushes, lacrimation,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 85, 'page_label': '86'}, page_content='rhinorrhea, hypersomnia (typically in the initial phase) or insomnia, diarrhoe a and \\npiloerection. \\nNote: Code also the underlying condition \\n \\n6C43.5 Opioid-induced delirium \\nOpioid-induced delirium is characterized by an acute state of disturbed attention  \\nand awareness with specific features of delirium that develops during or soon af ter \\nsubstance intoxication or withdrawal or during the use of opioids. The amount and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 85, 'page_label': '86'}, page_content='duration of opioid use must be capable of producing delirium. The symptoms are \\nnot better explained by a primary mental disorder, by use of or withdrawal from a  \\ndifferent substance, or by another health condition that is not classified un der \\nMental, Behavioural, and Neurodevelopmental Disorders. \\nNote: Code also the underlying condition \\nInclusions: Delirium induced by opioid withdrawal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 86, 'page_label': '87'}, page_content='86  ICD-11 MMS - 2018 \\n \\n6C43.6 Opioid-induced psychotic disorder \\nOpioid-induced psychotic disorder is characterized by psychotic symptoms  (e.g., \\ndelusions, hallucinations, disorganized thinking, grossly disorganized behavi our) \\nthat develop during or soon after intoxication with or withdrawal from opioids. The \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of Opioid'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 86, 'page_label': '87'}, page_content='intoxication or Opioid withdrawal. The amount and duration of opioid use must  be \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe opioid use, if the symptoms persist for a substantial period of time after \\ncessation of the opioid use or withdrawal, or if there is other evidence of a pre-'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 86, 'page_label': '87'}, page_content='existing primary mental disorder with psychotic symptoms (e.g., a history of pri or \\nepisodes not associated with opioid use). \\nNote: Code also the underlying condition \\n \\n6C43.7 Other opioid-induced disorders \\nNote: Code also the underlying condition \\n \\n6C43.70 Opioid-induced mood disorder \\nOpioid-induced mood disorder is characterized by mood symptoms (e.g., depressed  \\nor elevated mood, decreased engagement in pleasurable activities, increased or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 86, 'page_label': '87'}, page_content='decreased energy levels) that develop during or soon after intoxication with or \\nwithdrawal from opioids. The intensity or duration of the symptoms is substantially in \\nexcess of mood disturbances that are characteristic of Opioid intoxication or Opioid \\nwithdrawal. The amount and duration of opioid use must be capable of producing \\nmood symptoms. The symptoms are not better explained by a primary mental \\ndisorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disord er),'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 86, 'page_label': '87'}, page_content='as might be the case if the mood symptoms preceded the onset of the opioid use, if \\nthe symptoms persist for a substantial period of time after cessation of the opi oid \\nuse or withdrawal, or if there is other evidence of a pre-existing primary mental \\ndisorder with mood symptoms (e.g., a history of prior episodes not associated with \\nopioid use). \\n \\n6C43.71 Opioid-induced anxiety disorder \\nOpioid-induced anxiety disorder is characterized by anxiety symptoms (e. g.,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 86, 'page_label': '87'}, page_content='apprehension or worry, fear, physiological symptoms of excessive autonomi c \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from opioids. The intensity or duration of the symptoms is substantially in \\nexcess of anxiety symptoms that are characteristic of Opioid intoxication or Opioid \\nwithdrawal. The amount and duration of opioid use must be capable of producing \\nanxiety symptoms. The symptoms are not better explained by a primary mental'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 86, 'page_label': '87'}, page_content='disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder with \\nprominent anxiety symptoms), as might be the case if the anxiety symptoms \\npreceded the onset of the opioid use, if the symptoms persist for a substantial \\nperiod of time after cessation of the opioid use or withdrawal, or if there is oth er \\nevidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with opioid use).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 86, 'page_label': '87'}, page_content='Note: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 87, 'page_label': '88'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   87 \\n \\n6C43.Y Other specified disorders due to use of opioids \\nNote: Code also the underlying condition \\n \\n6C43.Z Disorders due to use of opioids, unspecified \\nNote: Code also the underlying condition \\n \\n  6C44   Disorders due to use of sedatives, hypnotics or anxiolytics \\nDisorders due to use of sedatives, hypnotics or anxiolytics are characterized b y the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 87, 'page_label': '88'}, page_content='pattern and consequences of sedative use. In addition to Sedative, hypnotic or  \\nanxiolytic intoxication, sedatives have dependence-inducing properties, resulti ng in \\nSedative, hypnotic or anxiolytic dependence in some people and Sedative, hyp notic \\nor anxiolytic withdrawal when use is reduced or discontinued. Sedatives are \\nimplicated in a wide range of harms affecting most organs and systems of the bo dy, \\nwhich may be classified as Single episode of harmful use of sedatives , hypnotics or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 87, 'page_label': '88'}, page_content='anxiolytics and Harmful pattern of use of sedatives, hypnotics or anxiolyti cs. Harm \\nto others resulting from behaviour during Sedative, hypnotic or anxiolytic \\nintoxication is included in the definitions of Harmful use of sedatives,  hypnotics or \\nanxiolytics. Several sedative-induced mental disorders and sedative-rel ated forms \\nof neurocognitive impairment are recognised. \\nNote: Code also the underlying condition \\nExclusions: Hazardous use of sedatives, hypnotics or anxiolytics (QE11.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 87, 'page_label': '88'}, page_content='6C44.0 Single episode of harmful use of sedatives, hypnotics or anxiolytics  \\nA single episode of use of a sedative, hypnotic or anxiolytic that has c aused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 87, 'page_label': '88'}, page_content='toxic effects on body organs and systems; or (3) a harmful route of administratio n. \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behavior due to sedative, hypnot ic or \\nanxiolytic intoxication on the part of the person to whom the diagnosis of  single \\nepisode of harmful use applies. This diagnosis should not be made if the harm  is \\nattributed to a known pattern of sedative, hypnotic or anxiolytic use.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 87, 'page_label': '88'}, page_content='Exclusions: Sedative, hypnotic or anxiolytic dependence (6C44.2) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1) \\n \\n6C44.1 Harmful pattern of use of sedatives, hypnotics or anxiolytics \\nA pattern of sedative, hypnotic, or anxiolytic use that has caused clinical ly \\nsignificant harm to a person ’s physical or mental health or in which behaviour \\ninduced by sedatives, hypnotics or anxiolytics has caused clinicall y significant harm'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 87, 'page_label': '88'}, page_content='to the health of other people. The pattern of sedative, hypnotic, or anxiolytic use is  \\nevident over a period of at least 12 months if use is episodic and at least  one month \\nif use is continuous (i.e., daily or almost daily). Harm may be caused  by the \\nintoxicating effects of sedatives, hypnotics or anxiolytics, the direct or secondary \\ntoxic effects on body organs and systems, or a harmful route of administration. \\nExclusions: Sedative, hypnotic or anxiolytic dependence (6C44.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 87, 'page_label': '88'}, page_content='Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 88, 'page_label': '89'}, page_content='88  ICD-11 MMS - 2018 \\n \\n6C44.10 Harmful pattern of use of sedatives, hypnotics or anxiolytics, episodic \\nA pattern of episodic or intermittent use of sedatives, hypnotics or anxiolytics that \\nhas caused clinically significant harm to a person ’s physical or mental health or in \\nwhich behaviour induced by sedatives, hypnotics or anxiolytics has caused c linically \\nsignificant harm to the health of other people. The pattern of episodic or intermitte nt'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 88, 'page_label': '89'}, page_content='use of sedatives, hypnotics or anxiolytics is evident over a period of at least 12 \\nmonths. Harm may be caused by the intoxicating effects of sedatives, hypnotic s or \\nanxiolytics, the direct or secondary toxic effects on body organs and systems, or a \\nharmful route of administration. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nSedative, hypnotic or anxiolytic dependence (6C44.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 88, 'page_label': '89'}, page_content='6C44.11 Harmful pattern of use of sedatives, hypnotics or anxiolytics, continuous  \\nA pattern of continuous use of sedatives, hypnotics or anxiolytics (daily or almost \\ndaily) that has caused clinically significant harm to a person ’s physical or mental \\nhealth or in which behaviour induced by sedatives, hypnotics or anxiolyt ics has \\ncaused clinically significant harm to the health of other people. The patter n of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 88, 'page_label': '89'}, page_content='continuous use of sedatives, hypnotics or anxiolytics is evident over a perio d of at \\nleast one month. Harm may be caused by the intoxicating effects of sedatives, \\nhypnotics or anxiolytics, the direct or secondary toxic effects on body organs  and \\nsystems, or a harmful route of administration. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nSedative, hypnotic or anxiolytic dependence (6C44.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 88, 'page_label': '89'}, page_content='6C44.1Z Harmful pattern of use of sedatives, hypnotics or anxiolytics, unspecified \\n \\n6C44.2 Sedative, hypnotic or anxiolytic dependence \\nSedative, hypnotic or anxiolytic dependence is a disorder of regulation of s edative \\nuse arising from repeated or continuous use of these substances. The characteristic  \\nfeature is a strong internal drive to use sedatives, hypnotics, or anxiolytics, which  is \\nmanifested by impaired ability to control use, increasing priority give n to use over'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 88, 'page_label': '89'}, page_content='other activities and persistence of use despite harm or negative consequences. \\nThese experiences are often accompanied by a subjective sensation of urge or \\ncraving to use these substances. Physiological features of dependence may als o be \\npresent, including tolerance to the effects of sedatives, hypnotics or anxiolytics , \\nwithdrawal symptoms following cessation or reduction in use, or repeated use of \\nsedatives or pharmacologically similar substances to prevent or alleviate withdr awal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 88, 'page_label': '89'}, page_content='symptoms. The features of dependence are usually evident over a period of at least \\n12 months but the diagnosis may be made if sedative use is continuous (daily or \\nalmost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 89, 'page_label': '90'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   89 \\n \\n6C44.20 Sedative, hypnotic or anxiolytic dependence, current use \\nCurrent Sedative, hypnotic or anxiolytic dependence with use of a sedative, \\nhypnotic or anxiolytic drug within the past month. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 89, 'page_label': '90'}, page_content='(6C44.1) \\n \\n6C44.21 Sedative, hypnotic or anxiolytic dependence, early full remission \\nAfter a diagnosis of Sedative, hypnotic or anxiolytic dependence, and often  \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthe individual has been abstinent from sedatives, hypnotics or anxiolytics during a \\nperiod lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 89, 'page_label': '90'}, page_content='Harmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1) \\n \\n6C44.22 Sedative, hypnotic or anxiolytic dependence, sustained partial remission  \\nAfter a diagnosis of Sedative, hypnotic or anxiolytic dependence, and often  \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthere is a significant reduction in sedative, hypnotic or anxiolytic c onsumption for \\nmore than 12 months, such that even though sedative, hypnotic or anxiolytic use'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 89, 'page_label': '90'}, page_content='has occurred during this period, the definitional requirements for dependence hav e \\nnot been met. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1) \\n \\n6C44.23 Sedative, hypnotic or anxiolytic dependence, sustained full remission \\nAfter a diagnosis of Sedative, hypnotic or anxiolytic dependence, and often'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 89, 'page_label': '90'}, page_content='following a treatment episode or other intervention (including self-interventi on), the \\nperson has been abstinent from alcohol for 12 months or longer. \\nExclusions: Single episode of harmful use of sedatives, hypnotics or \\nanxiolytics (6C44.0) \\nHarmful pattern of use of sedatives, hypnotics or anxiolytics \\n(6C44.1) \\n \\n6C44.2Z Sedative, hypnotic or anxiolytic dependence, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 90, 'page_label': '91'}, page_content='90  ICD-11 MMS - 2018 \\n \\n6C44.3 Sedative, hypnotic or anxiolytic intoxication \\nSedative, hypnotic or anxiolytic intoxication is a clinically signific ant transien t \\ncondition that develops during or shortly after the consumption of sedatives, \\nhypnotics or anxiolytics that is characterized by disturbances in consci ousness, \\ncognition, perception, affect, behaviour, or coordination. These disturbances a re \\ncaused by the known pharmacological effects of sedatives, hypnotics or anxioly tics'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 90, 'page_label': '91'}, page_content='and their intensity is closely related to the amount of sedatives, hypnotics  or \\nanxiolytics consumed. They are time-limited and abate as sedatives, hypno tics or \\nanxiolytics are cleared from the body. Presenting features may incl ude somnolence, \\nimpaired judgment, slurred speech, impaired motor coordination, unsteady gait, \\nmood changes, as well as impaired memory, attention and concentration. \\nNystagmus (repetitive, uncontrolled eye movements) is a common physical sign.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 90, 'page_label': '91'}, page_content='Note: Code also the underlying condition \\nInclusions: \"Bad trips\" (Sedatives, hypnotics or anxiolytics) \\nExclusions: sedative, hypnotic drugs and other CNS depressants \\npoisoning (NE60) \\nPossession trance disorder (6B63) \\n \\n6C44.4 Sedative, hypnotic or anxiolytic withdrawal \\nSedative, hypnotic or anxiolytic withdrawal is a clinically significant cluster of \\nsymptoms, behaviours and/or physiological features, varying in degree of severit y'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 90, 'page_label': '91'}, page_content='and duration, that occurs upon cessation or reduction of use of sedatives, hypnotics \\nor anxiolytics in individuals who have developed dependence or have used \\nsedatives, hypnotics or anxiolytics for a prolonged period or in large amounts. \\nSedative, hypnotic or anxiolytic withdrawal can also occur when prescribed  \\nsedatives, hypnotics or anxiolytics have been used in standard therapeutic dos es. \\nPresenting features of Sedative, hypnotic or anxiolytic withdrawal may incl ude'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 90, 'page_label': '91'}, page_content='anxiety, psychomotor agitation, insomnia, increased hand tremor, nausea or \\nvomiting, and transient visual, tactile or auditory illusions or hallucinations . There \\nmay be signs of autonomic hyperactivity, or postural hypotension. The withdra wal \\nstate may be complicated by seizures. Less commonly there may be progressi on to \\na more severe form of delirium characterized by confusion and disorientation, \\ndelusions, and more prolonged visual, tactile or auditory hallucinations. In such'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 90, 'page_label': '91'}, page_content='cases, a separate diagnosis of Sedative, hypnotic, or anxiolytic-induced deli rium \\nshould be assigned. \\nNote: Code also the underlying condition \\n \\n6C44.40 Sedative, hypnotic or anxiolytic withdrawal, uncomplicated \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic Wi thdrawal are met \\nand the withdrawal state is not accompanied by perceptual disturbances or \\nseizures. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 91, 'page_label': '92'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   91 \\n \\n6C44.41 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic withdraw al are met \\nand the withdrawal state is accompanied by perceptual disturbances (e.g., vi sual or \\ntactile hallucinations or illusions) with intact reality testing. There is no  evidence of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 91, 'page_label': '92'}, page_content='confusion and other diagnostic requirements for Delirium are not met. The \\nwithdrawal state is not accompanied by seizures. \\nNote: Code also the underlying condition \\n \\n6C44.42 Sedative, hypnotic or anxiolytic withdrawal, with seizures \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic withdraw al are met \\nand the withdrawal state is accompanied by seizures (i.e., generalized tonic- clonic \\nseizures) but not by perceptual disturbances. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 91, 'page_label': '92'}, page_content='6C44.43 Sedative, hypnotic or anxiolytic withdrawal, with perceptual disturbances and \\nseizures \\nAll diagnostic requirements for Sedative, hypnotic or anxiolytic withdraw al are met \\nand the withdrawal state is accompanied by both seizures (i.e., generalized tonic -\\nclonic seizures) and perceptual disturbances (e.g., visual or tactile hallucina tions or \\nillusions) with intact reality testing. Diagnostic requirements for Delirium are not met. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 91, 'page_label': '92'}, page_content='6C44.4Z Sedative, hypnotic or anxiolytic withdrawal, unspecified \\nNote: Code also the underlying condition \\n \\n6C44.5 Sedative, hypnotic or anxiolytic-induced delirium \\nSedative, hypnotic or anxiolytic-induced delirium is characterized by an ac ute state \\nof disturbed attention and awareness with specific features of delirium that develops \\nduring or soon after substance intoxication or withdrawal or during the use of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 91, 'page_label': '92'}, page_content='sedatives, hypnotics, or anxiolytics. Specific features of Sedative, hypno tic or \\nanxiolytic-induced delirium may include confusion and disorientation, pa ranoid \\ndelusions, and recurrent visual, tactile or auditory hallucinations. The amount and \\nduration of sedative, hypnotic, or anxiolytic use must be capable of producing \\ndelirium. The symptoms are not better explained by a primary mental disorder, by \\nuse of or withdrawal from a different substance, or by another health condition t hat'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 91, 'page_label': '92'}, page_content='is not classified under Mental, behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\nInclusions: Delirium induced by sedative, hypnotic or anxiolytic withdrawal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 92, 'page_label': '93'}, page_content='92  ICD-11 MMS - 2018 \\n \\n6C44.6 Sedative, hypnotic or anxiolytic-induced psychotic disorder \\nSedative, hypnotic or anxiolytic-induced psychotic disorder is characterized b y \\npsychotic symptoms (e.g., delusions, hallucinations, disorganized thinking, grossly \\ndisorganized behaviour) that develop during or soon after intoxication with or \\nwithdrawal from sedatives, hypnotics or anxiolytics. The intensity or d uration of the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 92, 'page_label': '93'}, page_content='symptoms is substantially in excess of psychotic-like disturbances of per ception, \\ncognition, or behaviour that are characteristic of intoxication or withdrawal due t o \\nsedatives, hypnotics or anxiolytics. The amount and duration of sedative, hypnoti c \\nor anxiolytic use must be capable of producing psychotic symptoms. The symptoms  \\nare not better explained by a primary mental disorder (e.g., Schizophrenia, a Mood'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 92, 'page_label': '93'}, page_content='disorder with psychotic symptoms), as might be the case if the psychotic sym ptoms \\npreceded the onset of the sedative, hypnotic or anxiolytic use, if the symptoms \\npersist for a substantial period of time after cessation of the sedative, hypno tic or \\nanxiolytic use or withdrawal, or if there is other evidence of a pre-existin g primary \\nmental disorder with psychotic symptoms (e.g., a history of prior episodes not \\nassociated with sedative, hypnotic or anxiolytic use).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 92, 'page_label': '93'}, page_content='Note: Code also the underlying condition \\n \\n6C44.7 Other sedatives, hypnotics or anxiolytic-induced disorders \\nNote: Code also the underlying condition \\nCoded Elsewhere: Amnestic disorder due to use of sedatives, hypnotics or \\nanxiolytics (6D72.11) \\nDementia due to use of sedatives, hypnotics or anxiolytics \\n(6D84.1) \\n \\n6C44.70 Sedative, hypnotic or anxiolytic-induced mood disorder \\nSedative, hypnotic or anxiolytic-induced mood disorder is characterized by mood'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 92, 'page_label': '93'}, page_content='symptoms (e.g., depressed or elevated mood, decreased engagement in \\npleasurable activities, increased or decreased energy levels) that develop during or \\nsoon after intoxication with or withdrawal from sedatives, hypnotics or anxioly tics. \\nThe intensity or duration of the symptoms is substantially in excess of mood \\ndisturbances that are characteristic of intoxication or withdrawal due to sedatives, \\nhypnotics or anxiolytics. The amount and duration of sedative, hypnotic or anxiolytic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 92, 'page_label': '93'}, page_content='use must be capable of producing mood symptoms. The symptoms are not better \\nexplained by a primary mental disorder (e.g., a Depressive disorder, a Bip olar \\ndisorder, Schizoaffective disorder), as might be the case if the mood symptoms  \\npreceded the onset of the sedative, hypnotic or anxiolytic use, if the symptoms \\npersist for a substantial period of time after cessation of the sedative, hypno tic or \\nanxiolytic use or withdrawal, or if there is other evidence of a pre-existin g primary'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 92, 'page_label': '93'}, page_content='mental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with sedative, hypnotic or anxiolytic use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 93, 'page_label': '94'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   93 \\n \\n6C44.71 Sedative, hypnotic or anxiolytic-induced anxiety disorder \\nSedative, hypnotic or anxiolytic-induced anxiety disorder is characterize d by anxiety \\nsymptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive \\nautonomic arousal, avoidance behaviour) that develop during or soon after'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 93, 'page_label': '94'}, page_content='intoxication with or withdrawal from sedatives, hypnotics or anxiolytics. T he intensity \\nor duration of the symptoms is substantially in excess of anxiety sym ptoms that are \\ncharacteristic of intoxication or withdrawal due to sedatives, hypnotics or anxioly tics. \\nThe amount and duration of sedative, hypnotic or anxiolytic use must be capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 93, 'page_label': '94'}, page_content='mental disorder (e.g., an Anxiety and Fear-Related Disorder, a Depressive Disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety symptom s \\npreceded the onset of the sedative, hypnotic or anxiolytic use, if the symptoms \\npersist for a substantial period of time after cessation of the sedative, hypno tic or \\nanxiolytic use or withdrawal, or if there is other evidence of a pre-existin g primary \\nmental disorder with anxiety symptoms (e.g., a history of prior episodes not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 93, 'page_label': '94'}, page_content='associated with sedative, hypnotic or anxiolytic use). \\nNote: Code also the underlying condition \\n \\n6C44.Y Other specified disorders due to use of sedatives, hypnotics or anxiolytics  \\nNote: Code also the underlying condition \\n \\n6C44.Z Disorders due to use of sedatives, hypnotics or anxiolytics, unspecified  \\nNote: Code also the underlying condition \\n \\n  6C45   Disorders due to use of cocaine \\nDisorders due to use of cocaine are characterized by the pattern and consequences'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 93, 'page_label': '94'}, page_content='of cocaine use. In addition to Cocaine intoxication, cocaine has dependence-\\ninducing properties, resulting in Cocaine dependence in some people and Cocaine \\nwithdrawal when use is reduced or discontinued. Cocaine is implicated in a wide \\nrange of harms affecting most organs and systems of the body, which may be \\nclassified as Single episode of harmful use of cocaine and Harmful pattern of  use of \\ncocaine. Harm to others resulting from behaviour during Cocaine intoxicatio n is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 93, 'page_label': '94'}, page_content='included in the definitions of Harmful use of cocaine. Several cocaine-induced  \\nmental disorders are recognised. \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46) \\nHazardous use of cocaine (QE11.3)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 94, 'page_label': '95'}, page_content='94  ICD-11 MMS - 2018 \\n \\n6C45.0 Single episode of harmful use of cocaine \\nA single episode of use of cocaine that has caused damage to a person ’s physical \\nor mental health or has resulted in behaviour leading to harm to the health of others. \\nHarm to health of the individual occurs due to one or more of the following: (1) \\nbehaviour related to intoxication; (2) direct or secondary toxic effects on body \\norgans and systems; or (3) a harmful route of administration. Harm to health of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 94, 'page_label': '95'}, page_content='others includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behavior due to cocaine intoxication on the part of  the \\nperson to whom the diagnosis of single episode of harmful use applies. Thi s \\ndiagnosis should not be made if the harm is attributed to a known pattern of cocain e \\nuse. \\nExclusions: Cocaine dependence (6C45.2) \\nHarmful pattern of use of cocaine (6C45.1) \\n \\n6C45.1 Harmful pattern of use of cocaine'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 94, 'page_label': '95'}, page_content='A pattern of use of cocaine that has caused damage to a person ’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of other s. \\nThe pattern of cocaine use is evident over a period of at least 12 months if \\nsubstance use is episodic or at least one month if use is continuous (i.e., dai ly or \\nalmost daily). Harm to health of the individual occurs due to one or more of the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 94, 'page_label': '95'}, page_content='following: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to cocaine intoxicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of cocaine \\napplies. \\nExclusions: Cocaine dependence (6C45.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 94, 'page_label': '95'}, page_content='Single episode of harmful use of cocaine (6C45.0) \\n \\n6C45.10 Harmful pattern of use of cocaine, episodic \\nA pattern of episodic or intermittent cocaine use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic cocaine use is evident over a period of \\nat least 12 months. Harm to health of the individual occurs due to one or more of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 94, 'page_label': '95'}, page_content='the following: (1) behaviour related to intoxication; (2) direct or secondary toxic \\neffects on body organs and systems; or (3) a harmful route of administration. Harm  \\nto health of others includes any form of physical harm, including trauma, or mental  \\ndisorder that is directly attributable to behaviour related to cocaine intoxicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of cocaine \\napplies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 94, 'page_label': '95'}, page_content='applies. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nCocaine dependence (6C45.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 95, 'page_label': '96'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   95 \\n \\n6C45.11 Harmful pattern of use of cocaine, continuous \\nA pattern of continuous (daily or almost daily) cocaine use that has caused  damage \\nto a person’s physical or mental health or has resulted in behaviour leading to harm \\nto the health of others. The pattern of continuous cocaine use is evident over a \\nperiod of at least one month. Harm to health of the individual occurs due to one or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 95, 'page_label': '96'}, page_content='more of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administratio n. \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to cocaine \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern  of \\nuse of cocaine applies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 95, 'page_label': '96'}, page_content='Exclusions: Single episode of harmful use of cocaine (6C45.0) \\nCocaine dependence (6C45.2) \\n \\n6C45.1Z Harmful pattern of use of cocaine, unspecified \\n \\n6C45.2 Cocaine dependence \\nCocaine dependence is a disorder of regulation of cocaine use arising from \\nrepeated or continuous use of cocaine. The characteristic feature is a strong \\ninternal drive to use cocaine, which is manifested by impaired ability to control use,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 95, 'page_label': '96'}, page_content='increasing priority given to use over other activities and persistence of use despite  \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use cocaine. Physiological fea tures of \\ndependence may also be present, including tolerance to the effects of cocaine, \\nwithdrawal symptoms following cessation or reduction in use of cocaine, or \\nrepeated use of cocaine or pharmacologically similar substances to prevent or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 95, 'page_label': '96'}, page_content='alleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months but the diagnosis may be made if cocaine use is \\ncontinuous (daily or almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nHarmful pattern of use of cocaine (6C45.1) \\n \\n6C45.20 Cocaine dependence, current use \\nCurrent cocaine dependence with cocaine use within the past month.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 95, 'page_label': '96'}, page_content='Exclusions: Single episode of harmful use of cocaine (6C45.0) \\nHarmful pattern of use of cocaine (6C45.1) \\n \\n6C45.21 Cocaine dependence, early full remission \\nAfter a diagnosis of Cocaine dependence, and often following a treatment episode \\nor other intervention (including self-help intervention), the individual has been  \\nabstinent from cocaine during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of cocaine (6C45.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 95, 'page_label': '96'}, page_content='Harmful pattern of use of cocaine (6C45.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 96, 'page_label': '97'}, page_content='96  ICD-11 MMS - 2018 \\n \\n6C45.22 Cocaine dependence, sustained partial remission \\nAfter a diagnosis of Cocaine dependence, and often following a treatment episode \\nor other intervention (including self-help intervention), there is a signific ant reduction \\nin cocaine consumption for more than 12 months, such that even though cocaine \\nuse has occurred during this period, the definitional requirements for dependence \\nhave not been met.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 96, 'page_label': '97'}, page_content='have not been met. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nHarmful pattern of use of cocaine (6C45.1) \\n \\n6C45.23 Cocaine dependence, sustained full remission \\nAfter a diagnosis of cocaine dependence, and often following a treatment episode \\nor other intervention (including self-intervention), the person has been abs tinent \\nfrom cocaine for 12 months or longer. \\nExclusions: Single episode of harmful use of cocaine (6C45.0) \\nHarmful pattern of use of cocaine (6C45.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 96, 'page_label': '97'}, page_content='6C45.2Z Cocaine dependence, unspecified \\n \\n6C45.3 Cocaine intoxication \\nCocaine intoxication is a clinically significant transient condition that develops during \\nor shortly after the consumption of cocaine that is characterized by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. These \\ndisturbances are caused by the known pharmacological effects of cocaine and their \\nintensity is closely related to the amount of cocaine consumed. They are tim e-'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 96, 'page_label': '97'}, page_content='limited and abate as cocaine is cleared from the body. Presenting features  may \\ninclude inappropriate euphoria, anxiety, anger, impaired attention, hypervigilanc e, \\npsychomotor agitation, paranoid ideation (sometimes of delusional intensity),  \\nauditory hallucinations, confusion, and changes in sociability. Perspi ration or chills, \\nnausea or vomiting, and palpitations and chest pain may be experienced. Physic al'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 96, 'page_label': '97'}, page_content='signs may include tachycardia, elevated blood pressure, and pupillary di latation. In \\nrare instances, usually in severe intoxication, cocaine use can result in seizures, \\nmuscle weakness, dyskinesia, or dystonia. \\nNote: Code also the underlying condition \\nExclusions: cocaine poisoning (NE60) \\nPossession trance disorder (6B63) \\n \\n6C45.4 Cocaine withdrawal \\nCocaine withdrawal is a clinically significant cluster of symptoms, behavi ours and/or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 96, 'page_label': '97'}, page_content='physiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of cocaine in individuals who have developed Cocaine \\ndependence or have used cocaine for a prolonged period or in large amounts. \\nPresenting features of Cocaine withdrawal may include dysphoric mood, irritabili ty, \\nfatigue, inertia, vivid unpleasant dreams, insomnia or hypersomnia, increased \\nappetite, anxiety, psychomotor agitation or retardation, and craving for cocaine.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 96, 'page_label': '97'}, page_content='Note: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 97, 'page_label': '98'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   97 \\n \\n6C45.5 Cocaine-induced delirium \\nCocaine-induced delirium is characterized by an acute state of disturbed attenti on \\nand awareness with specific features of delirium that develops during or soon af ter \\nsubstance intoxication or withdrawal or during the use of cocaine. The amount and \\nduration of cocaine use must be capable of producing delirium. The symptoms are'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 97, 'page_label': '98'}, page_content='not better explained by a primary mental disorder, by use of or withdrawal from a  \\ndifferent substance, or by another health condition that is not classified unde r \\nMental, behavioural, and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C45.6 Cocaine-induced psychotic disorder \\nCocaine-induced psychotic disorder is characterized by psychotic symptoms  (e.g., \\ndelusions, hallucinations, disorganized thinking, grossly disorganized behavi our)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 97, 'page_label': '98'}, page_content='that develop during or soon after intoxication with or withdrawal from cocaine. The \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nCocaine intoxication or Cocaine withdrawal. The amount and duration of cocaine \\nuse must be capable of producing psychotic symptoms. The symptoms are no t \\nbetter explained by a primary mental disorder (e.g., Schizophrenia, a Mood disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 97, 'page_label': '98'}, page_content='with psychotic symptoms), as might be the case if the psychotic sympto ms \\npreceded the onset of the cocaine use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cocaine use or withdrawal, or if there is oth er \\nevidence of a pre-existing primary mental disorder with psychotic symptoms ( e.g., a \\nhistory of prior episodes not associated with cocaine use). \\nNote: Code also the underlying condition \\n \\n6C45.60 Cocaine-induced psychotic disorder with hallucinations'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 97, 'page_label': '98'}, page_content='Cocaine-induced psychotic disorder with hallucinations is characterized by the by \\nthe presence of hallucinations that are judged to be the direct consequence of \\ncocaine use. Neither delusions nor other psychotic symptoms are present. The \\nsymptoms do not occur exclusively during hypnogogic or hypnopompic states, are \\nnot better accounted for by another mental and behavioural disorder (e.g., \\nschizophrenia), and are not due to another disorder or disease classified elsewh ere'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 97, 'page_label': '98'}, page_content='(e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C45.61 Cocaine-induced psychotic disorder with delusions \\nCocaine-induced psychotic disorder with delusions is characterized by the by the \\npresence of delusions that are judged to be the direct consequence of cocaine use . \\nNeither hallucinations nor other psychotic symptoms are present. The symptoms  do \\nnot occur exclusively during hypnogogic or hypnopompic states, are not better'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 97, 'page_label': '98'}, page_content='accounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 98, 'page_label': '99'}, page_content='98  ICD-11 MMS - 2018 \\n \\n6C45.62 Cocaine-induced psychotic disorder with mixed psychotic symptoms \\nCocaine-induced psychotic disorder with mixed psychotic symptoms is \\ncharacterized by the presence of multiple psychotic symptoms, primarily \\nhallucinations and delusions, when these are judged to be the direct con sequence \\nof cocaine use. The symptoms do not occur exclusively during hypnogogic or \\nhypnopompic states, are not better accounted for by another mental and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 98, 'page_label': '99'}, page_content='behavioural disorder (e.g., Schizophrenia), and are not due to another disorder or \\ndisease classified elsewhere (e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C45.6Z Cocaine-induced psychotic disorder, unspecified \\nNote: Code also the underlying condition \\n \\n6C45.7 Other cocaine-induced disorders \\nNote: Code also the underlying condition \\n \\n6C45.70 Cocaine-induced mood disorder \\nCocaine-induced mood disorder is characterized by mood symptoms (e.g.,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 98, 'page_label': '99'}, page_content='depressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxi cation \\nwith or withdrawal from cocaine. The intensity or duration of the symptoms is  \\nsubstantially in excess of mood disturbances that are characteristic of Cocaine \\nintoxication or Cocaine withdrawal. The amount and duration of cocaine use must \\nbe capable of producing mood symptoms. The symptoms are not better explained'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 98, 'page_label': '99'}, page_content='by a primary mental disorder (e.g., a Depressive disorder, a Bipolar disorder, \\nSchizoaffective disorder), as might be the case if the mood symptoms preceded  the \\nonset of the cocaine use, if the symptoms persist for a substantial period of time \\nafter cessation of the cocaine use or withdrawal, or if there is other evidence of a \\npre-existing primary mental disorder with mood symptoms (e.g., a history of prior \\nepisodes not associated with cocaine use).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 98, 'page_label': '99'}, page_content='Note: Code also the underlying condition \\n \\n6C45.71 Cocaine-induced anxiety disorder \\nCocaine-induced anxiety disorder is characterized by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic  \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from cocaine. The intensity or duration of the symptoms is subs tantially \\nin excess of anxiety symptoms that are characteristic of Cocaine intoxication or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 98, 'page_label': '99'}, page_content='Cocaine withdrawal. The amount and duration of cocaine use must be capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary \\nmental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety symptom s \\npreceded the onset of the cocaine use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cocaine use or withdrawal, or if there is oth er'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 98, 'page_label': '99'}, page_content='evidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with cocaine use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 99, 'page_label': '100'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   99 \\n \\n6C45.72 Cocaine-induced obsessive-compulsive or related disorder \\nCocaine-induced obsessive-compulsive or related disorder is characterized by \\neither repetitive intrusive thoughts or preoccupations, normally associated with \\nanxiety and typically accompanied by repetitive behaviours performed in response, \\nor by recurrent and habitual actions directed at the integument (e.g., hair pulling,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 99, 'page_label': '100'}, page_content='skin picking) that develop during or soon after intoxication with or withdrawal f rom \\ncocaine. The intensity or duration of the symptoms is substantially in excess  of \\nanalogous disturbances that are characteristic of Cocaine intoxication or Cocaine \\nwithdrawal. The amount and duration of cocaine use must be capable of producing \\nobsessive-compulsive or related symptoms. The symptoms are not better explain ed \\nby a primary mental disorder (in particular an Obsessive-compulsive or rela ted'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 99, 'page_label': '100'}, page_content='disorder), as might be the case if the symptoms preceded the onset of the cocaine \\nuse, if the symptoms persist for a substantial period of time after cessation of  the \\ncocaine use or withdrawal, or if there is other evidence of a pre-existing primary  \\nmental disorder with obsessive-compulsive or related symptoms (e.g., a history of \\nprior episodes not associated with cocaine use). \\nNote: Code also the underlying condition \\n \\n6C45.73 Cocaine-induced impulse control disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 99, 'page_label': '100'}, page_content='Cocaine-induced impulse control disorder is characterized by persistently r epeated \\nbehaviours in which there is recurrent failure to resist an impulse, drive, or urg e to \\nperform an act that is rewarding to the person, at least in the short-term, des pite \\nlonger-term harm either to the individual or to others (e.g., fire setting or steali ng \\nwithout apparent motive, repetitive sexual behaviour, aggressive outbursts) that'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 99, 'page_label': '100'}, page_content='develop during or soon after intoxication with or withdrawal from cocaine. The \\nintensity or duration of the symptoms is substantially in excess of di sturbances of \\nimpulse control that are characteristic of Cocaine intoxication or Cocaine \\nwithdrawal. The amount and duration of cocaine use must be capable of producing \\ndisturbances of impulse control. The symptoms are not better explained by a \\nprimary mental disorder (e.g., an Impulse control disorder, a Disorder due to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 99, 'page_label': '100'}, page_content='addictive behaviours), as might be the case if the impulse control disturbances  \\npreceded the onset of the cocaine use, if the symptoms persist for a substantial \\nperiod of time after cessation of the cocaine use or withdrawal, or if there is oth er \\nevidence of a pre-existing primary mental disorder with impulse control symptoms \\n(e.g., a history of prior episodes not associated with cocaine use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 99, 'page_label': '100'}, page_content='6C45.Y Other specified disorders due to use of cocaine \\nNote: Code also the underlying condition \\n \\n6C45.Z Disorders due to use of cocaine, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 100, 'page_label': '101'}, page_content='100  ICD-11 MMS - 2018 \\n \\n  6C46   Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone \\nDisorders due to use of stimulants including amphetamines, methamphetamine or \\nmethcathinone are characterized by the pattern and consequences of stimulant use. \\nIn addition to Stimulant intoxication including amphetamines, methamphetamine or \\nmethcathinone, stimulants have dependence-inducing properties, resulting in'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 100, 'page_label': '101'}, page_content='Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone in some people and Stimulant withdrawal including amphetamines, \\nmethamphetamine or methcathinone when use is reduced or discontinued. \\nStimulants are implicated in a wide range of harms affecting most organs and \\nsystems of the body, which may be classified as Single episode of  harmful use of \\nstimulants including amphetamines, methamphetamine or methcathinone and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 100, 'page_label': '101'}, page_content='Harmful pattern of use of stimulants including amphetamines, methamphetamine or \\nmethcathinone. Harm to others resulting from behaviour during Stimulant \\nintoxication including amphetamines, methamphetamine or methcathinone is \\nincluded in the definitions of Harmful use of stimulants including amphetami nes, \\nmethamphetamine or methcathinone. Several stimulant-induced mental disorders \\nare recognised. \\nExclusions: Disorders due to use of synthetic cathinones (6C47)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 100, 'page_label': '101'}, page_content='Disorders due to use of caffeine (6C48) \\nDisorders due to use of cocaine (6C45) \\nHazardous use of stimulants including amphetamines or \\nmethamphetamine (QE11.4) \\n \\n6C46.0 Single episode of harmful use of stimulants including amphetamines, \\nmethamphetamine or methcathinone \\nA single episode of use of a stimulant including amphetamines, methamphetamine \\nand methcathinone that has caused damage to a person ’s physical or mental health'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 100, 'page_label': '101'}, page_content='or has resulted in behaviour leading to harm to the health of others. Harm to health \\nof the individual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 100, 'page_label': '101'}, page_content='behavior due to stimulant intoxication on the part of the person to whom the \\ndiagnosis of single episode of harmful use applies. This diagnosis shou ld not be \\nmade if the harm is attributed to a known pattern of stimulant including \\namphetamines, methamphetamine and methcathinone use. \\nExclusions: Harmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1) \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 101, 'page_label': '102'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   101 \\n \\n6C46.1 Harmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone \\nA pattern of use of stimulants including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 101, 'page_label': '102'}, page_content='leading to harm to the health of others. The pattern of stimulant use is evident over \\na period of at least 12 months if substance use is episodic or at least one mon th if \\nuse is continuous. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 101, 'page_label': '102'}, page_content='health of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to stimulant intoxicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of stimulants \\nincluding amphetamines, methamphetamine and methcathinone applies. \\nExclusions: Harmful pattern of use of caffeine (6C48.1) \\nHarmful pattern of use of cocaine (6C45.1) \\nHarmful pattern of use of synthetic cathinones (6C47.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 101, 'page_label': '102'}, page_content='Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2) \\n \\n6C46.10 Harmful pattern of use of stimulants including amphetamines, methamphetamine or \\nmethcathinone, episodic \\nA pattern of episodic or intermittent use of stimulants including amphetamines, \\nmethamphetamine and methcathinone but excluding caffeine, cocaine and synthetic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 101, 'page_label': '102'}, page_content='cathinones that has caused damage to a person ’s physical or mental health or has \\nresulted in behaviour leading to harm to the health of others. The pattern of episodic \\nstimulant use is evident over a period of at least 12 months. Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 101, 'page_label': '102'}, page_content='a harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to stimulant intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of stimulants including amphetamines, \\nmethamphetamine and methcathinone applies. \\nExclusions: Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 101, 'page_label': '102'}, page_content='(6C46.0) \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 102, 'page_label': '103'}, page_content='102  ICD-11 MMS - 2018 \\n \\n6C46.11 Harmful pattern of use of stimulants including amphetamines, methamphetamine or \\nmethcathinone, continuous \\nA pattern of use of stimulants including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour \\nleading to harm to the health of others. The pattern of stimulant use is evident over'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 102, 'page_label': '103'}, page_content='a period of at least 12 months if substance use is episodic or at least one month if \\nuse is continuous (i.e., daily or almost daily). Harm to health of the indiv idual occurs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 102, 'page_label': '103'}, page_content='including trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto stimulant intoxication on the part of the person to whom the diagnosis of Harmful  \\npattern of use of stimulants including amphetamines, methamphetamine and \\nmethcathinone applies. \\nExclusions: Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nStimulant dependence including amphetamines, \\nmethamphetamine or methcathinone (6C46.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 102, 'page_label': '103'}, page_content='6C46.1Z Harmful pattern of use of stimulants including amphetamines, methamphetamine \\nand methcathinone, unspecified \\n \\n6C46.2 Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant dependence including amphetamines, methamphetamine or \\nmethcathinone is a disorder of regulation of stimulant use arising from repeated or \\ncontinuous use of stimulants. The characteristic feature is a strong internal driv e to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 102, 'page_label': '103'}, page_content='use stimulants, which is manifested by impaired ability to control use, inc reasing \\npriority given to use over other activities and persistence of use despite harm or \\nnegative consequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use stimulants. Physiological features of \\ndependence may also be present, including tolerance to the effects of stimulants, \\nwithdrawal symptoms following cessation or reduction in use of stimulants, or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 102, 'page_label': '103'}, page_content='repeated use of stimulants or pharmacologically similar substances to prevent or \\nalleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months but the diagnosis may be made if stimulant us e \\nis continuous (daily or almost daily) for at least 1 month. \\nExclusions: Cocaine dependence (6C45.2) \\nSynthetic cathinone dependence (6C47.2) \\nSingle episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 102, 'page_label': '103'}, page_content='(6C46.0) \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 103, 'page_label': '104'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   103 \\n \\n6C46.20 Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, current use \\nStimulant dependence including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones refers to  \\namphetamine or other stimulant use within the past month. \\nExclusions: Harmful pattern of use of stimulants including amphetamines,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 103, 'page_label': '104'}, page_content='methamphetamine or methcathinone (6C46.1) \\nSingle episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\n \\n6C46.21 Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, early full remission \\nAfter a diagnosis of Stimulant dependence including amphetamines, \\nmethamphetamine and methcathinone but excluding caffeine, cocaine and synthetic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 103, 'page_label': '104'}, page_content='cathinones, and often following a treatment episode or other intervention (incl uding \\nself-help intervention), the individual has been abstinent from stimulants during a \\nperiod lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 103, 'page_label': '104'}, page_content='6C46.22 Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, sustained partial remission \\nAfter a diagnosis of Stimulant dependence including amphetamines, \\nmethamphetamine and methcathinone but excluding caffeine, cocaine and synthetic \\ncathinones, and often following a treatment episode or other intervention (incl uding \\nself-help intervention), there is a significant reduction in amphetamine or ot her'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 103, 'page_label': '104'}, page_content='stimulant consumption for more than 12 months, such that even though \\namphetamine or other stimulant use has occurred during this period, the definitional \\nrequirements for dependence have not been met. \\nExclusions: Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 103, 'page_label': '104'}, page_content='6C46.23 Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, sustained full remission \\nAfter a diagnosis of Stimulant dependence including amphetamines, \\nmethamphetamine and methcathinone but excluding caffeine, cocaine and synthetic \\ncathinones, and often following a treatment episode or other intervention (incl uding \\nself-intervention), the person has been abstinent from amphetamine or othe r \\nstimulants for 12 months or longer.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 103, 'page_label': '104'}, page_content='Exclusions: Single episode of harmful use of stimulants including \\namphetamines, methamphetamine or methcathinone \\n(6C46.0) \\nHarmful pattern of use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 104, 'page_label': '105'}, page_content='104  ICD-11 MMS - 2018 \\n \\n6C46.2Z Stimulant dependence including amphetamines, methamphetamine or \\nmethcathinone, unspecified \\n \\n6C46.3 Stimulant intoxication including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant intoxication including amphetamines, methamphetamine and \\nmethcathinone but excluding caffeine, cocaine and synthetic cathinones is a \\nclinically significant transient condition that develops during or shor tly after the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 104, 'page_label': '105'}, page_content='consumption of amphetamine or other stimulants that is characterized by \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof amphetamine or other stimulants and their intensity is closely related t o the \\namount of amphetamine or other stimulant consumed. They are time-limited and \\nabate as amphetamine or another stimulant is cleared from the body. Presenti ng'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 104, 'page_label': '105'}, page_content='features may include anxiety, anger, impaired attention, hypervigilance, \\npsychomotor agitation, paranoid ideation (often of delusional intensity), audi tory \\nhallucinations, confusion, and changes in sociability. Perspiration or chi lls, nausea \\nor vomiting, and palpitations may be experienced. Physical signs may i nclude \\ntachycardia, elevated blood pressure, pupillary dilatation, dyskinesias and \\ndystonias, and skin sores may be evident. In rare instances, usually in seve re'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 104, 'page_label': '105'}, page_content='intoxication, use of stimulants including amphetamines, methamphetamine and \\nmethcathinone can result in seizures. \\nNote: Code also the underlying condition \\nInclusions: \"Bad trips\" (Stimulants including amphetamines but excluding \\ncaffeine and cocaine) \\nTrance and possession disorders in stimulant intoxication \\nincluding amphetamines but excluding caffeine and \\ncocaine intoxication \\nExclusions: amphetamine poisoning (NE60) \\nCaffeine intoxication (6C48.2) \\nCocaine intoxication (6C45.3)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 104, 'page_label': '105'}, page_content='Synthetic cathinone intoxication (6C47.3) \\nPossession trance disorder (6B63)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 105, 'page_label': '106'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   105 \\n \\n6C46.4 Stimulant withdrawal including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant withdrawal including amphetamines, methamphetamine and \\nmethcathinone is a clinically significant cluster of symptoms, behaviours  and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 105, 'page_label': '106'}, page_content='cessation or reduction of use of stimulants in individuals who have develo ped \\nStimulant dependence or have used stimulants for a prolonged period or in large  \\namounts. Stimulant withdrawal can also occur when prescribed stimulants have \\nbeen used in standard therapeutic doses. Presenting features of stimulant \\nwithdrawal may include dysphoric mood, irritability, fatigue, insomnia or (m ore \\ncommonly) hypersomnia, increased appetite, psychomotor agitation or retardati on,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 105, 'page_label': '106'}, page_content='and craving for amphetamine and related stimulants. \\nNote: Code also the underlying condition \\nExclusions: Cocaine withdrawal (6C45.4) \\nCaffeine withdrawal (6C48.3) \\nSynthetic cathinone withdrawal (6C47.4) \\n \\n6C46.5 Stimulant-induced delirium including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant-induced delirium including amphetamines, methamphetamine and \\nmethcathinone is characterized by an acute state of disturbed attention and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 105, 'page_label': '106'}, page_content='awareness with specific features of delirium that develops during or soon after \\nsubstance intoxication or withdrawal or during the use of stimulants. The amount \\nand duration of stimulants use must be capable of producing delirium. The \\nsymptoms are not better explained by a primary mental disorder, by use of or \\nwithdrawal from a different substance, or by another health condition that is not \\nclassified under Mental, behavioural and neurodevelopmental disorders.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 105, 'page_label': '106'}, page_content='Note: Code also the underlying condition \\nExclusions: Cocaine-induced delirium (6C45.5) \\nSynthetic cathinone-induced delirium (6C47.5) \\nDisorders due to use of caffeine (6C48)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 106, 'page_label': '107'}, page_content='106  ICD-11 MMS - 2018 \\n \\n6C46.6 Stimulant-induced psychotic disorder including amphetamines, \\nmethamphetamine or methcathinone \\nStimulant-induced psychotic disorder including amphetamines, methamphetamine \\nand methcathinone is characterized by psychotic symptoms (e.g., delusions, \\nhallucinations, disorganized thinking, grossly disorganized behaviour) that develop  \\nduring or soon after intoxication or withdrawal due to stimulants. The intensity or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 106, 'page_label': '107'}, page_content='duration of the symptoms is substantially in excess of psychotic-lik e disturbances of \\nperception, cognition, or behaviour that are characteristic of Stimulant intoxication or \\nStimulant withdrawal. The amount and duration of stimulant use must be capable of \\nproducing psychotic symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 106, 'page_label': '107'}, page_content='the stimulant use, if the symptoms persist for a substantial period of time aft er \\ncessation of the stimulant use or withdrawal, or if there is other evidence of a pr e-\\nexisting primary mental disorder with psychotic symptoms (e.g., a history of pri or \\nepisodes not associated with use of stimulants). \\nNote: Code also the underlying condition \\nExclusions: Cocaine-induced psychotic disorder (6C45.6) \\nSynthetic cathinone-induced psychotic disorder (6C47.6)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 106, 'page_label': '107'}, page_content='Disorders due to use of caffeine (6C48) \\n \\n6C46.60 Stimulant-induced psychotic disorder including amphetamines, methamphetamine \\nor methcathinone with hallucinations \\nStimulant-induced psychotic disorder with hallucinations is characterized by  the \\npresence of hallucinations that are judged to be the direct consequence of stimula nt \\nuse. Neither delusions nor other psychotic symptoms are present. The symptoms \\ndo not occur exclusively during hypnogogic or hypnopompic states, are not better'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 106, 'page_label': '107'}, page_content='accounted for by another mental and behavioural disorder (e.g., schizophrenia), and \\nare not due to another disorder or disease classified elsewhere (e.g., epilepsies with \\nvisual symptoms). \\nNote: Code also the underlying condition \\nExclusions: Cocaine-induced psychotic disorder with hallucinations \\n(6C45.60) \\nDisorders due to use of caffeine (6C48) \\nSynthetic cathinone-induced psychotic disorder with \\nhallucinations (6C47.60)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 107, 'page_label': '108'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   107 \\n \\n6C46.61 Stimulant-induced psychotic disorder including amphetamines, methamphetamine \\nor methcathinone with delusions \\nStimulant-induced psychotic disorder including amphetamines, methamphetamine \\nand methcathinone is characterized by psychotic symptoms (e.g., delusions, \\nhallucinations, disorganized thinking, grossly disorganized behaviour) that dev elop'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 107, 'page_label': '108'}, page_content='during or soon after intoxication or withdrawal due to stimulants. The intensity or \\nduration of the symptoms is substantially in excess of psychotic-lik e disturbances of \\nperception, cognition, or behaviour that are characteristic of Stimulant intoxication or  \\nStimulant withdrawal. The amount and duration of stimulant use must be capable of \\nproducing psychotic symptoms. The symptoms are not better explained by a \\nprimary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 107, 'page_label': '108'}, page_content='symptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe stimulant use, if the symptoms persist for a substantial period of time aft er \\ncessation of the stimulant use or withdrawal, or if there is other evidence of a pr e-\\nexisting primary mental disorder with psychotic symptoms (e.g., a history of pri or \\nepisodes not associated with use of stimulants). \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of caffeine (6C48)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 107, 'page_label': '108'}, page_content='Cocaine-induced psychotic disorder with delusions (6C45.61) \\nSynthetic cathinone-induced psychotic disorder with delusions \\n(6C47.61) \\n \\n6C46.62 Stimulant-induced psychotic disorder including amphetamines but excluding \\ncaffeine or cocaine with mixed psychotic symptoms \\nStimulant-induced psychotic disorder with mixed psychotic symptoms is \\ncharacterized by the presence of multiple psychotic symptoms, primarily \\nhallucinations and delusions, when these are judged to be the direct con sequence'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 107, 'page_label': '108'}, page_content='of stimulant use. The symptoms do not occur exclusively during hypnogogic or \\nhypnopompic states, are not better accounted for by another mental and \\nbehavioural disorder (e.g., Schizophrenia), and are not due to another disorder or \\ndisease classified elsewhere (e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\nExclusions: Disorders due to use of caffeine (6C48) \\nCocaine-induced psychotic disorder with mixed psychotic \\nsymptoms (6C45.62)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 107, 'page_label': '108'}, page_content='symptoms (6C45.62) \\nSynthetic cathinone-induced psychotic disorder with mixed \\npsychotic symptoms (6C47.62) \\n \\n6C46.6Z Stimulant-induced psychotic disorder including amphetamines, methamphetamine \\nor methcathinone, unspecified \\nNote: Code also the underlying condition \\n \\n6C46.7 Other stimulant-induced disorders including amphetamines, \\nmethamphetamine or methcathinone \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 108, 'page_label': '109'}, page_content='108  ICD-11 MMS - 2018 \\n \\n6C46.70 Stimulant-induced mood disorder including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant-induced mood disorder including amphetamines, methamphetamine and \\nmethcathinone is characterized by mood symptoms (e.g., depressed or elevated \\nmood, decreased engagement in pleasurable activities, increased or decreased \\nenergy levels) that develop during or soon after intoxication or withdrawal due to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 108, 'page_label': '109'}, page_content='stimulants. The intensity or duration of the symptoms is substantially i n excess of \\nmood disturbances that are characteristic of Stimulant intoxication or Stimulant \\nwithdrawal. The amount and duration of stimulant use must be capable of producing \\nmood symptoms. The symptoms are not better explained by a primary mental \\ndisorder (e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), \\nas might be the case if the mood symptoms preceded the onset of the stimulant'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 108, 'page_label': '109'}, page_content='use, if the symptoms persist for a substantial period of time after cessation of  the \\nstimulant use or withdrawal, or if there is other evidence of a pre-existing primar y \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with use of stimulants). \\nNote: Code also the underlying condition \\nExclusions: Synthetic cathinone-induced mood disorder (6C47.70) \\nCocaine-induced mood disorder (6C45.70) \\nDisorders due to use of caffeine (6C48)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 108, 'page_label': '109'}, page_content='6C46.71 Stimulant-induced anxiety disorder including amphetamines, methamphetamine or \\nmethcathinone \\nStimulant-induced anxiety disorder including amphetamines, methamphetamine and \\nmethcathinone is characterized by anxiety symptoms (e.g., apprehension or worry,  \\nfear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) \\nthat develop during or soon after intoxication or withdrawal due to stimulants. The'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 108, 'page_label': '109'}, page_content='intensity or duration of the symptoms is substantially in excess of anxiety  symptoms \\nthat are characteristic of Stimulant intoxication or Stimulant withdrawal. The am ount \\nand duration of stimulant use must be capable of producing anxiety symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear-related disorder, a Depressive disorder with prominent anxiety symptoms),'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 108, 'page_label': '109'}, page_content='as might be the case if the anxiety symptoms preceded the onset of the stim ulant \\nuse, if the symptoms persist for a substantial period of time after cessation of  the \\nstimulant use or withdrawal, or if there is other evidence of a pre-existing primar y \\nmental disorder with anxiety symptoms (e.g., a history of prior episodes not \\nassociated with use of stimulants). \\nNote: Code also the underlying condition \\nExclusions: Cocaine-induced anxiety disorder (6C45 .71)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 108, 'page_label': '109'}, page_content='Caffeine-induced anxiety disorder (6C48.40) \\nSynthetic cathinone-induced anxiety disorder (6C47.71)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 109, 'page_label': '110'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   109 \\n \\n6C46.72 Stimulant-induced obsessive-compulsive or related disorder including \\namphetamines, methamphetamine or methcathinone \\nStimulant-induced obsessive-compulsive or related disorder including \\namphetamines, methamphetamine and methcathinone is characterized by either \\nrepetitive intrusive thoughts or preoccupations, normally associated with anxiety'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 109, 'page_label': '110'}, page_content='and typically accompanied by repetitive behaviours performed in response, or by \\nrecurrent and habitual actions directed at the integument (e.g., hair pulling, skin \\npicking) that develop during or soon after intoxication with or withdrawal fro m \\nstimulants. The intensity or duration of the symptoms is substantially i n excess of \\nanalogous disturbances that are characteristic of Stimulant intoxication or Stim ulant'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 109, 'page_label': '110'}, page_content='withdrawal. The amount and duration of stimulant use must be capable of producing \\nobsessive-compulsive or related symptoms. The symptoms are not better explain ed \\nby a primary mental disorder (in particular an Obsessive-compulsive or rela ted \\ndisorder), as might be the case if the symptoms preceded the onset of the stimulant \\nuse, if the symptoms persist for a substantial period of time after cessation of  the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 109, 'page_label': '110'}, page_content='stimulant use or withdrawal, or if there is other evidence of a pre-existing primar y \\nmental disorder with obsessive-compulsive or related symptoms (e.g., a history of \\nprior episodes not associated with stimulant use). \\nNote: Code also the underlying condition \\nExclusions: Cocaine-induced obsessive-compulsive or related disorder \\n(6C45.72) \\nSynthetic cathinone-induced obsessive-compulsive or related \\nsyndrome (6C47.72) \\nDisorders due to use of caffeine (6C48)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 109, 'page_label': '110'}, page_content='6C46.73 Stimulant-induced impulse control disorder including amphetamines, \\nmethamphetamine or methcathinone \\nStimulant-induced impulse control disorder including amphetamines, \\nmethamphetamine and methcathinone is characterized by persistently repeat ed \\nbehaviours in which there is recurrent failure to resist an impulse, drive, or urg e to \\nperform an act that is rewarding to the person, at least in the short-term, des pite'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 109, 'page_label': '110'}, page_content='longer-term harm either to the individual or to others (e.g., fire setting or stealing  \\nwithout apparent motive, repetitive sexual behaviour, aggressive outbursts) that \\ndevelop during or soon after intoxication with or withdrawal from stimulants. The  \\nintensity or duration of the symptoms is substantially in excess of di sturbances of \\nimpulse control that are characteristic of Stimulant intoxication or Stimulant'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 109, 'page_label': '110'}, page_content='withdrawal. The amount and duration of stimulant use must be capable of producing \\ndisturbances of impulse control. The symptoms are not better explained by a \\nprimary mental disorder (e.g., an Impulse control disorder, a Disorder due to \\naddictive behaviours), as might be the case if the impulse control disturbances  \\npreceded the onset of the stimulant use, if the symptoms persist for a substantial \\nperiod of time after cessation of the stimulant use or withdrawal, or if there is o ther'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 109, 'page_label': '110'}, page_content='evidence of a pre-existing primary mental disorder with impulse control symptoms \\n(e.g., a history of prior episodes not associated with stimulant use). \\nNote: Code also the underlying condition \\n \\n6C46.Y Other specified disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone \\n \\n6C46.Z Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 110, 'page_label': '111'}, page_content='110  ICD-11 MMS - 2018 \\n \\n  6C47   Disorders due to use of synthetic cathinones \\nDisorders due to use of synthetic cathinones are characterised by the pattern and \\nconsequences of synthetic cathinone use. In addition to Synthetic cathinone \\nintoxication, synthetic cathinones have dependence-inducing properties, res ulting in \\nSynthetic cathinone dependence in some people and Synthetic cathinone \\nwithdrawal when use is reduced or discontinued. Synthetic cathinones are'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 110, 'page_label': '111'}, page_content='implicated in a wide range of harms affecting most organs and systems of the bo dy, \\nwhich may be classified as Single episode of harmful use of synthetic cathinones \\nand Harmful pattern of use of synthetic cathinones. Harm to others resulting from \\nbehaviour during Synthetic cathinone intoxication is included in the def initions of \\nHarmful use of synthetic cathinones. Several synthetic cathinone-induced mental  \\ndisorders are recognised. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 110, 'page_label': '111'}, page_content='6C47.0 Single episode of harmful use of synthetic cathinones \\nA single episode of synthetic cathinone use that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health \\nof others. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 110, 'page_label': '111'}, page_content='health of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behavior due to synthetic cathinone \\nintoxication on the part of the person to whom the diagnosis of single episo de of \\nharmful use applies. This diagnosis should not be made if the harm is attri buted to a \\nknown pattern of synthetic cathinone use. \\nExclusions: Harmful pattern of use of synthetic cathinones (6C47.1) \\nSynthetic cathinone dependence (6C47.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 110, 'page_label': '111'}, page_content='6C47.1 Harmful pattern of use of synthetic cathinones \\nA pattern of use of synthetic cathinones that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health \\nof others. The pattern of synthetic cathinone use is evident over a period of at  least \\n12 months if substance use is episodic or at least one month if use is cont inuous \\n(i.e., daily or almost daily). Harm to health of the individual occurs due to on e or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 110, 'page_label': '111'}, page_content='more of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to synthetic \\ncathinone intoxication on the part of the person to whom the diagnosis of Harm ful \\npattern of use of synthetic cathinones applies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 110, 'page_label': '111'}, page_content='Exclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nSynthetic cathinone dependence (6C47.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 111, 'page_label': '112'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   111 \\n \\n6C47.10 Harmful pattern of use of synthetic cathinones, episodic \\nA pattern of episodic or intermittent use of synthetic cathinones that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of episodic synthetic cathinone use is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 111, 'page_label': '112'}, page_content='evident over a period of at least 12 months. Harm to health of the individual occu rs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 111, 'page_label': '112'}, page_content='to synthetic cathinone intoxication on the part of the person to whom the diagnosis \\nof Harmful pattern of use of synthetic cathinones applies. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nSynthetic cathinone dependence (6C47.2) \\n \\n6C47.11 Harmful use of synthetic cathinones, continuous \\nA pattern of continuous (daily or almost daily) use of synthetic cathinones  that has \\ncaused damage to a person’s physical or mental health or has resulted in behaviour'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 111, 'page_label': '112'}, page_content='leading to harm to the health of others. The pattern of continuous synthetic \\ncathinone use is evident over a period of at least one month. Harm to heal th of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 111, 'page_label': '112'}, page_content='physical harm, including trauma, or mental disorder that is directly attributable to \\nbehaviour related to synthetic cathinone intoxication on the part of the person to \\nwhom the diagnosis of Harmful use of synthetic cathinones applies. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nSynthetic cathinone dependence (6C47.2) \\n \\n6C47.1Y Other specified harmful pattern of use of synthetic cathinones \\n \\n6C47.1Z Harmful pattern of use of synthetic cathinones, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 111, 'page_label': '112'}, page_content='6C47.2 Synthetic cathinone dependence \\nSynthetic cathinone dependence is a disorder of regulation of synthetic cathinone \\nuse arising from repeated or continuous use of synthetic cathinones. The \\ncharacteristic feature is a strong internal drive to use synthetic cathinones, which is  \\nmanifested by impaired ability to control use, increasing priority given to use over \\nother activities and persistence of use despite harm or negative consequences.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 111, 'page_label': '112'}, page_content='These experiences are often accompanied by a subjective sensation of urge or \\ncraving to use synthetic cathinones. Physiological features of dependence may  also \\nbe present, including tolerance to the effects of synthetic cathinones, withdrawal \\nsymptoms following cessation or reduction in use of synthetic cathinones, or \\nrepeated use of synthetic cathinones or pharmacologically similar substances to  \\nprevent or alleviate withdrawal symptoms. The features of dependence are usually'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 111, 'page_label': '112'}, page_content='evident over a period of at least 12 months but the diagnosis may be made if \\nsynthetic cathinone use is continuous (daily or almost daily) for at least 1 month. \\nExclusions: Harmful pattern of use of synthetic cathinones (6C47.1) \\nSingle episode of harmful use of synthetic cathinones (6C47.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 112, 'page_label': '113'}, page_content='112  ICD-11 MMS - 2018 \\n \\n6C47.20 Synthetic cathinone dependence, current use \\nCurrent synthetic cathinone dependence with use of synthetic cathinones withi n the \\npast month. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nHarmful pattern of use of synthetic cathinones (6C47.1) \\n \\n6C47.21 Synthetic cathinone dependence, early full remission \\nAfter a diagnosis of synthetic cathinone dependence, and often following a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 112, 'page_label': '113'}, page_content='treatment episode or other intervention (including self-help intervention), the \\nindividual has been abstinent from synthetic cathinone use during a period las ting \\nfrom between 1 and 12 months. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nHarmful pattern of use of synthetic cathinones (6C47.1) \\n \\n6C47.22 Synthetic cathinone dependence, sustained partial remission \\nAfter a diagnosis of synthetic cathinone dependence, and often following a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 112, 'page_label': '113'}, page_content='treatment episode or other intervention (including self-help intervention), ther e is a \\nsignificant reduction in synthetic cathinone consumption for more than 12 months, \\nsuch that even though synthetic cathinone use has occurred during this period, the  \\ndefinitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nHarmful pattern of use of synthetic cathinones (6C47.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 112, 'page_label': '113'}, page_content='6C47.23 Synthetic cathinone dependence, sustained full remission \\nAfter a diagnosis of synthetic cathinone dependence, and often following a \\ntreatment episode or other intervention (including self-intervention), the person has \\nbeen abstinent from synthetic cathinone use for 12 months or longer. \\nExclusions: Single episode of harmful use of synthetic cathinones (6C47.0) \\nHarmful pattern of use of synthetic cathinones (6C47.1) \\n \\n6C47.2Y Other specified synthetic cathinone dependence'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 112, 'page_label': '113'}, page_content='6C47.2Z Synthetic cathinone dependence, unspecified \\n \\n6C47.3 Synthetic cathinone intoxication \\nSynthetic cathinone intoxication is a clinically significant transient  condition that \\ndevelops during or shortly after the consumption of synthetic cathinones that is  \\ncharacterized by disturbances in consciousness, cognition, perception, affect, \\nbehaviour, or coordination. These disturbances are caused by the known'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 112, 'page_label': '113'}, page_content='pharmacological effects of synthetic cathinones and their intensity is close ly related \\nto the amount of synthetic cathinones consumed. They are time-limited and abate \\nas the synthetic cathinone is cleared from the body. Presenting features may \\ninclude anxiety, anger, hypervigilance, psychomotor agitation, panic, conf usion, \\nparanoid ideation, auditory hallucinations and changes in sociability, p erspiration or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 112, 'page_label': '113'}, page_content='chills, and nausea or vomiting. Physical signs may include tachycardia, el evated \\nblood pressure, pupillary dilatation, and hyperthermia. In rare instances, usually in \\nsevere intoxication, use of synthetic cathinones can result in seizures. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 113, 'page_label': '114'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   113 \\n \\n6C47.4 Synthetic cathinone withdrawal \\nSynthetic cathinone withdrawal is a clinically significant cluster of sy mptoms, \\nbehaviours and/or physiological features, varying in degree of severity and durati on, \\nthat occurs upon cessation or reduction of use of synthetic cathinones in individu als \\nwho have developed Synthetic cathinone dependence or have used synthetic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 113, 'page_label': '114'}, page_content='cathinones for a prolonged period or in large amounts. Presenting features of \\nSynthetic cathinone withdrawal may include dysphoric mood, irritabil ity, fatigue, \\ninsomnia or hypersomnia, increased appetite, anxiety, and craving for stimulants, \\nincluding cathinones. \\nNote: Code also the underlying condition \\n \\n6C47.5 Synthetic cathinone-induced delirium \\nSynthetic cathinone-induced delirium is characterized by an acute state of di sturbed'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 113, 'page_label': '114'}, page_content='attention and awareness with specific features of delirium that develops during or \\nsoon after substance intoxication or withdrawal or during the use of synthetic \\ncathinones. The amount and duration of synthetic cathinone use must be capable of \\nproducing delirium. The symptoms are not better explained by a primary mental \\ndisorder, by use of or withdrawal from a different substance, or by another health \\ncondition that is not classified under Mental, behavioural and neurodevelopmental'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 113, 'page_label': '114'}, page_content='disorders. \\nNote: Code also the underlying condition \\n \\n6C47.6 Synthetic cathinone-induced psychotic disorder \\nSynthetic cathinone-induced psychotic disorder is characterized by psychotic \\nsymptoms (e.g., delusions, hallucinations, disorganized thinking, grossly \\ndisorganized behaviour) that develop during or soon after intoxication with or \\nwithdrawal from synthetic cathinones. The intensity or duration of the sy mptoms is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 113, 'page_label': '114'}, page_content='substantially in excess of psychotic-like disturbances of perception, cognit ion, or \\nbehaviour that are characteristic of Synthetic cathinone intoxication or Synthetic \\ncathinone withdrawal. The amount and duration of synthetic cathinone use must be \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 113, 'page_label': '114'}, page_content='the synthetic cathinone use, if the symptoms persist for a substantial period of time \\nafter cessation of the synthetic cathinone use or withdrawal, or if there is o ther \\nevidence of a pre-existing primary mental disorder with psychotic symptoms (e.g ., a \\nhistory of prior episodes not associated with synthetic cathinone use). \\nNote: Code also the underlying condition \\n \\n6C47.60 Synthetic cathinone-induced psychotic disorder with hallucinations'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 113, 'page_label': '114'}, page_content='Synthetic cathinone-induced psychotic disorder with hallucinations is characteriz ed \\nby the presence of hallucinations that are judged to be the direct consequenc e of \\nsynthetic cathinone use. Neither delusions nor other psychotic symptoms are \\npresent. The symptoms do not occur exclusively during hypnogogic or hypnopompic \\nstates, are not better accounted for by another mental and behavioural disorder \\n(e.g., schizophrenia), and are not due to another disorder or disease classified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 113, 'page_label': '114'}, page_content='elsewhere (e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 114, 'page_label': '115'}, page_content='114  ICD-11 MMS - 2018 \\n \\n6C47.61 Synthetic cathinone-induced psychotic disorder with delusions \\nSynthetic cathinone psychotic disorder with delusions is characterized by the \\npresence of delusions that are judged to be the direct consequence of syntheti c \\ncathinone use. Neither hallucinations nor other psychotic symptoms are present. \\nThe symptoms do not occur exclusively during hypnogogic or hypnopompic states , \\nare not better accounted for by another mental and behavioural disorder (e.g.,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 114, 'page_label': '115'}, page_content='schizophrenia), and are not due to another disorder or disease classified elsewh ere \\n(e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C47.62 Synthetic cathinone-induced psychotic disorder with mixed psychotic symptoms  \\nSynthetic cathinone-induced psychotic disorder with mixed psychotic sy mptoms is \\ncharacterized by the presence of multiple psychotic symptoms, primarily \\nhallucinations and delusions, when these are judged to be the direct con sequence'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 114, 'page_label': '115'}, page_content='of synthetic cathinone use. The symptoms do not occur exclusively during \\nhypnogogic or hypnopompic states, are not better accounted for by another mental \\nand behavioural disorder (e.g., Schizophrenia), and are not due to another disorder \\nor disease classified elsewhere (e.g., epilepsies with visual symptoms). \\nNote: Code also the underlying condition \\n \\n6C47.6Z Synthetic cathinone-induced psychotic disorder, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 114, 'page_label': '115'}, page_content='6C47.7 Other synthetic cathinones-induced disorders \\nNote: Code also the underlying condition \\n \\n6C47.70 Synthetic cathinone-induced mood disorder \\nSynthetic cathinone-induced mood disorder is characterized by mood sympto ms \\n(e.g., depressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after into xication \\nwith or withdrawal from synthetic cathinones. The intensity or duration of the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 114, 'page_label': '115'}, page_content='symptoms is substantially in excess of mood disturbances that are characteristic of \\nSynthetic cathinone intoxication or Synthetic cathinone withdrawal. The amount and \\nduration of synthetic cathinone use must be capable of producing mood symptoms. \\nThe symptoms are not better explained by a primary mental disorder (e.g., a \\nDepressive disorder, a Bipolar disorder, Schizoaffective disorder), as might be the  \\ncase if the mood symptoms preceded the onset of the synthetic cathinone use, if'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 114, 'page_label': '115'}, page_content='the symptoms persist for a substantial period of time after cessation of the synt hetic \\ncathinone use or withdrawal, or if there is other evidence of a pre-existing primary \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with synthetic cathinone use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 115, 'page_label': '116'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   115 \\n \\n6C47.71 Synthetic cathinone-induced anxiety disorder \\nSynthetic cathinone-induced anxiety disorder is characterized by anxiety symptoms \\n(e.g., apprehension or worry, fear, physiological symptoms of excessive auto nomic \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from synthetic cathinones. The intensity or duration of the sy mptoms is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 115, 'page_label': '116'}, page_content='substantially in excess of anxiety symptoms that are characteristic of Sy nthetic \\ncathinone intoxication or Synthetic cathinone withdrawal. The amount and durati on \\nof synthetic cathinone use must be capable of producing anxiety symptoms. T he \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear-related disorder, a Depressive disorder with prominent anxiety symptoms), \\nas might be the case if the anxiety symptoms preceded the onset of the synthe tic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 115, 'page_label': '116'}, page_content='cathinone use, if the symptoms persist for a substantial period of time after \\ncessation of the synthetic cathinone use or withdrawal, or if there is other evidenc e \\nof a pre-existing primary mental disorder with anxiety symptoms (e.g., a histor y of \\nprior episodes not associated with synthetic cathinone use). \\nNote: Code also the underlying condition \\n \\n6C47.72 Synthetic cathinone-induced obsessive-compulsive or related syndrome'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 115, 'page_label': '116'}, page_content='Synthetic cathinone-induced obsessi ve-compulsive or related disorder is \\ncharacterized by either repetitive intrusive thoughts or preoccupations, normally \\nassociated with anxiety and typically accompanied by repetitive behaviours \\nperformed in response, or by recurrent and habitual actions directed at the \\nintegument (e.g., hair pulling, skin picking) that develop during or soon after \\nintoxication with or withdrawal from synthetic cathinones. The intensity or duration'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 115, 'page_label': '116'}, page_content='of the symptoms is substantially in excess of analogous disturbances that are  \\ncharacteristic of Synthetic cathinone intoxication or Synthetic cathinone withdrawal. \\nThe amount and duration of synthetic cathinone use must be capable of producing \\nobsessive-compulsive or related symptoms. The symptoms are not better explain ed \\nby a primary mental disorder (in particular an Obsessive-compulsive or rela ted \\ndisorder), as might be the case if the symptoms preceded the onset of the synthetic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 115, 'page_label': '116'}, page_content='cathinone use, if the symptoms persist for a substantial period of time after \\ncessation of the synthetic cathinone use or withdrawal, or if there is other eviden ce \\nof a pre-existing primary mental disorder with obsessive-compulsive or related  \\nsymptoms (e.g., a history of prior episodes not associated with synthetic cathino ne \\nuse). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 116, 'page_label': '117'}, page_content='116  ICD-11 MMS - 2018 \\n \\n6C47.73 Synthetic cathinone-induced impulse control disorder \\nSynthetic cathinone-induced impulse control disorder is characterized by \\npersistently repeated behaviours in which there is recurrent failure to resist an \\nimpulse, drive, or urge to perform an act that is rewarding to the person, at least in \\nthe short-term, despite longer-term harm either to the individual or to others  (e.g., \\nfire setting or stealing without apparent motive, repetitive sexual behaviour,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 116, 'page_label': '117'}, page_content='aggressive outbursts) that develop during or soon after intoxication with or \\nwithdrawal from synthetic cathinones. The intensity or duration of the sy mptoms is \\nsubstantially in excess of disturbances of impulse control that are characteristic o f \\nSynthetic cathinone intoxication or Synthetic cathinone withdrawal. The amount and \\nduration of synthetic cathinone use must be capable of producing disturbances of \\nimpulse control. The symptoms are not better explained by a primary mental'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 116, 'page_label': '117'}, page_content='disorder (e.g., an Impulse control disorder, a Disorder due to addictive behaviours), \\nas might be the case if the impulse control disturbances preceded the onset of the  \\nsynthetic cathinone use, if the symptoms persist for a substantial period of time after \\ncessation of the synthetic cathinone use or withdrawal, or if there is other evidenc e \\nof a pre-existing primary mental disorder with impulse control symptoms (e.g., a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 116, 'page_label': '117'}, page_content='history of prior episodes not associated with synthetic cathinone use). \\nNote: Code also the underlying condition \\n \\n6C47.Y Other specified disorders due to use of synthetic cathinones \\nNote: Code also the underlying condition \\n \\n6C47.Z Disorders due to use of synthetic cathinones, unspecified \\nNote: Code also the underlying condition \\n \\n  6C48   Disorders due to use of caffeine \\nDisorders due to use of caffeine are characterised by the pattern and consequences'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 116, 'page_label': '117'}, page_content='of caffeine use. In addition to Caffeine intoxication, Caffeine withdrawal may oc cur \\nupon cessation or reduction of use of caffeine in individuals who have used caffei ne \\nfor a prolonged period or in large amounts. Caffeine is implicated in harms affecti ng \\norgans and systems of the body, which may be classified as Single episode  of \\nharmful use of caffeine and Harmful pattern of use of caffeine. Caffeine-induced \\nanxiety disorder and caffeine-induced sleep-wake disorder are recognised.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 116, 'page_label': '117'}, page_content='Note: Code also the underlying condition \\nExclusions: Disorders due to use of stimulants including amphetamines, \\nmethamphetamine or methcathinone (6C46) \\nHazardous use of caffeine (QE11.5) \\n \\n6C48.0 Single episode of harmful use of caffeine \\nA single episode of caffeine use that has caused damage to a person ’s physical or \\nmental health. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) direct or secondary toxic effects on body organs and systems; or (2) a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 116, 'page_label': '117'}, page_content='harmful route of administration. This diagnosis should not be made if the harm is \\nattributed to a known pattern of caffeine use. \\nExclusions: Harmful pattern of use of caffeine (6C48.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 117, 'page_label': '118'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   117 \\n \\n6C48.1 Harmful pattern of use of caffeine \\nA pattern of caffeine use that has caused clinically significant harm to a person ’s \\nphysical or mental health or in which caffeine-induced behaviour has caus ed \\nclinically significant harm to the health of other people. The pattern of caffeine use is \\nevident over a period of at least 12 months if use is episodic and at least  one month'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 117, 'page_label': '118'}, page_content='if use is continuous (i.e., daily or almost daily). Harm may be caused  by the \\nintoxicating effects of caffeine, the direct or secondary toxic effects on body orga ns \\nand systems, or a harmful route of administration. \\nExclusions: Single episode of harmful use of caffeine (6C48.0) \\n \\n6C48.10 Harmful pattern of use of caffeine, episodic \\nA pattern of episodic or intermittent caffeine use that has caused damage to a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 117, 'page_label': '118'}, page_content='person’s physical or mental health. The pattern of episodic caffeine use is ev ident \\nover a period of at least 12 months. Harm to health of the individual occurs due to \\none or more of the following: (1) direct or secondary toxic effects on body organs  \\nand systems; or (2) a harmful route of administration. \\nExclusions: Single episode of harmful use of caffeine (6C48.0) \\n \\n6C48.11 Harmful pattern of use of caffeine, continuous'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 117, 'page_label': '118'}, page_content='A pattern of continuous (daily or almost daily) caffeine use that has caus ed damage \\nto a person ’s physical or mental health. The pattern of continuous caffeine use is \\nevident over a period of at least one month. Harm to health of the individual occurs  \\ndue to one or more of the following: (1) direct or secondary toxic effects on  body \\norgans and systems; or (2) a harmful route of administration. \\nExclusions: Single episode of harmful use of caffeine (6C48.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 117, 'page_label': '118'}, page_content='6C48.1Z Harmful pattern of use of caffeine, unspecified \\n \\n6C48.2 Caffeine intoxication \\nCaffeine intoxication is a clinically significant transient conditi on that develops \\nduring or shortly after the consumption of caffeine that is characterized by \\ndisturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 117, 'page_label': '118'}, page_content='of caffeine and their intensity is closely related to the amount of caffeine  consumed. \\nThey are time-limited and abate as caffeine is cleared from the body. Presen ting \\nfeatures may include restlessness, anxiety, excitement, insomnia, flushed face, \\ndiuresis, gastrointestinal disturbances, muscle twitching, psychomotor agitation, \\nperspiration or chills, and nausea or vomiting. Panic attacks may occur.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 117, 'page_label': '118'}, page_content='Disturbances typical of intoxication tend to occur at relatively higher doses ( e.g., > 1 \\ng per day). Very high doses of caffeine (e.g., > 5 g) can result in r espiratory distress \\nor seizures and can be fatal. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 118, 'page_label': '119'}, page_content='118  ICD-11 MMS - 2018 \\n \\n6C48.3 Caffeine withdrawal \\nCaffeine withdrawal is a clinically significant cluster of symptoms, behav iours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon \\ncessation or reduction of use of caffeine (typically in the form of coffee, c affeinated \\ndrinks, or as an ingredient in certain over- the-counter medications) in individuals \\nwho have used caffeine for a prolonged period or in large amounts. Presenting'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 118, 'page_label': '119'}, page_content='features of Caffeine withdrawal may include headache, fatigue or drowsiness, \\nanxiety, dysphoric mood, nausea or vomiting, and difficulty concentrating. \\nNote: Code also the underlying condition \\n \\n6C48.4 Caffeine-induced disorders \\nNote: Code also the underlying condition \\n \\n6C48.40 Caffeine-induced anxiety disorder \\nCaffeine-induced anxiety disorder is characterized by anxiety symptoms (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 118, 'page_label': '119'}, page_content='arousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from caffeine. The intensity or duration of the symptoms is s ubstantially \\nin excess of anxiety symptoms that are characteristic of Caffeine intoxication or \\nCaffeine withdrawal. The amount and duration of caffeine use must be capable of \\nproducing anxiety symptoms. The symptoms are not better explained by a primary'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 118, 'page_label': '119'}, page_content='mental disorder (e.g., an Anxiety and fear-related disorder, a Depressive disorder \\nwith prominent anxiety symptoms), as might be the case if the anxiety symptom s \\npreceded the onset of the caffeine use, if the symptoms persist for a subs tantial \\nperiod of time after cessation of the caffeine use or withdrawal, or if there is ot her \\nevidence of a pre-existing primary mental disorder with anxiety symptoms (e.g., a \\nhistory of prior episodes not associated with caffeine use).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 118, 'page_label': '119'}, page_content='Note: Code also the underlying condition \\n \\n6C48.Y Other specified disorders due to use of caffeine \\nNote: Code also the underlying condition \\n \\n6C48.Z Disorders due to use of caffeine, unspecified \\nNote: Code also the underlying condition \\n \\n  6C49   Disorders due to use of hallucinogens \\nDisorders due to use of hallucinogens are characterised by the pattern and \\nconsequences of hallucinogen use. In addition to Hallucinogen intoxication,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 118, 'page_label': '119'}, page_content='hallucinogens have dependence-inducing properties, resulting in Hallucinogen \\ndependence in some people. Hallucinogens are implicated in a wide range of harms \\naffecting most organs and systems of the body, which may be classified as Si ngle \\nepisode of harmful use of hallucinogens and Harmful pattern of use of \\nhallucinogens. Harm to others resulting from behaviour during Hallucinog en \\nintoxication is included in the definitions of Harmful use of hallucinog ens. Several'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 118, 'page_label': '119'}, page_content='hallucinogen-induced mental disorders are recognised. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 119, 'page_label': '120'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   119 \\n \\n6C49.0 Single episode of harmful use of hallucinogens \\nA single episode of hallucinogen use that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health \\nof others. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 119, 'page_label': '120'}, page_content='on body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behavior due to hallucinogen intoxicati on on \\nthe part of the person to whom the diagnosis of single episode of harmful use \\napplies. This diagnosis should not be made if the harm is attributed to a known \\npattern of hallucinogen use. \\nExclusions: Hallucinogen dependence (6C49.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 119, 'page_label': '120'}, page_content='Harmful pattern of use of hallucinogens (6C49.1) \\n \\n6C49.1 Harmful pattern of use of hallucinogens \\nA pattern of use of hallucinogens that has caused damage to a person ’s physical or \\nmental health or has resulted in behaviour leading to harm to the health of other s. \\nThe pattern of hallucinogen use is evident over a period of at least 12 months  if \\nsubstance use is episodic or at least one month if use is continuous (i.e., dai ly or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 119, 'page_label': '120'}, page_content='almost daily). Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental \\ndisorder that is directly attributable to behaviour related to hallucinogen intox ication'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 119, 'page_label': '120'}, page_content='on the part of the person to whom the diagnosis of Harmful pattern of use of \\nhallucinogens applies. \\nExclusions: Hallucinogen dependence (6C49.2) \\nSingle episode of harmful use of hallucinogens (6C49.0) \\n \\n6C49.10 Harmful pattern of use of hallucinogens, episodic \\nA pattern of episodic or intermittent use of hallucinogens that has caused damage \\nto a person’s physical or mental health or has resulted in behaviour leading to harm'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 119, 'page_label': '120'}, page_content='to the health of others. The pattern of episodic hallucinogen use is evident over a \\nperiod of at least 12 months. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trau ma, or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 119, 'page_label': '120'}, page_content='mental disorder that is directly attributable to behaviour related to hallucinogen \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern  of \\nuse of hallucinogens applies. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHallucinogen dependence (6C49.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 120, 'page_label': '121'}, page_content='120  ICD-11 MMS - 2018 \\n \\n6C49.11 Harmful pattern of use of hallucinogens, continuous \\nA pattern of continuous (daily or almost daily) use of hallucinogens that has  caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous hallucinogen use is \\nevident over a period of at least one month. Harm to health of the individual occurs'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 120, 'page_label': '121'}, page_content='due to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour re lated \\nto hallucinogen intoxication on the part of the person to whom the diagnosis of \\nHarmful use of hallucinogens applies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 120, 'page_label': '121'}, page_content='Exclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHallucinogen dependence (6C49.2) \\n \\n6C49.1Z Harmful pattern of use of hallucinogens, unspecified \\n \\n6C49.2 Hallucinogen dependence \\nHallucinogen dependence is a disorder of regulation of hallucinogen use aris ing \\nfrom repeated or continuous use of hallucinogens. The characteristic fea ture is a \\nstrong internal drive to use hallucinogens, which is manifested by impaired ab ility to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 120, 'page_label': '121'}, page_content='control use, increasing priority given to use over other activities and persis tence of \\nuse despite harm or negative consequences. These experiences are often \\naccompanied by a subjective sensation of urge or craving to use hallucinogens. The  \\nfeatures of dependence are usually evident over a period of at least 12 months but \\nthe diagnosis may be made if hallucinogens use is continuous (daily or almost daily) \\nfor at least 1 month.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 120, 'page_label': '121'}, page_content='Exclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHarmful pattern of use of hallucinogens (6C49.1) \\n \\n6C49.20 Hallucinogen dependence, current use \\nCurrent hallucinogen dependence with hallucinogen use within the past month. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHarmful pattern of use of hallucinogens (6C49.1) \\n \\n6C49.21 Hallucinogen dependence, early full remission \\nAfter a diagnosis of Hallucinogen dependence, and often following a treatment'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 120, 'page_label': '121'}, page_content='episode or other intervention (including self-help intervention), the ind ividual has \\nbeen abstinent from hallucinogens during a period lasting from betwe en 1 and 12 \\nmonths. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHarmful pattern of use of hallucinogens (6C49.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 121, 'page_label': '122'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   121 \\n \\n6C49.22 Hallucinogen dependence, sustained partial remission \\nAfter a diagnosis of Hallucinogen dependence, and often following a treatment \\nepisode or other intervention (including self-help intervention), there is a  significant \\nreduction in hallucinogen consumption for more than 12 months, such that even'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 121, 'page_label': '122'}, page_content='though intermittent or continuing hallucinogen use has occurred during this period,  \\nthe definitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHarmful pattern of use of hallucinogens (6C49.1) \\n \\n6C49.23 Hallucinogen dependence, sustained full remission \\nAfter a diagnosis of Hallucinogen dependence, and often following a treatment \\nepisode or other intervention (including self-intervention), the person has  been'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 121, 'page_label': '122'}, page_content='abstinent from hallucinogens for 12 months or longer. \\nExclusions: Single episode of harmful use of hallucinogens (6C49.0) \\nHarmful pattern of use of hallucinogens (6C49.1) \\n \\n6C49.2Z Hallucinogen dependence, unspecified \\n \\n6C49.3 Hallucinogen intoxication \\nHallucinogen intoxication is a clinically significant transient conditio n that develops \\nduring or shortly after the consumption of hallucinogens that is characterized b y'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 121, 'page_label': '122'}, page_content='disturbances in consciousness, cognition, perception, affect, behaviour, or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof hallucinogens and their intensity is closely related to the amount of hal lucinogen \\nconsumed. They are time-limited and abate as the hallucinogen is cleared from the \\nbody. Presenting features may include hallucinations, illusions, perceptual  changes \\n(such as depersonalization, derealization, synesthesias (blending of senses, su ch'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 121, 'page_label': '122'}, page_content='as a visual stimulus evoking a smell), anxiety or depression, ideas of reference, \\nparanoid ideation, impaired judgment, palpitations, sweating, blurred vision, tremors  \\nand incoordination. Physical signs may include tachycardia, elevated blood \\npressure, and pupillary dilatation. In rare instances, hallucinogen intoxication may  \\nincrease suicidal behaviour. \\nNote: Code also the underlying condition \\nExclusions: hallucinogens poisoning (NE60) \\nPossession trance disorder (6B63)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 121, 'page_label': '122'}, page_content='6C49.4 Hallucinogen-induced delirium \\nHallucinogen-induced delirium is characterized by an acute state of disturbed  \\nattention and awareness with specific features of delirium that develops during or \\nsoon after substance intoxication or during the use of hallucinogens. The amount \\nand duration of hallucinogen use must be capable of producing delirium. The \\nsymptoms are not better explained by a primary mental disorder, by use of or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 121, 'page_label': '122'}, page_content='withdrawal from a different substance, or by another health condition that is not \\nclassified under Mental, behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 122, 'page_label': '123'}, page_content='122  ICD-11 MMS - 2018 \\n \\n6C49.5 Hallucinogen-induced psychotic disorder \\nHallucinogen-induced psychotic disorder is characterized by psychotic sym ptoms \\n(e.g., delusions, hallucinations, disorganized thinking, grossly disorganized \\nbehaviour) that develop during or soon after intoxication with hallucinogens. The \\nintensity or duration of the symptoms is substantially in excess of psy chotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 122, 'page_label': '123'}, page_content='hallucinogen intoxication. The amount and duration of hallucinogen use must be  \\ncapable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe hallucinogen use, if the symptoms persist for a substantial period of time after \\ncessation of the hallucinogen use, or if there is other evidence of a pre-exi sting'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 122, 'page_label': '123'}, page_content='primary mental disorder with psychotic symptoms (e.g., a history of prior episodes \\nnot associated with hallucinogen use). \\nNote: Code also the underlying condition \\nExclusions: Psychotic disorder induced by other specified psychoactive \\nsubstance (6C4E.6) \\nAlcohol-induced psychotic disorder (6C40.6) \\n \\n6C49.6 Other hallucinogen-induced disorders \\nNote: Code also the underlying condition \\n \\n6C49.60 Hallucinogen-induced mood disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 122, 'page_label': '123'}, page_content='Hallucinogen-induced mood disorder is characterized by mood symptoms (e.g., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intoxi cation \\nwith hallucinogens. The intensity or duration of the symptoms is substant ially in \\nexcess of mood disturbances that are characteristic of hallucinogen intoxication. \\nThe amount and duration of hallucinogen use must be capable of producing mood'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 122, 'page_label': '123'}, page_content='symptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g., a Depressive disorder, a Bipolar disorder, Schizoaffective disorder), as migh t \\nbe the case if the mood symptoms preceded the onset of the hallucinogen use, if \\nthe symptoms persist for a substantial period of time after cessation of the \\nhallucinogen use, or if there is other evidence of a pre-existing primary mental \\ndisorder with mood symptoms (e.g., a history of prior episodes not associated with'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 122, 'page_label': '123'}, page_content='hallucinogen use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 123, 'page_label': '124'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   123 \\n \\n6C49.61 Hallucinogen-induced anxiety disorder \\nHallucinogen-induced anxiety disorder is characterized by anxiety symptoms  (e.g., \\napprehension or worry, fear, physiological symptoms of excessive autonomic  \\narousal, avoidance behaviour) that develop during or soon after intoxication with \\nhallucinogens. The intensity or duration of the symptoms is substantially i n excess'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 123, 'page_label': '124'}, page_content='of anxiety symptoms that are characteristic of hallucinogen intoxication. The amou nt \\nand duration of hallucinogen use must be capable of producing anxiety symptoms. \\nThe symptoms are not better explained by a primary mental disorder (e.g., an \\nAnxiety and Fear-Related Disorder, a Depressive Disorder with prominent anxiety \\nsymptoms), as might be the case if the anxiety symptoms preceded the onset of the \\nhallucinogen use, if the symptoms persist for a substantial period of time aft er'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 123, 'page_label': '124'}, page_content='cessation of the hallucinogen use, or if there is other evidence of a pre-exi sting \\nprimary mental disorder with anxiety symptoms (e.g., a history of prior episodes not  \\nassociated with hallucinogen use). \\nNote: Code also the underlying condition \\n \\n6C49.Y Other specified disorders due to use of hallucinogens \\nNote: Code also the underlying condition \\n \\n6C49.Z Disorders due to use of hallucinogens, unspecified \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 123, 'page_label': '124'}, page_content='6C4A   Disorders due to use of nicotine \\nDisorders due to use of nicotine are characterised by the pattern and consequences \\nof nicotine use. In addition to Nicotine intoxication, nicotine has dependence-\\ninducing properties, resulting in Nicotine dependence in some people and Nicotine  \\nwithdrawal when use is reduced or discontinued. Nicotine is implicated in a wide \\nrange of harms affecting most organs and systems of the body, which may be'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 123, 'page_label': '124'}, page_content='classified as Single episode of harmful use of nicotine and Harmful pattern of use of \\nnicotine. Nicotine-induced sleep-wake disorder is recognised. \\nNote: Code also the underlying condition \\n \\n6C4A.0 Single episode of harmful use of nicotine \\nA single episode of nicotine use that has caused damage to a person ’s physical or \\nmental health. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) direct or secondary toxic effects on body organs and systems; or (2) a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 123, 'page_label': '124'}, page_content='harmful route of administration. This diagnosis should not be made if the harm is \\nattributed to a known pattern of nicotine use. \\nExclusions: Nicotine dependence (6C4A.2) \\nHarmful pattern of use of nicotine (6C4A.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 124, 'page_label': '125'}, page_content='124  ICD-11 MMS - 2018 \\n \\n6C4A.1 Harmful pattern of use of nicotine \\nA pattern of nicotine use that has caused damage to a person ’s physical or mental \\nhealth. The pattern of nicotine use is evident over a period of at least 12 months if \\nsubstance use is episodic or at least one month if use is continuous (i.e., dai ly or \\nalmost daily). Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) direct or secondary toxic effects on body organs and systems; or (2) a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 124, 'page_label': '125'}, page_content='harmful route of administration. \\nExclusions: Nicotine dependence (6C4A.2) \\nSingle episode of harmful use of nicotine (6C4A.0) \\n \\n6C4A.10 Harmful pattern of use of nicotine, episodic \\nA pattern of episodic or intermittent nicotine use that has caused damage to a \\nperson’s physical or mental health. The pattern of episodic nicotine use is evi dent \\nover a period of at least 12 months. Harm to health of the individual occurs due to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 124, 'page_label': '125'}, page_content='one or more of the following: (1) direct or secondary toxic effects on body organs \\nand systems; or (2) a harmful route of administration. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nNicotine dependence (6C4A.2) \\n \\n6C4A.11 Harmful pattern of use of nicotine, continuous \\nA pattern of continuous (daily or almost daily) nicotine use that has caus ed damage \\nto a person ’s physical or mental health. The pattern of continuous nicotine use is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 124, 'page_label': '125'}, page_content='evident over a period of at least one month. Harm to health of the individual occurs  \\ndue to one or more of the following: (1) direct or secondary toxic effects on  body \\norgans and systems; or (2) a harmful route of administration. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nNicotine dependence (6C4A.2) \\n \\n6C4A.1Z Harmful pattern of use of nicotine, unspecified \\n \\n6C4A.2 Nicotine dependence \\nNicotine dependence is a disorder of regulation of nicotine use arising from'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 124, 'page_label': '125'}, page_content='repeated or continuous use of nicotine. The characteristic feature is a strong \\ninternal drive to use nicotine, which is manifested by impaired ability to control use, \\nincreasing priority given to use over other activities and persistence of use despite  \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use nicotine. Physiological f eatures of \\ndependence may also be present, including tolerance to the effects of nicotine,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 124, 'page_label': '125'}, page_content='withdrawal symptoms following cessation or reduction in use of nicotine, or \\nrepeated use of nicotine or pharmacologically similar substances to prevent or \\nalleviate withdrawal symptoms. The features of dependence are usually evident \\nover a period of at least 12 months. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nHarmful pattern of use of nicotine (6C4A.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 125, 'page_label': '126'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   125 \\n \\n6C4A.20 Nicotine dependence, current use \\nCurrent nicotine dependence with nicotine use within the past month. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nHarmful pattern of use of nicotine (6C4A.1) \\n \\n6C4A.21 Nicotine dependence, early full remission \\nAfter a diagnosis of nicotine dependence, and often following a treatment episode'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 125, 'page_label': '126'}, page_content='or other intervention (including self-help intervention), the individual has been  \\nabstinent from nicotine during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nHarmful pattern of use of nicotine (6C4A.1) \\n \\n6C4A.22 Nicotine dependence, sustained partial remission \\nAfter a diagnosis of nicotine dependence, and often following a treatment episode'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 125, 'page_label': '126'}, page_content='or other intervention (including self-help intervention), there is a signific ant reduction \\nin nicotine consumption for more than 12 months, such that even though \\nintermittent or continuing nicotine use has occurred during this period, the \\ndefinitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nHarmful pattern of use of nicotine (6C4A.1) \\n \\n6C4A.23 Nicotine dependence, sustained full remission'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 125, 'page_label': '126'}, page_content='After a diagnosis of nicotine dependence, and often following a treatment episode  \\nor other intervention (including self-intervention), the person has been abs tinent \\nfrom nicotine for 12 months or longer. \\nExclusions: Single episode of harmful use of nicotine (6C4A.0) \\nHarmful pattern of use of nicotine (6C4A.1) \\n \\n6C4A.2Z Nicotine dependence, unspecified \\n \\n6C4A.3 Nicotine intoxication \\nNicotine intoxication is a clinically significant transient condition that de velops during'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 125, 'page_label': '126'}, page_content='or shortly after the consumption of nicotine that is characterized by disturbances in \\nconsciousness, cognition, perception, affect, behaviour, or coordination. These \\ndisturbances are caused by the known pharmacological effects of nicotine and their \\nintensity is closely related to the amount of nicotine consumed. They are ti me-\\nlimited and abate as nicotine is cleared from the body. Presenting fea tures may \\ninclude restlessness, psychomotor agitation, anxiety, cold sweats, head ache,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 125, 'page_label': '126'}, page_content='insomnia, palpitations, paresthesias, nausea or vomiting, abdominal cramps, \\nconfusion, bizarre dreams, burning sensations in the mouth, and salivation. In rare \\ninstances, paranoid ideation, perceptual disturbances, convulsions or coma and \\nmay occur. Nicotine intoxication occurs most commonly in naïve (non-tolerant) \\nusers or among those taking higher than accustomed doses. \\nNote: Code also the underlying condition \\nInclusions: \"Bad trips\" (nicotine)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 125, 'page_label': '126'}, page_content='Exclusions: intoxication meaning poisoning (NE61) \\nPossession trance disorder (6B63)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 126, 'page_label': '127'}, page_content='126  ICD-11 MMS - 2018 \\n \\n6C4A.4 Nicotine withdrawal \\nNicotine withdrawal is a clinically significant cluster of symptoms, behavi ours and/or \\nphysiological features, varying in degree of severity and duration, that occurs upon  \\ncessation or reduction of use of nicotine (typically used as a constituent of  tobacco) \\nin individuals who have developed Nicotine dependence or have used nicotine  for a \\nprolonged period or in large amounts. Presenting features of Nicotine withdrawal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 126, 'page_label': '127'}, page_content='may include dysphoric or depressed mood, insomnia, irritability, frustration, anger, \\nanxiety, difficulty concentrating, restlessness, bradycardia, increased appet ite, and \\nweight gain and craving for tobacco (or other nicotine-containing products). Other \\nphysical symptoms may include increased cough and mouth ulceration. \\nNote: Code also the underlying condition \\n \\n6C4A.Y Other specified disorders due to use of nicotine \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 126, 'page_label': '127'}, page_content='6C4A.Z Disorders due to use of nicotine, unspecified \\nNote: Code also the underlying condition \\n \\n  6C4B   Disorders due to use of volatile inhalants \\nDisorders due to use of volatile inhalants are characterised by the pattern and \\nconsequences of volatile inhalant use. In addition to Volatile inhalant intoxication, \\nvolatile inhalants have dependence-inducing properties, resulting in Volati le inhalant \\ndependence in some people and Volatile inhalant withdrawal when use is reduced'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 126, 'page_label': '127'}, page_content='or discontinued. Volatile inhalants are implicated in a wide range of harms affec ting \\nmost organs and systems of the body, which may be classified as Single epi sode of \\nharmful use of volatile inhalants and Harmful pattern of use of volatile inhalants. \\nHarm to others resulting from behaviour during Volatile inhalant intoxic ation is \\nincluded in the definitions of Harmful use of volatile inhalants. Several volatile \\ninhalant-induced mental disorders are recognised.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 126, 'page_label': '127'}, page_content='Note: Code also the underlying condition \\n \\n6C4B.0 Single episode of harmful use of volatile inhalants \\nA single episode of volatile inhalant use or unintentional exposure (e.g., \\noccupational exposure) that has caused damage to a person ’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behavi our'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 126, 'page_label': '127'}, page_content='related to intoxication; (2) direct or secondary toxic effects on body organs and \\nsystems; or (3) a harmful route of administration. Harm to health of others includes \\nany form of physical harm, including trauma, or mental disorder that is dire ctly \\nattributable to behavior due to volatile inhalant intoxication on the part of the person \\nto whom the diagnosis of single episode of harmful use applies. This diag nosis'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 126, 'page_label': '127'}, page_content='should not be made if the harm is attributed to a known pattern of volatile inhalant \\nuse. \\nExclusions: Harmful pattern of use of volatile inhalants (6C4B.1) \\nVolatile inhalant dependence (6C4B.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 127, 'page_label': '128'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   127 \\n \\n6C4B.1 Harmful pattern of use of volatile inhalants \\nA pattern of volatile inhalant use of that has caused damage to a person ’s physical \\nor mental health. The pattern of volatile inhalant use is evident over a period of at \\nleast 12 months if substance use is episodic or at least one month if use i s \\ncontinuous (i.e., daily or almost daily). Harm to health of the individual occurs due to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 127, 'page_label': '128'}, page_content='one or more of the following: (1) behaviour related to intoxication; (1) direct  or \\nsecondary toxic effects on body organs and systems; or (2) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto volatile inhalant intoxication on the part of the person to whom the diag nosis of \\nHarmful pattern of use of volatile inhalants applies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 127, 'page_label': '128'}, page_content='Exclusions: Volatile inhalant dependence (6C4B.2) \\nSingle episode of harmful use of volatile inhalants (6C4B.0) \\n \\n6C4B.10 Harmful pattern of use of volatile inhalants, episodic \\nA pattern of episodic or intermittent volatile inhalant use that has caused damag e to \\na person’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. The pattern of episodic volatile inhalant use is evident over  a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 127, 'page_label': '128'}, page_content='period of at least 12 months. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary  \\ntoxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behaviour related to volatile inhalant'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 127, 'page_label': '128'}, page_content='intoxication on the part of the person to whom the diagnosis of Harmful pattern  of \\nuse of volatile inhalants applies. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nVolatile inhalant dependence (6C4B.2) \\n \\n6C4B.11 Harmful pattern of use of volatile inhalants, continuous \\nA pattern of continuous (daily or almost daily) volatile inhalant use that ha s caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 127, 'page_label': '128'}, page_content='to harm to the health of others. The pattern of continuous volatile inhalant use is \\nevident over a period of at least one month. Harm to health of the individual occurs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 127, 'page_label': '128'}, page_content='including trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto volatile inhalant intoxication on the part of the person to whom the diag nosis of \\nHarmful pattern of use of volatile inhalants applies. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nVolatile inhalant dependence (6C4B.2) \\n \\n6C4B.1Z Harmful pattern of use of volatile inhalants, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 128, 'page_label': '129'}, page_content='128  ICD-11 MMS - 2018 \\n \\n6C4B.2 Volatile inhalant dependence \\nVolatile inhalant dependence is a disorder of regulation of volatile inhala nt use \\narising from repeated or continuous use of volatile inhalants. The characteristic  \\nfeature is a strong internal drive to use volatile inhalants, which is manifested  by \\nimpaired ability to control use, increasing priority given to use over other ac tivities \\nand persistence of use despite harm or negative consequences. These experiences'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 128, 'page_label': '129'}, page_content='are often accompanied by a subjective sensation of urge or craving to use vol atile \\ninhalants. Physiological features of dependence may also be present, including \\ntolerance to the effects of volatile inhalants, withdrawal symptoms following  \\ncessation or reduction in use of volatile inhalants, or repeated use of volatil e \\ninhalants or pharmacologically similar substances to prevent or alleviate withdra wal \\nsymptoms. The features of dependence are usually evident over a period of at least'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 128, 'page_label': '129'}, page_content='12 months but the diagnosis may be made if volatile inhalant use is c ontinuous \\n(daily or almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nHarmful pattern of use of volatile inhalants (6C4B.1) \\n \\n6C4B.20 Volatile inhalant dependence, current use \\nCurrent volatile inhalant dependence with volatile inhalant use within the past \\nmonth. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 128, 'page_label': '129'}, page_content='Harmful pattern of use of volatile inhalants (6C4B.1) \\n \\n6C4B.21 Volatile inhalant dependence, early full remission \\nAfter a diagnosis of volatile inhalant dependence, and often following a treatm ent \\nepisode or other intervention (including self-help intervention), the ind ividual has \\nbeen abstinent from volatile inhalants during a period lasting from between 1 and 12 \\nmonths. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 128, 'page_label': '129'}, page_content='Harmful pattern of use of volatile inhalants (6C4B.1) \\n \\n6C4B.22 Volatile inhalant dependence, sustained partial remission \\nAfter a diagnosis of Volatile inhalant dependence, and often following a treatment \\nepisode or other intervention (including self-help intervention), there is a significant \\nreduction in volatile inhalant consumption for more than 12 months, such that even \\nthough intermittent or continuing volatile inhalant use has occurred during this'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 128, 'page_label': '129'}, page_content='period, the definitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nHarmful pattern of use of volatile inhalants (6C4B.1) \\n \\n6C4B.23 Volatile inhalant dependence, sustained full remission \\nAfter a diagnosis of Volatile inhalant dependence, and often following a treatment \\nepisode or other intervention (including self-intervention), the person has  been \\nabstinent from volatile inhalants for 12 months or longer.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 128, 'page_label': '129'}, page_content='Exclusions: Single episode of harmful use of volatile inhalants (6C4B.0) \\nHarmful pattern of use of volatile inhalants (6C4B.1) \\n \\n6C4B.2Z Volatile inhalant dependence, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 129, 'page_label': '130'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   129 \\n \\n6C4B.3 Volatile inhalant intoxication \\nVolatile inhalant intoxication is a clinically significant transient cond ition that \\ndevelops during or shortly after the consumption of a volatile inhalant that is  \\ncharacterized by disturbances in consciousness, cognition, perception, affect, \\nbehaviour, or coordination. These disturbances are caused by the known'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 129, 'page_label': '130'}, page_content='pharmacological effects of volatile inhalants and their intensity is clos ely related to \\nthe amount of volatile inhalant consumed. They are time-limited and abate as the \\nvolatile inhalant is cleared from the body. Presenting features may incl ude \\ninappropriate euphoria, impaired judgment, aggression, somnolence, coma, \\ndizziness, tremor, lack of coordination, slurred speech, unsteady gait, letharg y and \\napathy, psychomotor retardation, and visual disturbance. Muscle weakness and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 129, 'page_label': '130'}, page_content='diplopia may occur. Use of volatile inhalants may cause cardiac arrthymi as, cardiac \\narrest, and death. Inhalants containing lead (e.g. some forms of petrol/gasoline)  \\nmay cause confusion, irritability, coma and seizures. \\nNote: Code also the underlying condition \\nExclusions: Possession trance disorder (6B63) \\n \\n6C4B.4 Volatile inhalant withdrawal \\nVolatile inhalant withdrawal is a clinically significant cluster of symptom s,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 129, 'page_label': '130'}, page_content='behaviours and/or physiological features, varying in degree of severity and durati on, \\nthat occurs upon cessation or reduction of use of volatile inhalants in individual s \\nwho have developed Volatile inhalant dependence or have used volatile inhalants \\nfor a prolonged period or in large amounts. Presenting features of Volatile inhalant \\nwithdrawal may include insomnia, anxiety, irritability, dysphoric mood, shakiness, \\nperspiration, nausea, and transient illusions.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 129, 'page_label': '130'}, page_content='Note: Code also the underlying condition \\n \\n6C4B.5 Volatile inhalant-induced delirium \\nVolatile inhalant-induced delirium is characterized by an acute state of distur bed \\nattention and awareness with specific features of delirium that develops during or \\nsoon after substance intoxication or withdrawal or during the use of volatile \\ninhalants. The amount and duration of volatile inhalant use must be capable of \\nproducing delirium. The symptoms are not better explained by a primary mental'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 129, 'page_label': '130'}, page_content='disorder, by use of or withdrawal from a different substance, or by another health \\ncondition that is not classified under Mental, behavioural and neurodevelopmental \\ndisorders. \\nNote: This category should never be used in primary tabulation. The codes are provided \\nfor use as supplementary or additional codes when it is desired to identify the \\npresence of dementia in diseases classified elsewhere. \\nWhen dementia is due to multiple aetiologies, code all that apply.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 130, 'page_label': '131'}, page_content='130  ICD-11 MMS - 2018 \\n \\n6C4B.6 Volatile inhalant-induced psychotic disorder \\nVolatile inhalant-induced psychotic disorder is characterized by psychoti c symptoms \\n(e.g., delusions, hallucinations, disorganized thinking, grossly disorganized \\nbeha1viour) that develop during or soon after intoxication with or withdrawal from \\nvolatile inhalants. The intensity or duration of the symptoms is substantial ly in \\nexcess of psychotic-like disturbances of perception, cognition, or behaviour tha t are'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 130, 'page_label': '131'}, page_content='characteristic of Volatile inhalant intoxication or Volatile inhalant withdrawa l. The \\namount and duration of volatile inhalant use must be capable of producing psychotic \\nsymptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be the \\ncase if the psychotic symptoms preceded the onset of the volatile inhalant use, if'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 130, 'page_label': '131'}, page_content='the symptoms persist for a substantial period of time after cessation of the vo latile \\ninhalant use or withdrawal, or if there is other evidence of a pre-existing prim ary \\nmental disorder with psychotic symptoms (e.g., a history of prior episodes not \\nassociated with volatile inhalant use). \\nNote: Code also the underlying condition \\n \\n6C4B.7 Other volatile inhalants-induced disorders \\nNote: Code also the underlying condition \\n \\n6C4B.70 Volatile inhalant-induced mood disorder'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 130, 'page_label': '131'}, page_content='Volatile inhalant-induced mood disorder is characterized by mood symptoms (e.g ., \\ndepressed or elevated mood, decreased engagement in pleasurable activities, \\nincreased or decreased energy levels) that develop during or soon after intox ication \\nwith or withdrawal from volatile inhalants. The intensity or duration of the symptom s \\nis substantially in excess of mood disturbances that are characteristic of Volatil e'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 130, 'page_label': '131'}, page_content='inhalant intoxication or Volatile inhalant withdrawal. The amount and durati on of \\nvolatile inhalant use must be capable of producing mood symptoms. The symptoms  \\nare not better explained by a primary mental disorder (e.g., a Depressive disorder, a \\nBipolar disorder, Schizoaffective disorder), as might be the case if the mood \\nsymptoms preceded the onset of the volatile inhalant use, if the symptoms pers ist \\nfor a substantial period of time after cessation of the volatile inhalant use or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 130, 'page_label': '131'}, page_content='withdrawal, or if there is other evidence of a pre-existing primary mental di sorder \\nwith mood symptoms (e.g., a history of prior episodes not associated with vol atile \\ninhalant use). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 131, 'page_label': '132'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   131 \\n \\n6C4B.71 Volatile inhalant-induced anxiety disorder \\nVolatile inhalant-induced anxiety disorder is characterized by anxiety sy mptoms \\n(e.g., apprehension or worry, fear, physiological symptoms of excessive auto nomic \\narousal, avoidance behaviour) that develop during or soon after intoxication with or \\nwithdrawal from volatile inhalants. The intensity or duration of the symptoms i s'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 131, 'page_label': '132'}, page_content='substantially in excess of anxiety symptoms that are characteristic of Vol atile \\ninhalant intoxication or Volatile inhalant withdrawal. The amount and duration  of \\nvolatile inhalant use must be capable of producing anxiety symptoms. The  \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand Fear-Related Disorder, a Depressive Disorder with prominent anxiety \\nsymptoms), as might be the case if the anxiety symptoms preceded the onset of the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 131, 'page_label': '132'}, page_content='volatile inhalant use, if the symptoms persist for a substantial period of  time after \\ncessation of the volatile inhalant use or withdrawal, or if there is other ev idence of a \\npre-existing primary mental disorder with anxiety symptoms (e.g., a history of pri or \\nepisodes not associated with volatile inhalant use). \\nNote: Code also the underlying condition \\n \\n6C4B.Y Other specified disorders due to use of volatile inhalants \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 131, 'page_label': '132'}, page_content='6C4B.Z Disorders due to use of volatile inhalants, unspecified \\nNote: Code also the underlying condition \\n \\n  6C4C   Disorders due to use of MDMA or related drugs, including MDA \\nDisorders due to use of MDMA or related drugs, including MDA are characterised \\nby the pattern and consequences of MDMA or related drug use. In addition to \\nMDMA or related drug intoxication, including MDA, MDMA or related drugs have \\ndependence-inducing properties, resulting in MDMA or related drug dependence,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 131, 'page_label': '132'}, page_content='including MDA in some people and MDMA or related drug withdrawal, including  \\nMDA when use is reduced or discontinued. MDMA or related drugs are implicated in \\na wide range of harms affecting most organs and systems of the body, which ma y \\nbe classified as Single episode of harmful use of MDMA or related drugs, i ncluding \\nMDA and Harmful pattern of use of MDMA or related drugs, including MDA. Harm to \\nothers resulting from behaviour during MDMA or related drug intoxication, including'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 131, 'page_label': '132'}, page_content='MDA is included in the definitions of Harmful use of MDMA or related drugs, \\nincluding MDA. Several MDMA or related drug-induced mental disorders and are \\nrecognised. \\nNote: Code also the underlying condition \\nExclusions: Hazardous use of MDMA or related drugs (QE11.6)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 132, 'page_label': '133'}, page_content='132  ICD-11 MMS - 2018 \\n \\n6C4C.0 Single episode of harmful use of MDMA or related drugs, including MDA  \\nA single episode of use of MDMA or related drugs, including MDA, that has caus ed \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. Harm to health of the individual occurs due to one or \\nmore of the following: (1) behaviour related to intoxication; (2) direct or secondary'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 132, 'page_label': '133'}, page_content='toxic effects on body organs and systems; or (3) a harmful route of administration.  \\nHarm to health of others includes any form of physical harm, including trauma, or \\nmental disorder that is directly attributable to behavior due to intoxication with \\nMDMA or related drugs, including MDA, on the part of the person to whom the \\ndiagnosis of single episode of harmful use applies. This diagnosis shou ld not be \\nmade if the harm is attributed to a known pattern of use of MDMA or related drugs,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 132, 'page_label': '133'}, page_content='including MDA. \\nExclusions: Harmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1) \\nMDMA or related drug dependence, including MDA (6C4C.2) \\n \\n6C4C.1 Harmful pattern of use of MDMA or related drugs, including MDA \\nA pattern of use of MDMA or related drugs, including MDA, that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of use of MDMA or related drugs is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 132, 'page_label': '133'}, page_content='evident over a period of at least 12 months if use is episodic or at least one mon th if \\nuse is continuous (i.e., daily or almost daily). Harm to health of the indivi dual occurs \\ndue to one or more of the following: (1) behaviour related to intoxication; (2) direct \\nor secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 132, 'page_label': '133'}, page_content='including trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto MDMA or related drug intoxication on the part of the person to whom the \\ndiagnosis of Harmful pattern of use of MDMA or related drugs, including MDA \\napplies. \\nExclusions: MDMA or related drug dependence, including MDA (6C4C.2) \\nSingle episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\n \\n6C4C.10 Harmful use of MDMA or related drugs, including MDA, episodic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 132, 'page_label': '133'}, page_content='A pattern of episodic or intermittent use of MDMA or related drugs, including MDA, \\nthat has caused damage to a person ’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. The pattern of episodic use of \\nMDMA or related drugs is evident over a period of at least 12 months. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behavi our \\nrelated to intoxication; (2) direct or secondary toxic effects on body organs and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 132, 'page_label': '133'}, page_content='systems; or (3) a harmful route of administration. Harm to health of others includes \\nany form of physical harm, including trauma, or mental disorder that is directl y \\nattributable to behaviour related to MDMA or related drug intoxication on the part of \\nthe person to whom the diagnosis of Harmful pattern of use of MDMA or related \\ndrugs, including MDA applies. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 132, 'page_label': '133'}, page_content='MDMA or related drug dependence, including MDA (6C4C.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 133, 'page_label': '134'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   133 \\n \\n6C4C.11 Harmful use of MDMA or related drugs, including MDA, continuous \\nA pattern of continuous (daily or almost daily) use of MDMA or related drugs, \\nincluding MDA, that has caused damage to a person ’s physical or mental health or \\nhas resulted in behaviour leading to harm to the health of others. The pattern of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 133, 'page_label': '134'}, page_content='continuous use of MDMA or related drugs is evident over a period of at least one \\nmonth. Harm to health of the individual occurs due to one or more of the followi ng: \\n(1) behaviour related to intoxication; (2) direct or secondary toxic effects on bod y \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 133, 'page_label': '134'}, page_content='is directly attributable to behaviour related to MDMA or related drug intoxic ation on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of MDMA or \\nrelated drugs, including MDA applies. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nMDMA or related drug dependence, including MDA (6C4C.2) \\n \\n6C4C.1Z Harmful pattern of use of MDMA or related drugs, including MDA, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 133, 'page_label': '134'}, page_content='6C4C.2 MDMA or related drug dependence, including MDA \\nMDMA or related drug dependence, including MDA is a disorder of regulation of \\nMDMA or related drug use arising from repeated or continuous use of MDMA or \\nrelated drugs. The characteristic feature is a strong internal drive to use MDMA or \\nrelated drugs, which is manifested by impaired ability to control use, increas ing \\npriority given to use over other activities and persistence of use despite harm or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 133, 'page_label': '134'}, page_content='negative consequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use MDMA or related drugs. Physiological features \\nof dependence may also be present, including tolerance to the effects of MDMA or \\nrelated drugs, withdrawal symptoms following cessation or reduction in use of \\nMDMA or related drugs, or repeated use of MDMA or pharmacologically similar \\nsubstances to prevent or alleviate withdrawal symptoms. The features of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 133, 'page_label': '134'}, page_content='dependence are usually evident over a period of at least 12 months but the \\ndiagnosis may be made if MDMA or related drug use is continuous (daily or almost \\ndaily) for at least 1 month. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1) \\n \\n6C4C.20 MDMA or related drug dependence, including MDA, current use'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 133, 'page_label': '134'}, page_content='Current MDMA or related drug dependence, including MDA, with MDMA or related \\ndrug use within the past month. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 134, 'page_label': '135'}, page_content='134  ICD-11 MMS - 2018 \\n \\n6C4C.21 MDMA or related drug dependence, including MDA, early full remission  \\nAfter a diagnosis of MDMA or related drug dependence, including MDA, and often \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthe individual has been abstinent from MDMA or related drug dependence, \\nincluding MDA, during a period lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of MDMA or related drugs,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 134, 'page_label': '135'}, page_content='including MDA (6C4C.0) \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1) \\n \\n6C4C.22 MDMA or related drug dependence, including MDA, sustained partial remission  \\nAfter a diagnosis of MDMA or related drug dependence, including MDA, and often \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthere is a significant reduction in consumption of MDMA or related drugs, inc luding'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 134, 'page_label': '135'}, page_content='MDA, for more than 12 months, such that even though intermittent or continuing use \\nof MDMA or related drugs, including MDA, has occurred during this period, the \\ndefinitional requirements for dependence have not been met. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1) \\n \\n6C4C.23 MDMA or related drug dependence, including MDA, sustained full remission'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 134, 'page_label': '135'}, page_content='After a diagnosis of MDMA or related drug dependence, including MDA, and often \\nfollowing a treatment episode or other intervention (including self-intervent ion), the \\nperson has been abstinent from MDMA or related drugs, including MDA, for 12 \\nmonths or longer. \\nExclusions: Single episode of harmful use of MDMA or related drugs, \\nincluding MDA (6C4C.0) \\nHarmful pattern of use of MDMA or related drugs, including \\nMDA (6C4C.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 134, 'page_label': '135'}, page_content='MDA (6C4C.1) \\n \\n6C4C.2Z MDMA or related drug dependence, including MDA, unspecified \\n \\n6C4C.3 MDMA or related drug intoxication, including MDA \\nMDMA or related drug intoxication, including MDA is a clinically significan t transient \\ncondition that develops during or shortly after the consumption of MDMA or related  \\ndrugs that is characterized by disturbances in consciousness, cognition, percepti on, \\naffect, behaviour, or coordination. These disturbances are caused by the known'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 134, 'page_label': '135'}, page_content='pharmacological effects of MDMA or related drugs and their intensity is closely \\nrelated to the amount of MDMA or a related drug consumed. They are time-limited \\nand abate as MDMA or a related drug is cleared from the body. Presenting features \\nmay include increased or inappropriate sexual interest and activity, anxiety, \\nrestlessness, agitation, and sweating. In rare instances, usually in severe \\nintoxication, use of MDMA or related drugs, including MDA can result in dyst onia'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 134, 'page_label': '135'}, page_content='and seizures. Sudden death is a rare but recognized complication. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 135, 'page_label': '136'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   135 \\n \\n6C4C.4 MDMA or related drug withdrawal, including MDA \\nMDMA or related drug withdrawal, including MDA is a clinically signific ant cluster of \\nsymptoms, behaviours and/or physiological features, varying in degree of severit y \\nand duration, that occurs upon cessation or reduction of use of MDMA or related \\ndrugs in individuals who have developed MDMA or related drug dependence or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 135, 'page_label': '136'}, page_content='have used MDMA or related drugs for a prolonged period or in large amounts. \\nPresenting features of MDMA or related drug withdrawal may include fatigue, \\nlethargy, hypersomnia or insomnia, depressed mood, anxiety, irritability, cravi ng, \\ndifficulty in concentrating, and appetite disturbance. \\nNote: Code also the underlying condition \\n \\n6C4C.5 MDMA or related drug-induced delirium, including MDA \\nMDMA or related drug-induced delirium, including MDA is characterized by an acute'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 135, 'page_label': '136'}, page_content='state of disturbed attention and awareness with specific features of delirium that \\ndevelops during or soon after substance intoxication or during the use of MDMA or \\nrelated drugs. The amount and duration of MDMA or related drug use must be \\ncapable of producing delirium. The symptoms are not better explained by a primary \\nmental disorder, by use of or withdrawal from a different substance, or by another \\nhealth condition that is not classified under Mental, behavioural and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 135, 'page_label': '136'}, page_content='neurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C4C.6 MDMA or related drug-induced psychotic disorder, including MDA \\nMDMA or related drug-induced psychotic disorder, including MDA is characterized \\nby psychotic symptoms (e.g., delusions, hallucinations, disorganized th inking, \\ngrossly disorganized behaviour) that develop during or soon after intoxication with \\nMDMA or related drugs. The intensity or duration of the symptoms is substantiall y in'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 135, 'page_label': '136'}, page_content='excess of psychotic-like disturbances of perception, cognition, or behaviour tha t are \\ncharacteristic of MDMA or related drug intoxication. The amount and duration of \\nMDMA or related drug use must be capable of producing psychotic symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., \\nSchizophrenia, a Mood disorder with psychotic symptoms), as might be the case if  \\nthe psychotic symptoms preceded the onset of the MDMA or related drug use, if the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 135, 'page_label': '136'}, page_content='symptoms persist for a substantial period of time after cessation of the MDMA or \\nrelated drug use, or if there is other evidence of a pre-existing primary mental \\ndisorder with psychotic symptoms (e.g., a history of prior episodes not associated \\nwith MDMA or related drug use, including MDA). \\nNote: Code also the underlying condition \\n \\n6C4C.7 Other MDMA or related drugs, including MDA-induced disorders \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 136, 'page_label': '137'}, page_content='136  ICD-11 MMS - 2018 \\n \\n6C4C.70 MDMA or related drug-induced mood disorder, including MDA \\nMDMA or related drug-induced mood disorder, including MDA is characterized by \\nmood symptoms (e.g., depressed or elevated mood, decreased engagement in \\npleasurable activities, increased or decreased energy levels) that develop during or \\nsoon after intoxication with MDMA or related drugs. The intensity or duration of the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 136, 'page_label': '137'}, page_content='symptoms is substantially in excess of mood disturbances that are characteristic of \\nMDMA or related drug intoxication, including MDA. The amount and duration of \\nMDMA or related drug use must be capable of producing mood symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., a Depressive \\ndisorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if t he \\nmood symptoms preceded the onset of the MDMA or related drug use, if the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 136, 'page_label': '137'}, page_content='symptoms persist for a substantial period of time after cessation of the MDMA or \\nrelated drug use, or if there is other evidence of a pre-existing primary mental \\ndisorder with mood symptoms (e.g., a history of prior episodes not associated with \\nMDMA or related drug use). \\nNote: Code also the underlying condition \\n \\n6C4C.71 MDMA or related drug-induced anxiety disorder \\nMDMA or related drug-induced anxiety disorder, including MDA is characterized b y'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 136, 'page_label': '137'}, page_content='anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms  of \\nexcessive autonomic arousal, avoidance behaviour) that develop during or soon \\nafter intoxication with MDMA or related drugs. The intensity or duration of the \\nsymptoms is substantially in excess of anxiety symptoms that are characteristic  of \\nMDMA or related drug intoxication, including MDA. The amount and duration of \\nMDMA or related drug use must be capable of producing anxiety symptoms. The'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 136, 'page_label': '137'}, page_content='symptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear-related disorder, a Depressive disorder with prominent anxiety symptoms), \\nas might be the case if the anxiety symptoms preceded the onset of the MDMA  or \\nrelated drug use, if the symptoms persist for a substantial period of time after \\ncessation of the MDMA or related drug use, or if there is other evidence of a pre-\\nexisting primary mental disorder with anxiety symptoms (e.g., a history of prior'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 136, 'page_label': '137'}, page_content='episodes not associated with MDMA or related drug use). \\nNote: Code also the underlying condition \\n \\n6C4C.Y Other specified disorders due to use of MDMA or related drugs, including \\nMDA \\nNote: Code also the underlying condition \\n \\n6C4C.Z Disorders due to use of MDMA or related drugs, including MDA, unspecified  \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 137, 'page_label': '138'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   137 \\n \\n  6C4D   Disorders due to use of dissociative drugs including ketamine and \\nphencyclidine [PCP] \\nDisorders due to use of dissociative drugs including ketamine and phencyclidine \\n[PCP] are characterised by the pattern and consequences of dissociative drug use. \\nIn addition to Dissociative drug intoxication including Ketamine or PCP, dissociati ve'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 137, 'page_label': '138'}, page_content='drugs have dependence-inducing properties, resulting in Dissociative drug \\ndependence including ketamine or PCP in some people. Dissociative drugs are \\nimplicated in a wide range of harms affecting most organs and systems of the bo dy, \\nwhich may be classified as Single episode of harmful use of dissociati ve drugs \\nincluding ketamine or PCP and Harmful pattern of use of dissociative drugs \\nincluding ketamine or PCP. Harm to others resulting from behaviour during'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 137, 'page_label': '138'}, page_content='Dissociative drug intoxication including Ketamine or PCP is included in the \\ndefinitions of Harmful use of dissociative drugs. Several dissociative drug -induced \\nmental disorders are recognised. \\nNote: Code also the underlying condition \\nExclusions: Hazardous use of dissociative drugs including ketamine or \\nPCP (QE11.7) \\n \\n6C4D.0 Single episode of harmful use of dissociative drugs including ketamine or \\nPCP \\nA single episode of use of a dissociative drug, including Ketamine and PCP, that'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 137, 'page_label': '138'}, page_content='has caused damage to a person ’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. Harm to health of the individual \\noccurs due to one or more of the following: (1) behaviour related to intoxication; (2) \\ndirect or secondary toxic effects on body organs and systems; or (3) a harmful route \\nof administration. Harm to health of others includes any form of physical harm ,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 137, 'page_label': '138'}, page_content='including trauma, or mental disorder that is directly attributable to behavior d ue to \\nintoxication with a dissociative drug, including Ketamine and PCP, on the par t of the \\nperson to whom the diagnosis of single episode of harmful use applies. Thi s \\ndiagnosis should not be made if the harm is attributed to a known pattern  of use of \\ndissociative drugs, including Ketamine and PCP. \\nExclusions: Dissociative drug dependence including ketamine or PCP \\n(6C4D.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 137, 'page_label': '138'}, page_content='(6C4D.2) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 138, 'page_label': '139'}, page_content='138  ICD-11 MMS - 2018 \\n \\n6C4D.1 Harmful pattern of use of dissociative drugs, including ketamine or PCP \\nA pattern of use of dissociative drugs, including ketamine and phencyclidine (PCP), \\nthat has caused damage to a person ’s physical or mental health or has resulted in \\nbehaviour leading to harm to the health of others. The pattern of dissociative drug \\nuse is evident over a period of at least 12 months if use is episodic or at leas t one'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 138, 'page_label': '139'}, page_content='month if use is continuous (i.e., daily or almost daily). Harm to health of the \\nindividual occurs due to one or more of the following: (1) behaviour related to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 138, 'page_label': '139'}, page_content='behaviour related to dissociative drug intoxication on the part of the person t o whom \\nthe diagnosis of Harmful pattern of use of dissociative drugs, including ketam ine \\nand PCP applies. \\nExclusions: Dissociative drug dependence including ketamine or PCP \\n(6C4D.2) \\nSingle episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\n \\n6C4D.10 Harmful pattern of use of dissociative drugs including ketamine or PCP, episodic'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 138, 'page_label': '139'}, page_content='A pattern of episodic or intermittent use of dissociative drugs, including ketami ne \\nand phencyclidine (PCP), that has caused damage to a person ’s physical or mental \\nhealth or has resulted in behaviour leading to harm to the health of others. The \\npattern of episodic use of dissociative drugs is evident over a period of at least 12 \\nmonths. Harm to health of the individual occurs due to one or more of the follow ing:'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 138, 'page_label': '139'}, page_content='(1) behaviour related to intoxication; (2) direct or secondary toxic effects on bod y \\norgans and systems; or (3) a harmful route of administration. Harm to health of \\nothers includes any form of physical harm, including trauma, or mental disorder t hat \\nis directly attributable to behaviour related to dissociative drug intoxication on the \\npart of the person to whom the diagnosis of Harmful pattern of use of dissociati ve \\ndrugs, including ketamine and PCP applies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 138, 'page_label': '139'}, page_content='Exclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nDissociative drug dependence including ketamine or PCP \\n(6C4D.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 139, 'page_label': '140'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   139 \\n \\n6C4D.11 Harmful pattern of use of dissociative drugs including ketamine or PCP, continuous  \\nA pattern of continuous (daily or almost daily) use of dissociative drugs, including \\nketamine and phencyclidine (PCP), that has caused damage to a person ’s physical \\nor mental health or has resulted in behaviour leading to harm to the health of others.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 139, 'page_label': '140'}, page_content='The pattern of continuous use of dissociative drugs is evident over a period of at \\nleast one month. Harm to health of the individual occurs due to one or more of t he \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 139, 'page_label': '140'}, page_content='disorder that is directly attributable to behaviour related to dissociative drug \\nintoxication on the part of the person to whom the diagnosis of Harmful pattern  of \\nuse of dissociative drugs, including ketamine and PCP applies. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nDissociative drug dependence including ketamine or PCP \\n(6C4D.2) \\n \\n6C4D.1Z Harmful pattern of use of dissociative drugs, including ketamine or PCP, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 139, 'page_label': '140'}, page_content='6C4D.2 Dissociative drug dependence including ketamine or PCP \\nDissociative drug dependence including ketamine or PCP is a disorder of regulation  \\nof dissociative drug use arising from repeated or continuous use of dis sociative \\ndrugs. The characteristic feature is a strong internal drive to use dissociative drugs, \\nwhich is manifested by impaired ability to control use, increasing priority gi ven to \\nuse over other activities and persistence of use despite harm or negative'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 139, 'page_label': '140'}, page_content='consequences. These experiences are often accompanied by a subjective \\nsensation of urge or craving to use dissociative drugs. The features of dependence \\nare usually evident over a period of at least 12 months but the diagnosis may be \\nmade if dissociative drugs use is continuous (daily or almost daily) for at  least 1 \\nmonth. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nHarmful pattern of use of dissociative drugs, including'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 139, 'page_label': '140'}, page_content='ketamine or PCP (6C4D.1) \\n \\n6C4D.20 Dissociative drug dependence including Ketamine or PCP, current use  \\nDissociative drug dependence including Ketamine and PCP, current use refers to \\nuse of dissociative drugs within the past month. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 140, 'page_label': '141'}, page_content='140  ICD-11 MMS - 2018 \\n \\n6C4D.21 Dissociative drug dependence including Ketamine or PCP, early full remission  \\nAfter a diagnosis of Dissociative drug dependence including Ketamine and PCP, \\nand often following a treatment episode or other intervention (including self-h elp \\nintervention), the individual has been abstinent from dissociative drugs duri ng a \\nperiod lasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of dissociative drugs including'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 140, 'page_label': '141'}, page_content='ketamine or PCP (6C4D.0) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1) \\n \\n6C4D.22 Dissociative drug dependence including Ketamine or PCP, sustained partial \\nremission \\nAfter a diagnosis of Dissociative drug dependence including Ketamine and PCP, \\nand often following a treatment episode or other intervention (including self-h elp \\nintervention), there is a significant reduction in dissociative drug consumption for'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 140, 'page_label': '141'}, page_content='more than 12 months, such that even though intermittent or continuing dissociative \\ndrug use has occurred during this period, the definitional requirements for \\ndependence have not been met. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1) \\n \\n6C4D.23 Dissociative drug dependence including Ketamine or PCP, sustained full remission'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 140, 'page_label': '141'}, page_content='After a diagnosis of Dissociative drug dependence including Ketamine and PCP, \\nand often following a treatment episode or other intervention (including self-\\nintervention), the person has been abstinent from dissociative drugs for 12 months \\nor longer. \\nExclusions: Single episode of harmful use of dissociative drugs including \\nketamine or PCP (6C4D.0) \\nHarmful pattern of use of dissociative drugs, including \\nketamine or PCP (6C4D.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 140, 'page_label': '141'}, page_content='6C4D.2Z Dissociative drug dependence including ketamine or PCP, unspecified \\n \\n6C4D.3 Dissociative drug intoxication including Ketamine or PCP \\nDissociative drug intoxication including Ketamine and PCP is a clinica lly significant \\ntransient condition that develops during or shortly after the consumption of a \\ndissociative drug that is characterized by disturbances in consciousness, cogni tion, \\nperception, affect, behaviour, or coordination. These disturbances are caused by'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 140, 'page_label': '141'}, page_content='the known pharmacological effects of a dissociative drug and their intensity  is \\nclosely related to the amount of the dissociative drug consumed. They are time-\\nlimited and abate as the dissociative drug is cleared from the body. Pres enting \\nfeatures may include aggression, impulsiveness, unpredictability, anxiety, \\npsychomotor agitation, impaired judgment, numbness or diminished responsiveness \\nto pain, slurred speech, and dystonia. Physical signs include nystagmus (r epetitive,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 140, 'page_label': '141'}, page_content='uncontrolled eye movements), tachycardia, elevated blood pressure, numbness, \\nataxia, dysarthria, and muscle rigidity. In rare instances, use of dissociative drug s \\nincluding Ketamine and PCP can result in seizures. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 141, 'page_label': '142'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   141 \\n \\n6C4D.4 Dissociative drug-induced delirium including ketamine or PCP \\nDissociative drug-induced delirium including Ketamine or PCP is characterized by \\nan acute state of disturbed attention and awareness with specific features of \\ndelirium that develops during or soon after substance intoxication or during the  use'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 141, 'page_label': '142'}, page_content='of dissociative drugs. The amount and duration of dissociative drug use must be \\ncapable of producing delirium. The symptoms are not better explained by a primary \\nmental disorder, by use of or withdrawal from a different substance, or by another \\nhealth condition that is not classified under Mental, behavioural and \\nneurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C4D.5 Dissociative drug-induced psychotic disorder including Ketamine or PCP'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 141, 'page_label': '142'}, page_content='Dissociative drug-induced psychotic disorder including Ketamine or PCP is \\ncharacterized by psychotic symptoms (e.g., delusions, hallucinations, disorgani zed \\nthinking, grossly disorganized behaviour) that develop during or soon after \\nintoxication with dissociative drugs. The intensity or duration of the symptoms  is \\nsubstantially in excess of psychotic-like disturbances of perception, cognit ion, or \\nbehaviour that are characteristic of Dissociative drug intoxication. The amount and'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 141, 'page_label': '142'}, page_content='duration of Dissociative drug use must be capable of producing psychotic \\nsymptoms. The symptoms are not better explained by a primary mental disorder \\n(e.g., Schizophrenia, a Mood disorder with psychotic symptoms), as might be  the \\ncase if the psychotic symptoms preceded the onset of the dissociative drug use , if \\nthe symptoms persist for a substantial period of time after cessation of the \\ndissociative drug use, or if there is other evidence of a pre-existing primary men tal'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 141, 'page_label': '142'}, page_content='disorder with psychotic symptoms (e.g., a history of prior episodes not associated \\nwith dissociative drug use). \\nNote: Code also the underlying condition \\n \\n6C4D.6 Other dissociative drugs including ketamine and phencyclidine [PCP]-\\ninduced disorders \\nNote: Code also the underlying condition \\n \\n6C4D.60 Dissociative drug-induced mood disorder including Ketamine or PCP \\nDissociative drug-induced mood disorder including Ketamine or PCP is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 141, 'page_label': '142'}, page_content='characterized by mood symptoms (e.g., depressed or elevated mood, decreased \\nengagement in pleasurable activities, increased or decreased energy levels) that \\ndevelop during or soon after intoxication with dissociative drugs. The intensity or \\nduration of the symptoms is substantially in excess of mood disturbances that are \\ncharacteristic of Dissociative drug intoxication. The amount and duration of \\nDissociative drug use must be capable of producing mood symptoms. The'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 141, 'page_label': '142'}, page_content='symptoms are not better explained by a primary mental disorder (e.g., a Depressive \\ndisorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if t he \\nmood symptoms preceded the onset of the dissociative drug use, if the symptoms \\npersist for a substantial period of time after cessation of the dissociative dru g use, \\nor if there is other evidence of a pre-existing primary mental disorder with mood'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 141, 'page_label': '142'}, page_content='symptoms (e.g., a history of prior episodes not associated with dissociative drug \\nuse). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 142, 'page_label': '143'}, page_content='142  ICD-11 MMS - 2018 \\n \\n6C4D.61 Dissociative drug-induced anxiety disorder including Ketamine or PCP \\nDissociative drug-induced anxiety disorder including Ketamine or PCP is \\ncharacterized by anxiety symptoms (e.g., apprehension or worry, fear, physiol ogical \\nsymptoms of excessive autonomic arousal, avoidance behaviour) that develop \\nduring or soon after intoxication with dissociative drugs. The intensity or duration of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 142, 'page_label': '143'}, page_content='the symptoms is substantially in excess of anxiety symptoms that are ch aracteristic \\nof Dissociative drug intoxication. The amount and duration of Dissociative drug use \\nmust be capable of producing anxiety symptoms. The symptoms are not better \\nexplained by a primary mental disorder (e.g., an Anxiety and Fear- Related Disorder, \\na Depressive Disorder with prominent anxiety symptoms), as might be the case i f \\nthe anxiety symptoms preceded the onset of the dissociative drug use, if the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 142, 'page_label': '143'}, page_content='symptoms persist for a substantial period of time after cessation of the dissoci ative \\ndrug use, or if there is other evidence of a pre-existing primary mental disorder with \\nanxiety symptoms (e.g., a history of prior episodes not associated with diss ociative \\ndrug use). \\nNote: Code also the underlying condition \\n \\n6C4D.Y Other specified disorders due to use of dissociative drugs including ketamine \\nand phencyclidine [PCP] \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 142, 'page_label': '143'}, page_content='6C4D.Z Disorders due to use of dissociative drugs including ketamine and \\nphencyclidine [PCP], unspecified \\nNote: Code also the underlying condition \\n \\n  6C4E   Disorders due to use of other specified psychoactive substances, \\nincluding medications \\nDisorders due to use of other specified psychoactive substances, including \\nmedications are characterised by the pattern and consequences of other specified \\npsychoactive substance use. In addition to Other specified psychoactive substa nce'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 142, 'page_label': '143'}, page_content='intoxication, other specified substances have dependence-inducing properties, \\nresulting in Other specified psychoactive substance dependence in some peopl e \\nand Other specified psychoactive substance withdrawal when use is reduced or \\ndiscontinued. Other specified substances are implicated in a wide range of harms \\naffecting most organs and systems of the body, which may be classified as Si ngle \\nepisode of harmful use of other specified psychoactive substance and Harmful'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 142, 'page_label': '143'}, page_content='pattern of use of other specified psychoactive substance. Harm to others resulting  \\nfrom behaviour during Other specified psychoactive substance intoxication  is \\nincluded in the definitions of Harmful use of other specified substances. S everal \\nother specified substance-induced mental disorders and other specified sub stance-\\nrelated forms of neurocognitive impairment are recognised. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 143, 'page_label': '144'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   143 \\n \\n6C4E.0 Single episode of harmful use of other specified psychoactive substance  \\nA single episode of use of a specified psychoactive substance or medication that is \\nnot included in the other substance classes specifically identified under Dis orders \\nDue to Substance Use that has caused damage to a person ’s physical or mental'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 143, 'page_label': '144'}, page_content='health or has resulted in behaviour leading to harm to the health of others. Harm to \\nhealth of the individual occurs due to one or more of the following: (1) behavi our \\nrelated to substance intoxication or psychoactive medication use; (2) direct or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 143, 'page_label': '144'}, page_content='to substance intoxication or psychoactive medication use on the part of the per son \\nto whom the diagnosis of single episode of harmful use of other specified \\npsychoactive substance applies. This diagnosis should not be made if the har m is \\nattributed to a known pattern of use of the specified psychoactive substance. \\nExclusions: Harmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1) \\nOther specified psychoactive substance dependence (6C4E.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 143, 'page_label': '144'}, page_content='6C4E.1 Harmful pattern of use of other specified psychoactive substance \\nA pattern of use of a specified psychoactive substance or medication that is not \\nincluded in the other substance classes specifically identified under Dis orders Due \\nto Substance Use that has caused damage to a person ’s physical or mental health \\nor has resulted in behaviour leading to harm to the health of others. The pattern of \\nsubstance use is evident over a period of at least 12 months if use is episod ic or at'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 143, 'page_label': '144'}, page_content='least one month if use is continuous (i.e., daily or almost daily). Harm  to health of \\nthe individual occurs due to one or more of the following: (1) behaviour related  to \\nintoxication; (2) direct or secondary toxic effects on body organs and systems ; or (3) \\na harmful route of administration. Harm to health of others includes any form of \\nphysical harm, including trauma, or mental disorder that is directly attributable to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 143, 'page_label': '144'}, page_content='behaviour related to intoxication due to the specified substance or medicati on on \\nthe part of the person to whom the diagnosis of Harmful pattern of use of other \\nspecified psychoactive substance applies. \\nExclusions: Other specified psychoactive substance dependence (6C4E.2) \\nSingle episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 144, 'page_label': '145'}, page_content='144  ICD-11 MMS - 2018 \\n \\n6C4E.10 Harmful pattern of use of other specified psychoactive substance, episodic  \\nA pattern of episodic or intermittent use of a specified psychoactive substance or \\nmedication that is not included in the other substance classes specificall y identified \\nunder Disorders Due to Substance Abuse that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 144, 'page_label': '145'}, page_content='of others. The pattern of episodic substance use is evident over a period of at lea st \\n12 months. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to \\nhealth of others includes any form of physical harm, including trauma, or mental'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 144, 'page_label': '145'}, page_content='disorder that is directly attributable to behaviour related to intoxication due to the \\nspecified substance or medication on the part of the person to whom the diagnosis \\nof Harmful pattern of use of other specified psychoactive substance applies. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nOther specified psychoactive substance dependence (6C4E.2) \\n \\n6C4E.11 Harmful pattern of use of other specified psychoactive substance, continuous'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 144, 'page_label': '145'}, page_content='A pattern of continuous (daily or almost daily) use of a specified psyc hoactive \\nsubstance or medication that is not included in the other substance classes \\nspecifically identified under Disorders Due to Substance Use that has caused \\ndamage to a person’s physical or mental health or has resulted in behaviour leading \\nto harm to the health of others. The pattern of continuous substance use is evi dent \\nover a period of at least one month. Harm to health of the individual occurs due to'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 144, 'page_label': '145'}, page_content='one or more of the following: (1) behaviour related to intoxication; (2) direct  or \\nsecondary toxic effects on body organs and systems; or (3) a harmful route of \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto intoxication due to the specified substance or medication on the part of the \\nperson to whom the diagnosis of Harmful pattern of use of other specified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 144, 'page_label': '145'}, page_content='psychoactive substance applies. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nOther specified psychoactive substance dependence (6C4E.2) \\n \\n6C4E.1Z Harmful pattern of use of other specified psychoactive substance, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 145, 'page_label': '146'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   145 \\n \\n6C4E.2 Other specified psychoactive substance dependence \\nOther specified psychoactive substance dependence is a disorder of regul ation of \\nuse of a specified substance arising from repeated or continuous use of the  \\nspecified substance. The characteristic feature is a strong internal drive to use the \\nspecified substance, which is manifested by impaired ability to contro l use,'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 145, 'page_label': '146'}, page_content='increasing priority given to use over other activities and persistence of use despite  \\nharm or negative consequences. These experiences are often accompanied by a \\nsubjective sensation of urge or craving to use the specified substance. Physiological \\nfeatures of dependence may also be present, including tolerance to the effects of \\nthe specified substance, withdrawal symptoms following cessation or reduction in \\nuse of the specified substance, or repeated use of the specified substance or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 145, 'page_label': '146'}, page_content='pharmacologically similar substances to prevent or alleviate withdrawal symptoms.  \\nThe features of dependence are usually evident over a period of at least 12 months \\nbut the diagnosis may be made if use of the specified substance is continuous (daily \\nor almost daily) for at least 1 month. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 145, 'page_label': '146'}, page_content='6C4E.20 Other specified psychoactive substance dependence, current use \\nCurrent Other specified psychoactive substance dependence, with use of the \\nspecified psychoactive substance within the past month. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1) \\n \\n6C4E.21 Other specified psychoactive substance dependence, early full remission'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 145, 'page_label': '146'}, page_content='After a diagnosis of Other specified psychoactive substance dependence, and  often \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthe individual has been abstinent from the specified substance during a per iod \\nlasting from between 1 and 12 months. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 145, 'page_label': '146'}, page_content='6C4E.22 Other specified psychoactive substance dependence, sustained partial remission  \\nAfter a diagnosis of Other specified psychoactive substance dependence, and  often \\nfollowing a treatment episode or other intervention (including self-help inter vention), \\nthere is a significant reduction in consumption of the specified substanc e for more \\nthan 12 months, such that even though intermittent or continuing substance use has'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 145, 'page_label': '146'}, page_content='occurred during this period, the definitional requirements for dependence have not \\nbeen met. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0) \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 146, 'page_label': '147'}, page_content='146  ICD-11 MMS - 2018 \\n \\n6C4E.23 Other specified psychoactive substance dependence, sustained full remission  \\nAfter a diagnosis of Other specified psychoactive substance dependence, and  often \\nfollowing a treatment episode or other intervention (including self-intervent ion), the \\nperson has been abstinent from the specified substance for 12 months or longer. \\nExclusions: Single episode of harmful use of other specified psychoactive \\nsubstance (6C4E.0)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 146, 'page_label': '147'}, page_content='substance (6C4E.0) \\nHarmful pattern of use of other specified psychoactive \\nsubstance (6C4E.1) \\n \\n6C4E.2Z Other specified psychoactive substance dependence, unspecified \\n \\n6C4E.3 Other specified psychoactive substance intoxication \\nOther specified psychoactive substance intoxication is a clinically si gnificant \\ntransient condition that develops during or shortly after the consumption of a \\nspecified psychoactive substance or medication that is characterized by'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 146, 'page_label': '147'}, page_content='disturbances in level of consciousness, cognition, perception, affect, behaviour,  or \\ncoordination. These disturbances are caused by the known pharmacological effects \\nof the specified psychoactive substance and their intensity is closely related to the \\namount of the specified psychoactive substance consumed. They are time-limi ted \\nand abate as the specified substance is cleared from the body. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 146, 'page_label': '147'}, page_content='6C4E.4 Other specified psychoactive substance withdrawal \\nOther specified psychoactive substance withdrawal is a clinically s ignificant cluster \\nof symptoms, behaviours and/or physiological features, varying in degree of severity \\nand duration, that occurs upon cessation or reduction of use of the specified \\nsubstance in individuals who have developed dependence or have used the \\nspecified substance for a prolonged period or in large amounts. Other specified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 146, 'page_label': '147'}, page_content='psychoactive substance withdrawal can also occur when prescribed psychoactive \\nmedications have been used in standard therapeutic doses. The specific features  of \\nthe withdrawal state depend on the pharmacological properties of the specified \\nsubstance. \\nNote: Code also the underlying condition \\n \\n6C4E.40 Other specified psychoactive substance withdrawal, uncomplicated \\nThe development of a withdrawal state not accompanied by perceptual'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 146, 'page_label': '147'}, page_content='disturbances or seizures following cessation or reduction of use of the specified \\nsubstance. \\nNote: Code also the underlying condition \\n \\n6C4E.41 Other specified psychoactive substance withdrawal, with perceptual disturbances  \\nThe development of a withdrawal state accompanied by perceptual disturbances \\nbut not by seizures following cessation or reduction of use of the specified \\nsubstance. \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 147, 'page_label': '148'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   147 \\n \\n6C4E.42 Other specified psychoactive substance withdrawal, with seizures \\nThe development of a withdrawal state accompanied by seizures but not by \\nperceptual disturbances following cessation or reduction of use of the specified \\nsubstance. \\nNote: Code also the underlying condition \\n \\n6C4E.43 Other specified psychoactive substance withdrawal, with perceptual disturbances \\nand seizures'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 147, 'page_label': '148'}, page_content='and seizures \\nThe development of a withdrawal state accompanied by both perceptual \\ndisturbances and seizures following cessation or reduction of use of the specified \\nsubstance. \\nNote: Code also the underlying condition \\n \\n6C4E.4Z Other specified psychoactive substance withdrawal, unspecified \\nNote: Code also the underlying condition \\n \\n6C4E.5 Delirium induced by other specified psychoactive substance including \\nmedications'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 147, 'page_label': '148'}, page_content='medications \\nDelirium induced by other specified psychoactive substance is characterize d by an \\nacute state of disturbed attention and awareness with specific features of deliri um \\nthat develops during or soon after substance intoxication or withdrawal or during the \\nuse of a specified psychoactive substance. The amount and duration of use of the \\nspecified substance must be capable of producing delirium. The symptoms are not'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 147, 'page_label': '148'}, page_content='better explained by a primary mental disorder, by use of or withdrawal from a \\ndifferent substance, or by another health condition that is not classified unde r \\nMental, behavioural and neurodevelopmental disorders. \\nNote: Code also the underlying condition \\n \\n6C4E.6 Psychotic disorder induced by other specified psychoactive substance  \\nPsychotic disorder induced by other specified psychoactive substance is  \\ncharacterized by psychotic symptoms (e.g., delusions, hallucinations, disorgani zed'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 147, 'page_label': '148'}, page_content='thinking, grossly disorganized behaviour) that develop during or soon after \\nintoxication with or withdrawal from a specified psychoactive substance. The  \\nintensity or duration of the symptoms is substantially in excess of psyc hotic-like \\ndisturbances of perception, cognition, or behaviour that are characteristic of \\nintoxication with or withdrawal from a specified psychoactive substance. The  \\namount and duration of use of the specified psychoactive substance must be'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 147, 'page_label': '148'}, page_content='capable of producing psychotic symptoms. The symptoms are not better explained \\nby a primary mental disorder (e.g., Schizophrenia, a Mood disorder with psychotic \\nsymptoms), as might be the case if the psychotic symptoms preceded the onset of \\nthe use of the specified psychoactive substance, if the symptoms persist for a \\nsubstantial period of time after cessation of the use of the specified psychoacti ve \\nsubstance or withdrawal from the specified psychoactive substance, or if there is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 147, 'page_label': '148'}, page_content='other evidence of a pre-existing primary mental disorder with psychotic symptoms \\n(e.g., a history of prior episodes not associated with the use of the specified \\npsychoactive substance). \\nNote: Code also the underlying condition \\n \\n6C4E.7 Other specified psychoactive substance-induced disorders \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 148, 'page_label': '149'}, page_content='148  ICD-11 MMS - 2018 \\n \\n6C4E.70 Mood disorder induced by other specified psychoactive substance \\nMood disorder induced by other specified psychoactive substance is characteri zed \\nby mood symptoms (e.g., depressed or elevated mood, decreased engagement in \\npleasurable activities, increased or decreased energy levels) that develop during or \\nsoon after intoxication with or withdrawal from a specified psychoactive subs tance.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 148, 'page_label': '149'}, page_content='The intensity or duration of the symptoms is substantially in excess of mood \\ndisturbances that are characteristic of intoxication with or withdrawal from a \\nspecified psychoactive substance. The amount and duration of use of the specified \\npsychoactive substance must be capable of producing mood symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., a Depressive \\ndisorder, a Bipolar disorder, Schizoaffective disorder), as might be the case if the'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 148, 'page_label': '149'}, page_content='mood symptoms preceded the onset of the use of the specified psychoactive \\nsubstance, if the symptoms persist for a substantial period of time after cessation  of \\nthe use of the specified psychoactive substance or withdrawal from the speci fied \\npsychoactive substance, or if there is other evidence of a pre-existing primary \\nmental disorder with mood symptoms (e.g., a history of prior episodes not \\nassociated with the use of the specified psychoactive substance).'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 148, 'page_label': '149'}, page_content='Note: Code also the underlying condition \\n \\n6C4E.71 Anxiety disorder induced by other specified psychoactive substance \\nAnxiety disorder induced by other specified psychoactive substance i s \\ncharacterized by anxiety symptoms (e.g., apprehension or worry, fear, physiol ogical \\nsymptoms of excessive autonomic arousal, avoidance behaviour) that develop \\nduring or soon after intoxication with or withdrawal from a specified psychoactiv e'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 148, 'page_label': '149'}, page_content='substance. The intensity or duration of the symptoms is substantially in exc ess of \\nanxiety symptoms that are characteristic of intoxication with or withdrawal  from a \\nspecified psychoactive substance. The amount and duration of use of the specified \\npsychoactive substance must be capable of producing anxiety symptoms. The \\nsymptoms are not better explained by a primary mental disorder (e.g., an Anxiety \\nand fear-related disorder, a Depressive disorder with prominent anxiety symptoms),'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 148, 'page_label': '149'}, page_content='as might be the case if the anxiety symptoms preceded the onset of the use of the  \\nspecified psychoactive substance, if the symptoms persist for a substanti al period of \\ntime after cessation of the use of the specified psychoactive substance or \\nwithdrawal from the specified psychoactive substance, or if there is other ev idence \\nof a pre-existing primary mental disorder with anxiety symptoms (e.g., a histor y of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 148, 'page_label': '149'}, page_content='prior episodes not associated with the use of the specified psychoactive substance). \\nNote: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 149, 'page_label': '150'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   149 \\n \\n6C4E.72 Obsessive-compulsive or related disorder induced by other specified psychoactive \\nsubstance \\nObsessive-compulsive or related disorder induced by other specified psychoacti ve \\nsubstance is characterized by either repetitive intrusive thoughts or preoccupat ions, \\nnormally associated with anxiety and typically accompanied by repetitive behaviours'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 149, 'page_label': '150'}, page_content='performed in response, or by recurrent and habitual actions directed at the \\nintegument (e.g., hair pulling, skin picking) that develop during or soon after \\nintoxication with or withdrawal from a specified psychoactive substance. The  \\nintensity or duration of the symptoms is substantially in excess of analogo us \\ndisturbances that are characteristic of intoxication with or withdrawal from the \\nspecified psychoactive substance. The amount and duration of the specified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 149, 'page_label': '150'}, page_content='psychoactive substance use must be capable of producing obsessive-compulsive or \\nrelated symptoms. The symptoms are not better explained by a primary mental \\ndisorder (in particular an Obsessive-compulsive or related disorder), as might be the \\ncase if the symptoms preceded the onset of the specified psychoactive substance \\nuse, if the symptoms persist for a substantial period of time after cessation of use or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 149, 'page_label': '150'}, page_content='withdrawal of the specified psychoactive substance, or if there is other evidence of a \\npre-existing primary mental disorder with obsessive-compulsive or related \\nsymptoms (e.g., a history of prior episodes not associated with specified \\npsychoactive substance use). \\nNote: Code also the underlying condition \\n \\n6C4E.73 Impulse control disorder induced by other specified psychoactive substance  \\nImpulse control disorder induced by other specified psychoactive substance is'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 149, 'page_label': '150'}, page_content='characterized by persistently repeated behaviours in which there is rec urrent failure \\nto resist an impulse, drive, or urge to perform an act that is rewarding to the person, \\nat least in the short-term, despite longer-term harm either to the individual or to \\nothers (e.g., fire setting or stealing without apparent motive, repetitive sexual  \\nbehaviour, aggressive outbursts) that develop during or soon after intoxication with'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 149, 'page_label': '150'}, page_content='or withdrawal from a specified psychoactive substance. The intensity or duration of \\nthe symptoms is substantially in excess of disturbances of impulse control that are \\ncharacteristic of intoxication with or withdrawal from the specified psycho active \\nsubstance. The amount and duration of the specified psychoactive substance u se \\nmust be capable of producing disturbances of impulse control. The symptoms ar e'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 149, 'page_label': '150'}, page_content='not better explained by a primary mental disorder (e.g., an Impulse control disorder , \\na Disorder due to addictive behaviours), as might be the case if the impul se control \\ndisturbances preceded the onset of the specified psychoactive substance use, if  the \\nsymptoms persist for a substantial period of time after cessation of use or \\nwithdrawal of the specified psychoactive substance, or if there is other evidence o f a'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 149, 'page_label': '150'}, page_content='pre-existing primary mental disorder with impulse control symptoms (e.g., a histor y \\nof prior episodes not associated with specified psychoactive substance use). \\nNote: Code also the underlying condition \\n \\n6C4E.Y Other specified disorders due to use of other specified psychoactive \\nsubstances, including medications \\nNote: Code also the underlying condition \\n \\n6C4E.Z Disorders due to use of other specified psychoactive substances, including \\nmedications, unspecified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 149, 'page_label': '150'}, page_content='Note: Code also the underlying condition'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 150, 'page_label': '151'}, page_content='150  ICD-11 MMS - 2018 \\n \\n  6C4F   Disorders due to use of multiple specified psychoactive substances, \\nincluding medications \\nDisorders due to use of multiple specified psychoactive substances, including \\nmedications are characterised by the pattern and consequences of multiple \\nspecified psychoactive substance use. In addition to Intoxication due to multipl e \\nspecified psychoactive substances, multiple specified substances have'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 150, 'page_label': '151'}, page_content='dependence-inducing properties, resulting in Multiple specified psychoactiv e \\nsubstances dependence in some people and Multiple specified psychoactive \\nsubstances withdrawal when use is reduced or discontinued. Multiple specified  \\npsychoactive substances are implicated in a wide range of harms affecting most \\norgans and systems of the body, which may be classified as Single episode  of \\nharmful use of multiple specified psychoactive substances and Harmful patt ern of'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 150, 'page_label': '151'}, page_content='use of multiple specified psychoactive substances. Harm to others resulting fro m \\nbehaviour during Intoxication due to multiple specified psychoactive substan ces is \\nincluded in the definitions of Harmful use of multiple specified psychoac tive \\nsubstances. Several multiple specified psychoactive substances-induced ment al \\ndisorders are recognised. \\nNote: Code also the underlying condition \\n \\n6C4F.0 Single episode of harmful use of multiple specified psychoactive substances'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 150, 'page_label': '151'}, page_content='A single episode of use of multiple specified psychoactive substances or \\nmedications that are not included in the other substance classes specifically  \\nidentified under Disorder Due to Substance Use that has caused damage to a \\nperson’s physical or mental health or has resulted in behaviour leading to harm to \\nthe health of others. Harm to health of the individual occurs due to one or more of \\nthe following: (1) behaviour related to multiple substance intoxication or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 150, 'page_label': '151'}, page_content='psychoactive medication use (2) direct or secondary toxic effects on body organs  \\nand systems; or (3) a harmful route of administration. Harm to health of others \\nincludes any form of physical harm, including trauma, or mental disorder that is \\ndirectly attributable to behavior due to multiple substance intoxication or \\npsychoactive medication use on the part of the person to whom the diagnosis of \\nsingle episode of harmful use of multiple specified psychoactive substances appli es.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 150, 'page_label': '151'}, page_content='This diagnosis should not be made if the harm is attributed to a known pattern  of \\nuse of the multiple psychoactive substances. \\nExclusions: Harmful pattern of use of multiple specified psychoactive \\nsubstances (6C4F.1) \\nMultiple specified psychoactive substances dependence \\n(6C4F.2)'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 151, 'page_label': '152'}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   151 \\n \\n6C4F.1 Harmful pattern of use of multiple specified psychoactive substances  \\nA pattern of use of a multiple specified psychoactive substances or medications that \\nare not included in the other substance classes specifically identified under \\nDisorders Due to Substance Use that has caused damage to a person ’s physical or'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 151, 'page_label': '152'}, page_content='mental health or has resulted in behaviour leading to harm to the health of other s. \\nThe pattern of substance use is evident over a period of at least 12 months i f use is \\nepisodic or at least one month if use is continuous (i.e., daily or almost dail y). Harm \\nto health of the individual occurs due to one or more of the following: (1) beha viour \\nrelated to multiple substance intoxication or psychoactive medication use; (2) direc t'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 151, 'page_label': '152'}, page_content='or secondary toxic effects on body organs and systems; or (3) a harmful route of  \\nadministration. Harm to health of others includes any form of physical harm, \\nincluding trauma, or mental disorder that is directly attributable to behaviour rel ated \\nto multiple substance intoxication or psychoactive medication use on the part of the \\nperson to whom the diagnosis of Harmful pattern of use of multiple specified \\npsychoactive substances applies.'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 151, 'page_label': '152'}, page_content='Exclusions: Single episode of harmful use of multiple specified \\npsychoactive substances (6C4F.0) \\nMultiple specified psychoactive substances dependence \\n(6C4F.2) \\n \\n6C4F.10 Harmful pattern of use of multiple specified psychoactive substances, episodic  \\nA pattern of episodic or intermittent use of a specified psychoactive substance or \\nmedication that is not included in the other substance classes specificall y identified'),\n",
       " Document(metadata={'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'creationdate': '2018-06-19T19:04:48-05:00', 'author': 'World Health Organisation', 'moddate': '2020-02-17T16:56:39+05:00', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'source': 'Data\\\\Diagnostic_233.pdf', 'total_pages': 233, 'page': 151, 'page_label': '152'}, page_content='under Disorders Due to Substance Use that has caused damage to a person ’s \\nphysical or mental health or has resulted in behaviour leading to harm  to the health \\nof others. The pattern of episodic substance use is evident over a period of at lea st \\n12 months. Harm to health of the individual occurs due to one or more of the \\nfollowing: (1) behaviour related to intoxication; (2) direct or secondary toxic effec ts \\non body organs and systems; or (3) a harmful route of administration. Harm to'),\n",
       " ...]"
      ]
     },
     "execution_count": 9,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# print the text chunks\n",
    "text_chunks"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "id": "b0c9ff73",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Download the embeddings model from hugging face\n",
    "from langchain.embeddings import HuggingFaceEmbeddings\n",
    "def download_hugging_face_embeddings():\n",
    "    embeddings = HuggingFaceEmbeddings(model_name = 'sentence-transformers/all-MiniLM-L6-v2')\n",
    "    return embeddings"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {},
   "outputs": [
    {
     "name": "stderr",
     "output_type": "stream",
     "text": [
      "C:\\Users\\ajaym\\AppData\\Local\\Temp\\ipykernel_11240\\2473295128.py:4: LangChainDeprecationWarning: The class `HuggingFaceEmbeddings` was deprecated in LangChain 0.2.2 and will be removed in 1.0. An updated version of the class exists in the :class:`~langchain-huggingface package and should be used instead. To use it run `pip install -U :class:`~langchain-huggingface` and import as `from :class:`~langchain_huggingface import HuggingFaceEmbeddings``.\n",
      "  embeddings = HuggingFaceEmbeddings(model_name = 'sentence-transformers/all-MiniLM-L6-v2')\n",
      "d:\\PRACTICE ON PYTHON\\GenerativeAI practice & projects\\GenAI_End_To_End_Medical_Chatbot\\.venv\\lib\\site-packages\\tqdm\\auto.py:21: TqdmWarning: IProgress not found. Please update jupyter and ipywidgets. See https://ipywidgets.readthedocs.io/en/stable/user_install.html\n",
      "  from .autonotebook import tqdm as notebook_tqdm\n",
      "d:\\PRACTICE ON PYTHON\\GenerativeAI practice & projects\\GenAI_End_To_End_Medical_Chatbot\\.venv\\lib\\site-packages\\huggingface_hub\\file_download.py:143: UserWarning: `huggingface_hub` cache-system uses symlinks by default to efficiently store duplicated files but your machine does not support them in C:\\Users\\ajaym\\.cache\\huggingface\\hub\\models--sentence-transformers--all-MiniLM-L6-v2. Caching files will still work but in a degraded version that might require more space on your disk. This warning can be disabled by setting the `HF_HUB_DISABLE_SYMLINKS_WARNING` environment variable. For more details, see https://huggingface.co/docs/huggingface_hub/how-to-cache#limitations.\n",
      "To support symlinks on Windows, you either need to activate Developer Mode or to run Python as an administrator. In order to activate developer mode, see this article: https://docs.microsoft.com/en-us/windows/apps/get-started/enable-your-device-for-development\n",
      "  warnings.warn(message)\n",
      "Xet Storage is enabled for this repo, but the 'hf_xet' package is not installed. Falling back to regular HTTP download. For better performance, install the package with: `pip install huggingface_hub[hf_xet]` or `pip install hf_xet`\n"
     ]
    }
   ],
   "source": [
    "# Download the models\n",
    "embeddings = download_hugging_face_embeddings()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "id": "5adce326",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "Length 384\n",
      "The complete vector of 'hello world' is :\n"
     ]
    },
    {
     "data": {
      "text/plain": [
       "[-0.03447727486491203,\n",
       " 0.03102317824959755,\n",
       " 0.006734970025718212,\n",
       " 0.026108985766768456,\n",
       " -0.03936202451586723,\n",
       " -0.16030244529247284,\n",
       " 0.06692401319742203,\n",
       " -0.006441489793360233,\n",
       " -0.0474504791200161,\n",
       " 0.014758856035768986,\n",
       " 0.07087527960538864,\n",
       " 0.05552763119339943,\n",
       " 0.019193334504961967,\n",
       " -0.026251312345266342,\n",
       " -0.01010954286903143,\n",
       " -0.02694045566022396,\n",
       " 0.022307461127638817,\n",
       " -0.022226648405194283,\n",
       " -0.14969263970851898,\n",
       " -0.017493007704615593,\n",
       " 0.00767625542357564,\n",
       " 0.05435224249958992,\n",
       " 0.0032543970737606287,\n",
       " 0.031725890934467316,\n",
       " -0.0846213847398758,\n",
       " -0.02940601296722889,\n",
       " 0.05159561336040497,\n",
       " 0.04812406003475189,\n",
       " -0.0033148222137242556,\n",
       " -0.058279167860746384,\n",
       " 0.04196927323937416,\n",
       " 0.022210685536265373,\n",
       " 0.1281888335943222,\n",
       " -0.022338971495628357,\n",
       " -0.011656315997242928,\n",
       " 0.06292839348316193,\n",
       " -0.032876335084438324,\n",
       " -0.09122604131698608,\n",
       " -0.031175347045063972,\n",
       " 0.0526994913816452,\n",
       " 0.04703482985496521,\n",
       " -0.08420311659574509,\n",
       " -0.030056199058890343,\n",
       " -0.02074483036994934,\n",
       " 0.009517835453152657,\n",
       " -0.0037217906210571527,\n",
       " 0.007343285251408815,\n",
       " 0.03932438790798187,\n",
       " 0.0932740643620491,\n",
       " -0.003788596484810114,\n",
       " -0.052742067724466324,\n",
       " -0.05805816128849983,\n",
       " -0.006864361464977264,\n",
       " 0.005283191800117493,\n",
       " 0.0828929990530014,\n",
       " 0.019362755119800568,\n",
       " 0.0062844837084412575,\n",
       " -0.010330787859857082,\n",
       " 0.009032378904521465,\n",
       " -0.037683695554733276,\n",
       " -0.04520607739686966,\n",
       " 0.024016305804252625,\n",
       " -0.006944137159734964,\n",
       " 0.013491630554199219,\n",
       " 0.10005494207143784,\n",
       " -0.07168391346931458,\n",
       " -0.021695120260119438,\n",
       " 0.031618405133485794,\n",
       " -0.051634665578603745,\n",
       " -0.08224772661924362,\n",
       " -0.06569333374500275,\n",
       " -0.00989533495157957,\n",
       " 0.005816374905407429,\n",
       " 0.07355456054210663,\n",
       " -0.034050311893224716,\n",
       " 0.0248861201107502,\n",
       " 0.014488042332231998,\n",
       " 0.02645738422870636,\n",
       " 0.009656722657382488,\n",
       " 0.0302172489464283,\n",
       " 0.05280393362045288,\n",
       " -0.07535984367132187,\n",
       " 0.009897145442664623,\n",
       " 0.029836809262633324,\n",
       " 0.01755557768046856,\n",
       " 0.023091984912753105,\n",
       " 0.001933806692250073,\n",
       " 0.0014002545503899455,\n",
       " -0.04717595875263214,\n",
       " -0.011194315738976002,\n",
       " -0.11420144140720367,\n",
       " -0.019811924546957016,\n",
       " 0.040266189724206924,\n",
       " 0.0021929906215518713,\n",
       " -0.07979220896959305,\n",
       " -0.02538231760263443,\n",
       " 0.09448299556970596,\n",
       " -0.02898104302585125,\n",
       " -0.14500252902507782,\n",
       " 0.23097744584083557,\n",
       " 0.027731187641620636,\n",
       " 0.03211146965622902,\n",
       " 0.03106505796313286,\n",
       " 0.04283284768462181,\n",
       " 0.06423777341842651,\n",
       " 0.03216316178441048,\n",
       " -0.004876770544797182,\n",
       " 0.055699463933706284,\n",
       " -0.03753238171339035,\n",
       " -0.02150554023683071,\n",
       " -0.028342634439468384,\n",
       " -0.028846951201558113,\n",
       " 0.0383530892431736,\n",
       " -0.017468664795160294,\n",
       " 0.052485305815935135,\n",
       " -0.07487601786851883,\n",
       " -0.03125976398587227,\n",
       " 0.021841565147042274,\n",
       " -0.03989570587873459,\n",
       " -0.008587091229856014,\n",
       " 0.026956576853990555,\n",
       " -0.04849553853273392,\n",
       " 0.011469882912933826,\n",
       " 0.02961820363998413,\n",
       " -0.02057218924164772,\n",
       " 0.013103843666613102,\n",
       " 0.028833510354161263,\n",
       " -3.1941990848222185e-33,\n",
       " 0.06478213518857956,\n",
       " -0.018130183219909668,\n",
       " 0.051789961755275726,\n",
       " 0.12198275327682495,\n",
       " 0.028780106455087662,\n",
       " 0.008721951395273209,\n",
       " -0.07052119821310043,\n",
       " -0.016907278448343277,\n",
       " 0.04073973000049591,\n",
       " 0.042116157710552216,\n",
       " 0.025447236374020576,\n",
       " 0.03574628755450249,\n",
       " -0.04914471507072449,\n",
       " 0.0021290204022079706,\n",
       " -0.015546582639217377,\n",
       " 0.050730545073747635,\n",
       " -0.0481853261590004,\n",
       " 0.03588061034679413,\n",
       " -0.0040670474991202354,\n",
       " 0.10172472149133682,\n",
       " -0.05597002059221268,\n",
       " -0.010681048966944218,\n",
       " 0.01123578567057848,\n",
       " 0.09068653732538223,\n",
       " 0.004234451334923506,\n",
       " 0.035138655453920364,\n",
       " -0.009702847339212894,\n",
       " -0.09386517852544785,\n",
       " 0.0928555428981781,\n",
       " 0.008004927076399326,\n",
       " -0.007705425377935171,\n",
       " -0.05208674445748329,\n",
       " -0.012587991543114185,\n",
       " 0.0032669377978891134,\n",
       " 0.006013509817421436,\n",
       " 0.007581559009850025,\n",
       " 0.01051718182861805,\n",
       " -0.08634556829929352,\n",
       " -0.06987880170345306,\n",
       " -0.0025338928680866957,\n",
       " -0.09097658842802048,\n",
       " 0.04688733071088791,\n",
       " 0.052076540887355804,\n",
       " 0.007193844299763441,\n",
       " 0.010903622955083847,\n",
       " -0.0052295587956905365,\n",
       " 0.013937311246991158,\n",
       " 0.021968349814414978,\n",
       " 0.03420866280794144,\n",
       " 0.060224682092666626,\n",
       " 0.00011665470083244145,\n",
       " 0.014731976203620434,\n",
       " -0.07008926570415497,\n",
       " 0.028499048203229904,\n",
       " -0.02760172076523304,\n",
       " 0.010768445208668709,\n",
       " 0.034830961376428604,\n",
       " -0.02248787134885788,\n",
       " 0.009769017808139324,\n",
       " 0.07722785323858261,\n",
       " 0.021588314324617386,\n",
       " 0.11495620757341385,\n",
       " -0.0680011734366417,\n",
       " 0.02376098558306694,\n",
       " -0.0159839428961277,\n",
       " -0.0178269911557436,\n",
       " 0.06439495831727982,\n",
       " 0.032025739550590515,\n",
       " 0.05027025192975998,\n",
       " -0.005913770757615566,\n",
       " -0.03370805084705353,\n",
       " 0.017840256914496422,\n",
       " 0.016573317348957062,\n",
       " 0.06329657882452011,\n",
       " 0.03467721864581108,\n",
       " 0.046473488211631775,\n",
       " 0.09790610522031784,\n",
       " -0.00663550291210413,\n",
       " 0.02520712837576866,\n",
       " -0.07798824459314346,\n",
       " 0.0169264767318964,\n",
       " -0.000945797364693135,\n",
       " 0.022471921518445015,\n",
       " -0.038253191858530045,\n",
       " 0.09570474177598953,\n",
       " -0.005350803025066853,\n",
       " 0.010469110682606697,\n",
       " -0.11524055153131485,\n",
       " -0.013262521475553513,\n",
       " -0.010709455236792564,\n",
       " -0.08311725407838821,\n",
       " 0.07327353954315186,\n",
       " 0.04939225688576698,\n",
       " -0.008994322270154953,\n",
       " -0.09584552049636841,\n",
       " 3.3661485617505796e-33,\n",
       " 0.12493184208869934,\n",
       " 0.01934972032904625,\n",
       " -0.05822571739554405,\n",
       " -0.03598826378583908,\n",
       " -0.05074676498770714,\n",
       " -0.04566238448023796,\n",
       " -0.08260336518287659,\n",
       " 0.1481948047876358,\n",
       " -0.08842118829488754,\n",
       " 0.06027443706989288,\n",
       " 0.05103015899658203,\n",
       " 0.01030314713716507,\n",
       " 0.14121422171592712,\n",
       " 0.03081384487450123,\n",
       " 0.061033159494400024,\n",
       " -0.052851270884275436,\n",
       " 0.1366489678621292,\n",
       " 0.00918989721685648,\n",
       " -0.01732518896460533,\n",
       " -0.012848555110394955,\n",
       " -0.007995282299816608,\n",
       " -0.0509800985455513,\n",
       " -0.05235064774751663,\n",
       " 0.007593012880533934,\n",
       " -0.015166307799518108,\n",
       " 0.01696030981838703,\n",
       " 0.021270520985126495,\n",
       " 0.020558107644319534,\n",
       " -0.12002813816070557,\n",
       " 0.014461833983659744,\n",
       " 0.02675991877913475,\n",
       " 0.025330696254968643,\n",
       " -0.0427546352148056,\n",
       " 0.006768387276679277,\n",
       " -0.01445858459919691,\n",
       " 0.04526195675134659,\n",
       " -0.09147648513317108,\n",
       " -0.019439145922660828,\n",
       " -0.017833467572927475,\n",
       " -0.05491018295288086,\n",
       " -0.052641112357378006,\n",
       " -0.010459048673510551,\n",
       " -0.052016086876392365,\n",
       " 0.020891955122351646,\n",
       " -0.07997036725282669,\n",
       " -0.012111340649425983,\n",
       " -0.05773142725229263,\n",
       " 0.023178234696388245,\n",
       " -0.008031732402741909,\n",
       " -0.02598930336534977,\n",
       " -0.07995671033859253,\n",
       " -0.020728832110762596,\n",
       " 0.048817697912454605,\n",
       " -0.020389137789607048,\n",
       " -0.04917657747864723,\n",
       " 0.014159622602164745,\n",
       " -0.06362202018499374,\n",
       " -0.007807393092662096,\n",
       " 0.01643155701458454,\n",
       " -0.0256824791431427,\n",
       " 0.013381040655076504,\n",
       " 0.026248741894960403,\n",
       " 0.009978413581848145,\n",
       " 0.06322886794805527,\n",
       " 0.002672201255336404,\n",
       " -0.006582767236977816,\n",
       " 0.01663188263773918,\n",
       " 0.03236646577715874,\n",
       " 0.03794245794415474,\n",
       " -0.036376070231199265,\n",
       " -0.006910930387675762,\n",
       " 0.0001596928050275892,\n",
       " -0.0016335808904841542,\n",
       " -0.02727821283042431,\n",
       " -0.02803807333111763,\n",
       " 0.049681417644023895,\n",
       " -0.028867173939943314,\n",
       " -0.0024180689360946417,\n",
       " 0.014774908311665058,\n",
       " 0.009764534421265125,\n",
       " 0.005797638092190027,\n",
       " 0.013486160896718502,\n",
       " 0.0055678957141935825,\n",
       " 0.03722710534930229,\n",
       " 0.007232527248561382,\n",
       " 0.04015626385807991,\n",
       " 0.08150326460599899,\n",
       " 0.07199167460203171,\n",
       " -0.013056126423180103,\n",
       " -0.0428820475935936,\n",
       " -0.01101123820990324,\n",
       " 0.004897820297628641,\n",
       " -0.009229730814695358,\n",
       " 0.035191506147384644,\n",
       " -0.05103502422571182,\n",
       " -1.571437557856825e-08,\n",
       " -0.08862441033124924,\n",
       " 0.02390925958752632,\n",
       " -0.01623876392841339,\n",
       " 0.031700510531663895,\n",
       " 0.027284247800707817,\n",
       " 0.05246882885694504,\n",
       " -0.047070957720279694,\n",
       " -0.058847445994615555,\n",
       " -0.06320822983980179,\n",
       " 0.04088849574327469,\n",
       " 0.04982800409197807,\n",
       " 0.10655171424150467,\n",
       " -0.07450230419635773,\n",
       " -0.012495421804487705,\n",
       " 0.01837071217596531,\n",
       " 0.03947412595152855,\n",
       " -0.024797886610031128,\n",
       " 0.014516262337565422,\n",
       " -0.03706921637058258,\n",
       " 0.02001572772860527,\n",
       " -4.85817035951186e-05,\n",
       " 0.00986657664179802,\n",
       " 0.024838753044605255,\n",
       " -0.05245814099907875,\n",
       " 0.029314178973436356,\n",
       " -0.08719190955162048,\n",
       " -0.01449968758970499,\n",
       " 0.026019077748060226,\n",
       " -0.01874636672437191,\n",
       " -0.07620512694120407,\n",
       " 0.03504333272576332,\n",
       " 0.10363949835300446,\n",
       " -0.028050510212779045,\n",
       " 0.012718182988464832,\n",
       " -0.07632549107074738,\n",
       " -0.01865232177078724,\n",
       " 0.02497672848403454,\n",
       " 0.0814453512430191,\n",
       " 0.06875883787870407,\n",
       " -0.0640566498041153,\n",
       " -0.08389385789632797,\n",
       " 0.06136231869459152,\n",
       " -0.033545564860105515,\n",
       " -0.10615336894989014,\n",
       " -0.040080588310956955,\n",
       " 0.032530225813388824,\n",
       " 0.07662483304738998,\n",
       " -0.0730162113904953,\n",
       " 0.00033755265758372843,\n",
       " -0.040871646255254745,\n",
       " -0.0757884755730629,\n",
       " 0.027527665719389915,\n",
       " 0.07462543249130249,\n",
       " 0.01771726831793785,\n",
       " 0.09121846407651901,\n",
       " 0.11022016406059265,\n",
       " 0.0005697731394320726,\n",
       " 0.05146336182951927,\n",
       " -0.014551310800015926,\n",
       " 0.03323203697800636,\n",
       " 0.023792240768671036,\n",
       " -0.02288980595767498,\n",
       " 0.038937538862228394,\n",
       " 0.030206844210624695]"
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Now lets test the model whether it is able to convert my sentence to vector embeddings so for this I have given one sentence here - \"hello world\" and there is a function called embed query so it will automatically give the vector embeddings ans I'm also checking the length whether it is giving me 384 dimensional vector. \n",
    "\n",
    "query_result = embeddings.embed_query(\"Hello world\")\n",
    "print(\"Length\", len(query_result))\n",
    "\n",
    "# Lets me show the complete vector \n",
    "print(\"The complete vector of 'hello world' is :\")\n",
    "query_result"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Now i have to intialize my pinecone, Inside pinecone i have to do store the vectors.\n",
    "# For vector store in pinecone, please log in pinecone and create an Index - that means i have to create a cluster,   in that cluster actually i'll be saving my vector.\n",
    "\n",
    "# Now create the api key of pinecone and mention it in .env file.\n",
    "# Now create a cluster by pinecone/database in  384 dimensional"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "270f237e",
   "metadata": {},
   "source": [
    "# Now I'll be creating the pinecone indexing by python code."
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 26,
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "✅ Pinecone index created successfully.\n"
     ]
    }
   ],
   "source": [
    "from pinecone.grpc import PineconeGRPC as Pinecone\n",
    "from pinecone import ServerlessSpec\n",
    "import os\n",
    "from dotenv import load_dotenv\n",
    "\n",
    "# Load environment variables\n",
    "load_dotenv()\n",
    "PINECONE_API_KEY = os.environ.get(\"PINECONE_API_KEY\")\n",
    "\n",
    "# Initialize Pinecone\n",
    "pc = Pinecone(api_key=PINECONE_API_KEY)\n",
    "\n",
    "# ✅ Use valid lowercase name\n",
    "index_name = \"medical-bot\"\n",
    "\n",
    "# Create index\n",
    "pc.create_index(\n",
    "    name=index_name,\n",
    "    dimension=384,\n",
    "    metric=\"cosine\",\n",
    "    spec=ServerlessSpec(\n",
    "        cloud=\"aws\",\n",
    "        region=\"us-east-1\"\n",
    "    )\n",
    ")\n",
    "\n",
    "print(\"✅ Pinecone index created successfully.\")\n"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Now we want to convert our chunks to vector embeddings and store it inside the pinecone vector database\n",
    "# NOw first of all set the pinecode api as an your environment variable\n",
    "\n",
    "import os\n",
    "os.environ['PINECONE_API_KEY'] = PINECONE_API_KEY"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {},
   "outputs": [],
   "source": [
    "# To store the vector embeddings embed each chunk and upsert the embeddings in your pinecone index.\n",
    "from langchain_pinecone import PineconeVectorStore\n",
    "\n",
    "docsearch = PineconeVectorStore.from_documents(\n",
    "                                                documents= text_chunks,\n",
    "                                                index_name = index_name,\n",
    "                                                embedding= embeddings\n",
    "                                              )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 30,
   "id": "2d0699e0",
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<langchain_pinecone.vectorstores.PineconeVectorStore at 0x16ecc757be0>"
      ]
     },
     "execution_count": 30,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Now load Existing index\n",
    "from langchain_pinecone import PineconeVectorStore\n",
    "docsearch = PineconeVectorStore.from_existing_index(\n",
    "                                                        index_name= index_name,\n",
    "                                                        embedding=embeddings\n",
    "                                                     )\n",
    "\n",
    "# print the docs search \n",
    "docsearch"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {},
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[Document(id='2278c47e-db55-4c42-96db-f3d572b6607d', metadata={'author': 'World Health Organisation', 'creationdate': '2018-06-19T19:04:48-05:00', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'moddate': '2020-02-17T16:56:39+05:00', 'page': 46.0, 'page_label': '47', 'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'source': 'Data\\\\Diagnostic_233.pdf', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'total_pages': 233.0}, page_content='habitual actions directed at the integument (e.g. hair-pulling, skin-picking , lip-biting), \\ntypically accompanied by unsuccessful attempts to decrease or stop the behavi our \\ninvolved, and which lead to dermatological sequelae (e.g., hair loss, sk in lesions, lip \\nabrasions). The behaviour may occur in brief episodes scattered throughout the day \\nor in less frequent but more sustained periods. The symptoms result in signific ant'),\n",
       " Document(id='aebe3b7e-ed5f-443a-921f-63eb07b731b2', metadata={'author': 'World Health Organisation', 'creationdate': '2018-06-19T19:04:48-05:00', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'moddate': '2020-02-17T16:56:39+05:00', 'page': 56.0, 'page_label': '57', 'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'source': 'Data\\\\Diagnostic_233.pdf', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'total_pages': 233.0}, page_content='characterized by experiencing the self as strange or unreal, or feeling detach ed \\nfrom, or as though one were an outside observer of, one ’s thoughts, feelings, \\nsensations, body, or actions. Derealization is characterized by experiencing othe r \\npersons, objects, or the world as strange or unreal (e.g., dreamlike, distant, foggy, \\nlifeless, colorless, or visually distorted) or feeling detached from one ’s surroundings.'),\n",
       " Document(id='6f072a79-eb10-4013-83b7-e64bde9b2cd6', metadata={'author': 'World Health Organisation', 'creationdate': '2018-06-19T19:04:48-05:00', 'creator': 'calibre (4.10.1) [https://calibre-ebook.com]', 'moddate': '2020-02-17T16:56:39+05:00', 'page': 47.0, 'page_label': '48', 'producer': 'calibre (4.10.1) [https://calibre-ebook.com]', 'source': 'Data\\\\Diagnostic_233.pdf', 'title': 'The ICD-11 Classification of Mental and Behavioural Disorders', 'total_pages': 233.0}, page_content='INTERNATIONAL CLASSIFICATION OF DISEASES - Mortality and Morbidity Statistics \\nICD-11 MMS - 2018   47 \\n \\n6B25.1 Excoriation disorder \\nExcoriation disorder is characterized by recurrent picking of one ’s own skin leading \\nto skin lesions, accompanied by unsuccessful attempts to decrease or stop the  \\nbehaviour. The most commonly picked sites are the face, arms and hands, but \\nmany individuals pick from multiple body sites. Skin picking may  occur in brief')]"
      ]
     },
     "execution_count": 31,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "# Now you can also perform the retrieve operation here that you can perform the similarity search \n",
    "retriever = docsearch.as_retriever(search_type = 'similarity', search_kwargs = {\"k\" : 3})\n",
    "\n",
    "# Now i will ask one question\n",
    "\n",
    "retriever_docs = retriever.invoke('What is Acne?') \n",
    "retriever_docs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 33,
   "id": "811c9c36",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Now if we need complete proper answer and definition of the question, then we need to integrate my LLM.\n",
    "from dotenv import load_dotenv\n",
    "load_dotenv()\n",
    "OPENAI_API_KEY = os.getenv('OPENAI_API_KEY')\n",
    "from langchain_openai import OpenAI\n",
    "llm = OpenAI(temperature= 0.4, max_tokens= 500)"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "3c638da0",
   "metadata": {},
   "source": [
    "# Now We have to create complete chain for this|"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "id": "b1759af3",
   "metadata": {},
   "outputs": [],
   "source": [
    "# Now import some necessary library\n",
    "from langchain.chains import create_retrieval_chain\n",
    "from langchain.chains.combine_documents import create_stuff_documents_chain\n",
    "from langchain.prompts import ChatPromptTemplate\n",
    "\n",
    "system_prompt = (\n",
    "                    \"You are an assistant for question-answering tasks.\"\n",
    "                    \"Use the following pieces of retrieved context to answer the question.\"\n",
    "                    \"If you don't know the answer, say that you don't know.\"\n",
    "                    \"USe three sentences maximum and keep the answer concise.\"\n",
    "                    \"\\n\\n\"\n",
    "                    \"{context}\"\n",
    "                )\n",
    "\n",
    "prompt = ChatPromptTemplate.from_messages(\n",
    "                                            [\n",
    "                                                (\"system\", system_prompt),\n",
    "                                                (\"human\",\"{input}\")\n",
    "                                            ]\n",
    "                                         )"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 37,
   "metadata": {},
   "outputs": [],
   "source": [
    "# Now create the chain \n",
    "question_answer_chain = create_stuff_documents_chain(llm, prompt)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 38,
   "id": "5b4579b1",
   "metadata": {},
   "outputs": [],
   "source": [
    "#\n",
    "rag_chain = create_retrieval_chain(retriever, question_answer_chain)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 39,
   "id": "51cb9218",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "Acne is a skin condition characterized by recurrent picking of one's own skin, leading to skin lesions and unsuccessful attempts to stop the behavior. It can occur in brief episodes throughout the day or in sustained periods. It is classified as excoriation disorder in the International Classification of Diseases.\n"
     ]
    }
   ],
   "source": [
    "# ask the question\n",
    "response = rag_chain.invoke({\"input\" :\"what is acne?\"})\n",
    "print(response['answer'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "id": "acf0708a",
   "metadata": {},
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "\n",
      "\n",
      "I don't know the answer to that question.\n"
     ]
    }
   ],
   "source": [
    "# If you giving the other question which is not relevant about the pdf \n",
    "response = rag_chain.invoke({\"input\" :\"what is photoshop?\"})\n",
    "print(response['answer'])"
   ]
  },
  {
   "cell_type": "markdown",
   "id": "82529c52",
   "metadata": {},
   "source": [
    "# Now let's try convert this project as our end to end implementation that means we'll be also implementing the UI"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "id": "0e07bad9",
   "metadata": {},
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": ".venv",
   "language": "python",
   "name": "python3"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 3
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython3",
   "version": "3.10.9"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 5
}
